(()=>{var e={};e.id=974,e.ids=[974],e.modules={846:e=>{"use strict";e.exports=require("next/dist/compiled/next-server/app-page.runtime.prod.js")},9121:e=>{"use strict";e.exports=require("next/dist/server/app-render/action-async-storage.external.js")},3295:e=>{"use strict";e.exports=require("next/dist/server/app-render/after-task-async-storage.external.js")},9294:e=>{"use strict";e.exports=require("next/dist/server/app-render/work-async-storage.external.js")},3033:e=>{"use strict";e.exports=require("next/dist/server/app-render/work-unit-async-storage.external.js")},3873:e=>{"use strict";e.exports=require("path")},9551:e=>{"use strict";e.exports=require("url")},368:(e,n,t)=>{"use strict";t.r(n),t.d(n,{GlobalError:()=>r.a,__next_app__:()=>p,pages:()=>d,routeModule:()=>u,tree:()=>c});var i=t(4250),a=t(2525),o=t(1813),r=t.n(o),s=t(5658),l={};for(let e in s)0>["default","tree","pages","GlobalError","__next_app__","routeModule"].indexOf(e)&&(l[e]=()=>s[e]);t.d(n,l);let c=["",{children:["__PAGE__",{},{page:[()=>Promise.resolve().then(t.bind(t,3105)),"/home/ubuntu/ocmca_protocol_app/src/app/page.tsx"],metadata:{icon:[async e=>(await Promise.resolve().then(t.bind(t,8798))).default(e)],apple:[],openGraph:[],twitter:[],manifest:void 0}}]},{layout:[()=>Promise.resolve().then(t.bind(t,6026)),"/home/ubuntu/ocmca_protocol_app/src/app/layout.tsx"],"not-found":[()=>Promise.resolve().then(t.t.bind(t,6731,23)),"next/dist/client/components/not-found-error"],forbidden:[()=>Promise.resolve().then(t.t.bind(t,5430,23)),"next/dist/client/components/forbidden-error"],unauthorized:[()=>Promise.resolve().then(t.t.bind(t,4607,23)),"next/dist/client/components/unauthorized-error"],metadata:{icon:[async e=>(await Promise.resolve().then(t.bind(t,8798))).default(e)],apple:[],openGraph:[],twitter:[],manifest:void 0}}],d=["/home/ubuntu/ocmca_protocol_app/src/app/page.tsx"],p={require:t,loadChunk:()=>Promise.resolve()},u=new i.AppPageRouteModule({definition:{kind:a.RouteKind.APP_PAGE,page:"/page",pathname:"/",bundlePath:"",filename:"",appPaths:[]},userland:{loaderTree:c}})},6060:(e,n,t)=>{Promise.resolve().then(t.t.bind(t,7501,23)),Promise.resolve().then(t.t.bind(t,3709,23)),Promise.resolve().then(t.t.bind(t,1813,23)),Promise.resolve().then(t.t.bind(t,724,23)),Promise.resolve().then(t.t.bind(t,2908,23)),Promise.resolve().then(t.t.bind(t,9464,23)),Promise.resolve().then(t.t.bind(t,7647,23))},4204:(e,n,t)=>{Promise.resolve().then(t.t.bind(t,6689,23)),Promise.resolve().then(t.t.bind(t,3977,23)),Promise.resolve().then(t.t.bind(t,9281,23)),Promise.resolve().then(t.t.bind(t,864,23)),Promise.resolve().then(t.t.bind(t,3872,23)),Promise.resolve().then(t.t.bind(t,4900,23)),Promise.resolve().then(t.t.bind(t,4547,23))},7600:()=>{},6976:()=>{},7583:(e,n,t)=>{Promise.resolve().then(t.bind(t,3105))},5831:(e,n,t)=>{Promise.resolve().then(t.bind(t,4272))},6564:e=>{"use strict";let n="undefined"!=typeof Buffer,t=/"(?:_|\\u005[Ff])(?:_|\\u005[Ff])(?:p|\\u0070)(?:r|\\u0072)(?:o|\\u006[Ff])(?:t|\\u0074)(?:o|\\u006[Ff])(?:_|\\u005[Ff])(?:_|\\u005[Ff])"\s*:/,i=/"(?:c|\\u0063)(?:o|\\u006[Ff])(?:n|\\u006[Ee])(?:s|\\u0073)(?:t|\\u0074)(?:r|\\u0072)(?:u|\\u0075)(?:c|\\u0063)(?:t|\\u0074)(?:o|\\u006[Ff])(?:r|\\u0072)"\s*:/;function a(e,a,r){null==r&&null!==a&&"object"==typeof a&&(r=a,a=void 0),n&&Buffer.isBuffer(e)&&(e=e.toString()),e&&65279===e.charCodeAt(0)&&(e=e.slice(1));let s=JSON.parse(e,a);if(null===s||"object"!=typeof s)return s;let l=r&&r.protoAction||"error",c=r&&r.constructorAction||"error";if("ignore"===l&&"ignore"===c)return s;if("ignore"!==l&&"ignore"!==c){if(!1===t.test(e)&&!1===i.test(e))return s}else if("ignore"!==l&&"ignore"===c){if(!1===t.test(e))return s}else if(!1===i.test(e))return s;return o(s,{protoAction:l,constructorAction:c,safe:r&&r.safe})}function o(e,{protoAction:n="error",constructorAction:t="error",safe:i}={}){let a=[e];for(;a.length;){let e=a;for(let o of(a=[],e)){if("ignore"!==n&&Object.prototype.hasOwnProperty.call(o,"__proto__")){if(!0===i)return null;if("error"===n)throw SyntaxError("Object contains forbidden prototype property");delete o.__proto__}if("ignore"!==t&&Object.prototype.hasOwnProperty.call(o,"constructor")&&Object.prototype.hasOwnProperty.call(o.constructor,"prototype")){if(!0===i)return null;if("error"===t)throw SyntaxError("Object contains forbidden prototype property");delete o.constructor}for(let e in o){let n=o[e];n&&"object"==typeof n&&a.push(n)}}}return e}function r(e,n,t){let i=Error.stackTraceLimit;Error.stackTraceLimit=0;try{return a(e,n,t)}finally{Error.stackTraceLimit=i}}e.exports=r,e.exports.default=r,e.exports.parse=r,e.exports.safeParse=function(e,n){let t=Error.stackTraceLimit;Error.stackTraceLimit=0;try{return a(e,n,{safe:!0})}catch(e){return null}finally{Error.stackTraceLimit=t}},e.exports.scan=o},5004:e=>{e.exports=function(e,n){let t;if("function"!=typeof e)throw TypeError(`Expected the first argument to be a \`function\`, got \`${typeof e}\`.`);let i=0;return function(...a){clearTimeout(t);let o=Date.now(),r=n-(o-i);r<=0?(i=o,e.apply(this,a)):t=setTimeout(()=>{i=Date.now(),e.apply(this,a)},r)}}},4845:(e,n,t)=>{"use strict";var i=t(8111),a="function"==typeof Object.is?Object.is:function(e,n){return e===n&&(0!==e||1/e==1/n)||e!=e&&n!=n},o=i.useState,r=i.useEffect,s=i.useLayoutEffect,l=i.useDebugValue;function c(e){var n=e.getSnapshot;e=e.value;try{var t=n();return!a(e,t)}catch(e){return!0}}var d="undefined"==typeof window||void 0===window.document||void 0===window.document.createElement?function(e,n){return n()}:function(e,n){var t=n(),i=o({inst:{value:t,getSnapshot:n}}),a=i[0].inst,d=i[1];return s(function(){a.value=t,a.getSnapshot=n,c(a)&&d({inst:a})},[e,t,n]),r(function(){return c(a)&&d({inst:a}),e(function(){c(a)&&d({inst:a})})},[e]),l(t),t};n.useSyncExternalStore=void 0!==i.useSyncExternalStore?i.useSyncExternalStore:d},6176:(e,n,t)=>{"use strict";e.exports=t(4845)},4272:(e,n,t)=>{"use strict";let i;t.r(n),t.d(n,{default:()=>s2});var a,o,r,s,l,c,d,p=t(8910),u=t(8111),h=t.t(u,2),m="vercel.ai.error",f=Symbol.for(m),g=class e extends Error{constructor({name:e,message:n,cause:t}){super(n),this[o]=!0,this.name=e,this.cause=t}static isInstance(n){return e.hasMarker(n,m)}static hasMarker(e,n){let t=Symbol.for(n);return null!=e&&"object"==typeof e&&t in e&&"boolean"==typeof e[t]&&!0===e[t]}};o=f;var y=g;function b(e){return null==e?"unknown error":"string"==typeof e?e:e instanceof Error?e.message:JSON.stringify(e)}Symbol.for("vercel.ai.error.AI_APICallError"),Symbol.for("vercel.ai.error.AI_EmptyResponseBodyError");var v="AI_InvalidArgumentError",A=`vercel.ai.error.${v}`,C=Symbol.for(A),w=class extends y{constructor({message:e,cause:n,argument:t}){super({name:v,message:e,cause:n}),this[r]=!0,this.argument=t}static isInstance(e){return y.hasMarker(e,A)}};r=C,Symbol.for("vercel.ai.error.AI_InvalidPromptError"),Symbol.for("vercel.ai.error.AI_InvalidResponseDataError");var S="AI_JSONParseError",_=`vercel.ai.error.${S}`,E=Symbol.for(_),M=class extends y{constructor({text:e,cause:n}){super({name:S,message:`JSON parsing failed: Text: ${e}.
Error message: ${b(n)}`,cause:n}),this[s]=!0,this.text=e}static isInstance(e){return y.hasMarker(e,_)}};s=E,Symbol.for("vercel.ai.error.AI_LoadAPIKeyError"),Symbol.for("vercel.ai.error.AI_LoadSettingError"),Symbol.for("vercel.ai.error.AI_NoContentGeneratedError"),Symbol.for("vercel.ai.error.AI_NoSuchModelError"),Symbol.for("vercel.ai.error.AI_TooManyEmbeddingValuesForCallError");var I="AI_TypeValidationError",P=`vercel.ai.error.${I}`,T=Symbol.for(P),R=class e extends y{constructor({value:e,cause:n}){super({name:I,message:`Type validation failed: Value: ${JSON.stringify(e)}.
Error message: ${b(n)}`,cause:n}),this[l]=!0,this.value=e}static isInstance(e){return y.hasMarker(e,P)}static wrap({value:n,cause:t}){return e.isInstance(t)&&t.value===n?t:new e({value:n,cause:t})}};function O(e){return null===e||"string"==typeof e||"number"==typeof e||"boolean"==typeof e||(Array.isArray(e)?e.every(O):"object"==typeof e&&Object.entries(e).every(([e,n])=>"string"==typeof e&&O(n)))}l=T,Symbol.for("vercel.ai.error.AI_UnsupportedFunctionalityError");let x=(e,n=21)=>(t=n)=>{let i="",a=0|t;for(;a--;)i+=e[Math.random()*e.length|0];return i};var D=t(6564),N=(({prefix:e,size:n=16,alphabet:t="0123456789ABCDEFGHIJKLMNOPQRSTUVWXYZabcdefghijklmnopqrstuvwxyz",separator:i="-"}={})=>{let a=x(t,n);if(null==e)return a;if(t.includes(i))throw new w({argument:"separator",message:`The separator "${i}" must not be part of the alphabet "${t}".`});return n=>`${e}${i}${a(n)}`})(),k=Symbol.for("vercel.ai.validator");function L({text:e,schema:n}){try{let t=D.parse(e);if(null==n)return{success:!0,value:t,rawValue:t};let i=function({value:e,schema:n}){let t="object"==typeof n&&null!==n&&k in n&&!0===n[k]&&"validate"in n?n:{[k]:!0,validate:e=>{let t=n.safeParse(e);return t.success?{success:!0,value:t.data}:{success:!1,error:t.error}}};try{if(null==t.validate)return{success:!0,value:e};let n=t.validate(e);if(n.success)return n;return{success:!1,error:R.wrap({value:e,cause:n.error})}}catch(n){return{success:!1,error:R.wrap({value:e,cause:n})}}}({value:t,schema:n});return i.success?{...i,rawValue:t}:i}catch(n){return{success:!1,error:M.isInstance(n)?n:new M({text:e,cause:n})}}}var{btoa:H,atob:F}=globalThis;Symbol("Let zodToJsonSchema decide on which parser to use");var B={code:"0",name:"text",parse:e=>{if("string"!=typeof e)throw Error('"text" parts expect a string value.');return{type:"text",value:e}}},j={code:"3",name:"error",parse:e=>{if("string"!=typeof e)throw Error('"error" parts expect a string value.');return{type:"error",value:e}}},q={code:"4",name:"assistant_message",parse:e=>{if(null==e||"object"!=typeof e||!("id"in e)||!("role"in e)||!("content"in e)||"string"!=typeof e.id||"string"!=typeof e.role||"assistant"!==e.role||!Array.isArray(e.content)||!e.content.every(e=>null!=e&&"object"==typeof e&&"type"in e&&"text"===e.type&&"text"in e&&null!=e.text&&"object"==typeof e.text&&"value"in e.text&&"string"==typeof e.text.value))throw Error('"assistant_message" parts expect an object with an "id", "role", and "content" property.');return{type:"assistant_message",value:e}}},V={code:"5",name:"assistant_control_data",parse:e=>{if(null==e||"object"!=typeof e||!("threadId"in e)||!("messageId"in e)||"string"!=typeof e.threadId||"string"!=typeof e.messageId)throw Error('"assistant_control_data" parts expect an object with a "threadId" and "messageId" property.');return{type:"assistant_control_data",value:{threadId:e.threadId,messageId:e.messageId}}}},z={code:"6",name:"data_message",parse:e=>{if(null==e||"object"!=typeof e||!("role"in e)||!("data"in e)||"string"!=typeof e.role||"data"!==e.role)throw Error('"data_message" parts expect an object with a "role" and "data" property.');return{type:"data_message",value:e}}},U=[B,j,q,V,z];B.code,j.code,q.code,V.code,z.code,B.name,B.code,j.name,j.code,q.name,q.code,V.name,V.code,z.name,z.code,U.map(e=>e.code);var G=[{code:"0",name:"text",parse:e=>{if("string"!=typeof e)throw Error('"text" parts expect a string value.');return{type:"text",value:e}}},{code:"2",name:"data",parse:e=>{if(!Array.isArray(e))throw Error('"data" parts expect an array value.');return{type:"data",value:e}}},{code:"3",name:"error",parse:e=>{if("string"!=typeof e)throw Error('"error" parts expect a string value.');return{type:"error",value:e}}},{code:"8",name:"message_annotations",parse:e=>{if(!Array.isArray(e))throw Error('"message_annotations" parts expect an array value.');return{type:"message_annotations",value:e}}},{code:"9",name:"tool_call",parse:e=>{if(null==e||"object"!=typeof e||!("toolCallId"in e)||"string"!=typeof e.toolCallId||!("toolName"in e)||"string"!=typeof e.toolName||!("args"in e)||"object"!=typeof e.args)throw Error('"tool_call" parts expect an object with a "toolCallId", "toolName", and "args" property.');return{type:"tool_call",value:e}}},{code:"a",name:"tool_result",parse:e=>{if(null==e||"object"!=typeof e||!("toolCallId"in e)||"string"!=typeof e.toolCallId||!("result"in e))throw Error('"tool_result" parts expect an object with a "toolCallId" and a "result" property.');return{type:"tool_result",value:e}}},{code:"b",name:"tool_call_streaming_start",parse:e=>{if(null==e||"object"!=typeof e||!("toolCallId"in e)||"string"!=typeof e.toolCallId||!("toolName"in e)||"string"!=typeof e.toolName)throw Error('"tool_call_streaming_start" parts expect an object with a "toolCallId" and "toolName" property.');return{type:"tool_call_streaming_start",value:e}}},{code:"c",name:"tool_call_delta",parse:e=>{if(null==e||"object"!=typeof e||!("toolCallId"in e)||"string"!=typeof e.toolCallId||!("argsTextDelta"in e)||"string"!=typeof e.argsTextDelta)throw Error('"tool_call_delta" parts expect an object with a "toolCallId" and "argsTextDelta" property.');return{type:"tool_call_delta",value:e}}},{code:"d",name:"finish_message",parse:e=>{if(null==e||"object"!=typeof e||!("finishReason"in e)||"string"!=typeof e.finishReason)throw Error('"finish_message" parts expect an object with a "finishReason" property.');let n={finishReason:e.finishReason};return"usage"in e&&null!=e.usage&&"object"==typeof e.usage&&"promptTokens"in e.usage&&"completionTokens"in e.usage&&(n.usage={promptTokens:"number"==typeof e.usage.promptTokens?e.usage.promptTokens:Number.NaN,completionTokens:"number"==typeof e.usage.completionTokens?e.usage.completionTokens:Number.NaN}),{type:"finish_message",value:n}}},{code:"e",name:"finish_step",parse:e=>{if(null==e||"object"!=typeof e||!("finishReason"in e)||"string"!=typeof e.finishReason)throw Error('"finish_step" parts expect an object with a "finishReason" property.');let n={finishReason:e.finishReason,isContinued:!1};return"usage"in e&&null!=e.usage&&"object"==typeof e.usage&&"promptTokens"in e.usage&&"completionTokens"in e.usage&&(n.usage={promptTokens:"number"==typeof e.usage.promptTokens?e.usage.promptTokens:Number.NaN,completionTokens:"number"==typeof e.usage.completionTokens?e.usage.completionTokens:Number.NaN}),"isContinued"in e&&"boolean"==typeof e.isContinued&&(n.isContinued=e.isContinued),{type:"finish_step",value:n}}},{code:"f",name:"start_step",parse:e=>{if(null==e||"object"!=typeof e||!("messageId"in e)||"string"!=typeof e.messageId)throw Error('"start_step" parts expect an object with an "id" property.');return{type:"start_step",value:{messageId:e.messageId}}}},{code:"g",name:"reasoning",parse:e=>{if("string"!=typeof e)throw Error('"reasoning" parts expect a string value.');return{type:"reasoning",value:e}}},{code:"h",name:"source",parse:e=>{if(null==e||"object"!=typeof e)throw Error('"source" parts expect a Source object.');return{type:"source",value:e}}},{code:"i",name:"redacted_reasoning",parse:e=>{if(null==e||"object"!=typeof e||!("data"in e)||"string"!=typeof e.data)throw Error('"redacted_reasoning" parts expect an object with a "data" property.');return{type:"redacted_reasoning",value:{data:e.data}}}},{code:"j",name:"reasoning_signature",parse:e=>{if(null==e||"object"!=typeof e||!("signature"in e)||"string"!=typeof e.signature)throw Error('"reasoning_signature" parts expect an object with a "signature" property.');return{type:"reasoning_signature",value:{signature:e.signature}}}},{code:"k",name:"file",parse:e=>{if(null==e||"object"!=typeof e||!("data"in e)||"string"!=typeof e.data||!("mimeType"in e)||"string"!=typeof e.mimeType)throw Error('"file" parts expect an object with a "data" and "mimeType" property.');return{type:"file",value:e}}}],W=Object.fromEntries(G.map(e=>[e.code,e]));Object.fromEntries(G.map(e=>[e.name,e.code]));var Y=G.map(e=>e.code),X=e=>{let n=e.indexOf(":");if(-1===n)throw Error("Failed to parse stream string. No separator found.");let t=e.slice(0,n);if(!Y.includes(t))throw Error(`Failed to parse stream string. Invalid code ${t}.`);let i=JSON.parse(e.slice(n+1));return W[t].parse(i)};async function $({stream:e,onTextPart:n,onReasoningPart:t,onReasoningSignaturePart:i,onRedactedReasoningPart:a,onSourcePart:o,onFilePart:r,onDataPart:s,onErrorPart:l,onToolCallStreamingStartPart:c,onToolCallDeltaPart:d,onToolCallPart:p,onToolResultPart:u,onMessageAnnotationsPart:h,onFinishMessagePart:m,onFinishStepPart:f,onStartStepPart:g}){let y=e.getReader(),b=new TextDecoder,v=[],A=0;for(;;){let{value:e}=await y.read();if(e&&(v.push(e),A+=e.length,10!==e[e.length-1]))continue;if(0===v.length)break;let C=function(e,n){let t=new Uint8Array(n),i=0;for(let n of e)t.set(n,i),i+=n.length;return e.length=0,t}(v,A);for(let{type:e,value:y}of(A=0,b.decode(C,{stream:!0}).split("\n").filter(e=>""!==e).map(X)))switch(e){case"text":await (null==n?void 0:n(y));break;case"reasoning":await (null==t?void 0:t(y));break;case"reasoning_signature":await (null==i?void 0:i(y));break;case"redacted_reasoning":await (null==a?void 0:a(y));break;case"file":await (null==r?void 0:r(y));break;case"source":await (null==o?void 0:o(y));break;case"data":await (null==s?void 0:s(y));break;case"error":await (null==l?void 0:l(y));break;case"message_annotations":await (null==h?void 0:h(y));break;case"tool_call_streaming_start":await (null==c?void 0:c(y));break;case"tool_call_delta":await (null==d?void 0:d(y));break;case"tool_call":await (null==p?void 0:p(y));break;case"tool_result":await (null==u?void 0:u(y));break;case"finish_message":await (null==m?void 0:m(y));break;case"finish_step":await (null==f?void 0:f(y));break;case"start_step":await (null==g?void 0:g(y));break;default:throw Error(`Unknown stream part type: ${e}`)}}}async function K({stream:e,update:n,onToolCall:t,onFinish:i,generateId:a=N,getCurrentDate:o=()=>new Date,lastMessage:r}){var s,l;let c,d,p;let u=(null==r?void 0:r.role)==="assistant",h=u?1+(null!=(l=null==(s=r.toolInvocations)?void 0:s.reduce((e,n)=>{var t;return Math.max(e,null!=(t=n.step)?t:0)},0))?l:0):0,m=u?structuredClone(r):{id:a(),createdAt:o(),role:"assistant",content:"",parts:[]};function f(e,n){let t=m.parts.find(n=>"tool-invocation"===n.type&&n.toolInvocation.toolCallId===e);null!=t?t.toolInvocation=n:m.parts.push({type:"tool-invocation",toolInvocation:n})}let g=[],y=u?null==r?void 0:r.annotations:void 0,b={},v={completionTokens:NaN,promptTokens:NaN,totalTokens:NaN},A="unknown";function C(){let e=[...g];(null==y?void 0:y.length)&&(m.annotations=y),n({message:{...structuredClone(m),revisionId:a()},data:e,replaceLastMessage:u})}await $({stream:e,onTextPart(e){null==c?(c={type:"text",text:e},m.parts.push(c)):c.text+=e,m.content+=e,C()},onReasoningPart(e){var n;null==p?(p={type:"text",text:e},null!=d&&d.details.push(p)):p.text+=e,null==d?(d={type:"reasoning",reasoning:e,details:[p]},m.parts.push(d)):d.reasoning+=e,m.reasoning=(null!=(n=m.reasoning)?n:"")+e,C()},onReasoningSignaturePart(e){null!=p&&(p.signature=e.signature)},onRedactedReasoningPart(e){null==d&&(d={type:"reasoning",reasoning:"",details:[]},m.parts.push(d)),d.details.push({type:"redacted",data:e.data}),p=void 0,C()},onFilePart(e){m.parts.push({type:"file",mimeType:e.mimeType,data:e.data}),C()},onSourcePart(e){m.parts.push({type:"source",source:e}),C()},onToolCallStreamingStartPart(e){null==m.toolInvocations&&(m.toolInvocations=[]),b[e.toolCallId]={text:"",step:h,toolName:e.toolName,index:m.toolInvocations.length};let n={state:"partial-call",step:h,toolCallId:e.toolCallId,toolName:e.toolName,args:void 0};m.toolInvocations.push(n),f(e.toolCallId,n),C()},onToolCallDeltaPart(e){let n=b[e.toolCallId];n.text+=e.argsTextDelta;let{value:t}=function(e){if(void 0===e)return{value:void 0,state:"undefined-input"};let n=L({text:e});return n.success?{value:n.value,state:"successful-parse"}:(n=L({text:function(e){let n=["ROOT"],t=-1,i=null;function a(e,a,o){switch(e){case'"':t=a,n.pop(),n.push(o),n.push("INSIDE_STRING");break;case"f":case"t":case"n":t=a,i=a,n.pop(),n.push(o),n.push("INSIDE_LITERAL");break;case"-":n.pop(),n.push(o),n.push("INSIDE_NUMBER");break;case"0":case"1":case"2":case"3":case"4":case"5":case"6":case"7":case"8":case"9":t=a,n.pop(),n.push(o),n.push("INSIDE_NUMBER");break;case"{":t=a,n.pop(),n.push(o),n.push("INSIDE_OBJECT_START");break;case"[":t=a,n.pop(),n.push(o),n.push("INSIDE_ARRAY_START")}}function o(e,i){switch(e){case",":n.pop(),n.push("INSIDE_OBJECT_AFTER_COMMA");break;case"}":t=i,n.pop()}}function r(e,i){switch(e){case",":n.pop(),n.push("INSIDE_ARRAY_AFTER_COMMA");break;case"]":t=i,n.pop()}}for(let s=0;s<e.length;s++){let l=e[s];switch(n[n.length-1]){case"ROOT":a(l,s,"FINISH");break;case"INSIDE_OBJECT_START":switch(l){case'"':n.pop(),n.push("INSIDE_OBJECT_KEY");break;case"}":t=s,n.pop()}break;case"INSIDE_OBJECT_AFTER_COMMA":'"'===l&&(n.pop(),n.push("INSIDE_OBJECT_KEY"));break;case"INSIDE_OBJECT_KEY":'"'===l&&(n.pop(),n.push("INSIDE_OBJECT_AFTER_KEY"));break;case"INSIDE_OBJECT_AFTER_KEY":":"===l&&(n.pop(),n.push("INSIDE_OBJECT_BEFORE_VALUE"));break;case"INSIDE_OBJECT_BEFORE_VALUE":a(l,s,"INSIDE_OBJECT_AFTER_VALUE");break;case"INSIDE_OBJECT_AFTER_VALUE":o(l,s);break;case"INSIDE_STRING":switch(l){case'"':n.pop(),t=s;break;case"\\":n.push("INSIDE_STRING_ESCAPE");break;default:t=s}break;case"INSIDE_ARRAY_START":"]"===l?(t=s,n.pop()):(t=s,a(l,s,"INSIDE_ARRAY_AFTER_VALUE"));break;case"INSIDE_ARRAY_AFTER_VALUE":switch(l){case",":n.pop(),n.push("INSIDE_ARRAY_AFTER_COMMA");break;case"]":t=s,n.pop();break;default:t=s}break;case"INSIDE_ARRAY_AFTER_COMMA":a(l,s,"INSIDE_ARRAY_AFTER_VALUE");break;case"INSIDE_STRING_ESCAPE":n.pop(),t=s;break;case"INSIDE_NUMBER":switch(l){case"0":case"1":case"2":case"3":case"4":case"5":case"6":case"7":case"8":case"9":t=s;break;case"e":case"E":case"-":case".":break;case",":n.pop(),"INSIDE_ARRAY_AFTER_VALUE"===n[n.length-1]&&r(l,s),"INSIDE_OBJECT_AFTER_VALUE"===n[n.length-1]&&o(l,s);break;case"}":n.pop(),"INSIDE_OBJECT_AFTER_VALUE"===n[n.length-1]&&o(l,s);break;case"]":n.pop(),"INSIDE_ARRAY_AFTER_VALUE"===n[n.length-1]&&r(l,s);break;default:n.pop()}break;case"INSIDE_LITERAL":{let a=e.substring(i,s+1);"false".startsWith(a)||"true".startsWith(a)||"null".startsWith(a)?t=s:(n.pop(),"INSIDE_OBJECT_AFTER_VALUE"===n[n.length-1]?o(l,s):"INSIDE_ARRAY_AFTER_VALUE"===n[n.length-1]&&r(l,s))}}}let s=e.slice(0,t+1);for(let t=n.length-1;t>=0;t--)switch(n[t]){case"INSIDE_STRING":s+='"';break;case"INSIDE_OBJECT_KEY":case"INSIDE_OBJECT_AFTER_KEY":case"INSIDE_OBJECT_AFTER_COMMA":case"INSIDE_OBJECT_START":case"INSIDE_OBJECT_BEFORE_VALUE":case"INSIDE_OBJECT_AFTER_VALUE":s+="}";break;case"INSIDE_ARRAY_START":case"INSIDE_ARRAY_AFTER_COMMA":case"INSIDE_ARRAY_AFTER_VALUE":s+="]";break;case"INSIDE_LITERAL":{let n=e.substring(i,e.length);"true".startsWith(n)?s+="true".slice(n.length):"false".startsWith(n)?s+="false".slice(n.length):"null".startsWith(n)&&(s+="null".slice(n.length))}}return s}(e)})).success?{value:n.value,state:"repaired-parse"}:{value:void 0,state:"failed-parse"}}(n.text),i={state:"partial-call",step:n.step,toolCallId:e.toolCallId,toolName:n.toolName,args:t};m.toolInvocations[n.index]=i,f(e.toolCallId,i),C()},async onToolCallPart(e){let n={state:"call",step:h,...e};if(null!=b[e.toolCallId]?m.toolInvocations[b[e.toolCallId].index]=n:(null==m.toolInvocations&&(m.toolInvocations=[]),m.toolInvocations.push(n)),f(e.toolCallId,n),C(),t){let n=await t({toolCall:e});if(null!=n){let t={state:"result",step:h,...e,result:n};m.toolInvocations[m.toolInvocations.length-1]=t,f(e.toolCallId,t),C()}}},onToolResultPart(e){let n=m.toolInvocations;if(null==n)throw Error("tool_result must be preceded by a tool_call");let t=n.findIndex(n=>n.toolCallId===e.toolCallId);if(-1===t)throw Error("tool_result must be preceded by a tool_call with the same toolCallId");let i={...n[t],state:"result",...e};n[t]=i,f(e.toolCallId,i),C()},onDataPart(e){g.push(...e),C()},onMessageAnnotationsPart(e){null==y?y=[...e]:y.push(...e),C()},onFinishStepPart(e){h+=1,c=e.isContinued?c:void 0,d=void 0,p=void 0},onStartStepPart(e){u||(m.id=e.messageId),m.parts.push({type:"step-start"}),C()},onFinishMessagePart(e){A=e.finishReason,null!=e.usage&&(v=function({promptTokens:e,completionTokens:n}){return{promptTokens:e,completionTokens:n,totalTokens:e+n}}(e.usage))},onErrorPart(e){throw Error(e)}}),null==i||i({message:m,finishReason:A,usage:v})}async function J({stream:e,onTextPart:n}){let t=e.pipeThrough(new TextDecoderStream).getReader();for(;;){let{done:e,value:i}=await t.read();if(e)break;await n(i)}}async function Q({stream:e,update:n,onFinish:t,getCurrentDate:i=()=>new Date,generateId:a=N}){let o={type:"text",text:""},r={id:a(),createdAt:i(),role:"assistant",content:"",parts:[o]};await J({stream:e,onTextPart:e=>{r.content+=e,o.text+=e,n({message:{...r},data:[],replaceLastMessage:!1})}}),null==t||t(r,{usage:{completionTokens:NaN,promptTokens:NaN,totalTokens:NaN},finishReason:"unknown"})}var Z=()=>fetch;async function ee({api:e,body:n,streamProtocol:t="data",credentials:i,headers:a,abortController:o,restoreMessagesOnFailure:r,onResponse:s,onUpdate:l,onFinish:c,onToolCall:d,generateId:p,fetch:u=Z(),lastMessage:h,requestType:m="generate"}){var f,g,y;let b="resume"===m?u(`${e}?chatId=${n.id}`,{method:"GET",headers:{"Content-Type":"application/json",...a},signal:null==(f=null==o?void 0:o())?void 0:f.signal,credentials:i}):u(e,{method:"POST",body:JSON.stringify(n),headers:{"Content-Type":"application/json",...a},signal:null==(g=null==o?void 0:o())?void 0:g.signal,credentials:i}),v=await b.catch(e=>{throw r(),e});if(s)try{await s(v)}catch(e){throw e}if(!v.ok)throw r(),Error(null!=(y=await v.text())?y:"Failed to fetch the chat response.");if(!v.body)throw Error("The response body is empty.");switch(t){case"text":await Q({stream:v.body,update:l,onFinish:c,generateId:p});return;case"data":await K({stream:v.body,update:l,lastMessage:h,onToolCall:d,onFinish({message:e,finishReason:n,usage:t}){c&&null!=e&&c(e,{usage:t,finishReason:n})},generateId:p});return;default:throw Error(`Unknown stream protocol: ${t}`)}}function en(e){return null==e?void 0:e.reduce((e,n)=>{var t;return Math.max(e,null!=(t=n.step)?t:0)},0)}function et(e){var n;return null!=(n=e.parts)?n:[...e.toolInvocations?e.toolInvocations.map(e=>({type:"tool-invocation",toolInvocation:e})):[],...e.reasoning?[{type:"reasoning",reasoning:e.reasoning,details:[{type:"text",text:e.reasoning}]}]:[],...e.content?[{type:"text",text:e.content}]:[]]}function ei(e){return e.map(e=>({...e,parts:et(e)}))}async function ea(e){if(!e)return[];if(globalThis.FileList&&e instanceof globalThis.FileList)return Promise.all(Array.from(e).map(async e=>{let{name:n,type:t}=e;return{name:n,contentType:t,url:await new Promise((n,t)=>{let i=new FileReader;i.onload=e=>{var t;n(null==(t=e.target)?void 0:t.result)},i.onerror=e=>t(e),i.readAsDataURL(e)})}}));if(Array.isArray(e))return e;throw Error("Invalid attachments type")}function eo(e){if("assistant"!==e.role)return!1;let n=e.parts.reduce((e,n,t)=>"step-start"===n.type?t:e,-1),t=e.parts.slice(n+1).filter(e=>"tool-invocation"===e.type);return t.length>0&&t.every(e=>"result"in e.toolInvocation)}Symbol.for("vercel.ai.schema");var er=t(6176),es=Object.prototype.hasOwnProperty;let el=new WeakMap,ec=()=>{},ed=ec(),ep=Object,eu=e=>e===ed,eh=e=>"function"==typeof e,em=(e,n)=>({...e,...n}),ef=e=>eh(e.then),eg={},ey={},eb="undefined"!=typeof document,ev=()=>!1,eA=(e,n)=>{let t=el.get(e);return[()=>!eu(n)&&e.get(n)||eg,i=>{if(!eu(n)){let a=e.get(n);n in ey||(ey[n]=a),t[5](n,em(a,i),a||eg)}},t[6],()=>!eu(n)&&n in ey?ey[n]:!eu(n)&&e.get(n)||eg]},eC=!0,[ew,eS]=[ec,ec],e_={initFocus:e=>(eb&&document.addEventListener("visibilitychange",e),ew("focus",e),()=>{eb&&document.removeEventListener("visibilitychange",e),eS("focus",e)}),initReconnect:e=>{let n=()=>{eC=!0,e()},t=()=>{eC=!1};return ew("online",n),ew("offline",t),()=>{eS("online",n),eS("offline",t)}}},eE=!u.useId,eM=e=>ev()?window.requestAnimationFrame(e):setTimeout(e,1),eI=(0,u.useEffect),eP="undefined"!=typeof navigator&&navigator.connection,eT=false,eR=new WeakMap,eO=(e,n)=>ep.prototype.toString.call(e)===`[object ${n}]`,ex=0,eD=e=>{let n,t;let i=typeof e,a=eO(e,"Date"),o=eO(e,"RegExp"),r=eO(e,"Object");if(ep(e)!==e||a||o)n=a?e.toJSON():"symbol"==i?e.toString():"string"==i?JSON.stringify(e):""+e;else{if(n=eR.get(e))return n;if(n=++ex+"~",eR.set(e,n),Array.isArray(e)){for(t=0,n="@";t<e.length;t++)n+=eD(e[t])+",";eR.set(e,n)}if(r){n="#";let i=ep.keys(e).sort();for(;!eu(t=i.pop());)eu(e[t])||(n+=t+":"+eD(e[t])+",");eR.set(e,n)}}return n},eN=e=>{if(eh(e))try{e=e()}catch(n){e=""}let n=e;return[e="string"==typeof e?e:(Array.isArray(e)?e.length:e)?eD(e):"",n]},ek=0,eL=()=>++ek;async function eH(...e){let[n,t,i,a]=e,o=em({populateCache:!0,throwOnError:!0},"boolean"==typeof a?{revalidate:a}:a||{}),r=o.populateCache,s=o.rollbackOnError,l=o.optimisticData,c=e=>"function"==typeof s?s(e):!1!==s,d=o.throwOnError;if(eh(t)){let e=[];for(let i of n.keys())!/^\$(inf|sub)\$/.test(i)&&t(n.get(i)._k)&&e.push(i);return Promise.all(e.map(p))}return p(t);async function p(t){let a;let[s]=eN(t);if(!s)return;let[p,u]=eA(n,s),[h,m,f,g]=el.get(n),y=()=>{let e=h[s];return(eh(o.revalidate)?o.revalidate(p().data,t):!1!==o.revalidate)&&(delete f[s],delete g[s],e&&e[0])?e[0](2).then(()=>p().data):p().data};if(e.length<3)return y();let b=i,v=eL();m[s]=[v,0];let A=!eu(l),C=p(),w=C.data,S=C._c,_=eu(S)?w:S;if(A&&u({data:l=eh(l)?l(_,w):l,_c:_}),eh(b))try{b=b(_)}catch(e){a=e}if(b&&ef(b)){if(b=await b.catch(e=>{a=e}),v!==m[s][0]){if(a)throw a;return b}a&&A&&c(a)&&(r=!0,u({data:_,_c:ed}))}if(r&&!a&&(eh(r)?u({data:r(b,_),error:ed,_c:ed}):u({data:b,error:ed,_c:ed})),m[s][1]=eL(),Promise.resolve(y()).then(()=>{u({_c:ed})}),a){if(d)throw a;return}return b}}let eF=(e,n)=>{for(let t in e)e[t][0]&&e[t][0](n)},eB=(e,n)=>{if(!el.has(e)){let t=em(e_,n),i=Object.create(null),a=eH.bind(ed,e),o=ec,r=Object.create(null),s=(e,n)=>{let t=r[e]||[];return r[e]=t,t.push(n),()=>t.splice(t.indexOf(n),1)},l=(n,t,i)=>{e.set(n,t);let a=r[n];if(a)for(let e of a)e(t,i)},c=()=>{!el.has(e)&&el.set(e,[i,Object.create(null),Object.create(null),Object.create(null),a,l,s])};return c(),[e,a,c,o]}return[e,el.get(e)[4]]},[ej,eq]=eB(new Map),eV=em({onLoadingSlow:ec,onSuccess:ec,onError:ec,onErrorRetry:(e,n,t,i,a)=>{let o=t.errorRetryCount,r=a.retryCount,s=~~((Math.random()+.5)*(1<<(r<8?r:8)))*t.errorRetryInterval;(eu(o)||!(r>o))&&setTimeout(i,s,a)},onDiscarded:ec,revalidateOnFocus:!0,revalidateOnReconnect:!0,revalidateIfStale:!0,shouldRetryOnError:!0,errorRetryInterval:eT?1e4:5e3,focusThrottleInterval:5e3,dedupingInterval:2e3,loadingTimeout:eT?5e3:3e3,compare:function e(n,t){var i,a;if(n===t)return!0;if(n&&t&&(i=n.constructor)===t.constructor){if(i===Date)return n.getTime()===t.getTime();if(i===RegExp)return n.toString()===t.toString();if(i===Array){if((a=n.length)===t.length)for(;a--&&e(n[a],t[a]););return -1===a}if(!i||"object"==typeof n){for(i in a=0,n)if(es.call(n,i)&&++a&&!es.call(t,i)||!(i in t)||!e(n[i],t[i]))return!1;return Object.keys(t).length===a}}return n!=n&&t!=t},isPaused:()=>!1,cache:ej,mutate:eq,fallback:{}},{isOnline:()=>eC,isVisible:()=>{let e=eb&&document.visibilityState;return eu(e)||"hidden"!==e}}),ez=(e,n)=>{let t=em(e,n);if(n){let{use:i,fallback:a}=e,{use:o,fallback:r}=n;i&&o&&(t.use=i.concat(o)),a&&r&&(t.fallback=em(a,r))}return t},eU=(0,u.createContext)({}),eG=[],eW=e=>eh(e[1])?[e[0],e[1],e[2]||{}]:[e[0],null,(null===e[1]?e[2]:e[1])||{}],eY=()=>em(eV,(0,u.useContext)(eU)),eX=eG.concat(e=>(n,t,i)=>{let a=t&&((...e)=>{let[i]=eN(n),[,,,a]=el.get(ej);if(i.startsWith("$inf$"))return t(...e);let o=a[i];return eu(o)?t(...e):(delete a[i],o)});return e(n,a,i)}),e$=(e,n,t)=>{let i=n[e]||(n[e]=[]);return i.push(t),()=>{let e=i.indexOf(t);e>=0&&(i[e]=i[i.length-1],i.pop())}},eK=()=>{};eK(),new WeakMap;let eJ=u.use||(e=>{switch(e.status){case"pending":throw e;case"fulfilled":return e.value;case"rejected":throw e.reason;default:throw e.status="pending",e.then(n=>{e.status="fulfilled",e.value=n},n=>{e.status="rejected",e.reason=n}),e}}),eQ={dedupe:!0};ep.defineProperty(e=>{let{value:n}=e,t=(0,u.useContext)(eU),i=eh(n),a=(0,u.useMemo)(()=>i?n(t):n,[i,t,n]),o=(0,u.useMemo)(()=>i?a:ez(t,a),[i,t,a]),r=a&&a.provider,s=(0,u.useRef)(ed);r&&!s.current&&(s.current=eB(r(o.cache||ej),a));let l=s.current;return l&&(o.cache=l[0],o.mutate=l[1]),eI(()=>{if(l)return l[2]&&l[2](),l[3]},[]),(0,u.createElement)(eU.Provider,em(e,{value:o}))},"defaultValue",{value:eV});let eZ=(i=(e,n,t)=>{let{cache:i,compare:a,suspense:o,fallbackData:r,revalidateOnMount:s,revalidateIfStale:l,refreshInterval:c,refreshWhenHidden:d,refreshWhenOffline:p,keepPreviousData:h}=t,[m,f,g,y]=el.get(i),[b,v]=eN(e),A=(0,u.useRef)(!1),C=(0,u.useRef)(!1),w=(0,u.useRef)(b),S=(0,u.useRef)(n),_=(0,u.useRef)(t),E=()=>_.current,M=()=>E().isVisible()&&E().isOnline(),[I,P,T,R]=eA(i,b),O=(0,u.useRef)({}).current,x=eu(r)?eu(t.fallback)?ed:t.fallback[b]:r,D=(e,n)=>{for(let t in O)if("data"===t){if(!a(e[t],n[t])&&(!eu(e[t])||!a(V,n[t])))return!1}else if(n[t]!==e[t])return!1;return!0},N=(0,u.useMemo)(()=>{let e=!!b&&!!n&&(eu(s)?!E().isPaused()&&!o&&!1!==l:s),t=n=>{let t=em(n);return(delete t._k,e)?{isValidating:!0,isLoading:!0,...t}:t},i=I(),a=R(),r=t(i),c=i===a?r:t(a),d=r;return[()=>{let e=t(I());return D(e,d)?(d.data=e.data,d.isLoading=e.isLoading,d.isValidating=e.isValidating,d.error=e.error,d):(d=e,e)},()=>c]},[i,b]),k=(0,er.useSyncExternalStore)((0,u.useCallback)(e=>T(b,(n,t)=>{D(t,n)||e()}),[i,b]),N[0],N[1]),L=!A.current,H=m[b]&&m[b].length>0,F=k.data,B=eu(F)?x&&ef(x)?eJ(x):x:F,j=k.error,q=(0,u.useRef)(B),V=h?eu(F)?eu(q.current)?B:q.current:F:B,z=(!H||!!eu(j))&&(L&&!eu(s)?s:!E().isPaused()&&(o?!eu(B)&&l:eu(B)||l)),U=!!(b&&n&&L&&z),G=eu(k.isValidating)?U:k.isValidating,W=eu(k.isLoading)?U:k.isLoading,Y=(0,u.useCallback)(async e=>{let n,i;let o=S.current;if(!b||!o||C.current||E().isPaused())return!1;let r=!0,s=e||{},l=!g[b]||!s.dedupe,c=()=>eE?!C.current&&b===w.current&&A.current:b===w.current,d={isValidating:!1,isLoading:!1},p=()=>{P(d)},u=()=>{let e=g[b];e&&e[1]===i&&delete g[b]},h={isValidating:!0};eu(I().data)&&(h.isLoading=!0);try{if(l&&(P(h),t.loadingTimeout&&eu(I().data)&&setTimeout(()=>{r&&c()&&E().onLoadingSlow(b,t)},t.loadingTimeout),g[b]=[o(v),eL()]),[n,i]=g[b],n=await n,l&&setTimeout(u,t.dedupingInterval),!g[b]||g[b][1]!==i)return l&&c()&&E().onDiscarded(b),!1;d.error=ed;let e=f[b];if(!eu(e)&&(i<=e[0]||i<=e[1]||0===e[1]))return p(),l&&c()&&E().onDiscarded(b),!1;let s=I().data;d.data=a(s,n)?s:n,l&&c()&&E().onSuccess(n,b,t)}catch(t){u();let e=E(),{shouldRetryOnError:n}=e;!e.isPaused()&&(d.error=t,l&&c()&&(e.onError(t,b,e),(!0===n||eh(n)&&n(t))&&(!E().revalidateOnFocus||!E().revalidateOnReconnect||M())&&e.onErrorRetry(t,b,e,e=>{let n=m[b];n&&n[0]&&n[0](3,e)},{retryCount:(s.retryCount||0)+1,dedupe:!0})))}return r=!1,p(),!0},[b,i]),X=(0,u.useCallback)((...e)=>eH(i,w.current,...e),[]);if(eI(()=>{S.current=n,_.current=t,eu(F)||(q.current=F)}),eI(()=>{if(!b)return;let e=Y.bind(ed,eQ),n=0;E().revalidateOnFocus&&(n=Date.now()+E().focusThrottleInterval);let t=e$(b,m,(t,i={})=>{if(0==t){let t=Date.now();E().revalidateOnFocus&&t>n&&M()&&(n=t+E().focusThrottleInterval,e())}else if(1==t)E().revalidateOnReconnect&&M()&&e();else if(2==t)return Y();else if(3==t)return Y(i)});return C.current=!1,w.current=b,A.current=!0,P({_k:v}),z&&(eu(B),e()),()=>{C.current=!0,t()}},[b]),eI(()=>{let e;function n(){let n=eh(c)?c(I().data):c;n&&-1!==e&&(e=setTimeout(t,n))}function t(){!I().error&&(d||E().isVisible())&&(p||E().isOnline())?Y(eQ).then(n):n()}return n(),()=>{e&&(clearTimeout(e),e=-1)}},[c,d,p,b]),(0,u.useDebugValue)(V),o&&eu(B)&&b){if(!eE)throw Error("Fallback data is required when using Suspense in SSR.");S.current=n,_.current=t,C.current=!1;let e=y[b];if(eu(e)||eJ(X(e)),eu(j)){let e=Y(eQ);eu(V)||(e.status="fulfilled",e.value=!0),eJ(e)}else throw j}return{mutate:X,get data(){return O.data=!0,V},get error(){return O.error=!0,j},get isValidating(){return O.isValidating=!0,G},get isLoading(){return O.isLoading=!0,W}}},function(...e){let n=eY(),[t,a,o]=eW(e),r=ez(n,o),s=i,{use:l}=r,c=(l||[]).concat(eX);for(let e=c.length;e--;)s=c[e](s);return s(t,a||r.fetcher||null,r)});var e0=t(5004);function e1(e,n){return null!=n?e0(e,n):e}var e2=function({api:e="/api/chat",id:n,initialMessages:t,initialInput:i="",sendExtraMessageFields:a,onToolCall:o,experimental_prepareRequestBody:r,maxSteps:s=1,streamProtocol:l="data",onResponse:c,onFinish:d,onError:p,credentials:h,headers:m,body:f,generateId:g=N,fetch:y,keepLastMessageOnError:b=!0,experimental_throttle:v}={}){let[A]=(0,u.useState)(g),C=null!=n?n:A,w="string"==typeof e?[e,C]:C,S=function(e){let[n,t]=(0,u.useState)(e);return(0,u.useEffect)(()=>{!function e(n,t){if(n===t)return!0;if(null==n||null==t)return!1;if("object"!=typeof n&&"object"!=typeof t)return n===t;if(n.constructor!==t.constructor)return!1;if(n instanceof Date&&t instanceof Date)return n.getTime()===t.getTime();if(Array.isArray(n)){if(n.length!==t.length)return!1;for(let i=0;i<n.length;i++)if(!e(n[i],t[i]))return!1;return!0}let i=Object.keys(n),a=Object.keys(t);if(i.length!==a.length)return!1;for(let o of i)if(!a.includes(o)||!e(n[o],t[o]))return!1;return!0}(e,n)&&t(e)},[e,n]),n}(null!=t?t:[]),{data:_,mutate:E}=eZ([w,"messages"],null,{fallbackData:(0,u.useMemo)(()=>ei(S),[S])}),M=(0,u.useRef)(_||[]);(0,u.useEffect)(()=>{M.current=_||[]},[_]);let{data:I,mutate:P}=eZ([w,"streamData"],null),T=(0,u.useRef)(I);(0,u.useEffect)(()=>{T.current=I},[I]);let{data:R="ready",mutate:O}=eZ([w,"status"],null),{data:x,mutate:D}=eZ([w,"error"],null),k=(0,u.useRef)(null),L=(0,u.useRef)({credentials:h,headers:m,body:f});(0,u.useEffect)(()=>{L.current={credentials:h,headers:m,body:f}},[h,m,f]);let H=(0,u.useCallback)(async(n,t="generate")=>{var i,u;O("submitted"),D(void 0);let h=ei(n.messages),m=h.length,f=en(null==(i=h[h.length-1])?void 0:i.toolInvocations);try{let i=new AbortController;k.current=i;let s=e1(E,v),p=e1(P,v),m=M.current;s(h,!1);let f=a?h:h.map(({role:e,content:n,experimental_attachments:t,data:i,annotations:a,toolInvocations:o,parts:r})=>({role:e,content:n,...void 0!==t&&{experimental_attachments:t},...void 0!==i&&{data:i},...void 0!==a&&{annotations:a},...void 0!==o&&{toolInvocations:o},...void 0!==r&&{parts:r}})),A=T.current;await ee({api:e,body:null!=(u=null==r?void 0:r({id:C,messages:h,requestData:n.data,requestBody:n.body}))?u:{id:C,messages:f,data:n.data,...L.current.body,...n.body},streamProtocol:l,credentials:L.current.credentials,headers:{...L.current.headers,...n.headers},abortController:()=>k.current,restoreMessagesOnFailure(){b||s(m,!1)},onResponse:c,onUpdate({message:e,data:n,replaceLastMessage:t}){O("streaming"),s([...t?h.slice(0,h.length-1):h,e],!1),(null==n?void 0:n.length)&&p([...null!=A?A:[],...n],!1)},onToolCall:o,onFinish:d,generateId:g,fetch:y,lastMessage:h[h.length-1],requestType:t}),k.current=null,O("ready")}catch(e){if("AbortError"===e.name)return k.current=null,O("ready"),null;p&&e instanceof Error&&p(e),D(e),O("error")}let A=M.current;(function({originalMaxToolInvocationStep:e,originalMessageCount:n,maxSteps:t,messages:i}){var a;let o=i[i.length-1];return t>1&&null!=o&&(i.length>n||en(o.toolInvocations)!==e)&&eo(o)&&(null!=(a=en(o.toolInvocations))?a:0)<t})({originalMaxToolInvocationStep:f,originalMessageCount:m,maxSteps:s,messages:A})&&await H({messages:A})},[E,O,e,L,c,d,p,D,P,T,l,a,r,o,s,M,k,g,y,b,v,C]),F=(0,u.useCallback)(async(e,{data:n,headers:t,body:i,experimental_attachments:a=e.experimental_attachments}={})=>{var o,r;let s=await ea(a);return H({messages:M.current.concat({...e,id:null!=(o=e.id)?o:g(),createdAt:null!=(r=e.createdAt)?r:new Date,experimental_attachments:s.length>0?s:void 0,parts:et(e)}),headers:t,body:i,data:n})},[H,g]),B=(0,u.useCallback)(async({data:e,headers:n,body:t}={})=>{let i=M.current;return 0===i.length?null:H({messages:"assistant"===i[i.length-1].role?i.slice(0,-1):i,headers:n,body:t,data:e})},[H]),j=(0,u.useCallback)(()=>{k.current&&(k.current.abort(),k.current=null)},[]),q=(0,u.useCallback)(async()=>{H({messages:M.current},"resume")},[H]),V=(0,u.useCallback)(e=>{"function"==typeof e&&(e=e(M.current));let n=ei(e);E(n,!1),M.current=n},[E]),z=(0,u.useCallback)(e=>{"function"==typeof e&&(e=e(T.current)),P(e,!1),T.current=e},[P]),[U,G]=(0,u.useState)(i),W=(0,u.useCallback)(async(e,n={},t)=>{var i;if(null==(i=null==e?void 0:e.preventDefault)||i.call(e),!U&&!n.allowEmptySubmit)return;t&&(L.current={...L.current,...t});let a=await ea(n.experimental_attachments);H({messages:M.current.concat({id:g(),createdAt:new Date,role:"user",content:U,experimental_attachments:a.length>0?a:void 0,parts:[{type:"text",text:U}]}),headers:n.headers,body:n.body,data:n.data}),G("")},[U,g,H]),Y=(0,u.useCallback)(({toolCallId:e,result:n})=>{let t=M.current;(function({messages:e,toolCallId:n,toolResult:t}){var i;let a=e[e.length-1],o=a.parts.find(e=>"tool-invocation"===e.type&&e.toolInvocation.toolCallId===n);if(null==o)return;let r={...o.toolInvocation,state:"result",result:t};o.toolInvocation=r,a.toolInvocations=null==(i=a.toolInvocations)?void 0:i.map(e=>e.toolCallId===n?r:e)})({messages:t,toolCallId:e,toolResult:n}),E([...t.slice(0,t.length-1),{...t[t.length-1]}],!1),"submitted"!==R&&"streaming"!==R&&eo(t[t.length-1])&&H({messages:t})},[E,R,H]);return{messages:null!=_?_:[],id:C,setMessages:V,data:I,setData:z,error:x,append:F,reload:B,stop:j,experimental_resume:q,input:U,setInput:G,handleInputChange:e=>{G(e.target.value)},handleSubmit:W,isLoading:"submitted"===R||"streaming"===R,status:R,addToolResult:Y}};function e3(e){return Array.isArray?Array.isArray(e):"[object Array]"===ne(e)}let e4=1/0;function e8(e){return"string"==typeof e}function e5(e){return"number"==typeof e}function e7(e){return"object"==typeof e}function e6(e){return null!=e}function e9(e){return!e.trim().length}function ne(e){return null==e?void 0===e?"[object Undefined]":"[object Null]":Object.prototype.toString.call(e)}let nn=e=>`Invalid value for key ${e}`,nt=e=>`Pattern length exceeds max of ${e}.`,ni=e=>`Missing ${e} property in key`,na=e=>`Property 'weight' in key '${e}' must be a positive integer`,no=Object.prototype.hasOwnProperty;class nr{constructor(e){this._keys=[],this._keyMap={};let n=0;e.forEach(e=>{let t=ns(e);this._keys.push(t),this._keyMap[t.id]=t,n+=t.weight}),this._keys.forEach(e=>{e.weight/=n})}get(e){return this._keyMap[e]}keys(){return this._keys}toJSON(){return JSON.stringify(this._keys)}}function ns(e){let n=null,t=null,i=null,a=1,o=null;if(e8(e)||e3(e))i=e,n=nl(e),t=nc(e);else{if(!no.call(e,"name"))throw Error(ni("name"));let r=e.name;if(i=r,no.call(e,"weight")&&(a=e.weight)<=0)throw Error(na(r));n=nl(r),t=nc(r),o=e.getFn}return{path:n,id:t,weight:a,src:i,getFn:o}}function nl(e){return e3(e)?e:e.split(".")}function nc(e){return e3(e)?e.join("."):e}var nd={isCaseSensitive:!1,ignoreDiacritics:!1,includeScore:!1,keys:[],shouldSort:!0,sortFn:(e,n)=>e.score===n.score?e.idx<n.idx?-1:1:e.score<n.score?-1:1,includeMatches:!1,findAllMatches:!1,minMatchCharLength:1,location:0,threshold:.6,distance:100,useExtendedSearch:!1,getFn:function(e,n){let t=[],i=!1,a=(e,n,o)=>{if(e6(e)){if(n[o]){var r,s;let l=e[n[o]];if(e6(l)){if(o===n.length-1&&(e8(l)||e5(l)||!0===(r=l)||!1===r||e7(s=r)&&null!==s&&"[object Boolean]"==ne(r)))t.push(null==l?"":function(e){if("string"==typeof e)return e;let n=e+"";return"0"==n&&1/e==-e4?"-0":n}(l));else if(e3(l)){i=!0;for(let e=0,t=l.length;e<t;e+=1)a(l[e],n,o+1)}else n.length&&a(l,n,o+1)}}else t.push(e)}};return a(e,e8(n)?n.split("."):n,0),i?t:t[0]},ignoreLocation:!1,ignoreFieldNorm:!1,fieldNormWeight:1};let np=/[^ ]+/g;class nu{constructor({getFn:e=nd.getFn,fieldNormWeight:n=nd.fieldNormWeight}={}){this.norm=function(e=1,n=3){let t=new Map,i=Math.pow(10,n);return{get(n){let a=n.match(np).length;if(t.has(a))return t.get(a);let o=parseFloat(Math.round(1/Math.pow(a,.5*e)*i)/i);return t.set(a,o),o},clear(){t.clear()}}}(n,3),this.getFn=e,this.isCreated=!1,this.setIndexRecords()}setSources(e=[]){this.docs=e}setIndexRecords(e=[]){this.records=e}setKeys(e=[]){this.keys=e,this._keysMap={},e.forEach((e,n)=>{this._keysMap[e.id]=n})}create(){!this.isCreated&&this.docs.length&&(this.isCreated=!0,e8(this.docs[0])?this.docs.forEach((e,n)=>{this._addString(e,n)}):this.docs.forEach((e,n)=>{this._addObject(e,n)}),this.norm.clear())}add(e){let n=this.size();e8(e)?this._addString(e,n):this._addObject(e,n)}removeAt(e){this.records.splice(e,1);for(let n=e,t=this.size();n<t;n+=1)this.records[n].i-=1}getValueForItemAtKeyId(e,n){return e[this._keysMap[n]]}size(){return this.records.length}_addString(e,n){if(!e6(e)||e9(e))return;let t={v:e,i:n,n:this.norm.get(e)};this.records.push(t)}_addObject(e,n){let t={i:n,$:{}};this.keys.forEach((n,i)=>{let a=n.getFn?n.getFn(e):this.getFn(e,n.path);if(e6(a)){if(e3(a)){let e=[],n=[{nestedArrIndex:-1,value:a}];for(;n.length;){let{nestedArrIndex:t,value:i}=n.pop();if(e6(i)){if(e8(i)&&!e9(i)){let n={v:i,i:t,n:this.norm.get(i)};e.push(n)}else e3(i)&&i.forEach((e,t)=>{n.push({nestedArrIndex:t,value:e})})}}t.$[i]=e}else if(e8(a)&&!e9(a)){let e={v:a,n:this.norm.get(a)};t.$[i]=e}}}),this.records.push(t)}toJSON(){return{keys:this.keys,records:this.records}}}function nh(e,n,{getFn:t=nd.getFn,fieldNormWeight:i=nd.fieldNormWeight}={}){let a=new nu({getFn:t,fieldNormWeight:i});return a.setKeys(e.map(ns)),a.setSources(n),a.create(),a}function nm(e,{errors:n=0,currentLocation:t=0,expectedLocation:i=0,distance:a=nd.distance,ignoreLocation:o=nd.ignoreLocation}={}){let r=n/e.length;if(o)return r;let s=Math.abs(i-t);return a?r+s/a:s?1:r}let nf=String.prototype.normalize?e=>e.normalize("NFD").replace(/[\u0300-\u036F\u0483-\u0489\u0591-\u05BD\u05BF\u05C1\u05C2\u05C4\u05C5\u05C7\u0610-\u061A\u064B-\u065F\u0670\u06D6-\u06DC\u06DF-\u06E4\u06E7\u06E8\u06EA-\u06ED\u0711\u0730-\u074A\u07A6-\u07B0\u07EB-\u07F3\u07FD\u0816-\u0819\u081B-\u0823\u0825-\u0827\u0829-\u082D\u0859-\u085B\u08D3-\u08E1\u08E3-\u0903\u093A-\u093C\u093E-\u094F\u0951-\u0957\u0962\u0963\u0981-\u0983\u09BC\u09BE-\u09C4\u09C7\u09C8\u09CB-\u09CD\u09D7\u09E2\u09E3\u09FE\u0A01-\u0A03\u0A3C\u0A3E-\u0A42\u0A47\u0A48\u0A4B-\u0A4D\u0A51\u0A70\u0A71\u0A75\u0A81-\u0A83\u0ABC\u0ABE-\u0AC5\u0AC7-\u0AC9\u0ACB-\u0ACD\u0AE2\u0AE3\u0AFA-\u0AFF\u0B01-\u0B03\u0B3C\u0B3E-\u0B44\u0B47\u0B48\u0B4B-\u0B4D\u0B56\u0B57\u0B62\u0B63\u0B82\u0BBE-\u0BC2\u0BC6-\u0BC8\u0BCA-\u0BCD\u0BD7\u0C00-\u0C04\u0C3E-\u0C44\u0C46-\u0C48\u0C4A-\u0C4D\u0C55\u0C56\u0C62\u0C63\u0C81-\u0C83\u0CBC\u0CBE-\u0CC4\u0CC6-\u0CC8\u0CCA-\u0CCD\u0CD5\u0CD6\u0CE2\u0CE3\u0D00-\u0D03\u0D3B\u0D3C\u0D3E-\u0D44\u0D46-\u0D48\u0D4A-\u0D4D\u0D57\u0D62\u0D63\u0D82\u0D83\u0DCA\u0DCF-\u0DD4\u0DD6\u0DD8-\u0DDF\u0DF2\u0DF3\u0E31\u0E34-\u0E3A\u0E47-\u0E4E\u0EB1\u0EB4-\u0EB9\u0EBB\u0EBC\u0EC8-\u0ECD\u0F18\u0F19\u0F35\u0F37\u0F39\u0F3E\u0F3F\u0F71-\u0F84\u0F86\u0F87\u0F8D-\u0F97\u0F99-\u0FBC\u0FC6\u102B-\u103E\u1056-\u1059\u105E-\u1060\u1062-\u1064\u1067-\u106D\u1071-\u1074\u1082-\u108D\u108F\u109A-\u109D\u135D-\u135F\u1712-\u1714\u1732-\u1734\u1752\u1753\u1772\u1773\u17B4-\u17D3\u17DD\u180B-\u180D\u1885\u1886\u18A9\u1920-\u192B\u1930-\u193B\u1A17-\u1A1B\u1A55-\u1A5E\u1A60-\u1A7C\u1A7F\u1AB0-\u1ABE\u1B00-\u1B04\u1B34-\u1B44\u1B6B-\u1B73\u1B80-\u1B82\u1BA1-\u1BAD\u1BE6-\u1BF3\u1C24-\u1C37\u1CD0-\u1CD2\u1CD4-\u1CE8\u1CED\u1CF2-\u1CF4\u1CF7-\u1CF9\u1DC0-\u1DF9\u1DFB-\u1DFF\u20D0-\u20F0\u2CEF-\u2CF1\u2D7F\u2DE0-\u2DFF\u302A-\u302F\u3099\u309A\uA66F-\uA672\uA674-\uA67D\uA69E\uA69F\uA6F0\uA6F1\uA802\uA806\uA80B\uA823-\uA827\uA880\uA881\uA8B4-\uA8C5\uA8E0-\uA8F1\uA8FF\uA926-\uA92D\uA947-\uA953\uA980-\uA983\uA9B3-\uA9C0\uA9E5\uAA29-\uAA36\uAA43\uAA4C\uAA4D\uAA7B-\uAA7D\uAAB0\uAAB2-\uAAB4\uAAB7\uAAB8\uAABE\uAABF\uAAC1\uAAEB-\uAAEF\uAAF5\uAAF6\uABE3-\uABEA\uABEC\uABED\uFB1E\uFE00-\uFE0F\uFE20-\uFE2F]/g,""):e=>e;class ng{constructor(e,{location:n=nd.location,threshold:t=nd.threshold,distance:i=nd.distance,includeMatches:a=nd.includeMatches,findAllMatches:o=nd.findAllMatches,minMatchCharLength:r=nd.minMatchCharLength,isCaseSensitive:s=nd.isCaseSensitive,ignoreDiacritics:l=nd.ignoreDiacritics,ignoreLocation:c=nd.ignoreLocation}={}){if(this.options={location:n,threshold:t,distance:i,includeMatches:a,findAllMatches:o,minMatchCharLength:r,isCaseSensitive:s,ignoreDiacritics:l,ignoreLocation:c},e=s?e:e.toLowerCase(),e=l?nf(e):e,this.pattern=e,this.chunks=[],!this.pattern.length)return;let d=(e,n)=>{this.chunks.push({pattern:e,alphabet:function(e){let n={};for(let t=0,i=e.length;t<i;t+=1){let a=e.charAt(t);n[a]=(n[a]||0)|1<<i-t-1}return n}(e),startIndex:n})},p=this.pattern.length;if(p>32){let e=0,n=p%32,t=p-n;for(;e<t;)d(this.pattern.substr(e,32),e),e+=32;if(n){let e=p-32;d(this.pattern.substr(e),e)}}else d(this.pattern,0)}searchIn(e){let{isCaseSensitive:n,ignoreDiacritics:t,includeMatches:i}=this.options;if(e=n?e:e.toLowerCase(),e=t?nf(e):e,this.pattern===e){let n={isMatch:!0,score:0};return i&&(n.indices=[[0,e.length-1]]),n}let{location:a,distance:o,threshold:r,findAllMatches:s,minMatchCharLength:l,ignoreLocation:c}=this.options,d=[],p=0,u=!1;this.chunks.forEach(({pattern:n,alphabet:t,startIndex:h})=>{let{isMatch:m,score:f,indices:g}=function(e,n,t,{location:i=nd.location,distance:a=nd.distance,threshold:o=nd.threshold,findAllMatches:r=nd.findAllMatches,minMatchCharLength:s=nd.minMatchCharLength,includeMatches:l=nd.includeMatches,ignoreLocation:c=nd.ignoreLocation}={}){let d;if(n.length>32)throw Error(nt(32));let p=n.length,u=e.length,h=Math.max(0,Math.min(i,u)),m=o,f=h,g=s>1||l,y=g?Array(u):[];for(;(d=e.indexOf(n,f))>-1;)if(m=Math.min(nm(n,{currentLocation:d,expectedLocation:h,distance:a,ignoreLocation:c}),m),f=d+p,g){let e=0;for(;e<p;)y[d+e]=1,e+=1}f=-1;let b=[],v=1,A=p+u,C=1<<p-1;for(let i=0;i<p;i+=1){let o=0,s=A;for(;o<s;)nm(n,{errors:i,currentLocation:h+s,expectedLocation:h,distance:a,ignoreLocation:c})<=m?o=s:A=s,s=Math.floor((A-o)/2+o);A=s;let l=Math.max(1,h-s+1),d=r?u:Math.min(h+s,u)+p,w=Array(d+2);w[d+1]=(1<<i)-1;for(let o=d;o>=l;o-=1){let r=o-1,s=t[e.charAt(r)];if(g&&(y[r]=+!!s),w[o]=(w[o+1]<<1|1)&s,i&&(w[o]|=(b[o+1]|b[o])<<1|1|b[o+1]),w[o]&C&&(v=nm(n,{errors:i,currentLocation:r,expectedLocation:h,distance:a,ignoreLocation:c}))<=m){if(m=v,(f=r)<=h)break;l=Math.max(1,2*h-f)}}if(nm(n,{errors:i+1,currentLocation:h,expectedLocation:h,distance:a,ignoreLocation:c})>m)break;b=w}let w={isMatch:f>=0,score:Math.max(.001,v)};if(g){let e=function(e=[],n=nd.minMatchCharLength){let t=[],i=-1,a=-1,o=0;for(let r=e.length;o<r;o+=1){let r=e[o];r&&-1===i?i=o:r||-1===i||((a=o-1)-i+1>=n&&t.push([i,a]),i=-1)}return e[o-1]&&o-i>=n&&t.push([i,o-1]),t}(y,s);e.length?l&&(w.indices=e):w.isMatch=!1}return w}(e,n,t,{location:a+h,distance:o,threshold:r,findAllMatches:s,minMatchCharLength:l,includeMatches:i,ignoreLocation:c});m&&(u=!0),p+=f,m&&g&&(d=[...d,...g])});let h={isMatch:u,score:u?p/this.chunks.length:1};return u&&i&&(h.indices=d),h}}class ny{constructor(e){this.pattern=e}static isMultiMatch(e){return nb(e,this.multiRegex)}static isSingleMatch(e){return nb(e,this.singleRegex)}search(){}}function nb(e,n){let t=e.match(n);return t?t[1]:null}class nv extends ny{constructor(e){super(e)}static get type(){return"exact"}static get multiRegex(){return/^="(.*)"$/}static get singleRegex(){return/^=(.*)$/}search(e){let n=e===this.pattern;return{isMatch:n,score:n?0:1,indices:[0,this.pattern.length-1]}}}class nA extends ny{constructor(e){super(e)}static get type(){return"inverse-exact"}static get multiRegex(){return/^!"(.*)"$/}static get singleRegex(){return/^!(.*)$/}search(e){let n=-1===e.indexOf(this.pattern);return{isMatch:n,score:n?0:1,indices:[0,e.length-1]}}}class nC extends ny{constructor(e){super(e)}static get type(){return"prefix-exact"}static get multiRegex(){return/^\^"(.*)"$/}static get singleRegex(){return/^\^(.*)$/}search(e){let n=e.startsWith(this.pattern);return{isMatch:n,score:n?0:1,indices:[0,this.pattern.length-1]}}}class nw extends ny{constructor(e){super(e)}static get type(){return"inverse-prefix-exact"}static get multiRegex(){return/^!\^"(.*)"$/}static get singleRegex(){return/^!\^(.*)$/}search(e){let n=!e.startsWith(this.pattern);return{isMatch:n,score:n?0:1,indices:[0,e.length-1]}}}class nS extends ny{constructor(e){super(e)}static get type(){return"suffix-exact"}static get multiRegex(){return/^"(.*)"\$$/}static get singleRegex(){return/^(.*)\$$/}search(e){let n=e.endsWith(this.pattern);return{isMatch:n,score:n?0:1,indices:[e.length-this.pattern.length,e.length-1]}}}class n_ extends ny{constructor(e){super(e)}static get type(){return"inverse-suffix-exact"}static get multiRegex(){return/^!"(.*)"\$$/}static get singleRegex(){return/^!(.*)\$$/}search(e){let n=!e.endsWith(this.pattern);return{isMatch:n,score:n?0:1,indices:[0,e.length-1]}}}class nE extends ny{constructor(e,{location:n=nd.location,threshold:t=nd.threshold,distance:i=nd.distance,includeMatches:a=nd.includeMatches,findAllMatches:o=nd.findAllMatches,minMatchCharLength:r=nd.minMatchCharLength,isCaseSensitive:s=nd.isCaseSensitive,ignoreDiacritics:l=nd.ignoreDiacritics,ignoreLocation:c=nd.ignoreLocation}={}){super(e),this._bitapSearch=new ng(e,{location:n,threshold:t,distance:i,includeMatches:a,findAllMatches:o,minMatchCharLength:r,isCaseSensitive:s,ignoreDiacritics:l,ignoreLocation:c})}static get type(){return"fuzzy"}static get multiRegex(){return/^"(.*)"$/}static get singleRegex(){return/^(.*)$/}search(e){return this._bitapSearch.searchIn(e)}}class nM extends ny{constructor(e){super(e)}static get type(){return"include"}static get multiRegex(){return/^'"(.*)"$/}static get singleRegex(){return/^'(.*)$/}search(e){let n,t=0,i=[],a=this.pattern.length;for(;(n=e.indexOf(this.pattern,t))>-1;)t=n+a,i.push([n,t-1]);let o=!!i.length;return{isMatch:o,score:o?0:1,indices:i}}}let nI=[nv,nM,nC,nw,n_,nS,nA,nE],nP=nI.length,nT=/ +(?=(?:[^\"]*\"[^\"]*\")*[^\"]*$)/,nR=new Set([nE.type,nM.type]);class nO{constructor(e,{isCaseSensitive:n=nd.isCaseSensitive,ignoreDiacritics:t=nd.ignoreDiacritics,includeMatches:i=nd.includeMatches,minMatchCharLength:a=nd.minMatchCharLength,ignoreLocation:o=nd.ignoreLocation,findAllMatches:r=nd.findAllMatches,location:s=nd.location,threshold:l=nd.threshold,distance:c=nd.distance}={}){this.query=null,this.options={isCaseSensitive:n,ignoreDiacritics:t,includeMatches:i,minMatchCharLength:a,findAllMatches:r,ignoreLocation:o,location:s,threshold:l,distance:c},e=n?e:e.toLowerCase(),e=t?nf(e):e,this.pattern=e,this.query=function(e,n={}){return e.split("|").map(e=>{let t=e.trim().split(nT).filter(e=>e&&!!e.trim()),i=[];for(let e=0,a=t.length;e<a;e+=1){let a=t[e],o=!1,r=-1;for(;!o&&++r<nP;){let e=nI[r],t=e.isMultiMatch(a);t&&(i.push(new e(t,n)),o=!0)}if(!o)for(r=-1;++r<nP;){let e=nI[r],t=e.isSingleMatch(a);if(t){i.push(new e(t,n));break}}}return i})}(this.pattern,this.options)}static condition(e,n){return n.useExtendedSearch}searchIn(e){let n=this.query;if(!n)return{isMatch:!1,score:1};let{includeMatches:t,isCaseSensitive:i,ignoreDiacritics:a}=this.options;e=i?e:e.toLowerCase(),e=a?nf(e):e;let o=0,r=[],s=0;for(let i=0,a=n.length;i<a;i+=1){let a=n[i];r.length=0,o=0;for(let n=0,i=a.length;n<i;n+=1){let i=a[n],{isMatch:l,indices:c,score:d}=i.search(e);if(l){if(o+=1,s+=d,t){let e=i.constructor.type;nR.has(e)?r=[...r,...c]:r.push(c)}}else{s=0,o=0,r.length=0;break}}if(o){let e={isMatch:!0,score:s/o};return t&&(e.indices=r),e}}return{isMatch:!1,score:1}}}let nx=[];function nD(e,n){for(let t=0,i=nx.length;t<i;t+=1){let i=nx[t];if(i.condition(e,n))return new i(e,n)}return new ng(e,n)}let nN={AND:"$and",OR:"$or"},nk={PATH:"$path",PATTERN:"$val"},nL=e=>!!(e[nN.AND]||e[nN.OR]),nH=e=>!!e[nk.PATH],nF=e=>!e3(e)&&e7(e)&&!nL(e),nB=e=>({[nN.AND]:Object.keys(e).map(n=>({[n]:e[n]}))});function nj(e,n,{auto:t=!0}={}){let i=e=>{let a=Object.keys(e),o=nH(e);if(!o&&a.length>1&&!nL(e))return i(nB(e));if(nF(e)){let i=o?e[nk.PATH]:a[0],r=o?e[nk.PATTERN]:e[i];if(!e8(r))throw Error(nn(i));let s={keyId:nc(i),pattern:r};return t&&(s.searcher=nD(r,n)),s}let r={children:[],operator:a[0]};return a.forEach(n=>{let t=e[n];e3(t)&&t.forEach(e=>{r.children.push(i(e))})}),r};return nL(e)||(e=nB(e)),i(e)}function nq(e,n){let t=e.matches;n.matches=[],e6(t)&&t.forEach(e=>{if(!e6(e.indices)||!e.indices.length)return;let{indices:t,value:i}=e,a={indices:t,value:i};e.key&&(a.key=e.key.src),e.idx>-1&&(a.refIndex=e.idx),n.matches.push(a)})}function nV(e,n){n.score=e.score}class nz{constructor(e,n={},t){this.options={...nd,...n},this.options.useExtendedSearch,this._keyStore=new nr(this.options.keys),this.setCollection(e,t)}setCollection(e,n){if(this._docs=e,n&&!(n instanceof nu))throw Error("Incorrect 'index' type");this._myIndex=n||nh(this.options.keys,this._docs,{getFn:this.options.getFn,fieldNormWeight:this.options.fieldNormWeight})}add(e){e6(e)&&(this._docs.push(e),this._myIndex.add(e))}remove(e=()=>!1){let n=[];for(let t=0,i=this._docs.length;t<i;t+=1){let a=this._docs[t];e(a,t)&&(this.removeAt(t),t-=1,i-=1,n.push(a))}return n}removeAt(e){this._docs.splice(e,1),this._myIndex.removeAt(e)}getIndex(){return this._myIndex}search(e,{limit:n=-1}={}){let{includeMatches:t,includeScore:i,shouldSort:a,sortFn:o,ignoreFieldNorm:r}=this.options,s=e8(e)?e8(this._docs[0])?this._searchStringList(e):this._searchObjectList(e):this._searchLogical(e);return function(e,{ignoreFieldNorm:n=nd.ignoreFieldNorm}){e.forEach(e=>{let t=1;e.matches.forEach(({key:e,norm:i,score:a})=>{let o=e?e.weight:null;t*=Math.pow(0===a&&o?Number.EPSILON:a,(o||1)*(n?1:i))}),e.score=t})}(s,{ignoreFieldNorm:r}),a&&s.sort(o),e5(n)&&n>-1&&(s=s.slice(0,n)),function(e,n,{includeMatches:t=nd.includeMatches,includeScore:i=nd.includeScore}={}){let a=[];return t&&a.push(nq),i&&a.push(nV),e.map(e=>{let{idx:t}=e,i={item:n[t],refIndex:t};return a.length&&a.forEach(n=>{n(e,i)}),i})}(s,this._docs,{includeMatches:t,includeScore:i})}_searchStringList(e){let n=nD(e,this.options),{records:t}=this._myIndex,i=[];return t.forEach(({v:e,i:t,n:a})=>{if(!e6(e))return;let{isMatch:o,score:r,indices:s}=n.searchIn(e);o&&i.push({item:e,idx:t,matches:[{score:r,value:e,norm:a,indices:s}]})}),i}_searchLogical(e){let n=nj(e,this.options),t=(e,n,i)=>{if(!e.children){let{keyId:t,searcher:a}=e,o=this._findMatches({key:this._keyStore.get(t),value:this._myIndex.getValueForItemAtKeyId(n,t),searcher:a});return o&&o.length?[{idx:i,item:n,matches:o}]:[]}let a=[];for(let o=0,r=e.children.length;o<r;o+=1){let r=t(e.children[o],n,i);if(r.length)a.push(...r);else if(e.operator===nN.AND)return[]}return a},i=this._myIndex.records,a={},o=[];return i.forEach(({$:e,i:i})=>{if(e6(e)){let r=t(n,e,i);r.length&&(a[i]||(a[i]={idx:i,item:e,matches:[]},o.push(a[i])),r.forEach(({matches:e})=>{a[i].matches.push(...e)}))}}),o}_searchObjectList(e){let n=nD(e,this.options),{keys:t,records:i}=this._myIndex,a=[];return i.forEach(({$:e,i:i})=>{if(!e6(e))return;let o=[];t.forEach((t,i)=>{o.push(...this._findMatches({key:t,value:e[i],searcher:n}))}),o.length&&a.push({idx:i,item:e,matches:o})}),a}_findMatches({key:e,value:n,searcher:t}){if(!e6(n))return[];let i=[];if(e3(n))n.forEach(({v:n,i:a,n:o})=>{if(!e6(n))return;let{isMatch:r,score:s,indices:l}=t.searchIn(n);r&&i.push({score:s,key:e,value:n,idx:a,norm:o,indices:l})});else{let{v:a,n:o}=n,{isMatch:r,score:s,indices:l}=t.searchIn(a);r&&i.push({score:s,key:e,value:a,norm:o,indices:l})}return i}}function nU(){for(var e,n,t=0,i="",a=arguments.length;t<a;t++)(e=arguments[t])&&(n=function e(n){var t,i,a="";if("string"==typeof n||"number"==typeof n)a+=n;else if("object"==typeof n){if(Array.isArray(n)){var o=n.length;for(t=0;t<o;t++)n[t]&&(i=e(n[t]))&&(a&&(a+=" "),a+=i)}else for(i in n)n[i]&&(a&&(a+=" "),a+=i)}return a}(e))&&(i&&(i+=" "),i+=n);return i}nz.version="7.1.0",nz.createIndex=nh,nz.parseIndex=function(e,{getFn:n=nd.getFn,fieldNormWeight:t=nd.fieldNormWeight}={}){let{keys:i,records:a}=e,o=new nu({getFn:n,fieldNormWeight:t});return o.setKeys(i),o.setIndexRecords(a),o},nz.config=nd,nz.parseQuery=nj,function(...e){nx.push(...e)}(nO);let nG=e=>{let n=n$(e),{conflictingClassGroups:t,conflictingClassGroupModifiers:i}=e;return{getClassGroupId:e=>{let t=e.split("-");return""===t[0]&&1!==t.length&&t.shift(),nW(t,n)||nX(e)},getConflictingClassGroupIds:(e,n)=>{let a=t[e]||[];return n&&i[e]?[...a,...i[e]]:a}}},nW=(e,n)=>{if(0===e.length)return n.classGroupId;let t=e[0],i=n.nextPart.get(t),a=i?nW(e.slice(1),i):void 0;if(a)return a;if(0===n.validators.length)return;let o=e.join("-");return n.validators.find(({validator:e})=>e(o))?.classGroupId},nY=/^\[(.+)\]$/,nX=e=>{if(nY.test(e)){let n=nY.exec(e)[1],t=n?.substring(0,n.indexOf(":"));if(t)return"arbitrary.."+t}},n$=e=>{let{theme:n,prefix:t}=e,i={nextPart:new Map,validators:[]};return nZ(Object.entries(e.classGroups),t).forEach(([e,t])=>{nK(t,i,e,n)}),i},nK=(e,n,t,i)=>{e.forEach(e=>{if("string"==typeof e){(""===e?n:nJ(n,e)).classGroupId=t;return}if("function"==typeof e){if(nQ(e)){nK(e(i),n,t,i);return}n.validators.push({validator:e,classGroupId:t});return}Object.entries(e).forEach(([e,a])=>{nK(a,nJ(n,e),t,i)})})},nJ=(e,n)=>{let t=e;return n.split("-").forEach(e=>{t.nextPart.has(e)||t.nextPart.set(e,{nextPart:new Map,validators:[]}),t=t.nextPart.get(e)}),t},nQ=e=>e.isThemeGetter,nZ=(e,n)=>n?e.map(([e,t])=>[e,t.map(e=>"string"==typeof e?n+e:"object"==typeof e?Object.fromEntries(Object.entries(e).map(([e,t])=>[n+e,t])):e)]):e,n0=e=>{if(e<1)return{get:()=>void 0,set:()=>{}};let n=0,t=new Map,i=new Map,a=(a,o)=>{t.set(a,o),++n>e&&(n=0,i=t,t=new Map)};return{get(e){let n=t.get(e);return void 0!==n?n:void 0!==(n=i.get(e))?(a(e,n),n):void 0},set(e,n){t.has(e)?t.set(e,n):a(e,n)}}},n1=e=>{let{separator:n,experimentalParseClassName:t}=e,i=1===n.length,a=n[0],o=n.length,r=e=>{let t;let r=[],s=0,l=0;for(let c=0;c<e.length;c++){let d=e[c];if(0===s){if(d===a&&(i||e.slice(c,c+o)===n)){r.push(e.slice(l,c)),l=c+o;continue}if("/"===d){t=c;continue}}"["===d?s++:"]"===d&&s--}let c=0===r.length?e:e.substring(l),d=c.startsWith("!"),p=d?c.substring(1):c;return{modifiers:r,hasImportantModifier:d,baseClassName:p,maybePostfixModifierPosition:t&&t>l?t-l:void 0}};return t?e=>t({className:e,parseClassName:r}):r},n2=e=>{if(e.length<=1)return e;let n=[],t=[];return e.forEach(e=>{"["===e[0]?(n.push(...t.sort(),e),t=[]):t.push(e)}),n.push(...t.sort()),n},n3=e=>({cache:n0(e.cacheSize),parseClassName:n1(e),...nG(e)}),n4=/\s+/,n8=(e,n)=>{let{parseClassName:t,getClassGroupId:i,getConflictingClassGroupIds:a}=n,o=[],r=e.trim().split(n4),s="";for(let e=r.length-1;e>=0;e-=1){let n=r[e],{modifiers:l,hasImportantModifier:c,baseClassName:d,maybePostfixModifierPosition:p}=t(n),u=!!p,h=i(u?d.substring(0,p):d);if(!h){if(!u||!(h=i(d))){s=n+(s.length>0?" "+s:s);continue}u=!1}let m=n2(l).join(":"),f=c?m+"!":m,g=f+h;if(o.includes(g))continue;o.push(g);let y=a(h,u);for(let e=0;e<y.length;++e){let n=y[e];o.push(f+n)}s=n+(s.length>0?" "+s:s)}return s};function n5(){let e,n,t=0,i="";for(;t<arguments.length;)(e=arguments[t++])&&(n=n7(e))&&(i&&(i+=" "),i+=n);return i}let n7=e=>{let n;if("string"==typeof e)return e;let t="";for(let i=0;i<e.length;i++)e[i]&&(n=n7(e[i]))&&(t&&(t+=" "),t+=n);return t},n6=e=>{let n=n=>n[e]||[];return n.isThemeGetter=!0,n},n9=/^\[(?:([a-z-]+):)?(.+)\]$/i,te=/^\d+\/\d+$/,tn=new Set(["px","full","screen"]),tt=/^(\d+(\.\d+)?)?(xs|sm|md|lg|xl)$/,ti=/\d+(%|px|r?em|[sdl]?v([hwib]|min|max)|pt|pc|in|cm|mm|cap|ch|ex|r?lh|cq(w|h|i|b|min|max))|\b(calc|min|max|clamp)\(.+\)|^0$/,ta=/^(rgba?|hsla?|hwb|(ok)?(lab|lch))\(.+\)$/,to=/^(inset_)?-?((\d+)?\.?(\d+)[a-z]+|0)_-?((\d+)?\.?(\d+)[a-z]+|0)/,tr=/^(url|image|image-set|cross-fade|element|(repeating-)?(linear|radial|conic)-gradient)\(.+\)$/,ts=e=>tc(e)||tn.has(e)||te.test(e),tl=e=>tw(e,"length",tS),tc=e=>!!e&&!Number.isNaN(Number(e)),td=e=>tw(e,"number",tc),tp=e=>!!e&&Number.isInteger(Number(e)),tu=e=>e.endsWith("%")&&tc(e.slice(0,-1)),th=e=>n9.test(e),tm=e=>tt.test(e),tf=new Set(["length","size","percentage"]),tg=e=>tw(e,tf,t_),ty=e=>tw(e,"position",t_),tb=new Set(["image","url"]),tv=e=>tw(e,tb,tM),tA=e=>tw(e,"",tE),tC=()=>!0,tw=(e,n,t)=>{let i=n9.exec(e);return!!i&&(i[1]?"string"==typeof n?i[1]===n:n.has(i[1]):t(i[2]))},tS=e=>ti.test(e)&&!ta.test(e),t_=()=>!1,tE=e=>to.test(e),tM=e=>tr.test(e);Symbol.toStringTag;let tI=function(e,...n){let t,i,a;let o=function(s){return i=(t=n3(n.reduce((e,n)=>n(e),e()))).cache.get,a=t.cache.set,o=r,r(s)};function r(e){let n=i(e);if(n)return n;let o=n8(e,t);return a(e,o),o}return function(){return o(n5.apply(null,arguments))}}(()=>{let e=n6("colors"),n=n6("spacing"),t=n6("blur"),i=n6("brightness"),a=n6("borderColor"),o=n6("borderRadius"),r=n6("borderSpacing"),s=n6("borderWidth"),l=n6("contrast"),c=n6("grayscale"),d=n6("hueRotate"),p=n6("invert"),u=n6("gap"),h=n6("gradientColorStops"),m=n6("gradientColorStopPositions"),f=n6("inset"),g=n6("margin"),y=n6("opacity"),b=n6("padding"),v=n6("saturate"),A=n6("scale"),C=n6("sepia"),w=n6("skew"),S=n6("space"),_=n6("translate"),E=()=>["auto","contain","none"],M=()=>["auto","hidden","clip","visible","scroll"],I=()=>["auto",th,n],P=()=>[th,n],T=()=>["",ts,tl],R=()=>["auto",tc,th],O=()=>["bottom","center","left","left-bottom","left-top","right","right-bottom","right-top","top"],x=()=>["solid","dashed","dotted","double","none"],D=()=>["normal","multiply","screen","overlay","darken","lighten","color-dodge","color-burn","hard-light","soft-light","difference","exclusion","hue","saturation","color","luminosity"],N=()=>["start","end","center","between","around","evenly","stretch"],k=()=>["","0",th],L=()=>["auto","avoid","all","avoid-page","page","left","right","column"],H=()=>[tc,th];return{cacheSize:500,separator:":",theme:{colors:[tC],spacing:[ts,tl],blur:["none","",tm,th],brightness:H(),borderColor:[e],borderRadius:["none","","full",tm,th],borderSpacing:P(),borderWidth:T(),contrast:H(),grayscale:k(),hueRotate:H(),invert:k(),gap:P(),gradientColorStops:[e],gradientColorStopPositions:[tu,tl],inset:I(),margin:I(),opacity:H(),padding:P(),saturate:H(),scale:H(),sepia:k(),skew:H(),space:P(),translate:P()},classGroups:{aspect:[{aspect:["auto","square","video",th]}],container:["container"],columns:[{columns:[tm]}],"break-after":[{"break-after":L()}],"break-before":[{"break-before":L()}],"break-inside":[{"break-inside":["auto","avoid","avoid-page","avoid-column"]}],"box-decoration":[{"box-decoration":["slice","clone"]}],box:[{box:["border","content"]}],display:["block","inline-block","inline","flex","inline-flex","table","inline-table","table-caption","table-cell","table-column","table-column-group","table-footer-group","table-header-group","table-row-group","table-row","flow-root","grid","inline-grid","contents","list-item","hidden"],float:[{float:["right","left","none","start","end"]}],clear:[{clear:["left","right","both","none","start","end"]}],isolation:["isolate","isolation-auto"],"object-fit":[{object:["contain","cover","fill","none","scale-down"]}],"object-position":[{object:[...O(),th]}],overflow:[{overflow:M()}],"overflow-x":[{"overflow-x":M()}],"overflow-y":[{"overflow-y":M()}],overscroll:[{overscroll:E()}],"overscroll-x":[{"overscroll-x":E()}],"overscroll-y":[{"overscroll-y":E()}],position:["static","fixed","absolute","relative","sticky"],inset:[{inset:[f]}],"inset-x":[{"inset-x":[f]}],"inset-y":[{"inset-y":[f]}],start:[{start:[f]}],end:[{end:[f]}],top:[{top:[f]}],right:[{right:[f]}],bottom:[{bottom:[f]}],left:[{left:[f]}],visibility:["visible","invisible","collapse"],z:[{z:["auto",tp,th]}],basis:[{basis:I()}],"flex-direction":[{flex:["row","row-reverse","col","col-reverse"]}],"flex-wrap":[{flex:["wrap","wrap-reverse","nowrap"]}],flex:[{flex:["1","auto","initial","none",th]}],grow:[{grow:k()}],shrink:[{shrink:k()}],order:[{order:["first","last","none",tp,th]}],"grid-cols":[{"grid-cols":[tC]}],"col-start-end":[{col:["auto",{span:["full",tp,th]},th]}],"col-start":[{"col-start":R()}],"col-end":[{"col-end":R()}],"grid-rows":[{"grid-rows":[tC]}],"row-start-end":[{row:["auto",{span:[tp,th]},th]}],"row-start":[{"row-start":R()}],"row-end":[{"row-end":R()}],"grid-flow":[{"grid-flow":["row","col","dense","row-dense","col-dense"]}],"auto-cols":[{"auto-cols":["auto","min","max","fr",th]}],"auto-rows":[{"auto-rows":["auto","min","max","fr",th]}],gap:[{gap:[u]}],"gap-x":[{"gap-x":[u]}],"gap-y":[{"gap-y":[u]}],"justify-content":[{justify:["normal",...N()]}],"justify-items":[{"justify-items":["start","end","center","stretch"]}],"justify-self":[{"justify-self":["auto","start","end","center","stretch"]}],"align-content":[{content:["normal",...N(),"baseline"]}],"align-items":[{items:["start","end","center","baseline","stretch"]}],"align-self":[{self:["auto","start","end","center","stretch","baseline"]}],"place-content":[{"place-content":[...N(),"baseline"]}],"place-items":[{"place-items":["start","end","center","baseline","stretch"]}],"place-self":[{"place-self":["auto","start","end","center","stretch"]}],p:[{p:[b]}],px:[{px:[b]}],py:[{py:[b]}],ps:[{ps:[b]}],pe:[{pe:[b]}],pt:[{pt:[b]}],pr:[{pr:[b]}],pb:[{pb:[b]}],pl:[{pl:[b]}],m:[{m:[g]}],mx:[{mx:[g]}],my:[{my:[g]}],ms:[{ms:[g]}],me:[{me:[g]}],mt:[{mt:[g]}],mr:[{mr:[g]}],mb:[{mb:[g]}],ml:[{ml:[g]}],"space-x":[{"space-x":[S]}],"space-x-reverse":["space-x-reverse"],"space-y":[{"space-y":[S]}],"space-y-reverse":["space-y-reverse"],w:[{w:["auto","min","max","fit","svw","lvw","dvw",th,n]}],"min-w":[{"min-w":[th,n,"min","max","fit"]}],"max-w":[{"max-w":[th,n,"none","full","min","max","fit","prose",{screen:[tm]},tm]}],h:[{h:[th,n,"auto","min","max","fit","svh","lvh","dvh"]}],"min-h":[{"min-h":[th,n,"min","max","fit","svh","lvh","dvh"]}],"max-h":[{"max-h":[th,n,"min","max","fit","svh","lvh","dvh"]}],size:[{size:[th,n,"auto","min","max","fit"]}],"font-size":[{text:["base",tm,tl]}],"font-smoothing":["antialiased","subpixel-antialiased"],"font-style":["italic","not-italic"],"font-weight":[{font:["thin","extralight","light","normal","medium","semibold","bold","extrabold","black",td]}],"font-family":[{font:[tC]}],"fvn-normal":["normal-nums"],"fvn-ordinal":["ordinal"],"fvn-slashed-zero":["slashed-zero"],"fvn-figure":["lining-nums","oldstyle-nums"],"fvn-spacing":["proportional-nums","tabular-nums"],"fvn-fraction":["diagonal-fractions","stacked-fractions"],tracking:[{tracking:["tighter","tight","normal","wide","wider","widest",th]}],"line-clamp":[{"line-clamp":["none",tc,td]}],leading:[{leading:["none","tight","snug","normal","relaxed","loose",ts,th]}],"list-image":[{"list-image":["none",th]}],"list-style-type":[{list:["none","disc","decimal",th]}],"list-style-position":[{list:["inside","outside"]}],"placeholder-color":[{placeholder:[e]}],"placeholder-opacity":[{"placeholder-opacity":[y]}],"text-alignment":[{text:["left","center","right","justify","start","end"]}],"text-color":[{text:[e]}],"text-opacity":[{"text-opacity":[y]}],"text-decoration":["underline","overline","line-through","no-underline"],"text-decoration-style":[{decoration:[...x(),"wavy"]}],"text-decoration-thickness":[{decoration:["auto","from-font",ts,tl]}],"underline-offset":[{"underline-offset":["auto",ts,th]}],"text-decoration-color":[{decoration:[e]}],"text-transform":["uppercase","lowercase","capitalize","normal-case"],"text-overflow":["truncate","text-ellipsis","text-clip"],"text-wrap":[{text:["wrap","nowrap","balance","pretty"]}],indent:[{indent:P()}],"vertical-align":[{align:["baseline","top","middle","bottom","text-top","text-bottom","sub","super",th]}],whitespace:[{whitespace:["normal","nowrap","pre","pre-line","pre-wrap","break-spaces"]}],break:[{break:["normal","words","all","keep"]}],hyphens:[{hyphens:["none","manual","auto"]}],content:[{content:["none",th]}],"bg-attachment":[{bg:["fixed","local","scroll"]}],"bg-clip":[{"bg-clip":["border","padding","content","text"]}],"bg-opacity":[{"bg-opacity":[y]}],"bg-origin":[{"bg-origin":["border","padding","content"]}],"bg-position":[{bg:[...O(),ty]}],"bg-repeat":[{bg:["no-repeat",{repeat:["","x","y","round","space"]}]}],"bg-size":[{bg:["auto","cover","contain",tg]}],"bg-image":[{bg:["none",{"gradient-to":["t","tr","r","br","b","bl","l","tl"]},tv]}],"bg-color":[{bg:[e]}],"gradient-from-pos":[{from:[m]}],"gradient-via-pos":[{via:[m]}],"gradient-to-pos":[{to:[m]}],"gradient-from":[{from:[h]}],"gradient-via":[{via:[h]}],"gradient-to":[{to:[h]}],rounded:[{rounded:[o]}],"rounded-s":[{"rounded-s":[o]}],"rounded-e":[{"rounded-e":[o]}],"rounded-t":[{"rounded-t":[o]}],"rounded-r":[{"rounded-r":[o]}],"rounded-b":[{"rounded-b":[o]}],"rounded-l":[{"rounded-l":[o]}],"rounded-ss":[{"rounded-ss":[o]}],"rounded-se":[{"rounded-se":[o]}],"rounded-ee":[{"rounded-ee":[o]}],"rounded-es":[{"rounded-es":[o]}],"rounded-tl":[{"rounded-tl":[o]}],"rounded-tr":[{"rounded-tr":[o]}],"rounded-br":[{"rounded-br":[o]}],"rounded-bl":[{"rounded-bl":[o]}],"border-w":[{border:[s]}],"border-w-x":[{"border-x":[s]}],"border-w-y":[{"border-y":[s]}],"border-w-s":[{"border-s":[s]}],"border-w-e":[{"border-e":[s]}],"border-w-t":[{"border-t":[s]}],"border-w-r":[{"border-r":[s]}],"border-w-b":[{"border-b":[s]}],"border-w-l":[{"border-l":[s]}],"border-opacity":[{"border-opacity":[y]}],"border-style":[{border:[...x(),"hidden"]}],"divide-x":[{"divide-x":[s]}],"divide-x-reverse":["divide-x-reverse"],"divide-y":[{"divide-y":[s]}],"divide-y-reverse":["divide-y-reverse"],"divide-opacity":[{"divide-opacity":[y]}],"divide-style":[{divide:x()}],"border-color":[{border:[a]}],"border-color-x":[{"border-x":[a]}],"border-color-y":[{"border-y":[a]}],"border-color-s":[{"border-s":[a]}],"border-color-e":[{"border-e":[a]}],"border-color-t":[{"border-t":[a]}],"border-color-r":[{"border-r":[a]}],"border-color-b":[{"border-b":[a]}],"border-color-l":[{"border-l":[a]}],"divide-color":[{divide:[a]}],"outline-style":[{outline:["",...x()]}],"outline-offset":[{"outline-offset":[ts,th]}],"outline-w":[{outline:[ts,tl]}],"outline-color":[{outline:[e]}],"ring-w":[{ring:T()}],"ring-w-inset":["ring-inset"],"ring-color":[{ring:[e]}],"ring-opacity":[{"ring-opacity":[y]}],"ring-offset-w":[{"ring-offset":[ts,tl]}],"ring-offset-color":[{"ring-offset":[e]}],shadow:[{shadow:["","inner","none",tm,tA]}],"shadow-color":[{shadow:[tC]}],opacity:[{opacity:[y]}],"mix-blend":[{"mix-blend":[...D(),"plus-lighter","plus-darker"]}],"bg-blend":[{"bg-blend":D()}],filter:[{filter:["","none"]}],blur:[{blur:[t]}],brightness:[{brightness:[i]}],contrast:[{contrast:[l]}],"drop-shadow":[{"drop-shadow":["","none",tm,th]}],grayscale:[{grayscale:[c]}],"hue-rotate":[{"hue-rotate":[d]}],invert:[{invert:[p]}],saturate:[{saturate:[v]}],sepia:[{sepia:[C]}],"backdrop-filter":[{"backdrop-filter":["","none"]}],"backdrop-blur":[{"backdrop-blur":[t]}],"backdrop-brightness":[{"backdrop-brightness":[i]}],"backdrop-contrast":[{"backdrop-contrast":[l]}],"backdrop-grayscale":[{"backdrop-grayscale":[c]}],"backdrop-hue-rotate":[{"backdrop-hue-rotate":[d]}],"backdrop-invert":[{"backdrop-invert":[p]}],"backdrop-opacity":[{"backdrop-opacity":[y]}],"backdrop-saturate":[{"backdrop-saturate":[v]}],"backdrop-sepia":[{"backdrop-sepia":[C]}],"border-collapse":[{border:["collapse","separate"]}],"border-spacing":[{"border-spacing":[r]}],"border-spacing-x":[{"border-spacing-x":[r]}],"border-spacing-y":[{"border-spacing-y":[r]}],"table-layout":[{table:["auto","fixed"]}],caption:[{caption:["top","bottom"]}],transition:[{transition:["none","all","","colors","opacity","shadow","transform",th]}],duration:[{duration:H()}],ease:[{ease:["linear","in","out","in-out",th]}],delay:[{delay:H()}],animate:[{animate:["none","spin","ping","pulse","bounce",th]}],transform:[{transform:["","gpu","none"]}],scale:[{scale:[A]}],"scale-x":[{"scale-x":[A]}],"scale-y":[{"scale-y":[A]}],rotate:[{rotate:[tp,th]}],"translate-x":[{"translate-x":[_]}],"translate-y":[{"translate-y":[_]}],"skew-x":[{"skew-x":[w]}],"skew-y":[{"skew-y":[w]}],"transform-origin":[{origin:["center","top","top-right","right","bottom-right","bottom","bottom-left","left","top-left",th]}],accent:[{accent:["auto",e]}],appearance:[{appearance:["none","auto"]}],cursor:[{cursor:["auto","default","pointer","wait","text","move","help","not-allowed","none","context-menu","progress","cell","crosshair","vertical-text","alias","copy","no-drop","grab","grabbing","all-scroll","col-resize","row-resize","n-resize","e-resize","s-resize","w-resize","ne-resize","nw-resize","se-resize","sw-resize","ew-resize","ns-resize","nesw-resize","nwse-resize","zoom-in","zoom-out",th]}],"caret-color":[{caret:[e]}],"pointer-events":[{"pointer-events":["none","auto"]}],resize:[{resize:["none","y","x",""]}],"scroll-behavior":[{scroll:["auto","smooth"]}],"scroll-m":[{"scroll-m":P()}],"scroll-mx":[{"scroll-mx":P()}],"scroll-my":[{"scroll-my":P()}],"scroll-ms":[{"scroll-ms":P()}],"scroll-me":[{"scroll-me":P()}],"scroll-mt":[{"scroll-mt":P()}],"scroll-mr":[{"scroll-mr":P()}],"scroll-mb":[{"scroll-mb":P()}],"scroll-ml":[{"scroll-ml":P()}],"scroll-p":[{"scroll-p":P()}],"scroll-px":[{"scroll-px":P()}],"scroll-py":[{"scroll-py":P()}],"scroll-ps":[{"scroll-ps":P()}],"scroll-pe":[{"scroll-pe":P()}],"scroll-pt":[{"scroll-pt":P()}],"scroll-pr":[{"scroll-pr":P()}],"scroll-pb":[{"scroll-pb":P()}],"scroll-pl":[{"scroll-pl":P()}],"snap-align":[{snap:["start","end","center","align-none"]}],"snap-stop":[{snap:["normal","always"]}],"snap-type":[{snap:["none","x","y","both"]}],"snap-strictness":[{snap:["mandatory","proximity"]}],touch:[{touch:["auto","none","manipulation"]}],"touch-x":[{"touch-pan":["x","left","right"]}],"touch-y":[{"touch-pan":["y","up","down"]}],"touch-pz":["touch-pinch-zoom"],select:[{select:["none","text","all","auto"]}],"will-change":[{"will-change":["auto","scroll","contents","transform",th]}],fill:[{fill:[e,"none"]}],"stroke-w":[{stroke:[ts,tl,td]}],stroke:[{stroke:[e,"none"]}],sr:["sr-only","not-sr-only"],"forced-color-adjust":[{"forced-color-adjust":["auto","none"]}]},conflictingClassGroups:{overflow:["overflow-x","overflow-y"],overscroll:["overscroll-x","overscroll-y"],inset:["inset-x","inset-y","start","end","top","right","bottom","left"],"inset-x":["right","left"],"inset-y":["top","bottom"],flex:["basis","grow","shrink"],gap:["gap-x","gap-y"],p:["px","py","ps","pe","pt","pr","pb","pl"],px:["pr","pl"],py:["pt","pb"],m:["mx","my","ms","me","mt","mr","mb","ml"],mx:["mr","ml"],my:["mt","mb"],size:["w","h"],"font-size":["leading"],"fvn-normal":["fvn-ordinal","fvn-slashed-zero","fvn-figure","fvn-spacing","fvn-fraction"],"fvn-ordinal":["fvn-normal"],"fvn-slashed-zero":["fvn-normal"],"fvn-figure":["fvn-normal"],"fvn-spacing":["fvn-normal"],"fvn-fraction":["fvn-normal"],"line-clamp":["display","overflow"],rounded:["rounded-s","rounded-e","rounded-t","rounded-r","rounded-b","rounded-l","rounded-ss","rounded-se","rounded-ee","rounded-es","rounded-tl","rounded-tr","rounded-br","rounded-bl"],"rounded-s":["rounded-ss","rounded-es"],"rounded-e":["rounded-se","rounded-ee"],"rounded-t":["rounded-tl","rounded-tr"],"rounded-r":["rounded-tr","rounded-br"],"rounded-b":["rounded-br","rounded-bl"],"rounded-l":["rounded-tl","rounded-bl"],"border-spacing":["border-spacing-x","border-spacing-y"],"border-w":["border-w-s","border-w-e","border-w-t","border-w-r","border-w-b","border-w-l"],"border-w-x":["border-w-r","border-w-l"],"border-w-y":["border-w-t","border-w-b"],"border-color":["border-color-s","border-color-e","border-color-t","border-color-r","border-color-b","border-color-l"],"border-color-x":["border-color-r","border-color-l"],"border-color-y":["border-color-t","border-color-b"],"scroll-m":["scroll-mx","scroll-my","scroll-ms","scroll-me","scroll-mt","scroll-mr","scroll-mb","scroll-ml"],"scroll-mx":["scroll-mr","scroll-ml"],"scroll-my":["scroll-mt","scroll-mb"],"scroll-p":["scroll-px","scroll-py","scroll-ps","scroll-pe","scroll-pt","scroll-pr","scroll-pb","scroll-pl"],"scroll-px":["scroll-pr","scroll-pl"],"scroll-py":["scroll-pt","scroll-pb"],touch:["touch-x","touch-y","touch-pz"],"touch-x":["touch"],"touch-y":["touch"],"touch-pz":["touch"]},conflictingClassGroupModifiers:{"font-size":["leading"]}}});function tP(...e){return tI(nU(e))}let tT=u.forwardRef(({className:e,type:n,...t},i)=>(0,p.jsx)("input",{type:n,className:tP("flex h-9 w-full rounded-md border border-input bg-transparent px-3 py-1 text-base shadow-sm transition-colors file:border-0 file:bg-transparent file:text-sm file:font-medium file:text-foreground placeholder:text-muted-foreground focus-visible:outline-none focus-visible:ring-1 focus-visible:ring-ring disabled:cursor-not-allowed disabled:opacity-50 md:text-sm",e),ref:i,...t}));function tR(e,n){if("function"==typeof e)return e(n);null!=e&&(e.current=n)}function tO(...e){return n=>{let t=!1,i=e.map(e=>{let i=tR(e,n);return t||"function"!=typeof i||(t=!0),i});if(t)return()=>{for(let n=0;n<i.length;n++){let t=i[n];"function"==typeof t?t():tR(e[n],null)}}}}function tx(...e){return u.useCallback(tO(...e),e)}function tD(e){let n=function(e){let n=u.forwardRef((e,n)=>{let{children:t,...i}=e;if(u.isValidElement(t)){let e,a;let o=(e=Object.getOwnPropertyDescriptor(t.props,"ref")?.get)&&"isReactWarning"in e&&e.isReactWarning?t.ref:(e=Object.getOwnPropertyDescriptor(t,"ref")?.get)&&"isReactWarning"in e&&e.isReactWarning?t.props.ref:t.props.ref||t.ref,r=function(e,n){let t={...n};for(let i in n){let a=e[i],o=n[i];/^on[A-Z]/.test(i)?a&&o?t[i]=(...e)=>{o(...e),a(...e)}:a&&(t[i]=a):"style"===i?t[i]={...a,...o}:"className"===i&&(t[i]=[a,o].filter(Boolean).join(" "))}return{...e,...t}}(i,t.props);return t.type!==u.Fragment&&(r.ref=n?tO(n,o):o),u.cloneElement(t,r)}return u.Children.count(t)>1?u.Children.only(null):null});return n.displayName=`${e}.SlotClone`,n}(e),t=u.forwardRef((e,t)=>{let{children:i,...a}=e,o=u.Children.toArray(i),r=o.find(tL);if(r){let e=r.props.children,i=o.map(n=>n!==r?n:u.Children.count(e)>1?u.Children.only(null):u.isValidElement(e)?e.props.children:null);return(0,p.jsx)(n,{...a,ref:t,children:u.isValidElement(e)?u.cloneElement(e,void 0,i):null})}return(0,p.jsx)(n,{...a,ref:t,children:i})});return t.displayName=`${e}.Slot`,t}tT.displayName="Input";var tN=tD("Slot"),tk=Symbol("radix.slottable");function tL(e){return u.isValidElement(e)&&"function"==typeof e.type&&"__radixId"in e.type&&e.type.__radixId===tk}let tH=e=>"boolean"==typeof e?`${e}`:0===e?"0":e,tF=(e,n)=>t=>{var i;if((null==n?void 0:n.variants)==null)return nU(e,null==t?void 0:t.class,null==t?void 0:t.className);let{variants:a,defaultVariants:o}=n,r=Object.keys(a).map(e=>{let n=null==t?void 0:t[e],i=null==o?void 0:o[e];if(null===n)return null;let r=tH(n)||tH(i);return a[e][r]}),s=t&&Object.entries(t).reduce((e,n)=>{let[t,i]=n;return void 0===i||(e[t]=i),e},{});return nU(e,r,null==n?void 0:null===(i=n.compoundVariants)||void 0===i?void 0:i.reduce((e,n)=>{let{class:t,className:i,...a}=n;return Object.entries(a).every(e=>{let[n,t]=e;return Array.isArray(t)?t.includes({...o,...s}[n]):({...o,...s})[n]===t})?[...e,t,i]:e},[]),null==t?void 0:t.class,null==t?void 0:t.className)},tB=tF("inline-flex items-center justify-center gap-2 whitespace-nowrap rounded-md text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 focus-visible:ring-ring disabled:pointer-events-none disabled:opacity-50 [&_svg]:pointer-events-none [&_svg]:size-4 [&_svg]:shrink-0",{variants:{variant:{default:"bg-primary text-primary-foreground shadow hover:bg-primary/90",destructive:"bg-destructive text-destructive-foreground shadow-sm hover:bg-destructive/90",outline:"border border-input bg-background shadow-sm hover:bg-accent hover:text-accent-foreground",secondary:"bg-secondary text-secondary-foreground shadow-sm hover:bg-secondary/80",ghost:"hover:bg-accent hover:text-accent-foreground",link:"text-primary underline-offset-4 hover:underline"},size:{default:"h-9 px-4 py-2",sm:"h-8 rounded-md px-3 text-xs",lg:"h-10 rounded-md px-8",icon:"h-9 w-9"}},defaultVariants:{variant:"default",size:"default"}}),tj=u.forwardRef(({className:e,variant:n,size:t,asChild:i=!1,...a},o)=>{let r=i?tN:"button";return(0,p.jsx)(r,{className:tP(tB({variant:n,size:t,className:e})),ref:o,...a})});tj.displayName="Button";let tq=u.forwardRef(({className:e,...n},t)=>(0,p.jsx)("div",{ref:t,className:tP("rounded-xl border bg-card text-card-foreground shadow",e),...n}));tq.displayName="Card";let tV=u.forwardRef(({className:e,...n},t)=>(0,p.jsx)("div",{ref:t,className:tP("flex flex-col space-y-1.5 p-6",e),...n}));tV.displayName="CardHeader";let tz=u.forwardRef(({className:e,...n},t)=>(0,p.jsx)("div",{ref:t,className:tP("font-semibold leading-none tracking-tight",e),...n}));tz.displayName="CardTitle";let tU=u.forwardRef(({className:e,...n},t)=>(0,p.jsx)("div",{ref:t,className:tP("text-sm text-muted-foreground",e),...n}));tU.displayName="CardDescription";let tG=u.forwardRef(({className:e,...n},t)=>(0,p.jsx)("div",{ref:t,className:tP("p-6 pt-0",e),...n}));tG.displayName="CardContent",u.forwardRef(({className:e,...n},t)=>(0,p.jsx)("div",{ref:t,className:tP("flex items-center p-6 pt-0",e),...n})).displayName="CardFooter";var tW=t(3462),tY=["a","button","div","form","h2","h3","img","input","label","li","nav","ol","p","span","svg","ul"].reduce((e,n)=>{let t=tD(`Primitive.${n}`),i=u.forwardRef((e,i)=>{let{asChild:a,...o}=e,r=a?t:n;return"undefined"!=typeof window&&(window[Symbol.for("radix-ui")]=!0),(0,p.jsx)(r,{...o,ref:i})});return i.displayName=`Primitive.${n}`,{...e,[n]:i}},{}),tX=globalThis?.document?u.useLayoutEffect:()=>{},t$=e=>{let{present:n,children:t}=e,i=function(e){var n,t;let[i,a]=u.useState(),o=u.useRef({}),r=u.useRef(e),s=u.useRef("none"),[l,c]=(n=e?"mounted":"unmounted",t={mounted:{UNMOUNT:"unmounted",ANIMATION_OUT:"unmountSuspended"},unmountSuspended:{MOUNT:"mounted",ANIMATION_END:"unmounted"},unmounted:{MOUNT:"mounted"}},u.useReducer((e,n)=>t[e][n]??e,n));return u.useEffect(()=>{let e=tK(o.current);s.current="mounted"===l?e:"none"},[l]),tX(()=>{let n=o.current,t=r.current;if(t!==e){let i=s.current,a=tK(n);e?c("MOUNT"):"none"===a||n?.display==="none"?c("UNMOUNT"):t&&i!==a?c("ANIMATION_OUT"):c("UNMOUNT"),r.current=e}},[e,c]),tX(()=>{if(i){let e;let n=i.ownerDocument.defaultView??window,t=t=>{let a=tK(o.current).includes(t.animationName);if(t.target===i&&a&&(c("ANIMATION_END"),!r.current)){let t=i.style.animationFillMode;i.style.animationFillMode="forwards",e=n.setTimeout(()=>{"forwards"===i.style.animationFillMode&&(i.style.animationFillMode=t)})}},a=e=>{e.target===i&&(s.current=tK(o.current))};return i.addEventListener("animationstart",a),i.addEventListener("animationcancel",t),i.addEventListener("animationend",t),()=>{n.clearTimeout(e),i.removeEventListener("animationstart",a),i.removeEventListener("animationcancel",t),i.removeEventListener("animationend",t)}}c("ANIMATION_END")},[i,c]),{isPresent:["mounted","unmountSuspended"].includes(l),ref:u.useCallback(e=>{e&&(o.current=getComputedStyle(e)),a(e)},[])}}(n),a="function"==typeof t?t({present:i.isPresent}):u.Children.only(t),o=tx(i.ref,function(e){let n=Object.getOwnPropertyDescriptor(e.props,"ref")?.get,t=n&&"isReactWarning"in n&&n.isReactWarning;return t?e.ref:(t=(n=Object.getOwnPropertyDescriptor(e,"ref")?.get)&&"isReactWarning"in n&&n.isReactWarning)?e.props.ref:e.props.ref||e.ref}(a));return"function"==typeof t||i.isPresent?u.cloneElement(a,{ref:o}):null};function tK(e){return e?.animationName||"none"}function tJ(e,n=[]){let t=[],i=()=>{let n=t.map(e=>u.createContext(e));return function(t){let i=t?.[e]||n;return u.useMemo(()=>({[`__scope${e}`]:{...t,[e]:i}}),[t,i])}};return i.scopeName=e,[function(n,i){let a=u.createContext(i),o=t.length;t=[...t,i];let r=n=>{let{scope:t,children:i,...r}=n,s=t?.[e]?.[o]||a,l=u.useMemo(()=>r,Object.values(r));return(0,p.jsx)(s.Provider,{value:l,children:i})};return r.displayName=n+"Provider",[r,function(t,r){let s=r?.[e]?.[o]||a,l=u.useContext(s);if(l)return l;if(void 0!==i)return i;throw Error(`\`${t}\` must be used within \`${n}\``)}]},function(...e){let n=e[0];if(1===e.length)return n;let t=()=>{let t=e.map(e=>({useScope:e(),scopeName:e.scopeName}));return function(e){let i=t.reduce((n,{useScope:t,scopeName:i})=>{let a=t(e)[`__scope${i}`];return{...n,...a}},{});return u.useMemo(()=>({[`__scope${n.scopeName}`]:i}),[i])}};return t.scopeName=n.scopeName,t}(i,...n)]}function tQ(e){let n=u.useRef(e);return u.useEffect(()=>{n.current=e}),u.useMemo(()=>(...e)=>n.current?.(...e),[])}t$.displayName="Presence";var tZ=u.createContext(void 0);function t0(e){let n=u.useContext(tZ);return e||n||"ltr"}function t1(e,[n,t]){return Math.min(t,Math.max(n,e))}function t2(e,n,{checkForDefaultPrevented:t=!0}={}){return function(i){if(e?.(i),!1===t||!i.defaultPrevented)return n?.(i)}}var t3="ScrollArea",[t4,t8]=tJ(t3),[t5,t7]=t4(t3),t6=u.forwardRef((e,n)=>{let{__scopeScrollArea:t,type:i="hover",dir:a,scrollHideDelay:o=600,...r}=e,[s,l]=u.useState(null),[c,d]=u.useState(null),[h,m]=u.useState(null),[f,g]=u.useState(null),[y,b]=u.useState(null),[v,A]=u.useState(0),[C,w]=u.useState(0),[S,_]=u.useState(!1),[E,M]=u.useState(!1),I=tx(n,e=>l(e)),P=t0(a);return(0,p.jsx)(t5,{scope:t,type:i,dir:P,scrollHideDelay:o,scrollArea:s,viewport:c,onViewportChange:d,content:h,onContentChange:m,scrollbarX:f,onScrollbarXChange:g,scrollbarXEnabled:S,onScrollbarXEnabledChange:_,scrollbarY:y,onScrollbarYChange:b,scrollbarYEnabled:E,onScrollbarYEnabledChange:M,onCornerWidthChange:A,onCornerHeightChange:w,children:(0,p.jsx)(tY.div,{dir:P,...r,ref:I,style:{position:"relative","--radix-scroll-area-corner-width":v+"px","--radix-scroll-area-corner-height":C+"px",...e.style}})})});t6.displayName=t3;var t9="ScrollAreaViewport",ie=u.forwardRef((e,n)=>{let{__scopeScrollArea:t,children:i,nonce:a,...o}=e,r=t7(t9,t),s=tx(n,u.useRef(null),r.onViewportChange);return(0,p.jsxs)(p.Fragment,{children:[(0,p.jsx)("style",{dangerouslySetInnerHTML:{__html:"[data-radix-scroll-area-viewport]{scrollbar-width:none;-ms-overflow-style:none;-webkit-overflow-scrolling:touch;}[data-radix-scroll-area-viewport]::-webkit-scrollbar{display:none}"},nonce:a}),(0,p.jsx)(tY.div,{"data-radix-scroll-area-viewport":"",...o,ref:s,style:{overflowX:r.scrollbarXEnabled?"scroll":"hidden",overflowY:r.scrollbarYEnabled?"scroll":"hidden",...e.style},children:(0,p.jsx)("div",{ref:r.onContentChange,style:{minWidth:"100%",display:"table"},children:i})})]})});ie.displayName=t9;var it="ScrollAreaScrollbar",ii=u.forwardRef((e,n)=>{let{forceMount:t,...i}=e,a=t7(it,e.__scopeScrollArea),{onScrollbarXEnabledChange:o,onScrollbarYEnabledChange:r}=a,s="horizontal"===e.orientation;return u.useEffect(()=>(s?o(!0):r(!0),()=>{s?o(!1):r(!1)}),[s,o,r]),"hover"===a.type?(0,p.jsx)(ia,{...i,ref:n,forceMount:t}):"scroll"===a.type?(0,p.jsx)(io,{...i,ref:n,forceMount:t}):"auto"===a.type?(0,p.jsx)(ir,{...i,ref:n,forceMount:t}):"always"===a.type?(0,p.jsx)(is,{...i,ref:n}):null});ii.displayName=it;var ia=u.forwardRef((e,n)=>{let{forceMount:t,...i}=e,a=t7(it,e.__scopeScrollArea),[o,r]=u.useState(!1);return u.useEffect(()=>{let e=a.scrollArea,n=0;if(e){let t=()=>{window.clearTimeout(n),r(!0)},i=()=>{n=window.setTimeout(()=>r(!1),a.scrollHideDelay)};return e.addEventListener("pointerenter",t),e.addEventListener("pointerleave",i),()=>{window.clearTimeout(n),e.removeEventListener("pointerenter",t),e.removeEventListener("pointerleave",i)}}},[a.scrollArea,a.scrollHideDelay]),(0,p.jsx)(t$,{present:t||o,children:(0,p.jsx)(ir,{"data-state":o?"visible":"hidden",...i,ref:n})})}),io=u.forwardRef((e,n)=>{var t,i;let{forceMount:a,...o}=e,r=t7(it,e.__scopeScrollArea),s="horizontal"===e.orientation,l=iM(()=>d("SCROLL_END"),100),[c,d]=(t="hidden",i={hidden:{SCROLL:"scrolling"},scrolling:{SCROLL_END:"idle",POINTER_ENTER:"interacting"},interacting:{SCROLL:"interacting",POINTER_LEAVE:"idle"},idle:{HIDE:"hidden",SCROLL:"scrolling",POINTER_ENTER:"interacting"}},u.useReducer((e,n)=>i[e][n]??e,t));return u.useEffect(()=>{if("idle"===c){let e=window.setTimeout(()=>d("HIDE"),r.scrollHideDelay);return()=>window.clearTimeout(e)}},[c,r.scrollHideDelay,d]),u.useEffect(()=>{let e=r.viewport,n=s?"scrollLeft":"scrollTop";if(e){let t=e[n],i=()=>{let i=e[n];t!==i&&(d("SCROLL"),l()),t=i};return e.addEventListener("scroll",i),()=>e.removeEventListener("scroll",i)}},[r.viewport,s,d,l]),(0,p.jsx)(t$,{present:a||"hidden"!==c,children:(0,p.jsx)(is,{"data-state":"hidden"===c?"hidden":"visible",...o,ref:n,onPointerEnter:t2(e.onPointerEnter,()=>d("POINTER_ENTER")),onPointerLeave:t2(e.onPointerLeave,()=>d("POINTER_LEAVE"))})})}),ir=u.forwardRef((e,n)=>{let t=t7(it,e.__scopeScrollArea),{forceMount:i,...a}=e,[o,r]=u.useState(!1),s="horizontal"===e.orientation,l=iM(()=>{if(t.viewport){let e=t.viewport.offsetWidth<t.viewport.scrollWidth,n=t.viewport.offsetHeight<t.viewport.scrollHeight;r(s?e:n)}},10);return iI(t.viewport,l),iI(t.content,l),(0,p.jsx)(t$,{present:i||o,children:(0,p.jsx)(is,{"data-state":o?"visible":"hidden",...a,ref:n})})}),is=u.forwardRef((e,n)=>{let{orientation:t="vertical",...i}=e,a=t7(it,e.__scopeScrollArea),o=u.useRef(null),r=u.useRef(0),[s,l]=u.useState({content:0,viewport:0,scrollbar:{size:0,paddingStart:0,paddingEnd:0}}),c=iC(s.viewport,s.content),d={...i,sizes:s,onSizesChange:l,hasThumb:!!(c>0&&c<1),onThumbChange:e=>o.current=e,onThumbPointerUp:()=>r.current=0,onThumbPointerDown:e=>r.current=e};function h(e,n){return function(e,n,t,i="ltr"){let a=iw(t),o=n||a/2,r=t.scrollbar.paddingStart+o,s=t.scrollbar.size-t.scrollbar.paddingEnd-(a-o),l=t.content-t.viewport;return i_([r,s],"ltr"===i?[0,l]:[-1*l,0])(e)}(e,r.current,s,n)}return"horizontal"===t?(0,p.jsx)(il,{...d,ref:n,onThumbPositionChange:()=>{if(a.viewport&&o.current){let e=iS(a.viewport.scrollLeft,s,a.dir);o.current.style.transform=`translate3d(${e}px, 0, 0)`}},onWheelScroll:e=>{a.viewport&&(a.viewport.scrollLeft=e)},onDragScroll:e=>{a.viewport&&(a.viewport.scrollLeft=h(e,a.dir))}}):"vertical"===t?(0,p.jsx)(ic,{...d,ref:n,onThumbPositionChange:()=>{if(a.viewport&&o.current){let e=iS(a.viewport.scrollTop,s);o.current.style.transform=`translate3d(0, ${e}px, 0)`}},onWheelScroll:e=>{a.viewport&&(a.viewport.scrollTop=e)},onDragScroll:e=>{a.viewport&&(a.viewport.scrollTop=h(e))}}):null}),il=u.forwardRef((e,n)=>{let{sizes:t,onSizesChange:i,...a}=e,o=t7(it,e.__scopeScrollArea),[r,s]=u.useState(),l=u.useRef(null),c=tx(n,l,o.onScrollbarXChange);return u.useEffect(()=>{l.current&&s(getComputedStyle(l.current))},[l]),(0,p.jsx)(iu,{"data-orientation":"horizontal",...a,ref:c,sizes:t,style:{bottom:0,left:"rtl"===o.dir?"var(--radix-scroll-area-corner-width)":0,right:"ltr"===o.dir?"var(--radix-scroll-area-corner-width)":0,"--radix-scroll-area-thumb-width":iw(t)+"px",...e.style},onThumbPointerDown:n=>e.onThumbPointerDown(n.x),onDragScroll:n=>e.onDragScroll(n.x),onWheelScroll:(n,t)=>{if(o.viewport){let i=o.viewport.scrollLeft+n.deltaX;e.onWheelScroll(i),function(e,n){return e>0&&e<n}(i,t)&&n.preventDefault()}},onResize:()=>{l.current&&o.viewport&&r&&i({content:o.viewport.scrollWidth,viewport:o.viewport.offsetWidth,scrollbar:{size:l.current.clientWidth,paddingStart:iA(r.paddingLeft),paddingEnd:iA(r.paddingRight)}})}})}),ic=u.forwardRef((e,n)=>{let{sizes:t,onSizesChange:i,...a}=e,o=t7(it,e.__scopeScrollArea),[r,s]=u.useState(),l=u.useRef(null),c=tx(n,l,o.onScrollbarYChange);return u.useEffect(()=>{l.current&&s(getComputedStyle(l.current))},[l]),(0,p.jsx)(iu,{"data-orientation":"vertical",...a,ref:c,sizes:t,style:{top:0,right:"ltr"===o.dir?0:void 0,left:"rtl"===o.dir?0:void 0,bottom:"var(--radix-scroll-area-corner-height)","--radix-scroll-area-thumb-height":iw(t)+"px",...e.style},onThumbPointerDown:n=>e.onThumbPointerDown(n.y),onDragScroll:n=>e.onDragScroll(n.y),onWheelScroll:(n,t)=>{if(o.viewport){let i=o.viewport.scrollTop+n.deltaY;e.onWheelScroll(i),function(e,n){return e>0&&e<n}(i,t)&&n.preventDefault()}},onResize:()=>{l.current&&o.viewport&&r&&i({content:o.viewport.scrollHeight,viewport:o.viewport.offsetHeight,scrollbar:{size:l.current.clientHeight,paddingStart:iA(r.paddingTop),paddingEnd:iA(r.paddingBottom)}})}})}),[id,ip]=t4(it),iu=u.forwardRef((e,n)=>{let{__scopeScrollArea:t,sizes:i,hasThumb:a,onThumbChange:o,onThumbPointerUp:r,onThumbPointerDown:s,onThumbPositionChange:l,onDragScroll:c,onWheelScroll:d,onResize:h,...m}=e,f=t7(it,t),[g,y]=u.useState(null),b=tx(n,e=>y(e)),v=u.useRef(null),A=u.useRef(""),C=f.viewport,w=i.content-i.viewport,S=tQ(d),_=tQ(l),E=iM(h,10);function M(e){v.current&&c({x:e.clientX-v.current.left,y:e.clientY-v.current.top})}return u.useEffect(()=>{let e=e=>{let n=e.target;g?.contains(n)&&S(e,w)};return document.addEventListener("wheel",e,{passive:!1}),()=>document.removeEventListener("wheel",e,{passive:!1})},[C,g,w,S]),u.useEffect(_,[i,_]),iI(g,E),iI(f.content,E),(0,p.jsx)(id,{scope:t,scrollbar:g,hasThumb:a,onThumbChange:tQ(o),onThumbPointerUp:tQ(r),onThumbPositionChange:_,onThumbPointerDown:tQ(s),children:(0,p.jsx)(tY.div,{...m,ref:b,style:{position:"absolute",...m.style},onPointerDown:t2(e.onPointerDown,e=>{0===e.button&&(e.target.setPointerCapture(e.pointerId),v.current=g.getBoundingClientRect(),A.current=document.body.style.webkitUserSelect,document.body.style.webkitUserSelect="none",f.viewport&&(f.viewport.style.scrollBehavior="auto"),M(e))}),onPointerMove:t2(e.onPointerMove,M),onPointerUp:t2(e.onPointerUp,e=>{let n=e.target;n.hasPointerCapture(e.pointerId)&&n.releasePointerCapture(e.pointerId),document.body.style.webkitUserSelect=A.current,f.viewport&&(f.viewport.style.scrollBehavior=""),v.current=null})})})}),ih="ScrollAreaThumb",im=u.forwardRef((e,n)=>{let{forceMount:t,...i}=e,a=ip(ih,e.__scopeScrollArea);return(0,p.jsx)(t$,{present:t||a.hasThumb,children:(0,p.jsx)(ig,{ref:n,...i})})}),ig=u.forwardRef((e,n)=>{let{__scopeScrollArea:t,style:i,...a}=e,o=t7(ih,t),r=ip(ih,t),{onThumbPositionChange:s}=r,l=tx(n,e=>r.onThumbChange(e)),c=u.useRef(void 0),d=iM(()=>{c.current&&(c.current(),c.current=void 0)},100);return u.useEffect(()=>{let e=o.viewport;if(e){let n=()=>{if(d(),!c.current){let n=iE(e,s);c.current=n,s()}};return s(),e.addEventListener("scroll",n),()=>e.removeEventListener("scroll",n)}},[o.viewport,d,s]),(0,p.jsx)(tY.div,{"data-state":r.hasThumb?"visible":"hidden",...a,ref:l,style:{width:"var(--radix-scroll-area-thumb-width)",height:"var(--radix-scroll-area-thumb-height)",...i},onPointerDownCapture:t2(e.onPointerDownCapture,e=>{let n=e.target.getBoundingClientRect(),t=e.clientX-n.left,i=e.clientY-n.top;r.onThumbPointerDown({x:t,y:i})}),onPointerUp:t2(e.onPointerUp,r.onThumbPointerUp)})});im.displayName=ih;var iy="ScrollAreaCorner",ib=u.forwardRef((e,n)=>{let t=t7(iy,e.__scopeScrollArea),i=!!(t.scrollbarX&&t.scrollbarY);return"scroll"!==t.type&&i?(0,p.jsx)(iv,{...e,ref:n}):null});ib.displayName=iy;var iv=u.forwardRef((e,n)=>{let{__scopeScrollArea:t,...i}=e,a=t7(iy,t),[o,r]=u.useState(0),[s,l]=u.useState(0),c=!!(o&&s);return iI(a.scrollbarX,()=>{let e=a.scrollbarX?.offsetHeight||0;a.onCornerHeightChange(e),l(e)}),iI(a.scrollbarY,()=>{let e=a.scrollbarY?.offsetWidth||0;a.onCornerWidthChange(e),r(e)}),c?(0,p.jsx)(tY.div,{...i,ref:n,style:{width:o,height:s,position:"absolute",right:"ltr"===a.dir?0:void 0,left:"rtl"===a.dir?0:void 0,bottom:0,...e.style}}):null});function iA(e){return e?parseInt(e,10):0}function iC(e,n){let t=e/n;return isNaN(t)?0:t}function iw(e){let n=iC(e.viewport,e.content),t=e.scrollbar.paddingStart+e.scrollbar.paddingEnd;return Math.max((e.scrollbar.size-t)*n,18)}function iS(e,n,t="ltr"){let i=iw(n),a=n.scrollbar.paddingStart+n.scrollbar.paddingEnd,o=n.scrollbar.size-a,r=n.content-n.viewport,s=t1(e,"ltr"===t?[0,r]:[-1*r,0]);return i_([0,r],[0,o-i])(s)}function i_(e,n){return t=>{if(e[0]===e[1]||n[0]===n[1])return n[0];let i=(n[1]-n[0])/(e[1]-e[0]);return n[0]+i*(t-e[0])}}var iE=(e,n=()=>{})=>{let t={left:e.scrollLeft,top:e.scrollTop},i=0;return function a(){let o={left:e.scrollLeft,top:e.scrollTop},r=t.left!==o.left,s=t.top!==o.top;(r||s)&&n(),t=o,i=window.requestAnimationFrame(a)}(),()=>window.cancelAnimationFrame(i)};function iM(e,n){let t=tQ(e),i=u.useRef(0);return u.useEffect(()=>()=>window.clearTimeout(i.current),[]),u.useCallback(()=>{window.clearTimeout(i.current),i.current=window.setTimeout(t,n)},[t,n])}function iI(e,n){let t=tQ(n);tX(()=>{let n=0;if(e){let i=new ResizeObserver(()=>{cancelAnimationFrame(n),n=window.requestAnimationFrame(t)});return i.observe(e),()=>{window.cancelAnimationFrame(n),i.unobserve(e)}}},[e,t])}let iP=u.forwardRef(({className:e,children:n,...t},i)=>(0,p.jsxs)(t6,{ref:i,className:tP("relative overflow-hidden",e),...t,children:[(0,p.jsx)(ie,{className:"h-full w-full rounded-[inherit]",children:n}),(0,p.jsx)(iT,{}),(0,p.jsx)(ib,{})]}));iP.displayName=t6.displayName;let iT=u.forwardRef(({className:e,orientation:n="vertical",...t},i)=>(0,p.jsx)(ii,{ref:i,orientation:n,className:tP("flex touch-none select-none transition-colors","vertical"===n&&"h-full w-2.5 border-l border-l-transparent p-[1px]","horizontal"===n&&"h-2.5 flex-col border-t border-t-transparent p-[1px]",e),...t,children:(0,p.jsx)(im,{className:"relative flex-1 rounded-full bg-border"})}));iT.displayName=ii.displayName;var iR={xmlns:"http://www.w3.org/2000/svg",width:24,height:24,viewBox:"0 0 24 24",fill:"none",stroke:"currentColor",strokeWidth:2,strokeLinecap:"round",strokeLinejoin:"round"};let iO=e=>e.replace(/([a-z0-9])([A-Z])/g,"$1-$2").toLowerCase(),ix=(e,n)=>{let t=(0,u.forwardRef)(({color:t="currentColor",size:i=24,strokeWidth:a=2,absoluteStrokeWidth:o,className:r="",children:s,...l},c)=>(0,u.createElement)("svg",{ref:c,...iR,width:i,height:i,stroke:t,strokeWidth:o?24*Number(a)/Number(i):a,className:["lucide",`lucide-${iO(e)}`,r].join(" "),...l},[...n.map(([e,n])=>(0,u.createElement)(e,n)),...Array.isArray(s)?s:[s]]));return t.displayName=`${e}`,t},iD=ix("Calculator",[["rect",{width:"16",height:"20",x:"4",y:"2",rx:"2",key:"1nb95v"}],["line",{x1:"8",x2:"16",y1:"6",y2:"6",key:"x4nwl0"}],["line",{x1:"16",x2:"16",y1:"14",y2:"18",key:"wjye3r"}],["path",{d:"M16 10h.01",key:"1m94wz"}],["path",{d:"M12 10h.01",key:"1nrarc"}],["path",{d:"M8 10h.01",key:"19clt8"}],["path",{d:"M12 14h.01",key:"1etili"}],["path",{d:"M8 14h.01",key:"6423bh"}],["path",{d:"M12 18h.01",key:"mhygvu"}],["path",{d:"M8 18h.01",key:"lrp35t"}]]),iN=ix("Search",[["circle",{cx:"11",cy:"11",r:"8",key:"4ej97u"}],["path",{d:"m21 21-4.3-4.3",key:"1qie3q"}]]),ik=ix("MessageSquare",[["path",{d:"M21 15a2 2 0 0 1-2 2H7l-4 4V5a2 2 0 0 1 2-2h14a2 2 0 0 1 2 2z",key:"1lielz"}]]),iL=ix("Filter",[["polygon",{points:"22 3 2 3 10 12.46 10 19 14 21 14 12.46 22 3",key:"1yg77f"}]]),iH=ix("CircleX",[["circle",{cx:"12",cy:"12",r:"10",key:"1mglay"}],["path",{d:"m15 9-6 6",key:"1uzhvr"}],["path",{d:"m9 9 6 6",key:"z0biqf"}]]),iF=ix("CircleAlert",[["circle",{cx:"12",cy:"12",r:"10",key:"1mglay"}],["line",{x1:"12",x2:"12",y1:"8",y2:"12",key:"1pkeuh"}],["line",{x1:"12",x2:"12.01",y1:"16",y2:"16",key:"4dfq90"}]]),iB=ix("LoaderCircle",[["path",{d:"M21 12a9 9 0 1 1-6.219-8.56",key:"13zald"}]]),ij=JSON.parse('{"1-1":{"name":"GENERAL PRE-HOSPITAL CARE","content":"Patient care should be initiated at the patients side prior to patient movement or\\ntransport for most medical conditions.  EVERY PATIENT CONTACT BEGINS WITH\\nTHIS PROTOCOL\\n1.  Pediatric patients (< 14 years of age or up to 36 kg) are treated under pediatric\\nprotocols when applicable.\\na.  Refer to MI MEDIC cards for medication dosing and equipment sizes.\\n2.  Assess scene safety and use appropriate personal protective equipment.\\n3.  For trauma refer to 2.2 General Trauma-Treatment Protocol\\n4.  A patient exhibiting any signs of a life-threatening illness or injury shall not be\\nrequired to move on their own.  This includes patients with illnesses of unknown\\netiology.\\n5.  If applicable, refer to 3.7 Adult or 4.9 Pediatric Crashing Patient/Impending\\nArrest-Treatment Protocol.\\n6.  Complete primary survey.\\n7.  When indicated, implement airway intervention per the 7.9 Airway Management-\\nProcedure Protocol.\\n8.  When indicated, administer oxygen, and assist ventilations per the 7.12 Oxygen\\nAdministration-Procedure Protocol.\\n9.  Assess and treat other life-threatening conditions per appropriate protocol.\\n10. Obtain vital signs including pulse oximetry if available or required, approximately\\nevery 15 minutes, or more frequently as necessary to monitor the patients condition\\n(A minimum of 2 sets are required for all patient transports.  Two sets are suggested\\nfor patient refusals and treat and release patients.)\\n11. Perform a secondary survey consistent with patient condition.\\n12. Follow specific protocol for patient condition.\\n13. Document patient care according to the 7.15 Documentation and Patient Care\\nRecords Protocol.\\n14. Establish vascular access per 7.23 Vascular Access & IV Fluid Therapy-\\nProcedure Protocol when fluid or medication administration may be necessary.\\n15. If applicable, apply cardiac monitor and treat rhythm according to appropriate\\nprotocol.\\n16. If applicable, obtain 12-lead ECG (Per MCA selection, may be a BLS or Specialist\\nprocedure) see 7.1 12 Lead ECG-Procedure Protocol.  Provide a copy of the\\nrhythm strip or 12-lead ECG to the receiving facility, be sure to place patient\\nidentifiers on strip.\\n17. Use capnography/capnometry as directed per 7.24 End Tidal Carbon Dioxide\\nMonitoring-Procedure Protocol\\nNOTE:  When possible, provide a list of the patients medications or bring the medications to\\nthe hospital.","source_file":"1.1-GENERAL-PRE-HOSPITAL-CARE-Clean-7.31.24.txt","categories":["adult","trauma","medical","pediatric"]},"1.10":{"name":"FOREIGN BODY AIRWAY OBSTRUCTION","content":"This procedure is intended for situations in which a severe foreign body airway\\nobstruction (FBAO) has occurred. EMS personnel must be able to rapidly initiate\\ntreatment in such cases. EMS personnel should consider these cases to be potential\\ncardiac arrests.\\nFOREIGN BODY AIRWAY OBSTRUCTION\\nThis procedure is intended for situations in which a severe foreign body airway obstruction\\n(FBAO) has occurred. EMS personnel must be able to rapidly initiate treatment in such cases.\\nNote: Sudden cardiac arrest that occurs while a person is eating is frequently dispatched as\\nchoking. EMS personnel should consider these cases to be potential cardiac arrests.\\n1.  In conscious (responsive) adults and children >1 year of age, deliver abdominal thrusts in\\nrapid sequence until the obstruction is relieved.\\n2.  Administer chest thrusts in conscious patients in place of abdominal thrusts when:\\na.  Abdominal thrusts are ineffective (optional consideration)\\nb.  Patient is obese and rescuer is unable to encircle the patients abdomen\\nc.  Patient is in the later stages of pregnancy (e.g., greater than 20 weeks)\\nd.  Patient is under 1 year of age\\ne.  Wheelchair bound patients\\n3.  For conscious infants (under 1 year old) with evidence of severe FBAO:\\na.   Deliver repeated cycles of 5 back blows followed by 5 chest compressions until the\\nobject is expelled or the patient becomes unresponsive.\\nb.  Note: Abdominal thrusts are not recommended for infants because they may damage\\nthe infants relatively large and unprotected liver.\\n4.  If any patient becomes unresponsive or is found unresponsive and is unable to be ventilated\\nusing the 2-person bag-valve-mask technique with oropharyngeal airway start CPR\\n5.  For unconscious patients, while chest compressions are being provided, perform direct\\nlaryngoscopy. If foreign body is visible, remove using adult or pediatric Magill forceps.\\n6.  If unsuccessful in visualizing foreign body, continue chest compressions and repeat direct\\nlaryngoscopy while alternating with attempts to ventilate.\\n7.  Once FBAO is relieved, if spontaneous respiration does not return, refer to 7.9 Airway\\nManagement-Procedure Protocol","source_file":"1.10-FBAO-8.31.23-clean.txt","categories":["adult","medical","pediatric"]},"1.100":{"name":"GENERAL TREATMENT","content":"Diabetic Emergencies\\nThe purpose of this protocol is to provide for the assessment and treatment of patients\\nsuffering from a diabetic emergency.\\nMFR Agencies may carry glucometers and oral glucose paste (optional).\\n1.  Follow 1.1 General Pre-Hospital Care Protocol.\\n2.  Obtain blood glucose level if equipment is available.\\na.  Awake and with a gag reflex\\ni.  If blood glucose is:\\n1.  below 40mg/dl for patients less than or equal to 60 days old;\\n2.  below 60mg/dl for adults and pediatric patients over 60 days old;\\na.  Administer 15 grams of oral glucose, for infants contact\\nmedical direction if IV not available.\\nb.  Re-evaluate after 10 minutes and if the blood sugar does\\nnot improve or only improves slightly repeat the oral\\nglucose or,\\nc.  Establish an IV and,\\nd.  Consider administration of IV Dextrose.\\nNote: At the provider discretion, if available IV Dextrose may be\\ngiven without attempting oral glucose first.\\ni.  Adults IV Dextrose 50% (25g)\\nii.  Pediatric refer to MIMEDIC cards\\nii.  If the blood glucose is normal follow specific protocol for patient condition.\\niii.  For adult if the blood glucose is above 250mg/dl with symptoms of\\nhyperglycemia.\\n1.  Start an IV and administer NS or LR IV bolus, up to 1 L.\\na.  For patients with renal failure or heart failure, decrease\\nvolume to 500 mL.\\n2.  Monitor EKG.\\niv.  For pediatrics if the blood glucose is above 250mg/dl with symptoms of\\nhyperglycemia\\n1.  Contact medical control\\nb.  Altered Mental Status\\ni.  If blood glucose is:\\n1.  below 40mg/dl for patients less or equal to than 60 days old;\\n2.  below 60mg/dl for adults and pediatric patients over 60 days old;\\na.  Establish an IV\\ni.  If unable to establish IV contact Medical Control.\\nb.  Administer IV Dextrose 50% (25g) or small amounts of\\noral glucose.\\nc.  For Pediatrics follow MIMEDIC\\nii.  If blood glucose is normal and the patients mental status is altered refer\\nto 3.1 Altered Mental Status.\\niii.  For adults, if the blood glucose is above 250mg/dl with symptoms of","source_file":"1.100-DIabetic-Emergencies-9-28-23-Clean-Amended.txt","categories":["adult","medical","pediatric"]},"1.101":{"name":"GENERAL TREATMENT","content":"Citizen Assist/Lift Assist\\nThis protocol should be used when dispatched to a citizen assist or lift assist patient.\\nTreatment\\n1.  Follow 1.1 General Pre-Hospital Care Protocol.\\n2.  Perform a patient assessment, follow 7.14 Patient Assessment.\\n3.  Obtain a full set of vital signs.\\n4.  Lift or move the patient as appropriate.\\n5.  Treat any injuries or illness per the appropriate protocol.\\n6.  If the patient requires or requests transport to the hospital transport per 8.33\\nTransportation Protocol.\\n7.  If the patient does not wish to have any further treatment or feels no treatment is\\nnecessary follow 7.19 Refusal of Care Adult and Minor.\\nDocumentation\\n1.  All Citizen Assist/Lift Assist incidents shall be documented in an ePCR.\\n2.  If the patient refuses any treatment or transport, document in the ePCR and on the\\npatient refusal of care form.","source_file":"1.101-Citizen-Assist-Lift-Assist-9.14.23-Clean.txt","categories":["adult"]},"1-2":{"name":"ABDOMINAL PAIN (NON-TRAUMATIC)","content":"1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2.  Conduct physical exam of abdomen including assessment of central and bilateral distal\\npulses.\\n3.  If symptoms of shock present refer to 1.5 Shock-Treatment Protocol.\\n4.  Position patient in a position of comfort if pain is non-traumatic.  If trauma related, refer\\nto 2.2 General Trauma-Treatment Protocol\\n5.  Do not allow patient to drink or eat anything (does not include ODT medications)\\n6.  If patient is experiencing nausea and vomiting refer to 1.3 Nausea and Vomiting-\\nTreatment Protocol.\\n7.  Treat pain per 7.13 Pain Management-Procedure Protocol.\\n8.  Consider 12 Lead (Per MCA selection, may be a BLS or Specialist procedure) follow\\n7.1 12 Lead ECG-Procedure Protocol.","source_file":"1.2-ABDOMINAL-PAIN-NON-TRAUMATIC-8.31.23-Clean.txt","categories":["trauma","medical"]},"1-3":{"name":"NAUSEA & VOMITING","content":"1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2.  Consider underlying causes of nausea and vomiting (i.e., stroke, trauma,\\ncardiac, diabetes etc.) and further evaluate according to appropriate protocol.\\n3.  Pediatric patients (< 14 years of age) utilize MI MEDIC cards for appropriate\\nmedication dosage.  When unavailable utilize pediatric dosing listed within\\nprotocol.\\n4.  Isopropyl alcohol  Consider allowing patient to inhale vapor from isopropyl\\nalcohol wipe 3 times every 15 minutes as tolerated\\n5.  For patients > 30 kg that are not actively vomiting, administer ondansetron\\n(i.e., Zofran) 4mg ODT (availability and licensure level per MCA selection).\\na.  Contraindications: Patients with Phenylketonuria (PKU)\\nODT ondansetron included?\\nYES     NO\\nPer MCA Selection\\nEMT\\nSpecialist\\n6.  For signs of dehydration, administer NS or LR IV/IO fluid bolus (refer to 7.23\\nVascular Access and IV Fluid Therapy-Procedure Protocol).\\na.   Adults: up to 1 liter.\\n  b.   Pediatrics: up to 20 ml/kg\\n7.  Hypotensive patients should receive additional IV/IO fluid boluses, as indicated\\nby hemodynamic state.\\na.  Adults: repeat IV/IO fluid bolus to a maximum of 2 liters.\\n  b.  Pediatrics: repeat dose of 20 ml/kg to a maximum of 40 ml/kg\\nc.   Monitor for pulmonary edema.\\nd.   If pulmonary edema presents, stop fluids and contact Medical Control for\\n  direction.\\n   8. Administer ondansetron IV/IM if ODT not already administered or if patient\\n  vomited post ODT administration. (Per MCA selection, may be a Specialist\\n  skill)\\nOndansetron IV/IM\\nSpecialist\\na.  Adults 4mg IV/IM\\nb.  Pediatrics refer to MI MEDIC cards.\\nc.  i. If MI MEDIC cards are not available administer 0.1 mg/kg IV/IM,\\nmaximum dose of 4 mg","source_file":"1.3-NAUSEA-AND-VOMITING-8.31.23-Clean-Edit.txt","categories":["adult","medical","pediatric"]},"1-4":{"name":"SYNCOPE","content":"Initial Date: 8/31/2023\\nRevised Date:\\nSyncope\\n1.  Assess for mechanism of injury, if trauma sustained, refer to 2.2 General Trauma-\\nTreatment Protocol.\\n2.  Follow 1.1 General Pre-Hospital Care-Treatment Protocol.\\n3.  Pediatric patients (< 14 years of age) utilize MI MEDIC cards for appropriate\\nmedication dosage.  When unavailable utilize pediatric dosing listed within protocol.\\n4.  Position patient\\nA.  If third trimester pregnancy, position patient left lateral recumbent.\\nB.  Supine for all other patients\\n5.  Check blood glucose (may be MFR skill, see 7.21 Blood Glucose Testing-\\nProcedure Protocol)\\n6.  If altered mental status perform stroke assessment and evaluate for stroke per\\n3.2 Stroke/Suspected Stroke-Treatment Protocol\\n7.  If altered mental status, refer to 3.1 Adult or 4.4 Pediatric Altered Mental Status-\\nTreatment Protocol.\\n8.  For signs of dehydration or hypotension, administer NS or LR IV/IO fluid bolus (refer\\nto 7.23 Vascular Access and IV Fluid Therapy-Procedure Protocol).\\nA.  Adults: up to 1 liter\\nB.  Pediatrics: up to 20 mL/kg\\n9.  Hypotensive/dehydrated patients should receive additional IV/IO fluid boluses, as\\nindicated by hemodynamic state.\\na.  Adults: repeat IV/IO fluid bolus to a maximum of 2 liters.\\nb.  Pediatrics: repeat dose of 20 ml/kg to a maximum of 40 ml/kg\\nc.  Monitor for pulmonary edema.\\nd.  If pulmonary edema presents, stop fluids and contact Medical Control\\nfor direction.\\n10. Obtain 12-lead ECG (Per MCA selection, may be a BLS or Specialist procedure)\\nfollow 7.1 12 Lead ECG-Procedure Protocol. If ECG indicates cardiac event or\\ndysrhythmia, refer to appropriate Cardiac Protocol.\\n11. Contact medical control for additional IV fluids.","source_file":"1.4-SYNCOPE-8.31.23-Clean.txt","categories":["adult","trauma","medical","pediatric"]},"1-5":{"name":"SHOCK","content":"Initial Date: 8/31/2023\\nRevised Date:\\nShock\\n1.  Assessment:  Consider etiologies of shock and refer to specific types of\\nshock/injury first if known: 1.6 Anaphylaxis/Allergic Reaction-Treatment\\nProtocol, 2.14 Hemorrhagic Shock-Treatment Protocol, 5.4 Pulmonary\\nEdema/Cardiogenic Shock-Treatment Protocol\\n2.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n3.  Pediatric patients (< 14 years of age) utilize MI MEDIC cards for appropriate\\nmedication dosage.  When unavailable utilize pediatric dosing listed within\\nprotocol.\\n4.  Control major bleeding per 2.13 Bleeding Control (BCON)-Procedure Protocol.\\n5.  Remove all transdermal patches using gloves.\\n6.  Prompt transport per MCA Transport Protocol.\\n7.  Special consideration\\na. If 3rd trimester pregnancy, position patient left lateral recumbent.\\n8.  Obtain vascular access (in a manner that will not delay transport).\\n9.  Administer NS or LR fluid bolus IV/IO (refer to 7.23 Vascular Access and IV Fluid\\nTherapy-Procedure Protocol).\\na. Adults: up to 1 liter wide open,\\nb. Pediatrics: up to 20 ml/kg based on signs and symptoms of shock\\nc. Fluid should be slowed to TKO when SBP greater than 90 mmHg.\\n10. Consider establishing a second large bore IV of NS or LR enroute to the hospital.\\n11. Obtain 12-lead ECG, if suspected cardiac etiology. (Per MCA selection, may be a\\nBLS or Specialist procedure) follow 7.1 12 Lead ECG-Procedure Protocol.\\n12.  If accompanying head injury, refer to 2.12 Head Injury-Treatment Protocol.\\na. Maintain SpO2  90%\\nb. Maintain SBP > 90 mmHg < 140 mmHg\\nc. Do NOT hyperventilate.\\n13. Hypotensive patients should receive additional IV/IO fluid boluses, as indicated by\\nhemodynamic state (consider preparing epi push dose while administering\\nsecond bolus)\\na.  Adults: repeat IV/IO fluid bolus to a maximum of 2 liters.\\nb.  Pediatrics: repeat dose of 20 ml/kg to a maximum of 40 ml/kg\\nc.  Monitor for pulmonary edema.\\nd.  If pulmonary edema presents, stop fluids and contact Medical Control\\nfor direction.\\n14.  If hypotension persists after IV/IO fluid bolus, administer epinephrine IV/IO by\\npush dose (dilute boluses) while administering second fluid bolus.\\na.  Prepare (epinephrine 10 mcg/mL) by combining 1mL of 1mg/10mL\\n      epinephrine in 9mL NS, then\\na.  Adults:\\ni.  Administer 10-20 mcg (1-2 mL epinephrine 10 mcg/mL) IV/IO\\nii.  Repeat every 3 to 5 minutes\\niii.  Titrate SBP greater than 90 mm/Hg.","source_file":"1.5-Shock-8.31.23-Clean-edited.txt","categories":["trauma","medical","pediatric"]},"1-6":{"name":"ANAPHYLAXIS/ALLERGIC REACTION","content":"a.  Follow 1.1 General Pre-Hospital Care-Treatment Protocol.\\nb.  Pediatric patients (< 14 years of age) utilize MI MEDIC cards for appropriate\\nmedication dosage.  When unavailable utilize pediatric dosing listed within\\nprotocol.\\nc.  Ensure ALS response.\\nd.  Determine if anaphylaxis/severe allergic reaction (wheezing and/or hypotension)\\nor an allergic reaction (itching, hives).\\ne.  Determine substance or source of exposure, remove patient from source if\\nknown and able.\\nB.  Anaphylaxis/Severe Allergic reaction\\na.  Assist patient in use of their own prescribed epinephrine auto-injector, if\\navailable.\\nb.  Administer epinephrine auto-Injector IM.\\nMCA Approval of epinephrine auto-injector IM\\n  MFR\\n    MCAs will be responsible for maintaining a roster of the agencies choosing\\nto participate and will submit roster to MDHHS\\n1.  Contact Medical Control if child appears to weigh less than 10 kg\\n     (approx. 20 lbs.), prior to epinephrine administration, if possible .\\n2.  Administer pediatric epinephrine dose auto-injector IM if child weighs\\n                           between 10-30 kg (approximately 20-60 lbs.).\\n3.  Administer epinephrine auto-injector IM for adults and children weighing\\n                           greater than 30 kg (approximately 60 lbs.).\\n4.  May repeat epinephrine auto-injector IM one time after 3-5 minutes if the\\npatient remains hypotensive, and auto-injector available.\\nc.  Administer epinephrine IM (per MCA selection may be BLS or MFR skill)\\nNOTE: BLS not carrying epinephrine auto-injector MUST participate in draw\\nup epinephrine.\\nMCA Approval of draw up epinephrine.\\n  MFR\\n  BLS\\nPersonnel must complete MCA approved training prior to participating in draw\\nup epinephrine.\\nMCAs will be responsible for maintaining a roster of the agencies choosing to\\nparticipate and will submit roster to MDHHS.","source_file":"1.6-Anaphylaxis-Allergic-Reaction-8.31.23-Clean-edited.txt","categories":["adult","medical","pediatric"]},"1-7":{"name":"ADRENAL CRISIS","content":"Initial Date: 8/31/2023\\nRevised Date:\\nAdrenal Crisis\\nPurpose:  This protocol is intended for the management of patients with a known history of\\nadrenal insufficiency, experiencing signs of crisis.\\nIndications:\\n1.  Patient has a known history of adrenal insufficiency or Addisons disease.\\n2.  Presents with signs and symptoms of adrenal crisis including:\\na.  Pallor, headache, weakness, dizziness, nausea and vomiting, hypotension,\\nhypoglycemia, heart failure, decreased mental status, or abdominal pain.\\nTreatment:\\n1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2.  Pediatric patients (< 14 years of age) utilize MI MEDIC cards for appropriate\\nmedication dosage.  When unavailable utilize pediatric dosing listed within protocol.\\nContact Medical Control for all adrenal crisis patients prior to treatment:\\n1.  Administer fluid bolus NS or LR IV/IO (refer to 7.23 Vascular Access and IV Fluid\\nTherapy-Procedure Protocol)\\na.  Adults: up to 1 liter.\\nb.  Pediatrics: up to 20 ml/kg\\n2.  Assist with administration of patients own hydrocortisone sodium succinate (Solu-\\nCortef)\\na.  Adult: 100 mg IV/IM\\nb.  Pediatric: 1-2 mg/kg IV/IM\\n3.  If patient does not have their own hydrocortisone, administer prednisone tablet 50 mg\\nPO to adults and children > 6 years of age (if available per MCA selection)\\nAdditional Medication Option:\\n Prednisone 50 mg tablet PO\\n(Adults and Children > 6 y/o)\\na.  If prednisone is not available, patient is < 6 years of age, or patient is unable to\\nreceive medication PO, administer methylprednisolone IV/IO/IM:\\ni.  Adults: 125 mg\\nii.  Pediatrics: 2mg/kg (max 125 mg)\\n4.  Transport\\n5.  Notify Medical Control of patients medical history.\\n6.  Refer to Adult or Pediatric 3.1 Altered Mental Status-Treatment Protocol.\\nMedication Reference\\nMethylprednisolone\\nPrednisone","source_file":"1.7-ADRENAL-CRISIS-8.31.23-Clean.txt","categories":["adult","medical","pediatric"]},"1-8":{"name":"BEHAVIORAL HEALTH EMERGENCIES","content":"Definition:\\nA patient with a psychiatric emergency is solely related to the effects of their mental illness\\nand not an acute medical emergency requiring life-supporting intervention. The patient may\\nhave risk for harm of self and/or others, which can include an inability to care for their own\\nactivities of daily life.\\nProcedure:\\nTransport all adult and pediatric psychiatric patients to the closest OCMCA hospital for\\nmedical clearance.\\n\\nIf EMS personnel witness an act, or acts, or hear significant threats made by the\\npatient that leads them to believe that the patient can reasonably be expected\\nwithin the near future to intentionally or unintentionally seriously physically injure\\nself or others, EMS personnel may complete a Petition for Mental Health\\nTreatment (PM201).\\no  Petitions should be obtained from a hospital ED representative.\\no  The Petition for Mental Health Treatment MUST be:\\n  Completed in black ink only.\\n  Completely free of errors.\\n  Patients may only refuse transport if they meet the criteria outlined in the 7.19\\nRefusal of Care Protocol.\\no\\nIf care is refused, per Refusal of Care Protocol, EMS providers may consider\\nreferring patients experiencing crisis to Common Grounds 24/7 Resource\\nand Crisis Center hotline at: 1-800-231-1127.\\nNOTE: If the psychiatric patient, his/her family, or other patient advocate requests transport\\nto a specific OCMCA hospital, and that request requires bypassing a closer OCMCA\\nhospital, the transporting crew must obtain online approval from the requested hospital prior\\nto initiating transport.\\n1.  Assure scene is secure.\\n2.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n3.  Respect the dignity of the patient.\\n4.  Treat known conditions such as hypoglycemia, hypoxia, or poisoning. Refer to\\nappropriate protocol.\\n5.  Patients experiencing behavioral health emergencies should be transported for\\ntreatment if they have any of the following:\\na.  Can be reasonably expected to intentionally or unintentionally physically injure\\nthemselves or others or has engaged in acts or made threats to support the\\nexpectation.\\nb.  Are unable to attend to basic physical needs.\\nc.  Have judgement that is so impaired that he or she is unable to understand the\\nneed for treatment and whose behavior will cause significant physical harm.","source_file":"1.8-Behavioral-EMERGENCIES-8.31.23-Clean.txt","categories":["adult","medical","pediatric"]},"1-9":{"name":"OPIOID OVERDOSE TREATMENT AND PREVENTION","content":"Opioid Overdose Treatment and Prevention\\nAliases:  OD, Naloxone administration, Naloxone leave behind, Accidental overdose\\nIndications: Decreased level of consciousness associated with respiratory depression from\\nOpioid Overdose, signs of opioid use, scenes with indications of opioid use.  For critically ill\\npatients see 3.7 Adult or 4.9 Pediatric Crashing Patient/Impending Arrest-Treatment\\nProtocol.\\nProcedure:\\n1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2.  Pediatric patients (< 14 years of age) utilize MI MEDIC cards for appropriate\\nmedication dosage.  When unavailable utilize pediatric dosing listed within protocol.\\n3.  If patient has respiratory depression, provide oxygenation and support ventilations.\\nTreatment goal is to restore effective respirations; the patient need not be completely\\nawakened.\\na.  Administer naloxone when (may be an MFR skill based on MCA selection):\\ni.  Ventilations have been established and patient has not regained\\nconsciousness.\\nii.  There is more than 1 rescuer on scene for personnel safety\\nprecautions.\\nMCA Selection for\\n MFR naloxone administration\\nMCAs will be responsible for maintaining a roster of the MFR agencies\\nchoosing to participate and will submit roster to MDHHS\\nb.  Per MCA Selection (below), administer naloxone intranasal May repeat one\\ntime in 3-5 minutes if effective respirations not restored.\\nMCA selection for intranasal naloxone (MUST SELECT AT LEAST ONE):\\nNarcan\xae Nasal Spray 4 mg (Adults Only).  Entire dose in one nostril.\\nAdditional dose in opposite nostril.\\n Naloxone Prefilled 2 mg/2 ml IN via Atomizer (Half dose in each nostril)\\n  Adult and child over 3 years: 2 ml\\n  Pediatric Dosing:\\no  Up to 3 months: 0.5 ml\\no  3 months up to 18 months: 1 ml\\no  Children 19-35 months: 1.5 ml\\nc.  Administer naloxone IM, IN or slowly IV, titrating to restore effective\\nrespirations.\\ni.  Adult: 2 mg IM or IN via atomizer.\\n1.  IN max of two doses total.","source_file":"1.9-Opioid-Overdose-Tx-and-Prev-8.31.23-Clean-edited.txt","categories":["adult","medical","pediatric"]},"10-1":{"name":"GENERAL CBRNE IDENTIFICATION OF AGENTS","content":"Purpose: This is written to provide general pre-arrival information for suspected HAZMAT\\nand CBRNE (chemical, biological, radiological, nuclear, and explosive) incidents.\\nNOTE: This information is an overview of different types of incidents and agents.\\nSigns of an Incident\\n1. A chemical or biological incident may not always be obvious.\\n2. Many of the early signs and symptoms produced by chemical agents may resemble\\nthose of a variety of disorders.  Biological symptoms are generally delayed.\\n3. The patient\'s clinical presentation may offer clues about the type of toxic substance\\nexposure.\\nA. CHEMICAL INCIDENT\\ni. Explosions or suspected release of liquids, vapors or gases\\nii. Mass casualties without obvious trauma\\niii. Similar presentation and/or symptoms for multiple patients.\\nB. BIOLOGICAL INCIDENT\\ni. An unusual increase in the number of individuals seeking care,\\nespecially with similar symptoms such as respiratory, neurological,\\ngastrointestinal, or dermatological symptoms.\\nii. Any clustering of patients in time or location (e.g., persons who\\nattended the same public event).\\nC. RADIOLOGICAL INCIDENT\\ni. Notification of the detonation of a nuclear device.\\nii. Dirty bomb\\niii. Known issues with nuclear power plant or other radioactive source.\\nD. NUCLEAR INCIDENT\\ni. Explosion with mushroom cloud and devastation of a large\\ngeographical area\\nE. EXPLOSIVE INCIDENT\\ni. Responders should be aware of the possibility of secondary\\nincendiary devices and agents.\\nii. Obvious trauma.\\nMedical Response\\n4. First responding units must approach with caution.\\n5. Approach upwind, uphill and upstream, as appropriate.\\n6. Utilize resource materials such as the Emergency Response Guidebook, Emergency\\nCare for Hazardous Materials Exposure, or smart phone applications.\\n7. Utilize appropriate PPE.\\n8. Be aware of contaminated terrain and contaminated objects.\\n9. Hazmat response protocols must be initiated, as well as unified incident command.\\n10. Maintain a safe distance from the exposure area.","source_file":"10.1-General-CBRNE-Identification-5.8.23.txt","categories":["adult","trauma","medical"]},"10-10":{"name":"TRANSPORT AND DESTINATION GUIDELINES","content":"Transportation and Destination Guidelines\\n Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.  This protocol will only\\nbe used by SPRN trained individuals.\\nPurpose:\\nThis protocol is to assist inter-facility transport of patients believed to be infected with a\\nspecial pathogen to a hospital that may be outside of the local Medical Control Authority.\\nDefinition:\\nSpecial pathogen refers to highly infectious diseases, including hemorrhagic viral diseases\\n(HVDs) such as Ebola and similar infections.\\nTransport Destination Decision\\n1. The patient will be transported to the closest appropriate hospital capable of providing\\nthe services needed. The closest appropriate hospital may be outside of an agencys\\nprimary service area.\\n2.\\nInter-facility transport of patients is permitted by pre-identified transport teams to\\nhospitals that may originate and end outside of the transporting agencys Medical Control\\nAuthority when no local pre-identified specialty transport team is available.","source_file":"10.10-SPRN-Transportation-and-Destimation-Guidelines-7.23.23.txt","categories":["medical"]},"10-100":{"name":"GENERAL HAZMAT TREATMENT","content":"This Protocol is intended for use by a Hazardous Materials Response Team.\\nGeneral HAZMAT Treatment\\nPurpose:  This  is  written  to  provide  general  pre-arrival  information  for  suspected  HAZMAT\\nincidents.  Hazardous  Materials  pose  a  threat  during  every  phase  of  their  existence:\\nproduction,  packaging, storage and delivery.  Many common hazardous materials used in\\nto  emergency  responders.  The  Hazardous  Materials  Medical\\nindustry  pose  a  threat\\nthe  HAZMAT  response  team  as  its  primary\\nResponse  Team  is  designed  to  support\\nmission, but may treat other exposed patients as well.\\nIn general, standard MCA treatment should be used in treating a patient exposed to hazardous\\nmaterials.  The  protocols  contained  in  this  section  are  to  be  used  by  the  systems\\nhazardous  materials  medical  response  teams  for  situations  that  are  amenable  to  treatment\\nbased on the teams training and equipment.\\nContact Medical Control as soon as possible. If possible contact should be made as soon as\\narriving on a  scene. Be prepared to provide the following information:\\nName and form of the chemical(s) involved\\nAmount of chemical(s)\\nRoutes of exposure\\nNumber of victims\\nAny updated information should be relayed to Medical Control as soon as possible.\\nPre-Medical Control\\nPARAMEDIC\\n1. Approach the scene with caution only after a safety perimeter has been established.\\n2. Maintain a safe distance.\\n3. Approach upwind, uphill and upstream, as appropriate.\\n4. Be aware of potential contaminated terrain and contaminated objects.\\n5. Determine the HAZMAT involved in the incident, medics should not enter a hot zone.\\n6. The patient\'s clinical presentation may offer clues about the type of HAZMAT substance.\\n7. Victims and potential victims must be evacuated rapidly from the contaminated area.  Major\\ndecontamination  should  be  conducted  by  the  HAZMAT  team  and  decontaminated  as\\nquickly  as  possible.    Additional  decontamination  may  be  necessary  as  described  under\\nprotocol.","source_file":"10.100-General-Hazmat-9.14.23-Clean-edited.txt","categories":["medical"]},"10.101":{"name":"AMMONIA (LIQUID & GAS)","content":"This Protocol is intended for use by a Hazardous Materials Response Team.\\nAmmonia (Liquid & Gas)\\nFORMS: Gas (anhydrous) and liquid (aqueous solutions, variable concentrations).\\nROUTES OF EXPOSURE: Skin and eye, inhalation, ingestion.\\nSIGNS AND SYMPTOMS:\\nCNS:\\nEye:\\nStupor, lethargy and coma. Seizures may be present.\\nChemical conjunctivitis with vapors, necrosis and blindness\\nwith liquids and anhydrous gas exposures.\\nCardiovascular:  Ventricular arrhythmias and hypotension.\\nRespiratory:  Acute  pulmonary  edema,  bronchospasm,  stridor,  cough,\\ndyspnea and chest pain. Respiratory tract irritation with\\npossible laryngeal edema.\\nGastrointestinal: G.I. bleeding due to liquefaction necrosis of the G.I. tract.\\nOther:\\nRespiratory damage can be severe with potential fatal results.\\nRespiratory symptoms may be delayed.\\nPre-Medical Control\\nPARAMEDIC\\n1.\\n2.\\n3.\\n4.\\nFollow 10.100 General HAZMAT Treatment Protocol.\\nIf the patient is unconscious, follow the 3.1 Altered Mental Status protocol\\nand the  7.9  Airway Management Procedure.  Aggressive airway\\nmanagement may be  indicated.\\nIf the patient is wheezing, administer Albuterol 2.5 mg/3 ml NS\\nnebulized.  Repeat as needed.\\nFollow 10.105 HAZMAT Eye Irrigation protocol.","source_file":"10.101-Ammonia-Liquid-Gas-9.14.23-Clean.txt","categories":["trauma","medical"]},"10.102":{"name":"ASPHYXIANTS - SIMPLE","content":"This Protocol is intended for use by a hazardous materials response team.\\nAsphyxiants - Simple\\nFORMS: Carbon Dioxide (CO2), Nitrogen, Helium, Methane and Propane Gas.\\nROUTES OF EXPOSURE:  Inhalation displaces oxygen in the normal\\nenvironmentcausing hypoxia, hypercapnea or other potentially incapacitating\\ncondition.\\nSIGNS AND SYMPTOMS:\\nCNS:\\nAltered mental status, stupor, lethargy and coma.\\nCardiorespiratory: Respiratory or cardiopulmonary arrest due to hypoxia.\\nPre-Medical Control\\nPARAMEDIC\\n1.  Follow 10.100 General HAZMAT Treatment protocol.\\n2.  Administer oxygen 10-15 L via non-rebreather mask or BVM.\\n3.  Follow 7.9 Airway Management Procedure.","source_file":"10.102-Asphyxiants-9.14.23-clean-edited.txt","categories":["medical"]},"10.103":{"name":"Unknown Protocol","content":"This Protocol is intended for use by a Hazardous Materials Response Team.\\nChlorine and Related Compounds\\nFORMS:  Found in liquid and gaseous forms. Colorless to amber-colored liquid,\\nand  greenish-yellow gas with a characteristic odor. Some solid compounds may\\ngenerate  chlorine when in contact with water.  Phosgene (COCl2) and Nitrogen\\nDioxide (NO2) are  related compounds.\\nTHERMAL  DECOMPOSITION  PRODUCTS:  Reacts  with  water\\nform\\nhydrochloric  and  hypochlorous  acid.  Chlorine  reacts  with  carbon  monoxide  to\\nform  phosgene.  Slightly  water-soluble\\ntoxicants  Phosgene  (COCl2)  and\\nNitrogen  Dioxide  (NO2)  may  produce  prolonged  exposure.  Toxic  substances\\nare  formed  when  combustibles  burn  in  chlorine.\\nto\\nROUTES OF EXPOSURE: Skin and eye, inhalation, ingestion\\nTARGET ORGANS:  Primary - Skin, eyes, respiratory system\\nSecondary - Central nervous  system,  cardiovascular\\nsystem,  gastrointestinal system, renal, hepatic, metabolism\\nLIFE  THREAT:    Severe  respiratory  tract  irritant  that  may  cause  pulmonary\\nedema.  Skin,  eye  and  mucous  membranes irritant.  Patients\\nmay  have  delayed  life-threatening  symptoms  (Chlorine  or\\nPhosgene).\\nSIGNS AND SYMPTOMS:\\nCNS:\\nEye:\\nDecreased level of consciousness to coma.\\nHeadache and  dizziness.\\nChemical conjunctivitis with lacrimation. Severe and\\npainful  irritation and burns.\\nCardiovascular:  Cardiovascular collapse and possible ventricular\\narrhythmias.\\nRespiratory:\\nAcute or delayed non cardiogenic pulmonary edema,","source_file":"10.103-Chlorine-and-Related-Compounds-9.14.23-Clean-edited.txt","categories":["trauma","medical"]},"10.104":{"name":"Unknown Protocol","content":"This Protocol is intended for use by a Hazardous Materials Response Team.\\nCorrosive Agents\\nCommon Acids:  Acetic acid, Hydrochloric acid, Nitric acid, Phosphoric acid\\nCommon Bases: Ammonium hydroxide, Potassium hydroxide, Sodium\\nand  Sulfuric acid,\\nhydroxide.\\nOxidizers include: Chlorine dioxide, Hydrogen peroxide, Methyl ethyl ketone\\nperoxide, Sodium chlorate. May cause hemolysis and methemoglobin.\\nWhite phosphorus is found in fireworks and explosives.  Monitor for cardiogenic\\nshock  and arrhythmias.\\nFORMS:\\nA corrosive agent may be found as solids in pellets, flakes,\\nlumps or  sticks and liquid.\\nUSES:\\nAcid neutralizer in petroleum refining, cleaning agents, hair\\nstraighteners,  paint removers, solvents, water treatment,\\nprocessing of cellulose, paper,  textiles and plastics.\\nROUTES OF EXPOSURE: Skin and eye contact, inhalation, ingestion\\nTARGET ORGANS:\\nPrimary  Skin, eyes, respiratory system,\\ngastrointestinal system.\\nSecondary  Central nervous system,\\ncardiovascular system.\\nSevere tissue irritant that may cause upper airway\\nburns  and edema, pulmonary edema and skin burns.\\nMay cause  GI perforation, hemorrhage and peritonitis\\nleading to  circulatory collapse.\\nLIFE THREAT:\\nSIGNS AND SYMPTOMS:\\nCNS:\\nApathy, mental confusion, blurred vision and tremors.","source_file":"10.104-Corrosive-Agents-9.14.23-Clean-edited.txt","categories":["trauma","medical"]},"10.105":{"name":"HAZMAT EYE IRRIGATION","content":"This Protocol is intended for use by a Hazardous Materials Response Team.\\nHAZMAT Eye Irrigation\\nEye irrigation should be performed on all patients with a significant exposure to\\na gas or  when the eye is contaminated by a substance.\\nPre-Medical Control\\nPARAMEDIC\\n1.  Remove contact lenses.\\n2.  Eyes should be flushed with 1000cc of Normal Saline minimum for each\\neye.\\n3.  Use Tetracaine hydrochloride 0.5% 1 - 2 drops in each eye.\\n4.  Insert an irrigation lens into each eye.\\n5.  Hook lenses up to Normal Saline and irrigate with minimum of 1000 cc\\nfor each  eye.\\n6.  If  the  chemical  the  patient  was  exposed  to  creates  a  potential  for\\nsecondary  exposure, care should be taken to contain the run-off.\\n7.  For corrosive agents, continue eye irrigation until arrival at hospital.\\n8.  For Hydrogen Fluoride irrigate with a 1% aqueous solution of Calcium\\nGluconate  (50ml of 10% Calcium Gluconate in 450 ml of NS).\\nSPECIAL CONSIDERATIONS:\\nCare should be taken that the patient does not rub eyes after administration of\\nTetracaine  as damage can occur.\\nIf available, perform a pretreatment pH test.","source_file":"10.105-HazMat-Eye-Irrigation-9.14.23-Clean.doc.txt","categories":["adult","medical"]},"10.106":{"name":"HYDROCARBONS AND HALOGENATED HYDROCARBONS","content":"This Protocol is intended for use by a Hazardous Materials Response Team.\\nHydrocarbons and Halogenated Hydrocarbons\\nHydrocarbons:  Methane, Propane, Gasoline, Mineral spirits, Kerosene,\\nTurpentine, and  Pine tar.\\nHalogenated hydrocarbons:  Chloroform, Ethyl Chloride, Methylene Chloride, and\\nTrichloroethane.\\nFORMS:\\nGas and liquid\\nROUTES OF EXPOSURE: Skin and eye, inhalation, ingestion.\\nSIGNS AND SYMPTOMS:\\nCNS:\\nStupor, lethargy and coma. Seizures may be present.\\nEye:\\nChemical conjunctivitis with vapors, irritation or corneal\\ninjury  with liquids.\\nCardiovascular:  Arrhythmias and hypotension.\\nRespiratory:  Respiratory depression.\\nSkin:\\nChemical burns with prolonged contact.\\nPre-Medical Control\\nPARAMEDIC\\nFollow 10.100 General Hazardous Materials Treatment protocol.\\n1.\\n2.  Administer oxygen 10-15 L via non-rebreather mask if inhalation exposure.\\n3.  Place the patient on cardiac monitor.\\n4.  Monitor level of consciousness for possible deterioration.\\n5.  Wash patient with mild soap/detergent and large quantities of water, for at\\nleast 15  minutes.\\nFollow 10.105 HAZMAT Eye Irrigation protocol if necessary.\\n6.","source_file":"10.106-Hydrocarbons-9.14.23-Clean-edited.txt","categories":["medical"]},"10.107":{"name":"HYDROGEN FLOURIDE","content":"Hydrogen Fluoride (Fluoric acid, Hydrofluoric acid, Fluorine monehydridel,\\nammonium  bifluoride)\\nFORMS:  Gas,  liquid.  (Fluoride  salts  in  the  presence  of  acids  may  generate\\nHydrogen  Sulfide) Metal cleaners and tire rim cleaners.\\nROUTES OF EXPOSURE: Skin and eye, inhalation, ingestion.\\nSIGNS AND SYMPTOMS:\\nCNS:\\nEye:\\nSymptoms of hypoxia, stupor, lethargy and coma.\\nChemical conjunctivitis, opafication of the cornea\\nand  blindness.\\nCardiovascular:  Hypovolemic shock and circulatory collapse.\\nTachycardia with  weak pulse. Dysrhythmias related to\\nhypocalcemia.\\nHyperkalemic arrhythmias.\\nRespiratory:\\nAcute pulmonary edema, asphyxia and chemical\\npneumonitis.  Upper airway obstruction with stridor, pain\\nand cough due to  edema.\\nGastrointestinal: Acute toxicity results in burns to the mouth, esophagus,\\nstomach and lower G.I. tract. Nausea, vomiting and\\ndiarrhea,  possibly containing blood.\\nSkin:\\nOther:\\nSevere pain with normal looking skin surface. Burn is in\\nlower  skin layers. Bone may be involved. Damage may\\nbe severe  with no outward signs, except patient will\\ncomplain of intense  pain.\\nHydrogen fluoride will form hydrofluoric acid upon\\ncontact  with water, such as in the respiratory system. It\\nbinds with the  calcium in bones and cause extreme\\npain. Both hypocalcemia  and hyperkalemia can be\\nassociated with cardiac  complications.","source_file":"10.107-Hydrogen-Fluoride-9.14.23-Clean-edited.txt","categories":["trauma","medical"]},"10.108":{"name":"HYDROGEN SULFIDE, SULFIDES AND MERCAPTANS","content":"This Protocol is intended for use by a Hazardous Materials Response Team.\\nHydrogen Sulfide, Sulfides and Mercaptans\\nFORMS: Gas (hydrogen sulfide, methyl & short-chain alkyl mercaptans), liquid\\n(other  mercaptans).\\nROUTES OF EXPOSURE: Skin and eye contact, inhalation, skin absorption.\\nSIGNS AND SYMPTOMS:\\nCNS:\\nHeadache, confusion, dizziness, excitement,\\ntiredness and a  garlic taste in mouth. Decreased\\nLOC, coma and seizures.\\nEye:\\nChemical conjunctivitis, lacrimation and photophobia.\\nCardiovascular:  Cardiovascular collapse, tachycardia and arrhythmias.\\nRespiratory:\\nIrritation of respiratory tract, cough, dyspnea and tachypnea.\\nRespiratory arrest and pulmonary edema may be present.\\nGastrointestinal: Nausea, vomiting, hemorrhage, perforation, abdominal\\npain,  painful swallowing, profuse salivation, and burns to\\nthe mouth,  esophagus, stomach and gastrointestinal\\ntract may occur.\\nSkin:\\n    Dermatitis, sweating and local pain. Cyanosis may be\\npresent.\\nOther:\\nSymptoms may be delayed. The ability to detect the\\nproduct by  smell may be lost after a short exposure time.\\nPre-Medical Control\\nPARAMEDIC\\n1.  Follow 10.100 General Hazardous Materials Treatment protocol.\\n2.  Administer oxygen 10-15 L via non-rebreather mask or BVM.\\n3.  In the symptomatic patient with significant exposure administer the\\nCyanide  Poisoning Kit.","source_file":"10.108-Hydrogen-Sulfide-Sulfides-and-Mercaptans-9.14.23-Clean-edited.txt","categories":["medical"]},"10.109":{"name":"METHEMOGLOBINEMIA","content":"This Protocol is intended for use by a Hazardous Materials Response Team.\\nMethemoglobinemia\\nMETHEMOGLOBINEMIA should be suspected in patients who have been\\nexposed to  Nitrogen Oxides. METHEMOGLOBINEMIA can also be induced\\nwhen treating a  patient with Cyanide Poisoning.\\nFORMS: Gas, liquid and solid. Substances tend to be brown or yellow in color,\\nespecially when impure.\\nROUTES OF EXPOSURE: Skin and eye, inhalation, ingestion\\nSIGNS AND SYMPTOMS:\\nCNS:\\nFatigue, restlessness and decreasing LOC are usually\\ndelayed  signs.\\nEye:\\nChemical conjunctivitis.\\nCardiovascular:  Cardiovascular collapse with a rapid and weak pulse.\\nReflex  bradycardia may occur.\\nRespiratory:  With most agents a mild and transient cough is the only\\nsymptom at the time of exposure. A delayed onset of\\ndyspnea,  rapid respirations, violent coughing and\\npulmonary edema  follows. Some agents work\\nimmediately on the upper airway,  resulting in pain and\\nchoking, spasm of the glottis, temporary  reflex arrest of\\nbreathing and cause upper airway obstruction  from\\nspasm or edema of the glottis.\\nGastrointestinal: Burning of the mucous membranes, nausea,\\nvomiting and  abdominal pain.\\nSkin:\\nOther:\\nIrritation of moist skin areas. Pallor and prominent\\ncyanosis.\\nWith most products, symptoms will be delayed for 5 to\\n72  hours. Certain products or high concentrations can\\nbring on  symptoms immediately. Blood may be a\\n\\"chocolate brown\\"  color.","source_file":"10.109-Methemoglobinemia-9.14.23-Clean-edited.txt","categories":["medical"]},"10-11":{"name":"PATIENT CONTAINMENT ALGORITHM","content":" Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.  This protocol will only\\nbe used by SPRN trained individuals.\\nType of Patient\\nPerson Under Investigation\\nLow Risk/Dry Patient\\nHigh Risk/Wet Patient\\nNo Containment\\nNo Containment\\nRefer to SPRN\\nTransport Protocols\\nPROPER PPE\\nSelf-report to Tier 1-4\\nhospital or EMS Transport\\nwith Proper PPE\\nRefer to SPRN\\nAmbulance\\nPreparation\\nand\\nPatient Care\\nDuring\\nTransport of\\nSuspected\\nHighly\\nInfectious\\nAgent","source_file":"10.11-SPRN-Patient-COntainment-Algorithm-7.23.23.txt","categories":["medical"]},"10.110":{"name":"AND REPLACEMENT PROCEDURE","content":"This Protocol is intended for use by a Hazardous Materials Response Team.\\nHazardous Materials Medication Exchange and Replacement Procedure\\nEMS Service Stock\\n1.\\n2.\\n3.\\n4.\\nEach EMS Agency assigned a hazardous materials medication box will be\\nresponsible for the security and storage of the box.\\nAll drug boxes and associated supplies such as needles and syringes will be stored in a\\nsecurely locked, temperature-controlled location in the base station. Medication boxes will\\nremain sealed at all times except when in actual use.\\nHazardous materials medication boxes are to be inspected on the first of each month for the\\nexpiration date listed on the label. Expiring or used drug boxes are to be taken by the\\nassigned agency to the designated participating emergency department or pharmacy within\\n7 days for exchange.\\nHazardous materials medication boxes are to be inspected daily by the EMS provider\\nsupervisor for evidence of loss, theft, discrepancy and expiration date. It is recommended\\nthat this inspection be included in a standard documented check list.\\nHospital Stock/Expired/Used Box Exchange\\n1.\\n2.\\n3.\\nAny replacement hazardous material medication box must be maintained in a locked area,\\nunder the control of hospital staff available 24 hours per day. This area will be located in\\nthe emergency department or pharmacy of the participating hospital. Appropriate record\\nkeeping and security measures are required at each exchange site to ensure that only\\nappropriately licensed and authorized personnel have access to medications and other\\nrelated supplies.\\nHazardous materials medication boxes stocked in the emergency department will\\nbe checked regularly by pharmacy staff for expiration and updated as needed.\\nExpiring/used medication boxes will be exchanged for an updated drug box in the\\nemergency department or designated pharmacy. At the time of exchange, the prehospital\\nprovider will notify the charge nurse or make arrangement for the exchange with the\\ndesignated pharmacy. If present, the white pharmacy lock will be removed and the green\\nlock applied.","source_file":"10.110-OCMCA-Haz-Mat-Medication-Box-and-Exchange-9.14.23-Clean-edited.txt","categories":[]},"10.111":{"name":"Unknown Protocol","content":"This Protocol is intended for use by a Hazardous Materials Response Team.\\nCyanokit\xae Medication Pack Exchange Procedure and Use Replacement Form\\nCyanokit\xae Medication Pack\\n1.\\nCyanokit\xae Medication Packs (CMPs) will be available to the HAZMAT Medical Response\\nTeam (HAZMAT MRT) and paramedics trained in use of the Cyanokit\xae.  Packs will be\\navailable for pickup, when needed by the HAZMAT MRT, at the participating hospital ED or\\npharmacy.  Alternatively, the CMPs may be issued to the HAZMAT MRT(s) or sponsoring\\nEMS agency designated by the MCA.  Each HAZMAT Medical Response Team (HAZMAT\\nMRT) or sponsoring EMS agency will provide an A-Pack style pack or equivalent to the\\ndesignated cooperating hospital pharmacy.  The hospital will be responsible for stocking\\nand restocking the pack.\\nHAZMAT MRT Sponsoring EMS Agency or other Sponsoring EMS Agency\\n1.\\n2.\\n3.\\n4.\\nWhen issued to the HAZMAT MRT, the EMS agency will be responsible for the security and\\nstorage of the Cyanokit\xae Medication Pack.  The Pack may also be issued to other\\nsponsoring EMS agencies.\\nAll drugs, needles, syringes and supplies will be stored in a securely locked, temperature-\\ncontrolled location.  The Medication Pack will remain sealed at all times except when in\\nactual use.\\nCyanokit\xae Medication Packs (CMPs) are to be inspected on the first of each month by the\\nhazardous materials paramedic supervisor or other sponsoring EMS agency for evidence of\\nloss, theft, and expiration date. It is recommended that this inspection be included in a\\nstandard documented check list.\\nUsed CMPs are to be taken to the emergency department or designated pharmacy within 7\\ndays for exchange. CMPs due to expire must be exchanged at least 30 days prior to the\\nexpiration date.\\nHospital Stock/Expired/Used Box Exchange\\n1.\\nAny replacement Cyanokit\xae Medication Packs must be maintained in a locked area, under\\nthe control of hospital staff available 24 hours per day. This area will be in the emergency\\ndepartment or pharmacy of the participating hospital.  Appropriate record keeping and\\nsecurity measures are required at each exchange site to insure that only appropriately\\nlicensed and authorized personnel have access to medications and other related supplies.\\n_________________________________________________________________________________________________________","source_file":"10.111-HazMat-Cyanokit-Medication-Kit-Exchange-Use-Replacement-9.14.23-Clean-edited.txt","categories":["medical"]},"10-112":{"name":"MEDICATION SECTION","content":"Initial Date: 9/19/2022\\nRevised Date: 9/14/2023\\nThis Protocol is intended for use by a Hazardous Materials Response Team.\\nCyanokit \xae (Hydroxocobalamin)\\nProtocols:\\n1.  Cyanide Exposure Supplement Protocol\\nIndications:\\n1.  Known or suspected cyanide poisoning\\nContraindications:\\n1.  Hypersensitivity to hydroxocobalamin or cyanocobalamin\\n2.  Cannot be administered in the same line as dopamine or fentanyl\\nDosing:\\n1.  A one vial (250ml) glass vial containing 5g of hydroxocobalamin in powder form\\nwhich must be reconstituted with 200mL of normal saline each, rotated or tipped for\\n30 seconds each (not shaken) and then administered through its own IV line (not\\nused with any other medications) over 7.5 minutes each.\\n2.  A one vial kit with 5g of hydroxocobalamin powder which must be reconstituted with\\n200mL of normal saline, be rotated or tipped for 60 seconds (not shaken) and\\nadministered through its own IV line (not used with any other medication) over 15\\nminutes.\\n3.  The starting dose of hydroxocobalamin for adults is 5g (i.e., two 2.5g vials OR one 5g\\nvial) administered as an intravenous (IV/IO) infusion over 15 minutes. Refer to table\\non page 2 for weight-based dosing.\\nExpected Effects:\\n1.  Increased blood glucose\\nSide Effects:\\n1.  Nausea\\n2.  Vomiting\\n3.  Abdominal pain\\n4.  Red colored urine, skin, mucus membranes\\n5.  Rash","source_file":"10.112-HYDROXOCOBALAMIN-CYANOKIT-9.14.23-Clean.txt","categories":["adult","medical"]},"10-113":{"name":"Unknown Protocol","content":"The purpose of this protocol is to provide direction for incidents that involve multiple\\npatients, ambulance or agency response that does not meet the definition of an MCI.\\nDEFINITIONS\\nMultiple Patient Incident is an incident that a single Life Support Agency (LSA) is\\ncapable of dealing with alone or with the use of routine local mutual or automatic aid\\npartners.\\nThe distinction between a multiple patient incident and a Mass Casualty incident\\n(MCI) does not lie in the number of patients or the extent of the damage but rather the\\nresources needed to deal with the situation.\\nProcedure:\\n1.  Determine the number of patients.\\n2.  Contact additional resources.\\n3.  Transport to closest appropriate facilities.\\na.  Be mindful not to over burden hospital resources (refer to Hospital\\nAutomatic Patient Load section),\\nb.  If a transport officer is not staffed the incident commander will be\\nresponsible for patient distribution.\\n4.  Hospital communications will be conducted by the transporting ambulance.","source_file":"10.113-Multiple-Patient-Incidents-Oakland-8.5.24.txt","categories":[]},"10-12":{"name":"TRANSPORT SUPPLIES","content":" Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.  This protocol will only\\nbe used by SPRN trained individuals.\\nTransport Supplies\\nSuggested Supplies to be Immediately Available:\\n Manual Suction\\n BP cuff (manual, disposable)\\n Pulse Ox (disposable)\\n Emesis containers (sealable)\\n Absorbent paper towels\\n Sharps Container (small)\\n Nitrile gloves box (Small, Medium, Large, Extra-large)\\n Small trash bags\\n Disinfectant wipes for surfaces\\n Disinfectant wipes for skin\\n Portable 02 tank (15 LPM capable)\\n Nasal Cannula/NRB\\n Cooler/ice packs\\n Blankets (Space)\\n Pillow\\n Trauma Shears\\n 2 Buckets (for bodily fluids, hold trash bags, use for cleaning)\\n Time Keeping Device\\n Sedation and/or pain control guidelines as applicable\\n Medications, needleless delivery system\\nSuggested Supplies to be in accompanying vehicle or with driver:\\n IV Kit/Fluid/Saline Lock\\n 4X4 and/or Abdominal Pads\\n Tape\\n Rolled Gauze\\n Body bag\\n Cleaning / decontamination equipment\\n Solidifier for liquids\\n Donning/doffing protocols and checklists","source_file":"10.12-SPRN-Transport-Supplies-7.3.23-2.txt","categories":["trauma","medical"]},"10-13":{"name":"TRANSPORT PROCEDURE","content":" Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.\\nTransport Procedure\\nPurpose: The purpose of this procedure is to provide guidance for transport of a patient\\nwith a known or suspected highly infectious disease including pathogens referred to as\\nCategory A agents.\\n1.  Patient belongings\\nA.  All patient belongings shall be kept in transport vehicle and only be removed at\\nthe final destination.\\nB.  Belongings shall be placed in a biohazard bag if possible and sealed in a manner\\nthat will prevent any further contamination to its surroundings.\\nC.  Belongings will be labeled with the patient name and identification.\\n2.  Documentation\\nA.  Pt documentation may be performed in a normal manner as outlined by the\\ntransporting agencies guidelines. A note pad may be used to document vital signs\\nand times during transport.\\nB.  All documentation should be performed after the transport is complete as to avoid\\ncontamination of equipment and materials. Any materials used for documentation\\nin the patient environment (such as Toughbook, tablets, clipboards etc.) shall be\\ncleaned, disinfected, and decommissioned for the same duration as the transport\\nvehicle and equipment involved in transport.\\n3.  Travel plans\\nA.  The MDHHS will be the central coordinating agency for the patient transport.\\nLocal and state authorities will assist in planning the path of travel so as to assist\\nin the event of an emergency.\\nB.  A predetermined route will be planned in conjunction with the sending facility,\\ntransport agency, receiving facility or airport, and any facilities in between sending\\nfacility and receiving facility that are willing to participate and accommodate\\ntransport crews for crew changes or emergency procedures.\\na.  Path of travel should be planned out in a way that will keep transport crews\\non as many major roads as possible to ease the ability of possible\\nresponding EMS agencies to locate them in the event of an emergency or\\naccident.\\nb.  Consider communication to potential Medical Control Authority along the\\npath of travel in the event that assistance is required.","source_file":"10.13-SPRN-Transport-Procedure-7.23.23.txt","categories":["medical"]},"10-14":{"name":"PATIENT CARE DURING TRANSPORT OF SUSPECTED HIGHLY INFECTIOUS AGENT","content":" Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.  This protocol will only\\nbe used by SPRN trained individuals.\\nPatient Care During Transport of Suspected Highly Infectious Agent\\nPurpose: The purpose of this procedure is to provide guidance for transport of a patient\\nwith a known or suspected highly infectious disease including pathogens referred to as\\nCategory A agents from a health care facility to another, more specialized health care\\nfacility.\\nThe EMS Agency Will\\nA. Prior to transport, the transporting agency will communicate with the sending\\n(departing) and receiving (arriving) hospital facility to coordinate existing and\\nanticipated patient care needs.\\na. Determine the medical authority for the patient while in transit.  Refer to\\nthe state protocol.\\nb. Determine the number and mix of staff needed to provide care during\\ntransport.\\nc. Assure that equipment, devices, and crew can fit into the load-carrying\\ndimensions of all planned transport vehicles.\\nd. Determine if the patient has proper identification for transport.\\ne. Determine method for patient tracking.\\nf. Determine method to document patient care while preventing\\ncontamination.\\nB. Assess and develop plans for:\\na. Physical needs of the patient:  baseline vital signs via non-invasive\\nmethod.  Use blue tooth technology, disposable O2 saturation monitor.\\nb. Assess ability to provide for physical comfort of patient:\\ni. Heat\\nii. Air flow\\nc. Plans for failure of equipment.\\nd.\\nIdentified pre-existing conditions that will require medication or other\\nmeans of support (such as diabetes, oxygen therapy, etc.).  Identify\\nmethod to support these conditions if necessary.\\ne. Avoid use of sharps (needles, lancets) unless necessary.  Dispose in\\nf.\\ng.\\nsharps container.\\nIdentify current life support status and identify procedures that will or will\\nnot be performed during transport.\\nIdentify medications necessary for patient comfort during transport:\\nsedation, pain, nausea.","source_file":"10.14-SPRN-PC-During-Trans-of-Sus-Infectious-Agent-7.23.23.txt","categories":["medical"]},"10-15":{"name":"AMBULANCE CLEANING AND DISINFECTION","content":" Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.\\nAmbulance Cleaning and Disinfection\\nPurpose:\\nProper cleaning and disinfection of an ambulance and equipment are necessary to reduce\\nthe bioburden of disease and prevent secondary transmission of a known or unknown highly\\ncontagious disease.  The process describes the measures needed to clean and disinfect an\\nambulance prior to its return to service following the transport of a patient with a known or\\nsuspected Category A disease.\\nNote: All disinfection should use a U.S. Environmental Protection Agency (EPA)-registered\\nhospital disinfectant with a label claim for a non-enveloped virus (norovirus, rotavirus,\\nadenovirus, poliovirus) to disinfect environmental surfaces at appropriate concentration and\\ncontact time.\\n1. This process is to be done after the Biocell or visquine (see procedure) has been\\nremoved.\\n2. Site Set Up\\nA. Select an appropriate site for ambulance decontamination that protects the\\nvehicle and the decontamination team from weather elements, preferably a well-\\nventilated large, enclosed structure.\\nB. Establish a secure perimeter for safety of the public and decontamination\\npersonnel.\\nC. Include considerations for waste management, security plan, public perception,\\nand media visibility when selecting decontamination site.\\nD. Depending on the location, the ability for climate control is beneficial.\\nE. Define and mark hot, warm, and cold zones of contamination1 around the\\nambulance that require PPE to enter.\\n1 The hot zone is considered an area that is known or suspected to be contaminated and has a high risk of exposure. It\\nshould only be entered with full PPE. In ambulance decontamination, this would be the vehicle and an area about a\\nmeter beyond the ambulance.\\nThe warm zone can be considered a transitional area between the hot and cold zones that has no known contamination\\nbut has a moderate risk of exposure. It should only be entered when wearing full PPE. This is also the area where one\\nbegins the initial portion of the doffing process (following a full suit wipe down within the hot zone) when leaving the\\nhot zone. For ambulance decontamination, the warm zone can also be the place where waste barrels are pre-positioned\\nso that the waste bags can be placed directly into the containers without entering the hot zone.","source_file":"10.15-SPRN-Ambulance-Cleaning-7.23.23.txt","categories":["medical"]},"10-16":{"name":"MEDICAL ISOLATION TRANSPORT DEVICE","content":" Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.  This protocol will only\\nbe used by SPRN trained individuals.\\nMedical Isolation Transport Device\\nDefinition:  A Medical Isolation Transport Device is a vinyl enclosed patient containment device.\\nIt creates a negative air environment when closed.   It is used for the transport of highly infectious\\ndisease patients either internally at a facility or from one facility to another.\\n1.  Patient will be transported in impervious suit if ambulatory, in impervious suit and sheets (as\\ntolerated) if stretcher bound or in isolation pod, as indicated.  All transferred patient\\nbelongings are considered contaminated and are typically bagged, labeled, and transferred\\nwith patient.\\n2.  Any patient care documents should be free of contamination. When in doubt, consider them\\ncontaminated and package as appropriate for transport with patient. It may be desirable to\\nstore and transmit patient care records electronically if feasible.\\nIndications for use:\\n1.  A known or suspected case of highly infectious disease that may have been acquired via\\ntravel, health care provider, or lab.\\n2.  Drug resistant organism\\n3.  Some Medical Isolation Transport Devices may be used as a positive air environment to\\ntransport a patient with known immune deficiency or burns.\\nThings to know regarding use of Medical Isolation Transport Device:\\n1.  Assess if MEDICAL ISOLATION TRANSPORT DEVICE outside straps are approved for\\n2.\\ntransportation.  General rule:  vinyl straps are not tested and approved, but some material\\nstraps (such as those used in seat belts) may have been tested and approved.\\nThe head of the Medical Isolation Transport Device should be placed at the head of the\\ngurney or cart, so the patient is always moving feet first.\\nThe white noise created by the blower motor will reduce patient and staff level of hearing.\\n3.\\n4.  Be careful that wind may catch and move the Medical Isolation Transport Device, especially\\nwhen unsecured.\\n5.  As the outside temperature increases, the temperature inside the Medical Isolation\\nTransport Device will also increase.\\n6.  After using the Medical Isolation Transport Device during a drill, it may be cleaned and\\ndisinfected for future use.  Some disinfectants may leave a residue that can be wiped off\\nwith a clean towel.","source_file":"10.16-SPRN-Medical-Isolation-Transport-Device-7.23.23.txt","categories":["medical"]},"10-17":{"name":"TEAM SELECTION PROCEDURE","content":" Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.\\nTeam Selection Procedure\\nPurpose\\nThe purpose of this procedure is to provide guidance in selecting qualified and support\\ntraining of EMS personnel willing to transport a patient with known or suspected highly\\ninfectious disease including pathogens referred to as Category A agents.\\n1.  The selected team members will be chosen according to\\nA.  Previous physical and mental health history\\nB.  Ability to be in service and away from home for an extended period of time\\nC.  Knowledge of the potentially hazardous situation to which they may be placed\\nD.  Additional assets of team members may include:\\na.  Able to work in a restrictive environment\\nb.  Critical thinking skills\\nc.  Participation in education sessions, exercises and drills\\nd.  Able to follow strict guidelines to ensure the safety of the entire unit\\n2.  It is recommended that each team member may have on file with their agency\\nA.  Two or more emergency contacts\\nB.  Hospital or Health care system of preference\\nC.  Blood type\\nD.  Religious preference\\nE.  Advanced directives (if applicable)\\n3.  Team member health status\\nA.  Each team member shall be compliant with and have documentation they have\\npassed the medical screening requirements of the agencies Respiratory\\nProtection Program.  This includes acknowledging a new history of respiratory\\ndiseases (i.e. asthma, chronic lung disease, or upper respiratory infection) that\\nwould interfere with wearing a fully enclosed respiratory device, such as a PAPR\\nor would involve removal of the PAPR hood for medication administration.\\nB.  Consideration should be given to any team member having a condition that\\naffects them while being in an enclosed environment.\\nC.  Each team member shall be free of any medical conditions that require\\nmedication administration in any less than 6 hour increments.","source_file":"10.17-SPRN-Team-Selection-Procedure-7.23.23.txt","categories":["medical"]},"10-18":{"name":"DEATH DURING TRANSPORT","content":" Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.\\nDeath During Transport\\nPurpose\\nTo provide guidance for special pathogen crews when a patient suffers cardiac arrest during\\ntransport to a special pathogen treatment facility.\\nI.\\nII.\\nThis protocol is only for use by trained crews during the transport of a patient\\nbeing handled for treatment of a special pathogen.\\nIf a patient experiences cardiac arrest during transport,\\na.  No interventions will be performed\\nb.  Immediately discontinue transport\\nc.  Contact Community Health Emergency Coordination Center for destination\\ndetermination\\ni.  Crematorium\\nii.  ME needed?\\niii.  Receiving or sending hospital\\niv.  What about when its a county in between sending & receiving\\nIII.  MDHHS SPRN subject matter expert will provide technical assistance in the event\\nof a patient death using Bio Seal and body bags to complete safe and respectful\\nhandling of the decedent.\\nThe Community Health Coordination Center (CHECC) has identified a list of\\ncrematoriums to receive the body.\\nIV.","source_file":"10.18-SPRN-Death-During-Transport-7.23.23.txt","categories":["medical"]},"10-2":{"name":"CHEMICAL EXPOSURE","content":"Purpose: To provide guidance for the treatment of chemical exposure patients.\\nAssessment/Management  Chemical Agents\\nIf there is a confirmation of, or symptoms indicative of, a chemical incident, utilize\\nappropriate protective suits and respirators (PAPR) with Organic Vapor/HEPA cartridges\\nshould be donned.\\nI.  Nerve Agents & Cyanide Compounds  refer to 10.3 Nerve Agent/Organophosphate\\nPesticide Exposure-Special Operations Protocol and 10.5 Cyanide Exposure-\\nSpecial Operations Protocol.\\nII.  Choking Agents (e.g., Phosgene, Chlorine, Chloropicrin)\\nA.  Exposure Route: Inhalation\\nB.  Signs and symptoms:\\n1.  Cough, dyspnea, irritation of mucous membranes, pulmonary edema.\\nC.  Patients should be promptly removed from the area to a clean atmosphere.\\nD.  Treatment\\n1.  Assist ventilations, as necessary.\\n2.  Provide 100% oxygen\\n3.  If wheezing, administer albuterol 2.5 mg/3ml NS nebulized per 9.1\\nMedication Administration-Medication Protocol (Per MCA selection\\nmay be EMT skill).\\nNebulized albuterol administration\\n   EMT\\na.  4 puffs from patients own prescribed albuterol metered dose\\ninhaler (with spacer if available).\\n4.  For severe exposure consider early interventional airway and aggressive\\nventilatory support (including CPAP per 7.5 CPAP-Procedure Protocol)\\n5.  If eye exposure:\\na.  Eye irrigation\\ni.  Remove contact lenses\\nii.\\nFlush with 1000cc of NS each eye\\nb.  For eye pain, use tetracaine hydrochloride 1-2 drops in each\\neye, if available.\\nIII.  Vesicant Agents (Blister agents)\\nA.  Examples: Sulfur Mustard (HD), Nitrogen Mustard (HN), Lewisite, Phosgene\\nOxime (CX) Vesicant agents are named for their tendency to cause blisters.\\nB.  Exposure Route: Dermal/Inhalation\\nC.  Decontamination is critical:\\n1.  Medical providers will require the proper PPE as determined by\\nunified command before decontaminating patient.","source_file":"10.2-CHEMICAL-EXPOSURE-9.14.23-Clean-edited.txt","categories":["medical"]},"10-3":{"name":"EXPOSURE TREATMENT","content":"Nerve Agent/Organophosphate Pesticide Exposure Treatment\\nPurpose:\\nThis protocol is intended for EMS personnel at all levels that have been trained\\nin the use of these devices and authorized by the medical control authority to\\nassess and treat patients exposed to nerve agents and organophosphate\\npesticides utilizing the Duo Dote/Mark I Antidote Kits and/or a combination of\\nauto injectors and/or nasal sprays. Administration of non-prepackaged kits is\\nrestricted to ALS.\\nThe following medications in this protocol are not required to be carried on EMS\\nvehicles and may be available through special response units.\\nMedications/Definitions:\\nA.  One (1) Nerve Agent (NA) Antidote Kit  for the purpose of this protocol means either\\none (1) Duo Dote OR one (1) Mark I\\n1.  Duo Dote  a single device with 2 chambers.  The front chamber contains 2.1 mg\\natropine, the back chamber contains 600 mg pralidoxime (2-PAM).  When activated\\nthe device sequentially administers both drugs through a single needle.\\n2.  Mark I Antidote kit 2 separate injectors.  One containing 2mg atropine, the\\nsecond containing 600 mg of pralidoxime (2-PAM).\\nB.  Atropine auto injector- a single auto-injector of atropine that comes in 3 doses:\\natropine 0.5 mg, atropine 1 mg, atropine 2 mg.\\nC.  Midazolam auto-injector  20 mg midazolam per device\\nD.  Midazolam nasal spray  5 mg per device\\nE.  Diazepam auto-injector  10 mg per device\\nF.  Non prepackaged kit administration:  Administer 600 mg pralidoxime and 2 mg of\\natropine for every one (1) NA Antidote Kit.(ALS only)\\nChemical Agents\\n1.  Agents of Concern\\nA.  Military Nerve Agents including: Sarin (GB), Soman (GD), Tabun (GA), VX\\nB.  Organophosphate Pesticides (OPP) including Glutathione, Malathion,\\nParathion, etc.\\n2.  Detection:  The presence of these agents can be detected through a variety of\\nmonitoring devices available to most hazardous materials response teams and other\\npublic safety agencies.\\nPatient Assessment\\n1.  SLUDGEM Syndrome\\nS\\nL\\nU  Urination\\nD  Defecation / Diarrhea\\nG  Gastric Emptying (Vomiting) / GI Upset (Cramps)\\nSalivation / Sweating / Seizures\\nLacrimation (Tearing)\\nA.\\nB.\\nC.\\nD.\\nE.","source_file":"10.3-NERVE-AGENT-ORGANOPHOSPHATE-9.14.23-clean-edited.txt","categories":["medical"]},"10-4":{"name":"CHEMPACK/MEDDRUN","content":"Purpose: The CHEMPACK Project provided the State of Michigan, in collaboration with the\\nCenter for Disease Control (CDC) and the U.S. Department of Homeland Security, with a\\nsustainable, supplemental source of pre-positioned nerve agent/organophosphate antidotes\\nand associated pharmaceuticals.  A large-scale event would rapidly overwhelm both the pre-\\nhospital and hospital healthcare systems.\\nThe CHEMPACK project is one component of the Michigan Emergency Preparedness\\nPharmaceutical Plan (MEPPP), a comprehensive statewide plan for coordinating timely\\napplication of pharmaceutical resources in the event of an act of terrorism or large-scale\\ntechnological emergency/disaster.\\nThe Michigan Emergency Drug Delivery and Resource Utilization Network (MEDDRUN)\\nestablished standardized caches of medications and supplies strategically located\\nthroughout the State of Michigan.   In the event of a terrorist incident or other catastrophic\\nevent resulting in mass casualties, MEDDRUN is intended to rapidly deliver medications and\\nmedical supplies, when local supplies are not adequate or become exhausted.  The goal is\\nto deploy MedPack within 15 minutes of the request.\\nOnly authorized agencies and officials can request MEDDRUN.  These agencies include\\nany Michigan Hospital, local public health agency, or emergency management program.\\nAuthorized officials include designated representatives from the Bureau of Emergency\\nPreparedness, EMS, and Systems of Care (BEPESOC), the Michigan State Police (MSP)\\nand the Regional Bioterrorism Preparedness projects.\\nActivation\\nI. Recognition of need can come from EMS personnel, or it may be a hospital, public\\nhealth, EOC, or Emergency management that identifies the need for activation.\\nA. EMS Identifies a need for medication support.\\n1.\\n2.\\nContact Central Dispatch or a hospital/MCA\\nCentral Dispatch or hospital/MCA contacts MEDDRUN and/or\\nCHEMPACK Communications Agency\\nB. Hospital, Public Health, EOC or Emergency Management\\n1.\\n2.\\nIdentifies need\\nHospital, Public Health, EOC or Emergency Management contacts\\nMEDDRUN and/or CHEMPACK Communications Agency\\nC. To activate MEDDRUN and/or CHEMPACK call:\\nPrimary Communication Agency:  877-633-7786\\n1.\\n2. Backup Communication Agency:  616-391-5330\\nCHEMPACK/MEDDRUN Communications Agency:\\nA. Conducts analysis & issues deployment orders to selected\\nCHEMPACK/MEDDRUN storage sight, (CSS) Point of Contact (POC).\\nStorage site notifies the transport unit and moves cache to designated loading\\narea.\\nII.\\nIII.","source_file":"10.4-Chempack_Meddrun-12.27.22.txt","categories":["adult","medical"]},"10-5":{"name":"CYANIDE EXPOSURE","content":"Purpose: This Protocol is intended for EMS personnel at all levels to assess and treat\\npatients exposed to cyanide. Additionally, the protocol allows trained and authorized\\nparamedics to administer antidotes when available.\\nNOTE: A single medical control order in a mass casualty incident may be applied to all\\nsymptomatic patients.\\nDefinitions: For the purposes of this protocol Cyanokit\xae (brand name) refers to\\nHydroxocobalamin.\\nMedications in this protocol are not required to be carried on EMS vehicles and may\\nbe available through special response units.\\nChemical Agent\\n1.  Agents of Concern: Cyanide\\na.  Hydrogen Cyanide\\nb.  Potassium/Sodium Cyanide\\nc.  Cyanogen Chloride\\n2.  Detection: The presence of these agents can be detected through specialized\\nenvironmental monitoring equipment available to hazardous materials response\\nteams.\\n3.  Modes of Exposure\\na.  Inhalation (including smoke inhalation)\\nb.  Ingestion\\nc.  Skin absorption unlikely\\n4.  Alert receiving hospital ASAP to prepare additional antidotes\\nAssessment\\n1.  Hypotension\\n2.  Shortness of breath\\na.  Possibly accompanied by chest pain\\nb.  Generally, not associated with cyanosis\\nc.  Pulse oximetry levels usually normal\\nd.  Usually associated with increased respiratory rate and depth\\ne.  Potential for rapid respiratory arrest\\n3.  Confusion, decreased level of consciousness, coma\\n4.  Seizures\\n5.  Headache, dizziness, vertigo (sense of things spinning)\\n6.  Pupils may be normal; dilation is a late sign\\nIndications for Antidote use in patient with suspected cyanide poisoning:\\n1.  Cardiac or Respiratory Arrest\\n2.  Hypotension SBP<90 mm Hg\\n3.  GCS <= 9\\nPersonal Protection","source_file":"10.5-Cyanide-Exposure-9.14.23-Clean-edited.txt","categories":["medical"]},"10-6":{"name":"MASS CASUALTY INCIDENTS","content":"The purpose of this protocol is to provide a uniform initial response to a Mass Casualty\\nIncident (MCI).\\nI.\\nII.\\nDefinition of MCI:  For the purpose of this document, an MCI will be defined as\\nany incident, which because of its physical size, the number and criticality of its\\nvictims, or its complexity, is likely to overwhelm those local resources (including\\nlocal hospitals), which would typically be available.\\nOverall MCI Management  DISASTER Paradigm\\nThe DISASTER Paradigm is part of the National Disaster Life Support (NDLS)\\nProgram and provides a framework for management of MCIs.  The components\\nmay be pursued concurrently.\\nA.  Detection: Do we have an MCI? If yes, immediately declare to dispatch.\\nB.  Incident Command: Establish or interface with the Incident Command System\\n(ICS)\\nC.  Safety and Security: Immediate action steps to immediately protect\\nresponders, casualties, public.\\nD.  Assess Hazards: Actively assess (initially and ongoing) for hazards that can\\nharm responders, casualties, public.\\nE.  Support: Request resources needed to effectively manage incident\\nF.  Triage and Treatment: Initiate SALT Triage and provide treatment to casualties\\nG.  Evacuation: Transport of casualties to appropriate hospitals (avoiding\\noverloading individual hospitals) or alternate treatment centers\\nH.  Recovery: Return responders and community to pre-incident status and\\nidentify lessons learned.\\nIII.  MCI Detection\\nA.  Actively assess the scene to determine if MCI is (or maybe) present\\nB.  Alert dispatch and assure hospitals and other stakeholders made aware\\nC.  For major incidents (including incidents involving multiple counties/MCA\\nresources) RMCC should be alerted\\nIV.\\nIncident Command System\\nA.  All incidents shall be managed in accordance with the National Incident\\nManagement System and the National Response Framework.\\nB.  If Incident Command (IC) has not been established, the most qualified EMS\\npersonnel shall assume the role of IC until command is transferred.\\nC.  The IC is responsible for all functions of the Incident Command System (ICS)\\nuntil other personnel are assigned those functions.\\nD.  Establish EMS Branch Director/EMS Group Supervisor\\nEstablished by IC\\n1.\\n2.  Responsible for all EMS activities\\n3.  Reports to IC or Operations Chief\\nE.  Establish functional subordinate EMS ICS positions, as appropriate. Note,\\npositions may be combined (e.g., Treatment/Transport) when appropriate.\\n1.\\nTriage Unit Leader Role\\na.  Report to EMS Branch Director/Group Supervisor","source_file":"10.6-MCI-Protocol-Clean-8.5.24.txt","categories":[]},"10.6.1":{"name":"Unknown Protocol","content":"10.6.1 MCI - OCMCA Initial Patient-Hospital Transport\\nThis protocol should be utilized in the early stages of a mass casualty incident.  It indicates the\\ninitial capability of all OCMCA and surrounding hospitals.  After the initial stages the hospitals\\nshould be contacted for additional capacities.\\nHospital\\nCorewell-Farmington Hills\\nCorewell-RO\\nCorewell-Troy\\nChildrens Hospital-Troy\\nAscension Rochester Hospital\\nAscension Genesys\\nHenry Ford Medical Center-WB\\nHuron Valley-Sinai\\nMcLaren Clarkston\\nMcLaren Hospital-Oakland\\nAscension Providence Novi\\nAscension Providence Southfield\\nAscension Macomb-Oakland\\nTrinity-Oakland\\nTrinity-Livonia\\nACS Trauma Level\\nLevel 2\\nLevel 1\\nLevel 2\\nPediatric only\\nLevel 3\\nLevel 2\\nLevel 3\\nLevel 3\\nLevel 2\\nLevel 2\\nLevel 2\\nLevel 2\\nLevel 2\\n# of High Acuity Patients\\n2\\n2\\n2\\n2\\n2\\n2\\n2\\n2\\n2\\n2\\n2\\n2\\n2\\n2\\n2","source_file":"10.6.1-MCI-OCMCA-Initial-Patient-Hospital-Transport-1.12.24-Updated.txt","categories":["trauma","medical"]},"10-7":{"name":"DURING DISASTER","content":"Pre-hospital (EMS) MCA Mutual Aid During Disaster\\nPurpose:  Establish a mechanism allowing EMS agencies/Medical Control Authorities (MCA) to\\ngive prehospital care across MCA boundaries during disaster conditions.\\n1. This agreement between the MCAs demonstrates the intention to assist and support each other\\nduring a disaster situation.  It provides an approved/authorized process allowing EMS agencies\\nto function within a MCA under their originating MCAs protocols, during a disaster.\\n2. During disaster conditions, whether natural or otherwise, MCAs may need assistance from\\nother MCAs.  For the purpose of this agreement, a disaster is considered to be an emergency\\nevent where a declared emergency and/or disaster condition as defined by local, state, or\\nfederal statutory laws, exists in which the responding MCA and EMS resources may be unable to\\nhandle the patient care needs without additional resources from outside its own Medical Control\\narea.\\n3. Requests for support may be made to any MCA or any EMS agency. It is agreed that mutual aid\\nresponse is dependent on the availability of equipment and personnel.\\n4. It is in the best interests of MCAs to include each other in disaster planning efforts.  It is expected\\nthat upon request, participating MCAs will extend any relevant information on emergency\\nplanning to other MCAs as deemed reasonably appropriate by the MCA distributing the\\ninformation.\\n5. Participating MCAs agree to adopt, as a minimum, the State Protocols for responding to a\\ndisaster event, and those agencies/EMS personnel will follow these when responding outside\\ntheir own MCA, unless prior arrangements with that MCA.","source_file":"10.7-Pre-Hospital-EMS-MCA-Mutual-Aid-During-Disaster-12.27.22.txt","categories":["medical"]},"10.8":{"name":"HAZARD CONTAMINATED PATIENT","content":"I.\\nIdentification of the Contaminated Patient\\na. Use all your senses.  Suspect hazardous material situation if you:\\ni.\\nii.\\niii.\\nSee containers, labels or placards, or a location suggesting a\\nhazardous substance\\nHear explosions, or reports of possible contamination, pre-arrival or\\non scene\\nSmell unusual odors  be suspicious\\nIf contamination of a patient is suspected, the local fire or public safety department\\nmust be informed of the hazardous material situation.\\nThe responding EMS agencies must prevent further contamination to themselves or\\nothers.  Determine if any contaminated patients have already left the scene and\\npromptly notify the hospital(s).\\nThe responding EMS agency must not spread any contamination outside the\\nresponse area until the responding fire or public safety department incident\\ncommander, or appropriate designee, has confirmed that decontamination is\\ncomplete.  Contaminated patients will not be transported out of the decontamination\\narea until field decontamination is complete.\\nEMS responders will not enter a known contaminated area without proper personal\\nprotective equipment, training, and direction by incident command.\\nInvasive patient care procedures (IV/IO, OPA, NPA, ET, and Emergency Airway\\nDevices) should not begin until decontamination of the patient is confirmed or until\\npersonal protective equipment is in place.\\nPrior to transport of a decontaminated patient, on-line medical control will be\\ncontacted to assure the patient is transported to a facility equipped to handle the\\nspecific needs of the patient.\\nII.\\nIII.\\nIV.\\nV.\\nVI.\\nVII.\\nVIII. Once the scene Incident Commander, or the appropriate designee, has confirmed\\nthat the patient is decontaminated, the responding EMS agency may transport the\\npatient to the designated facility.","source_file":"10.8-Hazard-Contaminated-Patient-12.27.22.txt","categories":["medical"]},"10-9":{"name":"SUSPECTED PANDEMIC","content":"Purpose: To have a standard approach to patients during a period of a declared pandemic\\nor state of Public Health Emergency.  This approach should increase awareness and\\nprotection of first responders and prehospital care while maximizing supplies that may\\nbecome limited.\\nCriteria:\\n1. This protocol will apply to patients encountered by all levels of EMS, during an\\ninfectious disease epidemic/pandemic.  All agencies should frequently check the\\nCDC.gov website for the latest recommendations with Personal Protective\\nEquipment (PPE) and treatment. These recommendations may change frequently\\nduring an evolving and ongoing epidemic/pandemic as regulatory standards are\\ninfluenced by CDC recommendations.\\n2. The center for Disease Control and Prevention (CDC) has declared that an epidemic\\nand/or the Michigan Department of Public Health has declared a statewide or local\\npublic health emergency.\\n3. Acute Febrile Respiratory Illness (AFRI) is defined as fever and at least one of the\\nfollowing (cough, nasal congestion/runny nose, or sore throat).\\nEMS System / Medical Control Authority (MCA) Recommendations:\\n1. Encourage all EMS personnel to receive seasonal and disease specific\\nvaccinations.\\n2. Each life support agency shall maintain a supply of fit tested N-95 respirators and\\neye protection (e.g., goggles, eye shield), disposable non-sterile gloves, and gowns.\\n3. Each life support agency shall provide approved pathogen neutralizing hand\\nsanitizer to staff.\\n4. Each life support agency should instruct their personnel to stay home and not report\\nfor duty if they have signs or symptoms of acute febrile respiratory illness. A staff\\nmember that develops these symptoms during a shift must inform the agency\\nsupervisor for appropriate follow up procedures.\\n5. Dispatch centers should be encouraged to screen callers to determine if the patient\\n6.\\nmay have an AFRI. Information should be provided to EMS personnel prior to\\narriving on the scene if suspected AFRI.\\nIf it is determined by EMS that the patient may have an AFRI, early notification to\\nthe receiving facility should be done so that appropriate infection control may be\\ntaken prior to patient arrival.\\nProcedure and Patient Categorizations/Situations\\n1. Limiting Personnel Exposure:\\nA. If the patient has symptoms of an Acute Febrile Respiratory Illness (AFRI)\\nbased upon the dispatch information the responding agency should consider\\nlimiting the initial number of personnel that approach or enter a residence.","source_file":"10.9-Suspected-Pandemic-12.27.22.txt","categories":["medical"]},"2-10":{"name":"HEAT EMERGENCIES","content":"Initial Date:8/31/2023\\nRevised Date:\\nHeat Emergencies\\n1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2.  Pediatric patients (< 14 years of age) utilize MI MEDIC cards for appropriate\\nmedication dosage.  When unavailable utilize pediatric dosing listed within protocol\\n3.  Determine history/evidence of heat exposure.\\n4.  Check blood glucose (may be MFR skill, see 7.21 Blood Glucose Testing-\\nProcedure Protocol) and treat hypoglycemia per 1.100 Diabetic Emergencies\\nHEAT CRAMPS:\\n1.  Move the patient to a cool environment and attempt oral liquids (may use commercial\\nsports/rehydration).\\nHEAT EXHAUSTION:\\n1.  Move the patient to a cool environment.\\n2.  Remove tight clothing.\\n3.  Cool patient, provide air conditioning/fanning.  Avoid chilling/shivering.\\n4.  Obtain IV/IO Access and administer fluid bolus NS or LR wide open (refer to 7.23\\nVascular Access and IV Fluid Therapy-Procedure Protocol).\\na.  Adults (> 14 years of age): up to 1 liter\\nb.  Pediatrics (<14 years of age): up to 20 mL/kg\\n5.  Patient may take oral fluid replacement rather than IV if no nausea.  Allow oral intake of\\ncool fluids or water (may use commercial sports/rehydration drinks).  Do not permit\\npatient to drink if altered mental status, abdominal pain, or nausea.  Avoid carbonated,\\nalcoholic and caffeinated beverages.\\n6.  Treat nausea according to 1.3 Nausea/Vomiting-Treatment Protocol.\\nHEAT STROKE:\\n1.  Move the patient to a cool environment.\\n2.  Remove tight clothing.\\n3.  Immediate cooling  provide air conditioning and fanning.  Avoid chilling/shivering.\\n4.  Place patient in semi-reclining position with head elevated.\\n5.  Obtain IV/IO Access and administer fluid bolus NS or LR wide open (refer to 7.23\\nVascular Access and IV Fluid Therapy-Procedure Protocol).\\na.  Adults (> 14 years of age): up to 1 liter\\nb.  Pediatrics (<14 years of age): up to 20 mL/kg\\n7.  Treat nausea according to 1.3 Nausea/Vomiting-Treatment Protocol.\\n8.  Initiation of aggressive cooling may take priority over transport.  Contact Medical Control\\nfor further cooling and transport guidance.\\nMANAGEMENT OF PATIENT WITH EXERTIONAL HEAT STROKE\\n1.  Cool as quickly as possible via ice or cool-water immersion, if possible. Alternative\\nmeans, such as continually misting the exposed skin with tepid water while fanning\\nthe victim, may be used if immersion is not possible.","source_file":"2.10-HEAT-EMERGENCIES-8.31.23-Clean.txt","categories":["adult","medical","pediatric"]},"2-100":{"name":"Unknown Protocol","content":"Initial Date: 8/7/2024\\nRevised Date:\\nStrangulation\\nStrangulation is defined as asphyxiation caused by closure of blood vessels and or air\\npassageways of the neck due to external pressure. External pressure can be manual via a\\nbody part such as hands, arms, knees, etc., or can be by an object such as a belt, rope, etc.\\nStrangulation can be self-inflicted or inflicted by another person. Patients are at risk of\\ndelayed death due to internal swelling, anoxia, hematoma or structural damage that cannot\\nbe identified externally. Patients should be encouraged to seek medical care; if transported,\\ncommunicate strangulation attempt to hospital.\\nI.\\nII.\\nScene Safety\\na.  Patient\'s spouse/partner, caregiver or parent may be the perpetrator; their\\npresence may hinder patient\'s disclosure of information and affect scene\\nsafety.\\nb.  If appropriate, ensure law enforcement response.\\nAssess and document:\\na.  Mechanism of injury.\\ni.  Mechanism of strangulation:\\n1. Left, right, or both hands.\\n2. Forearm.\\n3. Knee or foot.\\n4. Ligature (i.e., rope, belt, etc.).\\n5. Smothered.\\n6. Other, describe.\\nii.  Evaluate for:\\n1. Quantify grip strength of strangulation.\\n2. Level of pain using 1-10 scale.\\n3. Duration of strangulation in min/sec.\\n4. Prior incidents of strangulation, domestic violence, or threats.\\niii.  Evaluate additional mechanism of injuries.\\n1. Was the patient shaken, beaten or held against wall, ground, etc.\\nb.  Signs and symptoms of strangulation and neck injury are not visible over 50%\\nof the time. Evaluate for:\\ni.  Neck spasms.\\nii.  Petechiae on face, eyes/eyelids, nose, ears, head.\\niii.  Deformity of or bleeding from nose, ears; bruising, swelling of\\nmouth/lips.\\niv.  Redness, scratches, abrasions, bruising under chin, on neck,\\nshoulders, chest.\\nv.  Ligature marks, swelling, fingernail impressions (offensive or defensive)\\non neck.\\nvi.  Missing hair, fracture, or swelling/bruising on head, signs of concussion.\\nvii.  Difficulty breathing or speaking; coughing, hoarse or raspy voice;\\ndrooling, difficulty or pain swallowing.\\nviii.  Vision disturbances or changes (spots, light flashes, tunnel vision, etc.).","source_file":"2.100-Strangulation-8.7.24-Clean.txt","categories":["trauma","medical"]},"2-11":{"name":"HYPOTHERMIA/FROSTBITE","content":"1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol\\nHYPOTHERMIA:\\n1.  If cardiac arrest develops follow 5.1 Adult or 6.1 Pediatric General Cardiac Arrest-\\nTreatment Protocol.\\n2.  Move patient to a warm dry place, remove wet clothing & wrap in warm blankets and\\nprotect from wind exposure.\\n3.  If the patients temperature is greater than 30\xb0 C (86\xb0 F) or patient shivering &\\nconscious:\\nA.  Apply heat packs to groin, axillae, and neck if possible.\\nB.  Use warmed humidified oxygen if available.\\n4.  If patient is alert, administer warm non-caffeinated beverages (if available) by mouth,\\nslowly.\\n5.  If patient temperature is less than 30\xb0 C (86\xb0 F)\\nA.  Gentle handling is required.\\nB.  Facilitate transport immediately.\\n6.  If altered mental status, check blood glucose (may be MFR skill, see 7.21 Blood\\nGlucose Testing-Procedure Protocol) and treat as indicated per 3.1 Adult or 4.4\\nPediatric Altered Mental Status-Treatment Protocol and assess for other causes\\nof alterations of mentation.\\n7.  If hypotensive, follow 1.5 Shock-Treatment Protocol.\\nA.   If a commercial device designed for warming IV fluids is available, warm fluid\\nprior to administration.\\n8.  Administer oxygen, if available oxygen should be warmed and humidified.\\nSUSPECTED FROSTBITE:\\n1.  Remove wet or constricting clothing.  Keep skin dry and protected from wind.\\n2.  Do not allow the limb to thaw if there is a chance that limb may re-freeze before\\nevacuation is complete or if patient must walk to transportation.\\n3.  Dress injured areas lightly in clean cloth to protect from pressure, trauma or friction.\\nDo not rub. Do not break blisters.\\n4.  Keep patient warm.\\n5.  Frostbitten areas should be supported and elevated during transport.\\n6.  Treat pain per 7.13 Pain Management-Procedure Protocol.\\nProtocol Source/References: NASEMSO CLINICAL GUIDELINES","source_file":"2.11-HYPOTHERMIA-FROSTBITE-8.31.23-clean.txt","categories":["adult","trauma","medical","pediatric"]},"2-12":{"name":"MODERATE & SEVERE TBI","content":"Head Injury  Moderate & Severe TBI\\nPurpose:  Reduction of morbidity and mortality associated with Traumatic Brain Injury\\n(TBI). The treatment of a patient with suspected TBI should focus on four important clinically\\nidentifiable conditions: hypoxia, hyperventilation, hypotension, and hemorrhage.  Overall\\napproach:  Continuous monitoring of O2 saturation with high-flow oxygen regardless of O2\\nsaturation, avoidance of positive pressure ventilation (PPV) whenever possible and use of\\ncontinuous quantitative end-tidal CO2 (ETCO2) monitoring in patients requiring positive\\npressure ventilation, blood pressure monitoring every 3-5 minutes and using IV fluids to\\nmaintain BP above target, and assessment for signs of hemorrhage or hemorrhagic shock\\nwith use of applicable bleeding control interventions.\\nI.  TBI Criteria (moderate or severe TBI)\\n1.  Anyone with physical trauma and a mechanism consistent for a brain injury AND\\none or more of the following:\\na.  Any loss of consciousness OR any altered mental status (e.g., GCS <15)\\nb.  Multisystem trauma requiring PPV, whether the primary need for PPV was from\\nTBI or from other injuries.\\nc.  Seizures: pre-traumatic or post-traumatic seizures whether continuing or not.\\nd.  In infants (where mental status may be difficult to interpret): any decreased\\nlevel of consciousness or decreased responsiveness.\\nII.   Procedure:\\n1. Follow 1.1 General Pre-hospital Care Protocol\\n2. Transport according to 8.3 Transportation Protocol.\\n3. Manage Airway & Oxygenation (Prevent Hypoxemia)\\n  a. All patients identified with moderate or severe head injury should receive\\ncontinuous high-flow oxygen immediately by non-rebreather mask.\\nb. Monitor and maintain SpO2 equal to or greater than 90%.\\nc. If hypoxia is present despite high-flow oxygen, basic maneuvers for airway\\nrepositioning should be attempted, followed by reevaluation.\\n  d. If this does not restore SpO2 to 90% or greater, or if there is inadequate\\nventilatory effort, bag-valve-mask (BVM) ventilation should be performed, 2-\\nperson with supplemental oxygen and basic airway adjuncts.\\ne. Advanced airway placement only when BVM ventilation ineffective or other\\nconditions warrant advanced airway (e.g., long transport time) refer to 7.9\\nAirway Management-Procedure Protocol\\n4. Manage Ventilation (Prevent Hyperventilation)\\nNote:  Identify and treat hypoventilation as well as prevent hyperventilation when\\nassisting ventilation.  As much as possible maintain normal ventilation.  Hyper-\\nventilation decreases cerebral blood flow and worsens secondary brain injury.\\nStrict attention on avoiding hypo- and hyper- ventilation is critical. It has been\\nshown that repeatedly that inadvertent hyperventilation happens reliably if not\\nmeticulously prevented.  Use Pressure-Controlled Bags (PCBs) and Ventilation","source_file":"2.12-HEAD-INJURY-ADULT-8.31.23-Clean-edited.txt","categories":["trauma"]},"2-13":{"name":"BLEEDING CONTROL (BCON)","content":"Initial Date: 8/31/2023\\nRevised Date:\\nBleeding Control\\nIndications:\\nPatients with significant traumatic or non-traumatic (i.e., hemodialysis access) external\\nhemorrhage\\n1.\\n2.\\n3.\\nFollow 1.1 General Pre-hospital Care-Treatment Protocol and 2.5 Soft Tissue\\n& Orthopedic Injuries-Treatment Protocol.\\nApply direct pressure to the wound with clean gauze using universal precautions.\\nIf the bleeding is not controlled with direct pressure, treat according to the\\nlocation of the wound.\\na.  Extremity bleeding - apply tourniquet:(Refer to 7.22 Tourniquet Application-\\nProcedure Protocol)\\ni.  If tourniquet unsuccessful apply second/adjacent tourniquet per 7.22\\nTourniquet Application-Procedure Protocol.\\nii.  NOTE- tourniquet may be painful, see 7.13 Pain Management-\\nProcedure Protocol.\\nb.  Neck, axilla/shoulder or groin bleeding:\\ni.  Pack wound with MCA approved hemostatic dressing (if available,\\nfollowing manufacturers instructions) or clean gauze.\\nii.  Use as much of the dressing/gauze as needed to stop the blood flow.\\niii.  Quickly apply pressure until the bleeding stops. (Approximately 3-5\\nminutes)\\niv.  Leave the dressing in place and wrap area with bandaging to secure the\\ndressing.\\n4.\\n5.\\n6.\\n7.\\n8.\\nDo not remove the bandage or hemostatic dressing/gauze\\nElevate the injury, if possible.\\nReassess for bleeding through or around the dressing.\\nFor patients who have signs or symptoms of shock, secondary to hemorrhage,\\nrefer to 2.14 Hemorrhagic Shock-Treatment Protocol.\\nTransport according to 8.3 Transportation Protocol\\nNotes:\\nIf hemostatic dressing is used, contact medical control to advise of application,\\ndocument time of use, and send packaging from dressing to hospital with patient for\\nremoval instructions.","source_file":"2.13-BCON-8.31.23-Clean.txt","categories":["trauma","medical"]},"2-14":{"name":"HEMORRHAGIC SHOCK","content":"Hemorrhagic Shock\\nPurpose:  To provide treatment for patients displaying signs and symptoms of shock\\nattributed to hemorrhage including trauma and severe postpartum hemorrhage.\\n1.\\n2.\\n3.\\n4.\\n5.\\n6.\\n7.\\n8.\\nFollow 1.1 General Pre-hospital Care-Treatment Protocol control bleeding\\naccording to 2.13 Bleeding Control (BCON)-Treatment Protocol when\\napplicable.\\nTransport according to 8.3 Transportation Protocol.\\nNo intervention should delay transport.\\nObtain vascular access.\\nFor signs of hypotension unaccompanied by moderate to severe head trauma\\nadminister NS or LR IV/IO fluid bolus IV/IO (refer to 7.23 Vascular Access and\\nIV Fluid Therapy-Procedure Protocol).\\na.  Adults (> 14 years of age): up to 1 liter\\nb.  Pediatrics (< 14 years of age): up to 20 mL/kg\\nFor signs of hypotension accompanied by moderate to severe head trauma refer\\nto 2.12 Head InjuryTreatment Protocol for fluid administration guidelines.\\nConsider other causes of traumatic hypotension and treat accordingly. (Tension\\npneumothorax see 7.18 Pleural Decompression-Procedure Protocol,\\nneurogenic shock see 1.5 Shock-Treatment Protocol)\\nHypotensive patients unaccompanied by moderate to severe head trauma should\\nreceive additional IV/IO fluid boluses, as indicated by hemodynamic state.\\na.  Adults (> 14 years of age): repeat IV/IO fluid bolus to a maximum of 2 liters.\\nb.  Pediatrics (< 14 years of age): repeat dose of 20 ml/kg to a maximum of 40\\nml/kg.\\nc.  Monitor for pulmonary edema.\\nd.  If pulmonary edema presents, stop fluids and contact Medical Control for\\ndirection.\\n9.\\nPer MCA Selection, if bleeding is uncontrolled and non-compressible, administer\\nTranexamic Acid (TXA)\\nTranexamic Acid (TXA) Included\\n Yes\\n   No\\nAge greater than 18 years old AND > 50 kg\\n1.\\n2.\\n3.\\nDestination must be capable of administering 2nd dose.\\nDraw up and mix 1 gram of TXA into a 100 ml bag of normal saline solution\\n(0.9% Sodium Chloride Solution).\\na.  Use a filter needle if the medication is supplied in an ampule.\\nb.  Apply pre-printed TXA added fluorescent-colored label to IV bag.\\nAdminister mixed medication via piggyback into IV/IO line over 10 minutes.","source_file":"2.14-HEMORRHAGIC-SHOCK-8.31.23-Clean-edited.txt","categories":["adult","trauma","medical"]},"2-15":{"name":"SEXUAL ASSAULT","content":"Initial Date: 8/31/2023\\nRevised Date: 8/5/2024\\nSexual Assault\\nNote to Responders: Victims of sexual assault commonly require psychological support.\\n  Respect all stress they may be enduring and be thoughtful with your speech and\\nmovement.\\n  Touching may be traumatic. Be clear and communicate what you are doing and any\\nprocedures or physical assessments that are completed.\\nI.\\nII.\\nIII.\\nTreat any life-threatening injuries or other emergencies first and according to\\nprotocol.\\nNeck Injury (possible strangulation)  Refer to 2.100 Strangulation.\\nDuring treatment, attempt to maintain evidence, refer to 7.3 Crime Scene\\nManagement-Procedure Protocol.\\na.  Do not cut through tears or stains. Only cleanse skin when necessary to\\nprovide immediate treatment.\\nb.  Any clothes that have been removed from the patient, should be bagged in\\npaper bags, and brought with the patient to the hospital, if possible.\\nc.  Explain to the patient why they should not eat, drink, smoke, bathe, change\\nclothing, or go to the bathroom. If they must urinate, ask that they not wipe.\\nd.  If the patient desires and/or mandatory reporting is indicated, notify law\\nenforcement if they are not present.\\ne.  Any incident involving a minor or a vulnerable adult is a mandatory reporting\\nevent.\\nIV.\\nV.\\nVI.\\nVII.\\nAt the request of the patient, further assessment and treatment may be delayed\\nfor law enforcement arrival only if no life-threatening situation is present.\\nDuring transport, allow the patient to choose the preferable attendant, if possible.\\nDo not communicate details of a sexual assault over an open radio channel. Use\\ntelephone or other secure electronic communication.\\nIf the patient declines transport to the hospital:\\na.  Advise patients of risks and document according to the 7.19 Refusal of Care,\\nAdult and Minor-Procedure Protocol\\nb.  Encourage patients to seek follow-up care at a local specialized treatment\\ncenter.\\nc.  If law enforcement is not present, and the patient refuses law enforcement\\ncontact, advise patient that evidence of assault is best collected within 120\\nhours.\\nd.  Advise of available resources by seeking treatment or assistance, such as:\\ni.  MCA Specific resources, if available (i.e., Community Integrated\\nParamedicine if available and patient consents, MCA specific resource\\nsheets if available, etc.)\\nii.  Michigans sexual assault hotline 1-855-VOICES4 (1-855-864-2374)\\niii.  Links to local resources: https://www.michigan.gov/mdhhs/safety-injury-\\nprev/domestic-violence/find-services-in-your-area\\niv.  If unaware of local resources, and law enforcement is not available,\\ncontact Medical Control","source_file":"2.15-SEXUAL-ASSAULT-Clean-8.5.24.txt","categories":["adult","trauma","medical"]},"2-2":{"name":"GENERAL TRAUMA","content":"General Trauma\\nThis protocol should be followed for severely injured patients meeting trauma triage\\nguidelines and methodology, including chest injuries, and patients with symptoms of spinal\\ncord injury, along with extremity weakness, numbness, or sensory loss.  It consists of\\nassessment, stabilization, extrication, initiation of resuscitation, and rapid transportation to\\nthe closest appropriate trauma facility.\\nGENERAL TRAUMA MANAGEMENT\\n1.  Follow 1.1 General Pre-Hospital Care-Treatment Protocol.\\n2.  Stabilize spinal column while opening the airway, determine level of consciousness.\\nRefer to 2.6 Spinal Injury Assessment-Treatment Protocol.\\n3.  Manage airway and ventilation per 7.9 Airway Management-Procedure Protocol.\\nAvoid Hyperventilation/Hyperoxygenation.\\n4.  Control major external bleeding.  Refer to 2.13 Bleeding Control (BCON)-\\nTreatment Protocol.\\n5.  If signs of shock are present, refer to 1.5 Shock-Treatment Protocol.\\n6.  Refer to 10.6 Mass Casualty Incidents-Special Operations Protocol if appropriate.\\n7.  Determine if the patient is taking blood thinners and document the results in the PCR.\\n8.  Initiate transport according to 8.3 Transportation Protocol.\\n9.  Alert receiving hospital as soon as appropriate.  Include pertinent trauma triage\\ncriteria.\\n10. Obtain vascular access (in a manner that will not delay transport).\\n11. Refer to 7.13 Pain Management-Procedure Protocol.\\nCHEST INJURY\\n1.  Control hemorrhage per 2.13 Bleeding Control (BCON)-Treatment Protocol and\\n2.5 Soft Tissue and Orthopedic Injuries-Treatment Protocol and 2.13\\nBleeding Control-Treatment Protocol.\\n2.  Assess, monitor, and treat life threatening respiratory problems.\\nA.  Administer high-flow oxygen. Avoid positive pressure ventilation if possible.\\nB.  Cover open and/or sucking chest wounds with an occlusive dressing or an\\nFDA approved, MCA authorized commercial device.\\n1.  Release dressing if worsened shortness of breath, or signs of tension\\npneumothorax.\\n3.\\nIf tension pneumothorax suspected, perform needle decompression per 7.18\\nPleural Decompression-Procedure Protocol.\\nABDOMINAL INJURY\\n1.  Cover intestinal eviscerations with a sterile dressing moistened with sterile saline or\\nwater; cover the area with an occlusive material (aluminum foil or plastic wrap).\\nCover the area with a towel or blanket to keep it warm.  Transport with knees slightly\\nbent, if possible.  DO NOT PUSH VISCERA BACK INTO ABDOMEN.\\n2.  If signs of shock see 1.5 Shock-Treatment Protocol and/or 2.14 Hemorrhagic\\nShock-Treatment Protocol\\nHEAD INURY\\n1.  Avoid hypo or hyper ventilation.  See 2.12 Head Injury-Treatment Protocol","source_file":"2.2-General-Trauma-8.31.23-Clean.txt","categories":["trauma","medical"]},"2-3":{"name":"BURNS","content":"Initial Date: 8/31/2023\\nRevised Date:\\nBurns\\nNOTE:  When calculating Total Body Surface Area (TBSA) do not include superficial burns\\n(erythematous tissue) in the TBSA\\nBURN SEVERITY DETERMINATION/DEFINITIONS\\nSUPERFICIAL - NOT counted in TBSA\\nDry, red, easily blanching, sometimes painful (i.e., sunburn)\\nSUPERFICIAL PARTIAL THICKNESS  counted in TBSA\\nMoist, red, blanching, blisters, very painful\\nDEEP PARTIAL THICKNESS  counted in TBSA\\nDrier, more pale, less blanching, less pain\\nFULL THICKNESS  counted in TBSA\\nDry, leathery texture, variable color (white, brown, black), loss of pin prick sensation\\nGENERAL TREATMENT:\\n1.  Follow 1.1 General Pre-Hospital Care-Treatment Protocol.\\n2.  Pediatric patients (< 14 years of age) utilize MI MEDIC cards for appropriate\\nmedication dosage.  When unavailable utilize pediatric dosing listed within protocol\\n3.  If evidence of possible airway burn, consider proactive airway management per 7.9\\nAirway Management-Procedure Protocol.\\n4.  Administer 100% oxygen to all patients rescued from a confined space fire (i.e.,\\nbuilding, automobile) regardless of pulse oximetry reading.\\n5.  Determine burn extent & severity (rule of nines, or palm = 1%).\\n6.  Keep patient warm and avoid hypothermia.\\n7.  Assess and treat for associated injuries.\\n8.  If burns are associated with unconsciousness or respiratory burns, or cyanide\\npoisoning, refer to 10.5 Cyanide Exposure-Special Operations Protocol.\\nTHERMAL BURNS:\\n1.  Stop the burning process. Remove smoldering and non-adherent clothing.\\n2.  Consider potential for secondary contamination .\\n3.  Assess and treat associated trauma.\\n4.  Remove any constricting items.\\n5.  Cover burns with dry clean dressings to prevent hypothermia.\\nCHEMICAL BURNS:\\n1.  Protect personnel from contamination.\\na.  Identify chemical agent when possible.\\n2.  Remove all clothing and constricting items.\\n3.  Decontaminate patient prior to transport, brushing off dry chemicals prior to irrigation\\nrefer to 10.8 Hazard Contaminated Patient-Special Operations.\\n4.  Evaluate for systemic symptoms, which might be caused by chemical contamination.\\n5.  Notify receiving hospital of possible chemical contamination.\\n6.  Cover burned area in clean, dry dressing for transport.\\nELECTRICAL INJURY:\\n1.  Protect rescuers from live electric wires.\\n2.  When energy source is removed, remove patient from electrical source.","source_file":"2.3-BURNS-8.31.23-Clean.txt","categories":["trauma","medical","pediatric"]},"2-4":{"name":"GENERAL CRUSH INJURY","content":"Initial Date: 8/31/2023\\nRevised Date:\\nGeneral Crush Injury\\nPurpose:\\nThis protocol should be considered when the patient has been entrapped at the scene\\nfor more than one hour, one or more full extremities trapped by an object capable of\\ncausing a crush injury, including machinery, dirt, rock, and rubble or there is entrapment\\nof patient with history of previous cardiac or renal disease or dialysis treatment.\\nCrush Syndrome:\\nShould be suspected in patients with entrapment/compression of greater than one hour,\\nespecially when a large muscle mass/group is involved. Treatment of the patient at risk\\nfor Crush Syndrome should begin before the patient is removed when practical.\\nTreatment:\\n1.  Follow 1.1 General Trauma-Treatment Protocol, identify and treat life threats.\\n2.  Pediatric patients (< 14 years of age) utilize MI MEDIC cards for appropriate\\nmedication dosage.  When unavailable utilize pediatric dosing listed within protocol.\\n3.  Assess for signs of Compartment Syndrome or Crush Syndrome.\\n4.  Use tourniquet as indicated (see 7.22 Tourniquet Application-Procedure Protocol.\\n5.  Administer oxygen to patient if environment allows.\\n6. Administer albuterol 2.5 mg/3ml NS nebulized per 9.1 Medication Administration-\\nMedication Protocol continuous if IV access is not immediately available.  (Per MCA\\nselection may be EMT skill).  Albuterol may be continued to a maximum dose of 20 mg\\nNebulized albuterol administration\\n          EMT\\n7.  Establish large bore IV(s) and/or IO (refer to 7.23 Vascular Access and IV Fluid\\nTherapy-Procedure Protocol) and administer Normal Saline bolus prior to removal\\nof patient, when practical.\\na.  AVOID LR solution as it contains potassium\\nb.  Adults: 1 liters NS IV/IO wide open followed by 500-1,000 mL/hr\\nc.  Pediatrics: 20 ml/kg NS IV/IO wide open followed by 10/mL/kg/hr\\n8.  Treat patient pain per 7.13 Pain Management-Procedure Protocol.\\n9.  Initiate cardiac monitoring and assess for hyperkalemia, i.e., wide QRS or peaked T\\nwaves. Monitor continuously for changes.\\n10. If extrication is prolonged, and/or hyperkalemia is suspected (peaked T waves,\\nwidened QRS, hypotension):\\na.  Administer sodium bicarbonate","source_file":"2.4-GENERAL-CRUSH-INJURY-8.31.23-Clean.txt","categories":["trauma","medical","pediatric"]},"2-5":{"name":"SOFT TISSUE AND ORTHOPEDIC INJURIES","content":"1.  Follow 1.1 General Pre-hospital Care Protocol.\\n2.  Pediatric patients (< 14 years of age) utilize MI MEDIC cards for appropriate\\nmedication dosage.  When unavailable utilize pediatric dosing listed within protocol.\\n3.  Control bleeding (refer to 2.13 Bleeding Control (BCON)- Procedure Protocol)\\nA.  Utilize direct pressure.\\nB.  Consider early tourniquet use (refer to 7.22 Tourniquet Application-\\nProcedure Protocol).\\nC.  Consider MCA approved hemostatic agents and hemorrhage control devices.\\nD.  Consider use of pressure dressings with deep wound packing.\\nE.  Consider pelvic binding for suspected unstable pelvic fracture.\\n4.  For uncontrolled bleeding with hemorrhagic shock see 2.14 Hemorrhagic Shock-\\n5.\\nTreatment Protocol\\nIf appropriate, maintain spinal precautions for patient per 2.6 Spinal Injury\\nAssessment-Treatment Protocol.\\n6.  Assess pain on 1-10 scale and treat per 7.13 Pain Management-Procedure Protocol.\\n7.\\nImmobilize/splint orthopedic injuries as appropriate.\\nA.  Special Considerations\\ni.  Consider traction splinting for closed femur fractures (excluding\\nhip/femoral neck).\\nii.  Straighten severely angulated fractures if distal extremity has signs of\\ndecreased perfusion.\\niii.  Evaluate and document neurovascular status before and after\\nsplinting.\\n8.  Partial/complete  amputations,  major  soft  tissue  injuries  (e.g.,  mangled  extremity)  and\\nopen fractures.\\nA.  Control bleeding as above\\nB.  Cover wounds with sterile dressings moistened with sterile solution.\\nC.  Splint extremity.\\nD.  Recoverable amputated parts should be brought to hospital as soon as possible.\\nE.  Wrap amputated part in sterile dressing moistened with sterile solution.  Seal in\\na plastic bag and, if available, place bag in container of ice and water.  DO\\nNOT place part directly on ice.\\nF.  Obtain IV access per 7.23 Vascular Access and IV Therapy-Procedure\\nProtocol.\\nG.  Administer antibiotics (per MCA selection).","source_file":"2.5-SOFT-TISSUE-AND-ORTHOPEDIC-INJURIES-Clean-8.31.23.txt","categories":["trauma","pediatric"]},"2-6":{"name":"SPINAL INJURY ASSESSMENT","content":"1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2.  Assess the mechanism of injury.\\nA.  Negative mechanism does not need a spine injury clinical assessment.\\nB.  Patients with mechanism of injury with the potential for causing spine injury\\nshall have a spine injury clinical assessment performed.\\n3.  Clinical criteria are used as the basis for assessment.  If any of the clinical criteria are\\npresent or if the assessment cannot be completed, the patient has a positive spine\\ninjury assessment.\\n4.  If the mechanism of injury with the potential for causing spine injury exists, the\\nfollowing clinical criteria are assessed:\\nA.  Altered mental status\\nB.  Use of intoxicants\\nC.  A painful injury that distracts the patient from assessment of the spine.\\nD.  Motor and/or sensory deficit\\nE.  Spine pain and/or tenderness\\n5.  If any of the clinical criteria are present the patient has a positive spine injury\\nassessment.  If none of the clinical criteria are present the patient has a negative\\nspine injury assessment.\\n6.  Patients with a positive spine injury assessment should have spinal precautions\\nmaintained during movement and transport. Refer to 7.20 Spinal Precautions-\\nProcedure Protocol.\\n7.  Patients over the age of 65 with evidence of a head strike mechanism of injury will\\nhave a rigid extrication collar applied even if the spinal injury clinical assessment is\\nnegative.\\nProtocol Source/References: NASEMSO Clinical Guidelines","source_file":"2.6-SPINAL-INJURY-ASSESSMENT-8.31.23-clean.txt","categories":["trauma"]},"2-7":{"name":"TRAUMATIC ARREST","content":"Initial Date: 8/31/2023\\nRevised Date:\\nTraumatic Arrest\\nPurpose:  The patient in cardiac arrest from a traumatic cause requires rapid assessment\\nand treatment for any chance of meaningful recovery. Standard ACLS is not the optimal\\napproach. Successful resuscitation of the traumatic cardiac arrest patient requires rapid\\nidentification and correction of specific entities and rapid transport to an appropriate facility.\\n1.  Indications:\\na.  Patients in cardiac arrest from a traumatic source (blunt or penetrating)\\n2.  Contraindications:\\na.  Patient that meets DOA criteria, refer to 7.6 Dead on Scene/Termination of\\nResuscitation-Procedure Protocol.\\nb.  Suspected traumatic cardiac arrest of more than 10 minutes prior to any\\ninterventions, refer to 7.6 Dead on Scene Termination of Resuscitation-\\nProcedure Protocol\\nc.  If the trauma appears to be minor/minimal and a medical condition appears to\\nbe the cause of the cardiac arrest, refer to the appropriate cardiac arrest\\nprotocol.\\n3.  Procedures\\na.  CPR - high quality CPR needs to be maintained refer to 5.1 Adult or 6.1\\nPediatric General Cardiac Arrest-Treatment Protocol\\ni.\\nIt is permissible to interrupt CPR briefly for life saving interventions\\nlike needle decompression/hemorrhage control.\\nb.  MEDICATIONS - Prioritize findings and reversing life threatening injuries as\\nstandard ACLS medications may not be useful.\\nc.  AIRWAY - Rapid establishment of an advanced airway with 100% oxygen\\nadministration refer to 7.9 Airway Management-Procedure Protocol\\nd.  CHEST DECOMPRESSION - Refer to 7.18 Pleural Decompression-\\nProcedure Protocol.\\ni.  Consider bilateral needle decompression in the presence of chest\\ntrauma, regardless of findings.\\ne.  HEMORRHAGE CONTROL - Bleeding control is essential refer to 2.13\\nBleeding Control (BCON)-Treatment Protocol and if applicable 7.22\\nTourniquet Application-Procedure Protocol.\\ni.  Penetrating Trauma - Areas not amenable to tourniquet should have a\\npressure dressing and/or wound packing per 2.13 Bleeding Control\\n(BCON)-Procedure Protocol.\\nii.  Blunt Trauma  Place a pelvic binder (commercial or a sheet) on all\\npatients with blunt or blast trauma suffering traumatic arrest.  If using\\na sheet, it should be wrapped around the greater trochanters.","source_file":"2.7-TRAUMATIC-ARREST-8.31.23-clean-edited.txt","categories":["adult","trauma","medical"]},"2-8":{"name":"DROWNING/SUBMERSION INJURY","content":"Drowning is defined as, A process resulting in primary respiratory impairment from\\nsubmersion or immersion in a liquid medium. (American Heart Association, 2010).\\nFor patients who have been submerged and in cardiac arrest:\\n1.  In cold water (water temperature less than 70\xb0 F/21\xb0 C)\\nA.  Initiate resuscitative efforts if submersion time is less than 90 minutes.\\ni.  Contact Medical Control for instructions on transport timing and\\ndestination for in-hospital rewarming.\\nB.  For submersion time greater than 90 minutes see 7.6 Dead on\\nScene/Termination of Resuscitation-Procedure Protocol\\n2.  In warm water (temperature is greater than 70\xb0 F/21\xb0 C)\\nA.  Initiate resuscitative efforts if submersion time is less than 30 minutes.\\ni.  Contact Medical Control for futher direction, which may include\\ninstructions on transport timing, destination, or termination of\\nresuscitation.\\nB.   For submersion time greater than 30 minutes see 7.6 Dead on\\nScene/Termination of Resuscitation-Procedure Protocol\\n3.  It may be impractical to determine water temperature; subsurface water\\ntemperatures may be considerably colder than surface temperature. When in doubt,\\nconsider water to be cold.\\n4.  Time estimation begins when the patient is presumed to be submersed.\\nFor patients who have been submerged and NOT in cardiac arrest\\n1.  If SCUBA incident with rapid ascent, the maintain the patient in a supine position.\\n2.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\nA. Administer high flow oxygen.\\nB. Primary survey should include proactive airway management and restoration\\nof adequate oxygenation and ventilation.\\nC. Exam should include consideration of possible c-spine injury.\\nD. Assess for other associated injury such as injury to the head or dive-related\\nemergency.\\nE. Assess patients temperature.\\nF. If patient is hypothermic, go to 2.11 Hypothermia/Frostbite-Treatment\\nProtocol, handle patients gently.  Excessive/aggressive movement can\\nprecipitate cardiac arrest.\\nG. Prevent further heat loss by transport in a warm environment.\\nH. Patient should be dry and/or wrapped in vapor barrier, as available.\\nI.  Patients may develop subacute respiratory difficulty after drowning and\\ntherefore all victims of drowning should be transported for observation.\\ni.  Consider transport to facility with hyperbaric oxygen therapy capability.\\nJ.  Consider CPAP (Per MCA selection, may be a BLS procedure) follow 7.5\\nCPAP- Procedure Protocol.\\nK. Contact Medical Control if no transport is considered or no transport is\\nrequested.","source_file":"2.8-DROWNING-SUBMERSION-INJURY-8.31.23-clean.txt","categories":["trauma","medical"]},"2-9":{"name":"POISONING/OVERDOSE/ENVIRONMENTAL EXPOSURE","content":"Poisoning/Overdose/Environmental Exposure\\nNERVE AGENT/ORGANOPHOSPHATE EXPOSURE refer to 10.3 Nerve\\nAgent/Organophosphate Pesticide Exposure-Special Operations Protocol.\\nGENERAL MANAGEMENT OF TOXIC EXPOSURE (INCLUDING INGESTION)\\n1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2.  Pediatric patients (< 14 years) utilize MI MEDIC cards for appropriate medication\\ndosage.  When unavailable utilize pediatric dosing listed within protocol.\\n3.  Use proper personal protective equipment and prepare for decontamination if necessary.\\n4.  Remove clothing exposed to chemical (dry decon) refer to 10.8 Hazardous Contaminated\\nPatient-Special Operations\\n5.  Identification of the substance the patient has been exposed to.\\n6.  If altered mental status, refer to 3.1 Adult or 4.4 Pediatric Altered Mental Status-\\nTreatment Protocol.\\n7.  If suspected opioid overdose, refer to 1.9 Opioid Overdose Treatment and Prevention-\\nTreatment Protocol.\\n8.  If respiratory distress, refer to 3.3 Adult or 4.5 Pediatric Respiratory Distress-Treatment\\nProtocol.\\n9.  If the patient is seizing, refer to 3.4 Adult or 4.7 Pediatric Seizure-Treatment Protocol.\\n10. Alert receiving hospital if patient may present HAZMAT risk.\\n11. Sample of drug or substance and any medication or poison containers should be brought in\\nwith patient if it does NOT pose a risk to rescuers.\\n12.  Refer to 7.13 Pain Management-Procedure Protocol\\n13.  For inhalation exposures, ensure high flow oxygen is provided.\\n14. If suspected cyanide gas exposure, refer to 10.5 Cyanide Exposure-Special Operations\\nProtocol and contact Medical Control immediately.\\n15. If suspected nerve agent or organophosphate pesticide, refer to 10.3 Nerve\\nAgent/Organophosphate Pesticide Exposure-Special Operations Protocol and\\ncontact Medical Control immediately.\\n16. Obtain 12 lead (Per MCA selection, may be a BLS or Specialist procedure) refer to 7.1\\n12-Lead ECG- Procedure Protocol and monitor cardiac rhythm, treat dysrhythmia per\\nappropriate dysrhythmia protocol.\\n17. For extrapyramidal dystonic reactions, administer diphenhydramine.\\na.  For adults (>14 years of age), 50 mg IV.\\nb.  For pediatrics (<  14 years of age), 1 mg/kg IV (max dose 50 mg).\\n15. For symptomatic tricyclic antidepressant ingestions (tachycardia, wide complex QRS),\\ncontact Medical Control for administration of sodium bicarbonate\\na.  Adults (>14 years of age), 50 mEq IV, repeat as needed per medical control.\\nb.  Pediatrics (<  14 years of age), 1mEq/kg IV, repeat as needed per medical control.\\n16. For symptomatic calcium channel blocker overdose, contact Medical Control and consider\\ncalcium chloride\\na.  Adults (>14 years of age), 1 gm IV.\\nb.  Pediatrics (<  14 years of age), 20 mg/kg IV (max dose 1 gm).","source_file":"2.9-Poisoning-OD-Envir-8.31.23-Clean.txt","categories":["adult","medical","pediatric"]},"3-1":{"name":"ALTERED MENTAL STATUS","content":"The purpose of this protocol is to provide for the assessment and treatment of patients with\\naltered mental status.  Consideration should be given to treatable and reversible causes (e.g.,\\nhypoglycemia, opioid overdose, etc.).  For patients < 14 years of age refer to 4.4 Pediatric\\nAltered Mental Status-Treatment Protocol.\\n1.  Follow 1.1 General Pre-hospital Care Protocol-Treatment Protocol.\\n2.  If patient is not alert or vital signs are abnormal:\\na.  Evaluate and maintain airway, provide oxygenation, and support ventilations as\\nneeded per 7.9 Airway Management-Procedure Protocol.\\nb.  If no suspected spinal injury, place the patient in recovery position.\\n3.  If respiratory depression is present due to suspected opioid overdose, administer\\nnaloxone per 1.9 Opioid Overdose Treatment and Prevention-Treatment Protocol.\\n4.  Restrain patient, if necessary, refer to 7.16 Patient Restraint-Procedure Protocol.\\n5.  For a known diabetic, consider small amounts of oral glucose if unable to measure\\nblood glucose level.\\n6.  If the patient is demonstrating signs of hypoglycemia, refer to 1.100 Diabetic\\nEmergencies.\\n7.  Consider 12 Lead ECG (Per MCA selection, may be a BLS or Specialist procedure)\\nfollow 7.1 12 Lead ECG-Procedure Protocol.\\n8.   If the patient is not alert and the cause is not immediately known contact Medical\\nControl and consider:\\nA  Alcohol\\nE  Epilepsy\\nI  Insulin\\nO  Overdose\\nU  Uremia\\nT  Trauma\\nI  Ingestion\\nP  Psych\\nP  Phenothiazine\\nS  Salicylates\\nC  Cardiac\\nH  Hypoxia\\nE  Environmental\\nS  Stroke\\nS - Sepsis","source_file":"3.1-ALTERED-MENTAL-STATUS-8.31.23-Clean-Amended-12-4.txt","categories":["trauma","medical"]},"3-2":{"name":"STROKE OR SUSPECTED STROKE","content":"OCMCA FAST-ED Stroke Severity Scale Checklist\\n(FAST-ED LSAs only)\\nFacial Palsy  Ask the patient to show their teeth or smile.\\n1.  Both sides of the face move equally or not at all.\\n2.  One side of the face droops or is clearly asymmetric.\\n0\\n1\\nArm Weakness  Ask the patient to extend both arms with palms up out in front of them, close their\\neyes, and hold them there for a count of 10.\\n1.  Both arms remain up for >10 seconds or slowly move down equally.\\n2.  Patient can raise arms but one arm drifts down in <10 seconds.\\n3.  One or both arms fall rapidly, cannot be lifted, or no movement occurs at all.\\nSpeech Changes\\nExpressive Aphasia  Ask the patient to name 3 common items.\\n1.  Names 2 to 3 items correctly.\\n2.  Names only 0 - 1 items correctly.\\nReceptive Aphasia  Ask the patient to perform a simple command.\\n                                   Example: Ask the patient, show me two fingers.\\n1.  Normal, patient can follow the simple command.\\n2.  Unable to follow the simple command.\\nEye Deviation\\n1.  No deviation, eyes move equally to both sides.\\n2.  Patient has clear difficulty when looking to one side (left or right).\\n3.  Eyes are deviated to one side and do not move to the other side.\\nDenial/Neglect  (Do not perform if expressive or receptive aphasia is present)\\n0\\n1\\n2\\n0\\n1\\n0\\n1\\n0\\n1\\n2\\nAnosognosia  Show the patient their affected arm and ask, Do you feel weakness in this arm?\\n1.  Patient recognizes the weakness in their weak arm.\\n2.  Patient does NOT recognize the weakness in their weak arm.\\nAsomatognosia  Show the patient their affected arm and ask, Whose arm is this?\\n1.  Patient recognizes their weak arm.\\n2.  Patient does NOT recognize their weak arm.\\nA FAST-ED score > 4\\nindicates a high likelihood of a severe stroke\\nTotal Score\\n(0-9)\\n0\\n1\\n0\\n1\\nMCA:  Oakland County\\nMCA Approval Date: 10/10/2024\\nMCA Implementation Date:  11/15/2024\\nMDHHS Approval Date: 10/25/2024","source_file":"3.2-OCMCA-STROKE-OR-SUSPECTED-STROKE-Clean-5.24.24.txt","categories":["trauma","medical"]},"3-3":{"name":"RESPIRATORY DISTRESS","content":"Initial Date: 8/31/2023\\nRevised Date: 3/14/2024\\nRespiratory Distress\\nFor patients < 14 years of age refer to 4.5 Pediatric Respiratory Distress-Treatment\\nProtocol.\\n1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2.  Allow patient a position of comfort.\\n3.  Determine the type of respiratory problem involved.\\n4.  Crackles of suspected cardiac etiology or fluid overload (Refer to the 5.4 Pulmonary\\nEdema/Cardiogenic Shock-Treatment Protocol).\\n5.  Refer to the 7.24 End Tidal Carbon Dioxide Monitoring protocol.\\nCLEAR BREATH SOUNDS:\\n1.  Possible metabolic problems, MI, pulmonary embolus, hyperventilation\\n2.  Obtain 12-lead ECG (Per MCA selection, may be a BLS or Specialist procedure)\\nfollow 7.1 12 Lead ECG-Procedure Protocol.\\nASYMMETRICAL BREATH SOUNDS:\\n1.  If evidence of tension pneumothorax and patient unstable, consider decompression\\nrefer to 7.18 Pleural Decompression-Procedure Protocol\\nSTRIDOR/UPPER AIRWAY OBSTRUCTION:\\n1.  Complete Obstruction:\\n A. Follow 1.10 Foreign Body Airway Obstruction-Treatment Protocol.\\n2.  Partial Obstruction: epiglottitis, foreign body, anaphylaxis, etc.\\nA. Follow 7.9 Airway Management-Procedure Protocol.\\nB. Consider anaphylaxis see 1.6 Anaphylaxis/Allergic Reaction-Treatment\\n    Protocol.\\nC. Transport in position of comfort.\\nRHONCHI (SUSPECTED PNEUMONIA):\\n1.  Sit patient upright.\\n2.  Consider CPAP per 7.5 CPAP-Procedure Protocol.\\n3.  Consider NS or LR IV/IO fluid bolus up to 1 liter, wide open if tachycardia, repeat as\\nneeded per 7.23 Vascular Access and IV Fluid Therapy-Procedure Protocol\\nCRACKLES:\\n1.  Crackles of suspected non cardiac etiology/fluid  follow wheezing, diminished breath\\nsound below. For crackles of suspected cardiac etiology/CHF/cardiogenic shock refer\\nto 5.4 Pulmonary Edema/Cardiogenic Shock-Treatment Protocol.\\nWHEEZING, DIMINISHED BREATH SOUNDS (ASTHMA, COPD):\\n1.  Assist the patient in using their own albuterol Inhaler, if available\\na.  Administer albuterol 2.5 mg/3mL NS nebulized (Per MCA selection may be\\nEMT skill) per 9.1 Medication Administration-Medication Protocol","source_file":"3.3-RESPIRATORY-DISTRESS-Clean-Final-3.14.24.txt","categories":["medical","pediatric"]},"3-4":{"name":"SEIZURES","content":"Initial Date: 8/31/2023\\nRevised Date:\\nSeizures\\nFor patients < 14 years of age refer to 4.7 Pediatric Seizure-Treatment Protocol\\n1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2.  IF PATIENT IS ACTIVELY SEIZING:\\nA.  Protect patient from injury.\\nB.  Do not force anything between teeth.\\nC.  Pregnant women 20 weeks gestation up to 6 weeks post birth WITHOUT a\\nseizure disorder history treat as eclampsia, see Magnesium Sulfate\\nadministration below.\\nD.  Administer midazolam 10 mg IM prior to IV start\\n3.  Check blood glucose (may be MFR skill, see 7.21 Blood Glucose Testing-\\nProcedure Protocol),\\nA.  If blood glucose is found to be less than 60 mg/dL or hypoglycemia is suspected\\n                      administer dextrose 25 gm IV per 1.100 Diabetic Emergencies.\\nB.  If patient is pregnant (eclampsia)\\na.  Administer magnesium sulfate 4 gm over 10 minutes IV/IO until\\nseizure stops.  Administration of magnesium sulfate is best\\naccomplished by adding magnesium sulfate 4 gm to 100 or 250 ml\\nof NS and infusing over approximately 10 minutes.\\nb.  If eclamptic seizure does not stop after magnesium, then administer\\nbenzodiazepine as specified below.\\nC.  If IV already established and midazolam IM/IN has not been administered,\\nadminister midazolam 5 mg IV/IO\\nD.  If seizures persist\\na.  Repeat midazolam 5mg IV/IO/IM/IN\\nb.  Contact Medical Control\\n4.  IF PATIENT IS NOT ACTIVELY SEIZING and has/is:\\nA.  Altered level of consciousness, refer to 3.1 Altered Mental Status-Treatment\\nProtocol.\\nB.  Alert\\na.  Monitor for changes.\\nb.  Obtain vascular access see 7.23 Vascular Access & IV Fluid\\nTherapy.\\nc.  Check blood glucose (may be MFR skill, see 7.21 Blood Glucose\\nTesting-Procedure Protocol),\\nMedication References\\nDextrose\\nGlucagon\\nMagnesium Sulfate\\nMidazolam\\nProtocol Source/References: NAEMSO Clinical Guidelines","source_file":"3.4-SEIZURES-8.31.23-Clean-edited.txt","categories":["medical","pediatric"]},"3-5":{"name":"SEPSIS","content":"Initial Date: 8/31/2023\\nRevised Date:\\nSepsis\\nIt is the purpose of this protocol to recognize and treat sepsis early to promote\\noptimal care and survival of patients who may be septic. This protocol applies to\\npatients >14 years of age with a clinical suspicion of systemic infection who have 2 or\\nmore of the inclusion criteria. These patients are defined as meeting criteria for\\nsuspicion of sepsis and should be evaluated and treated per this protocol.\\nINCLUSION CRITERIA\\n1.  Clinical suspicion of systemic infection, and two or more of the following:\\nA.  Hyperthermia temp >38o C (100.4 F)\\nB.  Hypothermia temp<36o C (96.8 F)\\nC.  Heart rate >90bpm\\nD.  Respiratory rate  <10 or >20 per minute\\nE.  SBP <90 mmHg or evidence of hypoperfusion\\nTreatment\\n1.  Follow 1.1 General Pre-Hospital Care-Treatment Protocol.\\n2.  Place patient in supine position.\\n3.  Start large bore IV catheter per 7.23 Vascular Access and IV Fluid Therapy-\\nProcedure Protocol.\\na. Start second large bore IV catheter, if time permits.\\n4.  Place on cardiac monitor and treat rhythm according to appropriate protocol.\\n5.  Place on continuous pulse oximetry.\\n6.  Check blood glucose (may be MFR skill, see 7.21 Blood Glucose Testing-\\nProcedure Protocol\\n7.  If the patient meets inclusion criteria, administer a NS or LR IV/IO fluid bolus up to 1\\nliter, wide open. Reassess the patient, repeat boluses to a maximum of 2 L NS or\\nLR as long as vital sign abnormalities persist.\\nA.  Monitor for pulmonary edema.\\nB.  If pulmonary edema presents, stop fluids, and contact Medical Control for\\n     direction.\\n8.  If hypotension persists, refer to 1.5 Shock-Treatment Protocol.\\n9. Monitor ETCO2 level (see 7.24 End Tidal Carbon Dioxide Monitoring-Procedure\\nProtocol) and report levels outside of normal range (35-45 mm Hg) to the receiving\\nfacility as soon as possible","source_file":"3.5-SEPSIS-8.31.23-clean.txt","categories":["medical"]},"3-6":{"name":"SEVERE AGITATION","content":"Hyperactive Delirium Syndrome with Severe Agitation\\nIndications: Patient > 14 years of age who is an imminent physical threat to personnel\\nand/or themselves and  level of agitation is such that transport may place all parties at risk.\\nHyperactive delirium syndrome with severe agitation. is a life-threatening constellation of\\nsymptoms including, but not limited to, severe agitation and vital sign abnormalities\\n(tachycardia, hyperthermia). These patients are usually an imminent physical threat to\\npersonnel and/or themselves.\\nTreatment\\n1.  Ensure ALS response.\\n2.  Follow 1.1 General Pre-hospital Care-Treatment Protocol\\n3.  Ensure appropriate personnel available to provide patient and provider safety. Refer\\nto 7.16 Patient Restraint-Procedure Protocol.\\n4.  Obtain history, when possible, perform visual patient assessment, looking for cause\\nof behavior (i.e., visible trauma, stroke symptoms, etc.).  If an alternate cause of the\\nbehavior is likely, transition to the 3.1 Altered Mental Status-Treatment Protocol or\\nother applicable protocol.\\n5.  For patients who are uncontrollably agitated despite de-escalation techniques,\\nprepare for airway management, and administer per MCA selection:\\nPer MCA Selection\\n Ketamine 4 mg/kg IM maximum single dose 500 mg (3-5 minute onset)\\nor\\n Midazolam 10 mg IM/IN\\n6.  Once adequate sedation is obtained:\\na.  Continuously monitor SpO2\\nb.  Monitor and capnometry- see 7.24 End Tidal Carbon Dioxide Monitoring-\\nProcedure Protocol.\\nc.  Obtain temperature.\\ni.  If hyperthermic (temp >38o C or 100.4 F) provide cooling via ice packs to\\nneck, axilla  groin and/or fluids to skin while promoting evaporation (air\\nmovement).\\nd.  Establish IV per the 7.23 Vascular Access and IV Therapy-Procedure\\nProtocol and provide fluid bolus of up to 1 L of NS or LR.  Reassess the\\npatient, repeat boluses to a maximum of 2 L NS or LR as long as vital sign\\nabnormalities persist.\\ni.  Monitor for pulmonary edema.\\nii.  If pulmonary edema presents, stop fluids and contact Medical Control\\nfor direction.","source_file":"3.6-Hyperactive-Delirium-Syndrome-8.31.23-Clean-with-apv-date.txt","categories":["medical"]},"3-7":{"name":"CRASHING ADULT/IMPENDING ARREST","content":"Purpose:   EMS frequently encounters patients that are critically ill and quickly\\ndeteriorating to the point of cardiac or respiratory arrest. Deterioration can\\noften occur while packaging and loading these patients. It is important to\\nrapidly recognize the deteriorating patient taking immediate action to\\nstabilize the condition prior to loading and transporting.  The following\\ntimeline provides a prioritization of the goal-directed treatments to stabilize\\nthe patient and prevent deterioration. For patients < 14 years of age refer\\nto 4.9 Pediatric Crashing Patient/Impending Arrest-Treatment\\nProtocol.\\n1.  Criteria\\na.  Inclusion:\\ni.  Patient in whom cardiac or respiratory arrest appears imminent\\nii.  Patient with provider impression of critical illness, including new\\nonset altered mental status, airway compromise or severe\\nrespiratory distress/failure, and/or signs and symptoms of\\nshock/poor perfusion.\\n     b. Exclusion:\\ni.  Life-threatening trauma that has not been corrected (i.e.,\\nexsanguination, pneumothorax, etc.)\\n2.  Critical Actions (Initiate within first 5 minutes)\\na.   Airway\\ni.  Insert Nasopharyngeal or Oropharyngeal Airway as\\nindicated/tolerated if not following commands (GCS motor <6) or no\\nresponse to verbal stimuli per the 7.9 Airway Management-\\nProcedure Protocol.\\nb.  Breathing\\ni.  If respiratory failure or distress, sit patient up if tolerated and not\\ncontraindicated by suspected spine injury.\\nii.  Provide high-flow oxygen per the 7.12 Oxygen Administration-\\nProcedure Protocol.\\niii.  If respirations are <10 per minute, ventilate by BVM at 15LPM.\\nTwo-person, two-handed technique is most effective and is highly\\nrecommended if the number of providers allows.\\niv.  If respirations are >10 but inadequate, apply CPAP for respiratory\\ndistress/hypoxia per the 7.5 CPAP-Procedure Protocol.\\nv.  Respirations may be assisted with BVM in sitting position if patient\\ntolerates.\\nvi.  Consider PPV by BVM if not following commands or SpO2 <90%","source_file":"3.7-Crashing-Adult.Impending-Arrest-8.31.23-Clean-edited.txt","categories":["trauma","medical","pediatric"]},"4-1":{"name":"DOSING AND INTERVENTION CARDS","content":"Pediatric Medication Emergency Dosing and Intervention Cards\\nPurpose: Instructions for using the Michigan Medication Emergency Dosing and\\nIntervention Cards (MI-MEDIC). Pediatric patients (< 14 years) utilize MI MEDIC cards for\\nappropriate medication dosage. When unavailable utilize pediatric dosing listed within\\nprotocol\\n1.  Obtain correct weight of the child\\na.  If patients actual weight is known, use MI MEDIC card for that weight. (DO\\nNOT CONFUSE POUNDS and KILOGRAMS)\\nb.  If patients weight is not known, use length-based resuscitation tape to\\ndetermine the proper color zone.\\nc.  If a length-based resuscitation tape not available, use patients age to\\ndetermine color of card to use. DO NOT GUESS THE WEIGHT OF THE\\nCHILD.\\n2.  Select appropriate weight-based medication for intervention.\\n3.  Select the corresponding colored card\\n4.  Select desired medication from Cardiac Resuscitation or Medical Conditions\\n5.  ASSURE medication CONCENTRATION on hand is as specified on card\\n6.  Some medications should be diluted as instructed on card\\n7.  If dilution is required, follow steps to dilute entire vial of medication prior to drawing up\\nfinal ml volume to administer.\\n8.  Confirm medication dose and volume to be delivered.\\n9.  Administer volume of medication as desired.\\n  10. Contact Medical Control for questions or concerns.\\nNOTE: Some medication doses have been rounded for safety and ease of use for the\\nprevention of medication errors. These doses may not exactly correspond with the\\nmg/kg dose in the pediatric treatment protocols. The use of these rounded doses has\\nbeen approved for use and administration will be acceptable as long as the dose was\\nreferenced from the MI MEDIC cards.","source_file":"4.1-Pediatric-Medication-Emergency-Dosing-and-Intervention-Cards-1.27.23.txt","categories":["medical","pediatric"]},"4-2":{"name":"Unknown Protocol","content":"Childbirth and Related Obstetrical Emergencies\\nPurpose:  To provide the process for the assessment and management of\\nthe mother for childbirth and childbirth related emergencies.  Assessment and\\ncare of newborns and infants under 30 days old, see 4.3 Newborn/Neonatal\\nAssessment and Resuscitation-Treatment Protocol.\\n1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol\\n2.  Assessment Information\\nA. Past Medical History:  previous births, previous complications, history of\\npreeclampsia/eclampsia.\\nB. Current History:  duration of gestation (weeks), whether single or multiple births are\\nexpected, or any prior pregnancy complications.\\nC. Specific Objective Findings:  vital signs, assess contractions (duration, frequency).\\nD. In the presence of licensed health care providers (e.g., physician, licensed midwife),\\ncontact medical control for care not consistent with protocols.\\nE. Determine  whether  to  transport  or  remain  at  scene  due  to  imminent  delivery.\\nIndications of impending, imminent delivery may include:\\na. Multiple pregnancy, strong regular contractions, every 2 minutes or less,\\nruptured membrane, bloody show, need to push or bear down, crowning\\nF. Obtain vascular access if time permits per 7.23 Vascular Access and IV Fluid\\n     Therapy-Procedure Protocol\\n3.  Management of Normal Delivery\\nA. If signs of newborn delivery are imminent, and there is no time to\\ntransport, prepare for delivery.\\nB. Have oxygen and suction readily available for care of the newborn.\\nC. Try to find a place for maximum privacy, cleanliness, and warmth.\\nD. Allow safe birth position of choice.\\nE. Monitor patient for signs of hypotension. If signs develop, position patient\\nso weight of uterus is to patients left side.\\nF. Drape if possible, using clean sheets.\\nG. Encourage mother to relax and take slow deep breaths through her mouth.\\nH. Reassure her throughout process.\\nI.  As babys head begins to emerge from vagina, support it gently with hand and\\ntowel to assist in delivery.\\na. Do not pull babys head or neck once head is delivered.\\nJ.  After head is delivered look and feel to see if cord is wrapped around babys neck\\n(see Nuchal Cord management below).\\nK. As the shoulders deliver, carefully hold, and support the head and shoulders as\\nthe body delivers, may be suddenly  and the baby is very slippery!  Use a sterile\\ntowel if available to help support the baby.\\nL. Note the time of delivery.","source_file":"4.2-Childbirth-and-OB-Emergencies-8.31.23-Clean-Amended-12-4.txt","categories":["medical","pediatric"]},"4-5":{"name":"PEDIATRIC RESPIRATORY DISTRESS, FAILURE, OR ARREST","content":"Pediatric Respiratory Distress, Failure or Arrest\\n1. Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2. Pediatric patients (< 14 years) utilize MI MEDIC cards for appropriate medication\\ndosage.  When unavailable utilize pediatric dosing listed within protocol\\n3. Assess the patients airway\\nA. If unable to ventilate patient after airway repositioning refer to 1.10 Foreign Body\\nAirway Obstruction-Treatment Protocol and/or 7.9 Airway Management-\\nProcedure Protocol\\nB. Consider anaphylaxis refer to 1.6 Allergic Reaction/Anaphylaxis-Treatment\\nProtocol\\n4. Allow the patient a position of comfort that also maintains an open airway.\\n5. Titrate SpO2 to 94%\\nA. Have a parent assist with oxygen via blow by or mask support.\\n6. Airway should be managed by least invasive method possible.\\n7. Suction secretions if needed.\\n8. Consider CPAP if appropriate size available, follow 7.5 CPAP-Procedure Protocol\\n9. Do not delay transport for interventions.\\n10. Attempt vascular access only if necessary for patient treatment.\\nSuspected Bronchospasm (Wheezing):\\n1. Assist the patient in using their own albuterol Inhaler, if available and medication has\\nnot expired and is prescribed to patient.\\n2. Administer albuterol 2.5 mg/3ml NS nebulized (Per MCA selection may be EMT skill)\\nper 9.1 Medication Administration-Medication Protocol\\nNebulized albuterol administration per\\nMCA selection\\n EMT\\n3. Consider CPAP if appropriate size available, follow 7.5 CPAP- Procedure Protocol\\n4.\\nIn cases of respiratory failure administer epinephrine auto-injector\\nMCA Approval of epinephrine auto-injector IM\\n MFR\\n MCAs will be responsible for maintaining a roster of the agencies choosing\\nto participate and will submit roster to MDHHS.\\nA.\\nB.\\nIf child appears to weigh less than 10 kg (approximately 20 lbs.), contact medical\\ncontrol prior to epinephrine if possible.\\nIf child weighs between 10-30 kg (approximately 20-60 lbs.), administer\\npediatric epinephrine auto-injector IM.\\nC. Child weighing greater than 30 kg (approximately 60 lbs.), administer\\nepinephrine auto-injector IM.\\n5. In cases or respiratory failure administer epinephrine 1 mg/ml IM (per MCA selection\\nmay be BLS or MFR skill).","source_file":"4.5-PED-RESP-DISTRESS_FAIL_ARREST-1.11.24-Clean.txt","categories":["medical","pediatric"]},"4-3":{"name":"AND RESUSCITATION","content":"Newborn & Neonatal Assessment and Resuscitation\\nAliases:\\nresuscitation.\\nnewborn assessment, newborn treatment, newborn resuscitation, neonatal\\nPurpose:  Infants less than 30 days old are considered neonates.  This protocol is intended\\nfor assessment of newly born infants, and/or the resuscitation of newly born infants less\\nthan 30 days old.\\nASSESSMENT OF NEWLY BORN INFANTS\\n1.  History\\nA. Date and time of birth\\nB. Onset of symptoms\\nC. Prenatal history (prenatal care, substance abuse, multiple gestation, maternal\\nillness)\\nD. Birth history (maternal fever, meconium, prolapsed or nuchal cord, bleeding)\\nE. Estimated gestational age (may be based on last menstrual period)\\n2.  Immediate Assessment & Procedures\\nA. Respiratory (R of APGAR)\\ni. Assess rate and effort (strong, weak, or absent; regular or irregular)\\nii. Absent\\na.  If the baby does not breathe spontaneously, stimulate by gently rubbing\\nits back or slapping the soles of its feet.\\niii. Respiratory distress (grunting, nasal flaring, retractions, gasping, apnea OR no\\nreturn of spontaneous breathing after stimulation.\\na.  position airway (sniffing position) and clear airway as needed\\nb.  If thick meconium or secretions present suction mouth then nose\\nc.  Initiate ventilation with appropriately sized equipment and 21% oxygen\\n(room air)\\nB. Heart rate/pulse (P of APGAR)(fast, slow, or absent), auscultation of chest is the\\npreferred method\\ni. If heart rate >100 beats per minute\\na.  Monitor for central cyanosis, provide blow-by oxygen as needed\\nb.  Monitor for signs of respiratory distress. If apneic or significant distress:\\n1) Initiate bag-valve-mask ventilation with room air at 40-60 breaths\\nper minute\\nii. If heart rate < 100 beats per minute\\na.  Initiate bag-valve-mask ventilation with room air at 40-60 breaths per\\nminute\\nb.  Primary indicator of improvement is increased heart rate\\nc.  Only use minimum necessary volume to achieve chest rise\\nd.  If no improvement after 90 seconds, provide ventilations with\\nsupplemental oxygen (100%) until heart rate normalizes (100 or above)\\niii. If heart rate < 60 beats per minute","source_file":"4.3-Newborn_Neonatal-Assess_Resusc-8.31.23-clean-Amended-12-4.txt","categories":["medical","pediatric"]},"4-4":{"name":"PEDIATRIC ALTERED MENTAL STATUS","content":"The purpose of this protocol is to provide for the assessment and treatment of pediatric\\npatients with altered mental status of unknown etiology such as alcohol, trauma, poisonings,\\nseizures, behavioral problems, stroke, environmental causes, infection, etc.\\n  For pediatrics less than < 24 hours old  refer to 4.3 Newborn/Neonatal\\nAssessment and Resuscitation-Treatment Protocol\\n  For critically ill patients refer to 4.9 Pediatric Crashing Patient/Impending\\nArrest-Treatment Protocol\\n1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2.  Pediatric patients (< 14 years) utilize MI MEDIC cards for appropriate medication\\ndosage.  When unavailable utilize pediatric dosing listed within protocol\\n3.  Restrain patient, if necessary, refer to 7.16 Patient Restraint-Procedure\\nProtocol.\\n4.  Ensure adequate oxygenation, ventilation, and work of breathing\\nA.  Monitor SpO2\\nB.  Consider use of capnography\\n5.  Check blood glucose (may be MFR skill, see 7.21 Blood Glucose Testing-\\nProcedure Protocol\\n6.  Check temperature if febrile go to 4.6 Pediatric Fever-Treatment Protocol\\n7.  Start IV/IO if needed per 7.23 Vascular Access & IV Therapy-Procedure Protocol\\n8.  Check blood sugar, if high or low refer to Protocol 1.100 Diabetic Emergencies.\\n9.  If patient respiratory depression persists and/or patient has not regained\\nconsciousness despite adequate oxygenation and ventilatory support administer\\nnaloxone per 1.9 Opioid Overdose Treatment and Prevention-Treatment\\nProtocol\\n10. Contact Medical Control for repeat naloxone.\\nMedication References\\nDextrose\\nGlucagon\\nNaloxone","source_file":"4.4-PEDIATRIC-ALTERED-MENTAL-STATUS-8.31.23-Clean.txt","categories":["medical","pediatric"]},"4-6":{"name":"PEDIATRIC FEVER","content":"Initial Date: 8/31/2023\\nRevised Date:\\nPediatric Fever\\nThis protocol is intended to assist EMS providers in reducing fever in the pediatric patients\\nprior to arrival to the emergency department.  Fever is defined as a temperature of 100.4\\ndegrees Fahrenheit (38 degrees Celsius) or greater.  Emergency management of the\\nfebrile child involves an assessment to determine if any associated problems are present\\nwhich may require emergency treatment.\\n1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2.  Pediatric patients (< 14 years) utilize MI MEDIC cards for appropriate medication\\ndosage.  When unavailable utilize pediatric dosing listed within protocol.\\n3.  Obtain baseline temperature and document method used.\\na.  Children less 60 days old require a documented rectal temperature (including\\ntime temperature obtained) prior to antipyretic administration.\\n4.  Administer antipyretic according to MCA selection\\nMCA Antipyretic Selection\\n(Must select at least one)\\n Ibuprofen (children > 6 months of age)\\n Acetaminophen\\n5.  Administer ibuprofen if child is over 6 months old, has not been given ibuprofen\\n(e.g., Motrin/Advil) or any medication containing ibuprofen (i.e., cold medication) in\\nthe last 6 hours and is alert.\\ni.  If patients weight is known, utilize that weight and MI-MEDIC for\\ndosing.\\nii.  If patients weight is not available, utilize length-based tape and MI-\\nMEDIC for dosing.\\niii.  If MI-MEDIC is not available, use dosing chart below.\\nOR\\n6.  Administer acetaminophen if the child has not been given acetaminophen (e.g.,\\nTylenol) or any medication containing acetaminophen (i.e., cold medication) in last\\nfour (4) hours and is alert, and:\\ni.  If patients weight is known, utilize that weight and MI-MEDIC for\\ndosing.\\nii.  If patients weight is not available, utilize length-based tape and MI-\\nMEDIC for dosing\\niii.  If MI-Medic is not available, use dosing chart below.\\nIf any question concerning alertness or ability to swallow, DO NOT ADMINISTER.\\n7.\\n8.  Dosing questions should be directed to online medical control.","source_file":"4.6-PEDIATRIC-FEVER-8.31.23-Clean.txt","categories":["medical","pediatric"]},"4-7":{"name":"PEDIATRIC SEIZURES","content":"I.  Follow 1.1 General Pre-Hospital Care -Treatment Protocol.\\nII.  For focal seizure contact Medical Control\\nIII.\\nIF PATIENT IS ACTIVELY SEIZING (GENERALIZED TONIC CLONIC):\\nA.  Protect patient from injury.\\nB.  Maintain airway and provide supplemental oxygen\\nC.  Administer midazolam according to the MI-MEDIC cards\\na.  If MI-MEDIC unavailable administer midazolam 0.1mg/kg IM maximum\\n   individual dose 10 mg.\\nb.  If IV established prior to seizure activity administer midazolam 0.05 mg/kg\\n  IV/IO maximum single dose of 5 mg.\\n       c.  Monitor SpO2, EKG and waveform capnography (per 7.24 End Tidal Carbon\\nDioxide Monitoring-Procedure Protocol) after midazolam administration.\\nD.  Consider trauma if evidence or suspicion of trauma treat according to\\n    applicable protocol in addition to stopping the seizure.\\nE.  Check blood glucose (may be MFR skill, see 7.21 Blood Glucose Testing-\\n    Procedure Protocol).\\na.  If high or low refer to protocol 1.100 Diabetic Emergencies\\nF.   If seizure persists 10 minutes after initial dose of midazolam and correction of\\nlow blood glucose repeat one time midazolam (per MCA selection)\\n                     Pre radio midazolam administration (without Medical Control\\n                         contact)\\n   Post radio midazolam administration (contact Medical Control)\\n            prior to administration.\\ni. 0.1mg/kg IM maximum single dose of 10 mg\\n    OR\\n   ii. If IV already available 0.05 mg/kg IV/IO maximum single dose of 5 mg.\\nF. If seizures persist after second dose, consider underlying causes and contact\\n               Medical Control for further instructions.\\nIV.  For PATIENT NOT CURRENTLY SEIZING, monitor and treat known underlying causes,\\nif possible:\\nb.  A.  Check blood glucose (may be MFR skill, see 7.21 Blood Glucose Testing-\\nProcedure Protocol) and treat as outlined in protocol 1.100 Diabetic\\nEmergencies\\nB.  Check temperature and refer to 4.6 Pediatric Fever-Treatment Protocol if\\napplicable.\\nC.  Monitor oxygenation and mental status, administer oxygen to maintain 94%,\\nincluding ventilatory support as needed according to the 7.9 Airway\\nManagement- Procedure Protocol\\na.     For patients with respiratory depression and high suspicion opioid\\n  involvement, administer naloxone per 1.9 Opioid Overdose Treatment\\nand Prevention-Treatment Protocol.","source_file":"4.7-PEDIATRIC-SEIZURES-8.31.23-Clean.txt","categories":["trauma","medical","pediatric"]},"4-8":{"name":"SAFE TRANSPORTATION OF CHILDREN IN AMBULANCES","content":"Safe Transportation of Children in Ambulances\\nSafe transportation of children in ambulances is very important. This protocol will serve as\\na guideline to the safe transportation of children in an ambulance. These are a limited set of\\ncircumstances that may not fit every situation.\\nDefinitions:\\n1.  Child Restraint System (CRS) is a device that is designed for child safety in any\\nmode of transportation (e.g., vehicle, airplane, ambulance, etc.). This includes:\\n2.  Vehicle CRS such as car seats that are used in personal vehicles (e.g., forward and\\nrearward facing and booster seats\\n3.  Ambulance Child Restraints (ACR) are a subset of CRS and are a specific type of\\nchild restraint system that is designed to be used in ambulances and on ambulance\\nstretchers. ACR is not a brand name and devices that meet the definition of ACR\\nand are approved by the MCA may be utilized.\\na.  An ACR does NOT include car seats that were designed for use in personal\\nvehicles.\\nCriteria for Transport\\n1.  This protocol applies pediatric patients who are of a height/weight that require\\nthe use of a CRS.\\n2.  Any pediatric patient that requires a CRS that is transported in an ambulance\\nmust be in an ACR.\\na.  When not transported in an ACR, this must be documented as such and\\nreported to the MCA.\\n3.  This protocol is based on recommendations, as published by the National\\nHighway Traffic Safety Administration (NHTSA), for the transportation of\\nchildren in five possible situations:\\na.  The transport of a non-patient pediatric passenger, accompanying an injured\\nor ill patient\\nb.  The transport of a pediatric patient  whose condition does not require\\ncontinuous and/or intensive medical monitoring or intervention.\\nc.  The transport of a pediatric patient who does require continuous and/or\\nintensive monitoring or intervention.\\nd.  The transport of a pediatric patient  whose condition requires spinal motion\\nrestriction and/or lying flat, refer to 7.20 Spinal Precautions-Procedure\\nProtocol\\ne.  The transport of a pediatric patient who require transport as part of a multiple\\npatient transport (newborn with mother, multiple children, etc.)\\nProcedure\\n1.  Transport patient on ambulance stretcher secured with an ACR.\\n2.  The childs height and weight will be considered when determining an appropriate\\nACR, following manufacturers recommendations.\\n3.  When use of ACR is unavailable, unachievable or is detrimental see situational\\nguidelines below, document as such and report to the MCA.","source_file":"4.8-SAFE-TRANSPORT-OF-CHILDREN-8.31.23-clean.txt","categories":["trauma","medical","pediatric"]},"4-9":{"name":"PEDIATRIC CRASHING PATIENT/IMPENDING ARREST","content":"Purpose:   EMS frequently encounters patients that are critically ill and quickly\\ndeteriorating to the point of cardiac or respiratory arrest. Deterioration can\\noften occur while packaging and loading these patients. It is important to\\nrapidly recognize the deteriorating patient and taking immediate action to\\nstabilize the condition prior to loading and transporting.  The following\\ntimeline provides a prioritization of the goal-directed treatments to stabilize\\nthe patient and prevent deterioration.\\n1.  Criteria:  Patient < 14 years of age\\na.  Inclusion:\\ni.  Patient in whom cardiac or respiratory arrest appears imminent\\nii.  Patient with provider impression of critical illness, including new\\nonset altered mental status, airway compromise or severe\\nrespiratory distress/failure,(cyanosis, severe retractions, head\\nbobbing, grunting, respiratory rate extremes per age-adjusted\\nnormal MI-MEDIC),  and/or signs and symptoms of shock/poor\\nperfusion. (capillary refill greater than 3 seconds, tachycardia or\\nhypotension per age-adjusted normal on MI-MEDIC).\\n     b. Exclusion:\\ni.  Life-threatening trauma that has not been corrected (i.e.,\\n     exsanguination, pneumothorax, etc.)\\n2.  Critical Actions (within First 5 Minutes)\\n                a. Airway\\ni.   Open airway manually. For child <2 years old, place padding under\\n     shoulders (align auditory meatus with sternal notch).\\nInsert nasopharyngeal or oropharyngeal Airway as\\nii.\\nindicated/tolerated if not following commands (GCS motor <6), as\\nindicated/tolerated if GCS <9,  or no response to verbal stimuli per\\nthe 7.9 Airway Management-Procedure Protocol.\\n                 b.  Breathing\\ni. If respiratory failure or distress, sit patient up if tolerated and not\\n   contraindicated by suspected spine injury. keep the patient calm and\\n    allow them to maintain a position of comfort, if possible.\\nii. Provide high-flow oxygen per the 7.12 Oxygen Administration-\\nProcedure Protocol.\\nA.\\nIf respirations are <10 per minute, ventilate by BVM at 15LPM.\\nTwo-person, two-handed technique is most effective and is\\nhighly recommended if the number of providers allows.\\nIf respirations are inadequate, ventilate by BVM at 15LPM.\\nAdminister ventilations guided by chest rise. Two-person, two-\\nB.","source_file":"4.9-Ped-Crashing-Patient_Impending-Arrest-8.31.23-clean.txt","categories":["trauma","medical","pediatric"]},"5-1":{"name":"CARDIAC ARREST - GENERAL","content":"Cardiac Arrest  General\\nThis protocol should be followed for adult cardiac arrests.  Medical cardiac arrest patients\\nundergoing attempted resuscitation should not be transported unless return of spontaneous\\ncirculation (ROSC) is achieved, transport is ordered by Medical Control, or otherwise\\nspecified in protocol.\\n\\n\\n\\nIf an arrest is of a known traumatic origin, refer to the 2.7 Traumatic Arrest -\\nTreatment Protocol.\\nIf it is unknown whether the arrest is traumatic or medical, and the patient does not\\nmeet dead on scene criteria per 7.6 Dead on Scene Termination of Resuscitation-\\nProcedure Protocol, start CPR and continue with this protocol.\\nIf patient is hypothermic refer to 2.11 Hypothermia/Frostbite-Treatment Protocol\\nfor warming techniques when applicable.\\n  Patients displaying a Do Not Resuscitate (DNR) order, bracelet, or necklace; or valid\\nMichigan Physician Orders for Scope of Treatment (MI POST)  follow 7.7 DNR-\\nProcedure Protocol or 7.25 MI-POST-Procedure Protocol accordingly.\\n  Cardiac arrest patients undergoing resuscitation should only be moved if the scene\\nis unsafe, the physical location of the patient does not permit appropriate treatment,\\nor under a direct medical control order.\\nHIGH QUALITY CPR & DEFIBRILLATION\\nFocus should be on prompt defibrillation and effective chest compressions.\\n  CPR and electrical therapy should be consistent with current American Heart\\nAssociation guidelines.  For all patients, anterior/posterior placement of pads is\\npreferred and should be used, if possible, and if defibrillation not delayed.\\n  For all devices defibrillate with energy levels following manufacturers\\nrecommendations.\\no  If unknown use the maximum available\\nExcellent CPR is a priority:\\n  Keep pauses in CPR to a minimum by checking rhythm when rotating rescuer doing\\ncompressions and by avoiding pauses in CPR during airway management and other\\ninterventions. CPR pauses should be kept to less than 10 seconds.\\n  Use End Tidal Carbon Dioxide (ETCO2) monitoring throughout resuscitation.\\n  CPR initial sequence is CAB (Compressions, Airway, Breathing), except in drowning\\nor obvious respiratory cause which should use the ABC (Airway, Breathing,\\nCompressions) sequence.\\n  Chest compression rate is 100 to 120/min.\\n  Chest compression depth for adults is 2 inches (5 cm)\\n  Compressions and ventilations in a ratio of 30:2\\n  Supraglottic airways are an acceptable primary advanced airway device (i.e.,\\nconsidered at least as good as endotracheal intubation) for patients in cardiac arrest\\nwith exceptions noted in the 7.9 Airway Management-Procedure Protocol.","source_file":"5.1-Cardiac-Arrest-Gen-8.31.23-Amended-to-match-Clean-7.6-edited.txt","categories":["adult","medical"]},"5-2":{"name":"BRADYCARDIA","content":"This is a protocol for patients with serious symptomatic bradycardia, defined as patients with\\nheart rate less than 60 bpm and hypotension, or shock.  Titrate treatments to a heart rate\\nabove 60 bpm.  If the patient remains hypotensive, refer to the 1.5 Shock Treatment\\nProtocol.\\n1.  Follow the 1.1 General Pre-Hospital Care-Treatment Protocol.\\n2.  Administer atropine 1 mg IV/IO rapid push repeating every 3-5 minutes to a total dose of 3\\nmg IV/IO, until a heart rate of greater than 60/minute is reached.\\n3.  Transcutaneous pacing (TCP) when available may be initiated prior to establishment of IV\\naccess and/or before atropine begins to take effect. Pacing is the treatment of choice for\\nhigh degree A-V block (second-degree Type II, or third-degree), apply pacer pads. Follow\\nthe 7.8 Electrical Therapy- Procedure Protocol.\\n4.  Per MCA selection, provide sedation per 7.17 Patient Procedural Sedation-Procedure\\nProtocol\\n5.  For patients with persistent symptomatic bradycardia, administer epinephrine by\\npush dose (dilute boluses)\\na.  Prepare (10 mcg/mL) by adding 1mL of 1mg/10mL epinephrine in 9mL NS,\\nthen:\\ni.  Administer 10-20 mcg (1-2 mL epinephrine 10 mcg/mL) IV/IO\\nii.  Repeat every 3 to 5 minutes\\niii.  Titrate SBP greater than 90 mmHg\\nNotes:\\n1.  Consider possible etiologies:\\nA.  Hyper/hypokalemia, other metabolic disorders\\nB.  Hypothermia\\nC.  Hypovolemia (including vomiting/diarrhea)\\nD.  Hypoxia\\nE.  Hydrogen ion excess (acidosis)\\nF.  Toxins/ overdose (e.g., beta-blocker or calcium channel-blocker)\\nG.  Tamponade\\nH.  Tension pneumothorax\\nI.  Thrombosis (pulmonary or coronary)\\n2.  Transcutaneous pacemaker electrode pads may be applied to these patients without\\ninitiating pacing so that the pacemaker is ready if patient condition deteriorates.\\n3.  For symptomatic high-degree (second-degree Type II, or third-degree) AV block,\\nbegin pacing without delay.\\n4.   Heart transplant patients may not respond to atropine\\nMedication References\\nAtropine\\nEpinephrine\\nProtocol Source/References:  Highlights of the 2020 AHA Guidelines Update for CPR and ECC","source_file":"5.2-BRADYCARDIA-8.31.23-Clean.txt","categories":["medical"]},"5-3":{"name":"TACHYCARDIA","content":"Aliases: Supraventricular Tachycardia (SVT), Ventricular Tachycardia (VT or V-Tach),\\nAtrial Fibrillation with Rapid Ventricular Response (A-Fib with RVR)\\n  This protocol is used for the care of patients with persistent tachycardia (ventricular\\nrate greater than or equal to 150/minute) where the tachycardia is believed to be the\\nprimary cause of the patients symptoms.\\n  For rates <150, believed to be causing symptoms, contact Medical Control for\\npossible orders.  It is not intended to treat tachycardia that is secondary to\\nunderlying conditions (i.e., dehydration, trauma, sepsis, or toxins).  Consultation with\\nonline medical control should be considered for complex patients in whom the cause\\nof the arrhythmia is not obvious.\\n  Unstable patients may be defined as those with a tachycardia with:  hypotension,\\nacutely altered mental status, signs of shock, significant ischemic chest discomfort,\\nshortness of breath, or pulmonary edema that is likely due to the arrhythmia.\\nUnstable patients will usually have a ventricular rate >150 BPM.\\n  Note: Unstable patients with compensatory sinus tachycardia may resemble\\ntachycardic arrhythmias but should not be treated as such. Treat underlying cause.\\n  Adenosine is only used for regular monomorphic tachycardic rhythm\\n1.\\n2.\\n3.\\n Follow the 1.1 General Pre-Hospital Care-Treatment Protocol.\\n Identify and treat reversible causes.\\n Determine if patient is stable or unstable.\\nUNSTABLE\\n1.  Prepare for immediate cardioversion.  In conscious patients consider sedation prior to\\nelectrical cardioversion per 7.17 Patient Procedural Sedation-Procedure Protocol\\n2.  Electrical cardioversion\\na.  Perform synchronized cardioversion according to manufacturer recommendations.\\nb.  If unable to deliver synchronized cardioversion in polymorphic V Tach (including\\nTorsades), defibrillate (cardiovert without synchronization) according to\\nmanufacturer recommendations (or device maximum energy dose)\\nc.  Contact medical control if the patient does not convert at maximum energy, for\\nadditional orders.\\nSTABLE (But Symptomatic)\\n1.   If at any point a patient becomes unstable, go to UNSTABLE section, and perform\\n      synchronized cardioversion.\\n2.   Start an IV NS KVO. A large bore antecubital IV is preferred.\\n3.   Obtain 12 lead ECG see 7.1 12 Lead ECG.\\n4.   Contact Medical Control for guidance as needed.\\nMCA Name Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024","source_file":"5.3-Tachycardia-8.31.23-Clean-edited.txt","categories":["medical"]},"5-4":{"name":"PULMONARY EDEMA/CARDIOGENIC SHOCK","content":"Pulmonary Edema/Cardiogenic Shock\\nThis protocol is to be followed for patients in respiratory distress due to pulmonary edema\\nwith or without hypotension (i.e., CHF/fluid overload or Cardiogenic Shock).   Pulmonary\\nedema usually presents with crackles which should be continuously evaluated as they may\\nevolve with treatments.\\n1.  Follow 1.1 General Pre-Hospital Care-Treatment Protocol.\\n2.  Initiate supplemental oxygen by non-rebreather mask.\\n3.  Position patient upright with legs dependent, if possible.\\n4.  Consider CPAP per 7.5 CPAP-Procedure Protocol\\n5.  Establish IV access without delaying treatment per 7.23 Vascular Access & IV Fluid\\nTherapy-Procedure Protocol.\\n6.  If wheezing, administer albuterol 2.5 mg/3ml NS nebulized (Per MCA selection may\\nbe EMT skill) per 9.1 Medication Administration-Medication Protocol\\nNebulized albuterol administration per\\nMCA selection\\n    EMT\\n7.  If crackles (with or without wheezing) administer nitroglycerin as outlined below.\\na.  Inquire of all patients regardless of identified gender if they have taken an erectile\\ndysfunction medication or medications used to treat pulmonary hypertension in\\nthe last 48 hours.\\ni.  If yes, DO NOT ADMINISTER NITROGLYCERIN AND CONTACT\\nMEDICAL CONTROL.\\nb.  Prior to IV administration if no erectile dysfunction medication and systolic BP is\\nabove 120 mmHG, nitroglycerin 0.4mg sublingual may be administered up to a\\nmaximum of 3 doses.\\nc.  If SBP above 100 mmHg (with IV/IO in place), administer nitroglycerin 0.4 mg\\nSL, repeat every 3-5 minutes if SBP remains above 100 mmHg.\\nd.  If wheezing continues, continue nitroglycerin 0.4 mg SL and consider:\\n     albuterol/ipratropium bromide per 3.3 Respiratory Distress-Treatment\\nProtocol\\n8.  If SBP is below 100 mmHG treat for cardiogenic shock.\\na. Prepare (epinephrine 10 mcg/mL) by combining 1mL of 1mg/10mL\\n     epinephrine in 9mL NS\\ni.  Administer 20 mcg (2 mL epinephrine 10 mcg/mL) IV/IO\\nii.  Repeat every 3-5 minutes\\niii.  Titrate SBP greater than 90 mm/Hg.\\n9.  If indicated, consider an advanced airway see 7.9 Airway Management-Procedure\\nProtocol.\\n10. Obtain 12-lead ECG (May be a BLS or Specialist skill, per MCA selection, see 7.1 12\\nLead ECG-Procedure Protocol).  Follow MCA transport protocol if ECG is positive\\nfor ST segment elevation myocardial infarction (STEMI) and alert hospital as soon as\\npossible.","source_file":"5.4-PULM-EDEMA_CARDIOGEN-8.31.23-Clean.txt","categories":["medical"]},"5-5":{"name":"CHEST PAIN/ACUTE CORONARY SYNDROME","content":"Chest Pain/Acute Coronary Syndrome\\nThe goal is to reduce cardiac workload and to maximize myocardial oxygen delivery by\\nreducing anxiety, appropriately oxygenating, and relieving pain.  For non-cardiac causes of\\nchest pain, refer to appropriate protocol which may include 7.13 Pain Management-\\nProcedure Protocol.\\n1.  Follow General Pre-Hospital Care Protocol.\\n2.  Obtain 12-lead as early as possible without delaying medication administration. (Per\\nMCA selection, may be a BLS or Specialist procedure, follow 7.1 12 Lead ECG\\nProcedure-Protocol).\\n3.  Administer oxygen 4 L/min per nasal cannula if pulse oximetry SpO2 < 94%.\\n4.  Assist patient in the use of their own aspirin up to a dose of 325 mg and per\\nformulation (chew, swallow, etc.)\\n5.  Administer aspirin up to 325 mg PO, chew and swallow if no aspirin or suspected\\ninsufficient dose since the onset of chest pain. (Per MCA selection may be MFR\\nand/or EMT skill).\\n                 Aspirin Administration\\n                MFR          EMT\\n6.  Inquire of all patients regardless of identified gender if they have taken an erectile\\ndysfunction medication or medications used to treat pulmonary hypertension in the\\nlast 48 hours.\\na.   If yes, DO NOT ADMINISTER/ ASSIST WITH NITROGLYCERIN AND\\nCONTACT MEDICAL CONTROL.\\n7.  Consider fentanyl early when nitroglycerin is contraindicated due to erectile\\ndysfunction medication (see 14. below for fentanyl administration)\\n8.  If no erectile dysfunction medication, systolic BP is above 120 mmHG and patient has\\nnitroglycerin sublingual tabs prescribed to them available (check expiration date):\\nassist patient in use of their own nitroglycerin, up to a maximum of 3 doses.\\n9.  Prior to IV administration if no erectile dysfunction medication and systolic BP is\\nabove 120 mmHG, nitroglycerin 0.4mg sublingual may be administered up to a\\nmaximum of 3 doses.  (Per MCA selection may be EMT skill)\\nNitroglycerin  Administration\\n  EMT\\n10.  Start an IV NS or LR KVO per 7.23 Vascular Access and IV Fluid Therapy-\\nProcedure Protocol.\\n11. If the patient has a SBP of less than 100 mmHg:\\na.  Administer 250 ml fluid bolus (may repeat 3 times for a total of 1 liter)\\nb.  Between boluses assess patient response and monitor for pulmonary edema.\\nc.  If pulmonary edema is noted stop fluids and contact Medical Control","source_file":"5.5-CHEST-PAIN-ACS-8.31.23-Clean-edited.txt","categories":["medical"]},"5-6":{"name":"RETURN OF SPONTANEOUS CIRCULATION (ROSC)","content":"Return of Spontaneous Circulation (ROSC)\\nThis protocol should be followed for all cardiac arrests with ROSC.  If an arrest is of a known\\ntraumatic origin, refer to the 2.7 Traumatic Arrest -Treatment Protocol and MCA\\nTransport Protocol.  If it is unknown whether the arrest is traumatic or medical, consider\\nother treatable causes.  Initiate ALS response if available. After ROSC, patients should be\\nstabilized on scene prior to transport, for five to ten minutes before moving the patient. Refer\\nto 3.7 Crashing Adult /Impending Arrest-Treatment Protocol.\\n1.\\nIf ventilation assistance is required, ventilate at 10-12 breaths per minute.  Do not\\nhyperventilate.\\n2.  Monitor vital sign and reassess patient.  If patient becomes pulseless begin CPR and\\nrefer to 5.1 Adult Cardiac Arrest General-Treatment Protocol.\\n3.  Check blood glucose (may be MFR skill, see 7.21 Blood Glucose Testing-\\nProcedure Protocol\\n4.  Treat hypotension (systolic blood pressure less than 90 mm/Hg) with an IV/IO fluid\\nbolus of up to 1 liter.\\n5.  Perform 12- lead ECG (Per MCA selection, may be BLS or Specialist skill per 7.1 12\\nLead ECG-Procedure Protocol)\\n6.  Consider Transport to a facility capable of Percutaneous Coronary Intervention (PCI)\\nper MCA protocol if 12 Lead ECG indicates ST Elevation MI.\\n7.  Monitor waveform ETCO2.  If ventilation assistance is required, target ETCO2 of 35-\\n45 mm Hg per 7.24 End Tidal Carbon Dioxide Monitoring-Procedure Protocol\\nIf hypotension persists after initial IV/IO fluid bolus, prepare push dose epinephrine\\nwhile administering second 1 liter fluid bolus (maximum total fluid 2 liters)\\n8.\\n9.  Administer epinephrine by push dose (dilute boluses).\\na. Prepare (10 mcg/mL) by adding 1mL of 1mg/10mL epinephrine in 9mL NS, then:\\ni.  Administer 10-20 mcg (1-2 mL epinephrine 10 mcg/mL)\\nii.  Repeat every 3 to 5 minutes\\niii.  Titrate to SBP greater than 90 mm/Hg\\n10.  Anticipate airway intolerance and prepare for patient sedation. If patient becomes\\nagitated with advanced airway in place, refer to 7.17 Patient Procedural Sedation-\\nProcedure Protocol.\\nNotes:\\n1.  If a mechanical ventilator is available or there are spontaneous respirations in the\\nnon-intubated patient, titrate inspired oxygen on the basis of monitored SpO2 to\\nmaintain a saturation of 92% but <98%. Titrate ETCO2 between 35-45 mmHg.\\n2.  Consider removal of airway device only if wide awake, following commands, and\\nunable to tolerate airway device.\\nMedication References\\nEpinephrine","source_file":"5.6-ROSC-8.31.23-Clean-edited.txt","categories":["adult","medical"]},"6-1":{"name":"PEDIATRIC CARDIAC ARREST - GENERAL","content":"This protocol should be followed for all pediatric cardiac arrests.\\n\\n\\n\\nIf an arrest is of a known traumatic origin refer to the 2.7 Traumatic Arrest-Treatment\\nProtocol.\\nIf it is unknown whether the arrest is traumatic or medical, and the patient does not meet\\ndead on scene criteria per 7.6 Dead on Scene Termination of Resuscitation-\\nProcedure Protocol, start CPR and continue with this protocol.\\nIf patient is hypothermic refer to 2.11 Hypothermic/Frostbite-Treatment Protcol for\\nwarming techniques when applicable.\\nNote: Primary cardiac arrest in the pediatric patient is rare. Most arrests are secondary to\\nrespiratory failure. Maintaining basic airway management techniques unless unable or\\nineffective. Advanced airway insertion attempts should be performed only if BLS airway\\nmanagement is ineffective. Keep CPR interruptions to a minimum. Medications given during\\ncardiac arrest are given IV or IO.\\nHIGH QUALITY CPR & DEFIBRILLATION\\n  CPR and electrical therapy should be consistent with current American Heart Association\\nguidelines.  For all patients, anterior/posterior placement of pads is preferred and\\nshould be used, if possible, and if defibrillation not delayed.\\n  Once arrest is confirmed, emphasis should be on avoiding interruptions in CPR.\\n  CPR should be done in accordance with current guidelines established by the American\\nHeart Association.\\n  Compressions at least 1.5 in depth for infants, 2 in depth for children (at least one third\\nthe anteroposterior diameter of the chest).\\n  Compression rate of at least 100-120 per minute\\n  Allow full chest recoil with each compression for maximum perfusion.\\n  Avoid excessive ventilation (volume and rate).\\n  Continue CPR with minimal interruptions, changing the rescuer doing compressions\\n  Verify CPR quality frequently and any time rescuer providing compressions or\\nventilations change.\\n  Change rescuer performing compressions at least every 2 minutes to avoid fatigue.\\n\\n\\nInterruption in compressions must be less than 10 seconds\\nIf an advanced airway is placed, provide continuous CPR, without pauses for ventilation\\nand ventilate at 20 breaths per minute or 1 breath every 3 seconds\\nOPERATIONAL CONSIDERATIONS\\n1.  Prior to advanced airway placement, utilize ventilation periods to visualize the ECG\\nrhythm without compression artifact, this will allow you to plan for the assessment\\nperiod at the end of the two-minute CPR cycle.\\n2.  If AED has been applied by BLS personnel, skip to appropriate place in protocol that","source_file":"6.1-Pediatric-General-Arrest-8.31.23-Amended-to-match-Clean-7.6-edited.txt","categories":["medical","pediatric"]},"6-2":{"name":"PEDIATRIC SYMPTOMATIC  BRADYCARDIA","content":"Bradycardia should be considered to be due to hypoxia until proven otherwise. This protocol\\napplies to pediatric patients with bradycardia, a pulse, and poor perfusion (cardiopulmonary\\ncompromise).\\nNOTES: Signs of cardiopulmonary compromise include:\\n1.  Hypotension:\\na.  In neonates, SBP less than 60\\nb.  In infants 1 month to 1 year, SBP less than 70\\nc.  In children aged 2 to 10 years, SBP less than 70 + (age x 2).\\nd.  For children greater than 10, SBP less than 90\\n2.  Acutely altered mental status.\\n3.  Signs of shock - indicated by absent and/or weak peripheral and femoral pulses,\\nincreased capillary refill time (> 3 seconds), skin cool/mottled.\\n4.  Respiratory difficulty indicated by increased work of breathing (retractions, nasal\\nflaring, grunting, tracheal tugging), cyanosis, altered level of consciousness (unusual\\nirritability, lethargy, failure to respond to parents), stridor, wheezing.\\nGeneral Treatment\\nA.  Pediatric patients (< 14 years of age) utilize MI MEDIC cards for appropriate\\nmedication dosage.  When unavailable utilize pediatric dosing listed within\\nprotocol.\\nB.  Manage airway as necessary\\nC.  Provide supplemental oxygen as needed to maintain O2 saturation > 94%\\nD.  Initiate monitoring\\n1.  If pulse is < 60 confirm and support adequate oxygenation and ventilation.\\n2.  If pulse remains < 60 and patient remains symptomatic perform CPR\\n3.  Establish vascular access\\n4.  Apply cardiac monitor to identify rhythm\\n5.  If pulse remains < 60, despite oxygenation & ventilation\\nA.  Administer epinephrine according to MI MEDIC cards.\\ni.  If MI MEDIC cards are not available administer epinephrine:\\n1.  1mg/ 10mL,\\n2.  0.01 mg/kg (0.1 ml/kg) IV/IO up to 1 mg (10 ml),\\n3.  Repeat every 3-5 minutes.\\nB.  If patient remains unstable and pulse < 60 administer atropine according to MI\\nMEDIC cards.\\ni.  If MI MEDIC cards are not available administer atropine:","source_file":"6.2.Pediatric-Bradycardia-8.31.23-Clean-edited.txt","categories":["medical","pediatric"]},"6-3":{"name":"PEDIATRIC TACHYCARDIA","content":"Aliases: Supraventricular tachycardia (SVT), atrial fibrillation (a-fib), atrial flutter, ventricular\\ntachycardia (V-tach)\\nThis protocol is intended for symptomatic pediatric patients with elevated heart rate, relative\\nto their age.  Refer to MI-MEDIC for appropriate vital signs and medication doses.\\nI.\\nGeneral Treatment\\nA.  Pediatric patients (< 14 years of age) utilize MI MEDIC cards for appropriate\\nmedication dosage.  When unavailable utilize pediatric dosing listed within\\nprotocol.\\nB.  Follow 1.1 General Pre-Hospital Care-Treatment Protocol.\\nC.  Determine if patient is stable or unstable.\\nD.  Manage airway as necessary.\\nE.  Provide supplemental oxygen as needed to maintain O2 saturation > 94%.\\nF.  Initiate monitoring.\\nG.  Perform 12-lead ECG but do not delay care for 12-lead ECG on unstable\\npatients. Refer to 7.1 12 Lead ECG Protocol.\\nH.  Establish vascular access, see 7.23 Vascular Access and IV Fluid Therapy.\\nIdentify and treat underlying causes of tachycardia such as dehydration, fever,\\nI.\\nvomiting, sepsis and pain.\\nJ.  Administer NS or LR bolus 20ml/kg with possible hypovolemia.\\nK.  Consider the following additional therapies if specific dysrhythmias are\\nrecognized:\\nII.\\nUNSTABLE\\nA.  Regular Narrow Complex Tachycardia  Unstable\\ni.  Prepare for immediate cardioversion.  In conscious patients consider\\nsedation prior to electrical cardioversion.  Refer to 7.17 Patient\\nProcedural Sedation-Procedure Protocol.\\nii.  Deliver a synchronized shock; 1 J/kg for the first dose\\niii.  Repeat doses should be 2 J/kg\\niv.  DO NOT EXCEED ADULT DOSING.\\nB.  Regular, Wide Complex Tachycardia  Unstable\\ni.  Prepare for immediate cardioversion.  In conscious patients consider\\nsedation prior to electrical cardioversion.  Refer to 7.17 Patient\\nProcedural Sedation-Procedure Protocol.\\nii.  Synchronized cardioversion 1 J/kg\\niii.  For recurrent or refractory wide complex  unstable tachycardia, consult\\nMedical Control prior to medication administration (medication per MCA\\nselection)","source_file":"6.3-Pediatric-Tachycardia-8.31.23-Clean-edited.txt","categories":["adult","medical","pediatric"]},"6-4":{"name":"PEDIATRIC RETURN OF SPONTANEOUS CIRCULATION","content":"Return of Spontaneous Circulation (ROSC)\\nThis protocol should be followed for all cardiac arrests with ROSC.  If an arrest is of a known\\ntraumatic origin, refer to the 2.7 Traumatic Arrest-Treatment Protocol and MCA Transport\\nProtocol.  If it is unknown whether the arrest is traumatic or medical, consider other treatable\\ncauses.  Initiate ALS response if available. After ROSC, patients should be stabilized on\\nscene prior to transport, ideally for at least five minutes before moving the patient. Refer to\\n4.9 Pediatric Crashing Patient/Impending Arrest-Treatment Protocol.\\n1.  Pediatric patients (< 14 years) utilize MI MEDIC cards for appropriate medication\\ndosage.  When unavailable utilize pediatric dosing listed within protocol.\\n2.  If ventilation assistance is required, ventilate at 10-12 breaths per minute.  Do not\\nhyperventilate.\\n3.  Reassess patient, if patient becomes pulseless\\na.  Begin CPR\\nb.  Follow 6.1 Pediatric Cardiac Arrest-Treatment Protocol.\\n4.  Monitor vital signs.\\n5.  Check blood glucose (may be MFR skill, see 7.21 Blood Glucose Testing-\\nProcedure Protocol)\\n6.  Start an IV/IO NS or LR KVO.\\n7.  Treat hypotension with an IV/IO fluid bolus 20 ml/kg consistent with 1.5 Shock-\\nTreatment Protocol.\\n8.  May perform 12- lead ECG (Per MCA selection, may be BLS skill per 7.1 12 Lead\\nECG- Procedure Protocol) but must not delay or take precedence over other critical\\nassessments and interventions.\\n9.  Monitor waveform ETCO2. If ventilation assistance is required, target ETCO2 of 35-\\n45 mm Hg per 7.24 End Tidal Carbon Dioxide Monitoring-Procedure Protocol\\n10. If hypotension persists after IV/IO fluid bolus, administer push dose epinephrine\\n(diluted boluses) according to MI MEDIC cards.\\na.  If MI MEDIC cards are not available prepare (10 mcg/mL) by adding 1mL of\\n1mg/10mL epinephrine in 9mL NS, then\\ni.  Administer 1 mcg/kg (0.1 mL/kg epinephrine 10 mcg/mL)\\nii.  Maximum dose 10 mcg (1 mL)\\niii.  Repeat every 3-5 minutes\\niv.  Titrate to age appropriate SBP per MI MEDIC cards.  If MI MEDIC cards\\nare unavailable titrate SBP > 70 mmHg + (2 x age in years) up to 100\\nmmHg.\\n2.  Anticipate airway intolerance and prepare for patient sedation. If patient becomes\\nagitated with advanced airway in place, refer to 7.17 Patient Procedural Sedation-\\nProcedure Protocol.\\nMedication References\\nEpinephrine","source_file":"6.4-Peds-Return-of-Spontaneous-Circulation-8.31.23-Clean.txt","categories":["medical","pediatric"]},"7-1":{"name":"Unknown Protocol","content":"12-Lead ECG\\nParamedic Protocol (may be Specialist or EMS per MCA selection)\\nAliases:  EKG, 12 lead\\nIndications:\\n1.  A 12-lead ECG is indicated on patients exhibiting any of the following signs/symptoms:\\nA. Chest pain or pressure\\nB. Upper abdominal pain\\nC. Syncope\\nD. Shortness of breath\\nE. Pain/discomfort which are often associated with cardiac ischemia:\\na.  Jaw, neck, shoulder, left arm or other presentations; unless no other\\nsymptoms exist and the cause of the specific pain can be identified\\nwith a traumatic or musculoskeletal injury.\\nb.  If there is any doubt about the origin of the pain/discomfort, or the\\npresentation seems atypical for the mechanism, a 12-lead should be\\nperformed.\\n2.  Patients exhibiting the following signs/symptoms should have a 12-lead ECG\\nperformed if the etiology of the illness is indicative of an Acute Coronary Syndrome or\\nthe etiology of the illness is indeterminate:\\nA.  Nausea\\nB.  Vomiting\\nC.  Diaphoresis\\nD.  Dizziness\\nE.  Patient expression of feelings of doom\\n3.  A 12-lead ECG may be performed based on the clinical judgment of the paramedic\\neven in the absence of the above signs/symptoms.\\nProcedure:\\n1.  Follow 1.1 General Pre-hospital Care-Treatment Protocol.\\n2.  Perform 12-lead ECG per manufacturer guidelines, if available.\\nMCA approval to obtain ECG\\n    Specialist\\n   EMT\\nMCA approval to transmit ECG (and notify of STEMI)\\n   Specialist\\n   EMT\\nMCAs will be responsible for maintaining a roster of the BLS and LALS\\nagencies choosing to participate and will submit roster to MDHHS","source_file":"7.1-12-LEAD-ECG-9.14.23-clean-edited.txt","categories":["medical"]},"7-10":{"name":"HELMET REMOVAL","content":"Initial Date: 05/31/2012\\nRevised Date: 01/27/2023\\nHelmet Removal\\nTreatment of the injured patient with protective gear presents unique challenges. For\\npreplanned events an emergency action plan that has been discussed prior to the\\nevent may provide organized consistent treatment.\\n1.  High Impact Helmets (i.e., motorcycle, car racing)\\nA.  Whether the helmet is a closed or open-faced style helmet, the helmet must always\\nbe removed.\\nB.  Provide constant spinal precautions.\\n2.  Low Impact Helmets WITH Shoulder Pads (i.e., football, ice hockey, etc.)\\nA.  In those patients wearing a well-fitted helmet which conforms closely to the patient\'s\\nhead, unless there is a prearranged agreement between team training/medical\\nstaff, EMS providers and the likely receiving facility, helmet and shoulder pads\\nshould be removed as spinal precautions are maintained. Removal of all equipment\\nat the scene provides the best access to the athlete for treatment.\\nB.  If prearrangement is in place to keep the helmet and shoulder pads in place the\\nprocedure would be as follows (or as determined by agreement):\\n1.  If the patient is awake and able to protect his/her airway, the helmet should be left\\nin place and the patient should have spinal precautions maintained using the\\nhelmet to assist with spinal precautions. The face shield must be removed prior to\\ntransport.\\n2.  If the patient has an altered level of consciousness or, for any other reason, is\\nunable to protect his/her airway, the helmet should be left in place and the patient\\nshould have spinal precautions maintained using the helmet to assist with spinal\\nprecautions. The face shield should be immediately removed to allow access to\\nthe airway.\\n3.  If the face shield cannot easily be removed for any patient, the helmet and\\nshoulder pads should be removed using in-line stabilization.\\n4.  If the airway cannot be controlled for any reason with the helmet in place, the\\nhelmet and shoulder pads should immediately be removed, using in-line\\nstabilization.\\n3.  Low Impact Helmets WITHOUT Shoulder Pads (i.e., baseball, bicycle, rollerblade, etc.):\\nA.  Whether the helmet is a closed or open-faced style helmet, the helmet must always\\nbe removed.\\nB.  Provide constant spinal precautions.","source_file":"7.10-Helmet-Removal-1.27.23.txt","categories":["trauma"]},"7-12":{"name":"OXYGEN ADMINISTRATION","content":"Oxygen Administration\\nAssuring adequate patient oxygenation is a fundamental responsibility of EMS providers at\\nall levels.  Supplemental oxygen when clinically indicated and through the proper delivery\\nsystem can have an important impact on patient outcome.\\nIndications\\n1.  Real or suspected hypoxia\\n2.  Patients in respiratory or cardiac arrest\\n3.  Respiratory distress\\n4.  Chest pain, stroke, seizures, or altered mental status when pulse oximetry is\\nunavailable or when oxygen saturation is less than 94%\\n5.  General trauma (more than isolated trauma). Regardless of pulse oximeter reading,\\nall patients with significant trauma should receive oxygen administration.\\n6.  Shock\\n7.  Suspected carbon monoxide and/or cyanide poisoning (including smoke inhalation)\\nregardless of pulse oximetry value\\n8.  Complicated childbirth\\n9.  Patients who normally use supplemental oxygen as part of their routine care\\n10. Any condition in which pulse oximetry (when available) is <94%.\\nContraindications\\n1.  There are no absolute contraindications to oxygen administration.\\n2.  In general, supplemental oxygen should be guided by pulse oximetry (when\\navailable) to maintain oxygen saturations >94%.\\n3.  Patients with COPD may develop a hypoxic drive to breath.  High concentrations of\\noxygen may suppress their respiratory drive.  Oxygen should still be administered\\nwhen clinically indicated.  Providers should monitor for respiratory depression and\\nassist ventilations when indicated.\\nProcedure\\n1.  Assure the patient has an adequate airway or establish an airway in accordance\\nwith the 7.9 Airway Management-Procedure Protocol and whenever possible the\\npatients head should be elevated up to 30 degrees.\\n2.  In spontaneously breathing patients administer supplemental oxygen by appropriate\\nmeans.\\nA.  Nasal cannula at 2-6 LPM: This is appropriate for most patients with mild to\\nmoderate hypoxia and minimal or no respiratory distress.  Most patients\\ntolerate nasal cannulas.\\nB.  Non-rebreather (NRB) mask at 8-15 LPM (adjust flow rate to keep reservoir\\nbag inflated).  A NRB should be used on all spontaneously breathing patients\\nwith moderate to severe respiratory distress and all patients with suspected\\ncarbon monoxide and/or cyanide poisoning (e.g., smoke inhalation).\\nC.  If continuous positive airway pressure (per 7.5 CPAP-Procedure Protocol)\\nis utilized, using a nasal cannula to supplement oxygenation while a patient is\\non CPAP is acceptable, if seal remains adequate.","source_file":"7.12-OXYGEN-ADMINISTRATION-9.14.23-clean.txt","categories":["trauma","medical"]},"7-13":{"name":"PAIN MANAGEMENT","content":"Initial Date: 9/14/2023\\nRevised Date: 9/12/2024\\nPain Management\\nFor patients with suspected cardiac chest pain, refer to the 5.5 Chest Pain/Acute Coronary\\nSyndrome-Treatment Protocol.\\nThe goal is to reduce the level of pain for patients in the pre-hospital setting.\\nAll pain should be assessed and scored according to the Wong Pain Scale.\\nReassessment should be timed according to medication onset of action, changes in patient\\ncondition, patient positioning and other treatments. Pain treatment should be based on pain\\nscale but may need modification based on patient assessment or condition being treated.\\nNote: Medical Control contact is required for patients with labor pains, established care\\nplans that deter opioid pain management, or have established pain management care\\nplans.,\\n1.  Place the patient in the position of comfort.\\n2.  Pediatric patients (< 14 years) utilize MI MEDIC cards for appropriate medication\\ndosage.  When unavailable utilize pediatric dosing listed within protocol\\n3.  Verbally reassure the patient to control anxiety.\\n4.  Administer BLS interventions per applicable protocol (e.g., positioning, splinting, ice,\\netc.)","source_file":"7.13-Pain-Management-9.12.24-Clean.txt","categories":["medical","pediatric"]},"7-14":{"name":"PATIENT ASSESSMENT","content":"1.  Recognize environmental hazards to rescuers, and secure area for treatment.\\n2.  Recognize hazard for patient and protect from further injury.\\n3.  Identify number of patients.  Follow the 10.6 Mass Casualty Incident-Special\\nOperations Protocol if appropriate.\\n4.  Observe position of patient, mechanism of injury, surroundings.\\n5.  For pediatric patients, utilize the Pediatric Assessment Triangle.\\n6.  Identify self.\\n7.  Utilize universal precautions in all protocols.\\n8.  Determine if patient has a valid Do-not-resuscitate bracelet/order or a valid MI POST.\\nPrimary Survey\\n1.  Airway:\\nA.  Protect spine from movement in trauma victims.  Provide continuous spinal\\nprecautions.  Follow the 2.6 Spinal Injury Assessment-Treatment Protocol.\\nB.  Observe the mouth and upper airway for air movement.\\nC.  Establish and maintain the airway.  Follow the 7.9 Airway Management-\\nProcedure Protocol.\\nD.  Look for evidence of upper airway problems such as vomitus, bleeding, facial\\ntrauma, absent gag reflex.\\nE.  Clear upper airway of mechanical obstruction as needed.\\n2.  Breathing:  Look, Listen and Feel\\nA.  Note respiratory rate, noise, and effort.\\nB.  Treat respiratory distress or arrest with oxygenation and ventilation.\\nC.  Observe skin color and level of consciousness for signs of hypoxia.\\nD.  Expose chest and observe chest wall movement, as appropriate.\\nE.  Look for life-threatening respiratory problems and stabilize.\\nF.  Tension pneumothorax:  Follow 7.18 Pleural Decompression-Procedure\\nProtocol.\\n3.  Circulation\\nA.  Check pulse and begin CPR if no central pulse.  Follow 6.1 Pediatric or 5.1\\nAdult Cardiac Arrest-Treatment Protocol or 4.3 Newborn and Neonatal\\nAssessment and Resuscitation-Treatment Protocol.\\nB.  Note pulse quality and rate; compare distal to central pulses as appropriate.\\nC.  Control hemorrhage by direct pressure.  (If needed, use elevation, pressure\\npoints or follow the 7.22 Tourniquet Application-Procedure Protocol and/or\\n2.13 Bleeding Control-Treatment Protocol.)\\nD.  Check capillary refill time in fingertips.\\nE.  If evidence of shock or hypovolemia begin treatment according to 1.5 Shock-\\nTreatment Protocol.\\n4.  Level of consciousness:\\nA.  Note mental status (AVPU)\\na.  Alert\\nb.  Verbal stimuli response","source_file":"7.14-PATIENT-ASSESSMENT-9.14.23-clean.txt","categories":["trauma","medical","pediatric"]},"7-15":{"name":"DOCUMENTATION AND PATIENT CARE RECORDS","content":"Purpose: Patient care records (PCR) are legal documents and a part of a patients medical\\nrecord. EMS Personnel must be accurate and thorough in their documentation of EMS\\nincidents. This protocol defines the MINIMUM elements to be included in a patient care\\nrecord.\\nI.  Completion of records\\nA.  An electronic EMS PCR must be completed on any request for service to which a life\\nsupport agency (per MCA selection):\\nis dispatched\\narrives on scene\\nRegardless of MCA selection, this includes all emergency and non-emergency EMS\\nincidents and patients, ambulance inter-facility transfers, patient refusals, other\\npatient contact, no patient found and cancellations.\\nB.  For responses that do not necessitate an EMS PCR, an alternative form of electronic\\ndocumentation must be maintained (e.g., computer aided dispatch).\\nC.  If a patient is evaluated and/or treated and is not transported, a Refusal of Treatment\\nand/or Transport Evaluation Form must be completed and a patient signature\\nobtained per 7.19 Refusal of Care; Adult & Minor-Procedure Protocol.\\nD.  Personnel completing PCRs must do so in a timely fashion. If an electronic record is\\nnot transmitted immediately upon leaving the receiving facility, an MCA approved\\npaper form must be left at the receiving facility which includes at least the following:\\n1.  Patient demographic information\\n2.  Patient and history or medications obtained\\n3.  Vital signs and assessment information\\n4.  Any interventions performed\\n5.  Any diagnostics performed\\nE.  For all transports to the hospital: Prior to emergency department departure, a\\ncompleted patient care record (PCR) must be left at the ED either in an electronic\\nformat, an MCA-approved Field Note Form, or an Oakland County EMS Run Form. If\\na Field Note Form is left at the ED, an electronic PCR must be made available to the\\nED within two (2) hours. Electronic PCRs may be submitted to the ED via the\\nfollowing methods:\\na.  EMS printer\\nb.  Fax or e-fax\\nc.  Secured e-mail\\nd.  Each hospital will provide EMS with a computer with Internet access,\\nmonitor, printer (including ink and paper), as well as 24-hour\\nequipment support. Each hospital will also provide a secure fax\\nnumber, secure e-mail.","source_file":"7.15-DOCU-AND-PT-CARE-RECORD-Clean-Final-5.1.24.txt","categories":["adult","medical"]},"7-16":{"name":"PATIENT RESTRAINT","content":"Initial Date: 9/14/2023\\nRevised Date: 1/11/2024\\nPatient Restraint\\nPurpose:  To ensure appropriate and safe restraint of patients whose behavior is suggestive of\\nan imminent physical threat to personnel and/or themselves.\\nPediatric patients  (<  14  years)  utilize  MI  MEDIC  cards  for appropriate  medication  dosage.\\nWhen unavailable utilize pediatric dosing listed within this protocol.\\nIndications:\\n1. When an ill or injured person who is behaving in such a manner as to interfere with their\\nexamination, care and treatment to the extent they endanger their life or the safety of\\nothers.\\n2. The patient has a clear or suspected inability to understand their medical situation and\\nthe need for treatment of a potentially life-threatening injury or illness.\\nEscalation of Care:\\n1. Verbal de-escalation\\n2. Physical management and soft restraints\\n3. Physical management and pharmacological management\\nVerbal De-Escalation is defined as the use of communication or other techniques during an\\nencounter to stabilize, slow, or reduce the intensity of a potentially violent situation without\\nusing physical force, or with a reduction in force.  This should be continued throughout care.\\nSoft Restraint Procedure\\n1.  When the placement of soft restraints requires physical management that poses risk to\\nthe  patient  and/or  personnel,  anticipate  and  prepare  for  physical  management  and\\npharmacological management.\\n2.  Ensure that enough personnel are available to properly control the patient and establish\\nthe restraints.\\n3.  Explain the purpose of the restraints.\\n4.  Physically control the patient and apply restraints.\\n5.  Complete primary and secondary assessments.\\nA.  Restrained extremities should be evaluated for pulse quality, capillary refill time,\\ncolor, sensory and motor function continuously\\na.  Restraints must be adjusted if any of these functions are compromised.\\nb.  Restraints must not interfere with medical treatment.\\n6.  Attempt to identify common physical causes for patients abnormal behavior.\\n  Hypoxia\\n  Hypoglycemia\\n  Head Trauma\\n  ETOH/ Substances use/ abuse\\n7.  Patient  should  be  secured  to  a  backboard  or  stretcher  only.    Patients  must  never  be\\nsecured directly to a vehicle or immovable object.  Patients must NEVER be secured in\\na prone position.\\n8.  Transport patient.","source_file":"7.16-PATIENT-RESTRAINT-1.11.24-Clean.txt","categories":["trauma","medical","pediatric"]},"7-17":{"name":"PATIENT PROCEDURAL SEDATION","content":"Oakland County Medical Control Authority\\nPROCEDURES\\nPATIENT PROCEDURAL SEDATION\\nInitial Date: 8/17/2023\\nRevised Date:\\nPatient Procedural Sedation\\nParamedic Use Only\\nPurpose:\\nProper sedation of patients requiring a painful medical procedure.\\nIndications for Sedation\\n1.  Electrical therapy (cardioversion or transcutaneous pacing)\\n2.  Post intubation sedation\\n3.  CPAP and/or HFNC only under direct Medical Control Order\\ni.  **Ketamine is NOT to be used for this indication\\nContraindications\\n1.  Inability to control the patient\'s airway\\n2.  As an adjunct for establishing an airway\\n3.  Known allergy to sedation medications\\nAssessment\\n1.  Evaluate adequacy of airway, ventilation, and oxygenation\\n2.  Monitor vital signs and level of consciousness\\n3.  Monitor ECG\\n4.  Monitor pulse oximetry\\n5.  Monitor capnography\\nProcedure\\n1.  Maintain airway, provide oxygenation, and support ventilation\\n2.  Obtain vascular access\\n3.  For electrical cardioversion, transcutaneous pacing, and post intubation sedation\\nsedate patient to a level of consciousness where procedure can be performed, per\\nMCA selection\\n4.  Only one MCA authorized sedation medication may be given pre-radio.\\nMedical Control MUST be contacted if a different sedation medication is\\nneeded subsequent to initial dose (adults and pediatrics).\\nAdult Procedural Sedation:\\n(Titrate to minimum amount necessary)\\n  Midazolam 1-5 mg (0.05 mg/kg) IV/IO titrated slowly (IN,\\nif available); may repeat once in 5 minutes to a maximum\\nof 0.1 mg/kg.\\nDiazepam 5-10 mg (0.1 mg/kg) IV/IO titrated slowly, may\\nrepeat every 5 minutes to a maximum of 0.3 mg/kg.\\n  Fentanyl 50-100 mcg (1 mcg/kg) IV/IO titrated slowly (IN,\\nif available); may repeat every 4 minutes to a maximum of\\n3 mcg/kg.\\nKetamine 4 mg/kg IM or 1.5 mg/kg IV/IO (IN if available)\\ntitrated slowly to sedation (max dose 500 mg). NOT for\\nCPAP/HFNO sedation","source_file":"7.17-PROCEDURAL-SEDATION-8.17.23-Clean.txt","categories":["medical"]},"7-18":{"name":"PLEURAL DECOMPRESSION","content":"1.  Suspected Tension Pneumothorax (not simple pneumothorax) with hemodynamic\\ncompromise, severe respiratory distress, unilateral absent or severely diminished breath\\nsounds\\n2.  Considered for patients who remain in PEA after treatment of other reversible causes of\\nPEA have been unsuccessful.\\n3.  Traumatic arrest, refer to 2.7 Traumatic Arrest-Treatment Protocol\\nPresentation of Tension Pneumothorax\\n1.  A tension pneumothorax will have at least one of the following:\\nA.  Severe respiratory distress in the conscious/breathing patient with hemodynamic\\ncompromise (hypotension).\\nB.  Difficult ventilation in the hypotensive, unconscious/apneic patient in the presence\\nof a confirmed, correctly positioned endotracheal tube.\\nTechnique\\n1.  Evaluate and maintain the airway, provide oxygenation, and support ventilations.\\n2.  Decompression procedure:\\nA.  Assemble equipment\\na.  Adults (>14 years of age): large bore IV catheter - 14 gauge or larger\\nand at least 3.5 inches in length (catheter should not have any type of\\nflow restricting valve) OR other MCA approved commercial device, per\\nMCA selection.\\nb.  Pediatrics (<14 years of age): 18 gauge or 20 gauge over the needle\\ncatheter (catheter should not have any type of flow restricting valve) OR\\nother MCA approved commercial device, (per MCA selection).\\nMCA Approved Commercial Device Use\\nAdults\\n  Yes\\n  No\\nPediatrics\\n  Yes\\n  No\\nMCAs will be responsible for maintaining a roster of the agencies\\nchoosing to participate and will submit roster to MDHHS","source_file":"7.18-PLEURAL-DECOMPRESSION-9.14.23-clean.txt","categories":["adult","medical"]},"7-19":{"name":"Unknown Protocol","content":"EMS personnel have an affirmative duty to provide care to any patient presenting to them\\nafter a report of an emergency situation.\\nIf during an emergency medical situation, EMS personnel, based on clinical judgement,\\nconsider a patient to be incapable of making their own medical decisions, that patient may\\nbe considered incapable of competently objecting to treatment or transportation under the\\nlaw. Religious beliefs that lead a patient to refusal of treatment or transport are the\\nexception. EMSMCL 333.20969 states:\\nIf emergency medical services personnel, exercising professional judgment, determine\\nthat the individuals condition makes the individual incapable of competently objecting to\\ntreatment or transportation, emergency medical services may provide treatment or\\ntransportation despite the individuals objection unless the objection is expressly based\\non the individuals religious beliefs.\\nWhen EMS personnel, based on clinical judgement, consider a patient to be \\"capable,\\" that\\npatient may object to treatment and/or transport.\\n1.  Definition\\nA.  An individual who is capable to make medical decisions is:\\na.  One who is awake, oriented, and is capable of understanding the\\ncircumstances of the current situation. This includes risks, treatments,\\ntransport, and alternatives.\\nb.  Does not appear to be under the influence of alcohol, drugs or other\\nmind-altering substances or circumstances that may interfere with\\nmental functioning.\\nc.  Is not a clear danger to self or others.\\nd.  Is 18 years of age or older, or an emancipated minor.\\nB.  Emancipated Minor is one who is married, is on active duty with the Armed\\nForces of the United States or has been granted emancipation by the court.\\nC.  A minor is any individual under the age of 18 and who is not emancipated.\\n2.  Procedure for an individual who, in the clinical judgement of the EMS provider\\nis capable to object to treatment and/or transport.\\nA.  All patients with signs or symptoms of illness or injury shall be offered\\nassessment, medical treatment, and transport by EMS.\\nB.  Clearly explain the nature of the illness/injury and the need for emergency care\\nor transportation.\\nC.  Explain possible complications that may develop without proper care or\\ntransportation.\\n D. For individuals with signs or symptoms of serious or potentially fatal illness or\\ninjury, contact medical control prior to obtaining the patient signature and\\nleaving the scene.","source_file":"7.19-Refusal-of-Care-3.24.23.txt","categories":["trauma","medical"]},"7-2":{"name":"CHILD ABUSE AND NEGLECT (SUSPECTED)","content":"Purpose: To provide the process for assessment and management for patients of\\nsuspected child abuse.\\nWhen emergency personnel suspect that a patient has been abused (physically and/or\\nsexually), neglected, or exploited, a verbal and written report must be made to the\\nemergency physician on arrival at the hospital and to the Protective Services Agency\\n(child or adult). The primary purpose is protection of the patient from further harm. Do not\\nconfront the patient or family members with such suspicions at the scene.\\nMichigan law (MCL 722.623) requires that licensed EMS providers who have reasonable\\ncause to suspect child abuse or neglect shall report immediately, by telephone or\\notherwise their suspicions to the Protective Services Agency for the County involved. In\\ncases of suspected child abuse, this oral report shall also be followed with a written report\\non the Department of Human Services forms available in every hospital emergency\\ndepartment.\\nMichigan law (MCL 400.11a) also requires this same oral report for suspected cases of\\nabuse or neglect of an adult.\\nLicensed providers are required to make an immediate verbal report and a written report\\nwithin 72 hours when they suspect child abuse or neglect. Mandated reporters must also\\nnotify the head of their organization of the report. Reporting the suspected allegations of\\nchild abuse and/or neglect to the head of the organization does not fulfill the requirement to\\nreport directly to MDHHS.\\nThe verbal report can be completed by calling 855-444-3911. The pdf form is found here\\nDHS3200_report.dot (live.com) and is included in the protocol for reference. Reports can\\nbe made online (login required).\\n1. Definitions\\nChild Abuse means harm or threatened harm to a childs health or welfare by a\\nparent, legal guardian, or any other person responsible for the childs health or\\nwelfarethat occurs through non-accidental physical or mental injury; sexual abuse;\\nsexual exploitation, or maltreatment.\\nChild Neglect means harm or threatened harm to a childs health or welfare by a\\nparent, legal guardian, or any other person responsible for the child health or welfare\\nthat occurs through either of the following: 1) Negligent treatment, including the\\nfailure to provide adequate food, shelter, or medical care; 2) Placing a child at an\\nunreasonable risk to the childs health or welfare by failure of the parent, legal\\nguardian, or any other person responsible for the childs health or welfare to intervene\\nto eliminate that risk when that person is able to do so and has, or should have,\\nknowledge of the risk.","source_file":"7.2-Child-Abuse-and-Neglect-5.23.23.txt","categories":["medical","pediatric"]},"7-20":{"name":"SPINAL PRECAUTIONS","content":"1.  Refer to the 2.6 Spinal Injury Assessment Protocol. Patients with a positive spinal\\ninjury assessment should have spinal precautions maintained during transport.\\n2.  Major trauma patients who require extrication should have spinal precautions\\nmaintained using an extrication device (long backboard or equivalent) during\\nextrication. If sufficient personnel are present, the patient may be log rolled from the\\nextrication device to the ambulance cot during loading of the patient.\\n3.  Patients may remain on the extrication device if the crew deems it safer for the\\npatient considering stability, time and patient comfort considerations. This decision\\nwill be at the discretion of the crew.\\n4.  Patients with penetrating traumatic injuries do not require spinal precautions unless a\\nfocal neurologic deficit is noted on the spinal injury assessment.\\n5.  An ambulatory patient with a positive spinal injury assessment should have an\\nappropriately sized cervical collar placed. Place the patient directly on the ambulance\\ncot in a supine position or position with least amount of elevation to maintain comfort,\\nlimiting movement of the spine during the process.\\n6.  Patients, who are stable, alert and without neurological deficits may be allowed to\\nself-extricate to the ambulance cot after placement of a cervical collar. Limit\\nmovement of the spine during the process.\\n7.  Patients over the age of 65 with evidence of a head strike mechanism of injury will\\nhave a cervical collar applied even if the spinal injury clinical assessment is negative.\\nSpecific Techniques\\n1.  Cervical Collars\\nA.  Cervical collar should be placed on patient prior to patient movement, if\\npossible.\\nB.  If no collar can be made to fit patient, towel, blanket rolls, head block or similar\\ndevice may be used to support neutral head alignment.\\nC.  The cervical collar may be removed if interfering with airway management or\\nairway placement, or if causing extreme patient distress.\\n2.  Self-Extrication Procedure\\nA.  Patients, who are stable, alert and without neurological deficits may be allowed\\nto self-extricate to the ambulance cot after placement of a cervical collar.\\nB.  Limit movement of the spine during the process.\\n3.  Emergency Patient Removal\\nA.  Indicated when scene poses an imminent or potential life-threatening danger\\nto patient and/or rescuers, (e.g., vehicle or structure fire).","source_file":"7.20-SPINAL-PRECAUTIONS-9.14.23-clean.txt","categories":["trauma"]},"7-21":{"name":"BLOOD GLUCOSE LEVEL TESTING","content":"Michigan\\nPROCEDURES\\nBLOOD GLUCOSE LEVEL TESTING\\nInitial Date: 02/24/2023\\nRevised Date:\\nBlood Glucose Level Testing\\nIndications:\\n1.  Altered mental status\\n2.  Indicated in applicable treatment protocol\\nContraindications:\\n1. None\\n   Procedure: (may be MFR skill per MCA selection)\\nMCA approval for MFR Blood Glucose Level Testing\\n YES\\n NO\\nMCAs will be responsible for maintaining a roster of MFR agencies\\nchoosing to participate and will submit roster to MDHHS\\n1.  Obtain and test blood sample according to manufacturers instructions.\\n2.  Treat patient according to applicable treatment protocol.\\n3.  Document blood glucose level in electronic patient care record.\\nOakland County","source_file":"7.21-BGL-Testing-2.24.23.txt","categories":[]},"7-22":{"name":"TOURNIQUET APPLICATION","content":"1.  Life threatening extremity hemorrhage.  An amputation with hemorrhage does not\\nnecessitate the use of a tourniquet; most bleeding from these injuries is controllable\\nthrough use of direct pressure and elevation.\\n2.  Amputation with uncontrolled active bleeding.\\n3.  A mass causality incident may be an indication for the use of tourniquets for\\ntemporary control of hemorrhage while the situation is brought under control.\\nContraindications:\\n1.  Never use a tourniquet for more than the recommended period of time (product-\\nspecific).  With any extrication plus transport time of less than 180 minutes, there is\\nminimal risk of developing an ischemic limb.\\n2.  Never apply a tourniquet over an impaled object.\\nProcedure:\\n1.  If possible, check neurovascular status prior to tourniquet application (pulse,\\nsensation, motor function distal to hemorrhage).\\n2.  Apply tourniquet directly to the skin, proximal to the area of bleeding, at least 2-3\\ninches (5-8 centimeters) from the wound margins.\\n3.  Secure the tourniquet in place; continue to tighten the tourniquet until arterial\\nocclusion (bleeding stops).\\n4.  A successfully placed tourniquet may cause significant pain. (Refer to 7.13 Pain\\nManagement-Procedure Protocol).\\n5.  Document the time the tourniquet was applied.\\n6.  Note  neurovascular status every five minutes post application.\\n7.  Notify the receiving hospital that a tourniquet is in place.\\n8.  Do not adjust or remove a tourniquet once bleeding is controlled.\\n9.  A second tourniquet adjacent to the first may be necessary.\\nNotes:\\n1.  Tourniquets should not be applied over joints.  Application over the peroneal nerve\\n(knee or ankle) or ulnar nerve (the elbow) may result in nerve damage or paralysis.\\n2.  Any limb with an applied tourniquet should be fully exposed and the tourniquet should\\nnot be covered with any other bandage.\\n3.  Continued bleeding (other than medullary oozing from fractured bones) distal to the\\nsite of the tourniquet is a sign of insufficient pressure and a need to tighten the\\ntourniquet further.  A second tourniquet adjacent to the first may be necessary.  Refer\\nto 2.13 Bleeding Control-Treatment Protocol.\\n4.  A clinically indicated and appropriately applied tourniquet should not be loosened\\nonce applied.  If clinical judgement indicates that the tourniquet is not indicated, is\\nnonfunctional or is not appropriate, contact Medical Control prior to removal or\\nloosening.\\nProtocol Source/References: https://books.allogy.com/web/tenant/8/books/b729b76a-1a34-4bf7-b76b-\\n66bb2072b2a7/#ida54cdbed-5555-47f0-b791-2c86de208f76","source_file":"7.22-TOURNIQUET-APPLICATION-9.14.23-V2-Clean.txt","categories":["trauma","medical"]},"7-23":{"name":"VASCULAR ACCESS & IV FLUID THERAPY","content":"NOTE:  Do not access any existing port without direct online medical control approval (such as\\npicc lines, central lines, fistulas, etc).\\nIndications\\n1.  Patients with potential need for either fluid resuscitation or medication\\nadministration.\\n2.  External jugular cannulation should be initiated in patients in whom access is\\nnecessary and other peripheral vascular access is not accessible or is\\ncontraindicated.\\n3.  IO indications: Adult and pediatric life-threatening situations where venous\\naccess using peripheral veins has been unsuccessful.  IO access should be\\nconsidered early in situations where IV access is unsuccessful or technically\\nchallenging.  Indications may include:\\nA.  Cardiac Arrest\\nB.  Severe burn injury with shock\\nC.  Shock\\nD.  Severe multi-system trauma with shock\\nContraindications\\n1. To peripheral vascular access:\\nA.  No peripheral sites available.\\nB.  Burns overlying available peripheral sites unless no other sites available\\nC.  Infection overlying available peripheral sites\\n2. To intraosseous infusion and placement:\\nA.  Infiltration of previously placed IO. If infiltration occurs (rare), do not reuse\\nthe same bone as fluid will leak out of the original hole; select another\\nsite.\\nB.  Placement in fractured extremity. If the femur is fractured do not use the\\ntibia of same leg.\\nC.  Burns overlying available peripheral sites unless no other sites available.\\nD.  Infection overlying available peripheral sites.\\n3.  To fluid bolus:\\nA.  Pulmonary edema\\na.  Contact Medical Control when pulmonary edema is present yet clinical\\npresentation indicates the need for fluid resuscitation.\\nSpecial Considerations (Side effects/Complications)\\n1.  Initiation of vascular access generally should not delay patient transport to the\\nhospital.\\n2.  General side effects or complications: infection, air embolism, catheter shear,\\nhematoma, arterial puncture, and fluid overload.\\n3.  Intraosseous placement:\\nA.  Complications include subperiosteal infusion, osteomyelitis, sepsis, fat\\nembolism, and bone marrow damage.","source_file":"7.23-VASCULAR-ACCESS-AND-IV-FLUID-THERAPY-1.11.24-clean.txt","categories":["adult","trauma","medical","pediatric"]},"7-24":{"name":"END TIDAL CARBON DIOXIDE MONITORING","content":"End-Tidal Carbon Dioxide Monitoring (Capnometry and Capnography)\\nAliases:\\nETCO2, End Tidal, Capnography\\nDefinitions: For the purpose of all protocols the mention End Tidal Carbon Dioxide\\nmonitoring, these are the definitions:\\n  1. Capnography is a graphic representation of exhaled carbon dioxide displayed as a\\nwaveform along with a numeric (quantitative) representation.\\na.  Capnography is mandatory for endotracheal tube airway confirmation.\\nb.  Capnography via nasal cannula is mandatory during certain medication\\nadministrations per applicable protocol as it is also a valuable assessment tool\\nin critically ill patients.\\nMCA approval to utilize capnography.\\n EMT\\n\\nMCAs will be responsible for maintaining a roster of BLS agencies choosing to\\nparticipate and will submit roster to MDHHS\\n2.  Capnometry is a numeric representation of exhaled carbon dioxide.\\na.  A colorimetric (qualitative) end tidal carbon dioxide monitor is a rudimentary\\nform of capnometry and is acceptable for use in MFR and BLS applications.\\nb.  Capnometry that includes a numerical (quantitative) read out is preferred to\\ncolorimetric capnometry.\\nIndications:\\n1.  Determining appropriate placement of an airway has taken place.\\nA.  Capnography must be utilized to confirm endotracheal tube placement.\\nB.  Capnography or Capnometry must be utilized on all supraglottic airways per\\nlicensure level requirements.\\n2.  Continuous monitoring of the integrity of the ventilatory circuit.\\nA.  Capnography may be utilized in patients receiving assisted ventilations without\\nadvanced airways (used between the face mask and the bag-valve).\\nB.  Capnography must be used for patients on transport ventilators.\\n3.  Monitoring severity of pulmonary disease (bronchospasm) and evaluating response\\nto therapy\\nA.  Capnography may be utilized in patients with respiratory distress, or with signs\\nand symptoms suggestive of acidosis.\\n4.  Monitoring therapy intended to increase coronary blood flow, reflected in CO2\\nelimination","source_file":"7.24-End-Tidal-Carbon-Dioxide-Monitoring-2.13.23.txt","categories":["medical"]},"7-25":{"name":"POST","content":"Purpose:  The purpose of this policy is to provide a guideline to prehospital providers, who\\nunder certain circumstances may accommodate patients who do not wish to receive and/or\\nmay not benefit from certain interventions.  This protocol is drafted in accordance with Public\\nAct 154 of 2017. This protocol is intended to facilitate kind, humane, and compassionate\\nservice for patients who have executed a valid MI-POST under the law.\\nI.  Definitions\\nA.  Attending health professional  means a physician, physicians assistant, or\\ncertified nurse practitioner, who has primary responsibility for the treatment of\\na patient and is authorized to issue the medical orders on a POST form.\\nB.  Patient  means an adult with an advanced illness or means an adult with\\nanother medical condition that, despite available curative therapies or\\nmodulation, compromises his or her health so as to make death within 1 year\\nforeseeable though not a specific or predicted prognosis.\\nC.  Guardian  means a person with the powers and duties to make medical\\ntreatment decisions on behalf of a patient to the extent granted by court order\\nunder section 5314 of the Estates and Protected Individuals Code, 1998 PS\\n386, MCL 700.5314.\\nD.  Patient Advocate  means an individual designated to make medical treatment\\ndecisions for a patient under Section 496 of the revised Probate Code, Act No.\\n642 of the Public Acts of 1978, being section 700.496 of the Michigan\\nCompiled Laws.\\nII.  Introduction - EMS providers who encounter an approved MI-POST in the field should\\nbe aware of the different levels of care in Sections A and B of the form.\\nIII.  Procedure for Use of Form\\n    A.  If there are issues with the form, the orders contained therein, or the\\ncircumstances of the situation are unclear, personnel may initiate treatment\\nand contact Medical Control for direction.\\nB.  Section A  Applies to only individuals who do NOT have a pulse and are not\\nbreathing upon arrival of EMS personnel or become pulseless or apneic during\\ntreatment.\\na.  If Attempt Resuscitation is checked, provide treatment according to\\nappropriate 5.1 Cardiac Arrest-Treatment Protocol.\\nb.  If DO NOT attempt resuscitation is checked, refer to 7.6 Dead on\\nScene and Termination of Resuscitation-Procedure Protocol or\\n8.22 Medical Examiner Notification and Body Disposition\\nProtocol as appropriate.\\nC.  Section B  For patients who have a pulse and/or are breathing\\na.  Comfort-Focused Treatment box is selected:","source_file":"7.25-MI-POST-9.14.23-clean.txt","categories":["adult","medical"]},"7-26":{"name":"INTERFACILITY HIGH FLOW NASAL OXYGEN (HNFO)","content":"Interfacility High Flow Nasal Oxygen (MCA Optional Protocol)\\nThis protocol is for paramedic use only\\nPurpose:  To outline the process for paramedics who have received MCA approved training,\\nto transport a patient on a high flow nasal cannula during an interfacility transport.\\n Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.\\nIn conjunction the MCA must also select the option for Interfacility High Flow\\nNasal Oxygen on the 8.15 Interfacility Facility Patient Transfers Protocol.\\nI.\\nIndications\\nA.  Order from sending facility/physician\\nB.  Hypoxic respiratory failure, hypoxic respiratory distress, respiratory distress\\nC.  Availability of an MCA approved high flow nasal cannula device and necessary\\nsupplies required to facilitate transport of patient.\\nD.  Adults (> 14 years of age)\\nE.  Pediatrics (< 14 years of age) per MCA selection for allowance and/or staff\\nrequirements.\\nMCA approval for pediatric HFNO (< 14 years of age) WITHOUT\\n accompanying hospital staff\\n   NO  Staff must accompany patient\\n   YES - Enhanced Paramedic or Critical Care Paramedic only\\n   YES  Paramedic who has received additional MCA approved training.\\nMCAs will be responsible for maintaining a roster of the agencies choosing to participate\\nand will submit roster to MDHHS\\nII.\\nContraindications\\nA.  Inability to provide continuous, humidification using an approved delivery device\\nB.  Inability to provide therapy through appropriately sized nasal prongs\\nC.  Insufficient supply of oxygen to complete the transport\\nIII.\\nProcedure\\nA.  Ensure that an adequate supply of oxygen is available for the transport.","source_file":"7.26-Interfacility-HFNO-9.14.23-clean.txt","categories":["adult","medical","pediatric"]},"7-27":{"name":"TRANSPORT OF ADULT VENTILATOR-DEPENDENT PATIENT","content":"Transport of Adult Ventilator-Dependent Patient\\nThe purpose of this protocol is to establish a uniform procedure for using mechanical\\nventilation for the transport of patients who are otherwise stable and do not meet criteria for\\nMICU or Air Medical transport.\\nCriteria\\nA.  BLS may transport patients on their own ventilator if:\\na.  Patient caregiver trained on the ventilator accompanies patient\\nb.  Waveform capnography if available per MCA selection in 7.24 End-Tidal\\nCarbon Dioxide Monitoring-Procedure Protocol\\ni.  If waveform capnography not available, capnometry that includes a\\nnumerical (quantitative) read out is required.\\nc.  One of the following conditions:\\ni.  Scheduled transport (interfacility, facility to home, home to appointment,\\netc.) OR\\nii.  Low acuity 9-1-1 that requires BLS level care.\\nB.  ALS (non-Critical Care, non-Enhanced Paramedic) in which all agency paramedic\\npersonnel are trained on and carry ventilators.\\nProcedure\\nA.  Always keep a bag valve mask resuscitator close by in case of ventilator failure.\\nB.  Patients who are ventilator dependent may be transported on their own ventilator\\n       (home ventilator) if desired. Assure the BVM is available for back up use if\\n       transporting with a home ventilator. Patient caregiver trained in the use of ventilator\\n       should attend during transport if possible.\\n1.  Verify tube placement with waveform capnography.\\n2.  Patient lung sounds should be checked and documented. Tube placement must\\nbe rechecked via lung sounds and continuous waveform capnography every\\ntime the patient is moved, i.e., stretcher to stretcher or in or out of a vehicle.\\nContinuous monitoring with the pulse oximeter will be used on all patients.\\nC.  Patients on agency supplied ventilator:\\n1.  Newly vented - Ventilatory status should be established via Venous Blood Gas\\n(VBG) in the newly intubated patient and documented when available.\\nContinuous monitoring with the pulse oximeter and capnography will be used on\\nall patients. If pulse oximetry is not attainable due to poor circulation, an ABG\\nmay be used to ensure adequate oxygenation. If unavailable, consider MICU or\\nair medical transport.\\n2.  Ventilator and circuit must be set up according to manufacturers\\nrecommendations.\\n3.  Patient should be placed on the ventilator approximately 5 minutes prior to\\ndeparture to ensure the patient tolerates the ventilator. Appropriate adjustments\\nshould be made prior to departure.\\n4.  Assist Control (AC) and Synchronized Intermittent Mandatory Ventilations (SIMV)\\nare acceptable modes of operation. Set Positive End Expiratory Pressure (PEEP)","source_file":"7.27-Tnxp-Adult-Vent-Depenedent-Patients-9.14.23-clean.txt","categories":["adult","medical"]},"7-28":{"name":"LEFT VENTRICULAR ASSIST DEVICE","content":"A Left Ventricular Assist Device (LVAD) is an implanted device that pumps blood from the\\nleft ventricle into the aorta to support circulation. For some of these patients this device is a\\nbridge to transplant but for others it is a life prolonging therapy if transplant is not an option.\\nCare of patients supported by these devices can present a challenge for care givers in the\\npre-hospital environment. This document provides guidance for the provision of emergency\\ncare for patients in the pre-hospital environment who have an LVAD in place.\\nIf the information is not readily available, contact medical control for assistance.\\n1.  LVADs create non-pulsatile flow; it may be difficult to obtain vital signs using\\nstandard equipment and or methods. Utilize skin color, mental status and capillary\\nrefill to assess the patient.\\n2.  The device supports left ventricular function and is dependent on some right heart\\nfunction and adequate circulating volume. Even minor volume depletion may cause\\ndiminished perfusion and require fluid administration.\\n3.  All LVAD patients are anticoagulated.\\n4.  LVADs are powered electrically, a driveline exits the body, connects to a controller\\nwhich in turn is connected to a power source. Proper functioning of the device is\\ndependent on the integrity of these connections. Exercise caution related to the\\ndrive line, which exits through the skin in the upper abdomen. Do not cut, pull or\\ndamage it in any way. It will be secured by some type of binder or other device to\\nprotect it.\\n5.  Connections should not be forced together or apart. All connections are secured by\\na locking device.\\n6.  Generally, patients, their families and caregivers are familiar with the operation of\\nthe device and should accompany the patient as a resource for operation of the\\ndevice if promptly available.\\n7.  All LVAD patients are assigned a hospital-based coordinator who is available by\\nphone and should be contacted urgently.\\n8.  All LVAD patients should have a go bag close by which contains an additional\\npower supply as well as an extra controller. This should be brought with the patient\\nto the hospital. This should contain charged batteries, a back-up controller and a\\npower-based unit.\\n9.  If possible, the patient should be transported with four fully charged batteries. Two\\nwill be connected to the patient and the other will serve as backups.\\n10. Most issues will be the result of medical problems rather than device failure.\\nProcedure\\nDo NOT use the following devices on an LVAD patient\\n  AED\\n  Mechanical Compression Device","source_file":"7.28-LVAD-1-11-24-Clean.txt","categories":["medical"]},"7-29":{"name":"MECHANICAL CHEST COMPRESSION DEVICE","content":"Mechanical Chest Compression Device (MCA Optional Protocol)\\nManual chest compressions remain the standard of care for the treatment of cardiac\\narrest by all levels of EMS providers.  Mechanical chest compression devices may only be\\nused as alternative to conventional CPR in specific settings where the delivery of high-\\nquality manual compressions may be challenging or dangerous for the provider (e.g., limited\\nrescuers available, CPR during hypothermic cardiac arrest, CPR in a moving ambulance).\\n Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.\\nMCAs will be responsible for maintaining a roster of the agencies choosing to\\nparticipate and will submit roster (including brand name/model number of device)\\nto MDHHS.\\nRequirements:\\n1.  FDA approved MCA authorized mechanical chest compression devices as listed\\nbelow (brand name and model if applicable)\\n  All mechanic chest compression devices approved by the FDA for EMS use.\\n2.  Providers utilizing the device are trained on use of the device per MCA requirements\\n3.  Follow manufacturers instructions for use unless otherwise directed by the MCA.\\nIndications:\\n1.  Cardiac Arrest\\nContraindications:\\n1.  Return of Spontaneous Circulation\\n2.  Age and weight restrictions per manufacturers recommendations.\\n3.  Patients with LVAD\\nProcedure:\\n1.  Perform high-quality CPR while the device is being prepared for use.\\n2.  Utilize device according to manufacturer\'s recommendations.\\n3.  Refer to  5.1 Adult or 6.1 Pediatric General Cardiac Arrest -Treatment Protocol\\n4.  Document use of Mechanical Chest Compression Device in patient care record\\nincluding but not limited to:\\nA.  Type/brand of device\\nB.  Applicable times Mechanical Chest Compression Device was in use.\\nC.  Rate at which the device is set/delivering mechanical chest compressions.","source_file":"7.29-Mechanical-CPR-Device-9.14.23-Clean-edited.txt","categories":["adult","medical","pediatric"]},"7-3":{"name":"CRIME SCENE MANAGEMENT","content":"1.  Follow 1.1 General Pre-hospital Care Protocol-Treatment Protocol\\n2.  Preserve evidence whenever possible.\\nA.  Wear gloves for all patient care and other activities within the crime scene.\\nB.  Never cut through holes in clothing created by bullets or knives.\\nC.  Retain all clothing, place in a paper bag. Be alert for torn clothing, fragments of\\ncloth, blood, or body fluids, etc. for they need to be preserved as evidence.\\nD.  Law enforcement is responsible for the disposition of this evidence.\\nE.  When transporting a patient who may be dying, ascertain name and/or\\ndescription of assailant if possible.\\nF.  At an outdoor crime scene do not disturb shoe prints, tire marks, shell casings,\\netc.\\nG.  Limit movement at the crime scene.\\nH.  Attempt to keep others out of the area.\\n3.  Advise patient to not shower, change clothes, or dispose of pertinent objects.  If\\napplicable, refer to 2.15 Sexual Assault-Treatment Protocol.\\n4.  Assess patient for injury and treat according to protocol.\\n5.  Use sensitivity in asking victim about history/events.\\n6.  Thoroughly document all injuries and voluntary statements of patient.  Red marks may\\ndisappear and your documentation may be the only witness that the victim was choked\\nor struck, even though he/she stated it.\\n7.  Document patients emotional state.\\n8.  Assure law enforcement agency has been notified.\\nA.  Notify the investigating law enforcement of any alteration of the crime scene by\\nEMS personnel including:\\na.  Any movement of furniture, tables, etc.\\nb.  The original position of the patient and items.\\nc.  If you turned on lights.\\nd.  What you touched, moved, etc.\\n9.  Transport, treating according to appropriate protocol.\\nA.  If transport is refused, refer patient to support agency and/or hospital whenever\\npossible and contact medical control if applicable.\\nNOTES:\\n1.  Your first duty is to provide emergency medical care at the scene of an illness/injury.\\n2.  Certain measures can be taken to assist law enforcement personnel in preserving a\\ncrime without jeopardy to the patient.\\n3.  The investigation of the circumstances surrounding the incident is the responsibility of\\nthe law enforcement agency.\\n4.  Do not touch firearms (loaded or unloaded) unless it poses a potential or immediate\\nthreat.  Secure any weapon that can be used against you or the crew out of the reach of\\nthe patient and bystanders.","source_file":"7.3-CRIME-SCENE-MANAGEMENT-9.14.23-clean.txt","categories":["trauma","medical"]},"7-4":{"name":"VULNERABLE ADULT","content":"Vulnerable Adult Abuse, Neglect, or Exploitation (Suspected)\\nAliases: elder abuse, mandatory reporting\\nPurpose: To provide the process for assessment and management of vulnerable adult\\npatients with suspicion of elder abuse.\\nI.\\nDefinitions\\na.  Vulnerable adult  means an individual age 18 and older who is unable to\\nprotect himself or herself from abuse, neglect or exploitation because of a\\nmental or physical impairment or because of advanced age.\\nb.  Abuse - means harm or threatened harm to an adult\'s health or welfare caused\\nby another person. Abuse includes, but is not limited to, non-accidental\\nphysical or mental injury, sexual abuse, or maltreatment.\\nc.  Exploitation - means an action that involves the misuse of an adult\'s funds,\\nproperty, or personal dignity by another person.\\nd.  Neglect - means harm to an adult\'s health or welfare caused by the inability of\\nthe adult to respond to a harmful situation or by the conduct of a person who\\nassumes responsibility for a significant aspect of the adult\'s health or welfare.\\nNeglect includes the failure to provide adequate food, clothing, shelter, or\\nmedical care.\\nNote: A person shall not be considered to be abused, neglected, or in need of\\nemergency or protective services for the sole reason that the person is\\nreceiving or relying upon treatment by spiritual means through prayer alone in\\naccordance with the tenets and practices of a recognized church or religious\\ndenomination, and this act shall not require any medical care or treatment in\\ncontravention of the stated or implied objection of that person.\\nII.\\nProcedure\\na.  Do not confront the suspected abuser with suspicions as this could create an\\nunsafe situation for the patient and EMS personnel.\\nb.  Do not question the patient about suspected abuse/maltreatment in front of the\\nsuspected abuser. The primary goal, after treating life threatening injuries, is to\\nprotect the patient and personnel from harm.\\nc.  Request police assistance if there is any history of threatening, abusive, or\\nviolent acts. Protect yourself while obtaining a safe environment for the\\npatient.\\nd.  Focus the interview on the patients injury. Do not address the specifics of\\nabuse, maltreatment, or neglect at this point.\\ne.  Determine and chart past medical history, and any cognitive or physical\\nimpairment.\\nf.  During assessment, pay attention to signs and symptoms of abuse, neglect, or\\nexploitation.\\ni.  Physical","source_file":"7.4-Vulnerable-Adult-1.5.23.txt","categories":["adult","medical"]},"7-5":{"name":"ADMINISTRATION","content":"Continuous Positive Airway Pressure (CPAP) Administration\\nFor use of this protocol, patients must meet one or more of the indications. Contraindicated\\npatients and those that do not meet the inclusion criteria will be treated according to existing\\nprotocols without the application of CPAP.\\nIndications:\\nSevere respiratory distress not responding to initial treatment with any of the following:\\n1. CHF/Pulmonary edema/near drowning\\n2. Hypoxia, i.e., SpO2 less than 92% on supplemental oxygen.\\n3. Acute exacerbation of asthma/COPD.\\nContraindications:\\n1. Respiratory/cardiac arrest.\\n2. Blood Pressure\\na. Adult (>10 years of age)  less than 90mmHg systolic\\ni. NOTE:  70 + (2x10 years of age) = 90 mmHg\\nb. Pediatrics (<10 years of age) less than (70 mmHg + [2x age in years]).\\ni. Small adult CPAP mask does not properly fit the patient and/or pediatric\\nsize CPAP mask is not available.\\nInability to maintain patent airway.\\n3.\\n4. Major trauma, pneumothorax, penetrating or blunt chest trauma and blast injury.\\n5. Vomiting or active GI bleeding with emesis.\\n6. Unstable facial fractures.\\nProcedure\\n1. EXPLAIN THE PROCEDURE TO THE PATIENT.\\n2. Apply appropriately sized and properly sealing CPAP  mask per manufacturers\\nrecommendations.\\n3. Place the patient on continuous pulse oximetry.\\n4. Secure the mask with provided straps and tighten to obtain a good seal, check for air\\nleaks.\\n5. Continue to coach the patient to keep the mask in place, readjust as needed.\\n6. Begin with 5 cmH20 with titration as necessary and as tolerated.\\n7. Advise medical control of CPAP use during radio report.\\n8.\\nIf respiratory status deteriorates, remove the device and assist ventilations with a\\nBVM/supplemental oxygen; place an appropriate airway control device.\\n9. Obtain/monitor vital signs.\\n10. Administer medications, per appropriate protocol, as indicated.\\na. The CPAP mask can be briefly removed for oral or SL medication (e.g.,\\nnitroglycerin) administration.\\n11. Contact medical control and consider sedation to reduce anxiety per 7.17 Patient\\nProcedural Sedation- Procedure Protocol.","source_file":"7.5.CPAP-1.11.24-Clean.txt","categories":["adult","trauma","medical"]},"7-6":{"name":"TERMINATION OF RESUSCITATION","content":"Dead on Scene & Termination of Resuscitation\\nPurpose:  For patients in cardiac arrest, when and when not to initiate CPR, and when to\\nterminate efforts.\\nA.  Dead on Scene Criteria - CPR should NOT be initiated in the following cardiac arrest\\npatients:\\n1.  Decomposition\\n2.  Rigor mortis (Caution: do not confuse with stiffness due to cold environment)\\n3.  Dependent lividity\\n4.  Decapitation\\n5.  Traumatic cardiac arrest while entrapped (witnessed or unwitnessed)\\n6.  Incinerated or frozen body\\n7.  Submersion greater than 90 minutes in cold water (water temperature less\\nthan 70\xb0 F/21\xb0 C) as documented by the licensed health care professional\\nafter arrival on scene.\\n8.  Submersion greater than 30 minutes in warm water (water temperature greater\\nthan 70\xb0 F/21\xb0 C) as documented by the licensed health care professional\\nafter arrival on scene.\\n9.  Gross dismemberment or obvious mortal wounds/conditions (injuries\\ninconsistent with life  i.e., crushing injuries of the head and/or chest)\\n10. Unwitnessed arrest of traumatic origin, without organized electrical activity\\n(must be asystole or pulseless rhythm with rate less than 40/min).\\ni. Exception to this is electrocution (including lightning strike) or acute\\n   hypothermia.\\n11. Patient has a valid Do Not Resuscitate identification bracelet or order refer to\\n7.7 DNR-Procedure Protocol\\n12. Patient has MI-POST with Do Not Resuscitate selected in section A refer to\\n7.25 MI POST-Procedure Protocol\\n13. In cases of mass casualty incidents, where the number of patients exceeds the\\nproviders and resources to care for them, any patient who is pulseless and\\napneic may be triaged as deceased.\\nB.  Exceptions to Dead on Scene Criteria in which CPR should be initiated:\\n1.  In EMS professional judgement potential viability despite meeting Dead on\\nScene criteria.\\n2.  Pregnant patient arrest witnessed by either bystanders or EMS personnel\\ni.  Resuscitation and immediate transport to the closest receiving facility\\nii.  Contact Medical Control as early as possible\\nC.\\nFor all other patients:\\n1.  Follow the 5.1 Adult or 6.1 Pediatric Cardiac Arrest-Treatment Protocol.","source_file":"7.6-Dead-on-Scene.Termination-of-Resuscitation-8.27.24.txt","categories":["adult","medical","pediatric"]},"7-7":{"name":"DO-NOT-RESUSCITATE","content":"Purpose:    The purpose of this policy is to provide a guideline to prehospital providers, who\\nunder certain circumstances may accommodate patients who do not wish to receive and/or\\nmay not benefit from cardiopulmonary resuscitation.  This policy is drafted in accordance\\nwith Public Act 368 of 1978, as amended, as well as Act 192 and 193 of the Public Acts of\\n1996. This policy is intended to facilitate kind, humane, and compassionate service for\\npatients who have executed a valid Do-not-resuscitate order under the aforementioned\\nActs.\\n1.  Definitions\\nA.  Attending Physician  means the physician who has primary responsibility for\\nthe treatment and care of a declarant.\\nB.  Declarant  means a person who has executed a do-not-resuscitate order, or\\non whose behalf a do-not-resuscitate order has been executed pursuant to\\napplicable laws.\\nC.  Do-not-resuscitate order  means a document executive pursuant to Act 193,\\ndirecting that in the event a patient suffers cessation of both spontaneous\\nrespiration and circulation in a setting outside of a hospital, nursing home, or\\nmental health facility owned or operated by the Department of Community\\nHealth, no resuscitation will be initiated.\\nD.  Do-not-resuscitate Identification Bracelet or Identification Bracelet  means a\\nwrist bracelet that meets the requirements of Act 193 and worn by a declarant\\nwhile a do-not-resuscitate order is in effect.\\nE.  Order  means a do-not-resuscitate order.\\nF.  Patient Advocate  means an individual designated to make medical treatment\\ndecisions for a patient under Section 496 of the revised probate code, Act No.\\n642 of the Public Acts of 1978, being section 700.496 of the Michigan\\nCompiled Laws.\\nG.  Vital Sign  means a pulse or evidence of respiration.\\nH.  MI-POST Michigan Physician Order for Scope of Treatment see 7.25 MI\\nPOST-Procedure Protocol\\n2.  Procedure\\nA do-not-resuscitate order is applicable to all prehospital life support agencies and\\npersonnel.  A do-not-resuscitate order may be executed by an individual 18 years of\\nage or older and of sound mind OR by an individual 18 years of age or older and of\\nsound mind, and adherent of a church or religious denomination whose members\\ndepend upon spiritual means through prayer alone for healing OR by a patient\\nadvocate of an individual 18 years of age or older.\\nA.  CRITERIA: EMS providers shall not attempt resuscitation of any individual\\nwho meets ALL of the following criteria:\\na.  18 years of age or older","source_file":"7.7-DO-NOT-RESUSCITATE-9.14.23-clean.txt","categories":["medical"]},"7-8":{"name":"ELECTRICAL THERAPY","content":"Initial Date: 9/14/2023\\nRevised Dat:\\nElectrical Therapy\\nAliases:\\nAED, Cardioversion, defibrillation, pacing\\nI. Precautions for all Electrical Therapy\\n1.  Dry the chest-wall if wet or diaphoretic\\n2.  Nitroglycerin paste should be removed; paddles should not be placed over nitroglycerin\\npatches.\\n3.  Avoid placing the paddles over a pacemaker or an implantable cardioverter defibrillator\\n(ICD).\\n4.  Ensure no provider or bystander contact with the patient or the pads during\\ndefibrillation.\\nII. Automatic External Defibrillation (AED)\\n1.  Do NOT apply AED to patient with LVAD, go 7.28 LVAD-Procedure Protocol.\\n2.  The AED shall be applied only to patients found in cardiopulmonary arrest.\\n3.  Interruptions to CPR should be kept to a minimum.\\n4.  The AED should not be used on patients found lying on conductive surfaces or\\npatients in moving vehicles.\\n5.  For all patients, anterior/posterior placement of pads is preferred and should be used,\\nif possible.\\n6.  There are no age or weight limits for AED use.\\n7.  In pediatric patients, attenuated pads should be used, if available. If adult pads are\\nused in pediatric patients, pads must be placed in an anterior/posterior configuration.\\n8.  The word shock instead of defibrillation shall be used in this section as devices\\nutilize this verbiage.\\n9.  Follow the 5.1 Adult or 6.1 Pediatric Cardiac Arrest-Treatment Protocol.\\n10. Stop CPR to analyze patient and shock once, if indicated.\\n11. Continue CPR immediately after the shock, or immediately if no shock is indicated\\nand continue for 2 minutes (5 cycles) or when AED initiates analysis.\\n12. If no pulse, analyze the patient and repeat one shock, if indicated.\\n13. If patient converts to a non-shockable rhythm at any time, continue CPR until AED\\nprompts to check the patient.\\n14. Should a patient who is successfully defibrillated arrest again, analyze the patient\\nagain.\\nIII. Manual Defibrillation\\n1.  Indications:\\nA.  Ventricular fibrillation\\nB.  Pulseless ventricular tachycardia\\nC.  Unstable irregular wide complex tachycardia\\n2.  Technique:\\nA.  Turn defibrillator on.\\nB.  Apply defibrillator pads according to manufacturer specifications.  For all patients,\\nanterior/posterior placement of pads is preferred and should be used, if possible.","source_file":"7.8-ELECTRICAL-THERAPY-9.14.23-clean-edited.txt","categories":["adult","medical","pediatric"]},"7-9":{"name":"AIRWAY MANGEMENT","content":"Initial Date: 9/14/2023\\nRevised Date: 12/19/2024\\nAirway Management\\nMCAS are responsible for training on all airway devices, techniques, securing methods and\\ndocumentation.  All pediatric advanced airway interventions will have a 100% review by the\\nMCA.  All cricothyroidotomy procedures will have a 100% review by the MCA.\\nMFR\\nEMT\\nEMT-A\\n(Specialist)\\nPARAMEDIC\\nX\\nX\\nX\\nX\\nMCA\\nSelection\\nRequired\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nBasic Airway\\nOropharyngeal Airway\\nNasopharyngeal Airway\\nBag-Valve-Mask Ventilation\\nOral Suctioning\\nCPAP\\nAdvance Airway-Supraglottic\\ni-Gel\\n(Adult sizes)\\ni-Gel\\n(Pediatric sizes)\\nAir-Qsp3 or AirQsp3G\\n(Adult sizes only patients > 35 kg)\\nLMA Supreme\\n(Adult Only)\\nKing\\n(Adult Only)\\nAdvance Airways\\nParamedic Only\\n Oral Endotracheal Intubation\\nNeedle / Surgical\\nCricothyroidotomy\\nTracheal Suctioning\\nMonitoring\\nWaveform capnography\\nNumeric capnometry\\nColorimetric capnometry\\nX\\nManagement Overview\\nMCA\\nSelection\\nRequired\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nX\\nMCA Selection\\nRequired\\nX\\nX\\nX\\nX\\n1.  Maintain a patent airway.\\n2.  Provide effective oxygenation and adequate ventilation using the least invasive\\n     possible method to achieve those goals paired with pulse oximetry and end-tidal\\n     capnography (EtCO2) data.\\n3.  Anticipate, recognize, and alleviate respiratory distress.\\n4.  Provide necessary interventions quickly and safely to patients with the need for\\n     respiratory support.\\n5.  Anticipate, identify, and plan for a potentially difficult airway.\\n6.  Optimize the patient for any advanced airway attempt.","source_file":"7.9-AIRWAY-MANAGEMENT-12.19.24-Clean-April-10-Implementation.txt","categories":["medical","pediatric"]},"7.9.1":{"name":"Unknown Protocol","content":"Video laryngoscopy may be used as an adjunct in orotracheal intubation. The device used for\\nvideo laryngoscopy must be approved by the MCA. The device shall be used according to\\nmanufacturer instructions. All requirements for endotracheal tube placement and verification\\nshall otherwise be followed per the Airway Management protocol.","source_file":"7.9.1-Video-Laryngoscopy-clean-8.27.24.txt","categories":[]},"9-1":{"name":"MEDICATION ADMINISTRATION","content":"EMS providers preparing to administer medications in the out of hospital setting should\\nreview and/or recite the \\"6 Rights\\" prior to administering any medication to a patient.\\nWhile all 6 elements are important, In the out of hospital setting, special attention should\\nbe paid to the right medication, right dose, and right route - as these are frequently the\\nareas of error in the EMS environment. In addition, EMS providers should ensure the\\npatient is informed as to what medications they are receiving and afford an opportunity\\nfor the patient to refuse. Lastly, documentation is essential so that medications\\nadministered in the out of hospital setting become part of the patient\'s clinical medical\\nrecord. By following the \\"6 Rights\\" of medication administration, EMS providers will\\nsignificantly decrease the potential and number of errors associated with medication\\nadministration.\\nDefinitions:\\nI.\\nII.\\nMedication: Any pharmacological intervention used to treat, prevent, or reduce\\nsigns and symptoms of diseases, disorders, and/or traumatic injuries.\\nMedication administration routes include the following: Intramuscular, Intravenous,\\nIntraosseous, Oral, Buccal, Rectal, Inhaled, and Subcutaneous.\\nProcedure:\\nI.\\nII.\\nPrior to the administration of any medication ensure the following are reviewed\\nand/or verbalized by at least two providers  if available (checked, and double\\nchecked):\\nA. 6 Rights of Medication Administration \\nRight Patient\\nRight Dose\\nRight Medication (including indication)\\nRight Route\\nRight Time\\nRight Documentation (including response)\\nCalculating medications when given a dosage range and a per kg dose:\\nA. Calculate weight in kilos and multiply by the prescribed dosage (e.g. - mg/kg)\\nB. The resultant dose should be less than the maximum single dose.\\n1.\\n2.\\n3.\\n4.\\n5.\\n6.\\n1.\\nIn adults, for ease of administration, doses may be rounded to the\\nnearest whole number within the range for those calculated doses at\\nor above 1 dosage unit, or to the nearest tenth for those below 1\\ndosage unit (examples: 1.2 mg rounded to 1 mg, and 0.26mg rounded\\nto 0.3mg). That calculated and rounded dose may be given and\\nrepeated in timed intervals, as indicated for that medication, to the\\ncontrol of symptoms or maximum stated cumulative dose if symptom\\ncontrol is not previously achieved.\\n2. For pediatric patients, utilize MI-MEDIC and a length-based tape for\\nall medication calculations.","source_file":"9.1-Medication-Administration-2.13.23.txt","categories":["trauma","medical","pediatric"]},"9.100":{"name":"Unknown Protocol","content":"Medication Under Direct Medical Control\\nThe following medications are designated for use ONLY under direct medical control.\\nCefazolin\\nCeftriaxone\\nTo use the medication the paramedic must:\\n1.  Request direct medical control to use the medication.\\na.  If there is communications failure the medication cannot be used.\\n2.  Describe to the medical control physician the rationale for use of the medication.\\n3.  Advise the physician that there is no treatment protocol in the OCMCA that allows the\\nuse of this medication.\\n4.  Advise the physician that they have been trained on the use of the medication.\\n5.  Report the usage of the medication to their agency administration within 1 hour of its\\nuse.\\n6.  The agency must notify the OCMCA within 72 hours of the medications use.\\n7.  The agency must provide the incident ePCR along with proof that the paramedic has\\nbeen trained to use this medication.\\na.  Any use of the medication by untrained paramedic may lead to disciplinary\\naction.\\n8.  The OCMCA PSRO shall review all administration of medications in this protocol.\\n________________________________________________________________________________________________________________","source_file":"9.100-Medication-Administration-Under-Direct-Medical-Control-9.14.23-CLean.txt","categories":["medical"]},"9.101":{"name":"Unknown Protocol","content":"Licensed BLS Units must carry; and OCMCA approved MFR Units may carry; either Epi Auto\\ninjectors or MaBEEs kits.\\nAccountability\\nA.  All medications will be stored in a securely locked compartment in a temperature-\\ncontrolled area of the EMS vehicle.\\nB.  All medications must be restocked at the pharmacy or through other Medical Control\\napproved process in conformity with current pharmacy laws and the public health\\ncode. Utilization forms must be completed for each use.\\nEpi-Auto Injectors Exchange Procedure\\nLife support agencies with BLS units, and approved MFR units will acquire and replace Epi-\\nAuto Injectors and Epi-Auto Injector Jrs as follows:\\n1.  Each life support agency will be responsible for obtaining Epi-Auto Injectors and Epi-\\nAuto Injector Jrs from an assigned hospital in the Oakland County Medical Control\\nAuthority (MCA).\\n2.  Each participating hospital of the OCMCA will acquire Epi-Auto Injectors and Epi-Auto\\nInjector Jrs for life support agencies. The hospital will determine a reasonable and\\ncustomary re-stocking fee to charge the LSA.\\n3.  The purchasing hospital will dispose of expired Epi-Auto Injectors at no additional cost.\\n4.  The Epi-Auto Injectors/Epi-Auto Injector Jrs and Use Form will be placed in a re-\\nsealable plastic bag.  A pharmacy label will be affixed to the bag with the expiration\\ndate.\\n5.  Epi-Auto Injectors and Epi-Auto Injector Jrs are to be inspected daily by the crew of the\\nunit for evidence of loss, theft, discrepancy, and expiration date.  It is recommended that\\nthis inspection be included in a standard documented vehicle checklist.\\n6.  Hospital pharmacy should be notified 30 days prior to expiration date of medication.\\nMaBEEs Kit Contents and Exchange Procedure\\nThis only applies to LSAs that have been approved to carry OCMCA MaBEEs Kits on BLS\\nand/or MFR licensed vehicles.\\n1.  The OCMCA Medical Control Hospital pharmacy will stock the OCMCA MaBEEs Kits in\\naccordance with the MaBEEs Kit Contents List.\\n________________________________________________________________________________________________________________","source_file":"9.101-New-MFR-EMT-Medication-Exchange-9.14.23-Clean.txt","categories":["medical"]},"9.102":{"name":"MFR/BLS","content":"3.  Press the plunger firmly to give the dose of Narcan\xae Nasal Spray. Remove\\nthe Narcan\xae Nasal Spray from the nostril after giving the dose.\\n4.  Repeat Step 12 as described above, if indicated.\\n______________________________________________________________________________________\\nMCA:  Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMDHHS Approval Date: February 1, 2024\\nMCA Implementation Date: 1/10/2024","source_file":"9.102-MFR-BLS-Opioid-Overdose-Naloxone-Administration-Oakland-County-9.14.23-clean.txt","categories":[]},"9-2":{"name":"MEDICATION SUBSTITUTION","content":"This protocol allows for MCA to substitute medications during a time of shortage without\\nhaving to enact emergency protocols within the MCA. This protocol does not replace or\\noverride any portion of the Medication Shortage Procedure. All procedures within that\\nprocedure must still be followed in regards to substitutions in concentration or\\nmedication.\\nIndications:\\nNone of the medication options indicated in the MCA approved protocol are available.\\nProcedure:\\n1.  Follow Medication Shortage Procedure.\\n2.  Alternate concentrations are listed within this protocol for reference; these do not\\nrequire a protocol change and are outlined in the Medication Shortage Procedure.\\n3.  Notification and education of providers within the MCA should be done as soon as\\nthe substitution is known.\\na.  It is the responsibility of the MCA to distribute information on the shortages\\nand substitutions to agencies for distribution to providers.\\nb.  If a substitution is imminent, it is acceptable for an MCA to distribute\\ninformation prior to the medication being substituted.\\n4.  The MCA should notify the Division of EMS and Trauma if a substitution is suspected\\nto last more than 60 days so that a more permanent protocol solution can be\\nenacted.\\n5.  All uses of substitute medications will be reviewed by PSRO for appropriateness.\\nCurrent Medication\\nAmiodarone\\nCalcium Chloride\\nDiazepam\\nDiphenhydramine\\nFentanyl\\nLidocaine\\nMidazolam\\nMorphine\\nOndansetron\\nSubstitution\\nLidocaine\\nCalcium Gluconate\\nMidazolam\\nFamotidine\\nRanitidine\\nHydroxyzine\\nHydromorphone\\nAmiodarone\\nDiazepam\\nHydromorphone\\nMetoclopramide\\nCompazine","source_file":"9.2-MEDICATION-SUBSTITUTION-2024-Clean-Final.txt","categories":["trauma"]},"9-3":{"name":"MEDICATION SHORTAGE","content":"Initial Date: 10/25/2017\\nRevised Date: 02/13/2023\\nMedication Shortage\\nA. Definitions:\\n1. Alternate Concentration  same medication, different concentration, while\\nvolume may change, the delivered dose remains unchanged, dilution may be\\nrequired (Epinephrine 1: 10,000 replaced using Epi 1: 1,000 with a 10mL diluent)\\n2. Alternate Supplied Volume  same medication, same concentration, standard\\nvolume is unavailable, the delivered dose and volume remain the same (Epi 1:\\n1,000, typically supplied in a 1mL vial replaced with Epi 1: 1,000 in a 10mL multi-\\ndose vial due to shortage of the smaller vials)\\n3. Alternate Supply/Type  same medication, standard supply type is unavailable\\n(preloads vs. vials), dosing remains unchanged (diphenhydramine 50mg/5mL\\npreload is unavailable, replaced with diphenhydramine 50mg/5mL in a vial)\\n4. Alternate Form  same medication, different route such that identical dosing\\ndoes not yield the same systemic concentration or effect (ondansetron 4mg vial\\nunavailable, replaced with ondansetron 4mg ODT, option to repeat x 1 added to\\nallow approximation of equivalent dosing)\\n5. Alternate Medications  medication other than the standard approved\\nmedication which accomplishes an acceptably similar effect as the medication it\\nreplaces (fentanyl 100mcg approved to replace morphine 10mg, dosing adjusted\\nto obtain therapeutic equivalency)\\n6. Missing Medication  standard medication which is unavailable (amyl nitrite not\\navailable, acceptable alternative of Cyanokit is excessive in cost and size:\\nalternate means to access treatment established  MEDDRUN)\\n7. Outsourced medications  Repackaged by a 340B or 503 B medications in\\nthe same concentration and volume that have at least a 90 day expiration\\ndate.\\nB. Criteria:\\n1.\\nParticipating pharmacies be it at the individual MCA or at a wider regional level,\\nshall establish and maintain a listing of the standard medications and supplies\\ncontained in drug bags or boxes supplied to life support agencies for the purposes\\nof treating patients.\\nEach participating pharmacy shall maintain a dated listing of alternative\\nmedications which are approved as substitutes or replacements for medications\\nwhich are in shortage.\\n2.\\n3. Due to the frequency of medication shortages and the need for alternative dosing\\nor medication substitutions, each MCA shall develop and enact a medication\\ncross-check procedure, to which EMS personnel will be held accountable as a\\nmeans to avoid medication errors\\nBoth the standard list and the alternate list (may be combined into a single\\ndocument) shall be made readily available to system participants\\nThe participating pharmacy shall enact policies/procedures which guide each of\\nthe following:\\nA. Recognition of medication shortages and a means to report them\\n5.\\n4.","source_file":"9.3-Medication-Shortage-2.13.23.txt","categories":[]},"9.4":{"name":"PERSONAL METERED DOSE INHALER USE","content":"Personal Metered Dose Inhaler Use (MCA Optional Protocol)\\n Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.\\nPurpose: Nebulized respiratory treatments are preferred over MDIs.  This protocol is to\\nallow for the use of the patients own prescribed Metered Dose Inhaler (MDI) containing only\\nalbuterol, in place of nebulized albuterol administration by EMS personnel.  This is to be\\nused only in patients with febrile respiratory symptoms\\nA. To substitute administration of albuterol 2.5 mg/3ml NS nebulized with use of the\\npatients own prescribed MDI the following criteria MUST be met.\\n1. A specific and applicable treatment protocol is being followed\\n2. EMS provider administering patient prescribed MDI is MCA authorized to administer\\nalbuterol 2.5 mg/3ml NS nebulized within the treatment protocol\\nB. Indications\\n1. Patients with febrile respiratory symptoms in need of bronchodilator treatment\\nC. Requirements\\n1. Patient has a prescribed rescue Metered Dosed Inhaler (MDI) containing albuterol\\nonly\\n2. MDI is prescribed to the patient (no one else)\\n3. Medication is not expired\\n3. MDI has a functioning spacer (preferred not required)\\nD. Procedure\\n1. Assist patient in receiving four (4) puffs of their own rescue Albuterol Metered Dose\\nInhaler (MDI), with spacer, in place of each nebulized treatment of albuterol 2.5\\nmg/3ml NS as indicated in applicable treatment protocol.\\n2. Use of a spacer is optimal. When no spacer is available, ensure that that patient\\nbreathes out completely before each puff in order to inhale as much medication as is\\npossible.\\n3. Do not use an MDI prescribed to another person.\\n4. All MDIs should be brought to the hospital with the patient, if transported.","source_file":"9.4-MDI-Fillable-2.14.23.txt","categories":["medical"]},"9-5":{"name":"IV ANCILLARY SUPPLY EXCHANGE","content":"IV Ancillary Supply Exchange\\nVehicle Stock\\nA.\\nEach approved ALS/LALS unit will be initially provided with IV supplies\\nlisted  on the Southeast Michigan Regional Protocol IV Ancillary Supply\\nExchange  Form (Attached). The IV supplies listed on the IV Ancillary\\nSupply Exchange Form will be made available in the Emergency\\nDepartment or Pharmacy for all  Southeast Michigan Regional Protocol\\nparticipating EMS Agencies.\\nB.\\nC.\\nD.\\nEach ALS/LALS Agency and Advanced Life Support Agency will be\\nresponsible for providing any additional equipment required by the\\nMichigan Department of Health and Human Services (MDHHS).\\nAll IV solutions, needles, syringes, and supplies will be stored in a\\nsecurely  locked, temperature-controlled location on each approved\\nALS/LALS unit at all  times except when in use.\\nIV supplies/fluids are to be inspected daily by the crew of the unit for\\nevidence of loss, theft, discrepancy, and expiration date.  It is\\nrecommended that this  inspection be included in a standard documented\\nvehicle checklist.\\nUse / Replacement / Exchange\\nA.\\nIV supplies will only be used by a Paramedic or Specialist when\\npresented with a  patient requiring Advanced Life Support or Limited\\nAdvanced Life Support care and/or IV therapy and then only when acting\\non written or transmitted orders  from a physician at an appropriate on-line\\nmedical control facility or pre-contact  provisions of approved treatment\\nprotocols.\\nB.\\nAll hospitals participating in the regional EMS medication exchange\\nsystem will  stock and exchange IV supplies, as listed on the Southeast\\nMichigan Regional Protocol IV Ancillary Supply Exchange Form used by\\napproved ALS/LALS  providers.  IV supplies will be available within the\\nhospital pharmacy or  emergency department of the participating hospital\\n(24 hrs/day, 7 days/wk).  Appropriate record keeping and security\\nmeasures are required at each exchange site to ensure that only\\nappropriately licensed and authorized personnel have  access to IV\\nsolutions, and other related supplies.","source_file":"9.5-IV-Ancillary-Supply-Exchange-Clean-Final-3.14.24.txt","categories":["adult","medical"]},"9-6":{"name":"Unknown Protocol","content":"Southeast Michigan Medication Exchange and Replacement Procedure\\nVEHICLE STOCK\\nA.  Each approved ALS unit will carry one GREEN LOCK SEALED Southeast Michigan\\n(SEM) Regional Medication Box and A-Pack (Ancillary Pack).  Only appropriately\\nnumbered Medication Boxes and A-Packs issued by the participating Medical Control\\nAuthority are to be stocked by participating hospital pharmacies and issued to approved\\nALS units.\\nB.  Each EMS agency will be responsible for providing any additional equipment required\\nby Michigan Department of Health & Human Services  Bureau of EMS & Trauma\\n(MDHHS).\\nC.  All drugs, needles, syringes, and supplies will be stored in a securely locked and\\ntemperature-controlled location on each approved unit.  Medication Boxes/A-Packs will\\nremain sealed at all times except when in actual use.\\nD.  Medication Boxes/A-Packs are to be inspected daily by the crew of the unit for evidence\\nof loss, theft, discrepancy, and expiration date.  Inspection items include, but are not\\nlimited to: the Medication Box/A-Pack is locked in a compartment, the green lock is\\nintact, the lock # matches number on the label, and medications are not expired.  It is\\nrecommended that this inspection be included in a standard documented vehicle\\nchecklist.\\nE.  Agencies are responsible for maintaining Medication Boxes/A-Packs not in use by a\\ncrew in a locked and secured location, and have a system in place to restrict who\\naccesses that location.\\nF.  Unopened Medication Boxes/A-Packs are to be exchanged within seven (7) days of the,\\nUse or Replace By date.\\nUSE/REPLACEMENT/EXCHANGE\\nA.  Medication Boxes/A-Packs will only be opened by a Paramedic when presented with a\\npatient requiring Advanced Life Support care (when acting on written or transmitted\\norders from a physician at an appropriate On-Line Medical Control Facility) or the Pre-\\nMedical Control section of approved treatment protocols.\\nB.  Red/Green Lock Procedure for Medication Boxes/A-Packs\\n1.  The Medication Box/A-Pack will be sealed using a green lock bearing the number\\nindicated on the label.\\n2.  After the pharmacy inventory/restocking is complete, a red lock bearing the number\\nindicated on the label will be placed in the Medication Box/A-Pack to be used by the\\nParamedic to seal the Medication Box/A-Pack after it has been used.\\n3.  When the Medication Box/A-Pack is opened by the Paramedic the broken numbered\\ngreen lock will be placed in the Medication Box/A-Pack and delivered with the used\\nMedication Box/A-Pack to the replacing pharmacy.\\n4.  After use the Paramedic will seal the Medication Box/A-Pack for exchange\\nwith the red lock from the Medication Box/A-Pack bearing the number\\nindicated on the label.","source_file":"9.6-SEM-MedicationRegional-Exchange-Clean-3.22.24.txt","categories":["medical"]},"9.6.1":{"name":"DRUG/ITEM","content":"CONCENTRATION\\nPACKAGING\\nQUANTITY\\nAcetaminophen\\nAdenosine\\nAlbuterol\\nAmiodarone\\nAspirin\\nAtropine\\nCalcium Chloride\\nCeftriaxone\\nDextrose 50%\\nDiphenhydramine\\nEpinephrine\\nEpinephrine\\nFentanyl\\nIpratropium Bromide\\nKetamine\\nKetorolac\\nLidocaine\\nMagnesium Sulfate\\nMethylprednisolone\\nMidazolam\\nMorphine\\nNaloxone\\nNitroglycerin\\nOndansetron\\nOndansetron ODT\\nPrednisone\\nRacepinephrine  2.25% with 3 mL NS\\nSodium Bicarbonate\\nSodium Chloride\\nSodium Chloride\\nTranexamic Acid (TXA)\\nAlcohol Pad\\nIncident Report Form\\nIV Additive Labels\\nIV Tubing with Y Site Pre-pierced Reseal\\nNebulizer\\nBlunt Cannula\\nFilter Needle\\nIntranasal Mucosal Atomization Device\\nSyringe\\nSyringe\\nSyringe with needle/Luer Lock\\nSyringe with needle\\nOral Liquid Syringe\\nNeedle\\nPediatric Needle\\nRed Lock\\nReplacement Form\\nThree or Four-Way Stopcock","source_file":"9.6.1-SEM-Medication-Exchange-Addendums-6.17.24-Clean.txt","categories":["trauma"]},"9-7":{"name":"EPINEPHRINE AUTO-INJECTOR PROCEDURE","content":"Purpose:  To outline the use and resupply of epinephrine auto-injector/pediatric epinephrine\\nauto-injector by authorized prehospital providers for life-threatening anaphylaxis and\\nrespiratory emergencies as outlined in applicable treatment protocols Providers must be\\nlicensed at or above the Emergency Medical Technician level unless otherwise specified by\\nMCA selection. .\\nMCA Approval of Epinephrine Auto-injector for Select MFR Agencies\\n YES\\n  NO\\nMCAs will be responsible for maintaining a roster of the agencies choosing to\\nparticipate and will submit roster to MDHHS\\n1.\\nIndications\\nA. Life-threatening allergic/anaphylactic and respiratory emergencies\\nB. Use is outlined in applicable treatment protocol\\n2. Contraindications\\nA. No absolute contraindications to life-threatening allergic/anaphylactic\\nemergencies as described in applicable treatment protocols.\\n3. Cautions\\nA. Use with caution in patients with heart disease, high blood pressure, and\\nstroke.\\nB. Contact Medical Control if child appears to weigh less than 10 kg\\n(approx. 20 lbs.) prior to administration if possible.\\n4. Technique\\nA. Epinephrine auto-injector is an auto-injector that injects medication into the\\nintramuscular tissue when the device is pushed against the skin.  Injection is to\\nbe done at the anterolateral portion of the thigh.\\nB. Dosing:\\ni. Epinephrine auto-injector (0.3 mg) is used for patients weighing over\\n30 kg (approx. 60 lbs.)\\nii. Pediatric epinephrine auto-injector (0.15 mg) is used for patients\\nweighing between 10-30 kg (approx.20-60 lbs.)\\niii. Contact Medical Control if child appears to weigh less than 10 kg (approx.\\n20 lbs.), prior to pediatric epinephrine auto-injector administration, if\\npossible\\nC. Instructions for use are pictured on the side of each auto-injector.\\nD. The auto-injector must be held in place for ten (10) seconds once the needle\\ninjects into the thigh.","source_file":"9.7-Epinephrine-Auto-Injector-Procedure-2.15.23.txt","categories":["medical","pediatric"]},"9-8":{"name":"AND DISTRIBUTION PROCEDURE","content":"Naloxone Leave Behind Medication Kit Contents and Distribution\\nProcedure\\nI.\\nII.\\nIII.\\nMedications and supplies for naloxone kits will be supplied by participating\\npharmacies or the MCA.\\nAssembly, labeling, and access to kits will be done according to the 9.6 SE\\nMichigan Medication Exchange and Replacement Procedure.\\nOverdose Medication Kit Contents List:\\nConcentration\\n4mg / spray\\nPackaging\\nNasal Spray\\nMedication / Item\\nNaloxone (Narcan)\\nMDHHS Safety Advice\\nfor Patient and Family\\nMembers Card\\nResuscitation\\nFace shield*\\nReplacement Form\\nLocal Treatment\\nResources Form\\nQuantity\\n1\\n1\\n1*\\n*(MCA Optional)\\n1\\n1\\nIV.\\nProcedure\\nA.  Each participating EMS Agency will stock each of its licensed vehicles with 2\\nNaloxone Medication Kits.  After deployment, the naloxone medication kit will\\nbe replaced within 24 hours at the assigned stocking hospital pharmacy.\\nB.  Kits will be stored on the EMS vehicle in a secure way, not accessible to the\\npublic.\\nC.  Deployment of a Naloxone Medication Kit will be documented the patient care\\nrecord and uploaded to the Michigan EMS Information System.\\nD.  The replacement/use form will be completed and returned to the designated\\nhospital pharmacy for dispensing of a replacement Naloxone Kit.","source_file":"9.8-Naloxone-Leave-Behind-Med-Kit-9.14.23-clean-edited.txt","categories":["adult","medical"]},"downgrade_of_response":{"name":"Downgrade of Response","content":"Purpose: To allow downgrading of EMS vehicles responding to an EMS incident.\\nI.\\n\\nIf information is received, while en route, that the incident is not life-threatening, then that\\nambulance may use that information to alter response accordingly.\\n\\nII.\\n\\nNo EMS vehicle shall be canceled, once a request for emergency assistance is received,\\nunless one of the following occurs.\\nA. A police/fire department unit reports that no person/accident can be found at the\\nlocation,\\nB. Any licensed EMS personnel on the scene cancels the responding EMS vehicles.\\nC. A 1st party caller (the potential patient) states they no longer require a response from\\nemergency medical services AND an EMS response is no longer requested AND\\nthere is not another indication that an emergency exists.\\n\\nMCL 333.20967 If an emergency has been declared, the declaration that an emergency no\\nlonger exists shall be made only by a licensed EMS provider or a licensed health\\nprofessional who has training specific to the provision of emergency medical services in\\naccordance with protocols established by the local medical control authority.\\nNote: For the purposes of this protocol, a situation in which injuries or illness have not been\\nconfirmed does not constitute an emergency (i.e. motor vehicle crash with unknown\\ninjuries, unknown medical alarm).\\n\\nOakland County\\n\\n-~~DHHS\\nI\\nM\\nl,\\nPATIENT PRIORITIZATION AND\\nUSE OF LIGHTS AND SIRENS","source_file":"Section-8-TOC.pdf","categories":["trauma","medical"]},"section_8-2":{"name":"Patient Prioritization and Use of Lights and Siren\\nThis protocol is designed to provide a safe and orderly response to all requests for\\nemergency medical care in the State of Michigan","content":".\\nA.\\n\\nMichigan Motor Vehicle Code (\xa7257.603 and 257.653)\\nThe Michigan Motor Vehicle Code governs the driving of emergency vehicles. All\\nlicensed life support vehicles will abide by the Michigan Motor Vehicle Code.\\n1. This protocol does not supersede the Michigan Motor Vehicle Code.\\n\\nB.\\n\\nAuthority to Require Lights and Siren Use\\nNeither the patients sending nor receiving physician has the authority to require the use\\nof lights and siren during transport; this policy shall be followed at all times. Only the\\nEMS transport crew can determine transport mode, based on patient priority.\\n\\nC.\\n\\nUse of Emergency Medical Dispatch\\nWhere Emergency Medical Dispatchers (EMD) and/or a tiered EMS response are/is\\navailable, the EMS Agency is encouraged to develop procedures that reduce\\nunnecessary use of lights and sirens. The procedures may include, but are not\\nlimited to, the use of established EMD call screening protocols and evaluation of the\\nscene/patient by first responder personnel.\\n\\nD.\\n\\nPrudent Use of Lights and Siren During Transport\\nLights and sirens may be used to clear traffic and then shut down, if prudent, where no\\nobstruction or delay is present, provided both lights and siren are activated at least 500\\nfeet before any intersection or obstruction to be cleared. When lights and siren are not\\nin use, the vehicle must be operated as a typical non-emergency vehicle, per the Motor\\nVehicle Code.\\n\\nE.\\n\\nReturning from the transport, returning to a service area\\n1. EMS units may ONLY utilize lights and sirens to return to their area IF THEY ARE\\nRESPONDING TO AN EMERGENCY CALL.\\n2. Lights and sirens will NOT be used to return to an area when the unit is not\\nresponding to another emergency call.\\n\\nF.\\n\\nEducation\\nLife Support Agencies shall ensure MCA approved annual training surrounding the\\nMichigan Motor Vehicle Code, safe use of lights and siren, this protocol and related\\nagency polices.\\n\\nG.\\n\\nAgency and Medical Control Authority Specific Policies\\nThis protocol does not preclude MCAs from developing protocols and/or individual\\nagencies from developing internal policies on this subject, as long as it includes the\\ncontents of this protocol as a minimum.\\n\\n-~~DHHS\\nI\\nM\\nl,\\nPATIENT PRIORITIZATION AND\\nUSE OF LIGHTS AND SIRENS\\nSection: 8-2\\n\\nH.\\n\\nWhen in doubt, contact medical control to determine if there is an urgent need to\\ntransport with lights and siren.\\n\\nI.\\n\\nResponse and Transport\\nResponse to the scene and transport to the hospital is determined by patient priority.\\n1. If the on-scene patient priority is different from the dispatch priority, follow the onscene patient priority for transport.\\n2. If the patient priority changes during transport follow the appropriate use of lights\\nand sirens for the new patient priority.\\n\\n1. Unstable Patients\\nPriority\\nDescription\\n\\nUnstable\\n\\nExample(s) include, but not limited to\\nA patient that has an acutely life-threatening illness or\\ninjury and is unstable.\\n Unstable or deteriorating vital signs\\n Compromised airway that cannot be secured by\\nEMS.\\nUnstable patients with\\n Severe respiratory distress/failure\\na critical and\\nimmediate life Cardiac arrest or post cardiac arrest\\nthreatening illness or\\n STEMI\\ninjury, or require time\\n Tonic Clonic seizures unresponsive to treatment\\nsensitive interventions\\n Significant blunt or penetrating trauma including\\nbut not limited to:\\no Airway compromised\\no Respiratory distress\\no Signs of inadequate perfusion\\n\\nResponse to the scene and transport to the hospital:\\nMCA Selection Response to Unstable Patient Incidents and Transports\\nLife support vehicles, in compliance with Michigan Motor Vehicle Code, use lights and\\n\\nsirens while responding to the scene and/or transporting to the hospital\\n\\n\\nResponse\\n\\nTransport\\n\\n\\nLife support vehicles, in compliance with Michigan Motor Vehicle Code, use lights and\\nsiren only when necessary to circumvent significant traffic delays and obstructions\\nresponding to the scene and/or transporting to the hospital (per MCA selection).\\nResponse\\n\\nTransport\\n\\n-~~DHHS\\nI\\nM\\nl,\\nPATIENT PRIORITIZATION AND\\nUSE OF LIGHTS AND SIRENS\\nSection: 8-2\\n\\n2. Potentially Unstable Patients:\\nPriority\\nDescription\\n\\nPotentially\\nUnstable\\n\\nExample(s) include, but not limited to\\n\\nPotentially unstable\\npatients that are ill or\\ninjured without\\nimmediate lifethreatening condition\\nand do not require\\ntime sensitive\\ninterventions\\n\\nA patient that is currently stable but is felt to have a\\ncondition that may become unstable or life-threatening\\nif not evaluated and treated rapidly.\\n Hemodynamically stable chest pain without signs\\nof STEMI\\n Altered mental status  not acutely deteriorating\\n Seizure - Post-ictal not actively seizing\\n Hemodynamically stable abdominal pain\\n Hemodynamically stable >65 y/o fall with\\nconfirmed or suspicion of head injury and\\ncurrently taking blood thinner medications\\n\\na. Response to the scene.\\nMCA Selection for Response to Potentially Unstable Patients and Transports\\nLife support vehicles, in compliance with Michigan Motor Vehicle Code, use lights\\n\\nand sirens while responding to the scene, transports without lights and siren.\\n\\nEmergency Vehicles, in compliance with Michigan Vehicle Code, respond with no\\nlights and sirens to the scene or during transport.\\nOnly the first responding life support vehicle, in compliance with Michigan Motor\\nVehicle Code, responds lights and sirens to the scene. All other life support vehicles\\nrespond with no lights and sirens to the scene unless upgraded.\\n\\nb. Do not transport using lights and sirens unless the patients condition deteriorates.\\n\\n-~~DHHS\\nI\\nM\\nl,\\nPATIENT PRIORITIZATION AND\\nUSE OF LIGHTS AND SIRENS\\nSection: 8-2\\n\\n3. Stable Patients:\\nPriority\\nDescription\\nExample(s) include, but not limited to\\nStable patients are Ill\\nor injured patients not\\nfitting the above two\\nA patient that does need to receive medical evaluation\\nStable\\ncategories who require but does NOT have a potentially life-threatening illness\\nmedical attention but\\nor injury at the time of assessment or transport by EMS.\\ndo not have a lifethreatening condition.\\na. Respond and transport using normal traffic patterns to the incident and to the hospital\\n4. Dead Patients:\\nPriority\\nDescription\\n\\nDead\\n\\nExample(s) include, but not limited to\\n\\nDead patients are\\nabsent of all vital signs\\nand do not require\\nfurther medical attention,\\nper protocol.\\n\\nSee Patient Death, Termination of Resuscitation and\\nPronouncement Protocol\\n\\na. Do not transport using lights and sirens.\\n\\nTRANSPORTATION PROTOCOL\\nInitial Date: June, 2023\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["trauma","medical"]},"section_83":{"name":"Transportation Protocol\\nPurpose","content":": To define the decision-making process to be followed by EMS personnel in order\\nto ensure patients are transported to a facility appropriate for their condition.\\nNote:\\nClosest Appropriate Emergency Facility is the emergency facility that is closest to the\\nscene address in time or distance. The closest facility should be utilized, taking into\\nconsideration weather, traffic, construction, time of day, helicopter pad location on the\\nproperty and patient care history.\\nI. Transportation Procedure\\nA. Priority 3 patients (medical or trauma): Shall be transported to an appropriate\\nEmergency Facility of the patients or patients family choice, or closest if no\\npreference.\\n1. Patient Priority is defined in the Patient Prioritization Protocol 8.24 for\\ncriteria.\\n2. For psychiatric emergencies, transport patient to the closest facility per the\\nPsychiatric Emergencies Protocol 1-8.\\nB. Priority 1 and 2 (medical) Patients: All patients must be transported to the\\nclosest appropriate Emergency Facility. As noted above.\\n1. ST Elevation Myocardial Infarction (STEMI) - Acute\\nPatients with presumed acute myocardial infarction shall be transported to an\\ninterventional cardiac facility. Notify receiving hospital, as soon as possible,\\nof impending arrival of a STEMI ALERT patient and give ETA.\\n See Chest Pain/Acute Coronary Syndrome Protocol 5.5 for STEMI\\ncriteria.\\n2. Return of Spontaneous Circulation (ROSC)\\nPatients with ROSC, in most circumstances will be transported to an\\ninterventional cardiac facility. Notify receiving hospital, as soon as possible, of\\nimpending arrival of the patient and give ETA.\\n3. Burns\\nSee Burns Protocol 2.3 for criteria. If transporting directly to a burn center\\nnotify destination hospital as soon as possible of impending arrival of the\\npatient and give ETA.\\n4. Stroke\\nIf Cincinnati Stroke Scale is abnormal, notify receiving hospital as soon as\\npossible of impending arrival of a STROKE ALERT patient, with the time\\nthe patient was last seen normal and give ETA. Transport to closest\\nappropriate stroke facility.\\n See Stroke Protocol 3.2 for criteria.\\n 10/17/2023\\n\\nPage 1 of 3\\n\\nTRANSPORTATION PROTOCOL\\nInitial Date: June, 2023\\nRevised Date: 9/14/2023\\nSection 8.3\\n\\n5. Obstetrical\\nPregnancy greater than 20 weeks, transport to an OB facility. Notify receiving\\nhospital, as soon as possible, of impending arrival of the patient and give\\nETA.\\n See Obstetrical Emergencies Protocol 4.2 for criteria.\\nC. Trauma Patients that meet the Red Criteria: should be transported to the\\nclosest appropriate Level 1 or 2 trauma center.\\n\\nNote: Isolated hip fractures may be transported to a Level 1, 2 or 3 Trauma Center.\\n\\n 10/17/2023\\n\\nPage 2 of 3\\n\\nTRANSPORTATION PROTOCOL\\nInitial Date: June, 2023\\nRevised Date: 9/14/2023\\nSection 8.3\\n\\nD. Trauma Patients that meet the Yellow Criteria should be transported to a\\nLevel 1, 2 or 3 Trauma Center\\n\\nII.\\n\\nALS Intercept Procedure\\nWhen a transporting BLS Agency responds to an EMS request and subsequently initiated\\npatient transport to a receiving Hospital, and an ALS Agency has been simultaneously\\ndispatched to the same EMS request, ALS intercept will only occur:\\n1. When ALS intercept would probably result in an improved patient care outcome.\\n2. With Medical Control approval.\\n3. When requested by the transporting BLS Agency.\\n\\nIII. Inter-County EMS Response and Transporting Procedure\\nIn the pre-hospital setting, emergency medical services situations occurring in proximity to\\na county line are the responsibility of the Medical Control Authority in which the situation\\noccurred. As such, the responding EMS unit will operate under their home MCA\\nprotocols.\\n\\n 10/17/2023\\n\\nPage 3 of 3\\n\\nOakland Co. Hospital Transport Matrix for EMS (24/7 - 365)\\n*See the 8.3 Transportation Protocol and 8.12 Communications with Emergency Facilities Protocol for details\\nHospital ED Name\\n\\nHenry Ford\\nGenesys\\n\\nHenry Ford Warren\\n- Madison Heights\\n\\nHenry Ford\\nProvidence Novi\\n\\nHenry Ford\\nRochester\\n\\nHenry Ford\\nProvidence Southfield\\n\\nCorewell Health\\n- Farmington\\nHills\\n\\nCorewell Health\\nWilliam\\nCorewell Health Beaumont\\nBeaumont Troy\\nUniversity\\n\\n(810) 606-6922\\n\\n(248) 967-7656\\n\\n(248) 465-4213\\n\\n(248) 601-6060\\n\\n(248) 849-4160\\n\\n(248) 471-7273\\n\\n(248) 898-4566\\n(248) 898-8811\\n\\nX\\nX\\n\\nX\\n\\nX\\n\\nX\\n\\nX\\n\\nX\\n\\nX\\n\\nX\\n\\nX\\n\\nX\\n\\n3\\n\\nX\\nX\\n2\\n\\n800 MHz identifier\\nRecorded phone line\\nSTEMI Receiving (PCI Capable)\\n\\nX\\n\\nLevel-I Stroke Comprehensive\\n\\nX\\nX\\n\\n(248) 964-5486\\n\\nX\\n\\nLevel-II Stroke Thrombectomy Capable\\n\\nLevel-III Primary Stroke Center\\n\\nX\\n\\nX\\n\\nX\\n\\nLevel-IV Acute Stroke Ready\\nObstetrical (OB) Admission\\nPediatric Admission\\nAdult Trauma Center Level\\n\\nX\\n2\\n\\n4\\n\\n2\\n\\nDMC Huron\\nValley Sinai\\n\\nHenry Ford West\\nBloomfield\\n\\nMcLaren\\nOakland\\n\\n(248) 937-4555\\n\\n(248) 325-3671\\n\\n(248) 338-5369\\n\\n(248) 858-6660\\n\\nX\\n\\nX\\n\\nX\\n\\nX\\n\\nX\\nX\\n1\\n2\\n\\nX\\nX\\n2\\n\\nMcLaren\\nClarkston\\n\\nTrinity HealthLivonia\\n\\nChildren\'s\\nHospital of Troy\\n\\n(248) 922-6899\\n\\n(734) 464-1714\\n\\n(248) 457-1406\\n\\n2\\n\\nPediatric Trauma (<14 y/o) Level\\nHospital ED Name\\n\\nTrinity Health McLaren Oxford\\nOakland\\n\\n800 MHz identifier\\nRecorded phone line\\nSTEMI Receiving (PCI Capable)\\n\\n(248) 969-7359\\n\\nX\\n\\nLevel-I Stroke Comprehensive\\n\\nX\\n\\nLevel-II Stroke Thrombectomy Capable\\n\\nLevel-III Primary Stroke Center\\n\\nX\\n\\nX\\nX\\n\\nX\\n\\nLevel-IV Acute Stroke Ready\\nObstetrical (OB) Admission\\n\\nX\\n3\\n\\nX\\nX\\n3\\n\\n2\\n\\nUniversity of\\nMichigan Ann\\nArbor\\n\\nHenry Ford St.\\nJohn Hospital Detroit\\n\\nDMC Detroit\\nReceiving\\nHospital\\n\\nHurley Medical DMC Children\'s\\nCenter\\nHospital - Detroit\\n\\n(800) 822-2233\\n\\n(313) 417-2960\\n\\n(313) 833-0791\\n\\n(810) 262-9429\\n\\n(313) 966-7304\\n\\nX\\n\\nX\\n\\nX\\n\\n1\\n\\n1\\n2\\nX\\n\\n1\\nX\\n\\nPediatric Admission\\nAdult Trauma Center Level\\n\\nX\\nX\\n2\\n\\n2\\n\\nPediatric Trauma (<14 y/o) Level\\nOut of County/Specialty Hospitals\\n800 MHz identifier\\nRecorded phone line\\nBurn center\\n\\nX\\n\\nLVAD Facility\\nAdult Trauma Center Level\\nPediatric Trauma Center Level\\nPediatric Admission\\n\\n1\\nX\\n\\n1\\n2\\n\\nUpdated: 12-17-24\\n\\nDISPATCH PROTOCOL\\nInitial Date: October 1, 2021\\nRevision Date 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["trauma","medical"]},"section_86":{"name":"Dispatch Protocol\\nPurpose\\nAs mandated under Public Act 3","content":"68 of 1978, as amended,\\nSection 20919 (1)(b): A local medical\\ncontrol authority shall establish written protocols for the practice of life support agencies and\\nlicensed emergency medical services personnel within its region. The protocols shall be\\ndeveloped and adopted in accordance with procedures established by the department and shall\\ninclude medical protocols to ensure the appropriate dispatching of a life support agency based\\nupon medical need and the capability of the emergency medical services system.\\nLocal municipalities shall determine, in accordance with the rules and regulations of their local\\nMedical Control Authority, the level of agency licensure, as well as who will provide ALS service\\nin their area.\\n\\nProtocol\\n1.\\nE-911 shall be utilized and will dispatch the closest appropriate vehicle. By communicating\\neffectively with the use of an EMD program, the dispatcher may be able to reduce the\\nfrequency of death or the severity of disability.\\n2.\\nSince ALS can provide optimal medical care and any delay can negatively impact patient\\noutcome, in areas where ALS is available it shall be simultaneously dispatched to\\ncertain medical emergencies including, but not limited to:\\na.\\nCardiac Arrest\\nb.\\nChest Pain\\nc.\\nStroke\\nd.\\nDrug Overdose / Poison\\ne.\\nAltered Mental Status / Unconscious\\nf.\\nAllergic Reaction\\ng.\\nDifficulty Breathing\\nh.\\nDrowning or Near Drowning\\ni.\\nInjury with Bleeding or Immobility\\nj.\\nSeizures / Convulsions\\nk.\\nDiabetic Reactions\\nl.\\nChild Birth\\nm.\\nBurns\\nn.\\nAs determined through prioritized dispatch developed through an approved EMD\\nprogram by Michigan Department of Health and Human Services (MDHHS).\\no.\\nConsider more resources on scene.\\n3.\\nAn ALS transporting agency may dispatch a BLS unit instead of an ALS transporting unit,\\nif all of the following criteria are met:\\n There is a contractual transporting agreement with another ALS transporting\\nagency. (Does not include mutual aid agreements)\\n The transporting ALS unit will meet the EMS response time criteria. (Refer to\\nProtocol 8-104, EMS Response Time Standards)\\n4.\\nAll residents shall have access to pre-arrival instructions through an Emergency Medical\\nDispatch program approved by Michigan Department of Health and Human Services.\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 1 of 1\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nALS TO BLS TRANSFER OF CARE\\nInitial Date: June 3, 2022\\nRevision Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["trauma","medical"]},"section_87":{"name":"ALS to BLS Transfer of Care\\nPurpose\\nPatient needs or desires transport to a hospital and does not meet criteria for ALS\\ninterventions","content":", may be transferred by a BLS unit.\\n1.\\n\\nCriteria for transfer of care from ALS to BLS must include:\\na.\\nPatent airway, maintained without assistance or adjuncts.\\nb.\\nPatient appears hemodynamically stable with medical complaints or\\ninjuries that would be cared for at the BLS level.\\nc.\\nNo imminent changes are anticipated in the patient\'s present condition.\\nd.\\nPatient presents at baseline mentation and GCS or if unknown, GCS  14.\\ne.\\nThe EMT in attendance must be willing to accept the transfer of care in\\nregards to the patient\'s condition.\\nf.\\nNo patient may be transferred to BLS once an ALS intervention has been\\ninitiated. If the ALS unit provides ALS care as directed by protocol the\\npatient will remain ALS.\\ng.\\nNotify Medical Control of ALS to BLS transfer of care prior to transport.\\n\\nTransport by an ALS unit shall be considered if the transfer of care to the BLS staffed\\nambulance would incur a time delay greater than the projected transport time to the\\nintended receiving facility.\\nDocumentation\\n1.\\nIf care is transferred to BLS the following should be completed:\\na.\\nThe ALS Provider will complete a Patient Care Record (PCR) and submit\\nthe data electronically.\\nb.\\nThe ALS Provider will furnish the BLS transport unit with a record detailing\\nthe ALS assessment, a copy of which will be provided to the receiving\\nhospital.\\nc.\\nALS transferring unit is identified on the BLS PCR.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 1 of 1\\n\\nInitial Date: 12/27/2022\\nRevised Date:\\n\\nMichigan\\nSYSTEM\\nAIR AMBULANCE PERSONNEL\\nSCOPE OF PRACTICE\\n(MCA Optional Protocol)","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-8":{"name":"Air Ambulance Personnel Scope of Practice (MCA Optional Protocol)\\n\\nThe purpose of this protocol is to provide guidance for providers who are treating patients as\\npart of an aeromedical service response","content":".\\n\\n Medical Control Authorities choosing to adopt this supplement may do so\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.\\nScope:\\nAir ambulance programs may provide care over and above that specified in the local MCA\\nprotocols, including (but not limited to): administration of blood products, placement of\\ncentral venous access devices, placement of thoracostomy tubes, establishment of a\\nsurgical airway, and administration of medications not included in the local MCA protocols.\\nPolicies and procedures regarding the use of equipment and medications not included in the\\nlocal MCA Protocols will be made available by the flight service\'s medical director to the\\nlocal MCA EMS Medical Director. Responsibility for training and quality assurance regarding\\nthese additional protocols will be the responsibility of the air ambulance program.\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nAIRCRAFT TRANSPORTATION\\nInitial Date: October 1, 2021\\nRevision Date: 1/11/2024","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_89":{"name":"Aircraft Transportation\\nIndications\\nTo be used only if one or more of the following are met","content":":\\n1.\\nThe speed of the transport from the scene to definitive care may have an impact\\non patient outcome.\\n2.\\nWhen special equipment on-board the aircraft is anticipated.\\n3.\\nWhen special skills and expertise of the flight crew is anticipated, such as chest\\ntube insertion RSI, blood products, etc.\\n4.\\nWhen search, rescue and transport of victims is inaccessible by ground transport\\nsystems.\\n5.\\nEMT, Paramedic, or EMS ground crew discretion.\\nGeneral Guidelines\\n1.\\nOnly Oakland County Medical Control Authority approved air medical services\\ncan operate in Oakland County and may be requested (See below). In the event\\nof an MCI, refer to the 10.6 MCI Protocol.\\n2.\\nAny Oakland County Life Support Agency and/or dispatch personnel may\\nrequest air-medical transportation. Requesting Agency or at least one agency\\nmember on scene must have training in helicopter landing zone preparation and\\nsafety for emergency scenes.\\n3.\\nFixed-winged aircraft (non-rotary) must use most appropriate airport.\\n4.\\nAll pre-hospital requests for air medical transport will be reviewed by the PSRO\\nCommittee. All LSAs involved will provide their PCR to the OCMCA within 72\\nhours.\\nProcedure for Activation of Helicopter Transport\\n1.\\nRequest for helicopter service response can be made through dispatch or via\\ndirect contact (see below).\\n2.\\nMedical control approval is implied under this protocol and direct communication\\nis not required.\\n3.\\nThe helicopter may be cancelled at any time by the ground provider on scene.\\nSafety\\n1. Do not approach the helicopter unless signaled to do so by the pilot and/or flight\\ncrew.\\n2. Loading and unloading of the patient and/or equipment is done at the discretion\\nof the pilot and/or flight crew.\\n3. Make sure to follow all outlines as provided in Landing Zone training courses.\\nPatient Destination\\nMCA Oakland County\\nMCA Board Approval Date: 2/2/2024\\nMCA Implementation Date: 5/13/2024\\nMDHHS Approval Date: 4/11/2024\\n\\nPage 1 of 2\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nAIRCRAFT TRANSPORTATION\\nInitial Date: October 1, 2021\\nRevision Date: 1/11/2024\\n1.\\n2.","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_89_1":{"name":"Patient will be transported to the closest appropriate Emergency Facility\\naccording to the OCMCA transportation policy","content":".\\nPatient, family, or FD/EMS requests will be honored when appropriate.\\n\\nAircraft Dispatch Notification (24/7 Operations Only)\\nThe Oakland County Medical Control Authority recognizes the following aircraft\\ncompanies available for emergency calls 24/7. Note: Only Oakland County EMS and\\ndispatch personnel may request air medical transport.\\nAgency\\nMedstar LifeFlight\\nU of M Survival Flight\\n\\nTelephone Number\\n888-476-0005\\n800 822-2233\\n\\nMCA Oakland County\\nMCA Board Approval Date: 2/2/2024\\nMCA Implementation Date: 5/13/2024\\nMDHHS Approval Date: 4/11/2024\\n\\nLocation of Helicopter\\nTroy\\nAnn Arbor\\n\\nPage 2 of 2\\n\\nOakland County Medical Control Authority\\nAircraft Letter of Compliance 8.3.1\\n2024\\nAgency Name: __________________________________________\\n(Print Name)\\nCompliant\\n1.\\n\\n2.\\n\\nThis agency is licensed by the Michigan Department of Health and Human Services\\n(MDHHS), or license pending.\\nFixed Wing\\nHelicopter\\n\\n________\\n\\nThis agency will have assigned medical personnel shall be trained and licensed in\\naccordance with appropriate statutes, rules, criteria and ACLS certified.\\n\\n________\\n\\nThis agency will have medical supplies, communications, equipment, procedures and\\nprotocols utilized meet criteria as established by MDHHS and Oakland County\\nMedical Control Authority (OCMCA).\\n\\n________\\n\\nThis agency designates the OCMCA (including its PSRO) to perform professional\\npractice review functions on behalf of the agency, including review of pre-hospital\\ncare furnished in Oakland County and recommendations for improvement of such care.\\n\\n________\\n\\nThis agency understands that it is the agencys responsibility to educate and update all\\npersonnel on the OCMCA protocols and policies.\\n\\n________\\n\\n6.\\n\\nThis agency and its personnel will follow the OCMCA Medical Control Hospital Policy.\\n\\n________\\n\\n7.\\n\\nThis agency has medical protocols to ensure the appropriate dispatching of a life\\nsupport agency based upon medical need and the capability of the emergency\\nmedical services system.\\n\\n________\\n\\nThis agency is responsible for completing and forwarding the necessary quality\\nimprovement data, approved by the OCMCA Board of Directors, to MI-EMSIS.\\nFor any flight in or out of Oakland County the ePCR must be sent by email or fax\\nwithin 72 hours.\\n\\n________\\n\\nThis agency agrees to participate in PSRO studies, and abide by the PSRO\\nIncident Investigation Procedure.\\n\\n________\\n\\n3.\\n\\n4.\\n\\n5.\\n\\n8.\\n\\n9.\\n\\n10. This agency has designated a Medical Control Hospital and Medical Control Physician.\\n\\n________\\n\\n11. This agency is responsible for forwarding a completed copy of each 911 run report\\noriginating in Oakland County to the OCMCA office within 24 hours of the run.\\n\\n________\\n\\n12. This agency will transport Oakland County patients as per the Oakland County\\nTransportation Policy and Aircraft Transportation Policy (8-33, 8-3).\\n\\n________\\n\\n13. This agency will have aircraft available 24/7 for emergency scene responses.\\n\\n________\\n\\nNOTE: If any of the above criteria cannot be met, the provider will submit documentation explaining reasons for\\nthe exceptions.\\nThis agency agrees to comply with the protocols, operating procedures and standards of pre-hospital care\\npromulgated by MDHHS and the Oakland County Medical Control Authority. This will assure accountability for\\ncare rendered within our advanced emergency care system, effective this date, and as may be promulgated from\\ntime to time.\\nWe acknowledge that each criterion and verification are subject to inspection by the EMS Medical Director or\\nhis/her physician designee at any time and at his/her direction. Should cause exist, the EMS Medical Director, or\\nhis/her designee may request formal verification.\\nBe advised that if your aircraft is not available 24/7 for emergency scene responses, your aircraft dispatch number\\nwill not be added to the OCMCA dispatch list that is provided to all OCMCA Life Support Agencies and\\nDispatch Centers.\\n\\n***********************************************************************************\\nCOMPLIANCE: If any of the above criteria cannot be met, the provider will submit documentation of the\\nexceptions.\\nThis agency agrees to comply with protocols, operating procedures and standards of pre-hospital care promulgated\\nby MDHHS and the Oakland County Medical Control Authority, including the Agency and EMS Personnel\\nCriteria for Participation Policy. This will assure accountability for care rendered within our advanced emergency\\ncare system, effective this date, and as may be promulgated from time to time.\\nWe acknowledge that each criterion and verification is subject to inspection by the EMS Medical Director or\\nhis/her physician designee, at any time, and at his/her direction. Should cause exist, the EMS Medical Director,\\nor his/her designee may request formal verification.\\n\\n_________________________________\\nAuthorized Representative Signature\\n\\n_________________________________\\nMedical Control Physician Signature (MCC member/alt)\\n\\n_________________________________\\nTitle\\nDate\\n\\n_________________________________\\nMedical Control Physician (PRINT)\\n\\n_________________________________\\nState Licensed Instructor Coordinator (PRINT)\\n\\n_________________________________\\nHospital\\n\\n__________________________________\\nEMS Coordinator (PRINT)\\n\\n_________________________________\\nHospital EMS Coordinator/Liaison (PRINT)\\n\\n__________________________________\\nEMS QI Coordinator (PRINT)\\n\\nOCMCA Life Support Agency\\nEmergency Contact Information\\nIn the event that the Oakland County Emergency Operations Center (EOC) is activated due to\\ndisasters/emergencies, additional county resources may be required. Please provide the following\\ninformation:\\n\\nAgency:\\n\\nAddress:\\n\\nAgency Dispatch #:\\n\\nChief/CEO:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nEMS Coordinator:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nSecond Contact:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nThird Contact (if needed):\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nEMS QI Coordinator:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nState Licensed Instructor Coordinator:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nACES Representative:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nMIEMSIS:\\nE-mail address\\nThis person will be designated to receive weekly reports from the State EMS office in regards to monitoring their\\nagency\'s MIEMSIS submissions.\\nWork #\\n\\nCell #\\n\\nAttach a list of all personnel with their level of licensure.\\nAttach a copy of the current agency license.\\nAttach a list of Supraglottic Airway Devices and Sizes\\nList Dispatch Agency (PSAP)\\nAgency Annual Licensure Renewal Date\\nData e-PCR Reporting System (NEMSIS 3.0 or higher)\\nZoll\\nESO Solutions\\nImage Trend/MI-EMSIS\\nHealth EMS\\nEmergency Reporting\\nOther\\nType of IO device used by agency (ALS only).\\nNumber of EMS personnel, including volunteers.\\nNumber of Aircraft\\nPlease let the staff at the OCMCA know of any changes throughout the year.\\nOakland County EMS Medical Control Authority\\n1200 N. Telegraph Rd., Building 36E\\nPontiac, MI 48341\\nFax # - 248-975-9723\\nE-mail  ems@ocmca.org\\n\\n__________\\n\\nMichigan\\nSYSTEM\\n\\nINFECTION CONTROL\\nAND COMMUNICABLE DISEASE\\n\\nInitial Date: 03/24/2023\\nRevised Date:","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-10":{"name":"Infection Control and Communicable Disease\\nPURPOSE","content":": To outline procedures for infection control through personal protective equipment use and\\ndecontamination for people, equipment, and vehicles utilized in assessment, treatment, and\\ntransport of patients along with categorization and response for exposure. ALL patients are\\nconsidered potentially infectious.\\nNOTE:\\nAny information obtained or exchanged regarding communicable disease exposures must\\nbe handled with strict confidentiality\\nI.\\n\\nPRECAUTIONS AND PREVENTION\\nA. Standard Precautions and Body Substance Isolation (BSI)\\n1. Purpose: To prevent the transmission of all bloodborne pathogens that are\\nspread by blood, tears, sweat, saliva, sputum, gastric secretions, urine, feces,\\nCSF, amniotic fluid, semen, breast milk, skin rash and open wounds.\\n2. Rationale: Medical history and examination cannot identify all patients infected\\nwith bloodborne pathogens.\\n3. Practice: Standard Precautions/BSI will be done for patient encounters in which\\nthe risk of exposure to blood or body fluid exists.\\nB. Respiratory Precautions\\n1. Purpose: To prevent the transmission of airborne infections for patients with\\nrespiratory complaints.\\n2. Rationale: Medical history and examination cannot fully identify all patients with\\ntransmissible respiratory pathogens. Respiratory complaints include but are not\\nlimited to dyspnea, cough, shortness of breath, etc.\\n3. Practice: Respiratory precautions will be used for every patient with respiratory\\ncomplaints and/or receiving aerosolized treatments.\\nC. Precautions for patients highly suspicious communicable disease including but\\nnot limited to:\\n1. Fever > 100.5 F with headache or malaise or myalgia, and cough or shortness of\\nbreath or difficulty breathing.\\n2. Pustular, papular or vesicular rash distributed over the body (trunk, face, arms, or\\nlegs) preceded by fever with rash progressing over days (not weeks or months)\\nand the patient appears ill.\\na. Consider the patient to be both airborne and contact contagious.\\nb. Crew PPE and procedures:\\ni. N95 or higher protective mask/respiratory protection\\nii. Goggles or face shield\\niii. Gowns\\niv. Utilize waterless hand sanitizer between glove changes and upon\\nremoval of gloves.\\nOakland County\\n\\n10/6/23\\n2/1/24\\nMDHHS Reviewed 2023\\n\\nPage 1 of 10\\n\\nMichigan\\nSYSTEM\\n\\nINFECTION CONTROL\\nAND COMMUNICABLE DISEASE\\n\\nInitial Date: 03/24/2023\\nRevised Date:\\nSection: 8-10\\n\\nc. Source Control:\\ni. Patient wear a paper surgical mask if tolerated.\\nii. Cover patient with linen sheet to reduce chance of contaminating\\nobjects in area.\\niii. Patients should be encouraged to use hand sanitizer when tolerated.\\nd. Notify the receiving facility as soon as possible of the patient\'s\\ncondition to facilitate preparation of the facility and institution of\\nappropriate infection control procedures\\ni. Confirm entrance and procedure for transfer of patient into facility.\\nii. Ensure proper notification and preparation of receiving facility for\\ninter-facility transfers.\\ne. Vehicles that have separate driver and patient compartments and can\\nprovide separate ventilation to these areas are preferred for patient\\ntransportation. If a vehicle without separate compartments and\\nventilation must be used, the outside air vents in the driver\\ncompartment should be turned on at the highest setting during\\ntransport of patient to provide relative negative pressure in the patient\\ncare compartment.\\nf.\\ng.\\n\\nDO NOT REMOVE protective equipment during patient transport.\\nDiscourage non-essential personnel and family members from entry\\nor accompanying patient in ambulance.\\nh. Patient cohorting may occur if resources are exhausted and patients are\\ngrouped with same disease. Cohorting should only be utilized as a last\\nresort.\\ni.\\nThe ambulance(s)/transport vehicle will not be used to transport other\\npatients (or for any other use) until it is decontaminated using the CDC\\nguidelines for decontamination.\\nD. Procedures\\n1. Handwashing will be done before and after contact with ALL patients.\\n2. Nonsterile disposable gloves will be worn with patients that pose a potential\\nexposure through blood or body fluids. Gloves will be changed in-between\\npatients and not used repeatedly.\\n3. Outerwear (example: gown, coveralls, turnout gear) will be worn if contact with\\nblood or body fluids contamination may occur.\\n\\nOakland County\\n\\n10/6/23\\n2/1/24\\nMDHHS Reviewed 2023\\n\\nPage 2 of 10\\n\\nMichigan\\nSYSTEM\\n\\nINFECTION CONTROL\\nAND COMMUNICABLE DISEASE\\n\\nInitial Date: 03/24/2023\\nRevised Date:\\nSection: 8-10\\n\\n4. Face Protection (including eye protection) will be worn if aerosolization of blood\\nor body fluids may occur (examples include but are not limited to suctioning,\\ninsertion of endotracheal tubes, patient with excessive coughing, invasive\\nprocedures).\\n5. Mouth-to-mouth resuscitation: CDC recommends that EMS personnel NOT\\nperform mouth to mouth, instead use adjunctive aids (pocket masks, face shields,\\nBVM).\\n6. N95 or higher will be worn during contact with patients with respiratory complaints,\\nduring any aerosolizing treatments, and with all mechanically ventilated patients.\\n7. Mechanically Ventilated Patients (including bag-valve-mask)\\na. HEPA filtration of airflow exhaust shall be used, EMS provider shall don a\\nsimple face mask.\\ni. If no HEPA filtration, EMS provider shall don an N95\\nb. Consult ventilator equipment manufacturer to confirm appropriate filtration\\ncapability and the effect of filtration on positive pressure ventilation.\\nII.\\n\\nCLEANING AND DECONTAMINATION\\nA. Wear gloves for ALL decontamination\\nB. Non-disposable contaminated articles:\\n1. Bag according to agency procedures.\\n2. Articles must be decontaminated prior to being placed back into service.\\nRefer to manufacturers recommendations for proper cleaning and\\ndisinfecting\\nC. Disposable contaminated articles\\n1. Articles contaminated with blood or body fluids must be bagged and\\ndiscarded in accordance with MIOSHA guidelines.\\nD. Medication/IV Bags or Boxes shall be inspected and all contaminated waste\\nremoved prior to bag exchange. If the medication/IV bag or box is contaminated, it\\nmust be spot cleaned or laundered prior to being placed back into service.\\nE. Linens soiled with blood or body fluids shall be placed in appropriately marked\\ncontainer.\\nF. Needles and syringes shall be disposed of in a rigid, puncture-resistant container.\\nAny grossly contaminated container, or one that has reached the fill line, should\\nbe disposed of appropriately.\\nG. Blood spills shall be cleaned up promptly with a solution of 5.25% sodium\\nhypochlorite (household bleach) diluted 1:10 with water or other FDA approved\\ndisinfectant.\\nH. Non contaminated but utilized equipment will be disinfected after every patient\\nencounter in accordance with MCA approved agency guidelines.\\nI. Vehicle surfaces will be disinfected after every patient encounter in accordance\\nwith MCA approved agency guidelines.\\nOakland County\\n\\n10/6/23\\n2/1/24\\nMDHHS Reviewed 2023\\n\\nPage 3 of 10\\n\\nMichigan\\nSYSTEM\\n\\nINFECTION CONTROL\\nAND COMMUNICABLE DISEASE\\n\\nInitial Date: 03/24/2023\\nRevised Date:\\n\\nIII.\\n\\nIV.","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-10_1":{"name":"RADIO COMMUNICATIONS\\nA","content":". Radio communications of any kind regarding a communicable disease should be\\ndone so in a format that ensures patient confidentiality.\\nEXPOSURES\\nA. Definitions:\\n1. Emergency source patient means an individual who is transported to an\\n\\norganized emergency department located in and operated by a licensed\\nhospital or a facility other than a hospital that is routinely available for the\\ngeneral care of medical patients.\\n\\n2. Definition of Reportable Exposure:\\na. Any breach of the skin by cut, needle stick, absorption, or open wound.\\nb. Blood/body fluid splash to the moth, nose, eye, or other parenteral route.\\nc. Blood/body fluid splash into non-intact skin area\\nB. Reporting Exposures:\\n1. Police, Fire or EMS personnel who, in the performance of their duty, sustain a\\nneedle stick, mucous membrane or open wound exposure to blood or other\\npotentially infectious material (OPIM) may request, under Public Act 368,","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section":{"name":"Section","content":"333.20191, that the patient be tested for HIV/Hepatitis B and C surface antigen.\\nThe exposed individual shall make the request on a MDHHS Form (DCH-1179):\\nFirst Responder Provider Request for HIV and/or Hepatitis B Testing of\\nEmergency Patient.\\nC. Cooperating Hospitals Responsibilities\\n1. Each cooperating hospital in the Medical Control region will designate an infection\\ncontrol contact to serve as liaison(s) with the staff of medical control and all EMS\\nagencies for the purpose of communicating information about infectious patients\\nor potential exposures.\\n2. Hospitals, upon learning that any patient has a reportable infectious or\\ncommunicable disease, will check the patient chart to determine if any EMS\\nagencies were involved with the patient prior to hospitalization. When determined\\nthat EMS may have had contact with the patient, designated individual will notify\\nthe EMS agency for further follow-up and complete the required State forms.\\n3. Hospitals, when requested to do so, will obtain lab tests and results on source\\npatients when exposure to a pre-hospital provider has occurred.\\na. Hospitals will report the results of testing on MDHHS Form (DCH-1179) and\\nreturn to the address indicated on the form.\\n4. Hospitals will notify transporting agencies at the time a transfer is scheduled if any\\ninfection potential exists with the patient and the precautions necessary (standard\\nprecautions and/or mask).\\nOakland County\\n\\n10/6/23\\n2/1/24\\nMDHHS Reviewed 2023\\n\\nPage 4 of 10\\n\\nMichigan\\nSYSTEM\\n\\nINFECTION CONTROL\\nAND COMMUNICABLE DISEASE\\n\\nInitial Date: 03/24/2023\\nRevised Date:\\nSection: 8-10\\n\\nD. Pre-hospital Agency Responsibilities\\n1. Each pre-hospital provider agency will be responsible for assuring that their\\npersonnel, trainees and students are familiar with infection control procedures,\\nepidemiology, modes of transmission and means of preventing transmission of\\ncommunicable disease per CDC guidelines and MIOSHA regulations.\\n2. Each pre-hospital provider agency will be responsible for supplying personnel\\nwith the appropriate personal protective equipment.\\n3. It is recommended that each pre-hospital provider agency ensures adequate\\nimmunizations per CDC Immunization Guidelines for Health Care Workers.\\nE. Follow-up Care/Counseling\\n1. Follow-up care and counseling of exposed personnel shall be the responsibility of\\nthe pre-hospital provider agency and shall be carried out without delay upon\\nnotification of exposure.\\nF. Summary of EMS Personnel Post-Exposure Procedures\\n1. Irrigate and wash exposed area very well.\\n2. Notify agency supervisor of possible exposure.\\n3. Each exposed individual complete section 1 and sign form DCH-1179 (E) and\\nsign\\n4. If source patient is transported submit (in person or via fax) DCH-1179 (E) form at\\nhospital receiving the source patient\\n5. Contact (preferably in person but may be by phone) the emergency department of\\nthe health care facility receiving the source patient and review\\nSection 1 of DCH1179 (E).\\na. The health care facility authorized staff member will complete\\nSection 2 of\\nthe form and determine if an exposure did or did not occur. If determined\\nexposure did occur, the health care facility will:\\ni. Complete testing of source patient for HIV, Hepatitis B, and other\\npathogens, as applicable\\nii. Rapid HIV testing should be conducted\\niii. If HIV rapid testing is positive, the health care facility will coordinate\\nappropriate post exposure prophylaxis for the exposed individual.\\niv.\\nSection 3 of form DCH-1179 (E) will be completed\\nb. If determined that an exposure did not occur, the health care facility will\\nexplain the rationale of determining that it was a non-exposure.\\nc. The exposed individual, health care facility, agencies and the Medical\\nControl Authority will comply with all parts of Public Act 368,","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_1":{"name":"Section","content":"333.20191\\n\\nOakland County\\n\\n10/6/23\\n2/1/24\\nMDHHS Reviewed 2023\\n\\nPage 5 of 10\\n\\nMichigan\\nSYSTEM\\n\\nINFECTION CONTROL\\nAND COMMUNICABLE DISEASE\\n\\nInitial Date: 03/24/2023\\nRevised Date:\\nSection: 8-10\\n\\n6. The exposed personnel shall follow up with the agency occupational health in\\naccordance with agency requirements.\\n7. If the patient is deceased and not transported to a hospital\\na. If the source patient remains on scene or is transported to somewhere other\\nthan a hospital, collaboration between the medical examiners office (if\\napplicable), EMS agency, the agency occupational health provider and/or the\\nmedical control authority should be notified to facilitate source patient testing.\\n8. If the source patient is living and not transported the exposed individual should\\nwork with the EMS agency, the agency occupational health provider and/or the\\nmedical control authority for potential testing of the source patient.\\na. The EMS agency may contact the individual with a request for prompt\\ntesting.\\nb. The exposed personnel and EMS agency shall follow up with agency\\noccupational health and the medical control authority.\\nG. Any first responders (Police, Fire or EMS personnel) who may have had an exposure\\nshould be encouraged to follow the protocol as described.\\n\\nProtocol Source/References: Testing and Reporting (including HIV and STI Case Reporting Forms and Aphirm)\\n\\n(michigan.gov)\\n\\nOakland County\\n\\n10/6/23\\n2/1/24\\nMDHHS Reviewed 2023\\n\\nPage 6 of 10\\n\\nMichigan\\nSYSTEM\\n\\nINFECTION CONTROL\\nAND COMMUNICABLE DISEASE\\n\\nInitial Date: 03/24/2023\\nRevised Date:","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-10_2":{"name":"DCH-1","content":"179, FIRST RESPONDER PROVIDER REQUEST FOR HIV\\nAND/OR HEPATITIS B TESTING OF EMERGENCY PATIENT\\nMichigan Department of Health and Human Services (MDHHS)\\n\\nIn Accordance with Michigan Public Act 419 of 1994 (MCL 333.20191)\\n(Revised 11-22)\\nNOTICE TO EXPOSED INDIVIDUAL:\\n Test results will not be provided over the telephone.\\n This request should be made before the emergency patient is released from the health care facility.\\n Contact the health care facility if the interpretation of test results on the emergency patient is not\\nreceived by you within ten (10) days.\\n Information contained on this form is confidential.\\n See page 3 for PA 431 and non-discrimination information.\\nSECTION 1  To be completed by EXPOSED INDIVIDUAL (Please Print)\\n1. Name of Exposed Individual\\n\\n2. Job Classification\\n\\n3. Home Address (Number & Street, etc.)\\n\\nGood Samaritan\\nState\\nZip Code\\n\\nCity\\n\\n4. Home Phone Number\\n5. Name of Employer\\n\\n6. Employer Phone Number\\n\\n7. Employer Address (Number & Street, etc.)\\n\\nCity\\n\\n8. Emergency Source Patient ID Number 9. Date of Exposure\\n\\nState\\n\\n10. Approximate time of Exposure\\nAM\\nPM\\n\\n11. Route of Exposure\\nOpen Wound\\nMucous Membrane\\nPercutaneous\\nOther\\n12. Provide a detailed description of the exposure (attach an additional sheet as needed)\\n\\nOakland County\\n\\n10/6/23\\n2/1/24\\nMDHHS Reviewed 2023\\n\\nZip Code\\n\\nPage 7 of 10\\n\\nMichigan\\nSYSTEM\\n\\nINFECTION CONTROL\\nAND COMMUNICABLE DISEASE\\n\\nInitial Date: 03/24/2023\\nRevised Date:\\nSection: 8-10\\n\\n13. Personal Protective Equipment used when exposed (check all that apply)\\nGlove\\nGown\\nEye Protection\\nTurnout Gear\\nNone\\nOther explain\\n\\nFace Mask\\n\\n14. Based on my exposure described above, I am requesting that this source individual be tested for the\\nfollowing (check all that apply)\\nHIV\\nHepatitis B\\nOther explain\\n\\n15. Where do you want the Test Results Sent to: (check all that apply)\\nMe at my Home (Address Above)\\nMy Physician (Complete #16 below)\\nMe at Work (Address Above)\\nOther Health Care Professional (Complete #17 below)\\n16. Name of Your Physician\\n\\nPhysician Phone Number\\n\\nPhysician Address (Number & Street, etc.)\\n\\nCity\\n\\n17. Name of Other Health Care Professional\\n\\nOther Health Care Professional Phone Number\\n\\nOther Health Care Professional Address (No. & St.) City\\n\\nState\\n\\nState\\n\\nZip Code\\n\\nZip Code\\n\\n\\n\\nI understand that the NAME of the source individual to be tested, and that person\'s test results are\\nconfidential according to\\nSection 5131 of Michigan Compiled Laws (MCL). I understand that a person\\nwho discloses information in violation of this Section is guilty of a misdemeanor.\\n\\n\\n\\nI also understand that I am ultimately responsible for the payment of the charges associated with the\\ntesting of this individual to whom I have been exposed, unless an agreement has been worked out\\nbetween me and my employer, or is otherwise covered by my health care or benefits plan.\\n\\n18. Signature of Exposed Individual\\n\\nDate\\n\\n\\n\\nFirst Responder Provider is defined as a police officer, fire fighter, or an individual licensed under\\nMCL.333.20950 or 333.20952 as one of the following: medical first responder, emergency medical\\ntechnician, emergency medical technician specialist, paramedic, or an emergency medical services\\ninstructor or coordinator. A lay citizen, or Good Samaritan, if they assist an emergency patient, may\\nalso be included as a pre-hospital provider (for purposes of this law).\\n\\n\\n\\nEmergency source patient means an individual who is transported to an organized emergency\\ndepartment located in and operated by a licensed hospital or a facility other than a hospital that is\\nroutinely available for the general care of medical patients.\\n\\nSECTION 2  EVALUATION OF EXPOSURE  To be completed by the HEALTH CARE FACILITY.\\n1. Name of Exposed Individual\\n\\n2. Emergency Source Patient ID Number\\n\\nMDHHS Reviewed 2023\\n\\nPage 8 of 10\\n\\nMichigan\\nSYSTEM\\n\\nINFECTION CONTROL\\nAND COMMUNICABLE DISEASE\\n\\nInitial Date: 03/24/2023\\nRevised Date:\\nSection: 8-10\\n\\n3. Based upon the information provided\\nExposure DID Occur (see #4 below)\\nExposure DID NOT Occur (see #5 below)\\n4. Exposure DID Occur  The type of exposure was determined to be\\nOpen Wound\\nMucous Membrane\\nPercutaneous\\nOther\\nWas the emergency patient informed at the time of admission about the possibility of being tested if a first\\nresponder exposure occurred? (In accordance with MCL 333.5133)?\\nYes\\nNo\\nNOTE: The Exposed Individual SHOULD BE counseled and tested for HIV and Hepatitis B. Testing for\\nhepatitis C is also recommended although it is not mentioned in the law. Prophylaxis should also be\\nconsidered for the exposed individual. If appropriate, please refer the exposed individual for follow-up\\nmedical evaluation.\\n5. Exposure did not Occur  Explain\\nPrint Persons Name\\n\\nJob Title\\n\\nAuthorized Signature at Health Facility\\n\\nDate\\n\\nSECTION 3  TEST RESULTS  to be completed by the HEALTH FACILITY\\n1. Emergency Patient was Tested for (check all that apply)\\nHIV\\nHepatitis B\\nOther explain\\n2. Test Results on Source Individual\\nHIV:\\nRapid Test:\\nEIA:\\nWestern Blot:\\n\\nReactive*\\nReactive\\nReactive\\n\\nNon-Reactive\\nNon-Reactive\\nNon-Reactive\\n\\nHepatitis B:\\n\\nFound\\n\\nNot Found\\n\\nHBsAG:\\n\\nIndeterminate\\n\\nOther (explain)\\n*HIV Rapid Tests are for screening purposes only. A reactive Rapid Test requires follow-up testing to\\nconfirm patient status.\\n. Emergency Patient was NOT Tested\\nEmergency source patient refused testing/to have blood drawn.\\nEmergency source patient expired before test(s) could be performed.\\nEmergency source patient was released from the health care facility before testing could be\\nperformed.\\nEmergency source patient did not present to this facility for care.\\nDate Test Results were Completed\\n\\nDate Test Results were Reported Out\\n\\nMDHHS Reviewed 2023\\n\\nPage 9 of 10\\n\\nMichigan\\nSYSTEM\\n\\nInitial Date: 03/24/2023\\nRevised Date:\\n\\nINFECTION CONTROL\\nAND COMMUNICABLE DISEASE","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-10_3":{"name":"Print Name and Title of Person Providing Test Results Signature of Person Providing Test Results\\nTest Results were Mailed to (Name)\\nAddress Results were mailed to (Number & Street)\\n\\nCity\\n\\nState\\n\\nThe Michigan Department of Health and Human Services will not exclude from\\nparticipation in","content":", deny benefits of, or discriminate against any individual or group\\nbecause of race, sex, religion, age, national origin, color, height, weight, marital\\nstatus, partisan considerations, or a disability or genetic information that is unrelated\\nto the persons eligibility.\\nAUTHORITY: PA 419 OF 1994 (M.C.L. 333.20191\\nCOMPLETION: Is voluntary, but is required if testing of the source patient is desired.\\n\\nMDHHS Reviewed 2023\\n\\nPage 10 of 10\\n\\nZip Code\\n\\nMiDHHS\\nMichigan Department oF Health & Human Services\\n\\nBureau of Emergency\\nPreparedness, EMS\\nand Systems of Care\\n\\nMichigan\\nSPECIAL OPERATIONS\\nIMMUNIZATION & TESTING\\n\\nInitial Date: 5/31/2012\\nRevised Date: 12/27/2022","source_file":"Section-8-TOC.pdf","categories":[]},"section_8-11":{"name":"Immunization & Testing\\nPurpose","content":":\\nTo allow paramedics or other Medical Control Authority (MCA) approved personnel to\\nprovide testing and vaccinations for agency personnel and the community. Community\\nimmunization and other public health applications are important duties that EMS personnel\\nmay perform as determined necessary in cooperation with the medical control authority,\\nlocal hospitals, and the local public health department. Training will be approved by the\\nEMS Medical Director and the MCA, and may be accomplished under the direction of the\\nMCA and/or local public health department.\\n1. Indications for immunization and/or testing:\\nA. Public or EMS agency personnel may be immunized or tested under guidelines\\ndeveloped by the public health department or MCA. Testing may include tests for\\ninfectious diseases or other diagnostic testing as needed.\\nB. Age groups for immunization will be determined by the MCA or public health\\ndepartment as appropriate.\\nC. Timing of immunizations or testing will be determined by the MCA, hospital, EMS\\nagency and public health department to comply with public health needs or agency\\nimmunization requirements as determined by agency infection control guidance.\\nD. Immunizations or testing may be performed in clinic, NEHC, mass immunization or\\nagency setting as approved by the MCA and/or local public health department.\\n2. Immunization or testing\\nA. Immunizations may be administered via intramuscular (IM), subcutaneous (SQ), or\\nintranasal (IN) route in dosing determined by guidance provided by the MCA or local\\npublic health department as required for the agent administered.\\nB. Screening will be performed as determined appropriate for the agent administered\\nby the MCA or local health department.\\nC. TB tests are intradermal and require additional training and certification in order to\\nperform. Tests will be interpreted by paramedics performing the tests or personnel\\ntrained to review TB tests under MCA approved training programs.\\n3. Training\\nA. Training for immunization will be provided by local public health department\\npersonnel or under an approved MCA program.\\n4. Personnel requirements\\nA. Immunizations or testing may be performed by paramedics trained by local public\\nhealth department personnel or under approved MCA training programs.\\n5. Record keeping\\nA. A record of public or agency personnel receiving immunizations or TB testing will be\\nmaintained by the agency performing the immunizations or TB testing as\\ndetermined by the local public health department/Medical Control Authority.\\nB. The Michigan Care Improvement Registry (MCIR) record keeping is required for\\nimmunizations.\\n\\nCOMMUNICATIONS WITH\\nEMERGENCY FACILITIES\\nInitial Date: 6/2018\\nRevised Date: 5/29/2024","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-12":{"name":"Communications with Emergency Facilities\\nPurpose","content":": Facilitate effective communications between EMS units and the OCMCA\\nEmergency Facilities. Medical direction is available from all OCMCA Emergency Facilities\\n(see 8.3 Transportation Protocol).\\nCommunicating with Emergency Facilities\\nEMS units may contact an Emergency Facility by the following:\\n E-Bridge (special study, preferred method)\\n Cell phone (recorded line  see Appendix A)\\n 800 MHz Radio\\n VHF Radio\\nEmergency Facilities must assure that all forms of communication (listed above) are\\nrecorded. Recordings from cell phone calls will be stored for at least one year.\\nEMS units should contact the Emergency Facility based on the following:\\n Transporting: As soon as possible prior to arrival at the Emergency Facility.\\n Non-transporting: Prior to leaving the scene, if necessary.\\nNotification of Transport\\nA. Approved OCMCA Emergency Facilities\\n1. When transporting a patient, start your communication with one of the following:\\n Request for Medical Direction\\no Example: Hospital this is Alpha 431 with a priority 1 traffic, requesting a\\nphysician to the radio.\\n Notification only\\no Example: Hospital this is Bravo 042 with priority 3 traffic. Notification of\\ntransport only.\\n2. After the Emergency Facility acknowledges your communication provide the\\nfollowing information:\\n Patient priority\\n Age\\n Gender\\n Chief complaint\\n Vital signs if outside of normal limits, including significant EKG changes and\\nGCS.\\n Field treatment (e.g. IV, O2, Meds given)\\n ETA\\n Request for medical direction, if applicable.\\n3. Re-contact the receiving facility, if necessary.\\nMCA Name: Oakland County\\nMCA Board Approval Date: 10/10/2024\\nMCA Implementation Date: 11/15/2024\\nMDHHS Approval Date: 10/25/2024\\nPage 1 of 3\\n\\nCOMMUNICATIONS WITH\\nEMERGENCY FACILITIES\\nInitial Date: 6/2018\\nRevised Date: 5/29/2024","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-12_1":{"name":"Other Medical Direction Communications\\nIn the following situations","content":", EMS personnel will contact the closest appropriate facility (this is\\nthe facility to which the patient will be transported, if required by protocol or online medical\\ndirection) for medical direction from a physician or for documentation purposes.\\n1. Pronouncement of death on scene (See 7.6 Patient Death Termination of\\nResuscitation and Pronouncement).\\n2. In situations where EMS providers believe an emergency condition still exists and a\\npatient is attempting to refuse care or transport (See 7.19 Refusal of Care).\\n3. Deviations from any protocol (See 8.26 Protocol Deviation).\\n4. Any situation where EMS personnel feel medical direction from a physician is\\nindicated.\\nCommunications Failure\\nCommunications Failure is the inability to make contact with an Emergency Facility by all\\navailable methods, as defined in this protocol. This includes technology failures or failure of\\nthe Emergency Facility to acknowledge communication transmissions.\\n1. EMS personnel may initiate medical treatment protocols and procedures including\\ninterventions identified after the Post Medical Control section.\\n2. Notify your immediate supervisor and/or EMS Coordinator of the communications\\nfailure.\\n3. The LSA will provide a written report describing the situation, actions taken, and\\ndescription of the communication failure shall be provided to the Oakland County\\nMedical Control Authority within 24 hours.\\n\\nMCA Name: Oakland County\\nMCA Board Approval Date: 10/10/2024\\nMCA Implementation Date: 11/15/2024\\nMDHHS Approval Date: 10/25/2024\\nPage 2 of 3\\n\\nCOMMUNICATIONS WITH\\nEMERGENCY FACILITIES\\nInitial Date: 6/2018\\nRevised Date: 5/29/2024","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-12_2":{"name":"Appendix A\\nEMERGENCY FACILITY TELEPHONE NUMBERS\\n\\n8","content":"00MHz\\nIdentifier\\n\\nRecorded Line\\n\\nAscension Genesys Hospital\\n\\nGENESYS\\n\\n(810) 606-6922\\n\\nAscension Macomb  Oakland Hospital,\\nMadison Hts. Campus\\n\\nSTJOHNO\\n\\n(248) 967-7656\\n\\nAscension Providence Novi Campus\\n\\nPROVNOV\\n\\nAscension Providence Rochester Hospital\\n\\nPROVROC\\n\\n(248) 601-6060\\n\\nAscension Providence Southfield Campus\\n\\nPROVSFD\\n\\n(248) 849-4160\\n\\nCorewell Hospital-Farmington Hills (Botsford)\\n\\nBOTS\\n\\n(248) 471-7273\\n\\nCorwell Hospital-Royal Oak\\n\\nWBRO\\n\\n(248) 898-4566 Line 1\\n(248) 898-8811 Line 2\\n\\nCorewell Hospital-Troy\\n\\nWBTROY\\n\\n(248) 964-5486\\n\\nChildrens Hospital of MI - Troy\\n\\nCH_TROY\\n\\n(248) 457-1406\\n\\nDMC Huron Valley  Sinai Hospital\\n\\nHVSH\\n\\n(248) 937-4555\\n\\nHenry Ford West Bloomfield Hospital\\n\\nHFWB\\n\\n(248) 325-3671\\n\\nMcLaren Hospital-Clarkston\\n\\nMcCLARK\\n\\n(248) 922-6899\\n\\nMcLaren Hospital-Oakland\\n\\nMcLAREN\\n\\n(248) 338-5369\\n\\nSt. Joseph Mercy-Oakland\\n\\nSJMO\\n\\n(248) 858-6660\\n\\nST_MARY\\n\\n(734) 464-1714\\n\\nHospital Emergency Departments\\n\\nSt. Mary Mercy-Livonia\\n\\n(248) 465-4213\\n\\nMCA Name: Oakland County\\nMCA Board Approval Date: 10/10/2024\\nMCA Implementation Date: 11/15/2024\\nMDHHS Approval Date: 10/25/2024\\nPage 3 of 3\\n\\n-~~DHHS I\\nM\\nMichigan Department Of Health & Human Services\\n\\nBureau of Emergency\\nPreparedness, EMS\\nand Systems of Ca re\\n\\nMichigan\\nSYSTEM\\nELECTRONIC RECORDS &\\nEMS INFORMATION SYSTEM\\n\\nInitial Date: 08/28/2020\\nRevised Date: 05/30/2023","source_file":"Section-8-TOC.pdf","categories":[]},"section_8-13":{"name":"Electronic Records & EMS Information System\\nI","content":". Responsibility for Records\\nA. Any PCR software utilized by an EMS agency must be compliant with the\\nNational EMS Information System (NEMSIS) system and the Michigan EMS\\nInformation System (MIEMSIS) as determined by the department.\\nB. All PCR are considered confidential medical records and must be treated in\\naccordance with state and federal law.\\nC. Signed electronic or paper PCR shall be maintained by the EMS agency as\\nthe official medical record for each patient treated and/or transported.\\nD. All original PCR reports will be made available to the receiving facility, the\\nMCA and the Bureau of EMS, Trauma and Preparedness, in electronic format,\\nupon request.\\nII. Submission to MIEMSIS Data Repository\\nA. All agencies must transfer data at least monthly. Reporting period begins at\\n00:00:01 hours on the 1st day of the calendar month, ending at midnight on the\\nlast day of the calendar month. Data must be uploaded by the 15th of the month\\nfollowing the close of the reporting period. MCAs may require data to be\\ntransferred more frequently.\\nB. Agencies performing invasive skills (including supraglottic airways) must\\ntransfer data at least daily. PCR that include invasive skills will be available in\\nMIEMSIS within 24 hours of incident completion.\\nC. If technology permits, transfer should occur at the time of incident completion.\\nD. Agencies are responsible to work with their MCA(s) and the department to\\nensure that the quality of the data submitted to the MIEMSIS repository is an\\naccurate reflection of the information entered into their EMS information system.\\nAgencies are responsible for ensuring accuracy in data element mapping,\\naccuracy in data value coding, list compliance, and accuracy in data transfer\\nbetween the vendor and the MI-EMSIS system. Agencies may access MIEMSIS\\nto verify the submission of their records at any time.\\nE. Agencies entering data from paper PCR after-the-fact are responsible for\\nentering those PCR in accordance with the above time frames.\\nF. All PCR transferred to MIEMSIS must be compliant with the Michigan Required\\nElements.\\nG. All PCR transferred into MIEMSIS will use values from Department provided\\nlookup lists.\\nIII. Utilizing Data\\nA. The MCA professional standards review organization (PSRO) will utilize data\\nsubmitted by the life support agencies for the purpose of providing professional\\noversight and for improving the quality of medical care within the MCA region.\\nB. MCAs may utilize aggregate data that does not identify the patient or agency to\\nsupport EMS system and public health activities.\\n\\n-~~DHHS I\\nM\\nMichigan Department Of Health & Human Services\\n\\nBureau of Emergency\\nPreparedness, EMS\\nand Systems of Ca re\\n\\nMichigan\\nSYSTEM\\nELECTRONIC RECORDS &\\nEMS INFORMATION SYSTEM\\n\\nInitial Date: 08/28/2020\\nRevised Date: 05/30/2023\\nSection 8-13\\n\\nC. MCAs may choose to maintain its own repository and in turn submit the data to\\nthe Department of Health and Human Services.\\nD. The information accessed by the MCA is confidential in nature and is intended\\nfor the medical control PSRO. Data protection is critical and is provided for\\nthrough 1967 PA 270, MCL 331.531 to 331.533, other applicable confidentiality\\nlaws, and use and user agreements. The MCA will:\\n1. Only use or disclose data for the purposes described in Part 209 of the\\nPublic Health Code and the Michigan Administrative Code R 325.22101\\nthrough R 22217. Any other uses or disclosures will be made only as\\nrequired by applicable laws.\\n2. Use appropriate safeguards to prevent use or disclosure of the\\ninformation other than as provided by this agreement.\\n3. Limit access to the data to only those employees assigned to perform the\\nfunctions under the above statute and administrative rules and who have\\nsigned a data user agreement on file with the Department.\\n4. Report any actual or suspected breach, intrusion, or unauthorized use or\\ndisclosure to the Department and the affected life support agency within\\n10 days of becoming aware of such breach, intrusion, or unauthorized\\nuse or disclosure or such shorter time period as is reasonable under the\\ncircumstances.\\n5. Mitigate the effects of any breach, intrusion, or unauthorized use or\\ndisclosure.\\n6. Notify the Department when anyone with a signed user agreement and\\naccess to data systems leaves their position. Notification should occur\\nwithin 24 hours.\\n7. Comply with the Michigan Identity Theft Protection Act notification\\nprocedures at MCL 445.61 et seq.\\n8. As a public body subject to the Freedom of Information Act (FOIA),\\nredact all personal identifiers or other information pursuant to applicable\\nFOIA exemptions. 1976 PA 441: MCL 15.231 et seq.\\nE. CARES Data\\n1. The LSA will submit data for out-of-hospital cardiac arrest (OHCA)\\npatients to the Cardiac Arrest Registry to Enhance Survival (CARES).\\n2. If multiple agencies are on scene the transporting agency is responsible\\nfor CARES data entry.\\n3. The agency completing the CARES record will collect applicable CARES\\ndispatch elements.\\nF. Confidentiality\\n1. The EMS patient care record is a confidential patient care document and\\nis not to be released to anyone other than those involved in the patients\\ncare or Professional Standards Review Organization, without the patients\\nwritten release of information permission.\\n\\n-~DHHS\\nI Preparedness,\\nBureau of Emergency\\nM\\nl,\\nEMS\\nMichigan Department ~ H,alth , HumanServices\\n\\nand Systems of Care\\n\\nMichigan\\nSYSTEM\\nPROTECTED HEALTH INFORMATION (PHI)\\n\\nInitial Date: 09/2004\\nRevised Date: 12/27/2022","source_file":"Section-8-TOC.pdf","categories":["trauma","medical"]},"section_8-14":{"name":"Protected Health Information\\nPurpose","content":":\\nI.\\n\\nTo provide a standard for sharing protected health information (PHI) with entities that\\nfunction in the capacity of a life support agency.\\n\\nII.\\n\\nTo promote and improve overall patient care and pre-hospital EMS activities, Medical\\nControl Authorities shall establish patient care quality improvement programs. Patient\\ncare information will be utilized in these programs for quality improvement activities\\nonly and shall conform to all state and federal patient confidentiality and privacy laws.\\n\\nPolicy:\\nI.\\n\\nMedical Control Authorities and their Professional Standards Review Organization\\n(QI Committee) will collect patient care information through retrospective review of\\npatient care records generated and supplied by all life support agencies.\\n\\nII.\\n\\nPatient care records will be completed on all patients where any type of care or\\nassessment has occurred.\\n\\nIII.\\n\\nEach responding pre-hospital care provider shall complete Medical Control approved\\ndocumentation, a copy of which may be forwarded to Medical Control Authority for\\nquality improvement purposes.\\n\\nIV.\\n\\nThe Medical Control Authorities shall hold all patient care information in strictest\\nconfidence.\\n\\nV.\\n\\nQuality Improvement within the Medical Control Authority shall be conducted under\\nthe Professional Standards Review Organization, which may be comprised of\\nrepresentatives from various pre-hospital agencies. No patient identifiers will be used\\nor shared during reporting of any retrospective QI reviews of patient care.\\n\\nVI.\\n\\nPatient outcomes may be tracked by pre-hospital agencies and/or Medical Control\\nAuthorities and may be shared among pre-hospital agencies, including Medical First\\nResponse agencies, responsible for patient care. No patient identifiers will be used\\nor shared during reporting.\\n\\nVII.\\n\\nPatient care audits may occur as part of the QI process. No patient identifiers will be\\nused or shared during reporting. Aggregate data will be shared with pre-hospital\\nagencies using no patient identifiers. This data will be used for education,\\nremediation and overall improvement of system processes.\\n\\nOakland County Medical Control Authority\\nSYSTEM\\nINTER-FACILITY PATIENT TRANSFERS\\nInitial Date: 9/14/2023\\nRevised Date: 1/11/2024","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-15":{"name":"Inter-facility Patient Transfers\\nPurpose","content":": The purpose of this protocol is to establish a uniform procedure for inter-facility\\ntransfers. Providers of inter-facility transfers must have MCA privileges in the MCA in which\\nthe transfer begins or ends unless otherwise indicated (per MCA selection).\\nMCA Approval for Inter-Facility Transfer Resource Expansion\\n Inter-facility transfers initiated within the MCA may be carried out by\\nproviders that hold MCA privileges in an MCA other than the sending or\\nreceiving MCA.\\nThe MCA is responsible for establishing guidelines and\\ncommunications for this process and maintain a roster of providers .\\nProviders will provide care under their originating MCA protocols unless\\notherwise specified.\\n1. Responsibility:\\nA. Patient transfer is a physician-to-physician referral. The transferring physician\\nis responsible for securing the acceptance of the patient by an appropriate\\nphysician at the receiving facility prior to the transportation. The name of the\\naccepting physician must be included with the transfer orders.\\nB. It is the responsibility of the transferring facility to:\\na. Perform a screening examination.\\nb. Determine if transfer to another facility is in the patients best interest.\\nc. Initiate appropriate stabilization measures prior to transfer.\\nC. During transport, the transferring physician is responsible for patient care until\\narrival of the patient at the receiving facility.\\nD. It is the transferring physicians responsibility to know and understand the\\ntraining and capabilities of the transporting EMS personnel.\\nE. BLS may transport the following (per MCA selection):\\na. IV fluids without medications added on dial-a-flow or gravity run \\nperipheral site.\\nMCA Approval for BLS care during Interfacility transfer\\n IV Fluids on a pump\\n IV Antibiotics that have been infusing for at least 15 minutes prior to departure.\\n IV Lipids/TPN\\n PCA Pump\\n\\nPage 1 of 4\\n\\nOakland County Medical Control Authority\\nSYSTEM\\nINTER-FACILITY PATIENT TRANSFERS\\nInitial Date: 9/14/2023\\nRevised Date: 1/11/2024\\nSection: 8-15\\n\\nF. Additional/Accompanying Staff (Non-EMS personnel) assigned for transfer by\\nphysician:\\na. The transferring physician is responsible for ensuring the qualification\\nof accompanying staff.\\nb. Accompanying staff will render care to the patient under the order of\\nthe transferring physician.\\nc. It is the responsibility of the transferring facility to arrange for the\\nreturn of staff, equipment, and medications.\\n2. Transportation\\nA. Pre-transport\\na. Care initiated by the transferring facility that requires continuation\\nduring transport, along with additional treatment(s) will be determined\\nby the transferring physician.\\nb. Orders for treatment shall be provided in writing to the EMS personnel\\nprior to initiation of the transport by the transferring Physician.\\n1. A mutually agreed upon primary form of communication with the\\ntransferring physician for the duration of the transfer.\\nc. Ordered medications not contained within the EMS System\\nMedication Box must be supplied by the transferring hospital.\\nd. EMS personnel must be trained in all the equipment, procedures, and\\nmedications being used in the patients care during the transfer.\\ne. Patient care, procedures, equipment, or medications that exceed EMS\\npersonnel training require additional/accompanying staff (see section\\n1.F. above).\\nf. EMS personnel have the right to decline transport that is outside their\\nscope of practice and/or training when additional/accompanying staff\\nis unavailable.\\ng. The following information should accompany the patient (but not delay\\nthe transfer in acute situations):\\n1. Copies of pertinent hospital records\\n2. Written orders during transport\\n3. Any other pertinent information including appropriate transfer\\ndocuments.\\nB. During Transport\\na. Hospital supplied medications not used during transport must be\\nappropriately tracked, wasted and documented.\\n1. All controlled substances and Propofol must have a documented\\nchain of custody.\\nb. The concentration and administration rates of all medications being\\nadministered will be documented on the patient care record.\\nc. Interventions performed en route, and who performed them, will be\\ndocumented on the patient care record.\\nd. Intervention beyond the written orders provided by the transferring\\nPhysician, require contact with the transferring Physician.\\n\\nPage 2 of 4\\n\\nOakland County Medical Control Authority\\nSYSTEM\\nINTER-FACILITY PATIENT TRANSFERS\\nInitial Date: 9/14/2023\\nRevised Date: 1/11/2024\\nSection: 8-15\\n\\ne. Order of operation for care and communication when unable to\\ncontact the transferring physician.\\n1. Follow Medical Control approved Protocols under which the\\nEMS agency has Medical Control privileges and initiate contact\\nwith:\\na. Receiving physician\\nb. On-line Medical Control Physician from the sending\\nfacility.\\nc. On-line Medical Control Physician from the receiving\\nfacility\\nd. Closest appropriate on-line Medical Control facility.\\n3. Special Treatments\\nA. Interfacility High Flow Nasal Oxygen (HFNO) (per MCA selection)\\nInterfacility High Flow Nasal Oxygen\\nIncluded?\\n Yes\\n No\\na. See 7.26 Interfacility High Flow Nasal Oxygen-Procedure\\nProtocol\\nb. Ensure adequate supply of oxygen is available for transport.\\n1. Calculate amount of oxygen needed prior to departure.\\n2. Must have minimally two times the amount of oxygen calculated.\\n\\nProtocol Source/Reference: Michigan 8.15 Inter-Facility Patient Transfers; Version 7/28/23.\\n\\nPage 3 of 4\\n\\nOakland County Medical Control Authority\\nSYSTEM\\nINTER-FACILITY PATIENT TRANSFERS\\nInitial Date: 9/14/2023\\nRevised Date: 1/11/2024","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-15_1":{"name":"Medication Custody Form\\n\\nPatient Name\\nEMS Staff Receiving Medication\\nName\\n\\nSignature\\n\\nName\\n\\nSignature\\n\\nHospital Staff Sending\\nMedication\\n\\nMedication\\n\\nAmount Received From\\nHospital\\n\\nAdministered\\n\\nWasted\\n\\nEMS Staff Wasting Medication\\nName\\n\\nSignature\\n\\nName\\n\\nSignature\\n\\nHospital Staff Witnessing Waste\\n\\nMCA Name","content":": Oakland County\\nMCA Board Approval Date: 2/2/2024\\nMCA Implementation Date: 5/13/2024\\nMDHHS Approval: 4/26/2024\\n\\nPage 4 of 4\\n\\nInitial Date: 10/2011\\nRevised Date: 12/27/2022\\n\\nMichigan\\nSYSTEM\\nLICENSURE LEVEL REQUIREMENT OF ATTENDANT\\nDURING TRANSPORT\\n(MCA Optional Protocol)","source_file":"Section-8-TOC.pdf","categories":[]},"section_8-16":{"name":"Licensure Level Requirement of Attendant during Transport (MCA\\nOptional Protocol","content":")\\n Medical Control Authorities choosing to adopt this supplement may do so\\n\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.\\nPurpose: To provide a protocol to fulfill the requirement that allows for EMS personnel to\\ntransport patients up to their individual licensure level in the event that the vehicle is\\nlicensed at a higher level as set forth in Michigan Administrative Code Part 3, Ambulance\\nOperations R325.22133 (f).\\nMichigan Administrative Code Part 3. Ambulance Operations R 325.22133 (f) states: that\\nan individual whose license is at least equal to the level of vehicle license is in the patient\\ncompartment when transporting an emergency patient, or consistent with department\\napproved medical control authority protocols.\\nI.\\n\\nPatient care transport level is to be determined by the individual(s) whose license is\\nat least equal to the level of the vehicle license. This individual will perform a patient\\nassessment to determine the level of patient care transport. The electronic patient\\ncare record must reflect this assessment both as a procedure and in components of\\nthe assessment.\\nA. EMT-Basic may attend in the patient compartment during transport on a\\npatient deemed to be within the scope of practice for an EMT-Basic as defined\\nby the State of Michigan.\\nB. EMT-Specialist may attend in the patient compartment during transport on a\\npatient deemed to be within the scope of practice for an EMT-Specialist as\\ndefined by the State of Michigan.\\nC. EMT-Paramedic may transport a patient at any level.\\n\\nII.\\n\\nAmbulance(s) must maintain minimum staffing in accordance with Public Health\\nCode Act 368 of 1978\\nSection 333.20921:\\n(3a) If designated as providing basic life support, with at least 1 emergency\\nmedical technician and 1 medical first responder.\\n(3b) If designated as providing limited advanced life support, with at least 1\\nemergency medical technician specialist and 1 emergency medical technician.\\n(3c) If designated as providing advanced life support, with at least 1 paramedic\\nand 1 emergency medical technician.\\n\\nIII.\\n\\nAn appropriate licensed health professional, designated by a physician with an\\nestablished patient relationship may be present in the patient compartment of the\\nambulance in place of EMS staffing, according to 333.20921 (6).\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nAGENCY AND EMS PERSONNEL CRITERIA FOR PARTICIPATION\\nInitial Date: June 2018\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_818":{"name":"Agency and EMS Personnel Criteria for Participation\\nThe Oakland County Medical Control Authority serves as the designee of the Michigan\\nDepartment of Health and Human Services (MDHHS) pursuant to Act 3","content":"68 of 1978, as\\namended in 2000, to serve as medical control authority for the Oakland County\\nemergency medical services system. Pursuant to Sec. 20919(a) the medical control\\nauthority shall develop protocols and policies for the acts, tasks, and function that may\\nbe performed by EMS personnel and life support agencies.\\nNEW AND UPGRADING AGENCIES\\n(see New or Upgrading EMS Agency Policy)\\nRENEWING AGENCIES (ANNUALLY)\\nRenewing EMS Agencies will be eligible to be designated as a life support agency in\\nOakland County and receive Medical Control upon annual submission to the\\nProfessional Standards Review Organization (PSRO) of:\\n1.\\n2.\\n\\n3.\\n\\n4.\\n5.\\n6.\\n\\nEvidence of licensure with the State EMS Division;\\nDesignate an EMS Coordinator for the LSA. The EMS Coordinator must be a\\nlicensed provider, at or above the LSAs licensure level (e.g., paramedic working\\nfor an ALS agency), and employed by the LSA. The EMS Coordinator will\\nserve as the liaison between the medical control hospital, the OCMCA and the\\nlife support agency. The responsibilities of the EMS Coordinator include, but\\nare not limited to meeting all the criterion listed in the OCMCA LSA Letter of\\nCompliance.\\nDesignate a State Licensed Instructor Coordinator (IC). State Licensed IC must\\nbe commensurate with the LSAs licensure level. The Oakland County Instructor\\nCoordinator will be responsible for maintaining ongoing education according to\\nthe OCMCA and MDHHS licensing requirements.\\nEvidence of compliance with OCMCA criteria for practice by completion of the\\nLetter of Compliance;\\nList of current personnel including level of licensure, expiration dates, and current\\nACLS certification; and\\nApproval of the PSRO, MCC and Board of Directors.\\n\\nAGENCY CRITERIA TO PARTICIPATE IN THE OCMCA\\nThe Oakland County Medical Control Authority has an approval process in place to\\ndesignate a life support agency in Oakland County to be eligible for Medical Control.\\nThis approval will be based on the PSRO review and approval; and MCC and Board of\\nDirectors approval. The criteria to operate as an OCMCA agency includes:\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 1 of 5\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nAGENCY AND EMS PERSONNEL CRITERIA FOR PARTICIPATION\\nInitial Date: June 2018","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_818_1":{"name":"Revised Date","content":": 9/14/2023\\n1.\\nLicensed by the Michigan Department of Health and Human Services (MDHHS),\\nor license pending.\\n2.\\nMaintain a physical station with a minimum of one life support vehicle with 24/7\\nstaffing (of a type commensurate with what is written on the agencys license)\\nthat is available for response to requests for emergency assistance, and is\\nstaffed on a 24/7 basis within Oakland County.\\n3.\\nThe ability to comply with the Oakland County EMS Response Time Standards.\\n4.\\nMedical supplies, communications, equipment, procedures and protocols utilized\\nmeet criteria as established by MDHHS and Oakland County Medical Control\\nAuthority.\\n5.\\nIt is the agencys responsibility to educate and update all EMS personnel on the\\nOCMCA protocols.\\n6.\\nThe agency designates the OCMCA (including its PSRO) to perform professional\\npractice review functions on behalf of the agency, including review of pre-hospital\\ncare provided in Oakland County and recommendations for improvement of such\\ncare.\\n7.\\nThe agency agrees to participate in PSRO studies, EMS QI Program (EQIP), and\\nabide by all PSRO Protocols and Policies.\\n8.\\nAgency has designated a medical control hospital and medical control hospital\\nphysician.\\n9.\\nUnits are identified through standard terminology and uniform numbering system,\\nissued\\nby the Oakland County Medical Control Authority. The OCMCA unit number will\\nbe documented on each run form and/or e-PCR and used in all radio\\ncommunications.\\n10.\\nThe agency has designated an EMS Coordinator, EMS QI Coordinator, and a\\nState Licensed Instructor Coordinator.\\n11.\\nThe agency has Emergency Medical Dispatch (EMD) protocols to ensure the\\nappropriate dispatching of a life support agency based upon medical need and\\ncapability of the emergency medical services system. All calls have access to\\npre-arrival instructions through an approved MCA EMD program.\\n12.\\nThe agency has a policy to ensure that use of lights and sirens is based on EMD\\nprotocols and patient condition.\\n13.\\nThe agency is responsible for completing and forwarding the necessary quality\\nimprovement data, approved by the OCMCA Board of Directors, and to MIEMSIS.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 2 of 5\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nAGENCY AND EMS PERSONNEL CRITERIA FOR PARTICIPATION\\nInitial Date: June 2018","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_818_2":{"name":"Revised Date","content":": 9/14/2023\\nALS Agencies Only\\nLICENSED NON-TRANSPORTING ALS UNITS\\n1.\\nProvide a minimum of one paramedic staffing each licensed Non-Transporting\\nALS unit at all times.\\n2.\\nContract for staffing services shall only be rendered with OCMCA approved Life\\nSupport Agencies.\\nLICENSED TRANSPORTING ALS UNITS\\n1.\\nProvide a minimum of one paramedic and one EMT staffing each licensed\\nTransporting ALS unit at all times.\\n2.\\nContract for staffing services shall only be rendered with OCMCA approved Life\\nSupport Agencies.\\nBLS Agencies Only\\nLICENSED NON-TRANSPORTING BLS AGENCY\\nMust provide a minimum of one (1) EMT to staff a licensed Non-Transporting BLS unit\\nat all times.\\nLICENSED TRANSPORTING BLS AGENCY\\nA transporting BLS agency must provide a minimum of one EMT and one MFR to staff a\\nlicensed Transporting BLS unit for transport.\\nAgency Communications\\nIn order to participate in the Oakland County Emergency Medical Services\\nCommunications system, it is required that all basic and advanced life support units are\\ncapable of communicating on the following channels:\\n-- 155.340 Michigan HERN Channel (Primary Vehicle to Hospital Channel)\\n-- 155.355 VMEDTAC (Scene Coordination Channel)\\n-- 155.7525 VCALL10 (National Interoperable Channel)\\n-- 151.1375 VTAC11 (National Interoperable Channel)\\n-- 154.4525 VTAC12 (National Interoperable Channel)\\n-- 158.7375 VTAC13 (National Interoperable Channel)\\n-- 159.4725 VTAC14 (National Interoperable Channel)\\nAll licensed EMS operations (transporting and non-transporting vehicles) will be\\nassigned a specific MEDCOM mobile unit radio identification number, in accordance\\nwith the Oakland County Unit Identification Number System. To designate the\\ncapability of the unit, a prefix will be added to the unit ID number (numbers obtained\\nthrough OCMCA), in accordance with the EMS capability and assignment codes.\\nThese identifiers will be used in all EMS radio and telephone traffic. All ALS units are\\nrequired to be equipped with an Oakland County 800 MHz Radio system EMS portable\\nradio.\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 3 of 5\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nAGENCY AND EMS PERSONNEL CRITERIA FOR PARTICIPATION\\nInitial Date: June 2018","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_818_3":{"name":"Revised Date","content":": 9/14/2023\\nEMS PERSONNEL TO PARTICIPATE IN THE OCMCA\\nAll EMS personnel shall participate in peer reviewed quality improvement (PSRO).\\nParamedic Qualifications\\nAll Paramedics must:\\n1.\\nBe licensed with the State of Michigan as a paramedic.\\n2.\\nPersonnel be trained and licensed in accordance with appropriate statutes, rules\\ncriteria and maintain current BCLS and ACLS, as approved by MDHHS.\\n3.\\nAdhere to the State of Michigans EMS/Trauma Systems Section continuing\\neducation requirements.\\n4.\\nRecommendation for a nationally recognized pediatric program.\\nAEMT Qualifications\\nAll AEMTs must:\\n1.\\nBe licensed in the State of Michigan as an AEMT.\\n2.\\nBe trained and licensed in accordance with appropriate statutes, rules criteria\\nand maintain current BCLS, as approved by MDHHS.\\n3.\\nAdhere to State of Michigan EMS Divisions continuing education requirements.\\n4.\\nThe AEMT is able to work up to their scope of practice on an ALS unit only.\\nEMT Qualifications\\nAll EMTs must:\\n1.\\nBe licensed in the State of Michigan as an EMT.\\n2.\\nBe trained and licensed in accordance with appropriate statutes, rules criteria\\nand maintain current BCLS, as approved by MDHHS.\\n3.\\nAdhere to State of Michigan EMS Divisions continuing education requirements.\\nMFR Qualifications\\nAll MFRs must:\\n1.\\nBe licensed in the State of Michigan as an MFR.\\n2.\\nBe trained and licensed in accordance with appropriate statutes, rules criteria\\nand maintain current BCLS, as approved by MDHHS.\\n3.\\nAdhere to State of Michigan EMS Divisions continuing education requirements.\\nEMS RESPONSE\\nWhen responding to a non-emergency facility (e.g. nursing home, Urgent Care,\\nphysicians office, private residence, etc.) to a patient with a potentially life threatening\\ncondition, EMS personnel/life support agency must activate, upon identification of a\\npotentially life threatening condition, the primary life support agency for that geographic\\nservice area of the call.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 4 of 5\\n\\nOakland County Medical Control Authority\\n2024 Life Support Agency Letter of Compliance 8-18.1\\nLife Support Agency Name: __________________________________________________________\\n(Print Name)\\nCompliant\\n1.\\nThis agency is licensed by the Michigan Department of Health and Human Services\\n(MDHHS), or license pending.\\n_________\\n\\n2.\\n\\n3.\\n\\n4.\\n\\n5.\\n\\n6.\\n\\n7.\\n\\n8.\\n\\nThis agency will maintain a physical station with a minimum of one life support\\n\\nvehicle with 24/7 staffing (of a type commensurate with what is written on the\\nagencys license) that is available for response to requests for emergency\\nassistance, and is staffed on a 24/7 basis within Oakland County.\\n\\n________\\n\\nThis agency agrees to comply with the Oakland County EMS Response Time\\nStandards. (See 8.104 EMS Response Time Standards)\\n\\n_________\\n\\nThis agency will have medical supplies, communications, equipment, procedures and\\nprotocols utilized meet criteria, as established by MDHHS and Oakland County\\nMedical Control Authority.\\n\\n_________\\n\\nThis agency shall educate and update all personnel on the OCMCA protocols and\\npolicies.\\n\\n_________\\n\\nThis agency designates the OCMCA (including its PSRO) to perform professional\\npractice review functions on behalf of the agency, including review of pre-hospital\\ncare provided in Oakland County and recommendations for improvement of such care.\\n\\n_________\\n\\nThis agency agrees to participate in PSRO studies, EMS QI Program (EQIP) and abide\\nby all PSRO Protocols and Polices.\\n\\n_________\\n\\nThis agency has designated a Medical Control Hospital and Medical Control Hospital\\nPhysician.\\n\\n_________\\n\\n9.\\n\\nThis agency understands that units are identified through standard terminology and\\nuniform numbering system, issued by the Oakland County Medical Control Authority.\\nThe OCMCA unit number will be documented on each run form and/or e-PCR and used\\nin all radio communications.\\n_________\\n\\n10.\\n\\nThis agency has designated an EMS Coordinator, EMS QI Coordinator and State\\nLicensed Instructor Coordinator.\\n\\n_________\\n\\n11.\\n\\nThis agency has Emergency Medical Dispatch (EMD) protocols to ensure the appropriate\\ndispatching of a life support agency based upon medical need and capability of the\\nemergency medical services system. All calls have access to pre-arrival instructions\\nthrough an approved MCA EMD program. (See 8.6 Dispatch Protocol)\\n_________\\n\\n12.\\n\\nThis agency has a policy to ensure that use of lights and sirens is based on EMD\\nprotocols and patient condition. (See 8.2 Use of Lights and Sirens Policy)\\n\\n_________\\n\\n13.\\n\\nThis agency is responsible for completing and forwarding the necessary quality\\nimprovement data, approved by the OCMCA Board of Directors, and to MI-EMSIS.\\n(See 7-15 Patient Care Record & Electronic Documentation & EMS Information\\nSystem)\\n\\n_________\\n\\nThis agency understands that all LSAs that provide emergency response in Oakland\\nCounty agrees to respond to emergency requests for aid across municipal boundaries,\\nif available to respond. This response will occur regardless of what type of primary\\nagency (private or public) provides primary response to that municipality.\\n\\n_________\\n\\n15.\\n\\nThis agency has completed the Addendum (See Addendum).\\n\\n_________\\n\\n16.\\n\\nThis agency shall provide staffing in accordance with the Agency and EMS Personnel\\nCriteria for Participation Policy\\n\\n_________\\n\\nThis agency affirms that its personnel are currently and will maintain their training and\\nlicensing in accordance with appropriate statutes, rules, and criteria for their specific\\nlicense levels as indicated in the EMS Personnel to participate in the OCMCA section\\nof protocol 8.18 Agency and EMS Personnel Criteria for Participation.\\n\\n_________\\n\\n14.\\n\\n17.\\n\\nFor ALS Agencies Only\\nLICENSED NON-TRANSPORTING ALS UNITS\\nA.\\nProvide a minimum of one paramedic staffing each licensed Non-Transporting ALS unit\\nat all times.\\nB.\\nContract for staffing services shall only be rendered with OCMCA approved Life Support\\nAgencies.\\nLICENSED TRANSPORTING ALS UNITS\\nA.\\nProvide a minimum of one (1) paramedic and one (1) EMT staffing each licensed Transporting\\nALS unit at all times.\\nB\\nContract for staffing services shall only be rendered with OCMCA approved Life Support\\nAgencies.\\nFor BLS Agencies Only\\nLICENSED NON-TRANSPORTING BLS AGENCY\\nA.\\nMust provide a minimum of one (1) EMT to staff a licensed Non-Transporting BLS unit\\nat all times.\\nLICENSED TRANSPORTING BLS AGENCY\\nB.\\nA transporting BLS agency must provide a minimum of one (1) Basic EMT and one (1) MFR to\\nstaff a licensed Transporting BLS unit for transport.\\nApproved to participate in the BEES Program (indicate yes or no)\\n\\n_________\\n\\nFor MFR Agencies Only\\nAgency is approved to participate/utilize any of the following:\\nGlucometer (per protocol 7.21 Blood Glucose Level Testing)\\nMaBEES Program (per protocol 9.101 MFR/EMT Medication Exchange)\\nNaloxone (per protocol 9.101 MFR/EMT Medication Exchange)\\ni-gel (per protocol 7-9 Airway Management)\\n\\nAddendum to Letter of Compliance\\nYes\\n\\nNo\\n\\n1.\\n\\nLicensed transporting agency?\\n\\n____\\n\\n____\\n\\n2.\\n\\nAgency regularly transports?\\n\\n____\\n\\n____\\n\\n3.\\n\\nList the communities your agency provides first (primary) response services.\\n\\n4.\\n\\nIf the agency does not provide a first (primary) response service for a geographic\\narea inside Oakland County, provide written documentation from each approving\\ngeographic service area (GSA), explaining how your agency will operate in the GSA\\nand respond to emergencies in that area. Documentation must be signed by the GSA,\\nor designee and agency within the last twelve months.\\n\\n5.\\n\\nList the communities your agency provides tiered response (transport) services.\\n\\n6.\\n\\nList the Life Support Agencys your agency has written mutual aid agreements.\\n\\n7.\\n\\nNumber of vehicles:\\nNon Transporting\\n\\nTransporting\\n\\nMFR\\n\\n________\\n\\nBLS\\n\\n________\\n\\n_________\\n\\nALS\\n\\n________\\n\\n_________\\n\\n8.\\n\\nNumber of EMS personnel, including volunteers.\\n\\n___________\\n\\n9.\\n\\nAgency has 12 lead EKG capabilities.\\n\\n____\\n\\n____\\n\\n10.\\n\\nBLS Agency Only transmits and notifies if STEMI\\n\\n____\\n\\n____\\n\\n11.\\n\\nAgency has capnography capabilities.\\n\\n____\\n\\n____\\n\\n12.\\n\\nAgency has CPAP capabilities.\\n\\n____\\n\\n____\\n\\n13.\\n\\nAgency has BiPAP\\n\\n____\\n\\n____\\n\\n14.\\n\\nType of IO device used by agency (ALS only).\\n\\n__________\\n\\n15.\\n\\nData e-PCR Reporting System (NEMSIS 3.0 or higher)\\nZoll\\nESO Solutions\\nImage Trend/MI-EMSIS\\nHealth EMS\\nEmergency Reporting\\nOther\\n\\n__________\\n\\n16.\\n\\nAgency Annual Licensure Renewal Date\\n\\n__________\\n\\n17.\\n\\nList Dispatch Agency (PSAP)\\n\\n__________\\n\\n18.\\n\\nAgency participates in the MaBEES program\\n\\n____\\n\\n____\\n\\n19.\\n\\nAgency participates in the ET3 Special Study\\n\\n____\\n\\n____\\n\\n20.\\n\\nAgency participates in the eComs/eBridge Study\\n\\n____\\n\\n____\\n\\n21.\\n\\nAgency participates in the Narcan Leave Behind Program\\n\\n____\\n\\n____\\n\\n22.\\n\\nAgency does interfacility transports.\\nUtilizes High Flow Nasal Canula\\n\\n____\\n____\\n\\n____\\n____\\n\\n23.\\n\\nAgency utilizes a mechanical CPR Device\\nProvide the brand name and model number of the device\\nBrand name ____________ Model Number _____________\\nBrand name ____________ Model Number _____________\\nBrand name ____________ Model Number _____________\\nBrand name ____________ Model Number _____________\\n\\n____\\n\\n____\\n\\n24.\\n\\n25.\\n\\nEMT Agency Only  Participate in the Capnography Program\\nQualitative\\nQuantitative\\nMFR Agency Only  Participate in Epi Auto Injector Program\\n\\n____\\n____\\n____\\n____\\n\\n____\\n____\\n____\\n____\\n\\n26.\\n\\nMFR Agency Only  Participate in the Glucometer Program\\n\\n____\\n\\n____\\n\\n27.\\n\\nMFR Agency Only  Participate in the Infra-nasal Medication Administration Program\\n\\n____\\n\\n____\\n\\n28.\\n\\nMFR Agency Only  Participate in the Narcan Administration Program\\n\\n____\\n\\n____\\n\\n29.\\n\\nPlease identify the supraglottic airways your agency utilizes\\niGel\\nAir Q3\\nKing\\nCombitube\\n\\n30.\\n\\nAll Agencies - list all vehicles carrying Narcan for BLS and MFR use, if applicable.\\n\\nAttach a list of all personnel with their level of licensure.\\nAttach a copy of the current agency license.\\n\\nOCMCA Life Support Agency\\nEmergency Contact Information\\nIn the event that the Oakland County Emergency Operations Center (EOC) is activated due to\\ndisasters/emergencies, additional county resources may be required. Please provide the following\\ninformation:\\nAgency:\\n\\nAddress:\\n\\nAgency Dispatch #:\\n\\nChief/CEO:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nEMS Coordinator:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nSecond Contact:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nThird Contact (if needed):\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nEMS QI Coordinator:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nState Licensed Instructor Coordinator:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nACES Representative:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nMIEMSIS:\\nE-mail address\\nThis person will be designated to receive weekly reports from the State EMS office in regards to monitoring their\\nagency\'s MIEMSIS submissions.\\nWork #\\n\\nCell #\\n\\nPlease let the staff at the OCMCA know of any changes throughout the year.\\n\\nCOMPLIANCE: If any of the above criteria cannot be met, the provider will submit documentation of the\\nexceptions.\\nThis agency agrees to comply with protocols, operating procedures and standards of pre-hospital care promulgated\\nby MDHHS and the Oakland County Medical Control Authority, including the Agency and EMS Personnel Criteria\\nfor Participation Policy. This will assure accountability for care rendered within our advanced emergency care\\nsystem, effective this date, and as may be promulgated from time to time.\\nWe acknowledge that each criterion and verification is subject to inspection by the EMS Medical Director or\\nhis/her physician designee, at any time, and at his/her direction. Should cause exist, the EMS Medical Director, or,\\nhis/her designee may request formal verification.\\n\\n_________________________________\\nAuthorized Representative (Signature)\\n\\n_________________________________\\nMedical Control Physician Signature (MCC member/alt)\\n\\n_________________________________\\nAuthorized Representative (Print)\\n\\n_________________________________\\nMedical Control Physician (PRINT)\\n\\n_________________________________\\nTitle\\nDate\\n\\n_________________________________\\nMedical Control Hospital\\n\\n_________________________________\\nEMS Coordinator (PRINT)\\n\\n_________________________________\\nHospital EMS Coordinator/Liaison (PRINT)\\n\\n__________________________________\\nEMS QI Coordinator (PRINT)\\n__________________________________\\nState Licensed Instructor Coordinator (PRINT)\\n\\nON-SCENE PHYSICIAN INTERACTION\\nInitial Date: 9/14/2023\\nRevised Date:","source_file":"Section-8-TOC.pdf","categories":["medical","pediatric"]},"section_8-19":{"name":"On-Scene Physician Interaction\\nThe EMS system will be available at all times to provide support for health professionals in\\nemergency medical settings","content":". It is ready to assume responsibility for patient care upon\\nrequest of a physician who has initiated treatment of a patient with whom he has an\\nestablished physician-patient relationship.\\nThe EMS system On-Line Medical Control Physician is considered the highest medical\\nauthority at the scene of a medical emergency with a patient unattended by a physician. An\\non-scene physician who does not have an established physician-patient relationship and\\nwishes to assume responsibility must seek permission from the Medical Control physician\\nin order to do so.\\nEMS Personnel are to receive orders for interfacility patient care from the referring\\nphysician provided those orders are consistent with the training of the paramedic and the\\n8.15 Interfacility Patient Transfer Protocol. If the patients condition changes to the point\\nthat the sending facilities orders did not meet the needs of the patient, the patient will\\nbecome the responsibility of the EMS system. Appropriate treatment will be performed\\nbased on the MCA protocols or from an on-line medical direction.\\nProcedure:\\nA. Physicians Office, Clinic or Ambulatory Patient Care Facility\\n1. Physician Office, Clinic or Ambulatory Patient Care Facility to hospital transfers are\\nconsidered scene calls unless a physician-to-physician transfer is designated by\\nthe Physician Office, Clinic or Ambulatory Patient Care Facility. EMS personnel will\\ntake responsibility for the patient as if the patient were coming from a prehospital\\nscene.\\n2. EMS personnel should obtain pertinent history, from the patient and physician (or\\ndesignee).\\na. If no destination is chosen, follow 8.3 Transport Protocol\\nb. If physician to physician destination decision has been determined, honor that\\nestablished agreement when possible.\\ni. If a valid reason exists to not honor the established transport agreement,\\ncontact Medical Control.\\nB. Free Standing Emergency Department (FSED) to Hospital Transfers\\n1. FSED is defined in the MCA Transport Protocol.\\n2. A FSED to hospital transfer is considered a physician-to-physician interfacility\\ntransfer.\\n3. EMS personnel responding to a FSED should receive a patient report from the\\ntreating physician (or designee). This report should include the physicians\\nassessment, the requested destination, name of the person who accepted the\\ntransfer, care to be given during transport, and any potential problems felt likely to\\noccur in route.\\n4. If EMS personnel do not agree with the destination or proposed orders, they\\nshould discuss this with the transferring physician. If an agreement is not reached,\\nmedical control should be contacted to determine the destination and care to be\\n\\nPage 1 of 2\\n\\nON-SCENE PHYSICIAN INTERACTION\\nInitial Date: 9/14/2023\\nRevised Date:","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-19_1":{"name":"given by EMS personnel in route to the hospital","content":".\\n5. The scope of practice for EMS when performing a FSED to Hospital transfer is\\ndetermined by the 8.15 Interfacility Patient Transfer Protocol.\\n6. At the discretion of the FSED physician, the FSED physician or designated facility\\nstaff may treat and accompany the patient during transport with the assistance of\\nthe EMS system.\\n7. Upon departure from the scene, contact Medical Control as would be done for any\\nEMS scene patient.\\nC. Physician On-scene\\n1. As time and patient condition permit, EMS personnel should make a reasonable\\neffort to establish the identity or credentials of anyone at the scene of a medical\\nemergency (not a covered by previous sections of this protocol) who professes to\\nbe a Michigan licensed physician who expresses an interest in participating in\\npatient care activities.\\n2. An on-scene physician must identify themself and verify to Medical Control either\\nthe fact of an established physician-patient relationship with the patient, or\\nwillingness to assume responsibility for the patient and to accompany the patient to\\nthe hospital. The Medical Control physician may allow the on-scene physician to\\nprovide on-scene Medical Direction and then not accompany the patient to the\\nhospital. Should this occur the Medical Control physician re-assumes responsibility\\nfor the patient during transport.\\n3. The Medical Control physician will verify over the radio his delegation of\\nresponsibility to the physician on-scene and the nature of that delegation.\\n4. A physician on-scene may participate with paramedic(s) in the resuscitation of a\\npatient with permission of Medical Control without assuming full responsibility for\\nthe patient. This responsibility will, in this case, remain with the Medical Control\\nphysician and the ALS system.\\n5. It should be noted that responsibility for the patient at the scene rests with the online medical control physician. Decisions releasing medical care responsibility to\\nanother physician should be considered carefully.\\n6. If an on-scene health care professional has identified themself, and obstructs\\nefforts of the paramedic(s) to aid a patient for whom they are called, or who insists\\non rendering patient care inconsistent with the system standards and resists all\\ninvitation to function appropriately to the point where his continued intervention will\\nresult in obstruction to rendering good and reasonable patient care, EMS personnel\\nshould:\\na. Request Public Safety Officers become involved, if necessary, so that the team\\nmembers can continue to provide patient care according to system protocol.\\nb. Communicate the situation promptly to On-Line Medical Control.\\nc. Document the behavior of the on-scene health care professional on the patient\\ncare record.\\nC. For on scene interaction with Emergency Medicine Residents, Fellows, Medical\\nControl Physicians, and the EMS Medical Director: MCAs may have an optional\\nprotocol specific to programs within their area.\\nProtocol Source/Reference: Michigan 8.19 On-Scene Physician Interaction; Version 3/24/23.\\n\\nPage 2 of 2\\n\\n-~l,\\n\xa3DHHS I\\nM\\nPROTOCOL DEVIATION\\n\\nInitial Date: 09/2004\\nRevised Date: 12/27/2022","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-20":{"name":"Protocol Deviation\\nI","content":".\\n\\nIt is acknowledged that there are situations in which deviation from the protocols,\\npolicies and procedures may be needed in the interest of patient care.\\nA. In those situations, EMS personnel should request permission for deviation\\nfrom on-line medical direction whenever possible.\\nB. Unavailability of on-line medical direction and the immediacy of patient care\\nneeds may, in very rare instances, prohibit such requests, but those situations\\nshould occur rarely.\\n\\nII.\\n\\nAll instances of protocol deviation must be documented in the EMS patient care\\nrecord, noting the deviation which occurred and the reason for that deviation.\\n\\nIII.\\n\\nAll deviations performed without online medical control approval must be reported to\\nthe MCA with 24 hours.\\n\\nIV.\\n\\nAll reported deviations will be reviewed within the MCA Professional Standard\\nReview Organization.\\n\\nOakland County Medical Control Authority\\nSYSTEM\\nVIOLENT/CHEMICAL/HAZARDOUS SCENE\\nInitial Date: 9/14/2023\\nRevised Date:","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-21":{"name":"Violent/Chemical/Hazardous Scene\\nNote","content":": This policy applies to any situation, which may expose EMS personnel to known or\\npotentially violent (e.g., shooting, stabbing, assault, other violent crimes) or other known or\\npotentially hazardous (e.g., hazardous material, chemical, biological) situations.\\nThe medical component of the response to a violent or hazardous incident will operate\\nunder the Incident Command System.\\nI.\\n\\nProcedure\\nA. Upon notification of a known or potentially violent situation, the EMS personnel\\nwill determine through dispatch, the nature and location of incident and:\\n1. Violent Situations\\na. Is assailant/weapon present?\\nb. Assure law enforcement notification?\\nc. Is scene secure?\\n2. Hazardous materials situation\\na. Is scene secure?\\nb. Nature and identification of material?\\nc. Assure FD/Hazmat Team notification?\\n\\nNOTE: The above information should be communicated to responding crews.\\nII.\\n\\nIII.\\n\\nIf the scene is not secured:\\nA. EMS personnel will stage an appropriate distance away from the scene to\\nprotect themselves from danger.\\nB. In hazardous material situations stage upwind, uphill and upstream.\\nC. In violent situations EMS personnel will NOT enter a potentially unsecure\\nscene until coordinated by law enforcement command and MUST maintain law\\nenforcement protection.\\nOnce on the scene, if the situation changes posing an immediate life or limb threat to\\nEMS personnel:\\nA. Attempt to safely exit scene.\\n1. Exit scene with patient, if possible.\\n2. Medical treatment protocols may be limited or deferred to assure\\nsafety of EMS personnel and patient.\\nB. Notify the dispatcher of the assistance needed.\\nC. Provide any additional information available  e.g., number of assailants,\\nweapons present/involved, any additional information.\\n\\nSpecial Considerations: For those patients, who have been contaminated in a hazardous\\nmaterial incident, refer to 10.8 Hazard Contaminated Patient-Special Operations\\nProtocol.\\nMCA Name: Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDSSH Approved: October 11, 2023\\n\\nPage 1 of 2\\n\\nOakland County Medical Control Authority\\nSYSTEM\\nVIOLENT/CHEMICAL/HAZARDOUS SCENE\\nInitial Date: 9/14/2023\\nRevised Date:","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-21_1":{"name":"Protocol Source/Reference","content":": Michigan 8.21 Violent/Chemical/Hazardous Scene; Version 12/27/22.\\n\\nMCA Name: Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDSSH Approved: October 11, 2023\\n\\nPage 2 of 2\\n\\nOakland County Medical Control Authority\\nMedical Control Hospital\\n2024 Letter of Compliance\\nHospital/Facility Name:____________________________________________________________\\n(Print Name)\\nYES\\n\\nNO\\n\\n1.\\n\\nLicensed by the Michigan Department of Health and Human Services (MDHHS) as:\\n(check one)\\nA.\\nHospital\\n_______\\nB.\\nFree Standing Facility\\n_______\\nC.\\nHospital Provider-based ED\\n_______\\n\\n____\\n\\n___\\n\\n2.\\n\\nIf a hospital/facility makes a permanent change in their categorization, the facility\\nshall notify the Oakland County Medical Control Authority (OCMCA) 30 days in\\nadvance of the change.\\n\\n____\\n\\n____\\n\\n3.\\n\\nHospital has 24/7 interventional cardiac catheterization capabilities.\\n\\n____\\n\\n____\\n\\n4.\\n\\nTrauma Levels:\\nA.\\nVerified by the American College of Surgeons as a Level 1, 2, or 3 Trauma\\nCenter.\\n\\n____\\n\\n____\\n\\nB.\\n\\nVerified by the State of Michigan as a Level 3 or 4 Trauma Center\\n\\n____\\n\\n____\\n\\nC.\\n\\nDesignated by MDHHS as a Level 1 through 4 Trauma Center.\\nPlease indicate level and date of last inspection/designation.\\nADULT LEVEL: ______________________ DATE: _____________\\nPEDIATRIC TRAUMA LEVEL: _________ DATE: _____________\\n\\n____\\n\\n____\\n\\n____\\n\\n____\\n\\n____\\n____\\n____\\n____\\n\\n____\\n____\\n____\\n____\\n\\nAssure that the emergency facility has a full-time emergency medicine Board\\nCertified/Eligible emergency physician director whose primary clinical responsibility\\nis emergency medicine.\\n\\n____\\n\\n____\\n\\nAssure that an emergency medicine Board Certified/Eligible emergency physician\\nbe available 24/7 to provide online medical direction and handle ALS runs at all times.\\n\\n____\\n\\n____\\n\\nAccept the responsibility for replenishing medication and medical supplies, expended\\nby ALS personnel during treatment of a patient, as per the Regional Drug Box Policy\\nand IV Auxiliary Supply Policy.\\n\\n____\\n\\n____\\n\\n5.\\n\\n6.\\n\\n7.\\n\\n8.\\n\\nStroke Levels:\\nCertified as a Stroke Center.\\nA.\\nIndicate the facilitys certifying body: _____________________\\nB.\\nLevel I Comprehensive Stroke Center\\nLevel II Thrombectomy Stroke Center\\nLevel III Primary Stroke Center\\nLevel IV Acute Stroke Ready\\nC.\\nPlease indicate date of last inspection/verification.\\nDATE: _____________\\n\\n9.\\n\\n10.\\n\\n11.\\n\\nThis facility designates the OCMCA (including its PSRO) to perform professional\\npractice review functions on behalf of the facility, including review of pre-hospital\\nmedical direction furnished in Oakland County and recommendations for improvement\\nof such care.\\n\\n____\\n\\n____\\n\\nFacility will participate in the EMS system quality assurance program, and will supply\\ndata on outcome of patients as agreed to by the OCMCA.\\n\\n____\\n\\n____\\n\\nMEDICAL CONTROL HOSPITALS WITH LSA OVERSIGHT\\nA.\\nFacility will provide education activities for LSAs, additional activities agreed upon\\nby the LSA and the facility, activities as directed by the OCMCA PSRO, and\\nactivities that may include EMS run report review.\\n____\\n\\n____\\n\\nB.\\n\\nFacility agrees to allow and encourage the Medical Control Physician the ability\\nto be an advisor to EMS personnel. Educate and communicate with hospital\\n\\nmedical staff on issues concerning the EMS community, including all\\nprotocols and protocol updates. This may include: auditing the medical direction\\ngiven by the Medical Control Hospital; and assist in developing EMS\\neducational programs. The Hospital shall report all EMS agency and personnel\\nincidents or concerns to the OCMCA office.\\n____ ____\\n12.\\n\\nFacility follows the OCMCA Medical Control and Participating Hospital Policy, and\\nthe Epi-Auto Injectors Exchange Policy.\\n\\n____\\n\\n____\\n\\n13.\\n\\nHospital/facility will enter CARES data, as necessary.\\n\\n____\\n\\n____\\n\\n14.\\n\\nCompletion of Addendum Facility Survey (see addendum).\\n\\n____\\n\\n____\\n\\n15.\\n\\nHospital admits patients under the age of 14.\\n\\n____\\n\\n____\\n\\nAddendum to Letter of Compliance\\nFacility Survey\\n\\n1.\\n\\nHelicopter Pad\\nOn-site ________\\n\\nOff-site ________\\nIndicate Number\\n\\n2.\\n\\nEstimated number of hospital personnel, including full/part time and volunteers.\\n\\n___________\\n\\n3.\\n\\nPatient bed capacity.\\n\\n___________\\n\\n4.\\n\\nEMS entrance code.\\n\\n___________\\n\\n5.\\n\\nPlease indicate the specialties that are available at your facility:\\n\\n Cardiac  Cooling\\n Cardiac  Open heart\\n Cardiac - 24/7 interventional cardiac catheterization capabilities\\n Neonatal\\n NICU Level III II I\\n OB/Labor\\n Pediatrics\\n PICU Level I II\\n Adult Burn (severe)\\n Pediatric Burn (severe)\\n6.\\n\\nSelect which Special Studies/Programs that your hospital participates:\\nStroke Systems of Care Study\\nEmergency Triage, Treat, and Transport (ET3) Special Study\\neComs/eBridge Study\\n\\nOCMCA Hospital\\nEmergency Contact Information\\nIn the event that the Oakland County Emergency Operations Center (EOC) is activated due to\\ndisasters/emergencies, additional county resources may be required. Please provide the following\\ninformation:\\nHospital:\\n\\nAddress:\\n\\nED 24/7 #:\\n\\nePCR Fax #:\\n\\nePCR E-mail Address\\n\\nEMS Recorded Line:\\n\\nCEO:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nHospital EMS Coordinator/Liaison:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nED Director:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nMCC Physician:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nMCC Physician Alternate:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nPharmacy Director:\\n\\nE-mail address\\n\\nWork #\\n\\nCell #\\n\\nPharmacy Secondary Contact ____________________ E-mail address\\nWork #\\n\\nCell #\\n\\nTrauma Program Coordinator:\\n(if applicable)\\nWork #\\n\\nE-mail address\\nCell #\\n\\nStroke Program Coordinator:\\n(if applicable)\\nWork #\\nPCI/STEMI Program Coordinator:\\n(if applicable)\\nWork #\\n\\n_______ E-mail address\\nCell #\\n__ E-mail address\\nCell #\\n\\nPlease let the staff at the OCMCA know of any changes throughout the year.\\n\\nElectronic Signature needed\\n_______________________________________\\nED Director (Signature)\\n\\n________________________________\\nED Director (PRINT)\\n\\nDate\\n\\nNote: MCC Physician Member and Member Alternate Physician serve as the Medical Control Physician on\\nbehalf of Life Support Agencies represented by your facility, in accordance with the OCMCA Medical Control\\nand Participating Hospital Policy.\\n\\nOakland County Medical Control Authority\\nSYSTEM\\nMEDICAL EXAMINER NOTIFICATION AND\\nBODY DISPOSITION\\nInitial Date: 9/14/2023\\nRevised Date:","source_file":"Section-8-TOC.pdf","categories":["adult","trauma","medical","pediatric"]},"section_8-22":{"name":"Medical Examiner Notification and Body Disposition\\nThe intent of this policy is to establish standards for proper and respectful disposition","content":",\\nhandling, and notifications for a deceased person.\\n\\n\\nRefer to 7.6 Dead on Scene & Termination of Resuscitation-Procedure Protocol\\nfor determination of when and when not to initiate CPR, and when to terminate\\nefforts.\\n\\nI.\\n\\nOut of hospital death  Notification of the Medical Examiner\\nA.\\nLaw enforcement shall be notified for any out-of-hospital death.\\nB.\\nResponsibility to notify the Medical Examiner:\\n1.\\nIf a patient is transported to a hospital from the scene, the hospital is\\nresponsible for the notification.\\n2.\\nIf a patient is pronounced dead without being transported to the\\nhospital, the notification is the responsibility of local law enforcement.\\nC. Provide gift of life status to the entity contacting the Medical Examiners office.\\n\\nII.\\n\\nOut of Hospital Death  Management, Handling and Movement of Body\\nA.\\nA body shall not be moved from the location of death without approval of the\\nMedical Examiners office.\\nB.\\nBodies must remain in the physical custody of the police or EMS until released\\nby the Medical Examiners office.\\nC.\\nMedical devices utilized during care by EMS must remain in place.\\nD.\\nIf there is evidence of suspicious, violent or unusual cause of death, caution\\nshould be taken to avoid contamination of the scene.\\n1.\\nPolice may choose to photograph or document the placement of\\nmedical devices, medical equipment, etc. in suspicious situations, prior\\nto their movement or removal.\\nE.\\nNo personal items should be removed from the body with the exception of\\nidentification.\\nF.\\nBodies may be covered with a sheet which does not shed fibers.\\nG.\\nIf a body is moved, the location should be to a private, secure and nearby\\nlocation.\\nH.\\nBodies must be handled with care and respect for the deceased, the family\\nand the public.\\n\\nIII.\\n\\nDeath in an Ambulance  termination of care\\nA.\\nPatients with valid DNR orders being transported for any reason, whether due\\nto an emergency condition or during an interfacility transfer, who experience\\ncardiac or respiratory arrest shall have the DNR honored unless, before\\narresting, the patient expressly withdraws their DNR.\\nB.\\nPatients for whom transport was initiated but who, during transport, meet the\\ncriteria for either Dead on Scene or Termination of Resuscitation protocols,\\n\\nPage 1 of 2\\n\\nOakland County Medical Control Authority\\nSYSTEM\\nMEDICAL EXAMINER NOTIFICATION AND\\nBODY DISPOSITION\\nInitial Date: 9/14/2023\\nRevised Date:","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-22_1":{"name":"and for whom On-line Medical Control (OLMC) has approved a termination of\\nresuscitation (as required by those protocols respectively","content":"), may have care\\nterminated while still en route to the hospital.\\nIV.\\n\\nDeath in an Ambulance  transportation of body\\nA.\\nIn the event of a patient death in an ambulance, the body shall be transported\\nto the original destination hospital.\\n1.\\nThe patients body shall be brought to the Emergency Department.\\n2.\\nThe patient will be registered at the hospital.\\n3.\\nThe Medical Examiner shall be contacted by the hospital.\\nB.\\nIf a patient is being transferred to a nursing home or to their home,\\nimmediately following discharge from a hospital, and death is determined, the\\nbody should be brought back to the hospital from which they were discharged,\\nunless the patient is a hospice patient.\\n1.\\nIf the patient is a hospice patient and hospice will be meeting you at the\\ndestination, or the destination is a hospice facility, you may continue on\\nto the destination and relinquish the body to hospice personnel.\\n2.\\nIf the patient is a hospice patient, and hospice personnel will not be\\nmeeting you at the destination, continue on toward the destination,\\ncontact a supervisor from your agency and evaluate the situation.\\nWhere you ultimately go is dependent on how far you are from the\\ndestination, if family was intending to meet you at the destination, if the\\ndeath was unexpected and any confounding factors. The body may not\\nbe left without there being a custodial transfer from EMS to an\\nappropriate healthcare provider.\\na)\\nConsider contacting the hospice care provider\\nb)\\nConsider consultation with online medical control\\nc)\\nIf the death was unexpected, contact local law enforcement.\\nC.\\nIf a patient is being transferred from a facility to an appointment, or vice versa,\\nwhere neither the starting or ending destination was a hospital:\\na)\\nIf no DNR exists, treat and transport the patient to a hospital.\\nb)\\nIf a DNR exists but the patient is not a hospice patient, determine\\ndeath, honor the DNR, and transport the body to a hospital\\nc)\\nIf a DNR exists and the patient is a hospice patient, determine\\ndeath; honor the DNR, refer to IV(B)(1) and (2) above.\\n\\nProtocol Source/Reference: Michigan 8.22 ME Notification and Body Disposition; Version 12/27/22.\\n\\nPage 2 of 2\\n\\n-~l,\\n\xa3DHHS I\\nM\\nMichigan Departmenl o, Health,HumanServices\\n\\nBureau of Emergency\\nPreparedness, EMS\\nand Systems of Care\\n\\nMichigan\\nSYSTEM\\nSAFE DELIVERY OF NEWBORNS\\n\\nInitial Date: 06/13/2017\\nRevised Date: 12/27/2022","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-23":{"name":"Safe Delivery of Newborns\\nPurpose\\nAccording to Public Act 4","content":"88 of 2006 and Public Acts 232, 233, 234, and 235 or 2000,\\nparents may surrender their newborn child to any hospital, fire department, police station, or\\ncall 911 from any location and remain anonymous. This protocol outlines steps to be taken\\nin this circumstance. *IMPORTANT* While there is opportunity for information\\ngathering through forms, the surrendering parent has the option of remaining\\ncompletely anonymous and disclosing no information.\\nDefinitions\\nNewborn: A child who a physician reasonably believes to be not more than 72 hours\\nold.\\nEmergency Service Provider (ESP): A uniformed or otherwise identified employee or\\ncontractor of a fire department, hospital, or police station when such an individual is\\ninside the premises and on duty. ESP also includes a paramedic or an emergency\\nmedical technician (EMT) when either of those individuals is responding to a 9-1-1\\nemergency call.\\nSurrender: To leave a newborn with an emergency service provider without expressing\\nan intent to return for the newborn.\\nProcedures\\n1. The surrender of the infant must occur inside the fire department, police station or in\\nresponse to a 9-1-1 emergency call to paramedics or EMT.\\n2. In the instance of a parent attempting to surrender a newborn to a staffed ambulance,\\nnot on an emergency call, immediately notify dispatch and establish an emergency\\ncall.\\n3. To protect the parents right to anonymity/confidentiality, the EMS agency responding\\nto a 911 emergency call from a parent(s) wanting to surrender a newborn, should\\nnot use the vehicle sirens or flashing lights.\\n4. The firefighter, police officer, paramedic or EMT personnel cannot refuse to accept\\nthe infant and must place the infant under temporary protective custody.\\n5. Fire departments, police stations, paramedics and EMTs have statutory obligations\\nunder the law, including:\\na. Assume that the child is a newborn and take into temporary protective\\ncustody.\\nb. Ask surrendering person(s) if they are the biological parent(s). If they are not\\nthe biological parent(s) the newborn cannot be surrendered under the Safe\\nDelivery of Newborns law.\\nc. Make a reasonable effort to inform the parent(s) that:\\ni. By surrendering the newborn, the parent(s) is releasing the newborn to\\na child placement agency to be placed for adoption.\\nii. He or she has 28 days to petition the Circuit Court, Family Division to\\nregain custody of the newborn.\\n\\n-~l,\\n\xa3DHHS I\\nM\\nMichigan Departmenl o, Health,HumanServices\\n\\nBureau of Emergency\\nPreparedness, EMS\\nand Systems of Care\\n\\nMichigan\\nSYSTEM\\nSAFE DELIVERY OF NEWBORNS\\n\\nInitial Date: 06/13/2017\\nRevised Date: 12/27/2022","source_file":"Section-8-TOC.pdf","categories":["medical","pediatric"]},"section_8-23_1":{"name":"iii","content":". There will be a public notice of this hearing and the notice will not\\ncontain the parent(s) name.\\niv. The parent(s) will not receive personal notice of the hearing.\\nv. Information the parent(s) provides will not be made public. A parent(s)\\nmay contact the Safe Delivery of Newborns hotline for information. The\\ntoll-free number is: 866-733-7733\\n6. Provide the parent(s) with written material from the Department of Health and Human\\nServices that includes:\\na. Safe Delivery Program FACT Sheet (DHHS Pub 867)\\nb. What Am I Going To Do? (DHHS Pub 864) Optional\\n7. Make a reasonable attempt to:\\na. Reassure parent(s) that shared information will be kept confidential.\\nb. Encourage parent(s) to identify him/herself.\\nc. Encourage the parent(s) to share any relevant family/medical background,\\nVoluntary Medical Background Form for a Surrendered Newborn (DHHS Form\\n4819).\\nd. Inform the parent(s) of the newborn he or she can receive counseling or\\nmedical attention.\\ne. Inform parent that in order to place the child for adoption the state is required\\nto make a reasonable attempt to identify both parents. Ask for the nonsurrendering parents name. Do not press if the name is refused.\\nf. Inform the parent(s) that he or she can sign a release for the child that could\\nbe used at the parental rights termination hearing, Voluntary Release for\\nAdoption of a Surrendered Newborn (DHHS Form 4820).\\n8. Fire and Police may contact emergency medical services (EMS) to transport newborn\\nto hospital. ESP will accompany newborn to the hospital to provide hospital with any\\nforms completed by the parent(s) and to transfer temporary protective custody.\\na. Note: Temporary protective custody cannot be transferred to EMS. A\\nrepresentative of the fire department or police station must go to the hospital to\\ntransfer temporary protective custody to the hospital.\\n9. The responding EMS crew will transport the newborn to closest appropriate facility,\\naccording to the MCA transport protocol, provide any forms completed by parent(s)\\nand transfer temporary protective custody to hospital staff.\\n* For Safe Delivery purposes EMS is defined as a paramedic or emergency medical\\ntechnician.\\n\\nBureau of Emergency\\nPreparedness, EMS\\nand Systems of Care\\n\\nMichigan\\nSYSTEM\\nSAFE DELIVERY OF NEWBORNS\\n\\nInitial Date: 06/13/2017\\nRevised Date: 12/27/2022\\n\\nMCA Name: Oakland County\\nMCA Board Approval Date: 10/6/23\\nMCA Implementation Date: 2/1/24\\nMDHHS Approval: 12/27/22","source_file":"Section-8-TOC.pdf","categories":["medical","pediatric"]},"section_8-23_2":{"name":"Page 3","content":"of 7\\nMDHHS Reviewed 2023\\n\\n-~l,\\n\xa3DHHS I\\nM\\nMichigan Departmenl o, Health,HumanServices\\n\\nMichigan\\nSYSTEM\\nSAFE DELIVERY OF NEWBORNS\\n\\nBureau of Emergency\\nPreparedness, EMS\\nand Systems of Care\\n\\nInitial Date: 06/13/2017\\nRevised Date: 12/27/2022","source_file":"Section-8-TOC.pdf","categories":[]},"section_8-23_3":{"name":"CONFIDEJNTIAL\\n\\n1","content":"VO LUNTARY MED\' CAl. BACKGROUND FORM FOR A SURRENDERED NEWBORN\\nMichigan Department of H11mani Seli\'Vices\\n\\nIM!ID? wai;. 1111! cMII IJom?\\n\\nSURRENDERilNG PARENT BACl~G.ROUND 1(Dptionalt\\nName\\n\\nI\\n\\nDale \xabB11111,\\n\\n1Ma111a1Slatll5\\n\\nP!Jooe Niinber\\n\\nDs  M D D\\n\\nAdG\\"eEl5\\n\\n\\n\\nHe!~\\n\\n1~1\\n\\n,Any Family History ot\\n\\nYes\\n\\nN\'o\\n\\nSid:le Celli D isease\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nHeart Disease\\nlliabetes\\nIHIV\\nHepatifis\\n~\\n\\nldealll\'I\' lilllJe\\n\\nAffllii1!!,dlWIIII l\'Jnellcan lrdilll Tt11Je\\nt,10\\nYES\\n\\nlilace\\n\\nI \\n\\nI\\n\\neye D:for\\n\\ntlla Ctl\'or\\n\\nCancer\\nGenetic Diseas;e\\nFarMy H is.i nly or Menial ill rnes\\nDl1\'g Usage\\n\\nAlcdildlUsage\\n\\nYes\\n\\nNa,\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nlfYes.Tp\\nlfYes.Tp\\nlfYesEll\xb5lain,\\n\\nIf Yes Explain,\\nIf Yes.Explain,\\n\\nSU\'glcal IH161D1y\\n\\nOIHER PARENli BACKGROUND 1(U ptiooal)\\n\\nIO s O M O D\\n\\nName\\n\\nI\\n\\nDale\xabB11111,\\n\\nMarllal SlatlJ5\\n\\nP!Jooe NIIllber\\n\\nAdG\\"eEl5\\n\\n\\n\\nHe!~\\n\\n1~1\\n\\n.Ari,, Family HisilD:ry ot\\n\\nYes\\n\\nN\'o\\n\\nSid:le Celli D isease\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nHeart Disease\\nlliabetes\\nHIV\\nHepatifis\\n\\nOilll!t\\"\\n\\nfdelllll\'l\'lilllle\\n\\nAffllii1!!,dlWIIII ~ lrdilll Tt11Je\\n\\nlilace\\n\\nn\\n\\nYES\\n\\nt,10\\n\\nleyeett\xab\\n\\nltllaettor\\n\\nCancer\\nGenetic Disease\\nFarMy Hisinly or Mental l l rnes\\nDl1\'g Usage\\n\\nAlcohol Usage\\n\\nYes\\n\\nNo,\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nlfYes.Tp\\nlfYes Tp\\nlfYesEl\\\\plain,\\n\\nIf Yes.Explain,\\nIf Yes Eicplain,\\n\\nSU\'glcal IHl6IDly\\n\\nI0\\n\\nINFORMATION AIBOUT liHE PRiEGNANCY\\n\\norug ix A10ana1 use lli:alrt91Pregnancy\\nYes\\n\\nO No,. If yes. E-9!!:!:!\\n\\nEIIERGHIICY SBRWCIE PRO\'llilD\'ER OBSEIRVATION!S\\noommen1a.\\n\\n1~\\n\\nESP ~\\n\\n--=\\n\\nICIiy\\n\\nP!Jone\xb7 Niinber\\nStale\\n\\n1~cooe\\n\\nMichigan\\nSYSTEM\\nSAFE DELIVERY OF NEWBORNS\\n\\nBureau of Emergency\\nPreparedness, EMS\\nand Systems of Care\\n\\nInitial Date: 06/13/2017\\nRevised Date: 12/27/2022","source_file":"Section-8-TOC.pdf","categories":[]},"section_8-23_4":{"name":"VOLUNTARY RELEASE FOR","content":".A DOP\'TION OF A SLIJRRE1NDEREU NEWBORN BY PARE1NT\\n!Michigan Dep amnent of Human SetVices\\n_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ .. a newborn child.\\n\\nIn lhe mattenJtf\\n\\n1.\\n\\nI.\\n\\n_ _ _ _ _ _ _ _ _ _ _ _ _  DOS. __l_ _ _ _ _ amihe\\n\\nD mother\\n\\nD f.a1her\\n\\nI\\n.at\\n-------------,6Ci\\n= ce-:)-, - - - - -\\n\\nof the abo,.,-e child, \xb7who \xb7was born on\\n\\n2.\\n\\nI umf,e.-stand lhat I have parental rights \xb7lo this child and lhat by ~ni~ this release. I \xa5Dllllntaliy Jete.ase\\nall of my p8l\'elltal rigJrts ro my child. (Subject \xb7ID number three below:.1,\\n\\n::i..\\n\\nI un derstand lhat I ha\xa5e 28 days .after SUIH!\'lldering my\xb7 newborn ,child \xb7lo pe:iim:m Ille couit ID reclaim\\ncustody of my\xb7child.\\n\\n4\xb7.\\n\\nI unde.-stand lhat I will not receive notice air any hearings..\\n\\n5,.\\n\\nUnde.-standing the above pro\'lliSXJns. I release completely a:nd perman,entty my parantal rig:trts ro my\\nchil\'d. aru:I release my chikl to a chil\'d placing agen,c.y far Ille purpose of adoption..\\n\\nI adl\'lO\'Medg,e receipt of the fullowing:\\n\\n6,.\\n\\n_ _ Fact Slieet (Pub 867)\\n\\nDale\\n\\nI\\n\\n!Parent Sign ature\\n\\nAddress\\n\\nCity\\n\\nstale\\n\\nZip - - - - - -\\n\\nWiln:e-ssed by\\nttame (l:)pe oqptlnli)\\nOil\\n\\n-==------ \\"at _,..............,.,,.,.,,...._ _ _ _ _ _ _ _ _ _ _ _ _ _ __\\nAgency aoo Mll\\"IS\\n\\nDii1I!\\n\\nS lgnalln!\\n\\nIF A. INOTA!RY ISAVAILAIBLJE: NalaJiY Public\\n\\nSubscribed aru:I swam \xb7ID befure m e or, _ _ _ __\\nCo:IE!y.-xlstale\\n\\nDate\\n\\nMyconmissian e xpoes:\\n\\n-==-----Dii1I!\\n\\nSlgllilhl\'e:\\n\\n____________________\\n\\nNifl\'.I! (1\xa5,pe-or prllll)\\n\\nAJ.m-lCJIRITI\': sbe I?A. 23:2 Of 2mllll\\nRIESPIJINSE: Vc:fUnta)\'\\nFIENAt.Tr. one\\n\\n~lil\'nenli OI Htman ser.fce6,CDHS) \'WII m:t II.Wlnmate\xb7 iilPll6I\\nall)\'nrmual or g:ou,p lll!!:aLEeoUace. i;a:,, 1re11g1on, ag~ lliillooal\\noCIJjln. COior. neqn. Wl!lm:1I. natlil\'I 6ialJJ.. paraca IJElleJ&. or\\ndl6ablll\'I\'. Iii yoo1 need l:le{p .\'IM.\'111 re;mr,g_ 1i1111i1g. t11g1ag1, etc:.,\\nUnder ~ Amet:1can5 IM1tl Dl6alllllle!i Act, \'.jlllU are UW11ed ID DlliE\xb7\\nI roi;a- nees b1o\\\\m 1D a DHS alllce ti voor aHli!c\\n\\nllHS-48211 (RE\'>\'. 5-1171MS IMml\\n\\n-~l,\\n\xa3DHHS I\\nM\\nMichigan Departmenl o, Health,HumanServices\\n\\nMichigan\\nSYSTEM\\nSAFE DELIVERY OF NEWBORNS\\n\\nBureau of Emergency\\nPreparedness, EMS\\nand Systems of Care\\n\\nInitial Date: 06/13/2017\\nRevised Date: 12/27/2022\\nSection 8-23\\n\\n\xb7s urrendering Parent Rights\\nBy surrenderi11g your newborn, you ,ne n!leasiag\\nyour newborn to a chid placi 11!1 agency to l,e,\\nplaced for adoption .\\n\\nYou have 28 days after sunemleri 11!1 your newborn\\n\\nto petition the court to regain CJJstody.\\nAfter the 28 days ead there will be a hearing to\\nterminah! your l]\'all!rltll rigb6.\\nJne-re, will be a pu\'blic notice oHhis hearing;\\nlhowewr, t!he notice\xb7wi not contain \'.J\'OlllT name.\\n\\nYou \xb7will. NOT receive personal notice of the heari11g.\\n\\nSurrender Your Baby\\n\\nAny information you aTewilling to provide to an\\nEmergency Service Provider will N01i be made public:.\\n\\n~\\n\\nhospital\\nfire department\\npolice statio\\n~ by calling 9-1-1\\n\\nFor more informatiom on ,safe delivery\\ncaU the hotline at 866-733-7733\\nThi! cardl lbalow 11 dlbchabla.\\nPlease keep ft wtfih you1o, ,au ft along\\nto IO.. l!OIII! JOU tfllnlc ft Illa)\' help_\\n\\n&e......,__\\n\\nA newbarn ca be 1u11115_.. within 72 .....\\nahirthinlide ..........\\npalice ltlml ar lly ailing t-1-1\\n\\n\':It,\\n\\nHOTLINE:\\n866-733-7733\\n\\nSAFE. LEGAL. ANONYMOUS.\\n\xb7meM ~ lilepartmecl D:1 li1ealfn .iooll11mar1 ser.t:86\\n\\nSAFE. LEGAL. ANONYMOUS. :\\nHOTLINE: 866-733-7733\\n\\nMichigan\'s\\nS.fe Delivery of Newborns Law\\n\\n:\\n\\n(MIDHHS) (t)ef; nold&emllr1lilte agaln&I ~ ~ ltvlllill or\\n!JOOP llecaLR ct race_ teflgkln, age. r:iailonai Orljllrl, COiar,\\n~ \'WE1Jlf. 1 1Btial lititus,, 9=nelk: lt11brn&boo. &eJC.. &emal\\n~ 9=nmen t1er1ttty orexprE651Cll\\\\ 1\\npom:al lbele15 or\\nll&ablllly:\\n\\ni\\nL------------------------------J\\nwww.michigan.gov/ safedelivery\\n\\nI\\n\\n-~l,\\n\xa3DHHS I\\nM\\nMichigan Departmenl o, Health,HumanServices\\n\\nBureau of Emergency\\nPreparedness, EMS\\nand Systems of Care\\n\\nMichigan\\nSYSTEM\\nSAFE DELIVERY OF NEWBORNS\\n\\nInitial Date: 06/13/2017\\nRevised Date: 12/27/2022\\n\\nYoung and Scared?\\nYou tnay be a teen or a young ildull who is\\nnot ready emotionally or financially to IK! a\\nl)ilrent Maybe you have been ilble to keep your\\npregnancy ii seael But now whilt? You haw a\\nchoice to take your nl!Wbom to a safe place.\\n\\nWhat i s a. Safe Place?\\nIf your baby is three days old or less, it is\\nnot a crime to surrender yo111r newborn to an\\nemployee of a hospita~ fire department, or a\\npolic-e station. You may also a ll 9-1-1.\\n\\nNo One Ne&ds t o Know ...\\nYou an I.eave without gMng your name. It\\nwou!d hl!fp th!! baby if you have some basic\\nheilll:h i nformation. However, you do not have\\nto answer any questions. It is YOOR choice.\\n\\nMCA Name: Oakland County\\nMCA Board Approval Date: 10/6/23\\nMCA Implementation Date: 2/1/24\\nMDHHS Approval: 12/27/22","source_file":"Section-8-TOC.pdf","categories":["pediatric"]},"section_8-23_5":{"name":"Surrender Your Baby\\n\\nMichigan","content":"\'s\\nSafe Delivery of Newborns Law\\n\\nSAFE . LEG.AL .ANONYMOUS.\\n\\nSAFE. LEGAL. ANONYMOUS.\\nr\\n\\nWhat Happens to Your Baby?\\nIf your baby needs rnediGll attention, he\xb7 or\\nshe wllll receive it The professional staff person\\nwho acc-epts the bilby will contact an adoption\\nagency. Social workers will plilc1! the bilby wil:h\\na pre-ildoptive family. There are many families\\nwho want to adopl The pliln is to make sUJe your\\nbaby hils a good home where he or she an grow\\nup heil~ and happy.\\n\\n~\\n\\nLOOK FOR THIS SIGN!\\nPLEASE DON\'T ABANDON YOUR BABY\\n\\nIt\'s Your Choice ...\\nMaybe you made a mistake, But you can make a\\ngood choice now. You can choO!iil! ii safe p~ce for\\nyour nl!Wbom. It is a decision that will help yo11\\nand yo111 baby. Your baby ciln hilVe a filmi[v.\\n\\nSafti DllliwllJ ., ....... La\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-24":{"name":"Complaint Investigation & Resolution\\nPurpose","content":": This policy is provided as a means to receive, investigate, and resolve complaints\\nregarding licensees falling under the purview of the Medical Control Authority\\n(MCA).\\nI. Definitions:\\nA. Allegation/Complaint Invalid:\\nThe allegation or compliant was found to have no administrative rule or protocol\\nviolation or the protocol deviation was considered acceptable for the situation.\\nB. Allegation Valid Minor:\\nThis can be viewed two ways:\\n1. The licensees role in the administrative rule or protocol violation was small.\\n2. The result of the administrative rule or protocol violation had a minor effect.\\nC. Allegation Valid Serious:\\nThis can be viewed two ways.\\n1. The licensees role in the administrative rule or protocol violation was great.\\n2. The result of the administrative rule or protocol violation had a major effect.\\nD. Appeal Hearing:\\nA hearing to appeal an Order of Disciplinary Action. This hearing is to re-examine\\nany new facts and/or review the incident to ensure due process has been followed.\\nE. Order of Disciplinary Action (ODA):\\nAn Order of Disciplinary Action (ODA) is a written document developed by the MCA\\nand sent to a subject licensee for the purposes of clearly and plainly identifying the\\nfindings of the MCA, any disciplinary action and any required remediation.\\nF. Complaint:\\nFor the purpose of this policy, a complaint shall be defined as any notification of\\ndissatisfaction or concern regarding medical care rendered by the MCA licensed\\nEMS provider/agency, or any issues that involve the performance of the EMS\\nsystem in whole or in part.\\nG. Due Process:\\nA course of formal proceedings carried out regularly and in accordance with\\nestablished rules and principles\\nH. Formal Inquiry:\\nFormal inquiry means that a complaint has been found to either be valid, or that\\nmore detailed inquiry is necessary to determine the validity of the complaint; either\\nof which will require that the subject licensee (individual/agency) be notified of the\\nspecific complaint. A formal inquiry may involve the gathering of incident reports\\nwhich provide explanations for care rendered or justification for actions, as well as\\nsubject/witness interviews. Some information gathering may not necessitate a\\nformal inquiry.\\n\\nPage 1 of 13\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:\\nSection: 8-24\\n\\nI. Just Culture Guidelines:\\nA just culture policy is a high-level statement of the values and commitment of an\\norganization to treat healthcare workers and agencies fairly in all complaint\\ninvestigations.\\nJ. Licensee:\\nA licensee is defined as an individual or an agency (fire department, rescue squad,\\nlife support agency, etc.) holding a valid State of Michigan Medical First Responder,\\nEmergency Medical Technician, Specialist, Paramedic, or agency licensed to\\noperate within the Medical Control Authority service area. Said individual licensee\\nshall be an employee of a provider licensed to operate within the Medical Control\\nAuthority.\\nK. Privileged Documents:\\nPrivileged documents are those which are collected by the Professional Standards\\nReview Organization (PSRO) of the MCA.\\nL. Quality Improvement Action:\\nAn action taken to remediate a valid complaint to the MCA.\\nM. Sentinel Event:\\nA sentinel event is any complaint which involves at least one single level I infraction,\\na violation of Michigan or Federal laws, EMS rules, or 2 or more level II infractions,\\nas described in the Medical Incident Review and Corrective Action Policy.\\nN. Subject Licensee:\\nThe individual provider that is the subject of the complaint received by the MCA\\nII. Complaints Received:\\nA. Complaints may be received at the MCA directly, at life support agencies or by\\nindividuals. Those in receipt of a complaint which involves violations of protocols,\\nstatutes, or administrative rules shall inform the MCA. The MCA will determine if\\nfurther investigation is necessary.\\nB. The complainant for a case should be asked if they would like to be contacted by the\\nagency/individual that is the subject of the complaint. This will allow the complainant\\nthe opportunity to voice a request to remain anonymous or to allow their information\\nto be provided to the subject of the complaint.\\nC. All complaints, in order to be considered for action by the MCA, shall meet the\\nfollowing Inclusion Criteria:\\n1. A complaint may be submitted either verbally or in writing. Hearsay or\\nsecond hand complaints may not be accepted or investigated by the\\nMCA.\\n2. The complainant must provide the MCA with his/her name, address, and\\ntelephone number. A request for anonymity by a complainant shall be\\nhonored by the MCA to the extent possible.\\n\\nPage 2 of 13\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:\\nSection: 8-24\\n\\n3. The complaint must be directed toward a licensee (individual or agency)\\nwithin the MCA.\\n4. The complaint must include a potential violation of Michigan or Federal\\nlaws, EMS rules, or MCA protocol\\ni. All complaint reviews will be based on MCA approved protocols that\\nwere approved and active on the date of the EMS call for service.\\nD. Complaints That Might Not Be Considered\\n1. Complaints regarding conduct of a licensee, exclusive of medical practice\\nor actions bearing upon medical practice, may be referred to the employer\\nof the individual. These complaints may also be referred to the PSRO for\\ninvestigation at the discretion of the MCA.\\n2. MCA reserves the right to retain the complaint investigation.\\nIII. Complaint Delegation:\\nA. Complaints directed toward an individual acting while employed by an agency outside\\nof the jurisdiction of the MCA shall not be accepted or investigated but will be\\nforwarded, or the complainant directed to, the MCA/agency under whose jurisdiction\\nit does fall.\\nB. MCAs may cooperate on investigations which overlap jurisdictional boundaries. For\\nthe purposes of Quality Improvement Actions, the MCA granting Medical Control to\\nthe provider or agency where the primary action or actions being investigated took\\nplace shall be considered the jurisdictional MCA.\\nC. Complaints more appropriately investigated at the agency or operational level may be\\nturned over to the life support agency or hospital involved. Investigation results\\nshould be reported to the MCA.\\nIV. Investigation of Complaints:\\nA. Once a complaint is received by the MCA, the complaint will be assigned to the\\nPSRO.\\n1. The person(s) charged with complaint investigation will gather information to\\ndetermine the validity of the complaint, if valid:\\ni. The investigator will utilize the following list to determine if the complaint\\nis a formal inquiry or sentinel event. These criteria are for example\\npurposes and do not form an all-inclusive list of potential violations.\\nViolations that are substantively similar in type or severity will fall under\\nthe closest, most appropriate classification category.\\n1. The following categories of incidents are defined as Level I\\nincidents:\\na. Willful neglect of a patient\\n\\nPage 3 of 13\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:\\nSection: 8-24\\n\\nb. Abandonment of a patient\\nc. Failure to obey medical control physician\'s legitimate\\norders either by omission or commission in the presence\\nof good communications.\\nd. Improper and inappropriate care which may result in\\ncompromise of wellbeing of the patient.\\ne. Conviction of a felony or misdemeanor\\nf. Two or more Level II offenses in any six-month period *\\ng. Breach of Confidentiality\\nh. Intentional falsification of EMS documentation, including\\npatient care records.\\ni. Found to be under the influence of drugs or intoxicants\\nwhile involved with patient care.\\nj. Violation of the EMS statute and its attendant rules and\\nregulations, including care outside the scope of practice,\\nas defined by protocol.\\nk. Practicing in the MCA without a current Michigan EMS\\nprovider license.\\nl. Practicing in the MCA without current privileges on two\\nseparate occasions within a single licensure period.\\nCertifications required by the MCA in order to maintain\\nprivileges are identified in the 8.18 Agency and EMS\\nPersonnel Criteria for Participation Protocol.\\nm. Any other patient care offense resulting from violation of\\npolicies, protocols and procedures of similar severity not\\nlisted above at the discretion of the EMS Medical Director.\\nn. Failure to complete prescribed Quality Improvement\\nActions from a previous incident. (Or see (n) of LEVEL II)\\no. Arrest or criminal charges for criminal sexual conduct of\\nany degree, violent crime, drug diversion or illegal\\npossession or distribution of controlled substances.\\np. Failure to notify the MCA of a criminal charge, arrest or\\nconviction within 1 business day\\nq. Gross negligence or willful misconduct\\n* Time measured from the time of occurrence of the initial\\nincident to the time of occurrence of the succeeding event.\\n\\nPage 4 of 13\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:\\nSection: 8-24\\n\\n2. The following categories of incidents are defined as Level II\\nincidents:\\na. Failure to adhere to system protocols, policies and\\nprocedures that had the potential to negatively impact\\npatient care, as determined by the EMS Medical Director.\\nb. Failure of personnel or agency to respond within 96 hours\\nof receipt of requests for information or documentation\\nregarding an incident under investigation by the MCA. A\\nresponse shall be submitted in writing and with a signed\\ndelivery receipt to MCA staff within the allotted time\\nperiod.\\nc. Abuse and/or loss of system equipment due to neglect.\\nd. Significant documentation errors.\\ne. Failure to accurately perform procedures as defined in\\nprotocols, policies and procedures.\\nf. Failure to check and maintain functional equipment\\nnecessary to provide adequate patient care at the level of\\nlicensure, the failure of which may lead to an inability to\\ncommunicate with medical control, inability to administer\\nappropriate medications, or otherwise negatively affecting\\nthe ability of the personnel to function at his/her level of\\ntraining in the field. This includes verification that a sealed\\ndrug and IV box, functional monitor/defibrillator, functional\\nairway equipment, etc. are present on the unit.\\ng. Improper or unprofessional medical communications\\nincluding, but not limited to, any violation of Federal\\nCommunications Regulations, and falsification of\\nidentification during medical communications.\\nh. Failure to appear before the EMS Medical Director,\\ndesignated PSRO committee or MCA Governing Body\\nwhen so requested by the MCA, as defined in the\\nComplaint Investigation, Quality Improvement and\\nDisciplinary Action Policies.\\ni. Furnishing of information known to be inaccurate in\\nresponse to any official request for information relative to\\nquality improvement activities or other investigations\\nsubsequent to this policy.\\nj. Two or more orders of disciplinary action within a 6-month\\nperiod. **\\n\\nPage 5 of 13\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:\\nSection: 8-24\\n\\nk. Any other patient care offense resulting from violation of\\npolicies, protocols and procedures of similar severity not\\nlisted above at the discretion of the EMS Medical Director.\\nl. Practicing in the MCA without current credentials required\\nin order to maintain privileges, as identified in the\\nAuthorization for Medical Control Privileges Policy.\\nm. Medication error, which has a negative impact on patient\\ncare.\\nn. A determination by the designated PSRO Committee of\\nfailure to complete prescribed Quality Improvement\\nActions within the prescribed time frame.\\n** Time measured from the time of occurrence of the initial\\nincident to the time of occurrence of the succeeding event.\\nii. Will communicate with the employing agency of the subject licensee or\\nagency involved in the complaint.\\niii. The PSRO may request copies of documents, incident reports, video\\nand audio recordings relating to a complaint without formal notification\\nof the complaint to the subject licensee and/or agency.\\niv. All requests for information will be documented in the investigation\\nnotes or with attached documentation/emails.\\nv. The agency and/or the individual will have 96 hours to turn over the\\nrequested documentation or provide statements the MCA.\\nvi. The MCA will redact all PHI prior to sending it to the PSRO for review.\\n2. Complaints found to be invalid will be closed as unsubstantiated; notification to\\nthe individual or the agency of the closure will only occur if prior knowledge of\\nthe complaint was provided to, or exists with, the involved individual/agency.\\n3. Formal notification of the subject licensee will occur if MCA Quality\\nImprovement Actions, formal inquiry, or sentinel are indicated. A copy of the\\ninitial complaint, or a complaint summary (if the initial complainant requested\\nanonymity), may be provided upon request.\\nB. Documentation\\nThe documentation of the investigation of a complaint may include, but is not limited\\nto, the following:\\n1. The name, address, and telephone number of the complainant (if known).\\n2. A copy of the stated complaint.\\n3. The date and time of the receipt of the complaint.\\n4. A copy of the complaint acknowledgement, if appropriate.\\n5. A copy of the notice to the subject licensee, if appropriate.\\n6. A copy of the pertinent protocol(s) and/or policy/policies.\\n\\nPage 6 of 13\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:\\nSection: 8-24\\n\\n7. Written statements of witnesses including notes from telephone interviews\\n8. Copies of pertinent reports, transcriptions of audio tapes; video recordings and\\ncopies of other pertinent documents or emails.\\nV. Due Process:\\nThis policy establishes the initial steps of Due Process. A complaint will be investigated\\nfor validity and severity. Subject licensees and agencies shall be notified of formal or\\nsentinel reviews.\\nA. The MCA will provide at least 4 business days notice to affected providers and\\nagencies prior to convening PSRO meetings to which they must attend.\\nB. The MCA will provide a copy of the Complaint Investigation Protocol to the\\nsubject licensee(s) of the complaint.\\nC. Subject licensee(s) and agencies of a complaint will be provided with copies of\\nall, complaint/investigation related materials at the time of the meeting with the\\nexception of materials that would reveal the identity of an individual that provided\\ninformation under the condition of anonymity. The subject licensee or agency\\nmay request the complaint/investigation related materials in advance of the\\nPSRO meeting.\\nD. Based on the complaint information and/or evidence the MCA Medical Director\\nmay temporarily suspend the privileges of a subject licensee or agency pending\\na sentinel event meeting.\\n1. Any MCA suspension enacted as a measure to ensure the safety of\\nthe community or patients shall remain in effect pending sentinel\\nevent review and disposition.\\n2. In the event of criminal charges being filed against a provider or\\nagency related to acts of violence, diversion of medications, illegal\\npossession of controlled substances, criminal sexual conduct, or other\\npractice which may pose a threat to the community or patients, the\\nMCA may act with suspension of MCA privileges without convening a\\nsentinel event PSRO meeting.\\na. The subject licensee or agency shall be notified in writing of the\\nsuspension.\\nb. If found guilty in a court of law, MCA privileges will be considered\\nto be revoked.\\nc. If found not guilty of charges, the individual or agency must\\nprovide copies of court documents, including transcripts, to the\\nMCA.\\nd. If a court case is dismissed based on procedural failings or\\nerrors, the MCA may decline to extend privileges if the conduct\\nof the individual or agency may pose a threat to the community\\nor patients. This should occur at a sentinel event meeting.\\nE. A subject licensee or agency may request a postponement of up to thirty (30)\\ncalendar days of a PSRO meeting appearance in order to prepare his/her\\nindividual or agency response to the complaint. The subject licensee must submit\\n\\nPage 7 of 13\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:","source_file":"Section-8-TOC.pdf","categories":["trauma","medical"]},"section_8-24_1":{"name":"a copy of all supporting documentation to the MCA at least one week (5","content":"business\\ndays) prior to the postponed review meeting.\\nF. The MCA is not a hiring entity and is not subject to collective bargaining. Union\\nrepresentation during MCA PSRO reviews is not permitted.\\nG. The MCAs PSRO investigates incidents, complaints, personnel and agencies.\\nWhile a deed or misdeed may be civil or criminal in nature, the MCAs PSRO is\\nnot an adjudicating body for either of these conditions. The PSRO is not subject\\nto the rules and statutes which govern civil or criminal adjudication; as such,\\nattorneys and legal representatives are not permitted in PSRO reviews.\\nH. Recording, monitoring, or any manner of duplicating a PSRO review is not\\npermitted unless conducted by the PSRO entity and expressly for PSRO\\npurposes.\\nI. Disclosure of confidential PSRO materials1 by individuals or agencies both\\nbefore and after review shall be cause for possible suspension or revocation of\\nMCA privileges, as well as possible statutory violations.\\nJ. The MCA may disclose non-specific information relating to discipline of\\nindividuals or agencies. Care must be taken to not compromise any confidential\\ninformation.2\\nK. Subject licensees or agencies may have agency representation at PSRO reviews\\nprovided PSRO standards are maintained.\\nL. Subject licensees or agencies failing to appear for PSRO reviews waive their\\nright to representation and are subject to the summary findings of the review\\nbody. Failure to appear also constitutes a violation as defined in the Incident\\nClassification Section.\\nM. The following steps shall be taken in the complaint review process for Formal\\nInquiries where the allegations could lead to an Order of Disciplinary Action be\\nprescribed by the PSRO and ALL Sentinel Events:\\n1. The violation of policy or protocol shall be defined.\\n2. The impact on patient outcome will be evaluated.\\n3. The subject licensee shall be given time to speak on the issue of the\\ncomplaint including the opportunity to present supporting\\ndocumentation.\\n4. Counseling, remedial, and/or disciplinary action shall be considered\\nand/or ordered as deemed appropriate by a majority vote of the MCA\\nor their designated and pre-established Professional Standards\\nReview Organization/Quality Review Committee.\\nN. The PSRO of the MCA will review the alleged violation(s) and by majority vote of\\nthe members present decide a course of action.\\n1. All alleged violations will be determined as the following for each\\nindividual subject licensee and/or agency.\\na. Invalid\\n1\\n\\nMCL 331.533\\nMCL 331.533\\n2\\n\\nPage 8 of 13\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:\\nSection: 8-24\\n\\nb. Valid  Minor\\nc. Valid  Serious\\nO. All valid allegations shall be followed by a Quality Improvement Action.\\nP. All system failures shall be addressed by the MCA.\\nQ. Subject licensees or agencies shall be notified of the findings of a PSRO review.\\nIf disciplinary action results, the individual or agency will be provided with any\\nrequired remediation steps/actions and a copy of the 8.25 Disciplinary Action\\nAppeal Protocol.\\nR. In the event that a complaint/investigation involves both the function of an\\nindividual and the compliance of their agency or department, the requirement for\\na 4-business day notice of any special meeting shall apply, unless a\\npostponement is granted to the individual agency or subject licensee.\\nVI. Application of Quality Improvement Action:\\nA. A primary function of Quality Improvement Action is to ensure the protection and\\nsafety of the community and patients.\\nB. The application of the Quality Improvement Action is intended to promote\\nimprovement in clinical and operational performance.\\nC. The MCA shall engage in a process to ensure that licensees maintain an\\nappropriate level of clinical and operational performance.\\nD. MCAs should utilize Just Culture when applying or considering Quality\\nImprovement Actions. There should be a balance between provider and system\\naccountability.\\nE. The subject licensees agency will be notified of any Quality Improvement Action\\nprescribed by the PSRO.\\nF. Quality Improvement Actions may or may not be ascending in severity. In cases\\nwhere misconduct (by action or omission), regardless of where the misconduct\\noccurred, is determined to be reckless, willful, or criminal, ascending discipline\\nmay be bypassed with a more severe disciplinary action imposed.\\nVII. Orders of Quality Improvement Action:\\nA. No Action (Warning Letter)\\n1. A letter can be sent to the subject licensee or agency or individual advising\\nthem that although the incident was determined to be valid; there will be no\\naction taken at this time.\\n2. The MCA may provide recommendations to prevent future occurrences.\\nB. Remediation\\n1. The Medical Control Authority may issue an order of remediation to correct\\nsubstandard clinical performance.\\n2. A defined time period for completion of remedial activity shall be stated in\\nthe order.\\n3. Subject licensees or agency shall be required to perform remedial activity\\nunder the supervision of an appointed proctor to correct an identified\\nperformance shortcoming.\\n\\nPage 9 of 13\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:\\nSection: 8-24\\n\\n4. For subject licensee(s): Notice of a remedial order, or the order itself, shall\\nbe forwarded to the licensees employer (or MCA board in the case of an\\nagency provider).\\n5. A subject licensee or agency shall be allowed only one opportunity for\\nremediation of repetitive substandard performance in a twelve-month\\nperiod. Subsequent episodes of substandard performance of the same\\nnature occurring within the same twelve-month period shall be addressed\\nunder the disciplinary portion of this policy.\\nC. Probation which does not include a restriction of privileges:\\n1. A probationary letter shall be issued to a subject licensee or agency stating;\\na. the details of the substandard performance;\\nb. the details of the probation;\\nc. the remedial action required;\\nd. the time of probationary period;\\ne. the consequences for repetitive noncompliance.\\n2. Notice of probationary action shall be forwarded to the licensees employer\\n(or MCA board in the case of an agency provider).\\nD. Order of Disciplinary Action:\\n1. An Order of Disciplinary Action (ODA) is a written document developed by\\nthe MCA and sent to a subject licensee for the purposes of clearly and\\nplainly identifying the findings of the MCA, any disciplinary action and any\\nrequired remediation.\\n2. ODAs include, but are not limited to, written reprimands, written notice of\\nsuspension, written notice of revocation, a letter of warning and a letter of\\nreprimand.\\n3. The ODA must be delivered in a way that confirmed receipt by the licensee\\nmay occur.\\n4. The licensee that receives an ODA must provide a copy to all MCAs in which\\nthey are privileged.\\n5. Licensees receiving an ODA from another MCA must provide a copy of the\\nODA to this MCA.\\n6. An Order of Disciplinary Action may be accompanied by assignment of\\nadditional remedial activity.\\n7. Temporary Suspension of Privileges:\\na. The Medical Director may temporarily suspend a licensees privileges in\\ncases where there is a clearly definable risk to the public health and\\nwelfare. The Medical Control Authority shall review such action within\\nthree business days after the Medical Directors determination.\\nb. If a licensees MCA privileges have been temporarily suspended from a\\nlicensee, the licensee shall not provide prehospital care until MCA\\nprivileges are reinstated.\\n8. Written Reprimand:\\nc. A written reprimand shall be issued to a licensee stating;\\n1. the details of the substandard performance;\\n2. the remedial action, if required;\\n\\nPage 10 of 13\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:\\nSection: 8-24\\n\\n3. the time allowed for completion of remedial action;\\n4. the consequences for repetitive noncompliance.\\nd. Notice of disciplinary action shall be forwarded to the licensees\\nemployer (or MCA board in the case of an agency provider).\\ne. A copy of the 8.25 Disciplinary Action Appeal policy shall be included\\nin the notice to the licensee.\\n9. Probation  that includes restriction of privileges:\\na. A probationary letter shall be issued to a licensee stating;\\n1. the details of the substandard performance;\\n2. the details of the probation;\\n3. the remedial action required;\\n4. the restriction of privileges, if applicable;\\n5. the time of probationary period;\\n6. the consequences for repetitive noncompliance.\\nb. Notice of probationary action shall be forwarded to the licensees\\nemployer (or MCA board in the case of an agency provider).\\nc. A copy of the 8.25 Disciplinary Action Appeal policy shall be included\\nin the notice to the licensee.\\n10. Suspension of Privileges - A licensees medical privileges shall be\\nsuspended for a specified period of time.\\na. A written notice of the suspension shall be issued to the licensee\\nstating:\\n1. the details of the substandard performance;\\n2. the violation(s) of protocol and/or policy;\\n3. the term of suspension;\\n4. the remedial activity, if required;\\n5. the time allowed for the completion of the remedial activity.\\nb. Notice of disciplinary action shall be forwarded to the licensees\\nemployer, if employed (or MCA board in the case of an agency\\nprovider).\\nc. A copy of the 8.25 Disciplinary Action Appeal policy shall be included\\nin the notice to the licensee.\\nd. If a licensees MCA privileges have been suspended from a licensee,\\nthe licensee shall not provide prehospital care until the MCA privileges\\nare reinstated.\\ne. The Medical Control Authority must notify the department within one (1)\\nbusiness day of the removal of medical control privileges from a\\nlicensee.\\n11. Revocation of Privileges\\na. The notice of revocation shall state the violation(s) of protocol and/or\\npolicy.\\nb. Notice of disciplinary action shall be forwarded to the licensees\\nemployer (or MCA board in the case of an agency provider).\\nc. A copy of the 8.25 Disciplinary Action Appeal policy shall be included\\nin the notice to the licensee.\\n\\nPage 11 of 13\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:\\nSection: 8-24\\n\\nd. The Medical Control Authority must notify the department within one (1)\\nbusiness day of the removal of medical control privileges from a\\nlicensee.\\ne. Within one (1) business day of the removal of medical control\\nprivileges, the Medical Control Authority must notify all other Medical\\nControl Authorities which it knows, or has reason to believe, have\\ngranted the licensee or agency Medical Control privileges.\\nE. A subject licensee and/or agency must notify the MCA of disciplinary action from\\nthe State of Michigan.\\nF. Additional Agency Quality Improvement Actions\\n1. The Medical Control Authority will notify the department chief or agency\\nofficial of the alleged protocol violation.\\n2. If a minor protocol violation is determined by the Medical Control Authority\\nto have occurred, a letter of warning will be sent to the EMS agency.\\n3. If an initial serious violation or a second minor protocol violation within a sixmonth period is determined to have occurred, a letter of reprimand will be\\nsent and the EMS agency may be required to submit, within 15 days, a\\nwritten statement of actions it will take to prevent future protocol violations.\\n4. At the discretion of the Medical Control Authority, notice of these actions\\nmay be made public.\\n5. The MCA may assess restrictions or limitations upon a licensed life support\\nagency for non-compliance with protocols.\\n6. If a third of more frequent minor protocol violation is determined by the\\nMedical Control Authority to have occurred within a period of 18 months, or\\nif the violation is a second serious violation within 18 months, the Medical\\nControl Authority may suspend or revoke its medical control oversight for\\nthe EMS agency. The EMS agency shall not provide pre-hospital care until\\nmedical control is reinstated. At its discretion, the Medical Control Authority\\nmay take any other action within its authority to prevent further protocol\\nviolations. Notice of this action shall be made public.\\n7. An EMS agency may appeal a decision of the Medical Control Authority.\\nThe EMS Agency must follow the 8.25 Disciplinary Action Appeal policy.\\nG. The complainant shall, to the extent allowed under confidentiality statutes, be\\nnotified of the outcome of the complaint review process.\\nH. Reapplication after Revocation\\n1. Following revocation of an involved party\'s privilege to practice in the MCA,\\nthe involved party may reapply to the MCA for privileges after no less than\\n24 months have elapsed from the date of revocation. Those issued a\\npermanent revocation may not reapply for privileges at any time.\\nI. Financial Penalties\\nThe MCA may not apply financial penalties to individuals, per this policy. No\\nsuch prohibition exists within statute; however, the MCA wishing to establish\\nindividual financial penalties must purposely develop an addendum to this\\npolicy.\\n\\nPage 12 of 13\\n\\nOakland County Medical Control Authority\\nSYSTEM PROTOCOL\\nCOMPLAINT INVESTIGATION & RESOLUTION\\nInitial Date: 9/14/2023\\nRevised Date:\\nSection: 8-24\\n\\nJ. PSRO Communications\\nPSRO protected entities may share PSRO information with other PSRO\\nentities for the following purposes3:\\n1. To advance health care research or health care education.\\n2. To maintain the standards of the health care professions.\\n3. To protect the financial integrity of any governmentally funded\\nprogram.\\n4. To provide evidence relating to the ethics or discipline of a health\\ncare provider, entity, or practitioner.\\n5. To review the qualifications, competence, and performance of a\\nhealth care professional with respect to the selection and\\nappointment of the health care professional to the medical staff of a\\nhealth facility.\\nProtocol Source/References: 1 MCL 331.532\\n\\nProtocol Source/Reference: Michigan 8.24 Complaint Investigation and Resolution; Version 12/27/22.\\n\\nPage 13 of 13\\n\\n-~l,\\n\xa3DHHS I\\nM\\nMichigan Departmento,Health,HumanServices\\n\\nBureau of Emergency\\nPreparedness, EMS\\nand Systems of Care\\n\\nMichigan\\nSYSTEM PROTOCOL\\nDISCIPLINARY ACTION APPEAL\\n\\nInitial Date: SEPTEMBER 2004\\nRevised Date: 12/27/2022","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-25":{"name":"Disciplinary Action Appeal\\nPurpose","content":": This protocol is provided to define the steps a licensee must take to appeal an\\norder of disciplinary action issued by the Medical Control Authority.\\nI.\\n\\nProcedure\\nA. A licensee having received an Order for Disciplinary Action (ODA) from the\\nMedical Control Authority (MCA) may initiate a Request to Appeal.\\nB. A licensee shall notify the MCA within seven (7) days of receipt of notice of an\\nODA of his/her/their request to Appeal. Such notice shall be in writing.\\n\\nII.\\n\\nAppeal Hearing\\nA. Upon receipt of a Request to Appeal an ODA, the MCA shall schedule a\\nspecial meeting for the purpose of hearing an appeal. This meeting shall be\\nscheduled as soon as practicable following receipt of a Request to Appeal.\\nB. The receipt of a Request to Appeal does not stay the ODA or the imposition of\\nthe discipline on the appellant licensee.\\nC. The MCA shall honor a request to postpone an appeal hearing, no later than\\nthirty (30) days past the originally scheduled hearing date, to allow the\\nappellant licensee opportunity to assemble information bearing upon\\nhis/her/their appeal.\\nD. The MCA shall hold an appeal hearing to review the appellant licensees new\\ninformation and exercise one of the following options:\\n1. Uphold the original decision and subsequent ODA.\\n2. Diminish the ODA to a lesser Disciplinary Action (i.e., suspension of\\nprivileges diminished to written reprimand).\\n3. Revoke the ODA (revocation of an ODA shall not expunge the\\nappellants record of the complaint process records for a period to\\ntwelve (12) months from date of original incident).\\nE. Following exhaustion of the procedure stated herein, an appellant may appeal\\nthe decision of the MCA to the State of Michigan Emergency Medical Services\\nCoordination Committee as defined in Part 209 of P.A. 368 of 1978, as\\namended\\nSection 20919(4). An appeal must be filed with the Department of\\nHealth and Human Services, in writing, no more than 30 calendar days\\nfollowing notification of the final determination by the MCA.\\n1. If a decision of the MCA is appealed to the Emergency Medical\\nServices Coordination Committee, the MCA shall make available, in\\nwriting, the information it considered in makings its decision.\\n\\nMichigan\\nSYSTEM\\nEMS PROVIDER\\nCRIMINAL CHARGES AND CONVICTIONS\\nInitial Date:\\nRevised Date: 05/30/23","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_826":{"name":"EMS Provider Criminal Charges and Convictions\\nPurpose","content":":\\nThe purpose of this policy is to provide the parameters for EMS licensure related to\\ncriminal charges and convictions.\\nDefinitions:\\nCharge: any formal accusation made by a governmental authority asserting that\\nsomebody has committed a criminal misdemeanor or felony (anything other than a civil\\ninfraction).\\nConviction: any plea of nolo contender, a guilty plea, or plea agreement,\\nincluding deferments, as well as conviction(s) after a trial.\\nPolicy:\\nFailure to disclose a criminal conviction or withholding of any material information\\nregarding such conviction on any application for licensure will be considered a violation\\nof\\nSection 20958(1)(a) of the Public Health Code.\\nAn EMS license or licensed EMS provider at any level may be denied, suspended, or\\nrevoked, or other appropriate action taken with respect to a felony or misdemeanor criminal\\ncharge or conviction under either\\nSection 20958(1) or\\nSection 20168 of the Public Health\\nCode. Applicants that have a criminal charge, may have their license suspended until\\nresolution of the criminal matter.\\nProcedure:\\n1. An EMS provider shall notify all their employers and all Medical Control Authority(s)\\nin which they hold MCA privilege(s) in writing within one business day of being\\ncharged and/or convicted of a felony or criminal misdemeanor.\\n2. The Medical Director shall make a determination whether to temporarily suspend\\nprivileges within the respective MCA.\\n3. The Medical Control Authority PSRO will review and make a recommendation\\nregarding the subject licensees privileges to practice EMS within the MCA.\\n4. The Medical Control Authority PSRO will notify the MDHHS and the subject licensee\\nof the results.\\nProtocol Source/References: Michigan Public Act 368 of 1978 Public Health Code, as amended. Parts 201 and 209.\\nRetrieved April 19, 2021, from the Michigan Legislature website.\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nPROFESSIONAL STANDARDS REVIEW ORGANIZATION\\nPSRO RESPONSIBILITIES, STRUCTURE, AND OPERATIONAL POLICY\\nInitial Date: June 2018\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-27":{"name":"PSRO Responsibilities","content":", Structure and Operational Policy\\nMission: The Oakland County Professional Standards Review Organization (PSRO)\\nSubcommittee exists to facilitate system-wide continuous quality assurance and\\nimprovement of EMS to ensure consistent, high-quality pre-hospital care in Oakland County,\\nMichigan.\\nPurpose: The Professional Standards Review Organization (PSRO) of the MCA is a review\\nentity that is provided information or data regarding the physical or psychological condition of\\na person, the necessity, appropriateness, or quality of health care rendered to a person, or\\nthe qualifications, competence, or performance of a health care provider. The PSRO is a\\ncommittee established by the MCA for the purpose of improving the quality of medical care\\nand oversight of appropriate protocol compliance within the EMS system.\\n1. Confidentiality Assurance\\nA. Information obtained for the purpose of Quality Review will be used to\\ndetermine if the current protocols in the MCA are being appropriately followed\\nand to improve the protocols and the EMS system. Data is protected under\\nP.A. 270 of 1967, MCL 331.531 to 331.533.\\nB. In specific cases where EMS providers may require corrective actions, the\\nemergency medical services personnel names may be given to the agency to\\naddress at the agency level.\\n2. Membership\\nThe PSRO may be comprised of members of the board, MCA staff and contract staff,\\nEMS agency staff, hospital staff, committee members, and other designated\\nindividuals when acting on behalf of, or at the direction of the MCA when performing\\nPSRO tasks.\\nA. Hospital Members\\ni. 3 ED physicians\\nii. 1 Deputy Medical Director\\niii. ED Coordinator Subcommittee Member\\nB. EMS Provider Members\\ni. ALS Public Provider**\\nii. ALS Private Provider**\\niii. BLS or MFR Provider**\\niv. Chair or vice chair of Protocols**\\nv. Chair or vice chair of EMS Operations or 1 ALS or BLS Provider nonadministrative**\\nvi. Ex Officio: OCMCA Staff, EMS Medical Director\\n\\nMCA: Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 1 of 8\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nPROFESSIONAL STANDARDS REVIEW ORGANIZATION\\nPSRO RESPONSIBILITIES, STRUCTURE, AND OPERATIONAL POLICY\\nInitial Date: June 2018\\nRevised Date: 9/14/2023\\nSection 8-27\\n\\nC. Total Membership: 10\\ni. All members must come from different Life Support Agencys and\\nHospitals, including the EMS Medical Director.\\nii. ** Indicates that the member must be from an Oakland County-based\\nLife Support Agency (LSA) that provides 24/7 primary 911 emergency\\nservices to at least one city, township, or village within the OCMCA\\narea.\\niii. Required Attendance: in person 75% required attendance with semiannual assessment.\\nD. Appointments for Chair, Vice Chair and membership shall be appointed by the\\nExecutive Committee and approved by Medical Control Committee (MCC) and\\nBoard of Directors for two year terms\\nE. Confidentiality Statement: Each PSRO Member (voting and ex-officio) will be\\nrequired to sign the OCMCA PSRO Confidentiality Statement annually (See\\nAppendix A of System Protocols).\\n3. Meetings\\nA. All PSRO meetings are closed meetings.\\nB. The PSRO will follow Roberts Rules.\\nC. Quorum, consists of:\\ni. 1 physician\\nii. 1 provider\\niii. Greater than 50% of voting members, with a minimum of five members\\nat each meeting.\\nD. Meeting Schedule\\ni. Standard Meeting\\n1. At least monthly, as directed by PSRO.\\na. Cancellation\\ni. PSRO motion and vote.\\nii. Anticipated no quorum by PSRO Chair or Medical\\nDirector.\\niii. No quorum at meeting.\\nii. Sentinel Event Meeting\\n1. Scheduled, as needed for Sentinel Event Incidents\\nE. Subject Matter Experts: Ad hoc, for subject-specific advice to PSRO.\\ni. Subject Matter Experts will be required to sign the PSRO\\nConfidentiality Statement.\\nF. Minutes\\nMCA: Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 2 of 8\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nPROFESSIONAL STANDARDS REVIEW ORGANIZATION\\nPSRO RESPONSIBILITIES, STRUCTURE, AND OPERATIONAL POLICY\\nInitial Date: June 2018\\nRevised Date: 9/14/2023\\nSection 8-27\\n\\ni. Minutes of all meetings will be prepared by MCA staff or designee.\\nii. Minutes must be approved at the next scheduled meeting.\\n4. MCA PSRO Responsibilities\\nA. The MCAs designated PSRO shall perform the duties and functions related to\\ncomplaints, investigations, or quality improvement activities, both prospective\\nand retrospective.\\nB. All Quality Improvement activities shall be performed by the PSRO, and all\\ndocuments collected for Quality Improvement activities shall be held by the\\nPSRO, subject to Michigans peer review privilege.1\\nC. Planning\\ni. The PSRO shall develop an annual plan and perform study evaluations\\nfor the purpose of EMS system assessment and improvement of\\nprocesses, protocols, EMS personnel, equipment, medications, etc.\\nthat may affect patient outcomes.\\nD. Licensure/Relicensure/Letter of Compliance\\ni. Assessment of LSAs and facilities applications, reapplications, and\\ncompliance with OCMCA protocols, policies, and quality improvement.\\nE. Incident Reviews\\ni. To assess, investigate and make recommendations to the Board of\\nDirectors pertaining to unusual circumstances and/or issues of concern\\nposed by any person(s) regarding EMS activities in the MCA.\\nInvestigations will be processed according to the Incident Investigation\\nProcedure Protocol.\\nii. Incidents that shall be reviewed\\n1. Unusual Occurrences\\na. Any ePCR that are unusual and possibly one-time\\nsituations that may serve as a learning tool for other\\nservices in the future may be reviewed.\\n2. Protocol Required Reviews\\na. Any incident that is required to be reviewed by protocol.\\n3. Complaints\\na. Complaints regarding patient care and/or protocol\\nviolations may be brought to the attention of the PSRO of\\nthe MCA.\\ni. The PSRO and/or the EMS Medical Director will\\ndetermine the severity of an incident and develop an\\naction plan to address the matter, if necessary.\\n1\\n\\nMCL 331.531 et seq.\\n\\nMCA: Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 3 of 8\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nPROFESSIONAL STANDARDS REVIEW ORGANIZATION\\nPSRO RESPONSIBILITIES, STRUCTURE, AND OPERATIONAL POLICY\\nInitial Date: June 2018\\nRevised Date: 9/14/2023\\n\\niii.\\n\\niv.\\n\\nv.\\nvi.\\nvii.\\nSection 8-27\\n\\n1. Any complaint will follow the 8.24 Complaint\\nInvestigation Protocol.\\n4. Topic quality improvement reviews will be performed.\\nThe following may be reviewed for EMS system and LSA compliance:\\n1. Dispatch information\\n2. Demographics, times, mileage, etc.\\n3. Accuracy of patient assessment\\n4. Appropriateness of treatment\\n5. Compliance with protocols\\n6. Competency of procedures\\n7. Communications\\n8. Completeness of documentation\\n9. Mutual aid/multi-agency problems\\n10. Any information that may impact patient care\\nIncident Review and Audit Recommendations/Findings:\\n1. Absolution, complaint unfounded, unsubstantiated, or not of\\nconsequence\\n2. Informational/educational reporting without recommendation for\\naction\\n3. Endorsement of activity\\n4. Trending\\n5. Revision of protocols/policies/procedures\\n6. Corrective action plan by personnel/LSA/facility\\n7. Education recommendations for the system\\nReferral to Due Process and Disciplinary Procedures\\n1. See the 8.24 Complaint Investigation Protocol\\nThe current protocols in place at the time of the event will be used to\\nreview the incident.\\nAny changes in protocols will not be used for evaluation until the\\nchanges are approved and distributed.\\n\\nF. Data Collection\\ni. The MCA is authorized to obtain access to ePCRs originating within\\ntheir service area; this includes all scene responses, interfacility\\ntransfers and critical care transfers. The Medical Control may elect to\\nreceive reports upon request.\\nii. The MCA is authorized to obtain electronic data and voice recordings\\nfrom any and all EMS agencies and/or departments, and dispatch\\nagencies with interaction with callers requesting a medical response\\nwithin the MCA service area. This includes mutual aid responses into\\nthe MCA service area. Data will be provided to the MCAs PSRO on a\\nmonthly basis or when individual records, recordings and reports are\\nrequested. The Medical Control may elect to receive electronic reports\\nMCA: Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 4 of 8\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nPROFESSIONAL STANDARDS REVIEW ORGANIZATION\\nPSRO RESPONSIBILITIES, STRUCTURE, AND OPERATIONAL POLICY\\nInitial Date: June 2018\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-27_1":{"name":"on a more frequent schedule","content":".\\niii.\\n\\niv.\\n\\nv.\\n\\nAny documents or data relating to requests for service, records of\\nprovided services, records of refused services, dispatch reports and\\nincident reports including all aggregated reports for benchmarking and\\nanalysis which are submitted to the PSRO of the MCA, or generated\\nby the PSRO, are privileged. The MCAs PSRO holds ownership of\\nonly protected Quality Improvement documents. The submitting\\nagency maintains ownership of any and all original records generated\\nby their agency and personnel.\\nIncident reports and requests for additional information directed to an\\nindividual provider or to an EMS agency/department requested by the\\nMCA/PSRO must be submitted to the MCA/PSRO within 96 hours or\\nas determined by the MCA. Additional time may be granted per\\nrequest of the LSA, and such request shall be determined by the MCA.\\nThe MCA may establish an online reporting system.\\n\\nG. MIEMSIS\\ni. The MCA shall maintain access to the MIEMSIS data and ensure that\\nagencies are accountable for the submission of data.\\nii. MIEMSIS data should be utilized as a tool for the evaluation of\\nperformance and function as a driving mechanism for quality\\nimprovement.\\nH. EQIP\\ni.\\nii.\\n\\niii.\\n\\nDetermination of annual education and/or skills verification\\nPreparation of annual protocol knowledge assessment based on the\\nannual education.\\n1. The PSRO will analyze the protocol knowledge assessments\\nmethods and results to determine the most appropriate\\nassessment parameters for each EMS license level (MFR, EMTBasic, Paramedic).\\nReview of LSA Compliance\\n1. OCMCA will verify the completion of all skills and knowledge\\neducation as dictated by the OCMCA PSRO Committee by\\nreviewing each LSAs OCMCA EQIP CE Completion Form. Any\\nLSA that does not complete skills and knowledge education as\\ndictated by the PSRO Committee will be subject to an OCMCA\\nEQIP CE Audit. In addition, all LSAs are subject to a random\\nOCMCA EQIP Audit to verify that the training was conducted\\ncompletely and that adequate records were maintained.\\n2. Review of LSA Data\\n\\nMCA: Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 5 of 8\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nPROFESSIONAL STANDARDS REVIEW ORGANIZATION\\nPSRO RESPONSIBILITIES, STRUCTURE, AND OPERATIONAL POLICY\\nInitial Date: June 2018\\nRevised Date: 9/14/2023\\nSection 8-27\\n\\nI. Special Studies\\ni. Evaluation of any special study requests\\n1. If a special study is approved, all e-PCRs that include the use of\\nequipment, skills, techniques, procedures, etc. that are currently\\nunder special study, will be reviewed.\\nJ. Research Projects\\ni. Evaluation of proposed research projects that involve the Oakland\\nCounty EMS System or EMS patients within the OCMCAs service\\narea.\\nK. Audits\\ni. Regularly assess quality assurance processes performed by prehospital care personnel/agencies/facilities.\\nL. Quality Improvement Recommendations\\ni. Protocol Revision Recommendations\\n1. The PSRO may review and recommend revised protocols as they\\npertain to quality improvement, patient care, or special\\ncircumstances.\\n5. LSA Responsibilities for PSRO\\nA. Each agency, or department licensed to provide prehospital care within the\\nMCA area, must develop and maintain a PSRO subgroup that reviews, either\\nthrough a peer evaluation group or individuals tasked with peer review\\nfunctions, and conducts audits requested by MCA.\\nB. Licensure/Relicensure/Letter of Compliance\\ni. Each LSA is required to complete the MCA letter of compliance in the\\ntimeframe required by the MCA.\\nC. MIEMSIS\\ni. Providers and agencies are required to report per the 7.15 Patient\\nCare Record, Electronic Documentation and EMS Information\\nSystem protocol.\\nii. Agencies shall work in cooperation with the MCA, under PSRO, to\\nensure the quality, consistency and accuracy of data submitted\\nthrough MIEMSIS.\\niii. MIEMSIS data should be utilized as a tool for the evaluation of\\nperformance and function as a driving mechanism for quality\\nimprovement.\\n\\nMCA: Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 6 of 8\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nPROFESSIONAL STANDARDS REVIEW ORGANIZATION\\nPSRO RESPONSIBILITIES, STRUCTURE, AND OPERATIONAL POLICY\\nInitial Date: June 2018\\nRevised Date: 9/14/2023\\nD. EQIP\\ni.","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-27_2":{"name":"Skill and/or knowledge verification process\\n1","content":". Education: All OCMCA LSAs will provide EMS skill and/or\\nknowledge education to their personnel as directed by the\\nOCMCA. All LSAs will be provided with the necessary education\\nmaterials to complete the training requirements.\\na. LSA Verification: All LSAs will submit an OCMCA EQIP\\nCE Completion form that signifies that all skill and\\nknowledge education was conducted as described by the\\nOCMCA PSRO Committee. This standardized form will\\nacknowledge that the training was successfully completed,\\nand all related skills and knowledge have been verified by\\nthe LSA. LSAs will maintain all related training records for\\na minimum of five (5) years.\\n\\nii.\\n\\nRequired data reporting  Quarterly\\n1. All OCMCA LSAs will provide a quarterly report (provided in\\ntemplate form) to the PSRO that verifies the following data:\\na. Comparison of e-PCR forms submitted to LSAs vendor\\nwith MIEMSIS, to include:\\ni. Number of ePCRs in LSAs vendor and number of\\nMIEMSIS ePCRs.\\nii. Other, as requested by PSRO.\\nb. 100% of cardiac arrests submitted to CARES.\\nc. 100% Multiple Casualty Incident (MCI) PCRs.\\nd. 100% of requested information pertaining to PSRO studies.\\n\\niii.\\n\\nMeasurement of protocol knowledge\\n1. The PSRO will analyze the protocol knowledge assessments\\nmethods and results to determine the most appropriate\\nassessment parameters for each EMS license level (MFR, EMTBasic, Paramedic).\\n2. 100% of all OCMCA LSA EMS personnel will participate in a\\nprotocol knowledge assessment. This assessment will be a\\nmultiple-choice test created and administrated by the OCMCA\\nPSRO Committee and kept confidential.\\n\\niv.\\n\\nAll OCMCA LSAs and their EMS personnel must comply with all EQIP\\ncomponents. Any LSA and/or EMS personnel that do not comply with\\nEQIP components are subject to PSRO review\\n\\nv.\\n\\nAny LSA that fails to send a representative to any mandatory EQIP inservice, without prior notification, will be subject to PSRO review and\\n\\nMCA: Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 7 of 8\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nPROFESSIONAL STANDARDS REVIEW ORGANIZATION\\nPSRO RESPONSIBILITIES, STRUCTURE, AND OPERATIONAL POLICY\\nInitial Date: June 2018\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-27_3":{"name":"possible sanctions","content":".\\nE. Attendance as Requested by PSRO\\ni. LSA\\n1. Any LSA that is requested to appear in front of PSRO shall\\nrespond to the request. The LSA may request a postponement of\\nup to 30 days to prepare for the meeting. If the LSA does not\\nappear on the prescribed meeting date, the PSRO will make a\\ndetermination based on the available information.\\nii.\\n\\nEMS Providers\\n1. Any EMS provider that is requested to appear in front of PSRO\\nshall respond to the request. The provider may request a\\npostponement of up to 30 days to prepare for the meeting. If the\\nprovider does not appear on the prescribed meeting date the\\nPSRO will make a determination based on the available\\ninformation.\\n\\n6. Reporting\\nA. PSRO reports to the EMS Medical Director, MCC and Board of Directors.\\nB. The following will be reported to the MCC and Board of Directors:\\ni. Topic quality improvement reviews\\nii. Retraining\\niii. Probation with conditions and reevaluation time frame\\niv. Suspension/removal of Medical Control for personnel/LSA/facility\\nv. Revocation of license  through the Michigan Department Health and\\nHuman Services (MDHHS).\\nC. The following will be reported to the State of Michigan (MDHHS):\\ni. Probation with license restrictions\\n1. Conditions and reevaluation time frame.\\nii. Suspension/removal of Medical Control for personnel/LSA/facility.\\n\\nMCA: Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 8 of 8\\n\\nInitial Date: 01/27/2023\\nRevised Date: 05/30/2023\\n\\nMichigan\\nSYSTEM\\nEVIDENTIARY BLOOD DRAW PROTOCOL\\n(MCA Optional Protocol)","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8-28":{"name":"Evidentiary Blood Draw Protocol (MCA Optional Protocol)\\nThis protocol is for specialist/AEMT and paramedic use only","content":"\\n Medical Control Authorities choosing to adopt this supplement may do so\\n\\nby selecting this check box. Adopting this supplement changes or clarifies the\\nreferenced protocol or procedure in some way. This supplement supersedes,\\nclarifies, or has authority over the referenced protocol.\\n\\nMCAs will be responsible for maintaining a roster of the agencies choosing to\\nparticipate and will submit roster to MDHHS.\\n\\nPurpose\\nIn order to effectively utilize the resources of the Medical Control Authority, licensed Life\\nSupport Agencies may allow Paramedics working for them to draw a sample specimen of\\nblood as allowed under the delegation of the Medical Control Authority EMS Medical\\nDirector, a licensed physician by the State of Michigan, pursuant to PA 368 (1978) MCL\\n333.16215 (Public Health Code) and PA 300 (1940) MCL 257.625a (Michigan Vehicle\\nCode) and subsequent amendments reference these Public Acts. This shall be considered\\na Priority 3 level of service. However, if a patient presents with a medical condition, the\\nGeneral Pre-hospital Care protocol will be initiated.\\nDefinitions\\nConsent to Search: Permission given by a person authorizing a law enforcement officer to\\nmake a seizure or conduct a search.\\nImplied Consent: A requirement under Michigan Law; all drivers are to have given their\\nconsent for a chemical test upon being arrested for Operating While Intoxicated as part of\\ntheir application and issuance of a drivers license.\\nMedical Environment: Any area not within a freestanding medical facility(e.g., booking area,\\njail, or other scene where the paramedics may provide medical care).\\nWarrant: A precept or writ issued by a competent judge or magistrate authorizing a law\\nenforcement officer to make a seizure or conduct a search.\\nProcedure\\nA paramedic may draw a blood specimen if one of the listed criteria is met:\\n1. When requested by a law enforcement officer, who provides verbal or written\\nverification from the subject who is in custody, that the subject is voluntarily\\nsubmitting to an Evidentiary Blood Draw as required by Implied Consent under PA\\n300 (1940) MCL 257.625a (Michigan Vehicle Code).\\n2. When requested by a law enforcement officer, who is in possession of a consent to\\nsearch form duly signed by the subject in custody.\\n\\nMDHHS Reviewed 2023\\n\\nInitial Date: 01/27/2023\\nRevised Date: 05/30/2023\\n\\nMichigan\\nSYSTEM\\nEVIDENTIARY BLOOD DRAW PROTOCOL\\n(MCA Optional Protocol)\\nSection 8-28\\n\\n3. When requested by a law enforcement officer, who is in possession of a search\\nwarrant duly signed by a magistrate or judge.\\nThis procedure is done at the delegation of the Medical Control Authority EMS Medical\\nDirector, a licensed physician, and under the supervision and at the direction of medical\\ncontrol, to draw blood for the purposes of determining the presence of alcohol and/or drugs\\nas allowed for in PA 368 (1978) MCL 333.16215 (Public Health Code) in a Medical\\nEnvironment.\\nPre-Radio\\nPARAMEDIC\\n1. Obtain a full set of vital signs.\\n2. Obtain blood draw kit from law enforcement officer and use the provided contents\\nwithin the kit for collection.\\n3. Sample shall be obtained in the presence of a law enforcement officer.\\n4. Do not use alcohol or alcoholic solutions to sterilize skin surface, needle or syringe.\\n5. In the presence of a law enforcement officer tell the subject that no alcohol was used\\nin sterilizing the skin surface, needle, or syringe; then draw two tubes of venous blood\\nfrom subject and upon completion of obtaining the specimen, slowly invert blood\\ncollection tube(s) several times to distribute the sodium fluoride/potassium oxalate\\npreservative.\\n6. Complete blood specimen label(s) by entering name of subject, date and time of\\nblood collection, and your name in ink.\\n7. In the presence of subject, hand tube(s) of blood and label(s) to law enforcement\\nofficer for signing, packaging, and transfer to the laboratory.\\n8. If the patient has no medical or trauma complaints and the vital signs are within\\nnormal limits consider this a treat and release from care.\\n9. If the patient has a medical or trauma complaint and/or vital signs are outside normal\\nlimits, transport the patient to the hospital.\\na. If officer refuses transport, contact medical control.\\n\\nO\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nBennett Bill Upgrade Policy\\n\\nInitial Date: June 22, 2020\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["trauma","medical"]},"section_8100":{"name":"Bennett Bill Upgrade Policy\\nRequirements\\nAll Oakland County Medical Control Authority (OCMCA) transporting BLS agencies\\nwishing to participate with Act 7","content":"8, Public Act of 1997, known as the Bennett Bill must\\nmeet the following requirements:\\n1. Must meet the requirements of the legislation and the Michigan Department of\\nHealth and Human Services, Bureau of EMS, Trauma, and Preparedness.\\n2. Must be a State licensed basic transporting service on or before the 22 nd of July\\n1997.\\n3. Must be owned or operated by a local unit of government, or must be under contract\\nwith a local unit of government.\\n4. Must provide first-line 911 or emergency transport services only. May not provide\\nnon-emergency transports with the upgraded vehicle.\\n5. Must meet or exceed Oakland County staffing requirements on upgraded vehicle.\\n6. Must comply with all patient care and radio equipment requirements of an advanced\\nlife support service.\\n7. The approved upgraded unit will not advertise in any manner or give the impression\\nof providing advanced life support 24 hours per day, 365 days per year.\\nProcedure for Participation\\n1. Submit a copy of the completed Conditional Upgrade License Application to the\\nOCMCA office, including all required attachments (as per the application) for PSRO\\nreview.\\n2. With the application, submit a support letter from the LSAs Medical Control Hospital\\nto the OCMCA office.\\n3. If approved by the PSRO, the application will go to the Medical Control Committee,\\nthen the Board of Directors for final approval. Application must include a two-year\\nplan for the agency to permanently upgrade to ALS.\\n4. A letter of recommendation will be issued by the OCMCA, if all requirements are\\nproperly met. Allow 60 days for this process.\\nOnce Approved by State BETP (before implementation)\\n1. Contact the OCMCA office to set up the following:\\na. Purchase of medication boxes and A-Packs.\\nb. Present proof of equipment which meets the minimum standards of the State\\nBETP and the OCMCA policies for the level you are conditionally licensed to\\nfunction.\\n\\nO\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nBennett Bill Upgrade Policy\\n\\nInitial Date: June 22, 2020\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8100_1":{"name":"Once Approved by State BETP (after implementation)\\n1","content":". ALS Supplies and Equipment must be locked/secured in the ambulance (lockable\\ncabinet) or taken out of the vehicle and secured in a locked area when not working\\nat the upgraded level.\\n2. All OCMCA protocols and policies must be followed at all times in accordance to the\\nstaffing level of care. No ALS procedures may be done if the ambulance is staffed\\nfor BLS service.\\n3. All ALS runs must be reviewed for quality control by the EMS Coordinator or their\\ndesignee(s) to ensure all protocols were followed. OCMCA may also review any run,\\nin accordance to protocol 8.24 Complaint Investigation & Resolution.\\n4. Quarterly reports must be submitted to the OCMCA PSRO during the use of the\\nBennett Bill (data to be determined by PSRO).\\n\\nPage 2 of 2\\n\\nOakland County\\nSystem Protocols\\nTransfer of Patient Care to Receiving Facility\\nInitial Date: 3/1/2023\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":[]},"section_8101":{"name":"Transfer of Patient Care to Receiving Facility\\nPurpose","content":": To create a professional standardized approach to optimize communication\\nbetween pre-hospital providers (EMS) and emergency department personnel when\\nproviding care for ill or injured patients. In addition, to decrease medical errors related to\\nmiscommunication between EMS and emergency department personnel.\\nProcedure:\\n1. Patient is brought into the designated room. EMS will give handoff report ONE\\ntime, at the patient side, to appropriate hospital personnel.\\n2. When patient requires emergent attention to airway, breathing, or circulation,\\ntransfer of patient care may occur prior to the formal handoff report.\\n3. Once an expeditious initial patient assessment is complete, a formal EMS\\nTimeout handoff report will occur.\\n4. EMS Timeout is called by the hospital team leader. Each facility is to identify\\nwho has this task (Attending, Senior Resident, Charge Nurse, etc.)\\nA. ALL participants in the room are expected to stop and listen to the\\nEMS handoff report.\\nB. ALL lifesaving interventions such as CPR, bag mask ventilation, etc.,\\ncontinues.\\n5. EMS delivers uninterrupted patient report, which should be no more than 30-45\\nseconds, when appropriate.\\n6. When EMS completes the handoff report, the EMS personnel will:\\nA. Answer questions.\\nB. A patient transfer of care signature is recommended*. If a signature is\\nobtained, it will be from the hospital team lead, or appropriate\\ndesignee. They will sign EMS patient care record (PCR) with legal\\nsignature, including full name and credentials.\\n7. Verbal EMS transfer of care report shall be treated as part of the health care\\nrecord and must be professional, accurate, and consistent with information\\nincluded in the final submitted EMS electronic, or written patient care report.\\n8. When on hospital property, the EMS provider cannot transport to another hospital\\nwithout physician notification and medical screening exam from the current\\nlocation.\\nA. Documentation Note: Physician name must be documented in the\\nnarrative.\\n\\nPage 1 of 1\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nALTERNATIVE EMS RESPONSE TEAM\\nInitial Date: June 3, 2022\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8102":{"name":"Alternative EMS Response Team\\nPurpose","content":":\\nThe purpose of the policy is to provide a protocol for the use of alternative EMS\\nresponse, which includes but is not limited to bicycles, golf carts, and other nontraditional response modes in the Oakland County Medical Control Authority\\n(OCMCA) during events where their use would be advantageous.\\nProcedure:\\nAny agency that wants to utilize an alternative EMS response team (Team) will\\ncarry at least all the equipment listed in this protocol. Staffing of the alternative\\nEMS response team will not exceed the agencys Oakland County licensing\\nlevel.\\nWhen responding to an emergency, the Team will ensure they are able to\\nrequest a transport capable unit, to assure appropriate transport of the patient(s).\\nIf needed/requested, and upon arrival of a transport unit, the Team will give a\\ncomplete report of patient condition(s) and treatments to the transporting unit(s),\\nand will follow the OCMCA protocols. Mandatory communication capabilities\\ninclude, allowing the Team to reach their agencys dispatch and to reach an\\nOCMCA approved hospital for medical control.\\nEquipment List:\\nMFR/BLS/Paramedic\\nAED\\nJump Kit\\nOxygen/Oxygen supplies\\nAirway management supplies\\nSuction\\nCommunication device\\nParamedic\\nECG Monitor/Defibrillator\\nIV Kit\\nDrug Box\\nA-pack\\nDrug Box (ALS only)\\nAny ALS agency wanting to obtain a drug box and A-pack for use on an\\nAlternative EMS Response Team vehicle will take use a standard Oakland\\nCounty drug box, A-pack, or use a device that can be sealed and is\\ncapable of carrying all of the medications consistent with what is carried in\\nMCA Oakland County\\nPage 1 of 2\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nALTERNATIVE EMS RESPONSE TEAM\\nInitial Date: June 3, 2022","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8102_1":{"name":"Revised Date","content":": 9/14/2023\\nthe Oakland County drug box (see 9.6 SE Michigan Medication\\nExchange and Replacement Procedure). Replenishment will be done at\\nthe agency Medical Control Hospital inpatient pharmacy only. Medication\\ncarriers other than standard drug boxes will not be exchanged in the\\nEmergency Department. The agency must ensure that all medication\\nboxes, A-packs, or carriers are secured via locking device, mechanism, or\\ncompartment, at all times when not in use. Only one set of (two)\\nmedication carriers may be filled for each paramedic Team an ALS\\nagency deploys. Both medication carriers will be inventoried and sealed\\nwith an expiration date labeled on them. The boxes medication carriers\\nwill be kept in a secured area when not in use.\\n\\n1.\\n2.\\n\\n3.\\n4.\\n\\nDrug Box Exchange:\\nDuring an event, all medications used by the team will be replaced from\\nthe drug box of the transporting ALS unit.\\nThe transporting ALS unit will use their opened drug box for any additional\\ntreatment the patient may need during the transport. The ALS unit will be\\nresponsible for documentation of drug use. Upon arrival at the hospital,\\nthe ALS unit will follow the usual drug box exchange procedure.\\nThe paramedic Team will keep a daily log of all patients treated, drugs\\nused and replaced from an ALS drug box.\\nAt the end of the paramedic Teams event, the medication carrier must be\\nreturned to the hospital pharmacy for update of its contents, seal, and\\nexpiration date.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 2 of 2\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nOCMCA APPROVED MEDICAL ABBREVIATIONS\\nInitial Date: 10/4/2013\\nRevised Date: 9/14/2023\\n\\nOCMCA Approved Medical Abbreviations\\na\\nbefore\\nabd.\\nabdomen\\nACLS\\nAdvanced Cardiac Life Support\\nAED\\nautomated external defibrillator\\nAIDS\\nAcquired Immune Deficiency\\nSyndrome\\nALS\\nadvanced life support\\nA/Ox3\\nalert and oriented to person,\\nplace, time\\na-fib\\natrial fibrillation\\na-flutter\\natrial flutter\\nAMA\\nagainst medical advice\\nAMI\\nacute myocardial infarction\\nant\\nanterior\\nA/P\\nanterior/posterior\\napprox.\\napproximate\\nARDS\\nadult respiratory distress\\nsyndrome\\nASA\\naspirin\\nASHD\\natherosclerotic heart disease\\nAtach\\natrial tachycardia\\nATF\\nArrived to find\\nATA\\nAt time of arrival\\nAV\\natrioventricular\\nBC\\nbirth control\\nBLS\\nbasic life support\\nBM\\nbowel movement\\nBP\\nblood pressure\\nBS\\nblood sugar / breath\\nsounds/bowel sounds\\nBSA\\nbody surface area\\nBVM\\nbag-valve-mask\\nCA\\ncancer/cardiac arrest\\nCAD\\ncoronary artery disease\\nCBC\\ncomplete blood count\\nCC\\nchief complaint\\nCABG\\ncoronary artery bypasses graft\\nCHF\\ncongestive heart failure\\ncm\\ncentimeter\\nCNS\\ncentral nervous system\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDCH Approval Date: 10/23/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8103":{"name":"c/o\\nCO\\nCO2\\nCOPD\\ndisease\\nCPR\\nCSF\\nc-spine\\nCVA\\nD 5","content":"W\\nD/C\\nD&C\\nDefib\\nDIB\\nDKA\\nIDDM\\nmellitus\\nDNR\\nDOA\\nDOE\\nDOS\\nDTs\\nDx\\nECG, EKG\\nEC\\nED\\nEDC\\nepi\\nET, ETT\\nETA\\nETOH\\nExp\\n\\nFx\\nFBAO\\nGI\\nGSW\\ngtt\\nGU\\nGYN\\nG/P\\nhr.\\n\\ncomplains of\\ncarbon monoxide\\ncarbon dioxide\\nchronic obstructive pulmonary\\ncardiopulmonary resuscitation\\ncerebrospinal fluid\\ncervical spine\\ncerebrovascular accident\\n5% dextrose in water\\ndiscontinue\\ndilation and curettage\\ndefibrillation\\ndifficulty in breathing\\ndiabetic ketoacidosis\\nInsulin-dependent diabetes\\ndo not resuscitate\\ndead on arrival\\ndyspnea on exertion\\ndead on scene\\ndelirium tremens\\ndiagnosis\\nelectrocardiogram\\nemergency center\\nemergency department\\nEstimated date of confinement\\nepinephrine\\nendotracheal, endotracheal tube\\nestimated time of arrival\\nalcohol (ethanol)\\nexpiratory\\nfemale\\nfracture\\nforeign body airway obstruction\\ngastrointestinal\\ngunshot wound\\ndrop\\ngastrourinary\\ngynecologic\\npregnancies/births (gravid/para)\\nhour\\nPage 1 of 2\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nOCMCA APPROVED MEDICAL ABBREVIATIONS\\nInitial Date: 10/4/2013\\nRevised Date: 9/14/2023\\nH/A\\nHIV\\nHR\\nHTN\\nHx\\nICP\\nICU\\nIM\\ninf.\\nInsp\\nIO\\nIV\\nIVP\\nIVPB\\nJVD\\nKg\\nKVO\\nL\\nlac\\nlbs\\nL&D\\nLLQ\\nLOC\\nLPM\\nLUQ\\n\\nm\\nMCI\\nmcg.\\nmeds\\nmEq\\nMI\\nmg\\nml\\nmm\\nMSDS\\nMVA\\nMVC\\nNaCl\\nNAD\\nNaHCO3\\nNC\\n\\nheadache\\nhuman immunodeficiency virus\\nheart rate\\nhypertension\\nhistory\\nintracranial pressure\\nintensive care unit\\nintramuscular\\nInferior\\ninspiratory\\nintraosseous\\nintravenous\\nintravenous push\\nintravenous piggyback\\njugular venous distention\\nkilogram\\nkeep vein open\\nliter\\nlaceration\\npound\\nlabor and delivery\\nleft lower quadrant\\nlevel of consciousness\\nliters per minute\\nleft upper quadrant\\nmale\\nmeter\\nmass casualty incident\\nmicrogram\\nmedications\\nmilliequivalent\\nmyocardial infarction\\nmilligram\\nmilliliter\\nmillimeter\\nmanufacturers safety data sheet\\nmotor vehicle accident\\nmotor vehicle crash\\nsodium chloride\\nno apparent distress\\nsodium bicarbonate\\nnasal cannula\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDCH Approval Date: 10/23/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8103_1":{"name":"neg","content":".\\nNIDDM\\nmellitus\\nNPO\\nNKA\\nNS\\nNSR\\nNTG\\nN/V\\nO2\\nOB\\nOD\\n\\nP\\nPt\\nPAC\\nPASG\\nPalp\\nPAT\\nP.E.\\nembolism\\nPEA\\nPERRL\\nlight\\nPID\\nPIH\\nPMD\\nmedical\\nPND\\np.o.\\npost.\\nPOV\\nPSVT\\ntachycardia\\npsych.\\npt.\\nPTA\\nPVC\\nq\\nR, RR\\nResp\\nRL\\n\\nnegative\\nNon-insulin-dependent diabetes\\nnothing by mouth\\nno known allergies\\nnormal saline\\nnormal sinus rhythm\\nnitroglycerin\\nnausea/vomiting\\noxygen\\nobstetrics\\noverdose\\nafter\\npulse\\nPatient\\npremature atrial contraction\\npneumatic anti-shock garment\\npalpation\\nparoxysmal atrial tachycardia\\nphysical exam, pulmonary\\npulseless electrical activity\\npupils equal round reactive to\\npelvic inflammatory disease\\npregnancy induced hypertension\\nprivate medical doctor / primary\\nparoxysmal nocturnal dyspnea\\nby mouth\\nposterior\\nprivately-owned vehicle\\nparoxysmal supraventricular\\npsychiatric\\npatient\\nprior to arrival\\npremature ventricular contraction\\nevery\\nrespirations, respiratory rate\\nrespiratory\\nRingers lactate\\nPage 2 of 2\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nOCMCA APPROVED MEDICAL ABBREVIATIONS\\nInitial Date: 10/4/2013\\nRevised Date: 9/14/2023\\nR/O\\nROM\\nRUQ\\nRx\\nS/S\\nSQ\\nSIDS\\nsubL\\nSOB\\nstat\\nSTD\\nSVT\\ntach.\\nTB\\nTIA\\nTKO\\ntemp.\\nTOT\\nTx\\nuncon.\\nURI\\nUTI\\nVF\\nVS\\nVT\\n\\n\\nWNL\\nW/S\\nwt.\\ny/o\\n\\n(R)\\n(L)\\n1\xb0\\n2\xb0\\n~\\nx\\n+\\n-\\n\\nrule out\\nrange of motion\\nright upper quadrant\\nprescription, treatment, therapy\\nsigns/symptoms\\nsubcutaneous\\nsudden infant death syndrome\\nsublingual\\nshortness of breath\\nimmediately\\nsexually transmitted disease\\nsupraventricular tachycardia\\ntachycardia\\ntuberculosis\\ntransient ischemic attack\\nto keep open\\ntemperature\\nTurned over to\\ntreatment, therapy\\nunconscious\\nupper respiratory infection\\nurinary tract infection\\nventricular fibrillation\\nvital signs\\nventricular tachycardia\\nwith\\nwithout\\nwithin normal limits\\nwatts/second\\nweight\\nyear old\\nincreased, elevated\\ndecreased, depressed\\nnone\\nright\\nleft\\nprimary, first degree\\nsecondary, second degree\\napproximate\\ntimes\\npositive\\nnegative\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDCH Approval Date: 10/23/2023\\nSection 8.103\\n\\n\\nchange\\n\\nPage 3 of 2\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nEMS RESPONSE TIME STANDARDS\\nInitial Date: 1/1/2014\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["medical","pediatric"]},"section_8104":{"name":"EMS Response Time Standards\\nPurpose\\nQuality pre-hospital emergency care is directly related to high performance life\\nsupport agencies with unified EMS response standards","content":". The purpose of this\\nprotocol is to establish unified and consistent EMS response expectations for the\\nOakland County Life Support Agencies.\\nGLOSSARY OF TERMS\\n90% Fractile Value: The value or measurement at which 90% of all events\\noccur. This is typically used in time measurements to better standardize\\nperformance across systems.\\nAutomatic Aid: assistance provided by one agency to another that the dispatch\\ncenter, without a command officers input, can send or request equipment based\\non the information from the call to the public safety answering center. The intent\\nof automatic aid is for day-to-day, pre-arranged, protocol driven, pre-hospital care\\ndeployment.\\nEmergent: A lights and sirens, emergent response to or from an EMS event.\\nEMS Aid: Agreement by all OCMCA agencies to provide response to\\nemergency requests (lights and sirens responses only) across municipal\\nboundaries, if available. Availability will be determined by the requested agency.\\nEMS Aid IS NOT a replacement for the required mutual aid agreements and shall\\nnot be used to supplement day to day operations of any Life Support Agency.\\nEMS Aid may only be utilized if Mutual Aid is not available.\\nMutual Aid: assistance provided by one agency to another and in return the\\nother agency can expect help when needed; requires an agencys command\\nofficers to make a specific request for assistance from a neighboring jurisdiction.\\nNon-Emergent: A normal trafc speed response (no lights and sirens) to or from\\nan EMS event.\\nResponse Time Measurement: Response time is measured from Unit Notified\\nby Dispatch to Unit Arrived on Scene.\\nScene Arrival\\nThe time of arrival on scene for Emergent responses is considered the arrival of\\na licensed EMS Unit.\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 1 of 3\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nEMS RESPONSE TIME STANDARDS\\nInitial Date: 1/1/2014","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8104_1":{"name":"Revised Date","content":": 9/14/2023\\nUnit Notified by Dispatch Date/Time: The date/time the responding unit was\\nnotified by dispatch.\\nUnit Arrived on Scene Date/Time: The date/time the responding unit arrived on\\nthe scene; that is, the time the vehicle stopped moving.\\nGEOGRAPHIC SERVICE AREA DESIGNATION CRITERIA\\nGSA\\nDesignation\\nUrban area\\n\\n\\n\\nDemographics\\n>1000 people/sq mi\\n\\nEmergency\\nResponse Time\\nRequirement*\\n9 mins 0 secs\\n\\nSuburban area 5001000 people/sq\\nmi\\n\\n9 mins 0 secs\\n\\nRural area\\n\\n12 mins 0 secs\\n\\n<500 people/sq mi\\n\\n* 90% of the time, fractal.\\n\\nGEOGRAPHIC SERVICE AREA\\n1. LSAs authorized to operate within the OCMCA will have a defined\\ngeographic service area (GSA) within the OCMCA.\\n2. The minimum service area defined for any Advanced Life Support (ALS),\\nBasic Life Support (BLS), or Medical First Response (MFR) agency will be\\na municipality jurisdiction. Municipality jurisdictions will be designated by\\nthe township, village, city, or county governmental body authorized to\\ndesignate public safety contracts whether subsidized or unsubsidized.\\n3. LSAs shall provide the OCMCA with written verification of all geographic\\nservice area agreements.\\n4. The geographic response area shall be explicitly declared on the Michigan\\nDepartment of Health and Human Services (MDHHS) Life Support Agency\\nLicense application.\\n5. The LSA will maintain 24-hour, 7 day per week availability and respond or\\nassure a response to all requests for emergency assistance occurring in\\ntheir designated geographic service area.\\n6. LSAs providing ancillary non-emergent and/or inter-facility transport\\nservices shall provide sufficient coverage through extra staffing and\\nvehicles to maintain emergency availability.\\n7. When a LSA is responding outside of its designated GSA to a nonemergency run (e.g., nursing home, urgent care, physicians office, private\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 2 of 3\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nEMS RESPONSE TIME STANDARDS\\nInitial Date: 1/1/2014","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8104_2":{"name":"Revised Date","content":": 9/14/2023\\nresidence, etc.) for a patient with a potentially life-threatening condition,\\nEMS personnel, the LSA or the LSA dispatcher must activate the LSA\\nresponsible for that geographic service area.\\nNon-Emergent Responses\\nFor non-emergent responses, the EMS agency shall make every effort to arrive\\non scene within 20 minutes.\\nResponse Time Exceptions\\n1. Severe weather conditions that would provide reason to believe that\\nattempting to comply with the response time performance would be\\nhazardous to the responders or others, or where the road or other weather\\nconditions would not allow safe driving.\\n2. During disaster situations within the primary service area or neighboring\\ncommunities.\\n3. Response time compliance should not include Automatic or Mutual Aid\\nResponses.\\n4. Scene safety concerns.\\nCompliance\\nThe OCMCA will address individual compliance issues in accordance with the\\n8.24 Complaint Investigation Protocol.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 3 of 3\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nEQUIPMENT PROTOCOL\\nInitial Date: 9/14/2023\\nRevised Date: 8-27-2024","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8105":{"name":"Equipment\\nThe patient-care equipment carried on MFR","content":", BLS or ALS vehicles is defined in the State\\nof Michigan minimum equipment list. Oakland County Life Support Agencies shall not\\ncarry other EMS equipment without OCMCA authorization. Authorization consists of\\nrequesting a review of the equipment by PSRO, for MCA approval. The following\\nequipment list must be carried unless stated otherwise. Each agency must choose a\\ndevice type (FDA approved, when applicable) with their Medical Control Hospital. The\\nOCMCA considers any item on this list that is FDA approved for EMS use, as approved\\nby the OCMCA.\\nMandatory Equipment\\nAll licensed EMS vehicles:\\n1.\\nAnything listed on the State of Michigan minimum equipment list for the\\nspecific vehicle license level.\\n2.\\nMass Casualty Triage Tape\\nALS vehicles\\n1.\\n12 lead ECG Capabilities\\nOptional Equipment\\nAll licensed EMS vehicles:\\n1.\\nNon-invasive Cardiac Compression Device as approved by the OCMCA.\\n2.\\nPelvic Binder\\n3.\\nSAD Holder\\n4.\\nTracheal tube introducer (i.e. Bougie)\\n5.\\nHemostatic Dressings\\n6.\\nCommercial Chest Seals\\n7.\\nSpit Hoods\\n8.\\nBlanket Warmers\\nMFR Vehicles\\n1.\\nGlucometer\\n2.\\nOral glucose paste\\nALS vehicles only\\n1.\\nCommercial Percutaneous Cricothyrotomy: Pertrach or Quicktrach only\\n2.\\nVideo Laryngoscope\\n4.\\nIV Warmer\\n5.\\nVenoscopes\\n6.\\nVentilator  Interfacility\\nMCA Oakland County\\nPage 1 of 2\\nMCA Board Approval Date: 10/10/2024\\nMCA Implementation Date: 11/15/2024\\nMDHHS Approval Date: 10/25/2024\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nEQUIPMENT PROTOCOL\\nInitial Date: 9/14/2023\\nRevised Date: 8-27-2024\\n7.\\nIV Pumps  Interfacility\\n8.\\nHigh flow O2 equipment  Interfacility\\n9.\\nMechanical IO Devices\\n10.\\nBuretrol Sets, Microdrip tubing, Blood tubing\\n11.\\nPediatric Blow by nebulizers\\n12.\\nCommercial IV Pressure Bag\\n\\nMCA Oakland County\\nMCA Board Approval Date: 10/10/2024\\nMCA Implementation Date: 11/15/2024\\nMDHHS Approval Date: 10/25/2024","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8105_1":{"name":"Page 2","content":"of 2\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nMUTUAL AID POLICY\\nInitial Date: 1/1/2014\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8106":{"name":"Mutual Aid Policy\\nThe Oakland County Medical Control Authority (OCMCA) requires all life support\\nagencies","content":", operating within the OCMCA area, to have written mutual aid\\nagreements with agencies that are geographically within and adjacent to the\\nOCMCA.\\nDefinitions\\nAutomatic Aid: assistance provided by one agency to another that the dispatch\\ncenter, without a command officers input, can send or request equipment based\\non the information from the call to the public safety answering center. The intent\\nof automatic aid is for day-to-day, pre-arranged, protocol driven, pre-hospital care\\ndeployment.\\nMutual Aid: assistance provided by one agency to another and in return the other\\nagency can expect help when needed; requires an agencys command officers to\\nmake a specific request for assistance from a neighboring jurisdiction.\\nProcedure\\n1.\\nMutual and Automatic aid agreements entered into by life support\\nagencies within the OCMCA, shall be retained by the agency and a copy\\ngiven to the OCMCA office upon request.\\n2.\\nAutomatic aid is restricted to congruent staffing and level of licensure.\\nMutual Aid is not restricted to congruent staffing and level of licensure.\\nRequest for Mutual Aid (as defined above) should not exceed more than 5% of\\nthe requesting LSAs annual call volume.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 1 of 1\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nNEW OR UPGRADED EMS AGENCY POLICY\\nInitial Date: June 3, 2022","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8107":{"name":"Revised Date","content":": 9/14/2023\\n\\nNew or Upgraded EMS Agency Policy\\nRequirements for new life support agencies (LSAs) and agencies that propose to\\nchange their level of services.\\nThis protocol applies to:\\n1.\\nAgencies that are applying as a new service in the Oakland County MCA area.\\n2.\\nExisting agencies that are upgrading/changing the level of service they provide\\n(e.g. MFR service that wants to now become a BLS service).\\n3.\\nAny change in service not requiring a license change (e.g. addition of inter-facility\\ntransports) must include notification to the OCMCA.\\nThe agency must electronically submit all of the required documentation (listed below)\\nto the Oakland County Medical Control Authority. All paperwork must be submitted at\\nleast two weeks prior to the next Professional Standards Review Organization (PSRO)\\nmeeting. It is highly recommended that the agency has OCMCA staff review completed\\napplication prior to submission.\\nList of Required Paperwork:\\n1.\\nA copy of the completed proposed application to be submitted to the State, with\\nall signatures present. This will include:\\na.\\nA list of all vehicles licensed/proposed to be licensed by the service with\\nthe State, the year, make, VIN, and license plate number for each vehicle.\\nb.\\nA list of all licensed EMS personnel, their names, license number, level,\\nexpiration date, and, if they are paramedics, ACLS certification expiration\\ndate; and\\nc.\\nProof of State of Michigan required insurance.\\n2.\\nA copy of the completed OCMCA Letters of Compliance, with all signatures\\npresent.\\n3.\\nCopies of all mutual aid agreements with other Oakland County approved LSAs\\nwho are licensed at or above the level proposed by the applying agency. One\\nmutual aid agreement is required with an OCMCA approved LSA at or above the\\nlevel proposed by the applying agency.\\n4.\\nA complete New/Upgraded EMS Agency Form signed by the Chief of the\\ndepartment, or the President of the agency.\\n5.\\nProvide written documentation from each approving geographic service area\\n(GSA), explaining how your agency will operate in the GSA and respond to\\nemergencies in that area. Documentation must be signed by the GSA, or\\ndesignee and agency. The documentation shall include the following:\\na.\\nProvide at least 1 vehicle available for response to requests for\\nemergency assistance on a 24-hour-a-day, 7-day-a-week basis in\\naccordance with local medical control authority protocols.\\nb.\\nRespond or ensure that a response is provided to each request for\\nemergency assistance originating from within the bounds of its\\ngeographic service area, within the requirements set forth in the 8.104\\nResponse Time Protocol.\\nMCA Oakland County\\nPage 1 of 2\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nNEW OR UPGRADED EMS AGENCY POLICY\\nInitial Date: June 3, 2022","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8107_1":{"name":"Revised Date","content":": 9/14/2023\\nc.\\nOperate under the direction of a medical control authority or the medical\\ncontrol authorities with jurisdiction over the ambulance operation.\\nd.\\nProposed start of operations date.\\ne.\\nUnderstands this documentation must be completed annually if the\\nagency does not have primary geographical service area in Oakland\\nCounty.\\n6.\\n\\nProvide the OCMCA with at least two references from other Medical Control\\nAuthorities where you have operated. The OCMCA will send a letter and form to\\neach MCA requesting a report of Good Standing.\\n\\n7.\\n\\nMaintain a physical station with a minimum of one life support vehicle with 24/7\\nstaffing (of a type commensurate with what is written on the agencys license)\\nthat is available for response to requests for emergency assistance, and is\\nstaffed on a 24/7 basis within Oakland County.\\n\\nThe agency (chief, president or designee), along with their Medical Control physician,\\nwill be required to attend the PSRO meeting, in which the application will be reviewed\\nand considered, and to answer questions regarding the application.\\nOnce reviewed and endorsed by the PSRO, the application will be forwarded to\\nthe Medical Control Committee and Board of Directors for review and approval or\\ndenial.\\nOnce approved, an agency will be placed on a 12-month evaluation period. During that\\nperiod, the PSRO will closely oversee the agency and ensure compliance with Oakland\\nCounty Protocols, Policies and Procedures. At the end of the evaluation period, the\\nPSRO will make a recommendation to the Medical Control Committee to end the\\nevaluation period, extend the period or deny the request to run in Oakland County. Final\\napproval will be recommended to the OCMCA Board of Directors.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 2 of 2\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nNEW OR UPGRADED EMS AGENCY APPLICATION\\nJune 3, 2022\\nSection 8.23.1\\n________________________________________________________________________\\n\\nNEW / UPGRADE LIFE SUPPORT AGENCY APPLICATION\\nDate: ___________________\\n\\nAgency: ______________________________________\\n\\nComplete the following:\\nAGENCY:\\n1. Agrees to operate under all Oakland County Medical Control\\nAuthority protocols, policies and procedures.\\n2. Has a medical control hospital and medical control hospital\\nphysician.\\nMedical Control Hospital:\\n______________________________________\\nPhysician (MCC member/alt):\\n3. If proposed coverage is less than current coverage in quantity of\\nvehicles, level of licensure, or average response time, justification is\\nattached explaining the reason for the proposed coverage.\\n4. Have the owners/officers of the agency have ever been convicted of\\na felony?\\nSTAFFING:\\n5. Meets Oakland County staffing requirements and the personnel\\nmeet Oakland County qualifications.\\n\\nYES\\n\\nNO\\n\\nYES\\n\\nNO\\n\\nNOTE: If No is checked for any statement (except for number 4), you must provide\\nsufficient documentation to explain the variance. If Yes is checked for number 4, provide\\nan explanation.\\nAgency will provide the following:\\n1.\\nAttach a detailed communication plan that meets OCMCA Communication Policy\\nrequirements, based on level of licensure. Requests must meet current MDHHS\\nMEDCOM plan requirements, as well.\\n2.\\nAttach a 2-month schedule for the units and personnel proposed in this application.\\n3.\\nList all types of service to be provided, as well as service area (list current as well\\nas proposed).\\n4.\\nAttach a written plan to meet and comply with the Oakland County EMS Response\\nTime Standards (8.13).\\n5.\\nAttach a map showing the response area for each Oakland County based vehicle\\n(this can be drawn on the map). Response area must be small enough to ensure\\nthat Oakland County Medical Control Authority response time criteria are met. List\\neach vehicle:\\n\\nMCA Oakland County\\nMCA Board Approval Date: June 3, 2022\\nMDHHS Approval Date: February 24, 2023\\nMCA Implementation Date: March 8, 2023\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nNEW OR UPGRADED EMS AGENCY APPLICATION\\nJune 3, 2022\\nSection 8.23.1\\n________________________________________________________________________\\n\\nLevel of Licensure:\\n\\n6.\\n\\n7.\\n\\n8.\\n9.\\n\\nNumber of Vehicles:\\n\\nAverage Response\\nTime:\\n\\nProvide written documentation from each approving geographic service area (GSA),\\nexplaining how your agency will operate in the GSA and respond to emergencies in\\nthat area. Documentation must be signed by the GSA or designee and agency. The\\ndocumentation shall include the following:\\na.\\nProvide at least 1 vehicle available for response to requests for emergency\\nassistance on a 24-hour-a-day, 7-day-a-week basis in accordance with local\\nmedical control authority protocols.\\nb.\\nRespond or ensure that a response is provided to each request for\\nemergency assistance originating from within the bounds of its geography\\nservice area, within the requirements set forth in the 8.13 Response Time\\nProtocol.\\nc.\\nOperate under the direction of a medical control authority or the medical\\ncontrol authorities with jurisdiction over the ambulance operation.\\nd.\\nProposed start of operations date.\\ne.\\nUnderstands this documentation must be completed annually if the agency\\ndoes not have primary geographical service area in Oakland County.\\nIf the application involves upgrading the level of service, a plan must be attached\\nthat explains how the agency will deal with newly licensed personnel working\\ntogether.\\nProvide mutual aid agreement(s) with an OCMCA approved LSA at or above the\\nlevel proposed by the applying agency.\\nIf the service is a corporation, articles of incorporation are included.\\nSignature  Chief of Department or Agency President\\n\\nMCA Oakland County\\nMCA Board Approval Date: June 3, 2022\\nMDHHS Approval Date: February 24, 2023\\nMCA Implementation Date: March 8, 2023\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nPROFESSIONAL STANDARDS REVIEW ORGANIZATION\\nEMS RESEARCH POLICY\\nInitial Date: June 3, 2022","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8108":{"name":"Revised Date","content":": 9/14/2023\\n\\nEMS Research Policy\\nGeneral Principles:\\nThe OCMCA generally supports EMS Research for the purpose of improving system\\nefficiencies, patient outcomes, cost burden, quality and safety. The OCMCA\\nreserves the right to review, recommend edits, approve or deny proposed research\\naffecting the pre-hospital system in Oakland County,\\nConfidentiality:\\nThe confidentiality rights of patients, agencies, and hospitals should be preserved in\\nall cases. No patient, agency or hospital identifying data will be reported without their\\nexpressed written approval. Case reports may be considered under special\\ncircumstances with approval by the OCMCA, and the patient, agency and hospital\\ninvolved.\\nReview Process:\\nThe OCMCA reserves the right to review, recommend edits, approve or deny\\nproposed research as stated above. The OCMCA PSRO Committee will perform this\\ninitial review. Only approvals by PSRO will be recommended for action by the MCC\\nand final action by OCMCA Board.\\nHospital-based research projects must be approved by the applicable hospitals\\nInstitutional Review Board before final approval by the OCMCA.\\nThe OCMCA reserves the right to remove its support of any approved study at any\\ntime and thereby terminate its allowance of the research project being conducted\\nwith respect to patients, hospitals, LSAs and providers located in OCMCAs region.\\nAuthorship:\\nThe OCMCA may require periodic updates of the research status from a Principal\\nInvestigator.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 1 of 1\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nPROFESSIONAL STANDARDS REVIEW ORGANIZATION\\nCONFIDENTIALITY STATEMENT\\nInitial Date: 10/4/2013","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8109":{"name":"Revised Date","content":": 9/14/2023\\n\\nConfidentiality Statement\\nResponsibilities:\\nThe responsibilities of the PSRO Committee shall be to:\\n1. Assess, investigate and when necessary, make recommendations to OCMCA\\nBoard pertaining to issues of concern regarding non-compliance with OCMCA policies,\\nprocedures or protocols posed by any person(s) regarding Oakland County EMS\\nactivities. Investigations will be processed in accordance with OCMCA Protocols.\\n2. Regularly assess quality assurance processes performed by Oakland County Life\\nSupport Agencies and their professional personnel through an audit process using data\\nprovided by the agencies and other system participants.\\n3. Develop an annual plan and perform study evaluations for the purpose of EMS\\nsystem assessment and improvement of processes, protocols, EMS personnel,\\nequipment, medications, etc. that may affect patient outcomes. Additional studies can\\nbe conducted on an ad hoc basis as issues arise or system deficiencies are\\nrecognized.\\n4. Assess agency and facility applications, reapplications, and compliance with\\nOCMCA protocols, policies, and PSRO recommendations.\\n5. Provide additional planning, coordination, monitoring and evaluation of the EMS\\nsystem within Oakland County as it relates to the quality of care provided by individuals\\nand Life Support Agencies within the system, or as designed by the OCMCA Board.\\nExpectations:\\n1. All data, discussions, deliberations, documents, correspondence, materials and any\\nother information either written or verbal shared either within the PSRO meeting setting\\nor provided or generated in connection with carrying out the responsibilities of the\\nPSRO are confidential, are not public records, may not be used for other purposes,\\nand are protected by federal and state laws. Furthermore, these items and information\\nas outlined are not to be discussed or disseminated to any person not currently serving\\nas a PSRO member or staff.\\n2. As an active member of the PSRO Committee I am committed to maintaining the\\nconfidentiality practices of this Committee as stated in the OCMCA Protocols and state\\nlaw. I understand that if I breach the aforementioned confidentiality I may be dismissed\\nfrom this Committee.\\nDate: ___________________________________\\nSignature: ________________________________\\nPrinted Name: _____________________________\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 1 of 1\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nREROUTING POLICY\\n\\nInitial Date: 12/4/2014\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8110":{"name":"Rerouting Policy\\nPurpose\\nMichigan Public Act 3","content":"68 of 1978, as amended, authorizes local medical control\\nauthorities to establish written protocols for the practice of life support agencies and\\nlicensed emergency medical services personnel within its region. To ensure the\\navailability of patient care, the following will be adhered to by OCMCA life support\\nagencies and emergency facilities:\\nA.\\n\\nB.\\n\\nC.\\n\\nD.\\n\\nE.\\n\\nF.\\n\\nG.\\n\\nH.\\n\\nED status limitation (rerouting of EMS patients) will only be considered in\\nextreme circumstances. These are defined as: Facility-specific loss of CT\\nscanner capability, loss of x-ray capability or lack of Operating Room capabilities.\\nFacility specific in-house disaster such as an extensive fire, flooding or loss of\\nelectrical power, or other catastrophic event. The facility cannot change to Status\\nC unless the facility has declared an in-house disaster, as defined in policy, by\\neach facility.\\nED status limitation (rerouting) is not to be initiated because of:\\n Lack of staffing\\n Lack of in-patient beds\\n Overcrowding of the emergency department\\n Actual community disaster (Unless system directed)\\nCritical patients will be accepted by the closest appropriate emergency facility\\nwhen transportation to a more distant facility could pose further significant risk to\\nthe patient, regardless of the facilitys rerouting status. Serious, but stable\\npatients may be rerouted by an on-line medical control physician.\\nThe Status B and C must be re-evaluated frequently by an authorized person\\nto ensure immediate communication of the change in status. At a minimum, the\\nED STATUS will be re-evaluated no less than at the end of each shift. Any\\nchange will be communicated immediately to all concerned.\\nIf the three closest facilities to the incident are all Status C, or all on similar\\nstatus, the unit should contact the closest facility for transport to that\\nfacility. The on-scene EMS crew will determine the three closest facilities.\\nEMSystem, through EMResource is to be utilized by all participating emergency\\nfacilities. EMResource shall be updated two (2) times per day, and as status\\nchanges, with the current status of the facility. If a facility is rerouting (Status B or\\nStatus C) and has not updated EMResource with this status change, the facility\\nshall accept incoming patients from the EMS system.\\nIt is the responsibility of the emergency facility to use the following categories to\\nindicate rerouting status:\\nSTATUS A: Accepting patients appropriate for that emergency facility.\\nSTATUS B: Emergency facilitys capabilities are limited. Services or resources\\nnot available should be specified, and that facilitys use avoided for\\npatients requiring them.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 1 of 2\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nREROUTING POLICY\\n\\nInitial Date: 12/4/2014","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8110_1":{"name":"Revised Date","content":": 9/14/2023\\nSTATUS C: The emergency facility meets the criteria to reroute EMS patients\\n(see A.).\\nI.\\nFacility\\n1.\\nEach facility shall have and follow their internal rerouting policy.\\n2.\\nPatients will not be rerouted on the basis of ability to pay.\\n3.\\nOn-line medical control, via participating Medical Control hospitals, will\\nremain available at all times.\\n4.\\nAmbulances already on hospital property will not be rerouted.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 2 of 2\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nSCENE PATIENT MANAGEMENT\\nInitial Date: September 2013","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8111":{"name":"Revised Date","content":": 9/14/2023\\n____________________________________________________________________________________\\n\\nScene Patient Management\\nPublic Act\\nAuthority for the management of a patient in an emergency is vested in the\\nlicensed health professional or licensed emergency medical services personnel\\nat the scene of the emergency who has the most training specific to the provision\\nof emergency medical care. If a licensed health professional or licensed\\nemergency medical services personnel is not available, the authority is vested in\\nthe most appropriately trained representative of a public safety agency at the\\nscene of the emergency.\\nNote: EMS Providers shall not allow other individuals (police, fire, other\\nphysician) to determine patient destination or disposition without prior approval\\nfrom the on-line medical control physician providing medical control.\\nTransfer to Another Life Support Unit\\nA Basic Life or Advanced Life Support unit may transfer patient management to\\nanother life support unit of equal or greater qualification by mutual agreement,\\nunless it falls under 8.7 ALS to BLS Transfer of Care Protocol.\\nMultiple Unit Response\\nSecond responding Advanced Life Support and Basic Life Support units are\\nresponsible to assist in patient care until released by the managing Advanced\\nLife Support Unit.\\nCall Jumping is defined as responding to another agencies geographic\\nservice area for an emergency response, without the knowledge of the agency\\nhaving jurisdiction. If an agency is responding into another agencies geographic\\nservice area, every effort shall be made to advise that agency to allow the\\nagency having jurisdiction the ability to respond. This will be dealt with\\naccordingly and reported to the appropriate agency.\\nExtended Care Facilities (ECF)\\nOnce an EMS unit is on the scene, management of the patient shall be according\\nto Oakland County policy with respect to patient care, communication and\\ntransportation.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/17/2023\\n\\nPage 1 of 1\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nTACTICAL EMERGENCY MEDICAL SERVICE (TEMS) TEAM\\nInitial Date: June 3, 2022\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8112":{"name":"Tactical Emergency Medical Services (TEMS) Team\\nPurpose","content":":\\nThe purpose of this protocol is to allow for the use of tactical EMS paramedics, within\\nthe Oakland County Medical Control Authority, during police related activities and\\ntraining. This protocol does not provide liability coverage as prescribed under the EMS\\nlaw, for tactical teams that originate and/or operate out of non-life support agencies (i.e.\\npolice departments, sheriff offices SWAT teams).\\nProcedure:\\nAny ALS agency that seeks to utilize a TEMS team will provide personnel with\\nparamedic level licensure within the State of Michigan, and training in tactical scenarios.\\nWhen responding to a tactical scene, within their geographical service area (GSA), the\\nTEMS team shall respond along with an ALS unit from their Agency. If responding\\noutside of their GSA an EMS transport unit, preferably ALS, should be requested from\\nthe local jurisdiction. This will only be done if tactically feasible or prudent.\\nIf responding to a tactical scene outside of their GSA, an ambulance from the local\\njurisdiction should be dispatched, or placed on standby, as well. In the event a\\npatient(s) arises out of the tactical situation, the TEMS paramedic(s) will provide a\\ncomprehensive verbal report upon transferring care to the transporting unit. If the\\ntransporting unit is not ALS, or when it is deemed necessary, the TEMS paramedic(s)\\nwill accompany the patient to the hospital as to maintain or optimize patient care.\\nThe TEMS paramedic(s) will follow the OCMCA protocols and will have radio\\ncapabilities to contact OCMCA hospitals for the purpose of accessing on-line medical\\ncontrol.\\n\\nMCA Name: Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 1 of 2\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nTACTICAL EMERGENCY MEDICAL SERVICE (TEMS) TEAM\\nInitial Date: June 3, 2022\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8112_1":{"name":"TEMS Equipment List\\nThe following is a list of equipment that should be deployed with a TEMS team","content":". In the\\ninterest of maintaining tactical mobility, items may be provided by the ALS unit providing\\nstandby.\\n-\\n\\nAED/Monitor (may be provided by standby unit)\\nJump kit/TEMS kit\\nOxygen and supplies (may be provided by the standby unit)\\nAirway management supplies\\nSuction (may be provided by the standby unit)\\nIV kit\\nDrug package/kit (modified)\\n\\nTEMS Drug Package\\nAny ALS agency wishing to obtain a modified drug package may do so by working with\\ntheir Medical Control Physician in developing a plan on how and which medications will\\nbe carried by the TEMS team. Once this plan is developed, it must be approved by the\\nMedical Director of the OCMCA, or his/her designee.\\nOnce approval is obtained, the agency must provide a device to the Medical Control\\nHospital Pharmacy, which is capable of being sealed. The drug package must remain\\nwith the TEMS team while deployed. This drug package must be inventoried and\\nsealed with an expiration date listed on the label. The drug package must be kept in a\\nsecured area when not in use.\\n\\nMCA Name: Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 2 of 2\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nMedical Control and Participating Hospital Policy\\nInitial Date: December 2014\\nRevised Date: 9/14/2023","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8113":{"name":"Medical Control and Participating Hospital Policy\\nDefinitions\\n1","content":".\\nEmergency Facility  a licensed hospital, freestanding surgical outpatient facility, or\\nhospital provider-based emergency department.\\n2.\\nReceiving Emergency Facility  an Emergency Facility approved by the OCMCA to give\\nmedical direction and receive EMS patients.\\n3.\\nMedical Control Hospital  approved by the OCMCA and fulfills the criteria set by the\\nOCMCA defining medical control hospital.\\n4.\\nOnline Medical Direction  pre-hospital direction given by an emergency physician over\\nthe radio or telephone to an EMS provider.\\nAnnual Review Process\\nThe Hospital Letter of Compliance will be completed annually in accordance with the published\\nschedule, forwarded to PSRO for review and recommendation to the Medical Control\\nCommittee (MCC) and approved by the Board of Directors.\\nEmergency Facility Criteria and Compliance\\n1.\\nCriteria \\na.\\nA qualified Emergency Physician will be available at all times to provide online\\nmedical direction at each Receiving Emergency Facility.\\nb.\\nA qualified Emergency Physician is defined as:\\ni. Board Certified in Emergency Medicine, by either the American Board of\\nEmergency Medicine or the American Osteopathic Board of Emergency\\nMedicine.\\nii. Residency trained in Emergency Medicine.\\niii. A physician practicing full-time in an Oakland County approved facility\\nprior to July 1, 1993 and practicing full-time in emergency Medicine since\\nthat time. A one-time request for approval for this category for each\\nphysician shall be made through PSRO with a recommendation to the\\nMedical Control Committee, and approval of the Board of Directors.\\nc.\\nAny variation in the above shall require special consideration by the Board of\\nDirectors.\\n2.\\n\\nNon-Compliance \\nUpon adequately establishing a Receiving Emergency Facilitys inability to comply with\\nthe OCMCA Hospital Letter of Compliance, PSRO will:\\na.\\nAdvise the facility of its noncompliance status.\\nb.\\nRequest a plan within two weeks from the hospital containing a timeline for\\nachieving compliance.\\ni. If the timeline to comply is less than one month, PSRO will monitor and\\nassure completion.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 1 of 2\\n\\nOakland County Medical Control Authority\\nSystem Protocols\\nMedical Control and Participating Hospital Policy\\nInitial Date: December 2014\\nRevised Date: 9/14/2023\\nSection 8.113\\n\\nii.\\n\\nc.\\n\\nIf the time allotted is more than one month, or, if the facility cannot\\ncomplete the plan, its 800 MHz radio shall be relinquished until\\ncompliance with criteria for participating is met.\\nAny appeals of the decision or actions shall be according to the Incident\\nInvestigation Procedure.\\n\\nReceiving Emergency Facility Responsibilities:\\n1.\\nReceive EMS patients and provide medical direction.\\n2.\\nProvide case-by-case quality assurance and performance reviews and communicate\\nwith the OCMCA office regarding deviations from protocol.\\n3.\\nParticipate in LSA QI programs, including a review of online medical control at their\\ninstitution, and provide documentation to PSRO, when requested.\\n4.\\nAdhere to Oakland County Medical Control Authority approved protocols and policies.\\n5.\\nEnsure that hospital staff answering the communication device and/or giving medical\\ndirection have access and knowledge of the OCMCA Protocols.\\nMedical Control Hospital Participation\\nTo provide the service of a Medical Control Hospital to a Life Support Agency, the Medical\\nControl Hospital shall participate in the following educational activities:\\na.\\nb.\\nc.\\nd.\\n\\nProvide lecture activities for Life Support Agencies.\\nAdditional activities as agreed by both the Life Support Agency and the Medical\\nControl Hospital/Medical Control Physician.\\nAdditional activities, as directed by OCMCA PSRO.\\nActivities/Programs may include EMS run reviews.\\n\\nMedical Control Hospital Physician Responsibilities\\n1.\\nAssign a Physician that is Board Certified in Emergency Medicine to serve on the\\nMedical Control Committee and other OCMCA committees, as deemed necessary.\\n2.\\nProvide a Medical Control Physician for EMS personnel of the Life Support Agency\\nassigned to the Medical Control Hospital, whose responsibilities include:\\na.\\nPhysician advisor to EMS personnel.\\nb.\\nEducate and communicate with hospital medical staff on issues concerning the\\nEMS community including all protocols and protocol updates. May include\\nauditing the medical direction given by the Medical Control Hospital.\\nc.\\nAssist in developing EMS educational programs.\\nd.\\nEMS personnel/Life Support Agency incidents or concerns shall be reported to\\nthe OCMCA office.\\n\\nMCA Oakland County\\nMCA Board Approval Date: October 6, 2023\\nMCA Implementation Date: February 1, 2024\\nMDHHS Approval Date: 10/12/2023\\n\\nPage 2 of 2\\n\\nOakland County Medical Control Authority\\n\\nSystem Protocols\\nHospital Provider-Based Emergency Department\\nInitial Date: June 1, 2018\\nRevision Date: February 2, 2024","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8114":{"name":"Hospital Provider-based Emergency Departments\\nDefinition\\nHospital Provider-based ED is a term used by CMS to describe an Emergency Department\\noperated by a Medicare-participating hospital at an off-campus location","content":". Services provided at\\nthe off-site ED are included under the hospitals Medicare Provider Agreement and must\\ncomply with all Hospital Conditions of Participation found in 42 CFR 482.1  482.45, which\\ninclude, but are not limited to the following:\\n Medical staff and nursing personnel practicing at the off-campus ED must be part of\\nthe hospitals medical staff/nursing service.\\n Hospitals Governing Body is responsible for the services and activities of the offcampus ED.\\n Emergency laboratory services must be available onsite to the off-campus ED 24/7.\\n Off-campus ED must be integrated into the hospitals quality assessment/performance\\nimprovement program as well as medical records system.\\n Policies and procedures regarding medical care provided at the off-campus ED are the\\nresponsibility of the hospitals medical staff, and must operate under the same general\\npolicies and procedures when practical.\\nGuidelines for Participation\\nA.\\nResponsibilities\\n1.\\nThe facility must agree to comply with the 8.113 Medical Control and\\nParticipating Hospital Policy.\\n2.\\nThe facility must agree to complete the OCMCA Letter of Compliance each\\nyear.\\n3.\\nEmergency care must be available 24 hours-a-day and 7 days-a-week.\\n4.\\nThe facility must agree to comply with any appropriate policies or protocols\\nestablished by the OCMCA.\\n5.\\nRadiological (CT scan and Plain Film Radiograph) and typical emergency\\ndepartment laboratory services shall be immediately available onsite 24 hours a\\nday to provide diagnostic evaluation of patients with life-or-limb threatening\\nconditions.\\n6.\\nThe facility will have Medication Boxes and A-Packs, with contents as approved\\nby the OCMCA and MDCH, available for replacement of supplies used by\\napproved ALS Units. Replacement Boxes/Packs will be maintained in a locked\\narea, under the control of facility staff, and made available 24 hours a day, 7\\ndays a week.\\n\\nB.\\n\\nResponsibilities for the Continuity of Patient Care\\n\\nMCA Name: Oakland County\\nMCA Board Approval Date: February 2, 2024\\nMDCH Approval Date: February 5, 2024\\nMCA Implementation Date: February 5, 2024\\n\\nPage 1 of 2\\n\\nOakland County Medical Control Authority\\n\\nSystem Protocols\\nHospital Provider-Based Emergency Department\\nInitial Date: June 1, 2018\\nRevision Date: February 2, 2024\\n1.\\n2.\\n\\n3.\\n4.\\n\\nC.","source_file":"Section-8-TOC.pdf","categories":["medical"]},"section_8114_1":{"name":"Patients should be transported to the nearest appropriate facility in accordance\\nwith then Oakland County MCA protocols","content":".\\nThe facility must comply with the States Medcom Plan, as well as the Oakland\\nCounty Radio System for notice of arrival or advance information concerning\\ncritically ill or injured patients, and to give medical control.\\nEmergency facility personnel shall be familiar with the OCMCA Protocols.\\nThe facility must have available a plan for transfer of patients by EMS vehicle or\\nother conveyance with appropriate life support capabilities when necessary.\\nTransfers must be EMTALA compliant.\\n\\nTransportation\\n1.\\nPriority one patients are not appropriate for hospital provider-based emergency\\ndepartments. Unstable priority two patients are not appropriate for hospital\\nprovider-based emergency department unless, in the opinion of the on-line\\nmedical control physician, transporting the patient to a further facility could have\\nan adverse effect on the patients outcome.\\n2.\\nStable Patients\\na.\\nStable Medical Patients  If no preference, transport to the closest\\napproved Oakland County Emergency Facility (see Transportation\\nProtocol).\\nb.\\nStable Trauma Patients -- Only patients with minor injuries (e.g. injured\\nankle from stumble, injured wrist from a fall, etc.) may be transported to a\\nhospital provider-based emergency department (see Transportation\\nProtocol).\\n3.\\nEMS will communicate to the patient or patients family of the hospital providerbased facilitys abilities that they are an emergency department, but not a\\nhospital emergency department with the ability to admit.\\n\\nMCA Name: Oakland County\\nMCA Board Approval Date: February 2, 2024\\nMDCH Approval Date: February 5, 2024\\nMCA Implementation Date: February 5, 2024\\n\\nPage 2 of 2","source_file":"Section-8-TOC.pdf","categories":["trauma","medical"]}}');var iq="dismissableLayer.update",iV=u.createContext({layers:new Set,layersWithOutsidePointerEventsDisabled:new Set,branches:new Set}),iz=u.forwardRef((e,n)=>{let{disableOutsidePointerEvents:t=!1,onEscapeKeyDown:i,onPointerDownOutside:a,onFocusOutside:o,onInteractOutside:r,onDismiss:s,...l}=e,d=u.useContext(iV),[h,m]=u.useState(null),f=h?.ownerDocument??globalThis?.document,[,g]=u.useState({}),y=tx(n,e=>m(e)),b=Array.from(d.layers),[v]=[...d.layersWithOutsidePointerEventsDisabled].slice(-1),A=b.indexOf(v),C=h?b.indexOf(h):-1,w=d.layersWithOutsidePointerEventsDisabled.size>0,S=C>=A,_=function(e,n=globalThis?.document){let t=tQ(e),i=u.useRef(!1),a=u.useRef(()=>{});return u.useEffect(()=>{let e=e=>{if(e.target&&!i.current){let i=function(){iG("dismissableLayer.pointerDownOutside",t,o,{discrete:!0})},o={originalEvent:e};"touch"===e.pointerType?(n.removeEventListener("click",a.current),a.current=i,n.addEventListener("click",a.current,{once:!0})):i()}else n.removeEventListener("click",a.current);i.current=!1},o=window.setTimeout(()=>{n.addEventListener("pointerdown",e)},0);return()=>{window.clearTimeout(o),n.removeEventListener("pointerdown",e),n.removeEventListener("click",a.current)}},[n,t]),{onPointerDownCapture:()=>i.current=!0}}(e=>{let n=e.target,t=[...d.branches].some(e=>e.contains(n));!S||t||(a?.(e),r?.(e),e.defaultPrevented||s?.())},f),E=function(e,n=globalThis?.document){let t=tQ(e),i=u.useRef(!1);return u.useEffect(()=>{let e=e=>{e.target&&!i.current&&iG("dismissableLayer.focusOutside",t,{originalEvent:e},{discrete:!1})};return n.addEventListener("focusin",e),()=>n.removeEventListener("focusin",e)},[n,t]),{onFocusCapture:()=>i.current=!0,onBlurCapture:()=>i.current=!1}}(e=>{let n=e.target;[...d.branches].some(e=>e.contains(n))||(o?.(e),r?.(e),e.defaultPrevented||s?.())},f);return function(e,n=globalThis?.document){let t=tQ(e);u.useEffect(()=>{let e=e=>{"Escape"===e.key&&t(e)};return n.addEventListener("keydown",e,{capture:!0}),()=>n.removeEventListener("keydown",e,{capture:!0})},[t,n])}(e=>{C!==d.layers.size-1||(i?.(e),!e.defaultPrevented&&s&&(e.preventDefault(),s()))},f),u.useEffect(()=>{if(h)return t&&(0===d.layersWithOutsidePointerEventsDisabled.size&&(c=f.body.style.pointerEvents,f.body.style.pointerEvents="none"),d.layersWithOutsidePointerEventsDisabled.add(h)),d.layers.add(h),iU(),()=>{t&&1===d.layersWithOutsidePointerEventsDisabled.size&&(f.body.style.pointerEvents=c)}},[h,f,t,d]),u.useEffect(()=>()=>{h&&(d.layers.delete(h),d.layersWithOutsidePointerEventsDisabled.delete(h),iU())},[h,d]),u.useEffect(()=>{let e=()=>g({});return document.addEventListener(iq,e),()=>document.removeEventListener(iq,e)},[]),(0,p.jsx)(tY.div,{...l,ref:y,style:{pointerEvents:w?S?"auto":"none":void 0,...e.style},onFocusCapture:t2(e.onFocusCapture,E.onFocusCapture),onBlurCapture:t2(e.onBlurCapture,E.onBlurCapture),onPointerDownCapture:t2(e.onPointerDownCapture,_.onPointerDownCapture)})});function iU(){let e=new CustomEvent(iq);document.dispatchEvent(e)}function iG(e,n,t,{discrete:i}){let a=t.originalEvent.target,o=new CustomEvent(e,{bubbles:!1,cancelable:!0,detail:t});(n&&a.addEventListener(e,n,{once:!0}),i)?a&&tW.flushSync(()=>a.dispatchEvent(o)):a.dispatchEvent(o)}iz.displayName="DismissableLayer",u.forwardRef((e,n)=>{let t=u.useContext(iV),i=u.useRef(null),a=tx(n,i);return u.useEffect(()=>{let e=i.current;if(e)return t.branches.add(e),()=>{t.branches.delete(e)}},[t.branches]),(0,p.jsx)(tY.div,{...e,ref:a})}).displayName="DismissableLayerBranch";var iW=0;function iY(){u.useEffect(()=>{let e=document.querySelectorAll("[data-radix-focus-guard]");return document.body.insertAdjacentElement("afterbegin",e[0]??iX()),document.body.insertAdjacentElement("beforeend",e[1]??iX()),iW++,()=>{1===iW&&document.querySelectorAll("[data-radix-focus-guard]").forEach(e=>e.remove()),iW--}},[])}function iX(){let e=document.createElement("span");return e.setAttribute("data-radix-focus-guard",""),e.tabIndex=0,e.style.outline="none",e.style.opacity="0",e.style.position="fixed",e.style.pointerEvents="none",e}var i$="focusScope.autoFocusOnMount",iK="focusScope.autoFocusOnUnmount",iJ={bubbles:!1,cancelable:!0},iQ=u.forwardRef((e,n)=>{let{loop:t=!1,trapped:i=!1,onMountAutoFocus:a,onUnmountAutoFocus:o,...r}=e,[s,l]=u.useState(null),c=tQ(a),d=tQ(o),h=u.useRef(null),m=tx(n,e=>l(e)),f=u.useRef({paused:!1,pause(){this.paused=!0},resume(){this.paused=!1}}).current;u.useEffect(()=>{if(i){let e=function(e){if(f.paused||!s)return;let n=e.target;s.contains(n)?h.current=n:i1(h.current,{select:!0})},n=function(e){if(f.paused||!s)return;let n=e.relatedTarget;null===n||s.contains(n)||i1(h.current,{select:!0})};document.addEventListener("focusin",e),document.addEventListener("focusout",n);let t=new MutationObserver(function(e){if(document.activeElement===document.body)for(let n of e)n.removedNodes.length>0&&i1(s)});return s&&t.observe(s,{childList:!0,subtree:!0}),()=>{document.removeEventListener("focusin",e),document.removeEventListener("focusout",n),t.disconnect()}}},[i,s,f.paused]),u.useEffect(()=>{if(s){i2.add(f);let e=document.activeElement;if(!s.contains(e)){let n=new CustomEvent(i$,iJ);s.addEventListener(i$,c),s.dispatchEvent(n),n.defaultPrevented||(function(e,{select:n=!1}={}){let t=document.activeElement;for(let i of e)if(i1(i,{select:n}),document.activeElement!==t)return}(iZ(s).filter(e=>"A"!==e.tagName),{select:!0}),document.activeElement===e&&i1(s))}return()=>{s.removeEventListener(i$,c),setTimeout(()=>{let n=new CustomEvent(iK,iJ);s.addEventListener(iK,d),s.dispatchEvent(n),n.defaultPrevented||i1(e??document.body,{select:!0}),s.removeEventListener(iK,d),i2.remove(f)},0)}}},[s,c,d,f]);let g=u.useCallback(e=>{if(!t&&!i||f.paused)return;let n="Tab"===e.key&&!e.altKey&&!e.ctrlKey&&!e.metaKey,a=document.activeElement;if(n&&a){let n=e.currentTarget,[i,o]=function(e){let n=iZ(e);return[i0(n,e),i0(n.reverse(),e)]}(n);i&&o?e.shiftKey||a!==o?e.shiftKey&&a===i&&(e.preventDefault(),t&&i1(o,{select:!0})):(e.preventDefault(),t&&i1(i,{select:!0})):a===n&&e.preventDefault()}},[t,i,f.paused]);return(0,p.jsx)(tY.div,{tabIndex:-1,...r,ref:m,onKeyDown:g})});function iZ(e){let n=[],t=document.createTreeWalker(e,NodeFilter.SHOW_ELEMENT,{acceptNode:e=>{let n="INPUT"===e.tagName&&"hidden"===e.type;return e.disabled||e.hidden||n?NodeFilter.FILTER_SKIP:e.tabIndex>=0?NodeFilter.FILTER_ACCEPT:NodeFilter.FILTER_SKIP}});for(;t.nextNode();)n.push(t.currentNode);return n}function i0(e,n){for(let t of e)if(!function(e,{upTo:n}){if("hidden"===getComputedStyle(e).visibility)return!0;for(;e&&(void 0===n||e!==n);){if("none"===getComputedStyle(e).display)return!0;e=e.parentElement}return!1}(t,{upTo:n}))return t}function i1(e,{select:n=!1}={}){if(e&&e.focus){var t;let i=document.activeElement;e.focus({preventScroll:!0}),e!==i&&(t=e)instanceof HTMLInputElement&&"select"in t&&n&&e.select()}}iQ.displayName="FocusScope";var i2=function(){let e=[];return{add(n){let t=e[0];n!==t&&t?.pause(),(e=i3(e,n)).unshift(n)},remove(n){e=i3(e,n),e[0]?.resume()}}}();function i3(e,n){let t=[...e],i=t.indexOf(n);return -1!==i&&t.splice(i,1),t}var i4=h[" useId ".trim().toString()]||(()=>void 0),i8=0;function i5(e){let[n,t]=u.useState(i4());return tX(()=>{e||t(e=>e??String(i8++))},[e]),e||(n?`radix-${n}`:"")}let i7=["top","right","bottom","left"],i6=Math.min,i9=Math.max,ae=Math.round,an=Math.floor,at=e=>({x:e,y:e}),ai={left:"right",right:"left",bottom:"top",top:"bottom"},aa={start:"end",end:"start"};function ao(e,n){return"function"==typeof e?e(n):e}function ar(e){return e.split("-")[0]}function as(e){return e.split("-")[1]}function al(e){return"x"===e?"y":"x"}function ac(e){return"y"===e?"height":"width"}function ad(e){return["top","bottom"].includes(ar(e))?"y":"x"}function ap(e){return e.replace(/start|end/g,e=>aa[e])}function au(e){return e.replace(/left|right|bottom|top/g,e=>ai[e])}function ah(e){return"number"!=typeof e?{top:0,right:0,bottom:0,left:0,...e}:{top:e,right:e,bottom:e,left:e}}function am(e){let{x:n,y:t,width:i,height:a}=e;return{width:i,height:a,top:t,left:n,right:n+i,bottom:t+a,x:n,y:t}}function af(e,n,t){let i,{reference:a,floating:o}=e,r=ad(n),s=al(ad(n)),l=ac(s),c=ar(n),d="y"===r,p=a.x+a.width/2-o.width/2,u=a.y+a.height/2-o.height/2,h=a[l]/2-o[l]/2;switch(c){case"top":i={x:p,y:a.y-o.height};break;case"bottom":i={x:p,y:a.y+a.height};break;case"right":i={x:a.x+a.width,y:u};break;case"left":i={x:a.x-o.width,y:u};break;default:i={x:a.x,y:a.y}}switch(as(n)){case"start":i[s]-=h*(t&&d?-1:1);break;case"end":i[s]+=h*(t&&d?-1:1)}return i}let ag=async(e,n,t)=>{let{placement:i="bottom",strategy:a="absolute",middleware:o=[],platform:r}=t,s=o.filter(Boolean),l=await (null==r.isRTL?void 0:r.isRTL(n)),c=await r.getElementRects({reference:e,floating:n,strategy:a}),{x:d,y:p}=af(c,i,l),u=i,h={},m=0;for(let t=0;t<s.length;t++){let{name:o,fn:f}=s[t],{x:g,y:y,data:b,reset:v}=await f({x:d,y:p,initialPlacement:i,placement:u,strategy:a,middlewareData:h,rects:c,platform:r,elements:{reference:e,floating:n}});d=null!=g?g:d,p=null!=y?y:p,h={...h,[o]:{...h[o],...b}},v&&m<=50&&(m++,"object"==typeof v&&(v.placement&&(u=v.placement),v.rects&&(c=!0===v.rects?await r.getElementRects({reference:e,floating:n,strategy:a}):v.rects),{x:d,y:p}=af(c,u,l)),t=-1)}return{x:d,y:p,placement:u,strategy:a,middlewareData:h}};async function ay(e,n){var t;void 0===n&&(n={});let{x:i,y:a,platform:o,rects:r,elements:s,strategy:l}=e,{boundary:c="clippingAncestors",rootBoundary:d="viewport",elementContext:p="floating",altBoundary:u=!1,padding:h=0}=ao(n,e),m=ah(h),f=s[u?"floating"===p?"reference":"floating":p],g=am(await o.getClippingRect({element:null==(t=await (null==o.isElement?void 0:o.isElement(f)))||t?f:f.contextElement||await (null==o.getDocumentElement?void 0:o.getDocumentElement(s.floating)),boundary:c,rootBoundary:d,strategy:l})),y="floating"===p?{x:i,y:a,width:r.floating.width,height:r.floating.height}:r.reference,b=await (null==o.getOffsetParent?void 0:o.getOffsetParent(s.floating)),v=await (null==o.isElement?void 0:o.isElement(b))&&await (null==o.getScale?void 0:o.getScale(b))||{x:1,y:1},A=am(o.convertOffsetParentRelativeRectToViewportRelativeRect?await o.convertOffsetParentRelativeRectToViewportRelativeRect({elements:s,rect:y,offsetParent:b,strategy:l}):y);return{top:(g.top-A.top+m.top)/v.y,bottom:(A.bottom-g.bottom+m.bottom)/v.y,left:(g.left-A.left+m.left)/v.x,right:(A.right-g.right+m.right)/v.x}}function ab(e,n){return{top:e.top-n.height,right:e.right-n.width,bottom:e.bottom-n.height,left:e.left-n.width}}function av(e){return i7.some(n=>e[n]>=0)}async function aA(e,n){let{placement:t,platform:i,elements:a}=e,o=await (null==i.isRTL?void 0:i.isRTL(a.floating)),r=ar(t),s=as(t),l="y"===ad(t),c=["left","top"].includes(r)?-1:1,d=o&&l?-1:1,p=ao(n,e),{mainAxis:u,crossAxis:h,alignmentAxis:m}="number"==typeof p?{mainAxis:p,crossAxis:0,alignmentAxis:null}:{mainAxis:p.mainAxis||0,crossAxis:p.crossAxis||0,alignmentAxis:p.alignmentAxis};return s&&"number"==typeof m&&(h="end"===s?-1*m:m),l?{x:h*d,y:u*c}:{x:u*c,y:h*d}}function aC(){return"undefined"!=typeof window}function aw(e){return aE(e)?(e.nodeName||"").toLowerCase():"#document"}function aS(e){var n;return(null==e||null==(n=e.ownerDocument)?void 0:n.defaultView)||window}function a_(e){var n;return null==(n=(aE(e)?e.ownerDocument:e.document)||window.document)?void 0:n.documentElement}function aE(e){return!!aC()&&(e instanceof Node||e instanceof aS(e).Node)}function aM(e){return!!aC()&&(e instanceof Element||e instanceof aS(e).Element)}function aI(e){return!!aC()&&(e instanceof HTMLElement||e instanceof aS(e).HTMLElement)}function aP(e){return!!aC()&&"undefined"!=typeof ShadowRoot&&(e instanceof ShadowRoot||e instanceof aS(e).ShadowRoot)}function aT(e){let{overflow:n,overflowX:t,overflowY:i,display:a}=aN(e);return/auto|scroll|overlay|hidden|clip/.test(n+i+t)&&!["inline","contents"].includes(a)}function aR(e){return[":popover-open",":modal"].some(n=>{try{return e.matches(n)}catch(e){return!1}})}function aO(e){let n=ax(),t=aM(e)?aN(e):e;return["transform","translate","scale","rotate","perspective"].some(e=>!!t[e]&&"none"!==t[e])||!!t.containerType&&"normal"!==t.containerType||!n&&!!t.backdropFilter&&"none"!==t.backdropFilter||!n&&!!t.filter&&"none"!==t.filter||["transform","translate","scale","rotate","perspective","filter"].some(e=>(t.willChange||"").includes(e))||["paint","layout","strict","content"].some(e=>(t.contain||"").includes(e))}function ax(){return"undefined"!=typeof CSS&&!!CSS.supports&&CSS.supports("-webkit-backdrop-filter","none")}function aD(e){return["html","body","#document"].includes(aw(e))}function aN(e){return aS(e).getComputedStyle(e)}function ak(e){return aM(e)?{scrollLeft:e.scrollLeft,scrollTop:e.scrollTop}:{scrollLeft:e.scrollX,scrollTop:e.scrollY}}function aL(e){if("html"===aw(e))return e;let n=e.assignedSlot||e.parentNode||aP(e)&&e.host||a_(e);return aP(n)?n.host:n}function aH(e,n,t){var i;void 0===n&&(n=[]),void 0===t&&(t=!0);let a=function e(n){let t=aL(n);return aD(t)?n.ownerDocument?n.ownerDocument.body:n.body:aI(t)&&aT(t)?t:e(t)}(e),o=a===(null==(i=e.ownerDocument)?void 0:i.body),r=aS(a);if(o){let e=aF(r);return n.concat(r,r.visualViewport||[],aT(a)?a:[],e&&t?aH(e):[])}return n.concat(a,aH(a,[],t))}function aF(e){return e.parent&&Object.getPrototypeOf(e.parent)?e.frameElement:null}function aB(e){let n=aN(e),t=parseFloat(n.width)||0,i=parseFloat(n.height)||0,a=aI(e),o=a?e.offsetWidth:t,r=a?e.offsetHeight:i,s=ae(t)!==o||ae(i)!==r;return s&&(t=o,i=r),{width:t,height:i,$:s}}function aj(e){return aM(e)?e:e.contextElement}function aq(e){let n=aj(e);if(!aI(n))return at(1);let t=n.getBoundingClientRect(),{width:i,height:a,$:o}=aB(n),r=(o?ae(t.width):t.width)/i,s=(o?ae(t.height):t.height)/a;return r&&Number.isFinite(r)||(r=1),s&&Number.isFinite(s)||(s=1),{x:r,y:s}}let aV=at(0);function az(e){let n=aS(e);return ax()&&n.visualViewport?{x:n.visualViewport.offsetLeft,y:n.visualViewport.offsetTop}:aV}function aU(e,n,t,i){var a;void 0===n&&(n=!1),void 0===t&&(t=!1);let o=e.getBoundingClientRect(),r=aj(e),s=at(1);n&&(i?aM(i)&&(s=aq(i)):s=aq(e));let l=(void 0===(a=t)&&(a=!1),i&&(!a||i===aS(r))&&a)?az(r):at(0),c=(o.left+l.x)/s.x,d=(o.top+l.y)/s.y,p=o.width/s.x,u=o.height/s.y;if(r){let e=aS(r),n=i&&aM(i)?aS(i):i,t=e,a=aF(t);for(;a&&i&&n!==t;){let e=aq(a),n=a.getBoundingClientRect(),i=aN(a),o=n.left+(a.clientLeft+parseFloat(i.paddingLeft))*e.x,r=n.top+(a.clientTop+parseFloat(i.paddingTop))*e.y;c*=e.x,d*=e.y,p*=e.x,u*=e.y,c+=o,d+=r,a=aF(t=aS(a))}}return am({width:p,height:u,x:c,y:d})}function aG(e,n){let t=ak(e).scrollLeft;return n?n.left+t:aU(a_(e)).left+t}function aW(e,n,t){void 0===t&&(t=!1);let i=e.getBoundingClientRect();return{x:i.left+n.scrollLeft-(t?0:aG(e,i)),y:i.top+n.scrollTop}}function aY(e,n,t){let i;if("viewport"===n)i=function(e,n){let t=aS(e),i=a_(e),a=t.visualViewport,o=i.clientWidth,r=i.clientHeight,s=0,l=0;if(a){o=a.width,r=a.height;let e=ax();(!e||e&&"fixed"===n)&&(s=a.offsetLeft,l=a.offsetTop)}return{width:o,height:r,x:s,y:l}}(e,t);else if("document"===n)i=function(e){let n=a_(e),t=ak(e),i=e.ownerDocument.body,a=i9(n.scrollWidth,n.clientWidth,i.scrollWidth,i.clientWidth),o=i9(n.scrollHeight,n.clientHeight,i.scrollHeight,i.clientHeight),r=-t.scrollLeft+aG(e),s=-t.scrollTop;return"rtl"===aN(i).direction&&(r+=i9(n.clientWidth,i.clientWidth)-a),{width:a,height:o,x:r,y:s}}(a_(e));else if(aM(n))i=function(e,n){let t=aU(e,!0,"fixed"===n),i=t.top+e.clientTop,a=t.left+e.clientLeft,o=aI(e)?aq(e):at(1),r=e.clientWidth*o.x;return{width:r,height:e.clientHeight*o.y,x:a*o.x,y:i*o.y}}(n,t);else{let t=az(e);i={x:n.x-t.x,y:n.y-t.y,width:n.width,height:n.height}}return am(i)}function aX(e){return"static"===aN(e).position}function a$(e,n){if(!aI(e)||"fixed"===aN(e).position)return null;if(n)return n(e);let t=e.offsetParent;return a_(e)===t&&(t=t.ownerDocument.body),t}function aK(e,n){let t=aS(e);if(aR(e))return t;if(!aI(e)){let n=aL(e);for(;n&&!aD(n);){if(aM(n)&&!aX(n))return n;n=aL(n)}return t}let i=a$(e,n);for(;i&&["table","td","th"].includes(aw(i))&&aX(i);)i=a$(i,n);return i&&aD(i)&&aX(i)&&!aO(i)?t:i||function(e){let n=aL(e);for(;aI(n)&&!aD(n);){if(aO(n))return n;if(aR(n))break;n=aL(n)}return null}(e)||t}let aJ=async function(e){let n=this.getOffsetParent||aK,t=this.getDimensions,i=await t(e.floating);return{reference:function(e,n,t){let i=aI(n),a=a_(n),o="fixed"===t,r=aU(e,!0,o,n),s={scrollLeft:0,scrollTop:0},l=at(0);if(i||!i&&!o){if(("body"!==aw(n)||aT(a))&&(s=ak(n)),i){let e=aU(n,!0,o,n);l.x=e.x+n.clientLeft,l.y=e.y+n.clientTop}else a&&(l.x=aG(a))}let c=!a||i||o?at(0):aW(a,s);return{x:r.left+s.scrollLeft-l.x-c.x,y:r.top+s.scrollTop-l.y-c.y,width:r.width,height:r.height}}(e.reference,await n(e.floating),e.strategy),floating:{x:0,y:0,width:i.width,height:i.height}}},aQ={convertOffsetParentRelativeRectToViewportRelativeRect:function(e){let{elements:n,rect:t,offsetParent:i,strategy:a}=e,o="fixed"===a,r=a_(i),s=!!n&&aR(n.floating);if(i===r||s&&o)return t;let l={scrollLeft:0,scrollTop:0},c=at(1),d=at(0),p=aI(i);if((p||!p&&!o)&&(("body"!==aw(i)||aT(r))&&(l=ak(i)),aI(i))){let e=aU(i);c=aq(i),d.x=e.x+i.clientLeft,d.y=e.y+i.clientTop}let u=!r||p||o?at(0):aW(r,l,!0);return{width:t.width*c.x,height:t.height*c.y,x:t.x*c.x-l.scrollLeft*c.x+d.x+u.x,y:t.y*c.y-l.scrollTop*c.y+d.y+u.y}},getDocumentElement:a_,getClippingRect:function(e){let{element:n,boundary:t,rootBoundary:i,strategy:a}=e,o=[..."clippingAncestors"===t?aR(n)?[]:function(e,n){let t=n.get(e);if(t)return t;let i=aH(e,[],!1).filter(e=>aM(e)&&"body"!==aw(e)),a=null,o="fixed"===aN(e).position,r=o?aL(e):e;for(;aM(r)&&!aD(r);){let n=aN(r),t=aO(r);t||"fixed"!==n.position||(a=null),(o?!t&&!a:!t&&"static"===n.position&&!!a&&["absolute","fixed"].includes(a.position)||aT(r)&&!t&&function e(n,t){let i=aL(n);return!(i===t||!aM(i)||aD(i))&&("fixed"===aN(i).position||e(i,t))}(e,r))?i=i.filter(e=>e!==r):a=n,r=aL(r)}return n.set(e,i),i}(n,this._c):[].concat(t),i],r=o[0],s=o.reduce((e,t)=>{let i=aY(n,t,a);return e.top=i9(i.top,e.top),e.right=i6(i.right,e.right),e.bottom=i6(i.bottom,e.bottom),e.left=i9(i.left,e.left),e},aY(n,r,a));return{width:s.right-s.left,height:s.bottom-s.top,x:s.left,y:s.top}},getOffsetParent:aK,getElementRects:aJ,getClientRects:function(e){return Array.from(e.getClientRects())},getDimensions:function(e){let{width:n,height:t}=aB(e);return{width:n,height:t}},getScale:aq,isElement:aM,isRTL:function(e){return"rtl"===aN(e).direction}};function aZ(e,n){return e.x===n.x&&e.y===n.y&&e.width===n.width&&e.height===n.height}let a0=e=>({name:"arrow",options:e,async fn(n){let{x:t,y:i,placement:a,rects:o,platform:r,elements:s,middlewareData:l}=n,{element:c,padding:d=0}=ao(e,n)||{};if(null==c)return{};let p=ah(d),u={x:t,y:i},h=al(ad(a)),m=ac(h),f=await r.getDimensions(c),g="y"===h,y=g?"clientHeight":"clientWidth",b=o.reference[m]+o.reference[h]-u[h]-o.floating[m],v=u[h]-o.reference[h],A=await (null==r.getOffsetParent?void 0:r.getOffsetParent(c)),C=A?A[y]:0;C&&await (null==r.isElement?void 0:r.isElement(A))||(C=s.floating[y]||o.floating[m]);let w=C/2-f[m]/2-1,S=i6(p[g?"top":"left"],w),_=i6(p[g?"bottom":"right"],w),E=C-f[m]-_,M=C/2-f[m]/2+(b/2-v/2),I=i9(S,i6(M,E)),P=!l.arrow&&null!=as(a)&&M!==I&&o.reference[m]/2-(M<S?S:_)-f[m]/2<0,T=P?M<S?M-S:M-E:0;return{[h]:u[h]+T,data:{[h]:I,centerOffset:M-I-T,...P&&{alignmentOffset:T}},reset:P}}}),a1=(e,n,t)=>{let i=new Map,a={platform:aQ,...t},o={...a.platform,_c:i};return ag(e,n,{...a,platform:o})};var a2="undefined"!=typeof document?u.useLayoutEffect:u.useEffect;function a3(e,n){let t,i,a;if(e===n)return!0;if(typeof e!=typeof n)return!1;if("function"==typeof e&&e.toString()===n.toString())return!0;if(e&&n&&"object"==typeof e){if(Array.isArray(e)){if((t=e.length)!==n.length)return!1;for(i=t;0!=i--;)if(!a3(e[i],n[i]))return!1;return!0}if((t=(a=Object.keys(e)).length)!==Object.keys(n).length)return!1;for(i=t;0!=i--;)if(!({}).hasOwnProperty.call(n,a[i]))return!1;for(i=t;0!=i--;){let t=a[i];if(("_owner"!==t||!e.$$typeof)&&!a3(e[t],n[t]))return!1}return!0}return e!=e&&n!=n}function a4(e){return"undefined"==typeof window?1:(e.ownerDocument.defaultView||window).devicePixelRatio||1}function a8(e,n){let t=a4(e);return Math.round(n*t)/t}function a5(e){let n=u.useRef(e);return a2(()=>{n.current=e}),n}let a7=e=>({name:"arrow",options:e,fn(n){let{element:t,padding:i}="function"==typeof e?e(n):e;return t&&({}).hasOwnProperty.call(t,"current")?null!=t.current?a0({element:t.current,padding:i}).fn(n):{}:t?a0({element:t,padding:i}).fn(n):{}}}),a6=(e,n)=>({...function(e){return void 0===e&&(e=0),{name:"offset",options:e,async fn(n){var t,i;let{x:a,y:o,placement:r,middlewareData:s}=n,l=await aA(n,e);return r===(null==(t=s.offset)?void 0:t.placement)&&null!=(i=s.arrow)&&i.alignmentOffset?{}:{x:a+l.x,y:o+l.y,data:{...l,placement:r}}}}}(e),options:[e,n]}),a9=(e,n)=>({...function(e){return void 0===e&&(e={}),{name:"shift",options:e,async fn(n){let{x:t,y:i,placement:a}=n,{mainAxis:o=!0,crossAxis:r=!1,limiter:s={fn:e=>{let{x:n,y:t}=e;return{x:n,y:t}}},...l}=ao(e,n),c={x:t,y:i},d=await ay(n,l),p=ad(ar(a)),u=al(p),h=c[u],m=c[p];if(o){let e="y"===u?"top":"left",n="y"===u?"bottom":"right",t=h+d[e],i=h-d[n];h=i9(t,i6(h,i))}if(r){let e="y"===p?"top":"left",n="y"===p?"bottom":"right",t=m+d[e],i=m-d[n];m=i9(t,i6(m,i))}let f=s.fn({...n,[u]:h,[p]:m});return{...f,data:{x:f.x-t,y:f.y-i,enabled:{[u]:o,[p]:r}}}}}}(e),options:[e,n]}),oe=(e,n)=>({...function(e){return void 0===e&&(e={}),{options:e,fn(n){let{x:t,y:i,placement:a,rects:o,middlewareData:r}=n,{offset:s=0,mainAxis:l=!0,crossAxis:c=!0}=ao(e,n),d={x:t,y:i},p=ad(a),u=al(p),h=d[u],m=d[p],f=ao(s,n),g="number"==typeof f?{mainAxis:f,crossAxis:0}:{mainAxis:0,crossAxis:0,...f};if(l){let e="y"===u?"height":"width",n=o.reference[u]-o.floating[e]+g.mainAxis,t=o.reference[u]+o.reference[e]-g.mainAxis;h<n?h=n:h>t&&(h=t)}if(c){var y,b;let e="y"===u?"width":"height",n=["top","left"].includes(ar(a)),t=o.reference[p]-o.floating[e]+(n&&(null==(y=r.offset)?void 0:y[p])||0)+(n?0:g.crossAxis),i=o.reference[p]+o.reference[e]+(n?0:(null==(b=r.offset)?void 0:b[p])||0)-(n?g.crossAxis:0);m<t?m=t:m>i&&(m=i)}return{[u]:h,[p]:m}}}}(e),options:[e,n]}),on=(e,n)=>({...function(e){return void 0===e&&(e={}),{name:"flip",options:e,async fn(n){var t,i,a,o,r;let{placement:s,middlewareData:l,rects:c,initialPlacement:d,platform:p,elements:u}=n,{mainAxis:h=!0,crossAxis:m=!0,fallbackPlacements:f,fallbackStrategy:g="bestFit",fallbackAxisSideDirection:y="none",flipAlignment:b=!0,...v}=ao(e,n);if(null!=(t=l.arrow)&&t.alignmentOffset)return{};let A=ar(s),C=ad(d),w=ar(d)===d,S=await (null==p.isRTL?void 0:p.isRTL(u.floating)),_=f||(w||!b?[au(d)]:function(e){let n=au(e);return[ap(e),n,ap(n)]}(d)),E="none"!==y;!f&&E&&_.push(...function(e,n,t,i){let a=as(e),o=function(e,n,t){let i=["left","right"],a=["right","left"];switch(e){case"top":case"bottom":if(t)return n?a:i;return n?i:a;case"left":case"right":return n?["top","bottom"]:["bottom","top"];default:return[]}}(ar(e),"start"===t,i);return a&&(o=o.map(e=>e+"-"+a),n&&(o=o.concat(o.map(ap)))),o}(d,b,y,S));let M=[d,..._],I=await ay(n,v),P=[],T=(null==(i=l.flip)?void 0:i.overflows)||[];if(h&&P.push(I[A]),m){let e=function(e,n,t){void 0===t&&(t=!1);let i=as(e),a=al(ad(e)),o=ac(a),r="x"===a?i===(t?"end":"start")?"right":"left":"start"===i?"bottom":"top";return n.reference[o]>n.floating[o]&&(r=au(r)),[r,au(r)]}(s,c,S);P.push(I[e[0]],I[e[1]])}if(T=[...T,{placement:s,overflows:P}],!P.every(e=>e<=0)){let e=((null==(a=l.flip)?void 0:a.index)||0)+1,n=M[e];if(n)return{data:{index:e,overflows:T},reset:{placement:n}};let t=null==(o=T.filter(e=>e.overflows[0]<=0).sort((e,n)=>e.overflows[1]-n.overflows[1])[0])?void 0:o.placement;if(!t)switch(g){case"bestFit":{let e=null==(r=T.filter(e=>{if(E){let n=ad(e.placement);return n===C||"y"===n}return!0}).map(e=>[e.placement,e.overflows.filter(e=>e>0).reduce((e,n)=>e+n,0)]).sort((e,n)=>e[1]-n[1])[0])?void 0:r[0];e&&(t=e);break}case"initialPlacement":t=d}if(s!==t)return{reset:{placement:t}}}return{}}}}(e),options:[e,n]}),ot=(e,n)=>({...function(e){return void 0===e&&(e={}),{name:"size",options:e,async fn(n){var t,i;let a,o;let{placement:r,rects:s,platform:l,elements:c}=n,{apply:d=()=>{},...p}=ao(e,n),u=await ay(n,p),h=ar(r),m=as(r),f="y"===ad(r),{width:g,height:y}=s.floating;"top"===h||"bottom"===h?(a=h,o=m===(await (null==l.isRTL?void 0:l.isRTL(c.floating))?"start":"end")?"left":"right"):(o=h,a="end"===m?"top":"bottom");let b=y-u.top-u.bottom,v=g-u.left-u.right,A=i6(y-u[a],b),C=i6(g-u[o],v),w=!n.middlewareData.shift,S=A,_=C;if(null!=(t=n.middlewareData.shift)&&t.enabled.x&&(_=v),null!=(i=n.middlewareData.shift)&&i.enabled.y&&(S=b),w&&!m){let e=i9(u.left,0),n=i9(u.right,0),t=i9(u.top,0),i=i9(u.bottom,0);f?_=g-2*(0!==e||0!==n?e+n:i9(u.left,u.right)):S=y-2*(0!==t||0!==i?t+i:i9(u.top,u.bottom))}await d({...n,availableWidth:_,availableHeight:S});let E=await l.getDimensions(c.floating);return g!==E.width||y!==E.height?{reset:{rects:!0}}:{}}}}(e),options:[e,n]}),oi=(e,n)=>({...function(e){return void 0===e&&(e={}),{name:"hide",options:e,async fn(n){let{rects:t}=n,{strategy:i="referenceHidden",...a}=ao(e,n);switch(i){case"referenceHidden":{let e=ab(await ay(n,{...a,elementContext:"reference"}),t.reference);return{data:{referenceHiddenOffsets:e,referenceHidden:av(e)}}}case"escaped":{let e=ab(await ay(n,{...a,altBoundary:!0}),t.floating);return{data:{escapedOffsets:e,escaped:av(e)}}}default:return{}}}}}(e),options:[e,n]}),oa=(e,n)=>({...a7(e),options:[e,n]});var oo=u.forwardRef((e,n)=>{let{children:t,width:i=10,height:a=5,...o}=e;return(0,p.jsx)(tY.svg,{...o,ref:n,width:i,height:a,viewBox:"0 0 30 10",preserveAspectRatio:"none",children:e.asChild?t:(0,p.jsx)("polygon",{points:"0,0 30,0 15,10"})})});oo.displayName="Arrow";var or="Popper",[os,ol]=tJ(or),[oc,od]=os(or),op=e=>{let{__scopePopper:n,children:t}=e,[i,a]=u.useState(null);return(0,p.jsx)(oc,{scope:n,anchor:i,onAnchorChange:a,children:t})};op.displayName=or;var ou="PopperAnchor",oh=u.forwardRef((e,n)=>{let{__scopePopper:t,virtualRef:i,...a}=e,o=od(ou,t),r=u.useRef(null),s=tx(n,r);return u.useEffect(()=>{o.onAnchorChange(i?.current||r.current)}),i?null:(0,p.jsx)(tY.div,{...a,ref:s})});oh.displayName=ou;var om="PopperContent",[of,og]=os(om),oy=u.forwardRef((e,n)=>{let{__scopePopper:t,side:i="bottom",sideOffset:a=0,align:o="center",alignOffset:r=0,arrowPadding:s=0,avoidCollisions:l=!0,collisionBoundary:c=[],collisionPadding:d=0,sticky:h="partial",hideWhenDetached:m=!1,updatePositionStrategy:f="optimized",onPlaced:g,...y}=e,b=od(om,t),[v,A]=u.useState(null),C=tx(n,e=>A(e)),[w,S]=u.useState(null),_=function(e){let[n,t]=u.useState(void 0);return tX(()=>{if(e){t({width:e.offsetWidth,height:e.offsetHeight});let n=new ResizeObserver(n=>{let i,a;if(!Array.isArray(n)||!n.length)return;let o=n[0];if("borderBoxSize"in o){let e=o.borderBoxSize,n=Array.isArray(e)?e[0]:e;i=n.inlineSize,a=n.blockSize}else i=e.offsetWidth,a=e.offsetHeight;t({width:i,height:a})});return n.observe(e,{box:"border-box"}),()=>n.unobserve(e)}t(void 0)},[e]),n}(w),E=_?.width??0,M=_?.height??0,I="number"==typeof d?d:{top:0,right:0,bottom:0,left:0,...d},P=Array.isArray(c)?c:[c],T=P.length>0,R={padding:I,boundary:P.filter(oC),altBoundary:T},{refs:O,floatingStyles:x,placement:D,isPositioned:N,middlewareData:k}=function(e){void 0===e&&(e={});let{placement:n="bottom",strategy:t="absolute",middleware:i=[],platform:a,elements:{reference:o,floating:r}={},transform:s=!0,whileElementsMounted:l,open:c}=e,[d,p]=u.useState({x:0,y:0,strategy:t,placement:n,middlewareData:{},isPositioned:!1}),[h,m]=u.useState(i);a3(h,i)||m(i);let[f,g]=u.useState(null),[y,b]=u.useState(null),v=u.useCallback(e=>{e!==S.current&&(S.current=e,g(e))},[]),A=u.useCallback(e=>{e!==_.current&&(_.current=e,b(e))},[]),C=o||f,w=r||y,S=u.useRef(null),_=u.useRef(null),E=u.useRef(d),M=null!=l,I=a5(l),P=a5(a),T=a5(c),R=u.useCallback(()=>{if(!S.current||!_.current)return;let e={placement:n,strategy:t,middleware:h};P.current&&(e.platform=P.current),a1(S.current,_.current,e).then(e=>{let n={...e,isPositioned:!1!==T.current};O.current&&!a3(E.current,n)&&(E.current=n,tW.flushSync(()=>{p(n)}))})},[h,n,t,P,T]);a2(()=>{!1===c&&E.current.isPositioned&&(E.current.isPositioned=!1,p(e=>({...e,isPositioned:!1})))},[c]);let O=u.useRef(!1);a2(()=>(O.current=!0,()=>{O.current=!1}),[]),a2(()=>{if(C&&(S.current=C),w&&(_.current=w),C&&w){if(I.current)return I.current(C,w,R);R()}},[C,w,R,I,M]);let x=u.useMemo(()=>({reference:S,floating:_,setReference:v,setFloating:A}),[v,A]),D=u.useMemo(()=>({reference:C,floating:w}),[C,w]),N=u.useMemo(()=>{let e={position:t,left:0,top:0};if(!D.floating)return e;let n=a8(D.floating,d.x),i=a8(D.floating,d.y);return s?{...e,transform:"translate("+n+"px, "+i+"px)",...a4(D.floating)>=1.5&&{willChange:"transform"}}:{position:t,left:n,top:i}},[t,s,D.floating,d.x,d.y]);return u.useMemo(()=>({...d,update:R,refs:x,elements:D,floatingStyles:N}),[d,R,x,D,N])}({strategy:"fixed",placement:i+("center"!==o?"-"+o:""),whileElementsMounted:(...e)=>(function(e,n,t,i){let a;void 0===i&&(i={});let{ancestorScroll:o=!0,ancestorResize:r=!0,elementResize:s="function"==typeof ResizeObserver,layoutShift:l="function"==typeof IntersectionObserver,animationFrame:c=!1}=i,d=aj(e),p=o||r?[...d?aH(d):[],...aH(n)]:[];p.forEach(e=>{o&&e.addEventListener("scroll",t,{passive:!0}),r&&e.addEventListener("resize",t)});let u=d&&l?function(e,n){let t,i=null,a=a_(e);function o(){var e;clearTimeout(t),null==(e=i)||e.disconnect(),i=null}return function r(s,l){void 0===s&&(s=!1),void 0===l&&(l=1),o();let c=e.getBoundingClientRect(),{left:d,top:p,width:u,height:h}=c;if(s||n(),!u||!h)return;let m=an(p),f=an(a.clientWidth-(d+u)),g={rootMargin:-m+"px "+-f+"px "+-an(a.clientHeight-(p+h))+"px "+-an(d)+"px",threshold:i9(0,i6(1,l))||1},y=!0;function b(n){let i=n[0].intersectionRatio;if(i!==l){if(!y)return r();i?r(!1,i):t=setTimeout(()=>{r(!1,1e-7)},1e3)}1!==i||aZ(c,e.getBoundingClientRect())||r(),y=!1}try{i=new IntersectionObserver(b,{...g,root:a.ownerDocument})}catch(e){i=new IntersectionObserver(b,g)}i.observe(e)}(!0),o}(d,t):null,h=-1,m=null;s&&(m=new ResizeObserver(e=>{let[i]=e;i&&i.target===d&&m&&(m.unobserve(n),cancelAnimationFrame(h),h=requestAnimationFrame(()=>{var e;null==(e=m)||e.observe(n)})),t()}),d&&!c&&m.observe(d),m.observe(n));let f=c?aU(e):null;return c&&function n(){let i=aU(e);f&&!aZ(f,i)&&t(),f=i,a=requestAnimationFrame(n)}(),t(),()=>{var e;p.forEach(e=>{o&&e.removeEventListener("scroll",t),r&&e.removeEventListener("resize",t)}),null==u||u(),null==(e=m)||e.disconnect(),m=null,c&&cancelAnimationFrame(a)}})(...e,{animationFrame:"always"===f}),elements:{reference:b.anchor},middleware:[a6({mainAxis:a+M,alignmentAxis:r}),l&&a9({mainAxis:!0,crossAxis:!1,limiter:"partial"===h?oe():void 0,...R}),l&&on({...R}),ot({...R,apply:({elements:e,rects:n,availableWidth:t,availableHeight:i})=>{let{width:a,height:o}=n.reference,r=e.floating.style;r.setProperty("--radix-popper-available-width",`${t}px`),r.setProperty("--radix-popper-available-height",`${i}px`),r.setProperty("--radix-popper-anchor-width",`${a}px`),r.setProperty("--radix-popper-anchor-height",`${o}px`)}}),w&&oa({element:w,padding:s}),ow({arrowWidth:E,arrowHeight:M}),m&&oi({strategy:"referenceHidden",...R})]}),[L,H]=oS(D),F=tQ(g);tX(()=>{N&&F?.()},[N,F]);let B=k.arrow?.x,j=k.arrow?.y,q=k.arrow?.centerOffset!==0,[V,z]=u.useState();return tX(()=>{v&&z(window.getComputedStyle(v).zIndex)},[v]),(0,p.jsx)("div",{ref:O.setFloating,"data-radix-popper-content-wrapper":"",style:{...x,transform:N?x.transform:"translate(0, -200%)",minWidth:"max-content",zIndex:V,"--radix-popper-transform-origin":[k.transformOrigin?.x,k.transformOrigin?.y].join(" "),...k.hide?.referenceHidden&&{visibility:"hidden",pointerEvents:"none"}},dir:e.dir,children:(0,p.jsx)(of,{scope:t,placedSide:L,onArrowChange:S,arrowX:B,arrowY:j,shouldHideArrow:q,children:(0,p.jsx)(tY.div,{"data-side":L,"data-align":H,...y,ref:C,style:{...y.style,animation:N?void 0:"none"}})})})});oy.displayName=om;var ob="PopperArrow",ov={top:"bottom",right:"left",bottom:"top",left:"right"},oA=u.forwardRef(function(e,n){let{__scopePopper:t,...i}=e,a=og(ob,t),o=ov[a.placedSide];return(0,p.jsx)("span",{ref:a.onArrowChange,style:{position:"absolute",left:a.arrowX,top:a.arrowY,[o]:0,transformOrigin:{top:"",right:"0 0",bottom:"center 0",left:"100% 0"}[a.placedSide],transform:{top:"translateY(100%)",right:"translateY(50%) rotate(90deg) translateX(-50%)",bottom:"rotate(180deg)",left:"translateY(50%) rotate(-90deg) translateX(50%)"}[a.placedSide],visibility:a.shouldHideArrow?"hidden":void 0},children:(0,p.jsx)(oo,{...i,ref:n,style:{...i.style,display:"block"}})})});function oC(e){return null!==e}oA.displayName=ob;var ow=e=>({name:"transformOrigin",options:e,fn(n){let{placement:t,rects:i,middlewareData:a}=n,o=a.arrow?.centerOffset!==0,r=o?0:e.arrowWidth,s=o?0:e.arrowHeight,[l,c]=oS(t),d={start:"0%",center:"50%",end:"100%"}[c],p=(a.arrow?.x??0)+r/2,u=(a.arrow?.y??0)+s/2,h="",m="";return"bottom"===l?(h=o?d:`${p}px`,m=`${-s}px`):"top"===l?(h=o?d:`${p}px`,m=`${i.floating.height+s}px`):"right"===l?(h=`${-s}px`,m=o?d:`${u}px`):"left"===l&&(h=`${i.floating.width+s}px`,m=o?d:`${u}px`),{data:{x:h,y:m}}}});function oS(e){let[n,t="center"]=e.split("-");return[n,t]}var o_=u.forwardRef((e,n)=>{let{container:t,...i}=e,[a,o]=u.useState(!1);tX(()=>o(!0),[]);let r=t||a&&globalThis?.document?.body;return r?tW.createPortal((0,p.jsx)(tY.div,{...i,ref:n}),r):null});function oE({prop:e,defaultProp:n,onChange:t=()=>{}}){let[i,a]=function({defaultProp:e,onChange:n}){let t=u.useState(e),[i]=t,a=u.useRef(i),o=tQ(n);return u.useEffect(()=>{a.current!==i&&(o(i),a.current=i)},[i,a,o]),t}({defaultProp:n,onChange:t}),o=void 0!==e,r=o?e:i,s=tQ(t);return[r,u.useCallback(n=>{if(o){let t="function"==typeof n?n(e):n;t!==e&&s(t)}else a(n)},[o,e,a,s])]}o_.displayName="Portal";var oM=u.forwardRef((e,n)=>(0,p.jsx)(tY.span,{...e,ref:n,style:{position:"absolute",border:0,width:1,height:1,padding:0,margin:-1,overflow:"hidden",clip:"rect(0, 0, 0, 0)",whiteSpace:"nowrap",wordWrap:"normal",...e.style}}));oM.displayName="VisuallyHidden";var oI=new WeakMap,oP=new WeakMap,oT={},oR=0,oO=function(e){return e&&(e.host||oO(e.parentNode))},ox=function(e,n,t,i){var a=(Array.isArray(e)?e:[e]).map(function(e){if(n.contains(e))return e;var t=oO(e);return t&&n.contains(t)?t:(console.error("aria-hidden",e,"in not contained inside",n,". Doing nothing"),null)}).filter(function(e){return!!e});oT[t]||(oT[t]=new WeakMap);var o=oT[t],r=[],s=new Set,l=new Set(a),c=function(e){!e||s.has(e)||(s.add(e),c(e.parentNode))};a.forEach(c);var d=function(e){!e||l.has(e)||Array.prototype.forEach.call(e.children,function(e){if(s.has(e))d(e);else try{var n=e.getAttribute(i),a=null!==n&&"false"!==n,l=(oI.get(e)||0)+1,c=(o.get(e)||0)+1;oI.set(e,l),o.set(e,c),r.push(e),1===l&&a&&oP.set(e,!0),1===c&&e.setAttribute(t,"true"),a||e.setAttribute(i,"true")}catch(n){console.error("aria-hidden: cannot operate on ",e,n)}})};return d(n),s.clear(),oR++,function(){r.forEach(function(e){var n=oI.get(e)-1,a=o.get(e)-1;oI.set(e,n),o.set(e,a),n||(oP.has(e)||e.removeAttribute(i),oP.delete(e)),a||e.removeAttribute(t)}),--oR||(oI=new WeakMap,oI=new WeakMap,oP=new WeakMap,oT={})}},oD=function(e,n,t){void 0===t&&(t="data-aria-hidden");var i,a=Array.from(Array.isArray(e)?e:[e]),o=n||(i=e,"undefined"==typeof document?null:(Array.isArray(i)?i[0]:i).ownerDocument.body);return o?(a.push.apply(a,Array.from(o.querySelectorAll("[aria-live]"))),ox(a,o,t,"aria-hidden")):function(){return null}},oN=function(){return(oN=Object.assign||function(e){for(var n,t=1,i=arguments.length;t<i;t++)for(var a in n=arguments[t])Object.prototype.hasOwnProperty.call(n,a)&&(e[a]=n[a]);return e}).apply(this,arguments)};function ok(e,n){var t={};for(var i in e)Object.prototype.hasOwnProperty.call(e,i)&&0>n.indexOf(i)&&(t[i]=e[i]);if(null!=e&&"function"==typeof Object.getOwnPropertySymbols)for(var a=0,i=Object.getOwnPropertySymbols(e);a<i.length;a++)0>n.indexOf(i[a])&&Object.prototype.propertyIsEnumerable.call(e,i[a])&&(t[i[a]]=e[i[a]]);return t}Object.create,Object.create;var oL=("function"==typeof SuppressedError&&SuppressedError,"right-scroll-bar-position"),oH="width-before-scroll-bar";function oF(e,n){return"function"==typeof e?e(n):e&&(e.current=n),e}var oB="undefined"!=typeof window?u.useLayoutEffect:u.useEffect,oj=new WeakMap;function oq(e){return e}var oV=function(e){void 0===e&&(e={});var n,t,i,a=(void 0===n&&(n=oq),t=[],i=!1,{read:function(){if(i)throw Error("Sidecar: could not `read` from an `assigned` medium. `read` could be used only with `useMedium`.");return t.length?t[t.length-1]:null},useMedium:function(e){var a=n(e,i);return t.push(a),function(){t=t.filter(function(e){return e!==a})}},assignSyncMedium:function(e){for(i=!0;t.length;){var n=t;t=[],n.forEach(e)}t={push:function(n){return e(n)},filter:function(){return t}}},assignMedium:function(e){i=!0;var n=[];if(t.length){var a=t;t=[],a.forEach(e),n=t}var o=function(){var t=n;n=[],t.forEach(e)},r=function(){return Promise.resolve().then(o)};r(),t={push:function(e){n.push(e),r()},filter:function(e){return n=n.filter(e),t}}}});return a.options=oN({async:!0,ssr:!1},e),a}(),oz=function(){},oU=u.forwardRef(function(e,n){var t,i,a,o,r=u.useRef(null),s=u.useState({onScrollCapture:oz,onWheelCapture:oz,onTouchMoveCapture:oz}),l=s[0],c=s[1],d=e.forwardProps,p=e.children,h=e.className,m=e.removeScrollBar,f=e.enabled,g=e.shards,y=e.sideCar,b=e.noIsolation,v=e.inert,A=e.allowPinchZoom,C=e.as,w=e.gapMode,S=ok(e,["forwardProps","children","className","removeScrollBar","enabled","shards","sideCar","noIsolation","inert","allowPinchZoom","as","gapMode"]),_=(t=[r,n],i=function(e){return t.forEach(function(n){return oF(n,e)})},(a=(0,u.useState)(function(){return{value:null,callback:i,facade:{get current(){return a.value},set current(value){var e=a.value;e!==value&&(a.value=value,a.callback(value,e))}}}})[0]).callback=i,o=a.facade,oB(function(){var e=oj.get(o);if(e){var n=new Set(e),i=new Set(t),a=o.current;n.forEach(function(e){i.has(e)||oF(e,null)}),i.forEach(function(e){n.has(e)||oF(e,a)})}oj.set(o,t)},[t]),o),E=oN(oN({},S),l);return u.createElement(u.Fragment,null,f&&u.createElement(y,{sideCar:oV,removeScrollBar:m,shards:g,noIsolation:b,inert:v,setCallbacks:c,allowPinchZoom:!!A,lockRef:r,gapMode:w}),d?u.cloneElement(u.Children.only(p),oN(oN({},E),{ref:_})):u.createElement(void 0===C?"div":C,oN({},E,{className:h,ref:_}),p))});oU.defaultProps={enabled:!0,removeScrollBar:!0,inert:!1},oU.classNames={fullWidth:oH,zeroRight:oL};var oG=function(e){var n=e.sideCar,t=ok(e,["sideCar"]);if(!n)throw Error("Sidecar: please provide `sideCar` property to import the right car");var i=n.read();if(!i)throw Error("Sidecar medium not found");return u.createElement(i,oN({},t))};oG.isSideCarExport=!0;var oW=function(){var e=0,n=null;return{add:function(i){if(0==e&&(n=function(){if(!document)return null;var e=document.createElement("style");e.type="text/css";var n=d||t.nc;return n&&e.setAttribute("nonce",n),e}())){var a,o;(a=n).styleSheet?a.styleSheet.cssText=i:a.appendChild(document.createTextNode(i)),o=n,(document.head||document.getElementsByTagName("head")[0]).appendChild(o)}e++},remove:function(){--e||!n||(n.parentNode&&n.parentNode.removeChild(n),n=null)}}},oY=function(){var e=oW();return function(n,t){u.useEffect(function(){return e.add(n),function(){e.remove()}},[n&&t])}},oX=function(){var e=oY();return function(n){return e(n.styles,n.dynamic),null}},o$={left:0,top:0,right:0,gap:0},oK=function(e){return parseInt(e||"",10)||0},oJ=function(e){var n=window.getComputedStyle(document.body),t=n["padding"===e?"paddingLeft":"marginLeft"],i=n["padding"===e?"paddingTop":"marginTop"],a=n["padding"===e?"paddingRight":"marginRight"];return[oK(t),oK(i),oK(a)]},oQ=function(e){if(void 0===e&&(e="margin"),"undefined"==typeof window)return o$;var n=oJ(e),t=document.documentElement.clientWidth,i=window.innerWidth;return{left:n[0],top:n[1],right:n[2],gap:Math.max(0,i-t+n[2]-n[0])}},oZ=oX(),o0="data-scroll-locked",o1=function(e,n,t,i){var a=e.left,o=e.top,r=e.right,s=e.gap;return void 0===t&&(t="margin"),"\n  .".concat("with-scroll-bars-hidden"," {\n   overflow: hidden ").concat(i,";\n   padding-right: ").concat(s,"px ").concat(i,";\n  }\n  body[").concat(o0,"] {\n    overflow: hidden ").concat(i,";\n    overscroll-behavior: contain;\n    ").concat([n&&"position: relative ".concat(i,";"),"margin"===t&&"\n    padding-left: ".concat(a,"px;\n    padding-top: ").concat(o,"px;\n    padding-right: ").concat(r,"px;\n    margin-left:0;\n    margin-top:0;\n    margin-right: ").concat(s,"px ").concat(i,";\n    "),"padding"===t&&"padding-right: ".concat(s,"px ").concat(i,";")].filter(Boolean).join(""),"\n  }\n  \n  .").concat(oL," {\n    right: ").concat(s,"px ").concat(i,";\n  }\n  \n  .").concat(oH," {\n    margin-right: ").concat(s,"px ").concat(i,";\n  }\n  \n  .").concat(oL," .").concat(oL," {\n    right: 0 ").concat(i,";\n  }\n  \n  .").concat(oH," .").concat(oH," {\n    margin-right: 0 ").concat(i,";\n  }\n  \n  body[").concat(o0,"] {\n    ").concat("--removed-body-scroll-bar-size",": ").concat(s,"px;\n  }\n")},o2=function(){var e=parseInt(document.body.getAttribute(o0)||"0",10);return isFinite(e)?e:0},o3=function(){u.useEffect(function(){return document.body.setAttribute(o0,(o2()+1).toString()),function(){var e=o2()-1;e<=0?document.body.removeAttribute(o0):document.body.setAttribute(o0,e.toString())}},[])},o4=function(e){var n=e.noRelative,t=e.noImportant,i=e.gapMode,a=void 0===i?"margin":i;o3();var o=u.useMemo(function(){return oQ(a)},[a]);return u.createElement(oZ,{styles:o1(o,!n,a,t?"":"!important")})},o8=!1;if("undefined"!=typeof window)try{var o5=Object.defineProperty({},"passive",{get:function(){return o8=!0,!0}});window.addEventListener("test",o5,o5),window.removeEventListener("test",o5,o5)}catch(e){o8=!1}var o7=!!o8&&{passive:!1},o6=function(e,n){if(!(e instanceof Element))return!1;var t=window.getComputedStyle(e);return"hidden"!==t[n]&&!(t.overflowY===t.overflowX&&"TEXTAREA"!==e.tagName&&"visible"===t[n])},o9=function(e,n){var t=n.ownerDocument,i=n;do{if("undefined"!=typeof ShadowRoot&&i instanceof ShadowRoot&&(i=i.host),re(e,i)){var a=rn(e,i);if(a[1]>a[2])return!0}i=i.parentNode}while(i&&i!==t.body);return!1},re=function(e,n){return"v"===e?o6(n,"overflowY"):o6(n,"overflowX")},rn=function(e,n){return"v"===e?[n.scrollTop,n.scrollHeight,n.clientHeight]:[n.scrollLeft,n.scrollWidth,n.clientWidth]},rt=function(e,n,t,i,a){var o,r=(o=window.getComputedStyle(n).direction,"h"===e&&"rtl"===o?-1:1),s=r*i,l=t.target,c=n.contains(l),d=!1,p=s>0,u=0,h=0;do{var m=rn(e,l),f=m[0],g=m[1]-m[2]-r*f;(f||g)&&re(e,l)&&(u+=g,h+=f),l instanceof ShadowRoot?l=l.host:l=l.parentNode}while(!c&&l!==document.body||c&&(n.contains(l)||n===l));return p&&(a&&1>Math.abs(u)||!a&&s>u)?d=!0:!p&&(a&&1>Math.abs(h)||!a&&-s>h)&&(d=!0),d},ri=function(e){return"changedTouches"in e?[e.changedTouches[0].clientX,e.changedTouches[0].clientY]:[0,0]},ra=function(e){return[e.deltaX,e.deltaY]},ro=function(e){return e&&"current"in e?e.current:e},rr=0,rs=[];let rl=(a=function(e){var n=u.useRef([]),t=u.useRef([0,0]),i=u.useRef(),a=u.useState(rr++)[0],o=u.useState(oX)[0],r=u.useRef(e);u.useEffect(function(){r.current=e},[e]),u.useEffect(function(){if(e.inert){document.body.classList.add("block-interactivity-".concat(a));var n=(function(e,n,t){if(t||2==arguments.length)for(var i,a=0,o=n.length;a<o;a++)!i&&a in n||(i||(i=Array.prototype.slice.call(n,0,a)),i[a]=n[a]);return e.concat(i||Array.prototype.slice.call(n))})([e.lockRef.current],(e.shards||[]).map(ro),!0).filter(Boolean);return n.forEach(function(e){return e.classList.add("allow-interactivity-".concat(a))}),function(){document.body.classList.remove("block-interactivity-".concat(a)),n.forEach(function(e){return e.classList.remove("allow-interactivity-".concat(a))})}}},[e.inert,e.lockRef.current,e.shards]);var s=u.useCallback(function(e,n){if("touches"in e&&2===e.touches.length||"wheel"===e.type&&e.ctrlKey)return!r.current.allowPinchZoom;var a,o=ri(e),s=t.current,l="deltaX"in e?e.deltaX:s[0]-o[0],c="deltaY"in e?e.deltaY:s[1]-o[1],d=e.target,p=Math.abs(l)>Math.abs(c)?"h":"v";if("touches"in e&&"h"===p&&"range"===d.type)return!1;var u=o9(p,d);if(!u)return!0;if(u?a=p:(a="v"===p?"h":"v",u=o9(p,d)),!u)return!1;if(!i.current&&"changedTouches"in e&&(l||c)&&(i.current=a),!a)return!0;var h=i.current||a;return rt(h,n,e,"h"===h?l:c,!0)},[]),l=u.useCallback(function(e){if(rs.length&&rs[rs.length-1]===o){var t="deltaY"in e?ra(e):ri(e),i=n.current.filter(function(n){var i;return n.name===e.type&&(n.target===e.target||e.target===n.shadowParent)&&(i=n.delta)[0]===t[0]&&i[1]===t[1]})[0];if(i&&i.should){e.cancelable&&e.preventDefault();return}if(!i){var a=(r.current.shards||[]).map(ro).filter(Boolean).filter(function(n){return n.contains(e.target)});(a.length>0?s(e,a[0]):!r.current.noIsolation)&&e.cancelable&&e.preventDefault()}}},[]),c=u.useCallback(function(e,t,i,a){var o={name:e,delta:t,target:i,should:a,shadowParent:function(e){for(var n=null;null!==e;)e instanceof ShadowRoot&&(n=e.host,e=e.host),e=e.parentNode;return n}(i)};n.current.push(o),setTimeout(function(){n.current=n.current.filter(function(e){return e!==o})},1)},[]),d=u.useCallback(function(e){t.current=ri(e),i.current=void 0},[]),p=u.useCallback(function(n){c(n.type,ra(n),n.target,s(n,e.lockRef.current))},[]),h=u.useCallback(function(n){c(n.type,ri(n),n.target,s(n,e.lockRef.current))},[]);u.useEffect(function(){return rs.push(o),e.setCallbacks({onScrollCapture:p,onWheelCapture:p,onTouchMoveCapture:h}),document.addEventListener("wheel",l,o7),document.addEventListener("touchmove",l,o7),document.addEventListener("touchstart",d,o7),function(){rs=rs.filter(function(e){return e!==o}),document.removeEventListener("wheel",l,o7),document.removeEventListener("touchmove",l,o7),document.removeEventListener("touchstart",d,o7)}},[]);var m=e.removeScrollBar,f=e.inert;return u.createElement(u.Fragment,null,f?u.createElement(o,{styles:"\n  .block-interactivity-".concat(a," {pointer-events: none;}\n  .allow-interactivity-").concat(a," {pointer-events: all;}\n")}):null,m?u.createElement(o4,{gapMode:e.gapMode}):null)},oV.useMedium(a),oG);var rc=u.forwardRef(function(e,n){return u.createElement(oU,oN({},e,{ref:n,sideCar:rl}))});rc.classNames=oU.classNames;var rd=[" ","Enter","ArrowUp","ArrowDown"],rp=[" ","Enter"],ru="Select",[rh,rm,rf]=function(e){let n=e+"CollectionProvider",[t,i]=tJ(n),[a,o]=t(n,{collectionRef:{current:null},itemMap:new Map}),r=e=>{let{scope:n,children:t}=e,i=u.useRef(null),o=u.useRef(new Map).current;return(0,p.jsx)(a,{scope:n,itemMap:o,collectionRef:i,children:t})};r.displayName=n;let s=e+"CollectionSlot",l=tD(s),c=u.forwardRef((e,n)=>{let{scope:t,children:i}=e,a=tx(n,o(s,t).collectionRef);return(0,p.jsx)(l,{ref:a,children:i})});c.displayName=s;let d=e+"CollectionItemSlot",h="data-radix-collection-item",m=tD(d),f=u.forwardRef((e,n)=>{let{scope:t,children:i,...a}=e,r=u.useRef(null),s=tx(n,r),l=o(d,t);return u.useEffect(()=>(l.itemMap.set(r,{ref:r,...a}),()=>void l.itemMap.delete(r))),(0,p.jsx)(m,{[h]:"",ref:s,children:i})});return f.displayName=d,[{Provider:r,Slot:c,ItemSlot:f},function(n){let t=o(e+"CollectionConsumer",n);return u.useCallback(()=>{let e=t.collectionRef.current;if(!e)return[];let n=Array.from(e.querySelectorAll(`[${h}]`));return Array.from(t.itemMap.values()).sort((e,t)=>n.indexOf(e.ref.current)-n.indexOf(t.ref.current))},[t.collectionRef,t.itemMap])},i]}(ru),[rg,ry]=tJ(ru,[rf,ol]),rb=ol(),[rv,rA]=rg(ru),[rC,rw]=rg(ru),rS=e=>{let{__scopeSelect:n,children:t,open:i,defaultOpen:a,onOpenChange:o,value:r,defaultValue:s,onValueChange:l,dir:c,name:d,autoComplete:h,disabled:m,required:f,form:g}=e,y=rb(n),[b,v]=u.useState(null),[A,C]=u.useState(null),[w,S]=u.useState(!1),_=t0(c),[E=!1,M]=oE({prop:i,defaultProp:a,onChange:o}),[I,P]=oE({prop:r,defaultProp:s,onChange:l}),T=u.useRef(null),R=!b||g||!!b.closest("form"),[O,x]=u.useState(new Set),D=Array.from(O).map(e=>e.props.value).join(";");return(0,p.jsx)(op,{...y,children:(0,p.jsxs)(rv,{required:f,scope:n,trigger:b,onTriggerChange:v,valueNode:A,onValueNodeChange:C,valueNodeHasChildren:w,onValueNodeHasChildrenChange:S,contentId:i5(),value:I,onValueChange:P,open:E,onOpenChange:M,dir:_,triggerPointerDownPosRef:T,disabled:m,children:[(0,p.jsx)(rh.Provider,{scope:n,children:(0,p.jsx)(rC,{scope:e.__scopeSelect,onNativeOptionAdd:u.useCallback(e=>{x(n=>new Set(n).add(e))},[]),onNativeOptionRemove:u.useCallback(e=>{x(n=>{let t=new Set(n);return t.delete(e),t})},[]),children:t})}),R?(0,p.jsxs)(r9,{"aria-hidden":!0,required:f,tabIndex:-1,name:d,autoComplete:h,value:I,onChange:e=>P(e.target.value),disabled:m,form:g,children:[void 0===I?(0,p.jsx)("option",{value:""}):null,Array.from(O)]},D):null]})})};rS.displayName=ru;var r_="SelectTrigger",rE=u.forwardRef((e,n)=>{let{__scopeSelect:t,disabled:i=!1,...a}=e,o=rb(t),r=rA(r_,t),s=r.disabled||i,l=tx(n,r.onTriggerChange),c=rm(t),d=u.useRef("touch"),[h,m,f]=se(e=>{let n=c().filter(e=>!e.disabled),t=n.find(e=>e.value===r.value),i=sn(n,e,t);void 0!==i&&r.onValueChange(i.value)}),g=e=>{s||(r.onOpenChange(!0),f()),e&&(r.triggerPointerDownPosRef.current={x:Math.round(e.pageX),y:Math.round(e.pageY)})};return(0,p.jsx)(oh,{asChild:!0,...o,children:(0,p.jsx)(tY.button,{type:"button",role:"combobox","aria-controls":r.contentId,"aria-expanded":r.open,"aria-required":r.required,"aria-autocomplete":"none",dir:r.dir,"data-state":r.open?"open":"closed",disabled:s,"data-disabled":s?"":void 0,"data-placeholder":r6(r.value)?"":void 0,...a,ref:l,onClick:t2(a.onClick,e=>{e.currentTarget.focus(),"mouse"!==d.current&&g(e)}),onPointerDown:t2(a.onPointerDown,e=>{d.current=e.pointerType;let n=e.target;n.hasPointerCapture(e.pointerId)&&n.releasePointerCapture(e.pointerId),0===e.button&&!1===e.ctrlKey&&"mouse"===e.pointerType&&(g(e),e.preventDefault())}),onKeyDown:t2(a.onKeyDown,e=>{let n=""!==h.current;e.ctrlKey||e.altKey||e.metaKey||1!==e.key.length||m(e.key),(!n||" "!==e.key)&&rd.includes(e.key)&&(g(),e.preventDefault())})})})});rE.displayName=r_;var rM="SelectValue",rI=u.forwardRef((e,n)=>{let{__scopeSelect:t,className:i,style:a,children:o,placeholder:r="",...s}=e,l=rA(rM,t),{onValueNodeHasChildrenChange:c}=l,d=void 0!==o,u=tx(n,l.onValueNodeChange);return tX(()=>{c(d)},[c,d]),(0,p.jsx)(tY.span,{...s,ref:u,style:{pointerEvents:"none"},children:r6(l.value)?(0,p.jsx)(p.Fragment,{children:r}):o})});rI.displayName=rM;var rP=u.forwardRef((e,n)=>{let{__scopeSelect:t,children:i,...a}=e;return(0,p.jsx)(tY.span,{"aria-hidden":!0,...a,ref:n,children:i||""})});rP.displayName="SelectIcon";var rT=e=>(0,p.jsx)(o_,{asChild:!0,...e});rT.displayName="SelectPortal";var rR="SelectContent",rO=u.forwardRef((e,n)=>{let t=rA(rR,e.__scopeSelect),[i,a]=u.useState();return(tX(()=>{a(new DocumentFragment)},[]),t.open)?(0,p.jsx)(rk,{...e,ref:n}):i?tW.createPortal((0,p.jsx)(rx,{scope:e.__scopeSelect,children:(0,p.jsx)(rh.Slot,{scope:e.__scopeSelect,children:(0,p.jsx)("div",{children:e.children})})}),i):null});rO.displayName=rR;var[rx,rD]=rg(rR),rN=tD("SelectContent.RemoveScroll"),rk=u.forwardRef((e,n)=>{let{__scopeSelect:t,position:i="item-aligned",onCloseAutoFocus:a,onEscapeKeyDown:o,onPointerDownOutside:r,side:s,sideOffset:l,align:c,alignOffset:d,arrowPadding:h,collisionBoundary:m,collisionPadding:f,sticky:g,hideWhenDetached:y,avoidCollisions:b,...v}=e,A=rA(rR,t),[C,w]=u.useState(null),[S,_]=u.useState(null),E=tx(n,e=>w(e)),[M,I]=u.useState(null),[P,T]=u.useState(null),R=rm(t),[O,x]=u.useState(!1),D=u.useRef(!1);u.useEffect(()=>{if(C)return oD(C)},[C]),iY();let N=u.useCallback(e=>{let[n,...t]=R().map(e=>e.ref.current),[i]=t.slice(-1),a=document.activeElement;for(let t of e)if(t===a||(t?.scrollIntoView({block:"nearest"}),t===n&&S&&(S.scrollTop=0),t===i&&S&&(S.scrollTop=S.scrollHeight),t?.focus(),document.activeElement!==a))return},[R,S]),k=u.useCallback(()=>N([M,C]),[N,M,C]);u.useEffect(()=>{O&&k()},[O,k]);let{onOpenChange:L,triggerPointerDownPosRef:H}=A;u.useEffect(()=>{if(C){let e={x:0,y:0},n=n=>{e={x:Math.abs(Math.round(n.pageX)-(H.current?.x??0)),y:Math.abs(Math.round(n.pageY)-(H.current?.y??0))}},t=t=>{e.x<=10&&e.y<=10?t.preventDefault():C.contains(t.target)||L(!1),document.removeEventListener("pointermove",n),H.current=null};return null!==H.current&&(document.addEventListener("pointermove",n),document.addEventListener("pointerup",t,{capture:!0,once:!0})),()=>{document.removeEventListener("pointermove",n),document.removeEventListener("pointerup",t,{capture:!0})}}},[C,L,H]),u.useEffect(()=>{let e=()=>L(!1);return window.addEventListener("blur",e),window.addEventListener("resize",e),()=>{window.removeEventListener("blur",e),window.removeEventListener("resize",e)}},[L]);let[F,B]=se(e=>{let n=R().filter(e=>!e.disabled),t=n.find(e=>e.ref.current===document.activeElement),i=sn(n,e,t);i&&setTimeout(()=>i.ref.current.focus())}),j=u.useCallback((e,n,t)=>{let i=!D.current&&!t;(void 0!==A.value&&A.value===n||i)&&(I(e),i&&(D.current=!0))},[A.value]),q=u.useCallback(()=>C?.focus(),[C]),V=u.useCallback((e,n,t)=>{let i=!D.current&&!t;(void 0!==A.value&&A.value===n||i)&&T(e)},[A.value]),z="popper"===i?rH:rL,U=z===rH?{side:s,sideOffset:l,align:c,alignOffset:d,arrowPadding:h,collisionBoundary:m,collisionPadding:f,sticky:g,hideWhenDetached:y,avoidCollisions:b}:{};return(0,p.jsx)(rx,{scope:t,content:C,viewport:S,onViewportChange:_,itemRefCallback:j,selectedItem:M,onItemLeave:q,itemTextRefCallback:V,focusSelectedItem:k,selectedItemText:P,position:i,isPositioned:O,searchRef:F,children:(0,p.jsx)(rc,{as:rN,allowPinchZoom:!0,children:(0,p.jsx)(iQ,{asChild:!0,trapped:A.open,onMountAutoFocus:e=>{e.preventDefault()},onUnmountAutoFocus:t2(a,e=>{A.trigger?.focus({preventScroll:!0}),e.preventDefault()}),children:(0,p.jsx)(iz,{asChild:!0,disableOutsidePointerEvents:!0,onEscapeKeyDown:o,onPointerDownOutside:r,onFocusOutside:e=>e.preventDefault(),onDismiss:()=>A.onOpenChange(!1),children:(0,p.jsx)(z,{role:"listbox",id:A.contentId,"data-state":A.open?"open":"closed",dir:A.dir,onContextMenu:e=>e.preventDefault(),...v,...U,onPlaced:()=>x(!0),ref:E,style:{display:"flex",flexDirection:"column",outline:"none",...v.style},onKeyDown:t2(v.onKeyDown,e=>{let n=e.ctrlKey||e.altKey||e.metaKey;if("Tab"===e.key&&e.preventDefault(),n||1!==e.key.length||B(e.key),["ArrowUp","ArrowDown","Home","End"].includes(e.key)){let n=R().filter(e=>!e.disabled).map(e=>e.ref.current);if(["ArrowUp","End"].includes(e.key)&&(n=n.slice().reverse()),["ArrowUp","ArrowDown"].includes(e.key)){let t=e.target,i=n.indexOf(t);n=n.slice(i+1)}setTimeout(()=>N(n)),e.preventDefault()}})})})})})})});rk.displayName="SelectContentImpl";var rL=u.forwardRef((e,n)=>{let{__scopeSelect:t,onPlaced:i,...a}=e,o=rA(rR,t),r=rD(rR,t),[s,l]=u.useState(null),[c,d]=u.useState(null),h=tx(n,e=>d(e)),m=rm(t),f=u.useRef(!1),g=u.useRef(!0),{viewport:y,selectedItem:b,selectedItemText:v,focusSelectedItem:A}=r,C=u.useCallback(()=>{if(o.trigger&&o.valueNode&&s&&c&&y&&b&&v){let e=o.trigger.getBoundingClientRect(),n=c.getBoundingClientRect(),t=o.valueNode.getBoundingClientRect(),a=v.getBoundingClientRect();if("rtl"!==o.dir){let i=a.left-n.left,o=t.left-i,r=e.left-o,l=e.width+r,c=Math.max(l,n.width),d=t1(o,[10,Math.max(10,window.innerWidth-10-c)]);s.style.minWidth=l+"px",s.style.left=d+"px"}else{let i=n.right-a.right,o=window.innerWidth-t.right-i,r=window.innerWidth-e.right-o,l=e.width+r,c=Math.max(l,n.width),d=t1(o,[10,Math.max(10,window.innerWidth-10-c)]);s.style.minWidth=l+"px",s.style.right=d+"px"}let r=m(),l=window.innerHeight-20,d=y.scrollHeight,p=window.getComputedStyle(c),u=parseInt(p.borderTopWidth,10),h=parseInt(p.paddingTop,10),g=parseInt(p.borderBottomWidth,10),A=u+h+d+parseInt(p.paddingBottom,10)+g,C=Math.min(5*b.offsetHeight,A),w=window.getComputedStyle(y),S=parseInt(w.paddingTop,10),_=parseInt(w.paddingBottom,10),E=e.top+e.height/2-10,M=b.offsetHeight/2,I=u+h+(b.offsetTop+M);if(I<=E){let e=r.length>0&&b===r[r.length-1].ref.current;s.style.bottom="0px";let n=Math.max(l-E,M+(e?_:0)+(c.clientHeight-y.offsetTop-y.offsetHeight)+g);s.style.height=I+n+"px"}else{let e=r.length>0&&b===r[0].ref.current;s.style.top="0px";let n=Math.max(E,u+y.offsetTop+(e?S:0)+M);s.style.height=n+(A-I)+"px",y.scrollTop=I-E+y.offsetTop}s.style.margin="10px 0",s.style.minHeight=C+"px",s.style.maxHeight=l+"px",i?.(),requestAnimationFrame(()=>f.current=!0)}},[m,o.trigger,o.valueNode,s,c,y,b,v,o.dir,i]);tX(()=>C(),[C]);let[w,S]=u.useState();tX(()=>{c&&S(window.getComputedStyle(c).zIndex)},[c]);let _=u.useCallback(e=>{e&&!0===g.current&&(C(),A?.(),g.current=!1)},[C,A]);return(0,p.jsx)(rF,{scope:t,contentWrapper:s,shouldExpandOnScrollRef:f,onScrollButtonChange:_,children:(0,p.jsx)("div",{ref:l,style:{display:"flex",flexDirection:"column",position:"fixed",zIndex:w},children:(0,p.jsx)(tY.div,{...a,ref:h,style:{boxSizing:"border-box",maxHeight:"100%",...a.style}})})})});rL.displayName="SelectItemAlignedPosition";var rH=u.forwardRef((e,n)=>{let{__scopeSelect:t,align:i="start",collisionPadding:a=10,...o}=e,r=rb(t);return(0,p.jsx)(oy,{...r,...o,ref:n,align:i,collisionPadding:a,style:{boxSizing:"border-box",...o.style,"--radix-select-content-transform-origin":"var(--radix-popper-transform-origin)","--radix-select-content-available-width":"var(--radix-popper-available-width)","--radix-select-content-available-height":"var(--radix-popper-available-height)","--radix-select-trigger-width":"var(--radix-popper-anchor-width)","--radix-select-trigger-height":"var(--radix-popper-anchor-height)"}})});rH.displayName="SelectPopperPosition";var[rF,rB]=rg(rR,{}),rj="SelectViewport",rq=u.forwardRef((e,n)=>{let{__scopeSelect:t,nonce:i,...a}=e,o=rD(rj,t),r=rB(rj,t),s=tx(n,o.onViewportChange),l=u.useRef(0);return(0,p.jsxs)(p.Fragment,{children:[(0,p.jsx)("style",{dangerouslySetInnerHTML:{__html:"[data-radix-select-viewport]{scrollbar-width:none;-ms-overflow-style:none;-webkit-overflow-scrolling:touch;}[data-radix-select-viewport]::-webkit-scrollbar{display:none}"},nonce:i}),(0,p.jsx)(rh.Slot,{scope:t,children:(0,p.jsx)(tY.div,{"data-radix-select-viewport":"",role:"presentation",...a,ref:s,style:{position:"relative",flex:1,overflow:"hidden auto",...a.style},onScroll:t2(a.onScroll,e=>{let n=e.currentTarget,{contentWrapper:t,shouldExpandOnScrollRef:i}=r;if(i?.current&&t){let e=Math.abs(l.current-n.scrollTop);if(e>0){let i=window.innerHeight-20,a=Math.max(parseFloat(t.style.minHeight),parseFloat(t.style.height));if(a<i){let o=a+e,r=Math.min(i,o),s=o-r;t.style.height=r+"px","0px"===t.style.bottom&&(n.scrollTop=s>0?s:0,t.style.justifyContent="flex-end")}}}l.current=n.scrollTop})})})]})});rq.displayName=rj;var rV="SelectGroup",[rz,rU]=rg(rV);u.forwardRef((e,n)=>{let{__scopeSelect:t,...i}=e,a=i5();return(0,p.jsx)(rz,{scope:t,id:a,children:(0,p.jsx)(tY.div,{role:"group","aria-labelledby":a,...i,ref:n})})}).displayName=rV;var rG="SelectLabel",rW=u.forwardRef((e,n)=>{let{__scopeSelect:t,...i}=e,a=rU(rG,t);return(0,p.jsx)(tY.div,{id:a.id,...i,ref:n})});rW.displayName=rG;var rY="SelectItem",[rX,r$]=rg(rY),rK=u.forwardRef((e,n)=>{let{__scopeSelect:t,value:i,disabled:a=!1,textValue:o,...r}=e,s=rA(rY,t),l=rD(rY,t),c=s.value===i,[d,h]=u.useState(o??""),[m,f]=u.useState(!1),g=tx(n,e=>l.itemRefCallback?.(e,i,a)),y=i5(),b=u.useRef("touch"),v=()=>{a||(s.onValueChange(i),s.onOpenChange(!1))};if(""===i)throw Error("A <Select.Item /> must have a value prop that is not an empty string. This is because the Select value can be set to an empty string to clear the selection and show the placeholder.");return(0,p.jsx)(rX,{scope:t,value:i,disabled:a,textId:y,isSelected:c,onItemTextChange:u.useCallback(e=>{h(n=>n||(e?.textContent??"").trim())},[]),children:(0,p.jsx)(rh.ItemSlot,{scope:t,value:i,disabled:a,textValue:d,children:(0,p.jsx)(tY.div,{role:"option","aria-labelledby":y,"data-highlighted":m?"":void 0,"aria-selected":c&&m,"data-state":c?"checked":"unchecked","aria-disabled":a||void 0,"data-disabled":a?"":void 0,tabIndex:a?void 0:-1,...r,ref:g,onFocus:t2(r.onFocus,()=>f(!0)),onBlur:t2(r.onBlur,()=>f(!1)),onClick:t2(r.onClick,()=>{"mouse"!==b.current&&v()}),onPointerUp:t2(r.onPointerUp,()=>{"mouse"===b.current&&v()}),onPointerDown:t2(r.onPointerDown,e=>{b.current=e.pointerType}),onPointerMove:t2(r.onPointerMove,e=>{b.current=e.pointerType,a?l.onItemLeave?.():"mouse"===b.current&&e.currentTarget.focus({preventScroll:!0})}),onPointerLeave:t2(r.onPointerLeave,e=>{e.currentTarget===document.activeElement&&l.onItemLeave?.()}),onKeyDown:t2(r.onKeyDown,e=>{l.searchRef?.current!==""&&" "===e.key||(rp.includes(e.key)&&v()," "===e.key&&e.preventDefault())})})})})});rK.displayName=rY;var rJ="SelectItemText",rQ=u.forwardRef((e,n)=>{let{__scopeSelect:t,className:i,style:a,...o}=e,r=rA(rJ,t),s=rD(rJ,t),l=r$(rJ,t),c=rw(rJ,t),[d,h]=u.useState(null),m=tx(n,e=>h(e),l.onItemTextChange,e=>s.itemTextRefCallback?.(e,l.value,l.disabled)),f=d?.textContent,g=u.useMemo(()=>(0,p.jsx)("option",{value:l.value,disabled:l.disabled,children:f},l.value),[l.disabled,l.value,f]),{onNativeOptionAdd:y,onNativeOptionRemove:b}=c;return tX(()=>(y(g),()=>b(g)),[y,b,g]),(0,p.jsxs)(p.Fragment,{children:[(0,p.jsx)(tY.span,{id:l.textId,...o,ref:m}),l.isSelected&&r.valueNode&&!r.valueNodeHasChildren?tW.createPortal(o.children,r.valueNode):null]})});rQ.displayName=rJ;var rZ="SelectItemIndicator",r0=u.forwardRef((e,n)=>{let{__scopeSelect:t,...i}=e;return r$(rZ,t).isSelected?(0,p.jsx)(tY.span,{"aria-hidden":!0,...i,ref:n}):null});r0.displayName=rZ;var r1="SelectScrollUpButton",r2=u.forwardRef((e,n)=>{let t=rD(r1,e.__scopeSelect),i=rB(r1,e.__scopeSelect),[a,o]=u.useState(!1),r=tx(n,i.onScrollButtonChange);return tX(()=>{if(t.viewport&&t.isPositioned){let e=function(){o(n.scrollTop>0)},n=t.viewport;return e(),n.addEventListener("scroll",e),()=>n.removeEventListener("scroll",e)}},[t.viewport,t.isPositioned]),a?(0,p.jsx)(r8,{...e,ref:r,onAutoScroll:()=>{let{viewport:e,selectedItem:n}=t;e&&n&&(e.scrollTop=e.scrollTop-n.offsetHeight)}}):null});r2.displayName=r1;var r3="SelectScrollDownButton",r4=u.forwardRef((e,n)=>{let t=rD(r3,e.__scopeSelect),i=rB(r3,e.__scopeSelect),[a,o]=u.useState(!1),r=tx(n,i.onScrollButtonChange);return tX(()=>{if(t.viewport&&t.isPositioned){let e=function(){let e=n.scrollHeight-n.clientHeight;o(Math.ceil(n.scrollTop)<e)},n=t.viewport;return e(),n.addEventListener("scroll",e),()=>n.removeEventListener("scroll",e)}},[t.viewport,t.isPositioned]),a?(0,p.jsx)(r8,{...e,ref:r,onAutoScroll:()=>{let{viewport:e,selectedItem:n}=t;e&&n&&(e.scrollTop=e.scrollTop+n.offsetHeight)}}):null});r4.displayName=r3;var r8=u.forwardRef((e,n)=>{let{__scopeSelect:t,onAutoScroll:i,...a}=e,o=rD("SelectScrollButton",t),r=u.useRef(null),s=rm(t),l=u.useCallback(()=>{null!==r.current&&(window.clearInterval(r.current),r.current=null)},[]);return u.useEffect(()=>()=>l(),[l]),tX(()=>{let e=s().find(e=>e.ref.current===document.activeElement);e?.ref.current?.scrollIntoView({block:"nearest"})},[s]),(0,p.jsx)(tY.div,{"aria-hidden":!0,...a,ref:n,style:{flexShrink:0,...a.style},onPointerDown:t2(a.onPointerDown,()=>{null===r.current&&(r.current=window.setInterval(i,50))}),onPointerMove:t2(a.onPointerMove,()=>{o.onItemLeave?.(),null===r.current&&(r.current=window.setInterval(i,50))}),onPointerLeave:t2(a.onPointerLeave,()=>{l()})})}),r5=u.forwardRef((e,n)=>{let{__scopeSelect:t,...i}=e;return(0,p.jsx)(tY.div,{"aria-hidden":!0,...i,ref:n})});r5.displayName="SelectSeparator";var r7="SelectArrow";function r6(e){return""===e||void 0===e}u.forwardRef((e,n)=>{let{__scopeSelect:t,...i}=e,a=rb(t),o=rA(r7,t),r=rD(r7,t);return o.open&&"popper"===r.position?(0,p.jsx)(oA,{...a,...i,ref:n}):null}).displayName=r7;var r9=u.forwardRef((e,n)=>{let{value:t,...i}=e,a=u.useRef(null),o=tx(n,a),r=function(e){let n=u.useRef({value:e,previous:e});return u.useMemo(()=>(n.current.value!==e&&(n.current.previous=n.current.value,n.current.value=e),n.current.previous),[e])}(t);return u.useEffect(()=>{let e=a.current,n=Object.getOwnPropertyDescriptor(window.HTMLSelectElement.prototype,"value").set;if(r!==t&&n){let i=new Event("change",{bubbles:!0});n.call(e,t),e.dispatchEvent(i)}},[r,t]),(0,p.jsx)(oM,{asChild:!0,children:(0,p.jsx)("select",{...i,ref:o,defaultValue:t})})});function se(e){let n=tQ(e),t=u.useRef(""),i=u.useRef(0),a=u.useCallback(e=>{let a=t.current+e;n(a),function e(n){t.current=n,window.clearTimeout(i.current),""!==n&&(i.current=window.setTimeout(()=>e(""),1e3))}(a)},[n]),o=u.useCallback(()=>{t.current="",window.clearTimeout(i.current)},[]);return u.useEffect(()=>()=>window.clearTimeout(i.current),[]),[t,a,o]}function sn(e,n,t){var i;let a=n.length>1&&Array.from(n).every(e=>e===n[0])?n[0]:n,o=(i=Math.max(t?e.indexOf(t):-1,0),e.map((n,t)=>e[(i+t)%e.length]));1===a.length&&(o=o.filter(e=>e!==t));let r=o.find(e=>e.textValue.toLowerCase().startsWith(a.toLowerCase()));return r!==t?r:void 0}r9.displayName="BubbleSelect";let st=ix("ChevronDown",[["path",{d:"m6 9 6 6 6-6",key:"qrunsl"}]]),si=ix("ChevronUp",[["path",{d:"m18 15-6-6-6 6",key:"153udz"}]]),sa=ix("Check",[["path",{d:"M20 6 9 17l-5-5",key:"1gmf2c"}]]),so=u.forwardRef(({className:e,children:n,...t},i)=>(0,p.jsxs)(rE,{ref:i,className:tP("flex h-9 w-full items-center justify-between whitespace-nowrap rounded-md border border-input bg-transparent px-3 py-2 text-sm shadow-sm ring-offset-background placeholder:text-muted-foreground focus:outline-none focus:ring-1 focus:ring-ring disabled:cursor-not-allowed disabled:opacity-50 [&>span]:line-clamp-1",e),...t,children:[n,(0,p.jsx)(rP,{asChild:!0,children:(0,p.jsx)(st,{className:"h-4 w-4 opacity-50"})})]}));so.displayName=rE.displayName;let sr=u.forwardRef(({className:e,...n},t)=>(0,p.jsx)(r2,{ref:t,className:tP("flex cursor-default items-center justify-center py-1",e),...n,children:(0,p.jsx)(si,{className:"h-4 w-4"})}));sr.displayName=r2.displayName;let ss=u.forwardRef(({className:e,...n},t)=>(0,p.jsx)(r4,{ref:t,className:tP("flex cursor-default items-center justify-center py-1",e),...n,children:(0,p.jsx)(st,{className:"h-4 w-4"})}));ss.displayName=r4.displayName;let sl=u.forwardRef(({className:e,children:n,position:t="popper",...i},a)=>(0,p.jsx)(rT,{children:(0,p.jsxs)(rO,{ref:a,className:tP("relative z-50 max-h-96 min-w-[8rem] overflow-hidden rounded-md border bg-popover text-popover-foreground shadow-md data-[state=open]:animate-in data-[state=closed]:animate-out data-[state=closed]:fade-out-0 data-[state=open]:fade-in-0 data-[state=closed]:zoom-out-95 data-[state=open]:zoom-in-95 data-[side=bottom]:slide-in-from-top-2 data-[side=left]:slide-in-from-right-2 data-[side=right]:slide-in-from-left-2 data-[side=top]:slide-in-from-bottom-2","popper"===t&&"data-[side=bottom]:translate-y-1 data-[side=left]:-translate-x-1 data-[side=right]:translate-x-1 data-[side=top]:-translate-y-1",e),position:t,...i,children:[(0,p.jsx)(sr,{}),(0,p.jsx)(rq,{className:tP("p-1","popper"===t&&"h-[var(--radix-select-trigger-height)] w-full min-w-[var(--radix-select-trigger-width)]"),children:n}),(0,p.jsx)(ss,{})]})}));sl.displayName=rO.displayName,u.forwardRef(({className:e,...n},t)=>(0,p.jsx)(rW,{ref:t,className:tP("px-2 py-1.5 text-sm font-semibold",e),...n})).displayName=rW.displayName;let sc=u.forwardRef(({className:e,children:n,...t},i)=>(0,p.jsxs)(rK,{ref:i,className:tP("relative flex w-full cursor-default select-none items-center rounded-sm py-1.5 pl-2 pr-8 text-sm outline-none focus:bg-accent focus:text-accent-foreground data-[disabled]:pointer-events-none data-[disabled]:opacity-50",e),...t,children:[(0,p.jsx)("span",{className:"absolute right-2 flex h-3.5 w-3.5 items-center justify-center",children:(0,p.jsx)(r0,{children:(0,p.jsx)(sa,{className:"h-4 w-4"})})}),(0,p.jsx)(rQ,{children:n})]}));sc.displayName=rK.displayName,u.forwardRef(({className:e,...n},t)=>(0,p.jsx)(r5,{ref:t,className:tP("-mx-1 my-1 h-px bg-muted",e),...n})).displayName=r5.displayName;var sd="Dialog",[sp,su]=tJ(sd),[sh,sm]=sp(sd),sf=e=>{let{__scopeDialog:n,children:t,open:i,defaultOpen:a,onOpenChange:o,modal:r=!0}=e,s=u.useRef(null),l=u.useRef(null),[c=!1,d]=oE({prop:i,defaultProp:a,onChange:o});return(0,p.jsx)(sh,{scope:n,triggerRef:s,contentRef:l,contentId:i5(),titleId:i5(),descriptionId:i5(),open:c,onOpenChange:d,onOpenToggle:u.useCallback(()=>d(e=>!e),[d]),modal:r,children:t})};sf.displayName=sd;var sg="DialogTrigger";u.forwardRef((e,n)=>{let{__scopeDialog:t,...i}=e,a=sm(sg,t),o=tx(n,a.triggerRef);return(0,p.jsx)(tY.button,{type:"button","aria-haspopup":"dialog","aria-expanded":a.open,"aria-controls":a.contentId,"data-state":sL(a.open),...i,ref:o,onClick:t2(e.onClick,a.onOpenToggle)})}).displayName=sg;var sy="DialogPortal",[sb,sv]=sp(sy,{forceMount:void 0}),sA=e=>{let{__scopeDialog:n,forceMount:t,children:i,container:a}=e,o=sm(sy,n);return(0,p.jsx)(sb,{scope:n,forceMount:t,children:u.Children.map(i,e=>(0,p.jsx)(t$,{present:t||o.open,children:(0,p.jsx)(o_,{asChild:!0,container:a,children:e})}))})};sA.displayName=sy;var sC="DialogOverlay",sw=u.forwardRef((e,n)=>{let t=sv(sC,e.__scopeDialog),{forceMount:i=t.forceMount,...a}=e,o=sm(sC,e.__scopeDialog);return o.modal?(0,p.jsx)(t$,{present:i||o.open,children:(0,p.jsx)(s_,{...a,ref:n})}):null});sw.displayName=sC;var sS=tD("DialogOverlay.RemoveScroll"),s_=u.forwardRef((e,n)=>{let{__scopeDialog:t,...i}=e,a=sm(sC,t);return(0,p.jsx)(rc,{as:sS,allowPinchZoom:!0,shards:[a.contentRef],children:(0,p.jsx)(tY.div,{"data-state":sL(a.open),...i,ref:n,style:{pointerEvents:"auto",...i.style}})})}),sE="DialogContent",sM=u.forwardRef((e,n)=>{let t=sv(sE,e.__scopeDialog),{forceMount:i=t.forceMount,...a}=e,o=sm(sE,e.__scopeDialog);return(0,p.jsx)(t$,{present:i||o.open,children:o.modal?(0,p.jsx)(sI,{...a,ref:n}):(0,p.jsx)(sP,{...a,ref:n})})});sM.displayName=sE;var sI=u.forwardRef((e,n)=>{let t=sm(sE,e.__scopeDialog),i=u.useRef(null),a=tx(n,t.contentRef,i);return u.useEffect(()=>{let e=i.current;if(e)return oD(e)},[]),(0,p.jsx)(sT,{...e,ref:a,trapFocus:t.open,disableOutsidePointerEvents:!0,onCloseAutoFocus:t2(e.onCloseAutoFocus,e=>{e.preventDefault(),t.triggerRef.current?.focus()}),onPointerDownOutside:t2(e.onPointerDownOutside,e=>{let n=e.detail.originalEvent,t=0===n.button&&!0===n.ctrlKey;(2===n.button||t)&&e.preventDefault()}),onFocusOutside:t2(e.onFocusOutside,e=>e.preventDefault())})}),sP=u.forwardRef((e,n)=>{let t=sm(sE,e.__scopeDialog),i=u.useRef(!1),a=u.useRef(!1);return(0,p.jsx)(sT,{...e,ref:n,trapFocus:!1,disableOutsidePointerEvents:!1,onCloseAutoFocus:n=>{e.onCloseAutoFocus?.(n),n.defaultPrevented||(i.current||t.triggerRef.current?.focus(),n.preventDefault()),i.current=!1,a.current=!1},onInteractOutside:n=>{e.onInteractOutside?.(n),n.defaultPrevented||(i.current=!0,"pointerdown"!==n.detail.originalEvent.type||(a.current=!0));let o=n.target;t.triggerRef.current?.contains(o)&&n.preventDefault(),"focusin"===n.detail.originalEvent.type&&a.current&&n.preventDefault()}})}),sT=u.forwardRef((e,n)=>{let{__scopeDialog:t,trapFocus:i,onOpenAutoFocus:a,onCloseAutoFocus:o,...r}=e,s=sm(sE,t),l=u.useRef(null),c=tx(n,l);return iY(),(0,p.jsxs)(p.Fragment,{children:[(0,p.jsx)(iQ,{asChild:!0,loop:!0,trapped:i,onMountAutoFocus:a,onUnmountAutoFocus:o,children:(0,p.jsx)(iz,{role:"dialog",id:s.contentId,"aria-describedby":s.descriptionId,"aria-labelledby":s.titleId,"data-state":sL(s.open),...r,ref:c,onDismiss:()=>s.onOpenChange(!1)})}),(0,p.jsxs)(p.Fragment,{children:[(0,p.jsx)(sj,{titleId:s.titleId}),(0,p.jsx)(sq,{contentRef:l,descriptionId:s.descriptionId})]})]})}),sR="DialogTitle",sO=u.forwardRef((e,n)=>{let{__scopeDialog:t,...i}=e,a=sm(sR,t);return(0,p.jsx)(tY.h2,{id:a.titleId,...i,ref:n})});sO.displayName=sR;var sx="DialogDescription",sD=u.forwardRef((e,n)=>{let{__scopeDialog:t,...i}=e,a=sm(sx,t);return(0,p.jsx)(tY.p,{id:a.descriptionId,...i,ref:n})});sD.displayName=sx;var sN="DialogClose",sk=u.forwardRef((e,n)=>{let{__scopeDialog:t,...i}=e,a=sm(sN,t);return(0,p.jsx)(tY.button,{type:"button",...i,ref:n,onClick:t2(e.onClick,()=>a.onOpenChange(!1))})});function sL(e){return e?"open":"closed"}sk.displayName=sN;var sH="DialogTitleWarning",[sF,sB]=function(e,n){let t=u.createContext(n),i=e=>{let{children:n,...i}=e,a=u.useMemo(()=>i,Object.values(i));return(0,p.jsx)(t.Provider,{value:a,children:n})};return i.displayName=e+"Provider",[i,function(i){let a=u.useContext(t);if(a)return a;if(void 0!==n)return n;throw Error(`\`${i}\` must be used within \`${e}\``)}]}(sH,{contentName:sE,titleName:sR,docsSlug:"dialog"}),sj=({titleId:e})=>{let n=sB(sH),t=`\`${n.contentName}\` requires a \`${n.titleName}\` for the component to be accessible for screen reader users.

If you want to hide the \`${n.titleName}\`, you can wrap it with our VisuallyHidden component.

For more information, see https://radix-ui.com/primitives/docs/components/${n.docsSlug}`;return u.useEffect(()=>{e&&!document.getElementById(e)&&console.error(t)},[t,e]),null},sq=({contentRef:e,descriptionId:n})=>{let t=sB("DialogDescriptionWarning"),i=`Warning: Missing \`Description\` or \`aria-describedby={undefined}\` for {${t.contentName}}.`;return u.useEffect(()=>{let t=e.current?.getAttribute("aria-describedby");n&&t&&!document.getElementById(n)&&console.warn(i)},[i,e,n]),null};let sV=ix("X",[["path",{d:"M18 6 6 18",key:"1bl5f8"}],["path",{d:"m6 6 12 12",key:"d8bk6v"}]]),sz=u.forwardRef(({className:e,...n},t)=>(0,p.jsx)(sw,{ref:t,className:tP("fixed inset-0 z-50 bg-black/80  data-[state=open]:animate-in data-[state=closed]:animate-out data-[state=closed]:fade-out-0 data-[state=open]:fade-in-0",e),...n}));sz.displayName=sw.displayName;let sU=u.forwardRef(({className:e,children:n,...t},i)=>(0,p.jsxs)(sA,{children:[(0,p.jsx)(sz,{}),(0,p.jsxs)(sM,{ref:i,className:tP("fixed left-[50%] top-[50%] z-50 grid w-full max-w-lg translate-x-[-50%] translate-y-[-50%] gap-4 border bg-background p-6 shadow-lg duration-200 data-[state=open]:animate-in data-[state=closed]:animate-out data-[state=closed]:fade-out-0 data-[state=open]:fade-in-0 data-[state=closed]:zoom-out-95 data-[state=open]:zoom-in-95 data-[state=closed]:slide-out-to-left-1/2 data-[state=closed]:slide-out-to-top-[48%] data-[state=open]:slide-in-from-left-1/2 data-[state=open]:slide-in-from-top-[48%] sm:rounded-lg",e),...t,children:[n,(0,p.jsxs)(sk,{className:"absolute right-4 top-4 rounded-sm opacity-70 ring-offset-background transition-opacity hover:opacity-100 focus:outline-none focus:ring-2 focus:ring-ring focus:ring-offset-2 disabled:pointer-events-none data-[state=open]:bg-accent data-[state=open]:text-muted-foreground",children:[(0,p.jsx)(sV,{className:"h-4 w-4"}),(0,p.jsx)("span",{className:"sr-only",children:"Close"})]})]})]}));sU.displayName=sM.displayName;let sG=({className:e,...n})=>(0,p.jsx)("div",{className:tP("flex flex-col space-y-1.5 text-center sm:text-left",e),...n});sG.displayName="DialogHeader";let sW=({className:e,...n})=>(0,p.jsx)("div",{className:tP("flex flex-col-reverse sm:flex-row sm:justify-end sm:space-x-2",e),...n});sW.displayName="DialogFooter";let sY=u.forwardRef(({className:e,...n},t)=>(0,p.jsx)(sO,{ref:t,className:tP("text-lg font-semibold leading-none tracking-tight",e),...n}));sY.displayName=sO.displayName;let sX=u.forwardRef(({className:e,...n},t)=>(0,p.jsx)(sD,{ref:t,className:tP("text-sm text-muted-foreground",e),...n}));sX.displayName=sD.displayName;var s$=u.forwardRef((e,n)=>(0,p.jsx)(tY.label,{...e,ref:n,onMouseDown:n=>{n.target.closest("button, input, select, textarea")||(e.onMouseDown?.(n),!n.defaultPrevented&&n.detail>1&&n.preventDefault())}}));s$.displayName="Label";let sK=tF("text-sm font-medium leading-none peer-disabled:cursor-not-allowed peer-disabled:opacity-70"),sJ=u.forwardRef(({className:e,...n},t)=>(0,p.jsx)(s$,{ref:t,className:tP(sK(),e),...n}));sJ.displayName=s$.displayName;let sQ={WEIGHT_DOSE:"WEIGHT_DOSE",DRIP_RATE:"DRIP_RATE",CONVERSION_LBS_KG:"CONVERSION_LBS_KG",CONVERSION_KG_LBS:"CONVERSION_KG_LBS"},sZ=[{label:"10 gtts/mL (Macro)",value:"10"},{label:"15 gtts/mL (Macro)",value:"15"},{label:"20 gtts/mL (Macro)",value:"20"},{label:"60 gtts/mL (Micro)",value:"60"}];function s0({isOpen:e,onClose:n}){let[t,i]=(0,u.useState)(sQ.WEIGHT_DOSE),[a,o]=(0,u.useState)(""),[r,s]=(0,u.useState)("kg"),[l,c]=(0,u.useState)(""),[d,h]=(0,u.useState)("1"),[m,f]=(0,u.useState)(""),[g,y]=(0,u.useState)("mg_kg"),[b,v]=(0,u.useState)(null),[A,C]=(0,u.useState)(""),[w,S]=(0,u.useState)(""),[_,E]=(0,u.useState)(sZ[3].value),[M,I]=(0,u.useState)(null),[P,T]=(0,u.useState)(""),[R,O]=(0,u.useState)(null),[x,D]=(0,u.useState)(null),N=()=>D(null);return e?(0,p.jsx)(sf,{open:e,onOpenChange:e=>!e&&n(),children:(0,p.jsxs)(sU,{className:"sm:max-w-md bg-white shadow-xl rounded-lg",children:[(0,p.jsxs)(sG,{children:[(0,p.jsx)(sY,{className:"text-2xl font-bold text-gray-800",children:"Medication Calculator"}),(0,p.jsx)(sX,{className:"text-sm text-gray-600",children:"Select calculation type and enter values. Ensure all inputs are correct before use."})]}),(0,p.jsxs)("div",{className:"py-4 space-y-4",children:[(0,p.jsx)(sJ,{className:"font-medium text-sm text-gray-700 mb-1 block",children:"Select Calculation Type:"}),(0,p.jsxs)(rS,{value:t,onValueChange:i,children:[(0,p.jsx)(so,{className:"w-full",children:(0,p.jsx)(rI,{placeholder:"Select Calculation Type"})}),(0,p.jsxs)(sl,{children:[(0,p.jsx)(sc,{value:sQ.WEIGHT_DOSE,children:"Weight-Based Dose"}),(0,p.jsx)(sc,{value:sQ.DRIP_RATE,children:"Drip Rate (gtts/min)"}),(0,p.jsx)(sc,{value:sQ.CONVERSION_LBS_KG,children:"Convert lbs to kg"}),(0,p.jsx)(sc,{value:sQ.CONVERSION_KG_LBS,children:"Convert kg to lbs"})]})]}),x&&(0,p.jsxs)("div",{className:"p-3 bg-red-100 border border-red-300 text-red-700 rounded-md flex items-center text-sm",children:[(0,p.jsx)(iF,{className:"h-5 w-5 mr-2 flex-shrink-0"}),(0,p.jsx)("span",{children:x}),(0,p.jsx)(tj,{variant:"ghost",size:"sm",onClick:N,className:"ml-auto p-0 h-auto text-red-700 hover:bg-red-200",children:(0,p.jsx)(sV,{className:"h-4 w-4"})})]}),(()=>{switch(t){case sQ.WEIGHT_DOSE:return(0,p.jsxs)("div",{className:"space-y-4",children:[(0,p.jsx)("h3",{className:"text-lg font-semibold text-gray-700 border-b pb-2 mb-3",children:"Weight-Based Dosing"}),(0,p.jsxs)("div",{children:[(0,p.jsx)(sJ,{htmlFor:"patientWeight",className:"font-medium text-sm text-gray-700 mb-1 block",children:"Patient Weight:"}),(0,p.jsxs)("div",{className:"flex space-x-2",children:[(0,p.jsx)(tT,{id:"patientWeight",type:"number",value:a,onChange:e=>o(e.target.value),placeholder:"e.g., 70",className:"text-gray-900"}),(0,p.jsxs)(rS,{value:r,onValueChange:s,children:[(0,p.jsx)(so,{className:"w-[100px]",children:(0,p.jsx)(rI,{})}),(0,p.jsxs)(sl,{children:[(0,p.jsx)(sc,{value:"kg",children:"kg"}),(0,p.jsx)(sc,{value:"lbs",children:"lbs"})]})]})]})]}),(0,p.jsxs)("div",{children:[(0,p.jsx)(sJ,{htmlFor:"drugConcentrationMg",className:"font-medium text-sm text-gray-700 mb-1 block",children:"Drug Concentration:"}),(0,p.jsxs)("div",{className:"flex items-center space-x-2",children:[(0,p.jsx)(tT,{id:"drugConcentrationMg",type:"number",value:l,onChange:e=>c(e.target.value),placeholder:"e.g., 100",className:"text-gray-900","aria-label":"Drug concentration in mg"}),(0,p.jsx)("span",{className:"text-gray-500",children:"mg /"}),(0,p.jsx)(tT,{id:"drugConcentrationMl",type:"number",value:d,onChange:e=>h(e.target.value),placeholder:"e.g., 1",className:"w-[80px] text-gray-900","aria-label":"Drug concentration in mL"}),(0,p.jsx)("span",{className:"text-gray-500",children:"mL"})]})]}),(0,p.jsxs)("div",{children:[(0,p.jsx)(sJ,{htmlFor:"doseRequired",className:"font-medium text-sm text-gray-700 mb-1 block",children:"Dose Required:"}),(0,p.jsxs)("div",{className:"flex space-x-2",children:[(0,p.jsx)(tT,{id:"doseRequired",type:"number",value:m,onChange:e=>f(e.target.value),placeholder:"e.g., 0.5",className:"text-gray-900"}),(0,p.jsxs)(rS,{value:g,onValueChange:y,children:[(0,p.jsx)(so,{className:"w-[120px]",children:(0,p.jsx)(rI,{})}),(0,p.jsxs)(sl,{children:[(0,p.jsx)(sc,{value:"mg_kg",children:"mg/kg"}),(0,p.jsx)(sc,{value:"mcg_kg",children:"mcg/kg"})]})]})]})]}),b&&(0,p.jsxs)("p",{className:"text-green-600 font-semibold pt-2 text-sm",children:["Result: ",b]})]});case sQ.DRIP_RATE:return(0,p.jsxs)("div",{className:"space-y-4",children:[(0,p.jsx)("h3",{className:"text-lg font-semibold text-gray-700 border-b pb-2 mb-3",children:"Drip Rate (gtts/min)"}),(0,p.jsxs)("div",{children:[(0,p.jsx)(sJ,{htmlFor:"totalVolume",className:"font-medium text-sm text-gray-700 mb-1 block",children:"Total Volume to Infuse (mL):"}),(0,p.jsx)(tT,{id:"totalVolume",type:"number",value:A,onChange:e=>C(e.target.value),placeholder:"e.g., 1000",className:"text-gray-900"})]}),(0,p.jsxs)("div",{children:[(0,p.jsx)(sJ,{htmlFor:"totalTime",className:"font-medium text-sm text-gray-700 mb-1 block",children:"Total Infusion Time (minutes):"}),(0,p.jsx)(tT,{id:"totalTime",type:"number",value:w,onChange:e=>S(e.target.value),placeholder:"e.g., 60",className:"text-gray-900"})]}),(0,p.jsxs)("div",{children:[(0,p.jsx)(sJ,{htmlFor:"dripSet",className:"font-medium text-sm text-gray-700 mb-1 block",children:"IV Drip Set:"}),(0,p.jsxs)(rS,{value:_,onValueChange:E,name:"dripSet",children:[(0,p.jsx)(so,{id:"dripSet",children:(0,p.jsx)(rI,{})}),(0,p.jsx)(sl,{children:sZ.map(e=>(0,p.jsx)(sc,{value:e.value,children:e.label},e.value))})]})]}),M&&(0,p.jsxs)("p",{className:"text-green-600 font-semibold pt-2 text-sm",children:["Result: ",M]})]});case sQ.CONVERSION_LBS_KG:return(0,p.jsxs)("div",{className:"space-y-4",children:[(0,p.jsx)("h3",{className:"text-lg font-semibold text-gray-700 border-b pb-2 mb-3",children:"Convert Pounds to Kilograms"}),(0,p.jsxs)("div",{children:[(0,p.jsx)(sJ,{htmlFor:"inputValueLbs",className:"font-medium text-sm text-gray-700 mb-1 block",children:"Weight in Pounds (lbs):"}),(0,p.jsx)(tT,{id:"inputValueLbs",type:"number",value:P,onChange:e=>T(e.target.value),placeholder:"Enter lbs",className:"text-gray-900"})]}),R&&(0,p.jsxs)("p",{className:"text-green-600 font-semibold pt-2 text-sm",children:["Result: ",R]})]});case sQ.CONVERSION_KG_LBS:return(0,p.jsxs)("div",{className:"space-y-4",children:[(0,p.jsx)("h3",{className:"text-lg font-semibold text-gray-700 border-b pb-2 mb-3",children:"Convert Kilograms to Pounds"}),(0,p.jsxs)("div",{children:[(0,p.jsx)(sJ,{htmlFor:"inputValueKg",className:"font-medium text-sm text-gray-700 mb-1 block",children:"Weight in Kilograms (kg):"}),(0,p.jsx)(tT,{id:"inputValueKg",type:"number",value:P,onChange:e=>T(e.target.value),placeholder:"Enter kg",className:"text-gray-900"})]}),R&&(0,p.jsxs)("p",{className:"text-green-600 font-semibold pt-2 text-sm",children:["Result: ",R]})]});default:return null}})()]}),(0,p.jsxs)(sW,{className:"sm:justify-between gap-2 pt-4 border-t mt-4",children:[(0,p.jsx)(tj,{type:"button",variant:"outline",onClick:()=>{o(""),c(""),h("1"),f(""),v(null),C(""),S(""),I(null),T(""),O(null),N()},className:"border-gray-300 text-gray-700 hover:bg-gray-50",children:"Clear Inputs"}),(0,p.jsxs)("div",{className:"flex gap-2",children:[(0,p.jsx)(sk,{asChild:!0,children:(0,p.jsx)(tj,{type:"button",variant:"ghost",onClick:n,className:"text-gray-600 hover:bg-gray-100",children:"Close"})}),(0,p.jsx)(tj,{type:"button",onClick:()=>{N(),v(null),I(null),O(null);let e=e=>{let n=parseFloat(e);if(isNaN(n)||n<0)throw Error("Invalid input: All numerical inputs must be positive numbers.");return n};try{switch(t){case sQ.WEIGHT_DOSE:let n=e(a),i="lbs"===r?n/2.20462:n,o=e(l),s=e(d);if(0===s)throw Error("Concentration volume (mL) cannot be zero.");let c=o/s,p=e(m),u=0;if("mg_kg"===g?u=i*p:"mcg_kg"===g&&(u=i*p/1e3),0===c&&0!==u)throw Error("Drug concentration (mg) cannot be zero if dose is required.");let h=0===c?0===u?0:1/0:u/c;h===1/0?v("Cannot calculate volume: Drug concentration is zero but dose is required."):v(`Total Dose: ${u.toFixed(2)} mg. Volume to Administer: ${h.toFixed(2)} mL.`);break;case sQ.DRIP_RATE:let f=e(A),y=e(w),b=e(_);if(0===y)throw Error("Time cannot be zero.");I(`Drip Rate: ${(f*b/y).toFixed(0)} gtts/min.`);break;case sQ.CONVERSION_LBS_KG:let C=e(P),S=C/2.20462;O(`${C.toFixed(2)} lbs = ${S.toFixed(2)} kg.`);break;case sQ.CONVERSION_KG_LBS:let E=e(P),M=2.20462*E;O(`${E.toFixed(2)} kg = ${M.toFixed(2)} lbs.`)}}catch(e){D(e.message||"An unexpected error occurred.")}},className:"bg-blue-600 hover:bg-blue-700 text-white",children:"Calculate"})]})]})]})}):null}new nz(Object.entries(ij).map(([e,n])=>({...n,id:e,categories:n.categories||[]})),{includeScore:!0,threshold:.4,keys:[{name:"name",weight:.6},{name:"id",weight:.5},{name:"content",weight:.2}]});let s1=[{id:"adult",label:"Adult"},{id:"pediatric",label:"Pediatric"},{id:"medical",label:"Medical"},{id:"trauma",label:"Trauma"}];function s2(){let[e,n]=(0,u.useState)(""),[t,i]=(0,u.useState)([]),[a,o]=(0,u.useState)(!1),[r,s]=(0,u.useState)(!1),l=(0,u.useRef)(null),[c,d]=(0,u.useState)([]),[h,m]=(0,u.useState)(!1),{messages:f,input:g,handleInputChange:y,handleSubmit:b,isLoading:v,error:A}=e2({api:"/api/chat"}),C=e=>{d(n=>n.includes(e)?n.filter(n=>n!==e):[...n,e])};return(0,p.jsxs)("div",{className:"flex flex-col items-center min-h-screen bg-gray-100 p-4 md:p-8 font-sans",children:[(0,p.jsxs)(tq,{className:"w-full max-w-4xl shadow-xl rounded-lg overflow-hidden",children:[(0,p.jsxs)(tV,{className:"text-center bg-gray-800 text-white p-6",children:[(0,p.jsxs)("div",{className:"flex justify-between items-center",children:[(0,p.jsx)("div",{})," ",(0,p.jsx)(tz,{className:"text-3xl md:text-4xl font-bold",children:"EMS Protocol Navigator"}),(0,p.jsx)(tj,{variant:"outline",size:"icon",onClick:()=>m(!0),title:"Open Medication Calculator",className:"bg-gray-700 hover:bg-gray-600 border-gray-600 text-white",children:(0,p.jsx)(iD,{className:"h-5 w-5"})})]}),(0,p.jsx)(tU,{className:"text-gray-300 mt-1",children:"Search protocols or use AI chat for assistance"})]}),(0,p.jsxs)(tG,{className:"p-6 bg-white",children:[(0,p.jsxs)("div",{className:"w-full flex items-center space-x-2 mb-4",children:[(0,p.jsx)(tT,{type:"text",placeholder:"Search protocols (e.g., cardiac arrest)...",value:e,onChange:e=>{n(e.target.value)},onKeyDown:e=>{e.key},className:"flex-grow border-gray-300 focus:ring-blue-500 focus:border-blue-500 rounded-md shadow-sm text-gray-900"}),(0,p.jsxs)(tj,{variant:"outline",onClick:()=>s(!r),title:r?"Switch to Search View":"Switch to AI Chat",className:"border-gray-300 text-gray-700 hover:bg-gray-50 rounded-md",children:[r?(0,p.jsx)(iN,{className:"h-5 w-5"}):(0,p.jsx)(ik,{className:"h-5 w-5"})," ",(0,p.jsx)("span",{className:"ml-2 hidden sm:inline",children:r?"Search View":"AI Chat"})]})]}),!r&&(0,p.jsx)("div",{className:"mb-6 p-4 bg-gray-50 rounded-md border border-gray-200",children:(0,p.jsxs)("div",{className:"flex flex-wrap items-center gap-2",children:[(0,p.jsxs)("span",{className:"text-sm font-medium text-gray-700 mr-2",children:[(0,p.jsx)(iL,{className:"h-4 w-4 inline-block mr-1 mb-px"}),"Filters:"]}),s1.map(e=>(0,p.jsx)(tj,{variant:c.includes(e.id)?"default":"outline",size:"sm",onClick:()=>C(e.id),className:`rounded-full text-xs px-3 py-1 ${c.includes(e.id)?"bg-blue-600 text-white hover:bg-blue-700":"border-gray-300 text-gray-600 hover:bg-gray-100"}`,children:e.label},e.id)),c.length>0&&(0,p.jsxs)(tj,{variant:"ghost",size:"sm",onClick:()=>{d([])},className:"text-xs text-red-500 hover:bg-red-50 rounded-full px-3 py-1",children:[(0,p.jsx)(iH,{className:"h-3 w-3 mr-1"})," Clear All"]})]})}),(0,p.jsx)("div",{className:"w-full h-[60vh] flex flex-col",children:r?(0,p.jsxs)("div",{className:"h-full flex flex-col border border-gray-300 rounded-md shadow-inner",children:[(0,p.jsxs)(iP,{className:"flex-grow p-4 bg-white",ref:l,children:[f.map(e=>(0,p.jsx)("div",{className:`mb-3 flex ${"user"===e.role?"justify-end":"justify-start"}`,children:(0,p.jsx)("div",{className:`p-3 rounded-lg shadow-md max-w-[80%] ${"user"===e.role?"bg-blue-600 text-white":"bg-gray-200 text-gray-800"}`,children:(0,p.jsx)("p",{className:"text-sm whitespace-pre-wrap",children:e.content})})},e.id)),A&&(0,p.jsx)("div",{className:"flex justify-start mb-3",children:(0,p.jsxs)("div",{className:"bg-red-100 text-red-700 p-3 rounded-lg shadow-md inline-flex items-center max-w-[80%]",children:[(0,p.jsx)(iF,{className:"inline-block h-4 w-4 mr-2 flex-shrink-0"}),(0,p.jsxs)("p",{className:"text-sm whitespace-pre-wrap",children:["Sorry, an error occurred: ",A.message]})]})}),v&&f[f.length-1]?.role==="user"&&(0,p.jsx)("div",{className:"flex justify-start mb-3",children:(0,p.jsxs)("div",{className:"bg-gray-200 text-gray-700 p-3 rounded-lg shadow-md inline-flex items-center",children:[(0,p.jsx)(iB,{className:"h-4 w-4 animate-spin mr-2"})," Thinking..."]})})]}),(0,p.jsxs)("form",{onSubmit:b,className:"flex items-center space-x-2 p-3 border-t border-gray-200 bg-gray-50 rounded-b-md",children:[(0,p.jsx)(tT,{placeholder:"Ask the AI about protocols...",value:g,onChange:y,disabled:v,className:"flex-grow border-gray-300 focus:ring-blue-500 focus:border-blue-500 rounded-md shadow-sm text-gray-900"}),(0,p.jsx)(tj,{type:"submit",disabled:v||!g.trim(),className:"bg-blue-600 hover:bg-blue-700 text-white rounded-md",children:v?(0,p.jsx)(iB,{className:"h-4 w-4 animate-spin"}):"Send"})]})]}):(0,p.jsxs)(iP,{className:"h-full border border-gray-300 rounded-md p-4 bg-gray-50 shadow-inner",children:[a&&(0,p.jsxs)("div",{className:"flex justify-center items-center h-full",children:[(0,p.jsx)(iB,{className:"h-8 w-8 animate-spin text-blue-600"}),(0,p.jsx)("p",{className:"ml-2 text-gray-600",children:"Searching..."})]}),!a&&t.length>0?(0,p.jsx)("div",{className:"space-y-4",children:t.map(e=>(0,p.jsxs)(tq,{className:"shadow-md hover:shadow-lg transition-shadow duration-200 rounded-lg overflow-hidden",children:[(0,p.jsxs)(tV,{className:"bg-gray-100 p-4 border-b border-gray-200",children:[(0,p.jsxs)(tz,{className:"text-lg font-semibold text-blue-700",children:[e.name," ",(0,p.jsxs)("span",{className:"text-xs text-gray-500 font-mono",children:["(",e.id,")"]})]}),(0,p.jsxs)(tU,{className:"text-xs text-gray-500",children:["Source: ",e.source_file]}),e.categories&&e.categories.length>0&&(0,p.jsx)("div",{className:"mt-1",children:e.categories.map(e=>(0,p.jsx)("span",{className:"inline-block bg-blue-100 text-blue-800 text-xs font-medium mr-2 px-2 py-0.5 rounded-full",children:e},e))})]}),(0,p.jsx)(tG,{className:"p-4 bg-white",children:(0,p.jsx)("pre",{className:"whitespace-pre-wrap text-sm font-mono bg-gray-50 text-gray-800 p-3 rounded-md overflow-x-auto border border-gray-200 min-h-[50px]",children:e.content||"Content not available."})})]},e.id))}):!a&&(0,p.jsxs)("div",{className:"text-center text-gray-500 pt-16",children:[(0,p.jsx)(iN,{className:"h-12 w-12 mx-auto text-gray-400 mb-2"}),e||c.length>0?"No protocols found matching your criteria.":"Enter a search term or select filters to begin."]})]})})]})]}),(0,p.jsx)(s0,{isOpen:h,onClose:()=>m(!1)}),(0,p.jsx)("footer",{className:"mt-8 text-center text-xs text-gray-500",children:(0,p.jsx)("p",{children:"EMS Protocol Navigator & AI Assistant"})})]})}},2622:e=>{(()=>{"use strict";"undefined"!=typeof __nccwpck_require__&&(__nccwpck_require__.ab=__dirname+"/");var n={};(()=>{n.parse=function(n,t){if("string"!=typeof n)throw TypeError("argument str must be a string");for(var a={},o=n.split(i),r=(t||{}).decode||e,s=0;s<o.length;s++){var l=o[s],c=l.indexOf("=");if(!(c<0)){var d=l.substr(0,c).trim(),p=l.substr(++c,l.length).trim();'"'==p[0]&&(p=p.slice(1,-1)),void 0==a[d]&&(a[d]=function(e,n){try{return n(e)}catch(n){return e}}(p,r))}}return a},n.serialize=function(e,n,i){var o=i||{},r=o.encode||t;if("function"!=typeof r)throw TypeError("option encode is invalid");if(!a.test(e))throw TypeError("argument name is invalid");var s=r(n);if(s&&!a.test(s))throw TypeError("argument val is invalid");var l=e+"="+s;if(null!=o.maxAge){var c=o.maxAge-0;if(isNaN(c)||!isFinite(c))throw TypeError("option maxAge is invalid");l+="; Max-Age="+Math.floor(c)}if(o.domain){if(!a.test(o.domain))throw TypeError("option domain is invalid");l+="; Domain="+o.domain}if(o.path){if(!a.test(o.path))throw TypeError("option path is invalid");l+="; Path="+o.path}if(o.expires){if("function"!=typeof o.expires.toUTCString)throw TypeError("option expires is invalid");l+="; Expires="+o.expires.toUTCString()}if(o.httpOnly&&(l+="; HttpOnly"),o.secure&&(l+="; Secure"),o.sameSite)switch("string"==typeof o.sameSite?o.sameSite.toLowerCase():o.sameSite){case!0:case"strict":l+="; SameSite=Strict";break;case"lax":l+="; SameSite=Lax";break;case"none":l+="; SameSite=None";break;default:throw TypeError("option sameSite is invalid")}return l};var e=decodeURIComponent,t=encodeURIComponent,i=/; */,a=/^[\u0009\u0020-\u007e\u0080-\u00ff]+$/})(),e.exports=n})()},103:e=>{(()=>{"use strict";"undefined"!=typeof __nccwpck_require__&&(__nccwpck_require__.ab=__dirname+"/");var n={};(()=>{function e(e,n){void 0===n&&(n={});for(var t=function(e){for(var n=[],t=0;t<e.length;){var i=e[t];if("*"===i||"+"===i||"?"===i){n.push({type:"MODIFIER",index:t,value:e[t++]});continue}if("\\"===i){n.push({type:"ESCAPED_CHAR",index:t++,value:e[t++]});continue}if("{"===i){n.push({type:"OPEN",index:t,value:e[t++]});continue}if("}"===i){n.push({type:"CLOSE",index:t,value:e[t++]});continue}if(":"===i){for(var a="",o=t+1;o<e.length;){var r=e.charCodeAt(o);if(r>=48&&r<=57||r>=65&&r<=90||r>=97&&r<=122||95===r){a+=e[o++];continue}break}if(!a)throw TypeError("Missing parameter name at "+t);n.push({type:"NAME",index:t,value:a}),t=o;continue}if("("===i){var s=1,l="",o=t+1;if("?"===e[o])throw TypeError('Pattern cannot start with "?" at '+o);for(;o<e.length;){if("\\"===e[o]){l+=e[o++]+e[o++];continue}if(")"===e[o]){if(0==--s){o++;break}}else if("("===e[o]&&(s++,"?"!==e[o+1]))throw TypeError("Capturing groups are not allowed at "+o);l+=e[o++]}if(s)throw TypeError("Unbalanced pattern at "+t);if(!l)throw TypeError("Missing pattern at "+t);n.push({type:"PATTERN",index:t,value:l}),t=o;continue}n.push({type:"CHAR",index:t,value:e[t++]})}return n.push({type:"END",index:t,value:""}),n}(e),i=n.prefixes,o=void 0===i?"./":i,r="[^"+a(n.delimiter||"/#?")+"]+?",s=[],l=0,c=0,d="",p=function(e){if(c<t.length&&t[c].type===e)return t[c++].value},u=function(e){var n=p(e);if(void 0!==n)return n;var i=t[c];throw TypeError("Unexpected "+i.type+" at "+i.index+", expected "+e)},h=function(){for(var e,n="";e=p("CHAR")||p("ESCAPED_CHAR");)n+=e;return n};c<t.length;){var m=p("CHAR"),f=p("NAME"),g=p("PATTERN");if(f||g){var y=m||"";-1===o.indexOf(y)&&(d+=y,y=""),d&&(s.push(d),d=""),s.push({name:f||l++,prefix:y,suffix:"",pattern:g||r,modifier:p("MODIFIER")||""});continue}var b=m||p("ESCAPED_CHAR");if(b){d+=b;continue}if(d&&(s.push(d),d=""),p("OPEN")){var y=h(),v=p("NAME")||"",A=p("PATTERN")||"",C=h();u("CLOSE"),s.push({name:v||(A?l++:""),pattern:v&&!A?r:A,prefix:y,suffix:C,modifier:p("MODIFIER")||""});continue}u("END")}return s}function t(e,n){void 0===n&&(n={});var t=o(n),i=n.encode,a=void 0===i?function(e){return e}:i,r=n.validate,s=void 0===r||r,l=e.map(function(e){if("object"==typeof e)return RegExp("^(?:"+e.pattern+")$",t)});return function(n){for(var t="",i=0;i<e.length;i++){var o=e[i];if("string"==typeof o){t+=o;continue}var r=n?n[o.name]:void 0,c="?"===o.modifier||"*"===o.modifier,d="*"===o.modifier||"+"===o.modifier;if(Array.isArray(r)){if(!d)throw TypeError('Expected "'+o.name+'" to not repeat, but got an array');if(0===r.length){if(c)continue;throw TypeError('Expected "'+o.name+'" to not be empty')}for(var p=0;p<r.length;p++){var u=a(r[p],o);if(s&&!l[i].test(u))throw TypeError('Expected all "'+o.name+'" to match "'+o.pattern+'", but got "'+u+'"');t+=o.prefix+u+o.suffix}continue}if("string"==typeof r||"number"==typeof r){var u=a(String(r),o);if(s&&!l[i].test(u))throw TypeError('Expected "'+o.name+'" to match "'+o.pattern+'", but got "'+u+'"');t+=o.prefix+u+o.suffix;continue}if(!c){var h=d?"an array":"a string";throw TypeError('Expected "'+o.name+'" to be '+h)}}return t}}function i(e,n,t){void 0===t&&(t={});var i=t.decode,a=void 0===i?function(e){return e}:i;return function(t){var i=e.exec(t);if(!i)return!1;for(var o=i[0],r=i.index,s=Object.create(null),l=1;l<i.length;l++)!function(e){if(void 0!==i[e]){var t=n[e-1];"*"===t.modifier||"+"===t.modifier?s[t.name]=i[e].split(t.prefix+t.suffix).map(function(e){return a(e,t)}):s[t.name]=a(i[e],t)}}(l);return{path:o,index:r,params:s}}}function a(e){return e.replace(/([.+*?=^!:${}()[\]|/\\])/g,"\\$1")}function o(e){return e&&e.sensitive?"":"i"}function r(e,n,t){void 0===t&&(t={});for(var i=t.strict,r=void 0!==i&&i,s=t.start,l=t.end,c=t.encode,d=void 0===c?function(e){return e}:c,p="["+a(t.endsWith||"")+"]|$",u="["+a(t.delimiter||"/#?")+"]",h=void 0===s||s?"^":"",m=0;m<e.length;m++){var f=e[m];if("string"==typeof f)h+=a(d(f));else{var g=a(d(f.prefix)),y=a(d(f.suffix));if(f.pattern){if(n&&n.push(f),g||y){if("+"===f.modifier||"*"===f.modifier){var b="*"===f.modifier?"?":"";h+="(?:"+g+"((?:"+f.pattern+")(?:"+y+g+"(?:"+f.pattern+"))*)"+y+")"+b}else h+="(?:"+g+"("+f.pattern+")"+y+")"+f.modifier}else h+="("+f.pattern+")"+f.modifier}else h+="(?:"+g+y+")"+f.modifier}}if(void 0===l||l)r||(h+=u+"?"),h+=t.endsWith?"(?="+p+")":"$";else{var v=e[e.length-1],A="string"==typeof v?u.indexOf(v[v.length-1])>-1:void 0===v;r||(h+="(?:"+u+"(?="+p+"))?"),A||(h+="(?="+u+"|"+p+")")}return new RegExp(h,o(t))}function s(n,t,i){return n instanceof RegExp?function(e,n){if(!n)return e;var t=e.source.match(/\((?!\?)/g);if(t)for(var i=0;i<t.length;i++)n.push({name:i,prefix:"",suffix:"",modifier:"",pattern:""});return e}(n,t):Array.isArray(n)?RegExp("(?:"+n.map(function(e){return s(e,t,i).source}).join("|")+")",o(i)):r(e(n,i),t,i)}Object.defineProperty(n,"__esModule",{value:!0}),n.parse=e,n.compile=function(n,i){return t(e(n,i),i)},n.tokensToFunction=t,n.match=function(e,n){var t=[];return i(s(e,t,n),t,n)},n.regexpToFunction=i,n.tokensToRegexp=r,n.pathToRegexp=s})(),e.exports=n})()},4131:(e,n,t)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),function(e,n){for(var t in n)Object.defineProperty(e,t,{enumerable:!0,get:n[t]})}(n,{fillMetadataSegment:function(){return u},normalizeMetadataPageToRoute:function(){return m},normalizeMetadataRoute:function(){return h}});let i=t(4587),a=function(e){return e&&e.__esModule?e:{default:e}}(t(1528)),o=t(9852),r=t(9026),s=t(4217),l=t(387),c=t(5095),d=t(2080);function p(e){let n=a.default.dirname(e);if(e.endsWith("/sitemap"))return"";let t="";return n.split("/").some(e=>(0,d.isGroupSegment)(e)||(0,d.isParallelRouteSegment)(e))&&(t=(0,s.djb2Hash)(n).toString(36).slice(0,6)),t}function u(e,n,t){let i=(0,l.normalizeAppPath)(e),s=(0,r.getNamedRouteRegex)(i,!1),d=(0,o.interpolateDynamicPath)(i,n,s),{name:u,ext:h}=a.default.parse(t),m=p(a.default.posix.join(e,u)),f=m?`-${m}`:"";return(0,c.normalizePathSep)(a.default.join(d,`${u}${f}${h}`))}function h(e){if(!(0,i.isMetadataRoute)(e))return e;let n=e,t="";if("/robots"===e?n+=".txt":"/manifest"===e?n+=".webmanifest":t=p(e),!n.endsWith("/route")){let{dir:e,name:i,ext:o}=a.default.parse(n);n=a.default.posix.join(e,`${i}${t?`-${t}`:""}${o}`,"route")}return n}function m(e,n){let t=e.endsWith("/route"),i=t?e.slice(0,-6):e,a=i.endsWith("/sitemap")?".xml":"";return(n?`${i}/[__metadata_id__]`:`${i}${a}`)+(t?"/route":"")}},4587:(e,n,t)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),function(e,n){for(var t in n)Object.defineProperty(e,t,{enumerable:!0,get:n[t]})}(n,{STATIC_METADATA_IMAGES:function(){return a},getExtensionRegexString:function(){return r},isMetadataRoute:function(){return d},isMetadataRouteFile:function(){return s},isStaticMetadataRoute:function(){return c},isStaticMetadataRouteFile:function(){return l}});let i=t(5095),a={icon:{filename:"icon",extensions:["ico","jpg","jpeg","png","svg"]},apple:{filename:"apple-icon",extensions:["jpg","jpeg","png"]},favicon:{filename:"favicon",extensions:["ico"]},openGraph:{filename:"opengraph-image",extensions:["jpg","jpeg","png","gif"]},twitter:{filename:"twitter-image",extensions:["jpg","jpeg","png","gif"]}},o=["js","jsx","ts","tsx"],r=(e,n)=>n?`(?:\\.(${e.join("|")})|((\\[\\])?\\.(${n.join("|")})))`:`\\.(?:${e.join("|")})`;function s(e,n,t){let o=[RegExp(`^[\\\\/]robots${t?`${r(n.concat("txt"),null)}$`:""}`),RegExp(`^[\\\\/]manifest${t?`${r(n.concat("webmanifest","json"),null)}$`:""}`),RegExp("^[\\\\/]favicon\\.ico$"),RegExp(`[\\\\/]sitemap${t?`${r(["xml"],n)}$`:""}`),RegExp(`[\\\\/]${a.icon.filename}\\d?${t?`${r(a.icon.extensions,n)}$`:""}`),RegExp(`[\\\\/]${a.apple.filename}\\d?${t?`${r(a.apple.extensions,n)}$`:""}`),RegExp(`[\\\\/]${a.openGraph.filename}\\d?${t?`${r(a.openGraph.extensions,n)}$`:""}`),RegExp(`[\\\\/]${a.twitter.filename}\\d?${t?`${r(a.twitter.extensions,n)}$`:""}`)],s=(0,i.normalizePathSep)(e);return o.some(e=>e.test(s))}function l(e){return s(e,[],!0)}function c(e){return"/robots"===e||"/manifest"===e||l(e)}function d(e){let n=e.replace(/^\/?app\//,"").replace(/\/route$/,"");return"/"!==n[0]&&(n="/"+n),!n.endsWith("/page")&&s(n,o,!1)}},4119:(e,n,t)=>{"use strict";function i(e){return function(){let{cookie:n}=e;if(!n)return{};let{parse:i}=t(2622);return i(Array.isArray(n)?n.join("; "):n)}}Object.defineProperty(n,"__esModule",{value:!0}),Object.defineProperty(n,"getCookieParser",{enumerable:!0,get:function(){return i}})},1874:(e,n,t)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),function(e,n){for(var t in n)Object.defineProperty(e,t,{enumerable:!0,get:n[t]})}(n,{INTERCEPTION_ROUTE_MARKERS:function(){return a},extractInterceptionRouteInformation:function(){return r},isInterceptionRouteAppPath:function(){return o}});let i=t(387),a=["(..)(..)","(.)","(..)","(...)"];function o(e){return void 0!==e.split("/").find(e=>a.find(n=>e.startsWith(n)))}function r(e){let n,t,o;for(let i of e.split("/"))if(t=a.find(e=>i.startsWith(e))){[n,o]=e.split(t,2);break}if(!n||!t||!o)throw Error(`Invalid interception route: ${e}. Must be in the format /<intercepting route>/(..|...|..)(..)/<intercepted route>`);switch(n=(0,i.normalizeAppPath)(n),t){case"(.)":o="/"===n?`/${o}`:n+"/"+o;break;case"(..)":if("/"===n)throw Error(`Invalid interception route: ${e}. Cannot use (..) marker at the root level, use (.) instead.`);o=n.split("/").slice(0,-1).concat(o).join("/");break;case"(...)":o="/"+o;break;case"(..)(..)":let r=n.split("/");if(r.length<=2)throw Error(`Invalid interception route: ${e}. Cannot use (..)(..) marker at the root level or one level up.`);o=r.slice(0,-2).concat(o).join("/");break;default:throw Error("Invariant: unexpected marker")}return{interceptingRoute:n,interceptedRoute:o}}},9852:(e,n,t)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),function(e,n){for(var t in n)Object.defineProperty(e,t,{enumerable:!0,get:n[t]})}(n,{getUtils:function(){return f},interpolateDynamicPath:function(){return h},normalizeDynamicRouteParams:function(){return m},normalizeVercelUrl:function(){return u}});let i=t(9551),a=t(5466),o=t(1794),r=t(9026),s=t(1819),l=t(2527),c=t(1226),d=t(387),p=t(9430);function u(e,n,t,a,o){if(a&&n&&o){let n=(0,i.parse)(e.url,!0);for(let e of(delete n.search,Object.keys(n.query))){let i=e!==p.NEXT_QUERY_PARAM_PREFIX&&e.startsWith(p.NEXT_QUERY_PARAM_PREFIX),a=e!==p.NEXT_INTERCEPTION_MARKER_PREFIX&&e.startsWith(p.NEXT_INTERCEPTION_MARKER_PREFIX);(i||a||(t||Object.keys(o.groups)).includes(e))&&delete n.query[e]}e.url=(0,i.format)(n)}}function h(e,n,t){if(!t)return e;for(let i of Object.keys(t.groups)){let a;let{optional:o,repeat:r}=t.groups[i],s=`[${r?"...":""}${i}]`;o&&(s=`[${s}]`);let l=n[i];a=Array.isArray(l)?l.map(e=>e&&encodeURIComponent(e)).join("/"):l?encodeURIComponent(l):"",e=e.replaceAll(s,a)}return e}function m(e,n,t,i){let a=!0;return t?{params:e=Object.keys(t.groups).reduce((o,r)=>{let s=e[r];"string"==typeof s&&(s=(0,d.normalizeRscURL)(s)),Array.isArray(s)&&(s=s.map(e=>("string"==typeof e&&(e=(0,d.normalizeRscURL)(e)),e)));let l=i[r],c=t.groups[r].optional;return((Array.isArray(l)?l.some(e=>Array.isArray(s)?s.some(n=>n.includes(e)):null==s?void 0:s.includes(e)):null==s?void 0:s.includes(l))||void 0===s&&!(c&&n))&&(a=!1),c&&(!s||Array.isArray(s)&&1===s.length&&("index"===s[0]||s[0]===`[[...${r}]]`))&&(s=void 0,delete e[r]),s&&"string"==typeof s&&t.groups[r].repeat&&(s=s.split("/")),s&&(o[r]=s),o},{}),hasValidParams:a}:{params:e,hasValidParams:!1}}function f({page:e,i18n:n,basePath:t,rewrites:i,pageIsDynamic:d,trailingSlash:f,caseSensitive:g}){let y,b,v;return d&&(y=(0,r.getNamedRouteRegex)(e,!1),v=(b=(0,s.getRouteMatcher)(y))(e)),{handleRewrites:function(r,s){let p={},u=s.pathname,h=i=>{let c=(0,o.getPathMatch)(i.source+(f?"(/)?":""),{removeUnnamedParams:!0,strict:!0,sensitive:!!g})(s.pathname);if((i.has||i.missing)&&c){let e=(0,l.matchHas)(r,s.query,i.has,i.missing);e?Object.assign(c,e):c=!1}if(c){let{parsedDestination:o,destQuery:r}=(0,l.prepareDestination)({appendParamsToQuery:!0,destination:i.destination,params:c,query:s.query});if(o.protocol)return!0;if(Object.assign(p,r,c),Object.assign(s.query,o.query),delete o.query,Object.assign(s,o),u=s.pathname,t&&(u=u.replace(RegExp(`^${t}`),"")||"/"),n){let e=(0,a.normalizeLocalePath)(u,n.locales);u=e.pathname,s.query.nextInternalLocale=e.detectedLocale||c.nextInternalLocale}if(u===e)return!0;if(d&&b){let e=b(u);if(e)return s.query={...s.query,...e},!0}}return!1};for(let e of i.beforeFiles||[])h(e);if(u!==e){let n=!1;for(let e of i.afterFiles||[])if(n=h(e))break;if(!n&&!(()=>{let n=(0,c.removeTrailingSlash)(u||"");return n===(0,c.removeTrailingSlash)(e)||(null==b?void 0:b(n))})()){for(let e of i.fallback||[])if(n=h(e))break}}return p},defaultRouteRegex:y,dynamicRouteMatcher:b,defaultRouteMatches:v,getParamsFromRouteMatches:function(e,t,i){return(0,s.getRouteMatcher)(function(){let{groups:e,routeKeys:a}=y;return{re:{exec:o=>{let r=Object.fromEntries(new URLSearchParams(o)),s=n&&i&&r["1"]===i;for(let e of Object.keys(r)){let n=r[e];e!==p.NEXT_QUERY_PARAM_PREFIX&&e.startsWith(p.NEXT_QUERY_PARAM_PREFIX)&&(r[e.substring(p.NEXT_QUERY_PARAM_PREFIX.length)]=n,delete r[e])}let l=Object.keys(a||{}),c=e=>{if(n){let a=Array.isArray(e),o=a?e[0]:e;if("string"==typeof o&&n.locales.some(e=>e.toLowerCase()===o.toLowerCase()&&(i=e,t.locale=i,!0)))return a&&e.splice(0,1),!a||0===e.length}return!1};return l.every(e=>r[e])?l.reduce((n,t)=>{let i=null==a?void 0:a[t];return i&&!c(r[t])&&(n[e[i].pos]=r[t]),n},{}):Object.keys(r).reduce((e,n)=>{if(!c(r[n])){let t=n;return s&&(t=parseInt(n,10)-1+""),Object.assign(e,{[t]:r[n]})}return e},{})}},groups:e}}())(e.headers["x-now-route-matches"])},normalizeDynamicRouteParams:(e,n)=>m(e,n,y,v),normalizeVercelUrl:(e,n,t)=>u(e,n,t,d,y),interpolateDynamicPath:(e,n)=>h(e,n,y)}}},4954:(e,n)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),Object.defineProperty(n,"escapeStringRegexp",{enumerable:!0,get:function(){return a}});let t=/[|\\{}()[\]^$+*?.-]/,i=/[|\\{}()[\]^$+*?.-]/g;function a(e){return t.test(e)?e.replace(i,"\\$&"):e}},4217:(e,n)=>{"use strict";function t(e){let n=5381;for(let t=0;t<e.length;t++)n=(n<<5)+n+e.charCodeAt(t)&0xffffffff;return n>>>0}function i(e){return t(e).toString(36).slice(0,5)}Object.defineProperty(n,"__esModule",{value:!0}),function(e,n){for(var t in n)Object.defineProperty(e,t,{enumerable:!0,get:n[t]})}(n,{djb2Hash:function(){return t},hexHash:function(){return i}})},8130:(e,n)=>{"use strict";function t(e){return e.startsWith("/")?e:"/"+e}Object.defineProperty(n,"__esModule",{value:!0}),Object.defineProperty(n,"ensureLeadingSlash",{enumerable:!0,get:function(){return t}})},5095:(e,n)=>{"use strict";function t(e){return e.replace(/\\/g,"/")}Object.defineProperty(n,"__esModule",{value:!0}),Object.defineProperty(n,"normalizePathSep",{enumerable:!0,get:function(){return t}})},387:(e,n,t)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),function(e,n){for(var t in n)Object.defineProperty(e,t,{enumerable:!0,get:n[t]})}(n,{normalizeAppPath:function(){return o},normalizeRscURL:function(){return r}});let i=t(8130),a=t(2080);function o(e){return(0,i.ensureLeadingSlash)(e.split("/").reduce((e,n,t,i)=>!n||(0,a.isGroupSegment)(n)||"@"===n[0]||("page"===n||"route"===n)&&t===i.length-1?e:e+"/"+n,""))}function r(e){return e.replace(/\.rsc($|\?)/,"$1")}},5995:(e,n,t)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),Object.defineProperty(n,"parseRelativeUrl",{enumerable:!0,get:function(){return a}}),t(4484);let i=t(2172);function a(e,n,t){void 0===t&&(t=!0);let a=new URL("http://n"),o=n?new URL(n,a):e.startsWith(".")?new URL("http://n"):a,{pathname:r,searchParams:s,search:l,hash:c,href:d,origin:p}=new URL(e,o);if(p!==a.origin)throw Error("invariant: invalid relative URL, router received "+e);return{pathname:r,query:t?(0,i.searchParamsToUrlQuery)(s):void 0,search:l,hash:c,href:d.slice(p.length)}}},3382:(e,n,t)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),Object.defineProperty(n,"parseUrl",{enumerable:!0,get:function(){return o}});let i=t(2172),a=t(5995);function o(e){if(e.startsWith("/"))return(0,a.parseRelativeUrl)(e);let n=new URL(e);return{hash:n.hash,hostname:n.hostname,href:n.href,pathname:n.pathname,port:n.port,protocol:n.protocol,query:(0,i.searchParamsToUrlQuery)(n.searchParams),search:n.search}}},1794:(e,n,t)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),Object.defineProperty(n,"getPathMatch",{enumerable:!0,get:function(){return a}});let i=t(103);function a(e,n){let t=[],a=(0,i.pathToRegexp)(e,t,{delimiter:"/",sensitive:"boolean"==typeof(null==n?void 0:n.sensitive)&&n.sensitive,strict:null==n?void 0:n.strict}),o=(0,i.regexpToFunction)((null==n?void 0:n.regexModifier)?new RegExp(n.regexModifier(a.source),a.flags):a,t);return(e,i)=>{if("string"!=typeof e)return!1;let a=o(e);if(!a)return!1;if(null==n?void 0:n.removeUnnamedParams)for(let e of t)"number"==typeof e.name&&delete a.params[e.name];return{...i,...a.params}}}},2527:(e,n,t)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),function(e,n){for(var t in n)Object.defineProperty(e,t,{enumerable:!0,get:n[t]})}(n,{compileNonPath:function(){return p},matchHas:function(){return d},prepareDestination:function(){return u}});let i=t(103),a=t(4954),o=t(3382),r=t(1874),s=t(6714),l=t(4119);function c(e){return e.replace(/__ESC_COLON_/gi,":")}function d(e,n,t,i){void 0===t&&(t=[]),void 0===i&&(i=[]);let a={},o=t=>{let i;let o=t.key;switch(t.type){case"header":o=o.toLowerCase(),i=e.headers[o];break;case"cookie":i="cookies"in e?e.cookies[t.key]:(0,l.getCookieParser)(e.headers)()[t.key];break;case"query":i=n[o];break;case"host":{let{host:n}=(null==e?void 0:e.headers)||{};i=null==n?void 0:n.split(":",1)[0].toLowerCase()}}if(!t.value&&i)return a[function(e){let n="";for(let t=0;t<e.length;t++){let i=e.charCodeAt(t);(i>64&&i<91||i>96&&i<123)&&(n+=e[t])}return n}(o)]=i,!0;if(i){let e=RegExp("^"+t.value+"$"),n=Array.isArray(i)?i.slice(-1)[0].match(e):i.match(e);if(n)return Array.isArray(n)&&(n.groups?Object.keys(n.groups).forEach(e=>{a[e]=n.groups[e]}):"host"===t.type&&n[0]&&(a.host=n[0])),!0}return!1};return!!t.every(e=>o(e))&&!i.some(e=>o(e))&&a}function p(e,n){if(!e.includes(":"))return e;for(let t of Object.keys(n))e.includes(":"+t)&&(e=e.replace(RegExp(":"+t+"\\*","g"),":"+t+"--ESCAPED_PARAM_ASTERISKS").replace(RegExp(":"+t+"\\?","g"),":"+t+"--ESCAPED_PARAM_QUESTION").replace(RegExp(":"+t+"\\+","g"),":"+t+"--ESCAPED_PARAM_PLUS").replace(RegExp(":"+t+"(?!\\w)","g"),"--ESCAPED_PARAM_COLON"+t));return e=e.replace(/(:|\*|\?|\+|\(|\)|\{|\})/g,"\\$1").replace(/--ESCAPED_PARAM_PLUS/g,"+").replace(/--ESCAPED_PARAM_COLON/g,":").replace(/--ESCAPED_PARAM_QUESTION/g,"?").replace(/--ESCAPED_PARAM_ASTERISKS/g,"*"),(0,i.compile)("/"+e,{validate:!1})(n).slice(1)}function u(e){let n;let t=Object.assign({},e.query);delete t.__nextLocale,delete t.__nextDefaultLocale,delete t.__nextDataReq,delete t.__nextInferredLocaleFromDefault,delete t[s.NEXT_RSC_UNION_QUERY];let l=e.destination;for(let n of Object.keys({...e.params,...t}))l=n?l.replace(RegExp(":"+(0,a.escapeStringRegexp)(n),"g"),"__ESC_COLON_"+n):l;let d=(0,o.parseUrl)(l),u=d.query,h=c(""+d.pathname+(d.hash||"")),m=c(d.hostname||""),f=[],g=[];(0,i.pathToRegexp)(h,f),(0,i.pathToRegexp)(m,g);let y=[];f.forEach(e=>y.push(e.name)),g.forEach(e=>y.push(e.name));let b=(0,i.compile)(h,{validate:!1}),v=(0,i.compile)(m,{validate:!1});for(let[n,t]of Object.entries(u))Array.isArray(t)?u[n]=t.map(n=>p(c(n),e.params)):"string"==typeof t&&(u[n]=p(c(t),e.params));let A=Object.keys(e.params).filter(e=>"nextInternalLocale"!==e);if(e.appendParamsToQuery&&!A.some(e=>y.includes(e)))for(let n of A)n in u||(u[n]=e.params[n]);if((0,r.isInterceptionRouteAppPath)(h))for(let n of h.split("/")){let t=r.INTERCEPTION_ROUTE_MARKERS.find(e=>n.startsWith(e));if(t){"(..)(..)"===t?(e.params["0"]="(..)",e.params["1"]="(..)"):e.params["0"]=t;break}}try{let[t,i]=(n=b(e.params)).split("#",2);d.hostname=v(e.params),d.pathname=t,d.hash=(i?"#":"")+(i||""),delete d.search}catch(e){if(e.message.match(/Expected .*? to not repeat, but got an array/))throw Error("To use a multi-match in the destination you must add `*` at the end of the param name to signify it should repeat. https://nextjs.org/docs/messages/invalid-multi-match");throw e}return d.query={...t,...d.query},{newUrl:n,destQuery:u,parsedDestination:d}}},2172:(e,n)=>{"use strict";function t(e){let n={};return e.forEach((e,t)=>{void 0===n[t]?n[t]=e:Array.isArray(n[t])?n[t].push(e):n[t]=[n[t],e]}),n}function i(e){return"string"!=typeof e&&("number"!=typeof e||isNaN(e))&&"boolean"!=typeof e?"":String(e)}function a(e){let n=new URLSearchParams;return Object.entries(e).forEach(e=>{let[t,a]=e;Array.isArray(a)?a.forEach(e=>n.append(t,i(e))):n.set(t,i(a))}),n}function o(e){for(var n=arguments.length,t=Array(n>1?n-1:0),i=1;i<n;i++)t[i-1]=arguments[i];return t.forEach(n=>{Array.from(n.keys()).forEach(n=>e.delete(n)),n.forEach((n,t)=>e.append(t,n))}),e}Object.defineProperty(n,"__esModule",{value:!0}),function(e,n){for(var t in n)Object.defineProperty(e,t,{enumerable:!0,get:n[t]})}(n,{assign:function(){return o},searchParamsToUrlQuery:function(){return t},urlQueryToSearchParams:function(){return a}})},1819:(e,n,t)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),Object.defineProperty(n,"getRouteMatcher",{enumerable:!0,get:function(){return a}});let i=t(4484);function a(e){let{re:n,groups:t}=e;return e=>{let a=n.exec(e);if(!a)return!1;let o=e=>{try{return decodeURIComponent(e)}catch(e){throw new i.DecodeError("failed to decode param")}},r={};return Object.keys(t).forEach(e=>{let n=t[e],i=a[n.pos];void 0!==i&&(r[e]=~i.indexOf("/")?i.split("/").map(e=>o(e)):n.repeat?[o(i)]:o(i))}),r}}},9026:(e,n,t)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),function(e,n){for(var t in n)Object.defineProperty(e,t,{enumerable:!0,get:n[t]})}(n,{getNamedMiddlewareRegex:function(){return f},getNamedRouteRegex:function(){return m},getRouteRegex:function(){return p},parseParameter:function(){return l}});let i=t(9430),a=t(1874),o=t(4954),r=t(1226),s=/\[((?:\[.*\])|.+)\]/;function l(e){let n=e.match(s);return n?c(n[1]):c(e)}function c(e){let n=e.startsWith("[")&&e.endsWith("]");n&&(e=e.slice(1,-1));let t=e.startsWith("...");return t&&(e=e.slice(3)),{key:e,repeat:t,optional:n}}function d(e){let n=(0,r.removeTrailingSlash)(e).slice(1).split("/"),t={},i=1;return{parameterizedRoute:n.map(e=>{let n=a.INTERCEPTION_ROUTE_MARKERS.find(n=>e.startsWith(n)),r=e.match(s);if(n&&r){let{key:e,optional:a,repeat:s}=c(r[1]);return t[e]={pos:i++,repeat:s,optional:a},"/"+(0,o.escapeStringRegexp)(n)+"([^/]+?)"}if(!r)return"/"+(0,o.escapeStringRegexp)(e);{let{key:e,repeat:n,optional:a}=c(r[1]);return t[e]={pos:i++,repeat:n,optional:a},n?a?"(?:/(.+?))?":"/(.+?)":"/([^/]+?)"}}).join(""),groups:t}}function p(e){let{parameterizedRoute:n,groups:t}=d(e);return{re:RegExp("^"+n+"(?:/)?$"),groups:t}}function u(e){let{interceptionMarker:n,getSafeRouteKey:t,segment:i,routeKeys:a,keyPrefix:r}=e,{key:s,optional:l,repeat:d}=c(i),p=s.replace(/\W/g,"");r&&(p=""+r+p);let u=!1;(0===p.length||p.length>30)&&(u=!0),isNaN(parseInt(p.slice(0,1)))||(u=!0),u&&(p=t()),r?a[p]=""+r+s:a[p]=s;let h=n?(0,o.escapeStringRegexp)(n):"";return d?l?"(?:/"+h+"(?<"+p+">.+?))?":"/"+h+"(?<"+p+">.+?)":"/"+h+"(?<"+p+">[^/]+?)"}function h(e,n){let t;let s=(0,r.removeTrailingSlash)(e).slice(1).split("/"),l=(t=0,()=>{let e="",n=++t;for(;n>0;)e+=String.fromCharCode(97+(n-1)%26),n=Math.floor((n-1)/26);return e}),c={};return{namedParameterizedRoute:s.map(e=>{let t=a.INTERCEPTION_ROUTE_MARKERS.some(n=>e.startsWith(n)),r=e.match(/\[((?:\[.*\])|.+)\]/);if(t&&r){let[t]=e.split(r[0]);return u({getSafeRouteKey:l,interceptionMarker:t,segment:r[1],routeKeys:c,keyPrefix:n?i.NEXT_INTERCEPTION_MARKER_PREFIX:void 0})}return r?u({getSafeRouteKey:l,segment:r[1],routeKeys:c,keyPrefix:n?i.NEXT_QUERY_PARAM_PREFIX:void 0}):"/"+(0,o.escapeStringRegexp)(e)}).join(""),routeKeys:c}}function m(e,n){let t=h(e,n);return{...p(e),namedRegex:"^"+t.namedParameterizedRoute+"(?:/)?$",routeKeys:t.routeKeys}}function f(e,n){let{parameterizedRoute:t}=d(e),{catchAll:i=!0}=n;if("/"===t)return{namedRegex:"^/"+(i?".*":"")+"$"};let{namedParameterizedRoute:a}=h(e,!1);return{namedRegex:"^"+a+(i?"(?:(/.*)?)":"")+"$"}}},4484:(e,n)=>{"use strict";Object.defineProperty(n,"__esModule",{value:!0}),function(e,n){for(var t in n)Object.defineProperty(e,t,{enumerable:!0,get:n[t]})}(n,{DecodeError:function(){return m},MiddlewareNotFoundError:function(){return b},MissingStaticPage:function(){return y},NormalizeError:function(){return f},PageNotFoundError:function(){return g},SP:function(){return u},ST:function(){return h},WEB_VITALS:function(){return t},execOnce:function(){return i},getDisplayName:function(){return l},getLocationOrigin:function(){return r},getURL:function(){return s},isAbsoluteUrl:function(){return o},isResSent:function(){return c},loadGetInitialProps:function(){return p},normalizeRepeatedSlashes:function(){return d},stringifyError:function(){return v}});let t=["CLS","FCP","FID","INP","LCP","TTFB"];function i(e){let n,t=!1;return function(){for(var i=arguments.length,a=Array(i),o=0;o<i;o++)a[o]=arguments[o];return t||(t=!0,n=e(...a)),n}}let a=/^[a-zA-Z][a-zA-Z\d+\-.]*?:/,o=e=>a.test(e);function r(){let{protocol:e,hostname:n,port:t}=window.location;return e+"//"+n+(t?":"+t:"")}function s(){let{href:e}=window.location,n=r();return e.substring(n.length)}function l(e){return"string"==typeof e?e:e.displayName||e.name||"Unknown"}function c(e){return e.finished||e.headersSent}function d(e){let n=e.split("?");return n[0].replace(/\\/g,"/").replace(/\/\/+/g,"/")+(n[1]?"?"+n.slice(1).join("?"):"")}async function p(e,n){let t=n.res||n.ctx&&n.ctx.res;if(!e.getInitialProps)return n.ctx&&n.Component?{pageProps:await p(n.Component,n.ctx)}:{};let i=await e.getInitialProps(n);if(t&&c(t))return i;if(!i)throw Error('"'+l(e)+'.getInitialProps()" should resolve to an object. But found "'+i+'" instead.');return i}let u="undefined"!=typeof performance,h=u&&["mark","measure","getEntriesByName"].every(e=>"function"==typeof performance[e]);class m extends Error{}class f extends Error{}class g extends Error{constructor(e){super(),this.code="ENOENT",this.name="PageNotFoundError",this.message="Cannot find module for page: "+e}}class y extends Error{constructor(e,n){super(),this.message="Failed to load static file for page: "+e+" "+n}}class b extends Error{constructor(){super(),this.code="ENOENT",this.message="Cannot find the middleware module"}}function v(e){return JSON.stringify({message:e.message,stack:e.stack})}},6026:(e,n,t)=>{"use strict";t.r(n),t.d(n,{default:()=>c,metadata:()=>l});var i=t(9786),a=t(8080),o=t.n(a),r=t(2798),s=t.n(r);t(6325);let l={title:"Create Next App",description:"Generated by create next app"};function c({children:e}){return(0,i.jsx)("html",{lang:"en",className:"dark",children:(0,i.jsx)("body",{className:`${o().variable} ${s().variable} antialiased`,children:e})})}},3105:(e,n,t)=>{"use strict";t.r(n),t.d(n,{default:()=>i});let i=(0,t(42).registerClientReference)(function(){throw Error("Attempted to call the default export of \"/home/ubuntu/ocmca_protocol_app/src/app/page.tsx\" from the server, but it's on the client. It's not possible to invoke a client function from the server, it can only be rendered as a Component or passed to props of a Client Component.")},"/home/ubuntu/ocmca_protocol_app/src/app/page.tsx","default")},8798:(e,n,t)=>{"use strict";t.r(n),t.d(n,{default:()=>a});var i=t(4131);let a=async e=>[{type:"image/x-icon",sizes:"16x16",url:(0,i.fillMetadataSegment)(".",await e.params,"favicon.ico")+""}]},6325:()=>{}};var n=require("../webpack-runtime.js");n.C(e);var t=e=>n(n.s=e),i=n.X(0,[0,309],()=>t(368));module.exports=i})();